Citrus Sinensis ID: 036144
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 336 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.895 | 0.660 | 0.710 | 1e-127 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.872 | 0.707 | 0.703 | 1e-122 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.883 | 0.702 | 0.670 | 1e-119 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.895 | 0.706 | 0.558 | 6e-92 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.889 | 0.606 | 0.535 | 5e-90 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.854 | 0.7 | 0.567 | 3e-89 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.892 | 0.612 | 0.537 | 3e-89 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.898 | 0.708 | 0.550 | 5e-89 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.979 | 0.806 | 0.480 | 5e-86 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.916 | 0.747 | 0.512 | 7e-86 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 453 bits (1165), Expect = e-127, Method: Compositional matrix adjust.
Identities = 214/301 (71%), Positives = 248/301 (82%)
Query: 35 GKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG 94
G + + F ++ELA AT NF+PD +GEGG+GRVYKG +++ QVVAVKQLDR+G QG
Sbjct: 65 GLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQG 124
Query: 95 SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDW 154
+REF EVLMLSL+ H NLVNLIGYCADGDQR+LVYEFM GSLE+H DLPPD+E LDW
Sbjct: 125 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDW 184
Query: 155 FTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214
RMKIA GAAKGLE+LHD A+PPVIYRDFK+SNILLD F+PKLSDFGLAKLGPTG K
Sbjct: 185 NMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKS 244
Query: 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW 274
HVSTRVMGTYGYCAPEYAMTGQLT KSDVYSFGVV LELITGR AID+ P EQNLV W
Sbjct: 245 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAW 304
Query: 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
A+PL D++KF +ADP L+G++P + LYQALAVA MC+QE A +RP + DVVTAL YL+
Sbjct: 305 ARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLA 364
Query: 335 S 335
+
Sbjct: 365 N 365
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1127), Expect = e-122, Method: Compositional matrix adjust.
Identities = 206/293 (70%), Positives = 241/293 (82%)
Query: 43 VFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV 102
F ++ELA AT+NF +CL+GEGG+GRVYKG +E +VAVKQLDR+G QG++EF EV
Sbjct: 66 TFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEV 125
Query: 103 LMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG 162
LMLSL+ H++LVNLIGYCADGDQR+LVYE+MS GSLE+H LDL PDQ PLDW TR++IA
Sbjct: 126 LMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIAL 185
Query: 163 GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMG 222
GAA GLEYLHD A+PPVIYRD KA+NILLD EFN KLSDFGLAKLGP G K HVS+RVMG
Sbjct: 186 GAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMG 245
Query: 223 TYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282
TYGYCAPEY TGQLT KSDVYSFGVVLLELITGR ID +RP +EQNLVTWA+P+ ++
Sbjct: 246 TYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEP 305
Query: 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
+F +ADP LEG +P K L QA+AVA MCLQE+A RP M DVVTAL +L +
Sbjct: 306 SRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 427 bits (1099), Expect = e-119, Method: Compositional matrix adjust.
Identities = 199/297 (67%), Positives = 238/297 (80%)
Query: 39 KTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF 98
K F +QELA+AT NF DC +GEGG+G+V+KG IE +DQVVA+KQLDR+G QG REF
Sbjct: 86 KKAQTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREF 145
Query: 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
EVL LSL H NLV LIG+CA+GDQR+LVYE+M GSLE+H LP ++PLDW TRM
Sbjct: 146 VVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKPLDWNTRM 205
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
KIA GAA+GLEYLHD PPVIYRD K SNILL ++ PKLSDFGLAK+GP+G K HVST
Sbjct: 206 KIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVST 265
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278
RVMGTYGYCAP+YAMTGQLT KSD+YSFGVVLLELITGR AIDN++ ++QNLV WA+PL
Sbjct: 266 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPL 325
Query: 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
+D++ F M DPLL+GQYP +GLYQALA++ MC+QE RP + DVV AL +L+S
Sbjct: 326 FKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLAS 382
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (865), Expect = 6e-92, Method: Compositional matrix adjust.
Identities = 176/315 (55%), Positives = 214/315 (67%), Gaps = 14/315 (4%)
Query: 32 RKFGKAKKTPNV--FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQ--------- 80
R G+ +PN+ F + EL +AT NF PD L+GEGG+G V+KG+I+
Sbjct: 57 RTEGEILSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGI 116
Query: 81 VVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLEN 140
VVAVK+L G QG +E+ EV L + H NLV L+GYC +G+ R+LVYEFM GSLEN
Sbjct: 117 VVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLEN 176
Query: 141 HFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS 200
H +PL W RMK+A GAAKGL +LHD A VIYRDFKA+NILLDAEFN KLS
Sbjct: 177 HLFRR--GAQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLS 233
Query: 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAI 260
DFGLAK GPTG K HVST+VMGT+GY APEY TG+LT KSDVYSFGVVLLEL++GR A+
Sbjct: 234 DFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAV 293
Query: 261 DNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSR 320
D S+ EQ+LV WA P L DK+K + D L GQYP+KG Y A ++A CL DA R
Sbjct: 294 DKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLR 353
Query: 321 PFMVDVVTALEYLSS 335
P M +V+ L+ L S
Sbjct: 354 PKMSEVLAKLDQLES 368
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (848), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 172/321 (53%), Positives = 211/321 (65%), Gaps = 22/321 (6%)
Query: 22 SKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIE----- 76
S++ I++ +RKF + +L +T NF P+ L+GEGG+G V+KG+IE
Sbjct: 118 SEELNISSHLRKF----------TFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTA 167
Query: 77 ----AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132
VAVK L+ G QG +E+ AE+ L + H NLV L+GYC + DQR+LVYEF
Sbjct: 168 PVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEF 227
Query: 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD 192
M GSLENH PL W RMKIA GAAKGL +LH+ A PVIYRDFK SNILLD
Sbjct: 228 MPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLD 284
Query: 193 AEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLE 252
A++N KLSDFGLAK P GK HVSTRVMGTYGY APEY MTG LT KSDVYSFGVVLLE
Sbjct: 285 ADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 344
Query: 253 LITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMC 312
++TGR ++D +RP+ E NLV WA+P L DK++F + DP LEG + KG + +A C
Sbjct: 345 MLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQC 404
Query: 313 LQEDADSRPFMVDVVTALEYL 333
L D RP M DVV AL+ L
Sbjct: 405 LSRDPKIRPKMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (842), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 168/296 (56%), Positives = 206/296 (69%), Gaps = 9/296 (3%)
Query: 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQV------VAVKQLDRSGNQGSRE 97
F EL T++F PD ++GEGG+G VYKGYI+ +V VAVK L++ G QG RE
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 98 FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTR 157
+ EV L ++H NLV LIGYC + D R+LVYEFM GSLENH PL W R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFR--KTTAPLSWSRR 174
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
M IA GAAKGL +LH+ A+ PVIYRDFK SNILLD+++ KLSDFGLAK GP G + HVS
Sbjct: 175 MMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 218 TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277
TRVMGTYGY APEY MTG LT +SDVYSFGVVLLE++TGR ++D +RPS+EQNLV WA+P
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
L DK+K + DP LE QY + +A ++A CL ++ +RP M DVV LE L
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (841), Expect = 3e-89, Method: Compositional matrix adjust.
Identities = 170/316 (53%), Positives = 208/316 (65%), Gaps = 16/316 (5%)
Query: 27 IAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIE---------A 77
I+ E+ + KK F + +L AT NF P+ L+GEGG+G V+KG++E
Sbjct: 111 ISEELNIYSHLKK----FSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 166
Query: 78 VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGS 137
VAVK L+ G QG +E+ AE+ L + H NLV L+GYC + DQR+LVYEFM GS
Sbjct: 167 TGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 226
Query: 138 LENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197
LENH PL W RMKIA GAAKGL +LH+ A PVIYRDFK SNILLD E+N
Sbjct: 227 LENHLFR---RSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNA 283
Query: 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
KLSDFGLAK P GK HVSTRVMGTYGY APEY MTG LT KSDVYSFGVVLLE++TGR
Sbjct: 284 KLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 343
Query: 258 SAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDA 317
++D +RP+ E NLV WA+P L DK++F + DP LEG + KG + +A CL D+
Sbjct: 344 RSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDS 403
Query: 318 DSRPFMVDVVTALEYL 333
RP M +VV L+ L
Sbjct: 404 KIRPKMSEVVEVLKPL 419
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 5e-89, Method: Compositional matrix adjust.
Identities = 174/316 (55%), Positives = 213/316 (67%), Gaps = 14/316 (4%)
Query: 31 IRKFGKAKKTPNV--FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQ-------- 80
+R G+ +PN+ F + EL +AT+NF D L+GEGG+G V+KG+I+
Sbjct: 59 LRTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSG 118
Query: 81 -VVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLE 139
VVAVKQL G QG +E+ EV L + H NLV L+GYCA+G+ R+LVYEFM GSLE
Sbjct: 119 IVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLE 178
Query: 140 NHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199
NH +PL W RMK+A GAAKGL +LH+ A VIYRDFKA+NILLDA+FN KL
Sbjct: 179 NHLFRR--GAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKL 235
Query: 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSA 259
SDFGLAK GPTG HVST+V+GT+GY APEY TG+LT KSDVYSFGVVLLELI+GR A
Sbjct: 236 SDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRA 295
Query: 260 IDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADS 319
+DNS E +LV WA P L DK+K + D L GQYP+KG + A +A CL DA
Sbjct: 296 MDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKL 355
Query: 320 RPFMVDVVTALEYLSS 335
RP M +V+ LE L S
Sbjct: 356 RPKMSEVLVTLEQLES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 318 bits (814), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 175/364 (48%), Positives = 227/364 (62%), Gaps = 35/364 (9%)
Query: 2 NCFHCCK---ADHSLSFKDKRRSSKQRRIAAEIRKFGKAKKTPN---------------- 42
NC+ C+ +H +S K S K++ E + + +K P+
Sbjct: 3 NCW--CRFEPLNHRVSANAKSESPKEQSPTVEDKHIKEVQKLPSNPKEVEDLRRDSAANP 60
Query: 43 --VFKYQELADATENFNPDCLVGEGGYGRVYKGYI--EAVDQ------VVAVKQLDRSGN 92
F Y+EL + T NF D ++G GG+G VYKG+I + DQ VAVK D +
Sbjct: 61 LIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNS 120
Query: 93 -QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEP 151
QG RE+ AEV+ L + H NLV LIGYC + + R+L+YE+M+ GS+EN+ P
Sbjct: 121 FQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRV--LLP 178
Query: 152 LDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211
L W RMKIA GAAKGL +LH+ A PVIYRDFK SNILLD ++N KLSDFGLAK GP G
Sbjct: 179 LSWAIRMKIAFGAAKGLAFLHE-AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVG 237
Query: 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNL 271
K HVSTR+MGTYGY APEY MTG LT SDVYSFGVVLLEL+TGR ++D SRP+ EQNL
Sbjct: 238 DKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNL 297
Query: 272 VTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
+ WA PLL++KKK + DP + +YP K + +A +A CL + +RP M D+V +LE
Sbjct: 298 IDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLE 357
Query: 332 YLSS 335
L +
Sbjct: 358 PLQA 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 317 bits (813), Expect = 7e-86, Method: Compositional matrix adjust.
Identities = 164/320 (51%), Positives = 213/320 (66%), Gaps = 12/320 (3%)
Query: 27 IAAEIRKFGKAKKTPNV--FKYQELADATENFNPDCLVGEGGYGRVYKGYIE-------- 76
I R G+ ++PN+ F + EL AT NF PD ++GEGG+G V+KG+I+
Sbjct: 38 IRTNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASK 97
Query: 77 -AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135
V+AVK+L++ G QG +E+ AEV L H NLV LIGYC + + R+LVYEFM
Sbjct: 98 PGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPR 157
Query: 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF 195
GSLENH +PL W R+K+A GAAKGL +LH+ A+ VIYRDFK SNILLD+E+
Sbjct: 158 GSLENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEY 216
Query: 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
N KLSDFGLAK GPTG K HVSTR+MGTYGY APEY TG LT KSDVYS+GVVLLE+++
Sbjct: 217 NAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLS 276
Query: 256 GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQE 315
GR A+D +RP EQ LV WA+PLL +K+K + D L+ QY + + +A CL
Sbjct: 277 GRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTF 336
Query: 316 DADSRPFMVDVVTALEYLSS 335
+ RP M +VV+ LE++ +
Sbjct: 337 EIKLRPNMNEVVSHLEHIQT 356
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 336 | ||||||
| 302142869 | 911 | unnamed protein product [Vitis vinifera] | 0.994 | 0.366 | 0.676 | 1e-140 | |
| 224126397 | 357 | predicted protein [Populus trichocarpa] | 0.994 | 0.935 | 0.668 | 1e-140 | |
| 147822535 | 427 | hypothetical protein VITISV_021095 [Viti | 0.994 | 0.782 | 0.676 | 1e-139 | |
| 449470433 | 406 | PREDICTED: serine/threonine-protein kina | 0.997 | 0.825 | 0.661 | 1e-139 | |
| 449513479 | 406 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.997 | 0.825 | 0.658 | 1e-139 | |
| 11994140 | 377 | receptor protein kinase-like protein [Ar | 0.979 | 0.872 | 0.706 | 1e-139 | |
| 359493591 | 421 | PREDICTED: serine/threonine-protein kina | 0.955 | 0.762 | 0.730 | 1e-138 | |
| 297830742 | 383 | kinase family protein [Arabidopsis lyrat | 0.979 | 0.859 | 0.703 | 1e-138 | |
| 15232294 | 386 | protein kinase family protein [Arabidops | 0.979 | 0.852 | 0.706 | 1e-138 | |
| 255563977 | 385 | receptor serine-threonine protein kinase | 0.955 | 0.833 | 0.716 | 1e-138 |
| >gi|302142869|emb|CBI20164.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 503 bits (1295), Expect = e-140, Method: Compositional matrix adjust.
Identities = 241/356 (67%), Positives = 279/356 (78%), Gaps = 22/356 (6%)
Query: 1 MNCFHCCKADHSLSFKDKRRS----------------------SKQRRIAAEIRKFGKAK 38
M CF CC +D ++ K ++S SK+R IA EI K GK
Sbjct: 484 MGCFACCMSDPNVGSKSLKKSIKEYGDAKRLASFVNISFKSDGSKRRYIAEEIAKMGKGS 543
Query: 39 KTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF 98
+VF EL+ AT NFN + L+GEGG+GRVYKG++E + VAVK+LDR+G QG+REF
Sbjct: 544 IPAHVFTIGELSAATNNFNHEALIGEGGFGRVYKGHVEKTNNSVAVKRLDRNGFQGNREF 603
Query: 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
EV MLSL+ H NLVN++GYC DGDQRILVYE+M+NGSLE+H LDL P+++PLDW TRM
Sbjct: 604 LVEVFMLSLLHHTNLVNMVGYCCDGDQRILVYEYMANGSLEDHLLDLAPNKKPLDWKTRM 663
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
KIA GAA+GLEYLHD A+PPVIYRDFKASNILLD +FNPKLSDFGLAKLGPTG K HVST
Sbjct: 664 KIAEGAARGLEYLHDTANPPVIYRDFKASNILLDEDFNPKLSDFGLAKLGPTGDKTHVST 723
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278
RVMGTYGYCAPEYA+TGQLT SDVYSFGVVLLE+ITGR IDNSRP+EEQNLVTWA+PL
Sbjct: 724 RVMGTYGYCAPEYALTGQLTTMSDVYSFGVVLLEIITGRRVIDNSRPTEEQNLVTWAQPL 783
Query: 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
L+D++KFT+MADPLLEG YP KGLYQALAVA MCLQE+A RP M DVV ALEYLS
Sbjct: 784 LKDRRKFTLMADPLLEGNYPIKGLYQALAVAAMCLQEEATIRPLMSDVVMALEYLS 839
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126397|ref|XP_002319828.1| predicted protein [Populus trichocarpa] gi|222858204|gb|EEE95751.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 502 bits (1293), Expect = e-140, Method: Compositional matrix adjust.
Identities = 238/356 (66%), Positives = 281/356 (78%), Gaps = 22/356 (6%)
Query: 1 MNCFHCCKADHSLSFKDKRRS----------------------SKQRRIAAEIRKFGKAK 38
M CF CC + L K ++S S++R IA EIR+ GK
Sbjct: 1 MGCFKCCISKERLCKKSLKKSIKEYHDARTLASFANISFKTDSSRKRYIAEEIRQIGKGN 60
Query: 39 KTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF 98
+ ++F +++L AT+NFN + L+GEGG+GRVYKG I+ QVVAVKQLDR+G QG+REF
Sbjct: 61 ISADIFTFRDLTTATKNFNHENLIGEGGFGRVYKGIIQKTKQVVAVKQLDRNGFQGNREF 120
Query: 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
EVLMLSL+ H NLV+L+GYCADGDQRILVYE+M NGSLE+H L+L PD++PLDW TRM
Sbjct: 121 LVEVLMLSLLHHPNLVSLVGYCADGDQRILVYEYMINGSLEDHLLELAPDKKPLDWNTRM 180
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
KIA GAA+GLEYLH+ A+PPVIYRDFKASN+LLD FNPKLSDFGLAKLGPTG K HVST
Sbjct: 181 KIAEGAARGLEYLHESANPPVIYRDFKASNVLLDENFNPKLSDFGLAKLGPTGDKTHVST 240
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278
RVMGTYGYCAPEYA+TGQLT KSDVYSFGVV LELITGR IDNSRP+EEQNLV+WA PL
Sbjct: 241 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLELITGRRVIDNSRPTEEQNLVSWATPL 300
Query: 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
+D++KFT+MADPLL+G YP KGLYQALAVA MCLQE+A +RP M DVVTALE+L+
Sbjct: 301 FKDRRKFTLMADPLLQGNYPLKGLYQALAVAAMCLQEEASTRPLMSDVVTALEFLA 356
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147822535|emb|CAN68395.1| hypothetical protein VITISV_021095 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 501 bits (1291), Expect = e-139, Method: Compositional matrix adjust.
Identities = 241/356 (67%), Positives = 278/356 (78%), Gaps = 22/356 (6%)
Query: 1 MNCFHCCKADHSLSFKDKRRS----------------------SKQRRIAAEIRKFGKAK 38
M CF CC +D ++ K ++S SK+R IA EI K GK
Sbjct: 1 MGCFACCMSDPNVGNKSLKKSIKEYGDAKRLASFVNISFKSDGSKRRYIAEEIAKMGKGS 60
Query: 39 KTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF 98
+VF EL+ AT NFN + L+GEGG+GRVYKG+ E + VAVK+LDR+G QG+REF
Sbjct: 61 IPAHVFTIGELSAATNNFNHEALIGEGGFGRVYKGHXEKTNNSVAVKRLDRNGFQGNREF 120
Query: 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
EV MLSL+ H NLVN++GYC DGDQRILVYE+M+NGSLE+H LDL P+++PLDW TRM
Sbjct: 121 LVEVFMLSLLHHTNLVNMVGYCCDGDQRILVYEYMANGSLEDHLLDLAPNKKPLDWKTRM 180
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
KIA GAA+GLEYLHD A+PPVIYRDFKASNILLD +FNPKLSDFGLAKLGPTG K HVST
Sbjct: 181 KIAEGAARGLEYLHDTANPPVIYRDFKASNILLDEDFNPKLSDFGLAKLGPTGDKTHVST 240
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278
RVMGTYGYCAPEYA+TGQLT SDVYSFGVVLLE+ITGR IDNSRP+EEQNLVTWA+PL
Sbjct: 241 RVMGTYGYCAPEYALTGQLTTMSDVYSFGVVLLEIITGRRVIDNSRPTEEQNLVTWAQPL 300
Query: 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
L+D++KFT+MADPLLEG YP KGLYQALAVA MCLQE+A RP M DVV ALEYLS
Sbjct: 301 LKDRRKFTLMADPLLEGNYPIKGLYQALAVAAMCLQEEASIRPLMSDVVMALEYLS 356
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470433|ref|XP_004152921.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 501 bits (1291), Expect = e-139, Method: Compositional matrix adjust.
Identities = 236/357 (66%), Positives = 280/357 (78%), Gaps = 22/357 (6%)
Query: 1 MNCFHCCKADHSLSFKDKRRS----------------------SKQRRIAAEIRKFGKAK 38
MNCF CC ++ ++ K ++S S++R I EI+K GK
Sbjct: 1 MNCFQCCGSEEKVNKKSLKKSIKEFEETKTLTSFANISFKSDASRRRYITEEIKKLGKGN 60
Query: 39 KTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF 98
T +F + EL+ AT NFN + L+GEGG+GRVYKG IE+ QV AVKQLDR+G QG++EF
Sbjct: 61 ITAQIFTFDELSTATNNFNHENLLGEGGFGRVYKGIIESTKQVTAVKQLDRNGFQGNKEF 120
Query: 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
EVLMLSL+ H NLVNL+GYCADGDQRILVYE+M+ GSLE+H LD+ D+ PLDW TRM
Sbjct: 121 LVEVLMLSLLHHPNLVNLVGYCADGDQRILVYEYMAKGSLEDHLLDIASDKPPLDWKTRM 180
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
KIA GAAKGLEYLH+ A+PPVIYRDFKASNILLD EFNPKLSDFGLAKLGPTG K HVST
Sbjct: 181 KIAEGAAKGLEYLHETANPPVIYRDFKASNILLDEEFNPKLSDFGLAKLGPTGDKSHVST 240
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278
RVMGTYGYCAPEYA+TGQLT KSDVYSFGVV LE+ITGR IDN+RP+ EQNL+TWA+PL
Sbjct: 241 RVMGTYGYCAPEYALTGQLTTKSDVYSFGVVFLEIITGRRVIDNARPTAEQNLITWAQPL 300
Query: 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
+D++KFT+MADP LEG YP K LYQALAVA MCLQE+A++RP + DVVTALEYL++
Sbjct: 301 FKDRRKFTLMADPKLEGDYPVKALYQALAVAAMCLQEEANTRPLISDVVTALEYLAA 357
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449513479|ref|XP_004164336.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1286), Expect = e-139, Method: Compositional matrix adjust.
Identities = 235/357 (65%), Positives = 279/357 (78%), Gaps = 22/357 (6%)
Query: 1 MNCFHCCKADHSLSFKDKRRS----------------------SKQRRIAAEIRKFGKAK 38
MNCF CC ++ ++ K ++S S++R I E +K GK
Sbjct: 1 MNCFQCCGSEEKVNKKSLKKSIKEFEETKTLTSFANISFKSDASRRRYITEEXKKLGKGN 60
Query: 39 KTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF 98
T +F + EL+ AT NFN + L+GEGG+GRVYKG IE+ QV AVKQLDR+G QG++EF
Sbjct: 61 ITAQIFTFDELSTATNNFNHENLLGEGGFGRVYKGIIESTKQVTAVKQLDRNGFQGNKEF 120
Query: 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
EVLMLSL+ H NLVNL+GYCADGDQRILVYE+M+ GSLE+H LD+ D+ PLDW TRM
Sbjct: 121 LVEVLMLSLLHHPNLVNLVGYCADGDQRILVYEYMAKGSLEDHLLDIASDKPPLDWKTRM 180
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
KIA GAAKGLEYLH+ A+PPVIYRDFKASNILLD EFNPKLSDFGLAKLGPTG K HVST
Sbjct: 181 KIAEGAAKGLEYLHETANPPVIYRDFKASNILLDEEFNPKLSDFGLAKLGPTGDKSHVST 240
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278
RVMGTYGYCAPEYA+TGQLT KSDVYSFGVV LE+ITGR IDN+RP+ EQNL+TWA+PL
Sbjct: 241 RVMGTYGYCAPEYALTGQLTTKSDVYSFGVVFLEIITGRRVIDNARPTAEQNLITWAQPL 300
Query: 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
+D++KFT+MADP LEG YP K LYQALAVA MCLQE+A++RP + DVVTALEYL++
Sbjct: 301 FKDRRKFTLMADPKLEGDYPVKALYQALAVAAMCLQEEANTRPLISDVVTALEYLAA 357
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|11994140|dbj|BAB01161.1| receptor protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 499 bits (1286), Expect = e-139, Method: Compositional matrix adjust.
Identities = 236/334 (70%), Positives = 281/334 (84%), Gaps = 5/334 (1%)
Query: 6 CCKADHSLSFKD----KRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCL 61
C A ++++ D K SS++R I+ EI K GK + ++F ++EL AT+NFNPD
Sbjct: 19 CIDAKNNITTFDNISFKTDSSRRRYISEEIAKLGKGNISAHIFTFRELCVATKNFNPDNQ 78
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+GEGG+GRVYKG IE +QVVAVKQLDR+G QG+REF EV+MLSL+ HQNLVNL+GYCA
Sbjct: 79 LGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCA 138
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQE-PLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
DGDQRILVYE+M NGSLE+H L+L +++ PLDW TRMK+A GAA+GLEYLH+ ADPPVI
Sbjct: 139 DGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVI 198
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
YRDFKASNILLD EFNPKLSDFGLAK+GPTGG+ HVSTRVMGTYGYCAPEYA+TGQLT K
Sbjct: 199 YRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVK 258
Query: 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRK 300
SDVYSFGVV LE+ITGR ID ++P+EEQNLVTWA PL +D++KFT+MADPLLEG+YP K
Sbjct: 259 SDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIK 318
Query: 301 GLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
GLYQALAVA MCLQE+A +RP M DVVTALEYL+
Sbjct: 319 GLYQALAVAAMCLQEEAATRPMMSDVVTALEYLA 352
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493591|ref|XP_002283397.2| PREDICTED: serine/threonine-protein kinase PBS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1282), Expect = e-138, Method: Compositional matrix adjust.
Identities = 236/323 (73%), Positives = 271/323 (83%), Gaps = 2/323 (0%)
Query: 12 SLSFKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVY 71
++SFK SK+R IA EI K GK +VF EL+ AT NFN + L+GEGG+GRVY
Sbjct: 29 NISFKSD--GSKRRYIAEEIAKMGKGSIPAHVFTIGELSAATNNFNHEALIGEGGFGRVY 86
Query: 72 KGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131
KG++E + VAVK+LDR+G QG+REF EV MLSL+ H NLVN++GYC DGDQRILVYE
Sbjct: 87 KGHVEKTNNSVAVKRLDRNGFQGNREFLVEVFMLSLLHHTNLVNMVGYCCDGDQRILVYE 146
Query: 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191
+M+NGSLE+H LDL P+++PLDW TRMKIA GAA+GLEYLHD A+PPVIYRDFKASNILL
Sbjct: 147 YMANGSLEDHLLDLAPNKKPLDWKTRMKIAEGAARGLEYLHDTANPPVIYRDFKASNILL 206
Query: 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLL 251
D +FNPKLSDFGLAKLGPTG K HVSTRVMGTYGYCAPEYA+TGQLT SDVYSFGVVLL
Sbjct: 207 DEDFNPKLSDFGLAKLGPTGDKTHVSTRVMGTYGYCAPEYALTGQLTTMSDVYSFGVVLL 266
Query: 252 ELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGM 311
E+ITGR IDNSRP+EEQNLVTWA+PLL+D++KFT+MADPLLEG YP KGLYQALAVA M
Sbjct: 267 EIITGRRVIDNSRPTEEQNLVTWAQPLLKDRRKFTLMADPLLEGNYPIKGLYQALAVAAM 326
Query: 312 CLQEDADSRPFMVDVVTALEYLS 334
CLQE+A RP M DVV ALEYLS
Sbjct: 327 CLQEEATIRPLMSDVVMALEYLS 349
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297830742|ref|XP_002883253.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297329093|gb|EFH59512.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1282), Expect = e-138, Method: Compositional matrix adjust.
Identities = 235/334 (70%), Positives = 282/334 (84%), Gaps = 5/334 (1%)
Query: 6 CCKADHSLSFKD----KRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCL 61
C A ++++ D K SS++R I+ EI K GK + ++F ++EL AT+NFNPD
Sbjct: 28 CIDAKNNITTFDNISFKTDSSRRRYISEEIAKLGKGNISAHIFTFRELCVATKNFNPDNQ 87
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+GEGG+GRVYKG+IE +QVVAVKQLDR+G QG+REF EV+MLSL+ HQNLVNL+GYCA
Sbjct: 88 LGEGGFGRVYKGHIETPEQVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCA 147
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQE-PLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
DGDQRILVYE+M NGSLE+H L+L +++ PLDW TRMK+A GAA+GLEYLH+ ADPPVI
Sbjct: 148 DGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVI 207
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
YRDFKASNILLD EFNPKLSDFGLAK+GPTGG+ HVSTRVMGTYGYCAPEYA+TGQLT K
Sbjct: 208 YRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVK 267
Query: 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRK 300
SDVYSFGVV LE+ITGR ID ++P++EQNLVTWA PL +D++KFT+MADPLLEG+YP K
Sbjct: 268 SDVYSFGVVFLEMITGRRVIDTTKPTQEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIK 327
Query: 301 GLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
GLYQALAVA MCLQE+A +RP M DVVTALEYL+
Sbjct: 328 GLYQALAVAAMCLQEEAATRPMMSDVVTALEYLA 361
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15232294|ref|NP_188689.1| protein kinase family protein [Arabidopsis thaliana] gi|332642870|gb|AEE76391.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1282), Expect = e-138, Method: Compositional matrix adjust.
Identities = 236/334 (70%), Positives = 281/334 (84%), Gaps = 5/334 (1%)
Query: 6 CCKADHSLSFKD----KRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCL 61
C A ++++ D K SS++R I+ EI K GK + ++F ++EL AT+NFNPD
Sbjct: 28 CIDAKNNITTFDNISFKTDSSRRRYISEEIAKLGKGNISAHIFTFRELCVATKNFNPDNQ 87
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+GEGG+GRVYKG IE +QVVAVKQLDR+G QG+REF EV+MLSL+ HQNLVNL+GYCA
Sbjct: 88 LGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCA 147
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQE-PLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
DGDQRILVYE+M NGSLE+H L+L +++ PLDW TRMK+A GAA+GLEYLH+ ADPPVI
Sbjct: 148 DGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVI 207
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
YRDFKASNILLD EFNPKLSDFGLAK+GPTGG+ HVSTRVMGTYGYCAPEYA+TGQLT K
Sbjct: 208 YRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVK 267
Query: 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRK 300
SDVYSFGVV LE+ITGR ID ++P+EEQNLVTWA PL +D++KFT+MADPLLEG+YP K
Sbjct: 268 SDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIK 327
Query: 301 GLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
GLYQALAVA MCLQE+A +RP M DVVTALEYL+
Sbjct: 328 GLYQALAVAAMCLQEEAATRPMMSDVVTALEYLA 361
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255563977|ref|XP_002522988.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223537800|gb|EEF39418.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 497 bits (1280), Expect = e-138, Method: Compositional matrix adjust.
Identities = 238/332 (71%), Positives = 276/332 (83%), Gaps = 11/332 (3%)
Query: 12 SLSFKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVY 71
++SFK SS++R IA EI+K GK + ++F ++EL+ AT+NFNPD L+GEGG+GRVY
Sbjct: 29 NISFKSD--SSRRRYIADEIKKIGKGNISADIFTFRELSSATKNFNPDNLIGEGGFGRVY 86
Query: 72 KGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131
KG +E +QVVAVKQLDR+G QG+REF EVLMLSL+ H NLVNL+GYCADGDQRILVY+
Sbjct: 87 KGQMEKTNQVVAVKQLDRNGFQGNREFLVEVLMLSLLHHPNLVNLVGYCADGDQRILVYD 146
Query: 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191
+M NGSLE+H LDL P ++PLDW TRMKIA GAA+GLEYLH+ A+PPVIYRDFKASNILL
Sbjct: 147 YMPNGSLEDHLLDLAPGKKPLDWKTRMKIAEGAARGLEYLHESANPPVIYRDFKASNILL 206
Query: 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLL 251
D +FNPKLSDFGLAKLGPTG K HVSTRVMGTYGYCAPEYA+TGQLT KSDVYSFGVV L
Sbjct: 207 DEDFNPKLSDFGLAKLGPTGDKTHVSTRVMGTYGYCAPEYALTGQLTSKSDVYSFGVVFL 266
Query: 252 ELITGRSAIDNSRPSEEQNLVTWAK---------PLLRDKKKFTMMADPLLEGQYPRKGL 302
E+ITGR IDNSR +EEQNLV WA PL +DKKKF +MADPLLEG+YP K L
Sbjct: 267 EIITGRRVIDNSRTTEEQNLVIWASLKHQAQNATPLFKDKKKFILMADPLLEGKYPLKSL 326
Query: 303 YQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
YQALAVA MCLQE+A +RP M DVVTALEYL+
Sbjct: 327 YQALAVAAMCLQEEAATRPLMSDVVTALEYLA 358
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 336 | ||||||
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.955 | 0.831 | 0.725 | 2.1e-128 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.988 | 0.853 | 0.672 | 1.7e-123 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.967 | 0.633 | 0.685 | 3.8e-117 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.964 | 0.857 | 0.660 | 3.9e-115 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.895 | 0.660 | 0.710 | 2.2e-114 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.869 | 0.705 | 0.705 | 8.7e-111 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.872 | 0.807 | 0.699 | 9e-109 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.883 | 0.700 | 0.653 | 1.6e-104 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.955 | 0.825 | 0.601 | 4.2e-102 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.866 | 0.763 | 0.657 | 2.3e-101 |
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1241 (441.9 bits), Expect = 2.1e-128, Sum P(2) = 2.1e-128
Identities = 235/324 (72%), Positives = 278/324 (85%)
Query: 12 SLSFKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVY 71
++SFK SS++R I+ EI K GK + ++F ++EL AT+NFNPD +GEGG+GRVY
Sbjct: 40 NISFKTD--SSRRRYISEEIAKLGKGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVY 97
Query: 72 KGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131
KG IE +QVVAVKQLDR+G QG+REF EV+MLSL+ HQNLVNL+GYCADGDQRILVYE
Sbjct: 98 KGQIETPEQVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYE 157
Query: 132 FMSNGSLENHFLDLPPDQE-PLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL 190
+M NGSLE+H L+L +++ PLDW TRMK+A GAA+GLEYLH+ ADPPVIYRDFKASNIL
Sbjct: 158 YMQNGSLEDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNIL 217
Query: 191 LDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVL 250
LD EFNPKLSDFGLAK+GPTGG+ HVSTRVMGTYGYCAPEYA+TGQLT KSDVYSFGVV
Sbjct: 218 LDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVF 277
Query: 251 LELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAG 310
LE+ITGR ID ++P+EEQNLVTWA PL +D++KFT+MADPLLEG+YP KGLYQALAVA
Sbjct: 278 LEMITGRRVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAA 337
Query: 311 MCLQEDADSRPFMVDVVTALEYLS 334
MCLQE+A +RP M DVVTALEYL+
Sbjct: 338 MCLQEEAATRPMMSDVVTALEYLA 361
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1214 (432.4 bits), Expect = 1.7e-123, P = 1.7e-123
Identities = 224/333 (67%), Positives = 275/333 (82%)
Query: 5 HCCKADHSLSFKDKRRSS-KQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVG 63
H K +F+ R+ S +Q+ I EI+K+G K +FK++EL AT+NF+ DC++G
Sbjct: 33 HSRKLFALFTFRSHRKGSCRQKYITEEIKKYGNVKNCGRIFKFKELIAATDNFSMDCMIG 92
Query: 64 EGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG 123
EGG+GRVYKG++ +++QVVAVK+LDR+G QG+REFFAEV++LSL QH NLVNLIGYC +
Sbjct: 93 EGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTREFFAEVMVLSLAQHPNLVNLIGYCVED 152
Query: 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRD 183
+QR+LVYEFM NGSLE+H DLP LDWFTRM+I GAAKGLEYLHD ADPPVIYRD
Sbjct: 153 EQRVLVYEFMPNGSLEDHLFDLPEGSPSLDWFTRMRIVHGAAKGLEYLHDYADPPVIYRD 212
Query: 184 FKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDV 243
FKASNILL ++FN KLSDFGLA+LGPT GKDHVSTRVMGTYGYCAPEYAMTGQLT KSDV
Sbjct: 213 FKASNILLQSDFNSKLSDFGLARLGPTEGKDHVSTRVMGTYGYCAPEYAMTGQLTAKSDV 272
Query: 244 YSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLY 303
YSFGVVLLE+I+GR AID RP+EEQNL++WA+PLL+D++ F + DP L+G YP KGL+
Sbjct: 273 YSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEPLLKDRRMFAQIVDPNLDGNYPVKGLH 332
Query: 304 QALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
QALA+A MCLQE+A++RP M DVVTALE+L+ P
Sbjct: 333 QALAIAAMCLQEEAETRPLMGDVVTALEFLAKP 365
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1154 (411.3 bits), Expect = 3.8e-117, P = 3.8e-117
Identities = 224/327 (68%), Positives = 260/327 (79%)
Query: 11 HSLSF-KDK-RRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYG 68
H +S K K RR +Q++ ++ A F ++ELA AT+NF P+CL+GEGG+G
Sbjct: 36 HHISLDKSKSRRGPEQKKELTAPKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFG 95
Query: 69 RVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128
RVYKG +E Q+VAVKQLDR+G QG+REF EVLMLSL+ H NLVNLIGYCADGDQR+L
Sbjct: 96 RVYKGRLETTGQIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 155
Query: 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASN 188
VYE+M GSLE+H DLPPD+EPLDW TRM IA GAAKGLEYLHD A+PPVIYRD K+SN
Sbjct: 156 VYEYMPLGSLEDHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSN 215
Query: 189 ILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGV 248
ILL ++PKLSDFGLAKLGP G K HVSTRVMGTYGYCAPEYAMTGQLT KSDVYSFGV
Sbjct: 216 ILLGDGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 275
Query: 249 VLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAV 308
V LELITGR AIDN+R E NLV WA+PL +D++KF MADP L+G+YP +GLYQALAV
Sbjct: 276 VFLELITGRKAIDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAV 335
Query: 309 AGMCLQEDADSRPFMVDVVTALEYLSS 335
A MCLQE A +RP + DVVTAL YL+S
Sbjct: 336 AAMCLQEQAATRPLIGDVVTALTYLAS 362
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1135 (404.6 bits), Expect = 3.9e-115, P = 3.9e-115
Identities = 216/327 (66%), Positives = 255/327 (77%)
Query: 9 ADHSLSFKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYG 68
+D S+S +K R+ +E + G F + ELA AT NF +CL+GEGG+G
Sbjct: 29 SDCSVSTSEKSRAKSS---LSESKSKGSDHIVAQTFTFSELATATRNFRKECLIGEGGFG 85
Query: 69 RVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128
RVYKGY+ + Q A+KQLD +G QG+REF EVLMLSL+ H NLVNLIGYCADGDQR+L
Sbjct: 86 RVYKGYLASTSQTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 145
Query: 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASN 188
VYE+M GSLE+H D+ P ++PLDW TRMKIA GAAKGLEYLHD PPVIYRD K SN
Sbjct: 146 VYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSN 205
Query: 189 ILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGV 248
ILLD ++ PKLSDFGLAKLGP G K HVSTRVMGTYGYCAPEYAMTGQLT KSDVYSFGV
Sbjct: 206 ILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 265
Query: 249 VLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAV 308
VLLE+ITGR AID+SR + EQNLV WA+PL +D++KF+ MADP+L+GQYP +GLYQALAV
Sbjct: 266 VLLEIITGRKAIDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAV 325
Query: 309 AGMCLQEDADSRPFMVDVVTALEYLSS 335
A MC+QE + RP + DVVTAL YL+S
Sbjct: 326 AAMCVQEQPNLRPLIADVVTALSYLAS 352
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1128 (402.1 bits), Expect = 2.2e-114, P = 2.2e-114
Identities = 214/301 (71%), Positives = 248/301 (82%)
Query: 35 GKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG 94
G + + F ++ELA AT NF+PD +GEGG+GRVYKG +++ QVVAVKQLDR+G QG
Sbjct: 65 GLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQG 124
Query: 95 SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDW 154
+REF EVLMLSL+ H NLVNLIGYCADGDQR+LVYEFM GSLE+H DLPPD+E LDW
Sbjct: 125 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDW 184
Query: 155 FTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214
RMKIA GAAKGLE+LHD A+PPVIYRDFK+SNILLD F+PKLSDFGLAKLGPTG K
Sbjct: 185 NMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKS 244
Query: 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW 274
HVSTRVMGTYGYCAPEYAMTGQLT KSDVYSFGVV LELITGR AID+ P EQNLV W
Sbjct: 245 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAW 304
Query: 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
A+PL D++KF +ADP L+G++P + LYQALAVA MC+QE A +RP + DVVTAL YL+
Sbjct: 305 ARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLA 364
Query: 335 S 335
+
Sbjct: 365 N 365
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1094 (390.2 bits), Expect = 8.7e-111, P = 8.7e-111
Identities = 206/292 (70%), Positives = 241/292 (82%)
Query: 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVL 103
F ++ELA AT+NF +CL+GEGG+GRVYKG +E +VAVKQLDR+G QG++EF EVL
Sbjct: 67 FSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVL 126
Query: 104 MLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG 163
MLSL+ H++LVNLIGYCADGDQR+LVYE+MS GSLE+H LDL PDQ PLDW TR++IA G
Sbjct: 127 MLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALG 186
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
AA GLEYLHD A+PPVIYRD KA+NILLD EFN KLSDFGLAKLGP G K HVS+RVMGT
Sbjct: 187 AAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGT 246
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283
YGYCAPEY TGQLT KSDVYSFGVVLLELITGR ID +RP +EQNLVTWA+P+ ++
Sbjct: 247 YGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPS 306
Query: 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
+F +ADP LEG +P K L QA+AVA MCLQE+A RP M DVVTAL +L +
Sbjct: 307 RFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1075 (383.5 bits), Expect = 9.0e-109, P = 9.0e-109
Identities = 205/293 (69%), Positives = 235/293 (80%)
Query: 43 VFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV 102
+F ++ELA AT+NF +CL+GEGG+GRVYKG +E QVVAVKQLDR+G QG REF EV
Sbjct: 34 IFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGLQGQREFLVEV 93
Query: 103 LMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG 162
LMLSL+ H+NLVNLIGYCADGDQR+LVYE+M GSLE+H LDL P Q+PLDW TR+KIA
Sbjct: 94 LMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDWNTRIKIAL 153
Query: 163 GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMG 222
GAAKG+EYLHD ADPPVIYRD K+SNILLD E+ KLSDFGLAKLGP G HVS+RVMG
Sbjct: 154 GAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTLHVSSRVMG 213
Query: 223 TYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282
TYGYCAPEY TG LT KSDVYSFGVVLLELI+GR ID RPS EQNLVTWA P+ RD
Sbjct: 214 TYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTWALPIFRDP 273
Query: 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
++ +ADPLL G YP K L QA+AVA MCL E+ RP M DV+TAL +L +
Sbjct: 274 TRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSFLGA 326
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.6e-104, P = 1.6e-104
Identities = 194/297 (65%), Positives = 231/297 (77%)
Query: 39 KTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF 98
K F ++EL+ +T NF DC +GEGG+G+VYKG+IE ++QVVA+KQLDR+G QG REF
Sbjct: 81 KKAQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIKQLDRNGAQGIREF 140
Query: 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
EVL LSL H NLV LIG+CA+G QR+LVYE+M GSL+NH DLP + PL W TRM
Sbjct: 141 VVEVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRM 200
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
KIA GAA+GLEYLHD PPVIYRD K SNIL+D ++ KLSDFGLAK+GP G + HVST
Sbjct: 201 KIAAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVST 260
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278
RVMGTYGYCAP+YA+TGQLT KSDVYSFGVVLLELITGR A DN+R Q+LV WA PL
Sbjct: 261 RVMGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPL 320
Query: 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
+D+K F M DPLLEG YP +GLYQALA+A MC+QE RP + DVV AL++L+S
Sbjct: 321 FKDRKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQPSMRPVIADVVMALDHLAS 377
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
Identities = 196/326 (60%), Positives = 247/326 (75%)
Query: 15 FKDKRRSSKQRRIAAEIRKFGKAKKTP-NV----FKYQELADATENFNPDCLVGEGGYGR 69
++ + RR G K++P N+ FK++ELA AT +F + L+GEGG+GR
Sbjct: 25 YEQQNLPRNDRRQITTWEAVGTNKESPKNIKAKSFKFRELATATNSFRQEFLIGEGGFGR 84
Query: 70 VYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129
VYKG +E QVVAVKQLDR+G QG+REF E+ LSL+ H NL NLIGYC DGDQR+LV
Sbjct: 85 VYKGKMEKTGQVVAVKQLDRNGLQGNREFLVEIFRLSLLHHPNLANLIGYCLDGDQRLLV 144
Query: 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNI 189
+EFM GSLE+H LD+ Q+PLDW +R++IA GAAKGLEYLH+ A+PPVIYRDFK+SNI
Sbjct: 145 HEFMPLGSLEDHLLDVVVGQQPLDWNSRIRIALGAAKGLEYLHEKANPPVIYRDFKSSNI 204
Query: 190 LLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVV 249
LL+ +F+ KLSDFGLAKLG G +VS+RV+GTYGYCAPEY TGQLT KSDVYSFGVV
Sbjct: 205 LLNVDFDAKLSDFGLAKLGSVGDTQNVSSRVVGTYGYCAPEYHKTGQLTVKSDVYSFGVV 264
Query: 250 LLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVA 309
LLELITG+ ID +RP EQNLVTWA+P+ R+ +F +ADPLL+G++P K L QA+A+A
Sbjct: 265 LLELITGKRVIDTTRPCHEQNLVTWAQPIFREPNRFPELADPLLQGEFPEKSLNQAVAIA 324
Query: 310 GMCLQEDADSRPFMVDVVTALEYLSS 335
MCLQE+ RP + DVVTAL ++S+
Sbjct: 325 AMCLQEEPIVRPLISDVVTALSFMST 350
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1005 (358.8 bits), Expect = 2.3e-101, P = 2.3e-101
Identities = 192/292 (65%), Positives = 232/292 (79%)
Query: 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVL 103
F ++ELA AT NF L+GEGG+GRVYKG +++ QVVA+KQL+ G QG+REF EVL
Sbjct: 66 FTFKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIVEVL 124
Query: 104 MLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG 163
MLSL+ H NLV LIGYC GDQR+LVYE+M GSLE+H DL +QEPL W TRMKIA G
Sbjct: 125 MLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVG 184
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
AA+G+EYLH A+PPVIYRD K++NILLD EF+PKLSDFGLAKLGP G + HVSTRVMGT
Sbjct: 185 AARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGT 244
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283
YGYCAPEYAM+G+LT KSD+Y FGVVLLELITGR AID + EQNLVTW++P L+D+K
Sbjct: 245 YGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQK 304
Query: 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
KF + DP L G+YPR+ L A+A+ MCL E+A RPF+ D+V ALEYL++
Sbjct: 305 KFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAA 356
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 336 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-44 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-04 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 4e-52
Identities = 67/195 (34%), Positives = 101/195 (51%), Gaps = 11/195 (5%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-EVLMLSLVQHQNLVNLIGYC 120
+GEGG+G VY + + VA+K + + + E E+ +L + H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
D + LV E+ GSL++ L ++ L ++I +GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDL---LKENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 181 YRDFKASNILLDA-EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE-YAMTGQLT 238
+RD K NILLD+ KL+DFGL+KL + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 239 KKSDVYSFGVVLLEL 253
+KSD++S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-46
Identities = 81/280 (28%), Positives = 117/280 (41%), Gaps = 42/280 (15%)
Query: 63 GEGGYGRVYKGY----IEAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
GEG +G VYKG VAVK L + + Q EF E ++ + H N+V L+
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G C + + +V E+M G L ++ L ++ L + A A+G+EYL
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSY---LRKNRPKLSLSDLLSFALQIARGMEYLESK--- 121
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMT 234
I+RD A N L+ K+SDFGL++ D R G + APE
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLY----DDDYYRKRGGKLPIRWMAPESLKE 177
Query: 235 GQLTKKSDVYSFGVVLLELIT-GRS---AIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290
G+ T KSDV+SFGV+L E+ T G + N +L K +
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------------VLEYLKNGYRLPQ 224
Query: 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330
P LY + C ED + RP ++V L
Sbjct: 225 P----PNCPPELYD---LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 6e-46
Identities = 81/277 (29%), Positives = 121/277 (43%), Gaps = 35/277 (12%)
Query: 63 GEGGYGRVYKGYIEA----VDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
GEG +G VYKG ++ + VAVK L + + Q EF E ++ + H N+V L+
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G C + + ++V E+M G L +L +E L + A A+G+EYL
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDL-LDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESK--- 122
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
I+RD A N L+ K+SDFGL++ V + APE G+
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGKF 181
Query: 238 TKKSDVYSFGVVLLELIT-GRS---AIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293
T KSDV+SFGV+L E+ T G + N+ +L KK + P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-------------VLEYLKKGYRLPKP-- 226
Query: 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330
LY+ + C ED + RP ++V L
Sbjct: 227 --PNCPPELYK---LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 90/280 (32%), Positives = 122/280 (43%), Gaps = 33/280 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVNLIGY 119
+G G +G VYK + ++VAVK L + + + E+ +L + H N+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
D D LV E+ G L D PL KIA +GLEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDL----FDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL-T 238
I+RD K NILLD K++DFGLAK ++T V GT Y APE + G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 239 KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298
K DV+S GV+L EL+TG+ + +L + + P LE P
Sbjct: 178 PKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPPLEFDEP 224
Query: 299 --RKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
G +A + CL +D RP TA E L P
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRP------TAEEILQHP 258
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-44
Identities = 77/284 (27%), Positives = 117/284 (41%), Gaps = 35/284 (12%)
Query: 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLV 114
+ +GEG +G+VY + ++VA+K + + + RE E+ +L ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
L D D+ LV E+ G L + E F LEYLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF----YLRQILSALEYLHSK 116
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
+++RD K NILLD + + KL+DFGLA+ G K T +GT Y APE +
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLG 170
Query: 235 GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE--QNLVTWAKPLLRDKKKFTMMADPL 292
K D++S GV+L EL+TG+ E + + P + + A L
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+ L +D + R TA E L P
Sbjct: 231 IRK----------------LLVKDPEKRL------TAEEALQHP 252
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 66/199 (33%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 63 GEGGYGRVYKGYI----EAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
GEG +G VYKG + E + VAVK L + + + EF E ++ + H N+V L+
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G C G+ +V E+M G L + L E L +++A AKG+EYL
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDF---LRKHGEKLTLKDLLQMALQIAKGMEYLESK--- 121
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
++RD A N L+ K+SDFGL++ + APE G+
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181
Query: 238 TKKSDVYSFGVVLLELITG 256
T KSDV+SFGV+L E+ T
Sbjct: 182 TSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 87/292 (29%), Positives = 128/292 (43%), Gaps = 54/292 (18%)
Query: 62 VGEGGYGRVYKGY---IEAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNLI 117
+GEG +G VYKG + VAVK L ++ R +F E ++ + H N+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 118 GYCADGDQRILVYEFMSNGSLENHFL------DLPPDQEPLDWFTRMKIAGGAAKGLEYL 171
G C + + LV E+M G L +L P++ L + A AKG+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDL-LDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP--------TGGKDHVSTRVMGT 223
++RD A N L+ + K+SDFGL++ TGGK + R M
Sbjct: 122 ASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI--RWM-- 174
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRS---AIDNSRPSEEQNLVTWAKPLL 279
APE G T KSDV+SFGV+L E+ T G + + N +L
Sbjct: 175 ----APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------------VL 217
Query: 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
+K + P P + LY+ + C Q D + RP ++V LE
Sbjct: 218 EYLRKGYRLPKPEY---CPDE-LYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 5e-36
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
L+G G +G VY + +++AVK L + E+ +LS +QH N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 118 GYCADGDQR-ILVY-EFMSNGSLENHFLDLPPDQEPL-DWFTRMKIAGGAAKGLEYLHDV 174
G D ++ + ++ E++S GSL + EP+ +TR + +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-----EGLAYLHSN 120
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
+++RD K +NIL+D++ KL+DFG AK + V GT + APE
Sbjct: 121 G---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 235 GQLTKKSDVYSFGVVLLELITGR 257
+ + +D++S G ++E+ TG+
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQN 112
N+ L+G G +G VYKG VA+KQ+ + + E+ +L ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLEN---HFLDLPPDQEPL--DWFTRMKIAGGAAKG 167
+V IG D ++ E+ NGSL F P E L + ++ +G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP---ESLVAVYVYQV------LQG 111
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGY 226
L YLH+ VI+RD KA+NIL + KL+DFG+A KL D V+GT +
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYW 165
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
APE + SD++S G ++EL+TG
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 68/204 (33%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 62 VGEGGYGRVYKGYIEAVD----QVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNL 116
+GEG +G+V + + + VAVK L+ SG Q +F E+ +L + H+N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 117 IGYCADGDQRI--LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
G C R L+ E++ +GSL ++ L ++ ++ + + KG++YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDY---LQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMG---TYGYCAPEY 231
I+RD A NIL+++E K+SDFGLAK+ P KD+ + G + Y APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPE-DKDYYYVKEPGESPIFWY-APEC 183
Query: 232 AMTGQLTKKSDVYSFGVVLLELIT 255
T + + SDV+SFGV L EL T
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 16/229 (6%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G+GG+G VYK + + VA+K + + + E+ +L +H N+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 122 DGDQRILVYEFMSNGSLENHFLDLP-PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
D+ +V EF S GSL++ E + + KGLEYLH +I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY----VCKELLKGLEYLHSNG---II 120
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
+RD KA+NILL ++ KL DFGL+ + ++GT + APE K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKPYDYK 177
Query: 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK---PLLRDKKKFT 286
+D++S G+ +EL G+ P + L A P LR+ +K++
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKA--LFKIATNGPPGLRNPEKWS 224
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 8e-30
Identities = 72/216 (33%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE---FFAEVLMLSLVQHQ 111
++ +GEG +G VY ++VA+K L + S+E F E+ +L+ + H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 112 -NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
N+V L + D LV E++ GSLE L + PL + I LEY
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLE-DLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 171 LHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGLAKL----GPTGGKDHVSTRVMGTYG 225
LH +I+RD K NILLD + KL DFGLAKL G T + + +GT G
Sbjct: 117 LHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 226 YCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRS 258
Y APE + + SD++S G+ L EL+TG
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 62 VGEGGYGRVYKGYIEAVDQ-----VVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVN 115
+GEG +G+V+ G ++ +VAVK L + + N ++F E +L+ QH+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFL-----------DLPPDQEPLDWFTRMKIAGGA 164
G C +GD I+V+E+M +G L N FL L ++IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
A G+ YL A ++RD N L+ + K+ DFG+++ T V M
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ PE M + T +SDV+SFGVVL E+ T
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
+G+G +G V G Q VAVK L ++ F AE +++ ++H NLV L+G
Sbjct: 13 TIGKGEFGDVMLGDYRG--QKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
G+ +V E+M+ GSL ++ + + ++ A +G+EYL + +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAK---LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
+RD A N+L+ + K+SDFGLAK G GK V + APE +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKF 176
Query: 238 TKKSDVYSFGVVLLELIT-GR 257
+ KSDV+SFG++L E+ + GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-27
Identities = 84/295 (28%), Positives = 125/295 (42%), Gaps = 42/295 (14%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-EVLMLSLVQHQN 112
+++ ++G G VY ++ VA+K++D Q S + EV +S H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG---GAAKGLE 169
+V GD+ LV ++S GSL LD+ P IA KGLE
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR--VMGTYGYC 227
YLH I+RD KA NILL + + K++DFG++ GG R +GT +
Sbjct: 117 YLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 228 APEYAMTGQ--LTKKSDVYSFGVVLLELITGRSAIDNSRPSEE-QNLVTWAKPLL---RD 281
APE M K+D++SFG+ +EL TG + P + + P L D
Sbjct: 174 APE-VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD 232
Query: 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
KK++ K + ++ +CLQ+D RP TA E L
Sbjct: 233 YKKYS-------------KSFRKMIS---LCLQKDPSKRP------TAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 9e-27
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 40/214 (18%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIG 118
+G+G +G+V + ++ A+K L + + E +LS + H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 119 YCADGDQR--ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG----GAAK------ 166
+ A + LV E+ G L F+ + G A+
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGEL----------------FSHLSKEGRFSEERARFYAAEI 102
Query: 167 --GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
LEYLH + +IYRD K NILLDA+ + KL+DFGLAK + G +T GT
Sbjct: 103 VLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTP 157
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
Y APE + K D +S GV+L E++TG+
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 62 VGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVN 115
+GEG +G+VYKG + VA+K L + + EF E ++S +QH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPD------------QEPLDWFTRMKIAGG 163
L+G C +++E++++G L + P + LD + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
A G+EYL + ++RD A N L+ K+SDFGL++ + V ++ +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLEL 253
+ PE + G+ T +SD++SFGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREF-FAEVLMLSLVQHQNLVNLIG 118
+G+G +G+VY ++ ++ +K++D S ++ RE EV +L + H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEP------LDWFTRMKIAGGAAKGLEYLH 172
+ + +V E+ G L + +P LDWF ++ L+YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYLH 120
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGKDHVSTRVMGTYGYCAPE- 230
+++RD K NI L + KL DFG++K L T D T V GT Y +PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST--VDLAKTVV-GTPYYLSPEL 174
Query: 231 -----YAMTGQLTKKSDVYSFGVVLLELITGRSA 259
Y KSD++S G VL EL T +
Sbjct: 175 CQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 63 GEGGYGRVYKGY----IEAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
G G +G VYKG E V VA+K L + + + ++E E +++ V H ++V L+
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 118 GYCADGDQRILVYEFMSNGSL----ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
G C Q L+ + M G L NH ++ Q L+W ++ AKG+ YL +
Sbjct: 76 GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNWCVQI------AKGMSYLEE 127
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
+++RD A N+L+ + K++DFGLAKL K++ + + A E +
Sbjct: 128 KR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 234 TGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLV 272
T KSDV+S+GV + EL+T G + E +L+
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 69/206 (33%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G G +G V+ G +V AVK L + G F E ++ ++H LV L C++
Sbjct: 15 GAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 123 GDQRILVYEFMSNGSL-------ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
+ +V E+MS GSL E L LP + +A A+G+ YL
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQ---------LVDMAAQIAEGMAYLESRN 123
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYA 232
I+RD A NIL+ K++DFGLA+L +D T G + APE A
Sbjct: 124 ---YIHRDLAARNILVGENLVCKIADFGLARLI----EDDEYTAREGAKFPIKWTAPEAA 176
Query: 233 MTGQLTKKSDVYSFGVVLLELIT-GR 257
G+ T KSDV+SFG++L E++T GR
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL-----DRSGNQGSREFFAEVLMLSLVQHQNLVN 115
L+G G +G VY+G AVK++ ++G + ++ E+ +LS +QH N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPL-DWFTRMKIAGGAAKGLEYLHDV 174
+G + D + E + GSL EP+ +TR + GLEYLHD
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-----LGLEYLHDR 121
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-----GTYGYCAP 229
++RD K +NIL+D KL+DFG+AK V G+ + AP
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAP 170
Query: 230 EYAM-TGQLTKKSDVYSFGVVLLELITGR 257
E G +D++S G +LE+ TG+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 62/200 (31%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLM-LSLVQHQNLVNLIGY-- 119
G G G V K +++AVK + N+ ++L L ++ N ++G+
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFYG 66
Query: 120 -CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
+ + E+M GSL+ L + P KIA KGL YLH+
Sbjct: 67 AFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILG--KIAVAVLKGLTYLHEKHK-- 121
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
+I+RD K SNIL+++ KL DFG++ +L + K V GT Y APE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDY 176
Query: 238 TKKSDVYSFGVVLLELITGR 257
+ KSD++S G+ L+EL TGR
Sbjct: 177 SVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-25
Identities = 73/217 (33%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 61 LVGEGGYGRV----YKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
+G+G +G V Y + +VVAVK+L S + R+F E+ +L +QH N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 117 IGYCADGDQR--ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
G C +R LV E++ GSL ++ L +E LD + A KG+EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDY---LQKHRERLDHRKLLLYASQICKGMEYL--- 124
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMG---TYGYCAPEY 231
++RD NIL+++E K+ DFGL K+ P K++ R G + Y APE
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APES 182
Query: 232 AMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE 268
+ + SDV+SFGVVL EL T + P E
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDK--SCSPPAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 81/277 (29%), Positives = 122/277 (44%), Gaps = 22/277 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
++ G G YKG VK+++ N A++ L QH N+V LIG C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDV-NSIPSSEIADMGKL---QHPNIVKLIGLC 752
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
L++E++ +L +L W R KIA G AK L +LH P V+
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
+ I++D + P L L L T K +S+ Y APE T +T+K
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEK 858
Query: 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP-- 298
SD+Y FG++L+EL+TG+S D ++V WA+ D M DP + G
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSD-CHLDMWIDPSIRGDVSVN 916
Query: 299 RKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
+ + + + +A C D +RP DV+ LE S
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 7e-24
Identities = 64/198 (32%), Positives = 106/198 (53%), Gaps = 16/198 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V++G + +V A+K L ++F EV L ++H++L++L C+
Sbjct: 14 LGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
G+ ++ E M GSL FL P+ + L + + +A A+G+ YL + I+
Sbjct: 73 VGEPVYIITELMEKGSLL-AFLR-SPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIH 127
Query: 182 RDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV----STRVMGTYGYCAPEYAMTGQL 237
RD A NIL+ + K++DFGLA+L K+ V ++ Y + APE A G
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLI----KEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 238 TKKSDVYSFGVVLLELIT 255
+ KSDV+SFG++L E+ T
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 72/283 (25%), Positives = 121/283 (42%), Gaps = 44/283 (15%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVK--QLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIG-Y 119
G+G G VYK + ++ A+K +D ++ E+ L + +V G +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPYVVKCYGAF 68
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
+G+ I V E+M GSL + + EP+ IA KGL+YLH +
Sbjct: 69 YKEGEISI-VLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLH--TKRHI 121
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE------YAM 233
I+RD K SN+L++++ K++DFG++K+ +T V GT Y +PE Y+
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYMSPERIQGESYSY 179
Query: 234 TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293
+D++S G+ LLE G+ P ++ + L++ P L
Sbjct: 180 ------AADIWSLGLTLLECALGKF------PFLPPGQPSFFE-LMQ---AICDGPPPSL 223
Query: 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+ ++ CLQ+D RP +A E L P
Sbjct: 224 PAEEFSPEFRDFIS---ACLQKDPKKRP------SAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 3e-23
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G YG VY+G + VAVK L + EF E ++ ++H NLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
++ EFM+ G+L ++ + +++ ++ + +A + +EYL I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 182 RDFKASNILLDAEFNPKLSDFGLAKL-------GPTGGKDHVSTRVMGTYGYCAPEYAMT 234
RD A N L+ K++DFGL++L G K + + APE
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPESLAY 179
Query: 235 GQLTKKSDVYSFGVVLLELIT 255
+ + KSDV++FGV+L E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-23
Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 23/219 (10%)
Query: 45 KYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLM 104
D E + +GEG G VYK A + VA+K++ R Q E+L+
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILI 68
Query: 105 LSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL----ENHFLDLPPDQEPLDWFTRMKI 160
+ +H N+V+ GD+ +V E+M GSL +F+ + Q I
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ----------I 118
Query: 161 A---GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
A +GLEYLH VI+RD K+ NILL + + KL+DFG A T K +
Sbjct: 119 AYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL-TKEKSKRN 174
Query: 218 TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG 256
+ V GT + APE K D++S G++ +E+ G
Sbjct: 175 SVV-GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-23
Identities = 82/299 (27%), Positives = 121/299 (40%), Gaps = 63/299 (21%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
E F+ +GEG YG VYK + QVVA+K + + +E E+ +L +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYI 60
Query: 114 VNLIG-YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG---------- 162
V G Y + D I V E+ GS D+ MKI
Sbjct: 61 VKYYGSYFKNTDLWI-VMEYCGAGS----VSDI------------MKITNKTLTEEEIAA 103
Query: 163 ---GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVST 218
KGLEYLH I+RD KA NILL+ E KL+DFG++ +L T K
Sbjct: 104 ILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK---RN 157
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAKP 277
V+GT + APE K+D++S G+ +E+ G+ + P ++ P
Sbjct: 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP 217
Query: 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
L D +K++ P CL +D + RP +A++ L P
Sbjct: 218 TLSDPEKWS----PEFN------------DFVKKCLVKDPEERP------SAIQLLQHP 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-23
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 62 VGEGGYGRVYKGYIEAVDQ---VVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVNL 116
+G G +G V +G ++ + VA+K L ++G+ +F E ++ H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
G +++ E+M NGSL+ FL + + + G A G++YL ++
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDK-FLRENDGK--FTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT--------GGKDHVSTRVMGTYGYCA 228
++RD A NIL+++ K+SDFGL++ GGK + R + A
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGK--IPIR------WTA 176
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELIT 255
PE + T SDV+SFG+V+ E+++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 73/272 (26%), Positives = 111/272 (40%), Gaps = 42/272 (15%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V+ G V A+K + R G +F E ++ + H NLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDV-AIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
+V E+M+NG L N +L + +W M + +EYL I+
Sbjct: 70 KQRPIFIVTEYMANGCLLN-YLRERKGKLGTEWLLDM--CSDVCEAMEYLESNG---FIH 123
Query: 182 RDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQLT 238
RD A N L+ + K+SDFGLA+ D T GT + PE + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY----VLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 239 KKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWA----KPLLRDKKKFTMMADPLL 293
KSDV+SFGV++ E+ + G+ + SE V+ +P L + +T+M
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS--- 236
Query: 294 EGQYPRKGLYQALAVAGMCLQEDADSRP-FMV 324
C E + RP F
Sbjct: 237 ------------------CWHEKPEDRPAFKK 250
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 25/207 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLVQHQNLVNL 116
+GEG YG+VYK + ++VA+K++ + +E F E+ +L ++H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 117 IGYCADGDQR--ILVYEFMS---NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL 171
+ +V+E+M G L++ + Q + + + + +GL+YL
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ--IKCYMKQLL-----EGLQYL 116
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
H +++RD K SNIL++ + KL+DFGLA+ T T + T Y PE
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPEL 172
Query: 232 AM-TGQLTKKSDVYSFGVVLLELITGR 257
+ + + D++S G +L EL G+
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-22
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 62 VGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
+GEG +G+V+ E +VAVK L + ++F E +L+++QHQ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE-----------PLDWFTRMKIAGGAA 165
G C +G ++V+E+M +G L PD + L + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
G+ YL A ++RD N L+ K+ DFG+++ + V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ PE + + T +SD++SFGVVL E+ T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 62 VGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVN 115
+G+G +G VY+G + VA+K ++ + + R EF E ++ ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE--------PLDWFTRMKIAGGAAKG 167
L+G + G ++V E M+ G L+++ P+ E L F +M A A G
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM--AAEIADG 131
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL------GPTGGKDHVSTRVM 221
+ YL ++RD A N ++ + K+ DFG+ + GGK + R M
Sbjct: 132 MAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
APE G T KSDV+SFGVVL E+ T
Sbjct: 189 ------APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-21
Identities = 61/206 (29%), Positives = 109/206 (52%), Gaps = 21/206 (10%)
Query: 61 LVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVN 115
++G G +G V +G ++ + VA+K L +SG + R+F +E ++ H N+++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG---GAAKGLEYLH 172
L G +++ EFM NG+L++ FL Q FT +++ G G A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDS-FLRQNDGQ-----FTVIQLVGMLRGIAAGMKYLS 123
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMG---TYGYCAP 229
++ ++RD A NIL+++ K+SDFGL++ D T +G + AP
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELIT 255
E + T SDV+S+G+V+ E+++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-21
Identities = 72/266 (27%), Positives = 113/266 (42%), Gaps = 34/266 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLD-RSGNQGSR-EFFAEVLMLSLVQHQNLVNLIGY 119
+G+G +G V+K +A +V A+KQ+D N+ R E E +L+ + ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 120 CADGDQRILVYEFMSNGSLEN--HFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
D + +V E+ NG L P E W + GL +LH
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLHS---K 120
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
+++RD K+ N+ LDA N K+ D G+AKL + + ++GT Y +PE
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 238 TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQY 297
+KSDV++ GVVL E TG+ P + N ++R
Sbjct: 179 NEKSDVWALGVVLYECCTGK------HPFDANNQGALILKIIRGVFP------------- 219
Query: 298 PRKGLY-QALA-VAGMCLQEDADSRP 321
P +Y Q LA + CL +D RP
Sbjct: 220 PVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA--EVLMLSLVQHQNLVNLIGY 119
+GEG YG VYK + ++VA+K++ A E+ +L + H N++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 120 CADGDQRILVYEFMSNGSLEN--HFLD---LPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
LV+EFM + + + + + + +GL + H
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLL-----QGLAFCHSH 117
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGG--KDHVSTRVMGTYGYCAPEY 231
+++RD K N+L++ E KL+DFGLA+ G +V TR Y APE
Sbjct: 118 G---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 232 AMT-GQLTKKSDVYSFGVVLLELITGR 257
+ + D++S G + EL++ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 77/289 (26%), Positives = 134/289 (46%), Gaps = 49/289 (16%)
Query: 61 LVGEGGYGRVYKGYIEA---VDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNL 116
++G G +G V++G ++ + VA+K L + R +F +E ++ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG---GAAKGLEYLHD 173
G +++ E+M NG+L+ + D D E F+ ++ G G A G++YL D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRD--HDGE----FSSYQLVGMLRGIAAGMKYLSD 125
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL---------GPTGGKDHVSTRVMGTY 224
+ ++RD A NIL+++ K+SDFGL+++ +GGK + R
Sbjct: 126 MN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK--IPIR----- 175
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284
+ APE + T SDV+SFG+V+ E+++ RP + + K + +
Sbjct: 176 -WTAPEAIAYRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMSNHEVMKAINDGFRL 229
Query: 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
M P +YQ + C Q+D RP VD+V L+ L
Sbjct: 230 PAPMDCP--------SAVYQLML---QCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-20
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 16/198 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+GEG +G V +G E Q VAVK + + ++ F E +++ + H+NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
I V E MS G+L N + + + A+G+EYL +++
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLES---KKLVH 123
Query: 182 RDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKS 241
RD A NIL+ + K+SDFGLA++G G ++++ + APE + + KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKL--PVKWTAPEALKHKKFSSKS 178
Query: 242 DVYSFGVVLLELIT-GRS 258
DV+S+GV+L E+ + GR+
Sbjct: 179 DVWSYGVLLWEVFSYGRA 196
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 71/226 (31%), Positives = 104/226 (46%), Gaps = 18/226 (7%)
Query: 62 VGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVN 115
+G G +G VY+G +AV+ VAVK L S ++ F E L++S HQN+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE---PLDWFTRMKIAGGAAKGLEYLH 172
LIG + R ++ E M+ G L++ + P E L + A AKG +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 173 DVADPPVIYRDFKASNILLDAEFNP----KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCA 228
+ I+RD A N LL + P K++DFG+A+ R M +
Sbjct: 134 ENH---FIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVT 273
PE + G T K+DV+SFGV+L E+ + G E VT
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-20
Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V+ GY VA+K L + G+ F AE ++ +QH LV L Y
Sbjct: 14 LGAGQFGEVWMGYYNG-HTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRL--YAV 69
Query: 122 DGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
+ I ++ E+M NGSL + FL P+ L + +A A+G+ ++ I
Sbjct: 70 VTQEPIYIITEYMENGSLVD-FLK-TPEGIKLTINKLIDMAAQIAEGMAFIERKN---YI 124
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQL 237
+RD +A+NIL+ K++DFGLA+L +D+ T G + APE G
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARL----IEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 238 TKKSDVYSFGVVLLELIT-GR 257
T KSDV+SFG++L E++T GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-20
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLI-GYCA 121
G+G +G+VYK + A K + + +F E+ +LS +H N+V L Y
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
+ IL+ EF G+L++ L+L + L + + L +LH VI+
Sbjct: 74 ENKLWILI-EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHS---HKVIH 126
Query: 182 RDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTK- 239
RD KA NILL + + KL+DFG+ AK T K +GT + APE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACETFKDN 183
Query: 240 ----KSDVYSFGVVLLELITGR 257
K+D++S G+ L+EL
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-20
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 8/197 (4%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNLIGY 119
+G+G +G VYKG ++ + VAVK + + F E +L H N+V LIG
Sbjct: 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
C +V E + GSL FL ++ + ++++ AA G+EYL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLT-FLRKKKNRLTVK--KLLQMSLDAAAGMEYLE---SKNC 114
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTK 239
I+RD A N L+ K+SDFG+++ G + APE G+ T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 240 KSDVYSFGVVLLELITG 256
+SDV+S+G++L E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-20
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 62 VGEGGYGRVY--KGYIEAVDQ---VVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
+GEG +G+V+ + Y +Q +VAVK L + + ++F E +L+ +QH+++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQ------EPLDWFTR---MKIAGGAAKG 167
G C +GD I+V+E+M +G L PD T+ + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
+ YL A ++RD N L+ K+ DFG+++ + V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELIT 255
PE M + T +SDV+S GVVL E+ T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-20
Identities = 65/205 (31%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLD------RSGNQGSREFFAEVLMLSLVQHQNLVN 115
+G+GG+G V ++A ++ A K+LD R G Q + E +L V + +V+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA---LNEKKILEKVSSRFIVS 57
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHF--LDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
L D LV M+ G L+ H + P E F +I G LE+LH
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ 113
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
++YRD K N+LLD N ++SD GLA G K GT GY APE
Sbjct: 114 RR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQ 167
Query: 234 TGQLTKKSDVYSFGVVLLELITGRS 258
D ++ G L E+I GRS
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-20
Identities = 71/240 (29%), Positives = 110/240 (45%), Gaps = 23/240 (9%)
Query: 62 VGEGGYGRVYKGYIEAVD-----QVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
+GEG +G+V+ + +VAVK L ++F E +L+ +QH+++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFL-----------DLPPDQE--PLDWFTRMKIAGG 163
G C DGD I+V+E+M +G L N FL D P Q L + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
A G+ YL A ++RD N L+ A K+ DFG+++ + V M
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDK 282
+ PE M + T +SDV+SFGV+L E+ T G+ +E +T + L R +
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPR 248
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-20
Identities = 78/288 (27%), Positives = 116/288 (40%), Gaps = 41/288 (14%)
Query: 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQ-LDRSGNQGSREFFA-EVLMLSLVQHQNLVNLI 117
+VGEG YG V K +A ++VA+K+ + ++ ++ EV +L ++H+N+VNL
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
+ LV+E++ LE L+ P P D + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPD--AVRSYIWQLLQAIAYCHSHN-- 120
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK----DHVSTRVMGTYGYCAPE--- 230
+I+RD K NIL+ KL DFG A+ D+V+TR Y APE
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPELLV 174
Query: 231 -YAMTGQLTKKSDVYSFGVVLLELITGR------SAIDN---------SRPSEEQNLVTW 274
G K DV++ G ++ EL+ G S ID P Q L +
Sbjct: 175 GDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS- 230
Query: 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF 322
+ P LE +YP K AL CL+ D R
Sbjct: 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 7e-20
Identities = 65/227 (28%), Positives = 111/227 (48%), Gaps = 13/227 (5%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G+G G VY A Q VA+KQ++ E+L++ +H N+VN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
GD+ +V E+++ GSL + + D+ + R + + LE+LH VI+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSNQ---VIH 138
Query: 182 RDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
RD K+ NILL + + KL+DFG A++ P K + ++GT + APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAKPLLRDKKKFT 286
D++S G++ +E++ G N P L+ T P L++ +K +
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-20
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 62 VGEGGYGRVYKGYIEAV-----DQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVN 115
+G+G +G VY+G + V + VA+K ++ + + R EF E ++ ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE------PLDWFTRMKIAGGAAKGLE 169
L+G + G +++ E M+ G L+++ L P+ E P +++AG A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK------LGPTGGKDHVSTRVMGT 223
YL+ ++RD A N ++ +F K+ DFG+ + GGK + R M
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 188
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+PE G T SDV+SFGVVL E+ T
Sbjct: 189 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 7e-20
Identities = 84/285 (29%), Positives = 128/285 (44%), Gaps = 35/285 (12%)
Query: 61 LVGEGGYGRVYKGYIEAVDQV---VAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNL 116
++G+G +G VY G + D AVK L+R + E F E +++ H N+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 117 IGYCADGDQRILV-YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG---GAAKGLEYLH 172
+G C + LV +M +G L N P T + G AKG+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRS--ETHNP----TVKDLIGFGLQVAKGMEYL- 114
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK--LGPTGGKDHVSTRVMGTYGYCAPE 230
A ++RD A N +LD F K++DFGLA+ H T + A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290
T + T KSDV+SFGV+L EL+T R A P + + LL+ ++
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT-RGA----PPYPDVDSFDITVYLLQGRR------- 220
Query: 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
LL+ +Y LY+ V C + RP ++V+ +E + S
Sbjct: 221 -LLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-20
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V++G + VAVK L + G ++F AE ++ ++H L+ L C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 122 DGDQRILVYEFMSNGSL-------ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
+ +V E M GSL L LP + +A A G+ YL
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLP---------QLIDMAAQVASGMAYLEAQ 122
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEY 231
I+RD A N+L+ K++DFGLA++ K+ + G + APE
Sbjct: 123 N---YIHRDLAARNVLVGENNICKVADFGLARVI----KEDIYEAREGAKFPIKWTAPEA 175
Query: 232 AMTGQLTKKSDVYSFGVVLLELIT-GR 257
A+ + + KSDV+SFG++L E++T GR
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 61/203 (30%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQV---VAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLI 117
+G G +G V KG VAVK L + G +EF E +++ + H +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLP--PDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
G C G+ +LV E G L + P + + ++ A G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGKDHVSTRVMGTY--GYCAPEYA 232
++RD A N+LL K+SDFG+++ LG G D+ G + + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRWPLKWYAPECI 170
Query: 233 MTGQLTKKSDVYSFGVVLLELIT 255
G+ + KSDV+S+GV L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLD-RSGNQGSREFFAEVLMLSLVQHQNLVNLIGY 119
+G+G +G VYK + +QVVA+K +D + E+ LS + + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
G + ++ E+ GS LDL LD I GLEYLH+
Sbjct: 68 FLKGSKLWIIMEYCGGGSC----LDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---K 119
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
I+RD KA+NILL E + KL+DFG++ +L T K + T V GT + APE
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN--TFV-GTPFWMAPEVIKQSGYD 176
Query: 239 KKSDVYSFGVVLLELITG 256
+K+D++S G+ +EL G
Sbjct: 177 EKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 1e-19
Identities = 62/227 (27%), Positives = 112/227 (49%), Gaps = 13/227 (5%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G+G G V+ A Q VA+KQ++ E+L++ +++ N+VN +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
GD+ +V E+++ GSL + + D+ + R + + LE+LH VI+
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLH---ANQVIH 138
Query: 182 RDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
RD K+ N+LL + + KL+DFG A++ P K + ++GT + APE K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAKPLLRDKKKFT 286
D++S G++ +E++ G N P L+ T P L++ +K +
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 60/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLD----RSGNQGSRE------FFAEVLMLSLVQH 110
L+G+G YGRVY +++AVKQ++ +G SR+ +E+ L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPL-DWFTRMKIAGGAAKGLE 169
N+V +G+ + + E++ GS+ + +E L +FT + +GL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
YLH +++RD KA N+L+DA+ K+SDFG++K + + + G+ + AP
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 230 EYAMTGQ--LTKKSDVYSFGVVLLELITGR 257
E + + K D++S G V+LE+ GR
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-19
Identities = 76/287 (26%), Positives = 122/287 (42%), Gaps = 41/287 (14%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGS----REFFAEVLMLSLVQHQNLV 114
++G+G YG VY G Q++AVKQ LD S + + EV +L ++H N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQ-GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEP-LDWFTRMKIAGGAAKGLEYLHD 173
+G C D + + EF+ GS+ + P EP +T+ + G+ YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHN 120
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAK----LGPTGGKDHVSTRVMGTYGYCAP 229
V++RD K +N++L KL DFG A+ +G G ++ + GT + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289
E +KSD++S G + E+ TG+ + + F + A
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM---------------FYIGA 222
Query: 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
L + P A+ CL D RP +AL+ L
Sbjct: 223 HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERP------SALQLLRHD 263
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 2e-19
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 38/212 (17%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQ--LDRS--GNQGS--REFFAEVLMLSLVQHQNLVN 115
+GEG YG VYK + ++VA+K+ LD G + RE + +L ++H N+V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELKHPNIVK 62
Query: 116 LIGYCADGDQRILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
L+ + LV+E+ L+ L P+ + + +GL Y H
Sbjct: 63 LLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNL--IKSIMYQLL-----RGLAYCH 115
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE-- 230
+++RD K NIL++ + KL+DFGLA+ + + + V+ T Y APE
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEIL 170
Query: 231 -----YAMTGQLTKKSDVYSFGVVLLELITGR 257
Y + D++S G + E+ITG+
Sbjct: 171 LGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 59 DCLVGEGGYGRVYKGYIEAVD-------QVVAVKQLDRSGN-QGSREFFAEVLMLSLV-Q 109
+GEG +G+V K EAV VAVK L + + +E+ M+ ++ +
Sbjct: 17 GKPLGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSL------------ENHFLDLPPDQEPLDWFTR 157
H+N++NL+G C +V E+ ++G+L D P +E L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
+ A A+G+E+L A I+RD A N+L+ + K++DFGLA+ D+
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYR 189
Query: 218 TRVMG--TYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
G + APE T +SDV+SFGV+L E+ T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 72/240 (30%), Positives = 117/240 (48%), Gaps = 28/240 (11%)
Query: 43 VFKYQELADATENFNPDCLVGEGGYGRVYKG-YIEAVDQV---VAVKQL-DRSGNQGSRE 97
+ K EL L+G G +G V+KG +I D + VA+K + DRSG Q +E
Sbjct: 3 ILKETELRKLK-------LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQE 55
Query: 98 FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFL----DLPPDQEPLD 153
+L + + H +V L+G C G LV + GSL +H L P Q L+
Sbjct: 56 ITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLN 113
Query: 154 WFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213
W ++ AKG+ YL + +++R+ A NILL ++ +++DFG+A L K
Sbjct: 114 WCVQI------AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164
Query: 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLV 272
+ + + A E + G+ T +SDV+S+GV + E+++ G RP E +L+
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-19
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 22/205 (10%)
Query: 62 VGEGGYGRV----YKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNL 116
+GEG +G+V Y + ++VAVK L R Q + + E+ +L + H+N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 117 IGYCADGDQRI--LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
G C++ + L+ E++ GSL ++ LP + L + A +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDY---LPKHKLNLAQL--LLFAQQICEGMAYLHS- 125
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM----GTYGYCAPE 230
I+RD A N+LLD + K+ DFGLAK P G H RV + A E
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWYAVE 180
Query: 231 YAMTGQLTKKSDVYSFGVVLLELIT 255
+ + SDV+SFGV L EL+T
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 65 GGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQHQNLVNLIGYCA 121
G YGRV+ ++ + A+K + ++ + E +LS Q +V L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 122 DGDQRI-LVYEFMSNG---SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G + + LV E++ G SL + L D R+ IA LEYLH
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDV------ARIYIAE-IVLALEYLHSNG-- 113
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS------TRVMGTYGYCAPEY 231
+I+RD K NIL+D+ + KL+DFGL+K+G + +++ R++GT Y APE
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 232 AMTGQLTKKSDVYSFGVVLLELITG 256
+ +K D +S G +L E + G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-19
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA--EVLMLSLVQHQNLVNLIG 118
+VG G +G V+ +A ++V +KQ+ A E +L L+ H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 119 YCADGDQRILVYEFMSNGSLENHFLD----LPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
+ ++V E+ G+L + L + L +F ++ +A LH V
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA---------LHHV 117
Query: 175 ADPPVIYRDFKASNILLDAEFNP-KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
+++RD K NILLD K+ DFG++K+ K T V+GT Y +PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCE 174
Query: 234 TGQLTKKSDVYSFGVVLLELITGRSAID 261
+KSD+++ G VL EL + + A +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-19
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 62 VGEGGYGRVYKG--YIEAVD--QVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
+GE +G++YKG Y+ +D Q+VA+K L D + Q EF E +++ + H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE-------------PLDWFTRMKIAGG 163
+G +++E+++ G L + P + LD + IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
A G+EYL + +++D A NIL+ + + K+SD GL++ + V + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ PE M G+ + SD++SFGVVL E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 5e-19
Identities = 86/290 (29%), Positives = 133/290 (45%), Gaps = 49/290 (16%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQ-LDRSGNQGSREF-FAEVLMLSLVQHQNLVNLIG 118
LVGEG YG V K + Q+VA+K+ L+ ++ ++ E+ ML ++H+NLVNLI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
+ LV+EF+ + L+ DL LD K +G+E+ H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCH---SHN 120
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK---DHVSTRVMGTYGYCAPEYAMTG 235
+I+RD K NIL+ KL DFG A+ G+ D+V+TR Y APE +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELLVGD 175
Query: 236 -QLTKKSDVYSFGVVLLELITGR------SAIDNSRPSEEQ---------NLVTWAKPLL 279
+ + D+++ G ++ E++TG S ID Q NL+ + +
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-------QLYHIIKCLGNLIPRHQEIF 228
Query: 280 RDKKKFTMMADPL------LEGQYPR-KGLYQALAVAGMCLQEDADSRPF 322
+ F M P LE ++P+ GL L +A CL+ D D RP
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGL--VLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-19
Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 24/232 (10%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG-SREFFAEVLMLSLVQHQNLVNLIG-YC 120
GEG G V K ++ + A+K + N ++ E+ + + +V G +
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 121 ADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
+ I + E+ GSL++ + + + KIA KGL YLH +
Sbjct: 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKI 126
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
I+RD K SNILL + KL DFG++ +L + GT Y APE +
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPERIQGKPYS 181
Query: 239 KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNL---------VTWAKPLLRD 281
SDV+S G+ LLE+ R P E L V P L+D
Sbjct: 182 ITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLGPIELLSYIVNMPNPELKD 230
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-19
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 16/213 (7%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIG 118
+G+G +G+V ++ A+K +++ R E +L + H LVNL
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI-AGGAAKGLEYLHDVADP 177
D + LV + + G L H E ++K LEYLH
Sbjct: 68 SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWICEIVLALEYLHSKG-- 120
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
+I+RD K NILLD + + ++DF +A +T GT GY APE
Sbjct: 121 -IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGY 176
Query: 238 TKKSDVYSFGVVLLELITGRSAID-NSRPSEEQ 269
+ D +S GV E + G+ +SR +Q
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-19
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 24/214 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V+ GY +V A+K + R G +F E ++ + H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
+ LV+EFM +G L ++ L + T + + +G+ YL VI+
Sbjct: 70 ERSPICLVFEFMEHGCLSDY---LRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 182 RDFKASNILLDAEFNPKLSDFGLAKL-------GPTGGKDHVSTRVMGTYGYCAPEYAMT 234
RD A N L+ K+SDFG+ + TG K V + +PE
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK--------WSSPEVFSF 175
Query: 235 GQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSE 267
+ + KSDV+SFGV++ E+ + G++ +N SE
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 8e-19
Identities = 64/229 (27%), Positives = 112/229 (48%), Gaps = 13/229 (5%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G+G G VY A Q VA++Q++ E+L++ ++ N+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
GD+ +V E+++ GSL + + D+ + R + + LE+LH VI+
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLH---SNQVIH 139
Query: 182 RDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
RD K+ NILL + + KL+DFG A++ P K + ++GT + APE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAKPLLRDKKKFTMM 288
D++S G++ +E+I G N P L+ T P L++ +K + +
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-19
Identities = 78/267 (29%), Positives = 117/267 (43%), Gaps = 35/267 (13%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVK--QLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIG 118
L+G G YG VY+G +VVA+K LD + S + EV +LS ++ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQPPNITK 66
Query: 119 YCA---DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
Y G + ++ E+ GS+ P ++ + R + L+Y+H V
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA-----LKYIHKV- 120
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
VI+RD KA+NIL+ N KL DFG+ A L K ST V GT + APE
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--STFV-GTPYWMAPEVITE 175
Query: 235 GQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293
G+ K+D++S G+ + E+ TG + L+ +KP P L
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-------------PRL 222
Query: 294 EGQYPRKGLYQALAVAGMCLQEDADSR 320
E K L + +A CL E+ R
Sbjct: 223 EDNGYSKLLREFVA---ACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-19
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 25/207 (12%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL--DRSGNQGSREFFA---EVLMLSLVQHQNLVN 115
L+G+G +GRVY Y + +AVKQ+ D + +E A E+ +L +QH+ +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 116 LIGYCADGDQRILVY-EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
G C D+ + ++ E+M GS+++ E + TR K +G+EYLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TR-KYTRQILEGVEYLHS- 122
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAK------LGPTGGKDHVSTRVMGTYGYCA 228
+++RD K +NIL D+ N KL DFG +K TG K V GT + +
Sbjct: 123 --NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----VTGTPYWMS 175
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELIT 255
PE +K+DV+S G ++E++T
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-18
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 62 VGEGGYGRV----YKGYIEAVDQVVAVKQLD-RSGNQGSREFFAEVLMLSLVQHQNLVNL 116
+GEG +G+V Y + + VAVK L SG + E+ +L + H+N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 117 IGYCA-DGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
G C DG I L+ EF+ +GSL+ + LP ++ ++ ++K A KG++YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEY---LPRNKNKINLKQQLKYAVQICKGMDYL--- 125
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG-----KDHVSTRVMGTYGYCAP 229
++RD A N+L+++E K+ DFGL K T KD + + V + AP
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF----WYAP 181
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELIT 255
E + + SDV+SFGV L EL+T
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 9/199 (4%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLD-RSGNQGSRE-FFAEVLMLSLVQHQNLVNLIG 118
+G+G YG VYK + +Q A+K++D S +Q RE E+ +L+ V H N+++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
DG++ +V E+ G L ++ + +I +GL+ LH+
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--- 123
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
+++RD K++NILL A K+ D G++K+ K +++ +GT Y APE +
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKV----LKKNMAKTQIGTPHYMAPEVWKGRPYS 179
Query: 239 KKSDVYSFGVVLLELITGR 257
KSD++S G +L E+ T
Sbjct: 180 YKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-18
Identities = 67/201 (33%), Positives = 104/201 (51%), Gaps = 18/201 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V+ G +V AVK L + G F E ++ ++H LV L Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 122 DGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
++ I +V E+MS GSL + D + L + +A A G+ Y+ + I
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN---YI 124
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQL 237
+RD +++NIL+ K++DFGLA+L +D+ T G + APE A+ G+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI----EDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 238 TKKSDVYSFGVVLLELIT-GR 257
T KSDV+SFG++L EL+T GR
Sbjct: 181 TIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 41/225 (18%)
Query: 62 VGEGGYGRVYKGYIEAV-----DQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVN 115
+G+G +GRV++ + +VAVK L + + +F E +++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFL-------------------DLPPDQEPLDWFT 156
L+G CA G L++E+M+ G L N FL + PL
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDL-NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 157 RMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL------AKLGPT 210
++ IA A G+ YL ++ ++RD N L+ K++DFGL A
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
D + R M PE + T +SDV+++GVVL E+ +
Sbjct: 189 SENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 70/230 (30%), Positives = 95/230 (41%), Gaps = 38/230 (16%)
Query: 49 LADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLML-SL 107
L D T F ++GEG YG+VYK + Q+VA+K +D ++ E E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59
Query: 108 VQHQNLVNLIG------YCADGDQRILVYEFMSNGS---LENHFLDLPPDQEPLDWFTRM 158
H N+ G + DQ LV E GS L R+
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG---------KRL 110
Query: 159 K------IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTG 211
K I +GL YLH+ VI+RD K NILL KL DFG+ A+L T
Sbjct: 111 KEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL 167
Query: 212 GKDHVSTRVMGTYGYCAPE-----YAMTGQLTKKSDVYSFGVVLLELITG 256
G+ + GT + APE +SDV+S G+ +EL G
Sbjct: 168 GRRNTFI---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-18
Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 35/229 (15%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS-------GNQGSREFFAEVLMLS 106
++F ++GEG + V + ++ A+K LD+ E EVL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE--KEVLTR- 57
Query: 107 LVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK 166
L H ++ L D + V E+ NG L + E F A
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF----YAAEILL 113
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK------------- 213
LEYLH +I+RD K NILLD + + K++DFG AK+
Sbjct: 114 ALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 214 -DHVSTR----VMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
+ R +GT Y +PE K SD+++ G ++ +++TG+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-18
Identities = 81/291 (27%), Positives = 128/291 (43%), Gaps = 49/291 (16%)
Query: 62 VGEGGYGRVYKGYIEAV-----DQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVN 115
+G+G +G VY+G + + VAVK ++ S + R EF E ++ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE-----PLDWFTRM-KIAGGAAKGLE 169
L+G + G ++V E M++G L+++ L P+ E P M ++A A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK------LGPTGGKDHVSTRVMGT 223
YL+ ++RD A N ++ +F K+ DFG+ + GGK + R M
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 188
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283
APE G T SD++SFGVVL E IT + S EQ L
Sbjct: 189 ----APESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL------------ 231
Query: 284 KFTMMADPLLEGQY---PRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
KF M +G Y P + + MC Q + RP +++V L+
Sbjct: 232 KFVM------DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-18
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 61 LVGEGGYGRVYKGYIEAVDQV------VAVKQLDR-SGNQGSREFFAEVLMLSLVQHQNL 113
+G G +G VY+G + VAVK L + + +Q +EF E ++S H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFT---RMKIAGGAAKGLEY 170
V L+G C + + ++ E M G L ++ D ++ T + I AKG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 171 LHDVADPPVIYRDFKASNILL-----DAEFNPKLSDFGLAK------LGPTGGKDHVSTR 219
L + I+RD A N L+ DA+ K+ DFGLA+ G+ + R
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 220 VMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
M APE + G+ T +SDV+SFGV++ E++T
Sbjct: 179 WM------APESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL-----DRSGNQGSREFFA----EVLMLSLVQHQ 111
L+G G +G VY G + +++AVKQ+ S R E+ +L +QH+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPL-DWFTRMKIAGGAAKGLEY 170
N+V +G D D + E++ GS+ + +E L F R + KGL Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-----KGLNY 121
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK------LGPTGGKDHVSTRVMGTY 224
LH+ +I+RD K +NIL+D + K+SDFG++K L S + G+
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS--LQGSV 176
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
+ APE T+K+D++S G +++E++TG+
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 29/263 (11%)
Query: 81 VVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLE 139
+VAVK L N+ +R +F EV +LS ++ N++ L+G C D D ++ E+M NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL- 106
Query: 140 NHFL-------------DLPPDQEPL---DWFTRMKIAGGAAKGLEYLHDVADPPVIYRD 183
N FL D P L + + + +A A G++YL + ++RD
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRD 163
Query: 184 FKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDV 243
N L+ K++DFG+++ G + R + + A E + G+ T SDV
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 244 YSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLY 303
++FGV L E++ ++EQ ++ A RD+ + + P Q GLY
Sbjct: 224 WAFGVTLWEILMLCKEQPYGELTDEQ-VIENAGEFFRDQGRQVYLFRPPPCPQ----GLY 278
Query: 304 QALAVAGMCLQEDADSRPFMVDV 326
+ + C D RP D+
Sbjct: 279 ELML---QCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 7e-18
Identities = 68/261 (26%), Positives = 119/261 (45%), Gaps = 29/261 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G+G G VY A Q VA+KQ++ E+L++ ++ N+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
GD+ +V E+++ GSL + + D+ + R + + L++LH VI+
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLH---SNQVIH 138
Query: 182 RDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
RD K+ NILL + + KL+DFG A++ P K + ++GT + APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAKPLLRDKKKFTMMADPLLEGQYPR 299
D++S G++ +E++ G N P L+ T P L++ ++ + + L
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN----- 250
Query: 300 KGLYQALAVAGMCLQEDADSR 320
CL+ D D R
Sbjct: 251 -----------RCLEMDVDRR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-18
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVD-----QVVAVKQLDRSGNQGS-REFFAEVLMLSLV 108
N +GEG +G+V K + VAVK L + + R+ +E +L V
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSL--------------------ENHFLDLPPD 148
H +++ L G C+ +L+ E+ GSL N PD
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 149 QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208
+ L + A ++G++YL A+ +++RD A N+L+ K+SDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-- 175
Query: 209 PTGGKDHVSTRVMG--TYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+D R G + A E T +SDV+SFGV+L E++T
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-18
Identities = 67/206 (32%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
E+ D +G+G +G V+ G +V A+K L + G F E ++ ++H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 114 VNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
V L Y ++ I +V EFM GSL + + D + L + +A A G+ Y+
Sbjct: 64 VPL--YAVVSEEPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAP 229
+ I+RD +A+NIL+ K++DFGLA+L +D+ T G + AP
Sbjct: 120 RMN---YIHRDLRAANILVGDNLVCKIADFGLARLI----EDNEYTARQGAKFPIKWTAP 172
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELIT 255
E A+ G+ T KSDV+SFG++L EL+T
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 7e-18
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 34/221 (15%)
Query: 62 VGEGGYGRVY------------KGYIEAVDQ--VVAVKQLDRSGNQGSR-EFFAEVLMLS 106
+GEG +G V+ +G E Q +VAVK L + +R +F E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 107 LVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTR--------- 157
+++ N++ L+G C D ++ E+M NG L N FL +E FT
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-NQFLS---QREIESTFTHANNIPSVSI 128
Query: 158 ---MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214
+ +A A G++YL A ++RD N L+ + K++DFG+++ +G
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ R + + A E + G+ T SDV++FGV L E+ T
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-18
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSL 107
N +G G +G V+ E + +V VK L ++ ++ + EF E+ M
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 108 VQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFL------DLPPDQEPLDWFTRMKIA 161
+ H+N+V L+G C + + ++ E+ G L+ FL D PL ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLK-QFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM 221
A G+++L ++ ++RD A N L+ ++ K+S L+K + + +
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNAL 179
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE + KSDV+SFGV++ E+ T
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-18
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 32/216 (14%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
E+ + +G+G +G V+ G +V A+K L + G F E ++ ++H+ L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 114 VNLIGYCADGDQRI-LVYEFMSNGSL-------ENHFLDLPPDQEPLDWFTRMKIAGGAA 165
V L Y ++ I +V E+MS GSL +L LP + +A A
Sbjct: 64 VQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP---------QLVDMAAQIA 112
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT-- 223
G+ Y+ + ++RD +A+NIL+ K++DFGLA+L +D+ T G
Sbjct: 113 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKF 165
Query: 224 -YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GR 257
+ APE A+ G+ T KSDV+SFG++L EL T GR
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 73/294 (24%), Positives = 135/294 (45%), Gaps = 37/294 (12%)
Query: 62 VGEGGYGRVY----KGYIEAVDQ------------VVAVKQLDRSGNQGSR-EFFAEVLM 104
+GEG +G V+ +G + +D+ +VAVK L N+ +R +F E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 105 LSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLD--------WFT 156
+S ++ N++ L+ C D ++ E+M NG L N FL QE + + T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISYST 131
Query: 157 RMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV 216
+ +A A G++YL + ++RD N L+ + K++DFG+++ +G +
Sbjct: 132 LIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK 276
R + + + E + G+ T SDV++FGV L E++T S+ S+EQ ++
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTG 247
Query: 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330
RD+ + + P P L ++ C + +A RP ++ L
Sbjct: 248 EFFRDQGRQVYLPKP---ALCPD--SLYKLMLS--CWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 63/212 (29%), Positives = 109/212 (51%), Gaps = 35/212 (16%)
Query: 61 LVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVN 115
++G G +G V G ++ + VA+K L ++G + R+F +E ++ H N+++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG---GAAKGLEYLH 172
L G ++V E+M NGSL+ FL Q FT +++ G G A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDA-FLRKHDGQ-----FTVIQLVGMLRGIASGMKYLS 123
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL---------GPTGGKDHVSTRVMGT 223
D+ ++RD A NIL+++ K+SDFGL+++ GGK + R
Sbjct: 124 DMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK--IPIR---- 174
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE + T SDV+S+G+V+ E+++
Sbjct: 175 --WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 21/199 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
+G G +G V+ G + A + VAVK + +F E +L H N+V LIG C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEP-LDWFTRMKIAGGAAKGLEYLHDVADPPV 179
+V E + G FL + P L +++ AA G+EYL
Sbjct: 63 TQKQPIYIVMELVQGGD----FLTFLRTEGPRLKVKELIQMVENAAAGMEYLES---KHC 115
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAK------LGPTGGKDHVSTRVMGTYGYCAPEYAM 233
I+RD A N L+ + K+SDFG+++ TGG + + + APE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK------WTAPEALN 169
Query: 234 TGQLTKKSDVYSFGVVLLE 252
G+ + +SDV+SFG++L E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 60/205 (29%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQV---VAVKQLDRSGNQG-SREFFAEV-LMLSLVQHQNLVN 115
+G+G +G V +G VAVK L +F E +M SL H+NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLD--WFTRMKIAGGAAKGLEYLHD 173
L G ++V E GSL + + ++IA G+ YL
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLES 115
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST---RVMGTYGYCAPE 230
I+RD A NILL ++ K+ DFGL + P +V +V + +CAPE
Sbjct: 116 ---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPE 170
Query: 231 YAMTGQLTKKSDVYSFGVVLLELIT 255
T + SDV+ FGV L E+ T
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 67/215 (31%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA--EVLMLSLVQHQNLVNLI 117
+GEG YG V+K Q+VA+K+ S + + A E+ ML ++H NLVNLI
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
+ LV+E+ + L + L+ P + KI + + + H
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVL--NELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN-- 120
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGK--DHVSTRVMGTYGYCAPEYAMT 234
I+RD K NIL+ + KL DFG A+ L G D+V+TR Y APE +
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL-LV 173
Query: 235 G--QLTKKSDVYSFGVVLLELIT------GRSAID 261
G Q DV++ G V EL+T G+S +D
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G YG VYK A ++VA+K + E+ ML +H N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 122 DGDQRILVYEFMSNGSLEN--HFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
D+ +V E+ GSL++ P + + + R KGL YLH+
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKGLAYLHETG---K 122
Query: 180 IYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYA---MTG 235
I+RD K +NILL + + KL+DFG+ A+L T K +GT + APE A G
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK---RKSFIGTPYWMAPEVAAVERKG 179
Query: 236 QLTKKSDVYSFGVVLLEL 253
K D+++ G+ +EL
Sbjct: 180 GYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-17
Identities = 79/264 (29%), Positives = 116/264 (43%), Gaps = 34/264 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNLIGYC 120
+G+G +G VYKG +VVA+K +D + E E+ +LS + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
G + ++ E++ GS LDL PL+ I KGL+YLH I
Sbjct: 72 LKGTKLWIIMEYLGGGSA----LDLL-KPGPLEETYIATILREILKGLDYLHSERK---I 123
Query: 181 YRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTK 239
+RD KA+N+LL + + KL+DFG+A +L T K + +GT + APE
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAYDF 180
Query: 240 KSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQY-- 297
K+D++S G+ +EL G + P L+ P P LEGQY
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQYSK 227
Query: 298 PRKGLYQALAVAGMCLQEDADSRP 321
P K +A CL +D RP
Sbjct: 228 PFKEFVEA------CLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 70/277 (25%), Positives = 112/277 (40%), Gaps = 41/277 (14%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V+ G A +V A+K + G +F E ++ + H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
+V EFM NG L N+ L Q L + + +G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCLLNY---LRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 182 RDFKASNILLDAEFNPKLSDFGLAK-------LGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
RD A N L+ + K+SDFG+ + +G K V + PE
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK--------WSPPEVFNF 175
Query: 235 GQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293
+ + KSDV+SFGV++ E+ T G+ + E +++ L R
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR------------- 222
Query: 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330
P+ V C E + RP +++ A+
Sbjct: 223 ----PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 55/183 (30%), Positives = 88/183 (48%), Gaps = 13/183 (7%)
Query: 82 VAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLEN 140
VAVK L + +R +F EV +LS + N+ L+G C ++ E+M NG L N
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-N 107
Query: 141 HFL--------DLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD 192
FL L + + L + T + +A A G+ YL ++RD N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVG 164
Query: 193 AEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLE 252
+ K++DFG+++ + V R + A E + G+ T KSDV++FGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 253 LIT 255
++T
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQL------DRSGNQGSREFFAEVLMLSLVQHQNLVN 115
+GEG +G V+K + VA+K++ NQ RE + L QH +V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVK 63
Query: 116 LIGYCADGDQRILVYEFMSNGSLEN--HFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
L+ G +LV E+M L + P + + + RM + KG+ Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL-----KGVAYMHA 117
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
+++RD K +N+L+ A+ K++DFGLA+L S +V T Y APE
Sbjct: 118 NG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLY 173
Query: 234 TGQ-LTKKSDVYSFGVVLLELITGR 257
+ D+++ G + EL+ G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY 119
+G G +G+VY +++AVK+ + + + +E E+ +L L++H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
++ + E+ S G+LE +L LD +GL YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLE----ELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGKDHVSTRV---MGTYGYCAPEYAMTG 235
++RD K +NI LD KL DFG A L V GT Y APE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPEVITGG 178
Query: 236 QLTKK---SDVYSFGVVLLELITGR---SAIDN 262
+ +D++S G V+LE+ TG+ S +DN
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 89/300 (29%), Positives = 129/300 (43%), Gaps = 34/300 (11%)
Query: 34 FGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ 93
+G ++ + L D T+ + +G+G YG+VYK + + AVK LD +
Sbjct: 2 YGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV 61
Query: 94 GSREFFAEVLML-SLVQHQNLVNLIG--YCAD---GDQRILVYEFMSNGSLENHFLDLPP 147
E AE +L SL H N+V G Y AD G Q LV E + GS+ L
Sbjct: 62 -DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 148 DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AK 206
+ LD I GA GL++LH+ +I+RD K +NILL E KL DFG+ A+
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKS-----DVYSFGVVLLELITGRSAID 261
L T + + S +GT + APE Q S DV+S G+ +EL G +
Sbjct: 178 LTSTRLRRNTS---VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
Query: 262 NSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
+ P K F + +P +P K CL +D ++RP
Sbjct: 235 DMHPV---------------KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARP 279
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V+ GY +V AVK L + G + F E ++ +QH LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQE--PLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
+ ++ E+M+ GSL LD E + + + A+G+ Y +
Sbjct: 72 KEEPIYIITEYMAKGSL----LDFLKSDEGGKVLLPKLIDFSAQIAEGMAY---IERKNY 124
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY--GYCAPEYAMTGQL 237
I+RD +A+N+L+ K++DFGLA++ + + R + + APE G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 238 TKKSDVYSFGVVLLELIT 255
T KSDV+SFG++L E++T
Sbjct: 182 TIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQL---DRSGNQGSREFFA--EVLMLSLVQ 109
+ +GEG Y VYK + ++VA+K++ +R + F A E+ +L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 110 HQNLVNLIG-YCADGDQRI-LVYEFMSNGSLE----NHFLDL-PPDQEPLDWFTRMKIAG 162
H N++ L+ + I LV+EFM LE + + L P D + T
Sbjct: 61 HPNIIGLLDVFGHK--SNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT------ 111
Query: 163 GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMG 222
+GLEYLH +++RD K +N+L+ ++ KL+DFGLA+ + + ++ +V+
Sbjct: 112 --LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-KMTHQVV- 164
Query: 223 TYGYCAPEYAM-TGQLTKKSDVYSFGVVLLELITGR 257
T Y APE D++S G + EL+
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 34/220 (15%)
Query: 62 VGEGGYGRVYKGYIEAVDQ-------VVAVKQL-DRSGNQGSREFFAEVLMLSLV-QHQN 112
+GEG +G+V + +D+ VAVK L D + ++ + +E+ ++ L+ +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHF-------LDLPPD-----QEPLDWFTRMKI 160
++NL+G C ++ E+ + G+L D D +E L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A A+G+EYL I+RD A N+L+ + K++DFGLA+ G +
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDIDYYK 191
Query: 221 MGTYG-----YCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ G + APE T +SDV+SFG+++ E+ T
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 62/234 (26%), Positives = 107/234 (45%), Gaps = 13/234 (5%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+GEG G V +++ ++VAVK++D Q F EV+++ QH+N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
GD+ +V EF+ G+L + ++E + + K L LH VI+
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQG---VIH 139
Query: 182 RDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKS 241
RD K+ +ILL + KLSDFG + ++GT + APE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 242 DVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295
D++S G++++E++ G N P + ++ + L K K P L+G
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKNLHKVSPSLKG 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 18/203 (8%)
Query: 61 LVGEGGYGRVYKGYI----EAVDQVVAVKQLDRS-GNQGSREFFAEVLMLSLVQHQNLVN 115
++G G +G VYKG E V VA+K L+ + G + + EF E L+++ + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHF---LDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
L+G C + LV + M +G L ++ D Q L+W ++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
+ +++RD A N+L+ + + K++DFGLA+L K++ + + A E
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 233 MTGQLTKKSDVYSFGVVLLELIT 255
+ T +SDV+S+GV + EL+T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 77/273 (28%), Positives = 118/273 (43%), Gaps = 30/273 (10%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQ 109
D E F +G+G +G V+KG QVVA+K +D + E E+ +LS
Sbjct: 1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
+ G G + ++ E++ GS LDL P D F + KGL+
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSA----LDLL-RAGPFDEFQIATMLKEILKGLD 115
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCA 228
YLH I+RD KA+N+LL + + KL+DFG+A +L T K + +GT + A
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT---FVGTPFWMA 169
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288
PE K+D++S G+ +EL G + P L+ P
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP----------- 218
Query: 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
P L G++ + ++ A CL +D RP
Sbjct: 219 --PTLTGEFSKP--FKEFIDA--CLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 17/227 (7%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+GEG G V ++ + VAVK++D Q F EV+++ QH N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
GD+ +V EF+ G+L + ++E + + K L +LH VI+
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVL-----KALSFLHAQG---VIH 138
Query: 182 RDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTR--VMGTYGYCAPEYAMTGQLT 238
RD K+ +ILL ++ KLSDFG A++ V R ++GT + APE
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQV-----SKEVPRRKSLVGTPYWMAPEVISRLPYG 193
Query: 239 KKSDVYSFGVVLLELITGRSAIDNSRPSEE-QNLVTWAKPLLRDKKK 284
+ D++S G++++E++ G N P + + + P L++ K
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 25/201 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---REFFAEVLMLSLVQHQNLVNLIG 118
+G G +G VY ++VVA+K++ SG Q + ++ EV L ++H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 119 YCADGDQRILVYEFM---SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
LV E+ ++ LE H ++PL I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAITHGALQGLAYLHS-- 143
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT- 234
+I+RD KA NILL KL+DFG A + + +GT + APE +
Sbjct: 144 -HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAM 196
Query: 235 --GQLTKKSDVYSFGVVLLEL 253
GQ K DV+S G+ +EL
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-16
Identities = 65/203 (32%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLI 117
++G+GG+G V + A ++ A K+L++ +G E +L V Q +VNL
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDL--PPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
D LV M+ G L+ H ++ P +E F +I G LE LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG----LEDLHREN 122
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG 235
+YRD K NILLD + ++SD GLA P G + + RV GT GY APE
Sbjct: 123 ---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV-GTVGYMAPEVLNNQ 176
Query: 236 QLTKKSDVYSFGVVLLELITGRS 258
+ T D + G ++ E+I G+S
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-16
Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 61 LVGEGGYGRVYK------GYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLV 114
+G G + Y+ G + AV QV V+ + E+ +++ + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 115 NLIG-YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
++G C D + V E+M+ GS+ + +E + + +GL YLH+
Sbjct: 67 RMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAV----IINYTEQLLRGLSYLHE 121
Query: 174 VADPPVIYRDFKASNILLDAEFNP-KLSDFGLA-KLGPTG-GKDHVSTRVMGTYGYCAPE 230
+I+RD K +N+L+D+ +++DFG A +L G G +++GT + APE
Sbjct: 122 ---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGR 257
Q + DV+S G V++E+ T +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 24/204 (11%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL----DRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
+VGEG +GR DQ A+K++ S + SR+ E ++L+ ++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 117 I-GYCADGDQRILVYEFMSNGSLENHFLD----LPPDQEPLDWFTRMKIAGGAAKGLEYL 171
+ ADG I V E+ G L L P+ L WF +M + G++++
Sbjct: 64 KESFEADGHLYI-VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
H+ V++RD K+ NI L KL DFG A+L + G + T V GT Y PE
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YACTYV-GTPYYVPPEI 171
Query: 232 AMTGQLTKKSDVYSFGVVLLELIT 255
KSD++S G +L EL T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 75/215 (34%), Positives = 101/215 (46%), Gaps = 29/215 (13%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLM-LSLVQHQN----LVN 115
+G G G+VYK + V+AVKQ+ R+GN +E +LM L +V + +V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN---KEENKRILMDLDVVLKSHDCPYIVK 78
Query: 116 LIGY-CADGDQRILVYEFMSNGSLENHFLD--LPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
GY D D I + E MS LD L Q P+ K+ K L YL
Sbjct: 79 CYGYFITDSDVFICM-ELMST------CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPEY 231
+ VI+RD K SNILLDA N KL DFG++ +L K TR G Y APE
Sbjct: 132 E--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK--TRSAGCAAYMAPER 185
Query: 232 ----AMTGQLTKKSDVYSFGVVLLELITGRSAIDN 262
+ ++DV+S G+ L+EL TG+ N
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 71/235 (30%), Positives = 105/235 (44%), Gaps = 31/235 (13%)
Query: 43 VFKYQELADATENFNPDCL------VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS- 95
V K E+AD +P+ + +G G +G VY ++VVAVK++ SG Q +
Sbjct: 4 VVKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE 63
Query: 96 --REFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM---SNGSLENHFLDLPPDQE 150
++ EV L ++H N + G LV E+ ++ LE H ++
Sbjct: 64 KWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH-------KK 116
Query: 151 PLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210
PL I GA +GL YLH +I+RD KA NILL KL+DFG A
Sbjct: 117 PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173
Query: 211 GGKDHVSTRVMGTYGYCAPEYAMT---GQLTKKSDVYSFGVVLLELITGRSAIDN 262
+ +GT + APE + GQ K DV+S G+ +EL + + N
Sbjct: 174 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 6e-16
Identities = 69/202 (34%), Positives = 94/202 (46%), Gaps = 27/202 (13%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---REFFAEVLMLSLVQHQNLVNLIG 118
+G G +G VY ++VVA+K++ SG Q + ++ EV L ++H N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 119 YCADGDQRILVYEFMSNGS----LENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
LV E+ GS LE H ++PL I GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVH-------KKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE--YA 232
I+RD KA NILL KL+DFG A L ++ V GT + APE A
Sbjct: 135 E---RIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFV-GTPYWMAPEVILA 185
Query: 233 M-TGQLTKKSDVYSFGVVLLEL 253
M GQ K DV+S G+ +EL
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 6e-16
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLM-----LSLV-QHQNLV 114
++G+G +G+V ++ D++ AVK L + + E M L+L +H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
L D+ V E+++ G L H EP F A GL++LH+
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF----YAAEIVLGLQFLHER 115
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAPEYAM 233
+IYRD K N+LLD+E + K++DFG+ K G GG V+T GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDYIAPEILS 169
Query: 234 TGQLTKKSDVYSFGVVLLELITGRSAID 261
D ++ GV+L E++ G+S +
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 30/213 (14%)
Query: 62 VGEGGYGRVYKGYIEAVDQ-VVAVKQLDRSGNQGSRE---FFAEVLMLSLVQHQNLVNLI 117
+G+G +G V K D ++ K++D GN +E +EV +L ++H N+V
Sbjct: 8 IGKGSFGTVRK-VRRKSDGKILVWKEID-YGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 118 GYCADGDQRIL--VYEFMSNGSL---------ENHFLDLPPDQEPLDWFTRMKIAGGAAK 166
D + L V E+ G L E ++ ++ T++ +A
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI---EEEFIWRILTQLLLA----- 117
Query: 167 GLEYLH--DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
L H V++RD K +NI LDA N KL DFGLAK+ T V GT
Sbjct: 118 -LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTYV-GTP 174
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
Y +PE +KSD++S G ++ EL
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 77/274 (28%), Positives = 112/274 (40%), Gaps = 32/274 (11%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQ 109
D E F +G+G +G V+KG +VVA+K +D + E E+ +LS
Sbjct: 1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
+ G + ++ E++ GS LDL + PLD I KGL+
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSA----LDLL-EPGPLDETQIATILREILKGLD 115
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
YLH I+RD KA+N+LL KL+DFG+A G +GT + AP
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAP 170
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289
E K+D++S G+ +EL G P + L+ P
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------ 218
Query: 290 DPLLEGQY--PRKGLYQALAVAGMCLQEDADSRP 321
P LEG Y P K +A CL ++ RP
Sbjct: 219 -PTLEGNYSKPLKEFVEA------CLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 65/254 (25%), Positives = 112/254 (44%), Gaps = 32/254 (12%)
Query: 82 VAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENH 141
VA+K + + G+ EF E ++ + H+ LV L G C +V E+MSNG L N+
Sbjct: 31 VAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89
Query: 142 FLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSD 201
+ +P +++ +G+ YL I+RD A N L+D + K+SD
Sbjct: 90 LREHGKRFQPSQL---LEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSD 143
Query: 202 FGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GR 257
FGL++ D T +G+ + PE + + + KSDV++FGV++ E+ + G+
Sbjct: 144 FGLSRY----VLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199
Query: 258 SAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDA 317
+ SE V+ L R P + A+ C E A
Sbjct: 200 MPYERFNNSETVEKVSQGLRLYR-----------------PHLASEKVYAIMYSCWHEKA 242
Query: 318 DSRPFMVDVVTALE 331
+ RP +++++E
Sbjct: 243 EERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-15
Identities = 54/218 (24%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH 110
+ EN ++G+G YG VY + +A+K++ ++ + E+ + S ++H
Sbjct: 6 EYDEN-GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH 64
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGS----LENHFLDLPPDQEPLDWFTRMKIAGGAAK 166
+N+V +G ++ + E + GS L + + L +++ + ++T+ + +
Sbjct: 65 RNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----E 119
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNP-KLSDFG----LAKLGPTGGKDHVSTRVM 221
GL+YLHD +++RD K N+L++ K+SDFG LA + P +
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFT 170
Query: 222 GTYGYCAPEYAMTGQ--LTKKSDVYSFGVVLLELITGR 257
GT Y APE G +D++S G ++E+ TG+
Sbjct: 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 17/199 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLVQHQNLVNLI 117
+ +G +G VY + A+K L +S NQ + +M+ + + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
D LV E+++ G + L P DW + G+E LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAK--QYIAEVVLGVEDLHQRG-- 117
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
+I+RD K N+L+D + KL+DFGL++ G + + +GT Y APE +
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGD 170
Query: 238 TKKSDVYSFGVVLLELITG 256
K SD +S G V+ E + G
Sbjct: 171 DKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 62 VGEGGYGRVYKGYIEAV-----DQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVN 115
+GE +G+VYKG++ Q VA+K L D++ EF E +M S +QH N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQ---------------EPLDWFTRMKI 160
L+G +++ + S+ L + P EP D+ I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV---HI 129
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A G+E+L + V+++D N+L+ + N K+SD GL + +
Sbjct: 130 VTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 221 MGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ + +PE M G+ + SD++S+GVVL E+ +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL--DRSGNQGSREFFA---EVLMLSLVQHQNLVN 115
L+G+G +GRVY Y + +A KQ+ D + S+E A E+ +L +QH+ +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 116 LIGYCADGDQRILV--YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
G D ++ L E+M GS+++ E + TR K +G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV---TR-KYTRQILEGMSYLHS 124
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR-VMGTYGYCAPEYA 232
+++RD K +NIL D+ N KL DFG +K T R V GT + +PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 233 MTGQLTKKSDVYSFGVVLLELITGR 257
+K+DV+S G ++E++T +
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-15
Identities = 73/302 (24%), Positives = 133/302 (44%), Gaps = 68/302 (22%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAV-------DQVVAVKQLD--RSGNQGSREFFAEVLML 105
++ P ++G+G +G EA D +V K+++ R + R+ E+++L
Sbjct: 1 HYIPIRVLGKGAFG-------EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVIL 53
Query: 106 SLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL--------ENHFLDLPPDQEPLDWFTR 157
SL+QH N++ + D + ++ E+ + G+L F ++ L + +
Sbjct: 54 SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF----EEEMVLWYLFQ 109
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
+ + Y+H +++RD K NI L KL DFG++K+ G + ++
Sbjct: 110 I------VSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMA 158
Query: 218 TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277
V+GT Y +PE + KSD+++ G VL EL+T + D + P NLV
Sbjct: 159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV---- 211
Query: 278 LLRDKKKFTMMADPLLEGQY-PRKGLYQA--LAVAGMCLQEDADSRPFMVDVVTALEYLS 334
+++G Y P +Y + +++ LQ+D + RP TA E L
Sbjct: 212 -------------KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRP------TADEVLD 252
Query: 335 SP 336
P
Sbjct: 253 QP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 3e-15
Identities = 60/221 (27%), Positives = 95/221 (42%), Gaps = 61/221 (27%)
Query: 62 VGEGGYGRVY------KGYIEAV-----DQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH 110
+G G +GRV G A+ ++V +KQ++ N E +L ++H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN--------EKRILQSIRH 60
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG----GAAK 166
LVNL G D LV E++ G L F+ ++ +G A+
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL----------------FSHLRKSGRFPEPVAR 104
Query: 167 --------GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
LEYLH + ++YRD K N+LLD++ K++DFG AK V
Sbjct: 105 FYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKG 153
Query: 219 RVM---GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG 256
R GT Y APE ++ K D ++ G+++ E++ G
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL--DRSGNQGSREFFA---EVLMLSLVQHQNLVN 115
L+G+G +GRVY Y + +AVKQ+ D + S+E A E+ +L + H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 116 LIGYCADGDQRIL--VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
G D +R L E M GS+++ E + TR K +G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV---TR-KYTRQILEGVSYLHS 124
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAK------LGPTGGKDHVSTRVMGTYGYC 227
+++RD K +NIL D+ N KL DFG +K L TG K V GT +
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----VTGTPYWM 176
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGR 257
+PE +K+D++S G ++E++T +
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 66/215 (30%), Positives = 105/215 (48%), Gaps = 33/215 (15%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLVQHQNLVNL 116
+GEG YG+VYK + ++VA+K++ R N+ +E F E+ +L + H+N+VNL
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV-RLDNE--KEGFPITAIREIKILRQLNHRNIVNL 71
Query: 117 IGYCADGDQRI----------LVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGG 163
D + LV+E+M + G LE+ + D + MK
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK----SFMK---Q 124
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
+GL Y H ++RD K SNILL+ + KL+DFGLA+L + + +V+ T
Sbjct: 125 LLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-T 180
Query: 224 YGYCAPEYAMTGQLTKKS-DVYSFGVVLLELITGR 257
Y PE + + + DV+S G +L EL T +
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIG 118
+G+GG+G V ++ ++ A K+LD+ G + E +L V +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 119 YCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
Y + + LV M+ G L+ H ++ + L+ + + G+ +LH +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
++YRD K N+LLD + N +LSD GLA GK T+ GT GY APE
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMAPEILKEEPY 171
Query: 238 TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285
+ D ++ G + E++ GR+ + + + + + L D+ KF
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK--RRTLEDEVKF 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQ-------VVAVKQL-DRSGNQGSREFFAEVLMLSLV-QHQN 112
+GEG +G+V +D+ VAVK L D + + + +E+ M+ ++ +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKI 160
++NL+G C ++ E+ S G+L + P E + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A+G+EYL A I+RD A N+L+ K++DFGLA+ D+
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTT 197
Query: 221 MGTY--GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
G + APE T +SDV+SFGV++ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 44/133 (33%), Positives = 71/133 (53%), Gaps = 14/133 (10%)
Query: 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKA 186
+ EFM GSL+ + P + KIA +GL YL++V +++RD K
Sbjct: 79 CMCMEFMDCGSLDRIYKKGGPIPVEI----LGKIAVAVVEGLTYLYNVHR--IMHRDIKP 132
Query: 187 SNILLDAEFNPKLSDFGLAKLGPTGGK--DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVY 244
SNIL+++ KL DFG++ G+ + ++ +GT Y +PE G+ T KSDV+
Sbjct: 133 SNILVNSRGQIKLCDFGVS------GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVW 186
Query: 245 SFGVVLLELITGR 257
S G+ ++EL G+
Sbjct: 187 SLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-15
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+GEG G V + + VAVK++D Q F EV+++ H+N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
GD+ +V EF+ G+L + ++E + + + L YLH+ VI+
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQG---VIH 141
Query: 182 RDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
RD K+ +ILL ++ KLSDFG A++ K ++GT + APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWMAPEVISRLPYGTE 198
Query: 241 SDVYSFGVVLLELITGRSAIDNSRP 265
D++S G++++E+I G N P
Sbjct: 199 VDIWSLGIMVIEMIDGEPPYFNEPP 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 59/220 (26%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYI--EAVDQVVAVKQLDRSGNQGS-REFFAEVLML-SLVQ 109
E+ + ++GEG +G+V + I + + A+K L ++ R+F E+ +L L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSL-----ENHFLDLPP-------DQEPLDWFTR 157
H N++NL+G C + + E+ G+L ++ L+ P L
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
++ A A G++YL ++ I+RD A N+L+ K++DFGL++ G++
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYV 173
Query: 218 TRVMGTYG--YCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ MG + A E T KSDV+SFGV+L E+++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 4e-15
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQV---VAVK--QLDRSGNQGSREFFAEVLMLSLVQHQNLVN 115
++GEG +G V +G + D VAVK +LD EF +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 116 LIGYCADGDQR------ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM--KIAGGAAKG 167
LIG C + +++ FM +G L + L P + K A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG---KDHVSTRVMGTY 224
+EYL ++ I+RD A N +L + ++DFGL+K +G + ++ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ A E T KSDV++FGV + E+ T
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-15
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 61 LVGEGGYGRVYKGYI--EAVDQVVAVKQLDRSGNQGS-REFFAEVLML-SLVQHQNLVNL 116
++GEG +G+V K I + + A+K++ ++ R+F E+ +L L H N++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 117 IGYCADGDQRILVYEFMSNGSL-----ENHFLDLPP-------DQEPLDWFTRMKIAGGA 164
+G C L E+ +G+L ++ L+ P L + A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
A+G++YL + I+RD A NIL+ + K++DFGL++ G++ + MG
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173
Query: 225 G--YCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ A E T SDV+S+GV+L E+++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIG 118
+G GG+GRV +++ ++ A+K + + F+E +L H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 119 YCADGDQRILVY---EFMSNGSL-----ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
Y D++ +Y E+ G L + D ++ R IA EY
Sbjct: 59 YRTFKDKK-YIYMLMEYCLGGELWTILRDRGLFD--------EYTARFYIAC-VVLAFEY 108
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
LH+ +IYRD K N+LLD+ KL DFG AK +G K GT Y APE
Sbjct: 109 LHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPE 162
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGR 257
+ D +S G++L EL+TGR
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 66/244 (27%), Positives = 111/244 (45%), Gaps = 25/244 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+GEG G V + + VAVK +D Q F EV+++ QHQN+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
G++ ++ EF+ G+L + ++E + + + L YLH VI+
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQG---VIH 140
Query: 182 RDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTR-VMGTYGYCAPEYAMTGQLTK 239
RD K+ +ILL + KLSDFG A++ KD + ++GT + APE
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI----SKDVPKRKSLVGTPYWMAPEVISRTPYGT 196
Query: 240 KSDVYSFGVVLLELITGR---------SAIDNSRPSEEQNLVTWAK--PLLRDKKKFTMM 288
+ D++S G++++E++ G A+ R S L K P+LRD + +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256
Query: 289 ADPL 292
+P
Sbjct: 257 REPQ 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 62 VGEGGYGRVYKGYIEAVDQ-------VVAVKQLDRSGNQGS-REFFAEVLMLSLV-QHQN 112
+GEG +G+V +D+ VAVK L + + +E+ M+ ++ +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHF---------LDLPPDQEPLDWFTRMKIAGG 163
++NL+G C ++ E+ S G+L + P Q P + + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 164 A---AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A A+G+EYL A I+RD A N+L+ + K++DFGLA+ H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 221 MGTYG-----YCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
T G + APE T +SDV+SFGV+L E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 6e-15
Identities = 71/237 (29%), Positives = 106/237 (44%), Gaps = 23/237 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLML-SLVQHQNLVNLIGY 119
LVG G YG+VYKG Q+ A+K +D +G++ E E+ ML H+N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 120 CAD------GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
DQ LV EF GS+ + + + +W I +GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH- 128
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
VI+RD K N+LL KL DFG+ A+L T G+ + +GT + APE
Sbjct: 129 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVI 183
Query: 233 MTGQLTK-----KSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW-AKPLLRDKK 283
+ KSD++S G+ +E+ G + + P L+ P L+ KK
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 28/217 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQ-------VVAVKQL-DRSGNQGSREFFAEVLMLSLV-QHQN 112
+GEG +G+V +D+ VAVK L D + ++ + +E+ M+ ++ +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHF-------LDLPPD-----QEPLDWFTRMKI 160
++NL+G C ++ E+ S G+L + +D D +E L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A A+G+EYL A I+RD A N+L+ + K++DFGLA+ D+
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDYYKKTT 194
Query: 221 MGTY--GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
G + APE T +SDV+SFGV+L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 15/218 (6%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQ 111
+FN ++G+G +G+V + D++ A+K L + + E +L+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 112 NLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
+ + C R+ V E+++ G L H + +EP F +I+ GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS----VGLFF 116
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAP 229
LH +IYRD K N++LD+E + K++DFG+ K G V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIAP 170
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267
E K D +++GV+L E++ G+ D E
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 24/208 (11%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQN---LV 114
++G GG+G VY ++ A+K LD+ QG E +MLSLV + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK---GLEYL 171
+ D+ + + M+ G L H Q + F+ ++ AA+ GLE++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGV--FSEAEMRFYAAEIILGLEHM 113
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
H+ V+YRD K +NILLD + ++SD GLA + K H S +GT+GY APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166
Query: 232 AMTGQLTKKS-DVYSFGVVLLELITGRS 258
G S D +S G +L +L+ G S
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 76/293 (25%), Positives = 120/293 (40%), Gaps = 48/293 (16%)
Query: 62 VGEGGYGRVYKGYIEAVDQV--VAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIG 118
+G G +G+V G V VK+L S F EV + H N++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPL----DWFTRMKIAGGAAKGLEYLHDV 174
C + +LV EF G L+N+ L ++ + ++A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNY---LRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLA------KLGPTGGKDHVSTRVMGTYGYCA 228
I+ D N L A+ + K+ D+GLA T V R + A
Sbjct: 120 D---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLA 170
Query: 229 PEYA-------MTGQLTKKSDVYSFGVVLLELITGRSAIDNSRP--SEEQNLVTWAKPLL 279
PE + TKKS+++S GV + EL T A D P S+EQ L K ++
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT---AADQPYPDLSDEQVL----KQVV 223
Query: 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332
R++ + P L+ +Y + Y+ + + D ++RP +V L Y
Sbjct: 224 REQD--IKLPKPQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 18/221 (8%)
Query: 56 FNPDCLVGEGGYGRVYKGYI----EAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQH 110
F ++G G +G VYKG E V VA+K+L + + + ++E E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFL---DLPPDQEPLDWFTRMKIAGGAAKG 167
++ L+G C + L+ + M G L ++ D Q L+W ++ AKG
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
+ YL + +++RD A N+L+ + K++DFGLAKL K++ + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE 268
A E + T +SDV+S+GV + EL+T S + P+ E
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLI 117
++G+GG+G V + A ++ A K+L++ +G E +L V + +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPD--QEPLDWFTRMKIAGGAAKGLEYLHDVA 175
D LV M+ G L+ H + +E F +I G LE LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQ-- 120
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG 235
++YRD K NILLD + ++SD GLA P G + RV GT GY APE
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GTVGYMAPEVVKNE 176
Query: 236 QLTKKSDVYSFGVVLLELITGRS 258
+ T D ++ G +L E+I G+S
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 52/155 (33%), Positives = 73/155 (47%), Gaps = 18/155 (11%)
Query: 108 VQHQNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK 166
+H LVNL C + + V E+ + G L H D F+ + AA
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT--------DVFSEPRAVFYAAC 109
Query: 167 ---GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
GL+YLH+ ++YRD K N+LLD E K++DFGL K G G D ST GT
Sbjct: 110 VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FCGT 164
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
+ APE T+ D + GV++ E++ G S
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 72/229 (31%), Positives = 108/229 (47%), Gaps = 66/229 (28%)
Query: 62 VGEGGYGRVYKGYIEAVD----QVVAVKQL-DRSGNQ-GSREFFAEVLMLS-LVQHQNLV 114
+G+G YG V+K A+D +VVA+K++ D N ++ F E++ L L H N+V
Sbjct: 15 LGKGAYGIVWK----AIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIV 70
Query: 115 NLIG-YCADGDQRI-LVYEFMSN--------GSLEN-HFLDLPPDQEPLDWFTRMKIAGG 163
L+ A+ D+ I LV+E+M LE+ H + I
Sbjct: 71 KLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH---------------KRYIMYQ 115
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGK-------DH 215
K L+Y+H VI+RD K SNILL+++ KL+DFGLA+ L D+
Sbjct: 116 LLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172
Query: 216 VSTRVMGTYGYCAPE-------YAMTGQLTKKSDVYSFGVVLLELITGR 257
V+TR Y APE Y TK D++S G +L E++ G+
Sbjct: 173 VATR-----WYRAPEILLGSTRY------TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLD-RSGNQG-SREFFAEVLMLSLVQHQNLVNLIGY 119
+GEG YG VYKG + Q+VA+K++ S +G E+ +L +QH N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP-- 177
+ L++EF+S L+ + LP Q +D +K YL+ +
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQY-MD-AELVK---------SYLYQILQGIL 115
Query: 178 -----PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
V++RD K N+L+D + KL+DFGLA+ G V T + T Y APE
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 233 MTGQL-TKKSDVYSFGVVLLELIT------GRSAID 261
+ + D++S G + E+ T G S ID
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 22/238 (9%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQ 111
+FN ++G+G +G+V + D++ A+K L + + E +L+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 112 NLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
+ + C R+ V E+++ G L H + +EP F +IA GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIA----IGLFF 116
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAP 229
LH +IYRD K N++LDAE + K++DFG+ K GGK +TR GT Y AP
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYIAP 170
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE------EQNLVTWAKPLLRD 281
E K D ++FGV+L E++ G+ D E E N V++ K L ++
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKE 227
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 58/203 (28%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 61 LVGEGGYGRVYKGYI----EAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVN 115
++G G +G VYKG E V VA+K L + + + ++E E +++ V +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFL---DLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
L+G C + LV + M G L ++ D Q+ L+W ++ AKG+ YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
+V +++RD A N+L+ + + K++DFGLA+L ++ + + A E
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 233 MTGQLTKKSDVYSFGVVLLELIT 255
+ + T +SDV+S+GV + EL+T
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQL--DRSGNQGSREFFA---EVLMLSLV 108
N+ L+G G +G VY Y + +AVKQ+ D + S+E A E+ +L +
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 109 QHQNLVNLIGYCADGDQRIL--VYEFMSNGSLENHFLDLPPDQEPLDW-FTRMKIAGGAA 165
+H +V G D +++ L E+M GS+++ E + +TR +
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----- 116
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK------LGPTGGKDHVSTR 219
+G+ YLH +++RD K +NIL D+ N KL DFG +K + TG K
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS----- 168
Query: 220 VMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
V GT + +PE +K+DV+S ++E++T
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLD------RSGNQGSREFFAEVLMLSLVQHQNLVN 115
+G+GG+G V + A ++ A K+L+ R G +G+ E +L+ V + +V+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGA---MVEKRILAKVHSRFIVS 57
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDL----PPDQEPLDWFTRMKIAGGAAKGLEYL 171
L LV M+ G L H ++ P EP F +I GLE+L
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQII----SGLEHL 113
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA---KLGPTGGKDHVSTRVMGTYGYCA 228
H +IYRD K N+LLD + N ++SD GLA K G + K + GT G+ A
Sbjct: 114 HQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMA 165
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELITGR 257
PE + D ++ GV L E+I R
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQN---LV 114
++G GG+G VY ++ A+K LD+ QG E +MLSLV + +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK---GLEYL 171
+ D+ + + M+ G L H Q + F+ ++ A + GLE++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGV--FSEKEMRFYATEIILGLEHM 113
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
H+ V+YRD K +NILLD + ++SD GLA + K H S +GT+GY APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166
Query: 232 AMTGQLTKKS-DVYSFGVVLLELITGRSAIDNSRPSEEQNL 271
G S D +S G +L +L+ G S + ++ +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 19/200 (9%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIG-YC 120
+G+G +G+VYK + + A K ++ + ++ E+ +L+ H +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPD-QEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
DG I++ EF G+++ L+L EP +I + LE L + +
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP-------QIQVICRQMLEALQYLHSMKI 131
Query: 180 IYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
I+RD KA N+LL + + KL+DFG+ AK T + +GT + APE M +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEVVMCETMK 188
Query: 239 K-----KSDVYSFGVVLLEL 253
K+D++S G+ L+E+
Sbjct: 189 DTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 73/257 (28%), Positives = 111/257 (43%), Gaps = 26/257 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLML-SLVQHQNLVNLIGY 119
+VG G YG+VYKG Q+ A+K +D + ++ E E+ ML H+N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 120 ------CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
DQ LV EF GS+ + + + DW I +GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH- 138
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
VI+RD K N+LL KL DFG+ A+L T G+ + +GT + APE
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVI 193
Query: 233 MTGQ-----LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW-AKPLLRDK---K 283
+ +SD++S G+ +E+ G + + P L+ P L+ K K
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253
Query: 284 KFTMMADPLLEGQYPRK 300
KF + L Y +
Sbjct: 254 KFIDFIEGCLVKNYLSR 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLV-QHQNLVNL 116
++G+G +G+V+ ++ +Q A+K L + + E +LSL +H L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
+ V E+++ G L H P F +I G L++LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSKG- 116
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
++YRD K NILLD + + K++DFG+ K G D + GT Y APE + +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQK 172
Query: 237 LTKKSDVYSFGVVLLELITGRS 258
D +SFGV+L E++ G+S
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 57/199 (28%), Positives = 104/199 (52%), Gaps = 17/199 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLI-GYC 120
+G+G +G+VYK + + A K +D + ++ E+ +L+ H N+V L+ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
+ + IL+ EF + G+++ L+L + PL T +I + LE L+ + + +I
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLEL---ERPL---TEPQIRVVCKQTLEALNYLHENKII 125
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTK- 239
+RD KA NIL + + KL+DFG++ + S +GT + APE M + +K
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMC-ETSKD 182
Query: 240 -----KSDVYSFGVVLLEL 253
K+DV+S G+ L+E+
Sbjct: 183 RPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLI 117
++G+GG+G V + A ++ A K+L++ +G E +L V + +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDL--PPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
D LV M+ G L+ H ++ P E F ++ G L D+
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG-------LEDLQ 119
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG 235
++YRD K NILLD + ++SD GLA P G + V RV GT GY APE
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETVRGRV-GTVGYMAPEVINNE 176
Query: 236 QLTKKSDVYSFGVVLLELITGRS 258
+ T D + G ++ E+I G+S
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLI 117
++G+G +G+V ++ ++ AVK L + + E +LSL ++ + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 118 GYCADGDQRIL-VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
C R+ V EF++ G L H E F +I L +LHD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SALMFLHDKG- 116
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
+IYRD K N+LLD E + KL+DFG+ K G GK ++ GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEML 172
Query: 237 LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQN 270
D ++ GV+L E++ G + P E +N
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHA------PFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 27/202 (13%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---REFFAEVLMLSLVQHQNLVNLIG 118
+G G +G VY +VVA+K++ SG Q + ++ EV L ++H N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 119 YCADGDQRILVYEFMSNGS---LENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
LV E+ + LE H ++PL + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHS-- 133
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKL-GPTGGKDHVSTRVMGTYGYCAPEYAMT 234
+I+RD KA NILL KL DFG A + P + +GT + APE +
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILA 185
Query: 235 ---GQLTKKSDVYSFGVVLLEL 253
GQ K DV+S G+ +EL
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 31/278 (11%)
Query: 61 LVGEGGYGRVYKGYI--EAVDQVVAVKQL-DRSGNQGSREFFAEVLML-SLVQHQNLVNL 116
++GEG +G+V K I + + A+K++ + + R+F E+ +L L H N++NL
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 117 IGYCADGDQRILVYEFMSNGSL-----ENHFLDLPP-------DQEPLDWFTRMKIAGGA 164
+G C L E+ +G+L ++ L+ P L + A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
A+G++YL + I+RD A NIL+ + K++DFGL++ G++ + MG
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 185
Query: 225 G--YCAPEYAMTGQLTKKSDVYSFGVVLLELI----TGRSAIDNSRPSEEQNL-VTWAKP 277
+ A E T SDV+S+GV+L E++ T + + E+ KP
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 245
Query: 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQE 315
L D + + +M E Y R Q L L+E
Sbjct: 246 LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-14
Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS-REFFAEVLMLSLVQHQNLVNLIGYC 120
+GEG Y VYKG ++VA+K++ +G+ E+ ++ ++H+N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
++ +LV+E+M L+ ++D + LD T KG+ + H+ V+
Sbjct: 68 HTENKLMLVFEYMDK-DLKK-YMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAK-LG-PTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
+RD K N+L++ KL+DFGLA+ G P + S V+ T Y AP+ + +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVV-TLWYRAPDVLLGSRTY 178
Query: 239 KKS-DVYSFGVVLLELITGR 257
S D++S G ++ E+ITGR
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 62 VGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLS-LVQHQNLV 114
+G G +G+V + VAVK L + + RE +E+ ++S L H+N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENH-------FLDLPPDQEPLDWFTRMKIAGGAAKG 167
NL+G C G +++ E+ G L N FL L E L F+ AKG
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL----EDLLSFSYQ-----VAKG 153
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV---STRVMGTY 224
+ +L A I+RD A N+LL K+ DFGLA+ ++V + R+
Sbjct: 154 MAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PV 207
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE T +SDV+S+G++L E+ +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLI 117
++G+GG+G V + A ++ A K+L++ +G E +L V + +V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK---GLEYLHDV 174
D LV M+ G L+ H ++ F + AA+ GLE LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-----FDEERAVFYAAEITCGLEDLHR- 120
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
++YRD K NILLD + ++SD GLA P G + + RV GT GY APE
Sbjct: 121 --ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRV-GTVGYMAPEVVKN 175
Query: 235 GQLTKKSDVYSFGVVLLELITGRS 258
+ T D + G ++ E+I G+S
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-14
Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 45/284 (15%)
Query: 61 LVGEGGYGRVYKGYIEAVDQ-VVAVKQLD----------RSGNQGSREFFAEVLML-SLV 108
+G G +G VYK + Q ++A+K+++ R ++ + +EV ++ +
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLD----W--FTRMKIAG 162
+H N+V + D+ +V + + L HF L ++ W F +M +A
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 163 GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMG 222
L YLH + +++RD +NI+L + ++DFGLAK + T V+G
Sbjct: 126 -----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVG 175
Query: 223 TYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282
T Y PE +K+DV++FG +L ++ T P N+++ A ++
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKIVEAV 229
Query: 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDV 326
+PL EG Y V CL DA++RP ++ V
Sbjct: 230 ------YEPLPEGMYSE----DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 62 VGEGGYGRVYKGYIEAVDQV--VAVKQLDRSGNQGSR--EFFAEVLMLSLVQHQNLVNLI 117
+GEG +G V +G + D + VAVK + + S +F +E + + H N++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 118 GYCADGDQR------ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM--KIAGGAAKGLE 169
G C + +++ FM +G L + L P T+M K A G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
YL + I+RD A N +L+ N ++DFGL+K G + A
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELIT 255
E T KSDV+SFGV + E+ T
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-14
Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQ---VVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
++G G +G + +G ++ + VA+ L ++ R F AE L L H N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
G G+ ++V E+MSNG+L++ FL Q L M + G A G++YL ++
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDS-FLRKHEGQ--LVAGQLMGMLPGLASGMKYLSEMG- 127
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG--YCAPEYAMT 234
+++ A +L++++ K+S F + + T + G + APE
Sbjct: 128 --YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182
Query: 235 GQLTKKSDVYSFGVVLLELIT 255
+ SDV+SFG+V+ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-14
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G+G +G V G VAVK + ++ F AE +++ ++H NLV L+G
Sbjct: 14 IGKGEFGDVMLGDYRGNK--VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 122 DGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
+ + +V E+M+ GSL ++ + L +K + + +EYL +
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 181 YRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
+RD A N+L+ + K+SDFGL K + +D V T APE + + K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 241 SDVYSFGVVLLELIT-GR 257
SDV+SFG++L E+ + GR
Sbjct: 180 SDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 39/232 (16%)
Query: 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLS 106
++ +GEG +G VYK +VVA+K++ ++ F E+ +L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILK 62
Query: 107 LVQHQNLVNLIGYC---ADGDQRI-----LVYEFMS---NGSLENHFLDLPPDQEPLDWF 155
++H N+V LI D +R +V +M +G LEN + L Q
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC--- 119
Query: 156 TRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL-------- 207
M +G+ YLH+ +++RD KA+NIL+D + K++DFGLA+
Sbjct: 120 -YML---QLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 208 -GPTGGKDHVSTRVMGTYGYCAPEYAM-TGQLTKKSDVYSFGVVLLELITGR 257
G GG T ++ T Y PE + + T D++ G V E+ T R
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVD-----QVVAVKQLDRSG---NQ-GSREFFAEVLMLSLVQHQ 111
++G+GGYG+V++ + V ++ A+K L ++ NQ + AE +L V+H
Sbjct: 3 VLGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL 171
+V+LI G + L+ E++S G L H E F +I+ LE+L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEIS----LALEHL 116
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
H +IYRD K NILLDA+ + KL+DFGL K G V+ GT Y APE
Sbjct: 117 HQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEI 171
Query: 232 AMTGQLTKKSDVYSFGVVLLELITG 256
M K D +S G ++ +++TG
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 11/194 (5%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNLIGY 119
L+G+G +G V+KG ++ VAVK Q + +F +E +L H N+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 120 CADGDQRILVYEFMSNGSLENHFLD-LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
C +V E + G FL L ++ L +K A AA G+ YL
Sbjct: 61 CTQRQPIYIVMELVPGGD----FLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KN 113
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
I+RD A N L+ K+SDFG+++ G S + APE G+ +
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 239 KKSDVYSFGVVLLE 252
+SDV+S+G++L E
Sbjct: 173 SESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 61/200 (30%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V+ +V AVK + + G+ F AE ++ +QH LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
+ ++ EFM+ GSL + ++PL + + A+G+ + + I+
Sbjct: 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAF---IEQRNYIH 125
Query: 182 RDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQLT 238
RD +A+NIL+ A K++DFGLA++ +D+ T G + APE G T
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKFPIKWTAPEAINFGSFT 181
Query: 239 KKSDVYSFGVVLLELIT-GR 257
KSDV+SFG++L+E++T GR
Sbjct: 182 IKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNL 116
++G+G +G+V ++ + AVK L + + E +L+L ++ L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
+ V EF++ G L H D+ D + A GL++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
+IYRD K N++LD + + K++DFG+ K G D+ ++ GT Y APE +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRASTFCGTPDYIAPEILQGLK 172
Query: 237 LTKKSDVYSFGVVLLELITGRS 258
T D +SFGV+L E++ G+S
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 64/241 (26%), Positives = 112/241 (46%), Gaps = 19/241 (7%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
E+F +G G YG VYK ++ A+K + + E++M+ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLEN-HFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
V G D+ + EF GSL++ + + P + + + +R + +GL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEY 231
++RD K +NILL + KL+DFG+ A++ T K +GT + APE
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYWMAPEV 177
Query: 232 AMT---GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT---WAKPLLRDKKKF 285
A G + D+++ G+ +EL + + + P L+T + P L+DK K+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237
Query: 286 T 286
+
Sbjct: 238 S 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 62 VGEGGYGRVY--KGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY 119
+GEG +G++Y K ++ V+ L + + EV++L+ ++H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 120 CADGDQRILVYEFMSNGSL-----ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
+ + +V E+ G L + DQ L WF ++ + GL+++HD
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSWFVQISL------GLKHIHD- 119
Query: 175 ADPPVIYRDFKASNILLDAE-FNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
+++RD K+ NI L KL DFG+A+ ++ +GT Y +PE
Sbjct: 120 --RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQ 175
Query: 234 TGQLTKKSDVYSFGVVLLELIT 255
K+D++S G VL EL T
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 64/205 (31%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE---FFAE-VLMLSLVQHQNLVNLI 117
+G+G +G+V +A + AVK L + +E AE ++L V+H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 118 GYCADGDQRILVYEFMSNGSL------ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL 171
D+ V ++++ G L E F EP F +IA L YL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFP------EPRARFYAAEIA----SALGYL 112
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
H + +IYRD K NILLD++ + L+DFGL K G ST GT Y APE
Sbjct: 113 HSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG-IEHSKTTST-FCGTPEYLAPEV 167
Query: 232 AMTGQLTKKSDVYSFGVVLLELITG 256
+ D + G VL E++ G
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 55/211 (26%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGNQGSREFFAEVLMLSLV 108
+ T + VG G +G V + Q VA+K++ + S ++ + E+ +L +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 109 QHQNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
+H+N+++L + I V E + L P +++ + +F + +G
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL-----RG 120
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
L+Y+H V++RD K SNIL++ + K+ DFGLA++ +VSTR Y
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YR 172
Query: 228 APEYAMTGQ-LTKKSDVYSFGVVLLELITGR 257
APE +T Q + D++S G + E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 15/218 (6%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQ 111
+FN ++G+G +G+V + D++ A+K L + + E +L+L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 112 NLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
+ + C R+ V E+++ G L + +EP F +IA GL +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIA----IGLFF 116
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAP 229
LH +IYRD K N++LD+E + K++DFG+ K D V+T+ GT Y AP
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAP 170
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267
E K D ++FGV+L E++ G++ + E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 4e-13
Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 37/249 (14%)
Query: 42 NVFKYQELADAT-------ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGN 92
N F E+ D+T +N P +G G G V Y +D+ VA+K+L R
Sbjct: 1 NQFYSVEVGDSTFTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ 57
Query: 93 QGSREFFAEVLMLSLVQHQNLVNLIGY------CADGDQRILVYEFMSNGSLENHFLDLP 146
++ + E++++ V H+N+++L+ + LV E M + + +
Sbjct: 58 THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQ--VIQME 115
Query: 147 PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206
D E + + + G +++LH +I+RD K SNI++ ++ K+ DFGLA+
Sbjct: 116 LDHERMSYLLYQMLCG-----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167
Query: 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELI------TGRSAI 260
T G + T + T Y APE + + D++S G ++ E++ GR I
Sbjct: 168 ---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
Query: 261 DNSRPSEEQ 269
D EQ
Sbjct: 225 DQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-13
Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 8/106 (7%)
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
L++LH + +IYRD K NILLD+E + L+DFGL+K ++ + GT Y
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYM 173
Query: 228 APEYAMTGQL--TKKSDVYSFGVVLLELITGRS--AIDNSRPSEEQ 269
APE G K D +S GV+ EL+TG S +D + S+ +
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL-DRSGNQGSREF-FAEVLMLSLVQHQNLVNLIG 118
+VGEG YG V K + ++VA+K+ D N+ +E E+ ML ++ +N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
+ LV+E++ LE L+ P+ P + K+ + ++ +H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKND 120
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
+++RD K N+L+ KL DFG A+ + G + T + T Y +PE +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFAR-NLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 239 KKSDVYSFGVVLLELITGR 257
K D++S G +L EL G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 44/216 (20%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGSREFFAEVLMLSLVQHQNLVNL--- 116
+GEG YG VY+ ++VA+K+ +D + E+ +L ++H N+V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 117 ------------IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK-IAGG 163
+ YC + D L+ + P E ++K +
Sbjct: 75 VVGKHLDSIFLVMEYC-EQDLASLLDNMPT------------PFSES-----QVKCLMLQ 116
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
+GL+YLH+ +I+RD K SN+LL + K++DFGLA+ G T + T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVT 171
Query: 224 YGYCAPE--YAMTGQLTKKSDVYSFGVVLLELITGR 257
Y APE T T D+++ G +L EL+ +
Sbjct: 172 LWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 42/112 (37%), Positives = 58/112 (51%), Gaps = 5/112 (4%)
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
A L++LH + +IYRD K NILLD E + KL+DFGL+K K S GT
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK 276
Y APE T+ +D +SFGV++ E++TG E ++ AK
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY 119
+GEG YG VYK + ++VA+K+ L+ E+ +L + H N+V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPP--DQEPLDWFTRMKIAG---GAAKGLEYLHDV 174
++ LV+EF+ LDL D PL I +G+ Y H
Sbjct: 67 VHSENKLYLVFEFLD--------LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS- 117
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
V++RD K N+L+D E KL+DFGLA+ G T + T Y APE +
Sbjct: 118 --HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLG 173
Query: 235 G-QLTKKSDVYSFGVVLLELITGR------SAID 261
Q + D++S G + E++ R S ID
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY 119
+GEG YG VYK + +VVA+K+ LD E+ +L + H N+V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
++ LV+EF+ + L+ P PL +GL + H V
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ--LLQGLAFCHS---HRV 121
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL-T 238
++RD K N+L++ E KL+DFGLA+ G T + T Y APE + + +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179
Query: 239 KKSDVYSFGVVLLELIT------GRSAID 261
D++S G + E++T G S ID
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKG-YIEAVDQV--VAVKQLDRSGNQGSRE-FFAEVLMLSLVQ 109
E+ +GEG +G VY+G Y+ ++ VAVK + RE F E ++
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
H ++V LIG + + +V E G L ++ L ++ LD + + + + L
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSY---LQVNKYSLDLASLILYSYQLSTALA 121
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV---STRVMGTYGY 226
YL ++RD A N+L+ + KL DFGL++ +D +++ +
Sbjct: 122 YLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY----LEDESYYKASKGKLPIKW 174
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVLLELI 254
APE + T SDV+ FGV + E++
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 26/219 (11%)
Query: 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGNQGSREFFAEVLML 105
E+ D +N +P VG G YG+V + + VA+K+L R ++ + E+ +L
Sbjct: 12 EVPDRYQNLSP---VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 106 SLVQHQNLVNLIG-YCADG-----DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK 159
+ H+N++ L+ + LV M G+ N+ + + F +
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQ 126
Query: 160 IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR 219
I +GL+Y+H +I+RD K SNI ++ + K+ DFGLA+ +V+TR
Sbjct: 127 IL----RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
Query: 220 VMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGR 257
Y APE + + D++S G ++ EL+TG+
Sbjct: 180 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 62/220 (28%), Positives = 90/220 (40%), Gaps = 59/220 (26%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN--------- 112
+G G +GRV + + A+K L + E+L + VQH
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKR----------EILKMKQVQHVAQEKSILMEL 75
Query: 113 ----LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG----GA 164
+VN++ D ++ + EF+ G L FT ++ AG
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGEL----------------FTHLRKAGRFPNDV 119
Query: 165 AK--------GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV 216
AK EYLH +IYRD K N+LLD + + K++DFG AK P D
Sbjct: 120 AKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----DRT 172
Query: 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG 256
T + GT Y APE + K D ++ GV+L E I G
Sbjct: 173 FT-LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-12
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVK--QLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY 119
+G G G VYK Y +++AVK LD + + ++ +E+ +L ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
++ + EFM GSL+ + +P E + +IA KGL YL + +
Sbjct: 68 FFVENRISICTEFMDGGSLD-VYRKIP---EHV----LGRIAVAVVKGLTYLWSLK---I 116
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTK 239
++RD K SN+L++ KL DFG++ T + ++ +GT Y APE Q
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 240 KSDVYSFGVVLLELITGR 257
SDV+S G+ +EL GR
Sbjct: 173 HSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 36/227 (15%)
Query: 54 ENFNPDCL--VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLS 106
+ + + L + EG YG VY+ + ++VA+K+L + +E F E+ +L
Sbjct: 5 DEY--EKLNRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILL 59
Query: 107 LVQHQNLVNL--IGYCADGDQRILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIA 161
+QH N+V + + ++ D+ +V E++ + +E + M
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM----KQPFLQSEVKCLML-- 113
Query: 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM 221
G+ +LHD +++RD K SN+LL+ K+ DFGLA+ G T+++
Sbjct: 114 -QLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLV 167
Query: 222 GTYGYCAPEYAM-TGQLTKKSDVYSFGVVLLELIT------GRSAID 261
T Y APE + + + D++S G + EL+T G+S ID
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 62 VGEGGYGRVYKG-------YIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLV 114
+G+G + +++KG Y E V +K LD+S S FF M+S + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
G C GD+ I+V E++ GSL+ +L + + W ++++A A L +L D
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDT-YLKKNKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT--YGYCAPEYA 232
+ + + A N+LL E + K + KL G V + + + PE
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 233 MTGQ-LTKKSDVYSFGVVLLELITGR----SAIDNSR 264
Q L+ +D +SFG L E+ +G SA+D+ +
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 71/241 (29%), Positives = 108/241 (44%), Gaps = 19/241 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEV-LMLSLVQHQNLVNL 116
++G+G +G+V +A ++ AVK L + + + +E ++L V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
D+ V ++++ G L H EP F +IA L YLH +
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA----SALGYLHSLN- 116
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAK--LGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
++YRD K NILLD++ + L+DFGL K + G ++ GT Y APE
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEYLAPEVLHK 170
Query: 235 GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294
+ D + G VL E++ G SR + E KP L+ K T A LLE
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKP-LQLKPNITNSARHLLE 228
Query: 295 G 295
G
Sbjct: 229 G 229
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 60/240 (25%), Positives = 97/240 (40%), Gaps = 61/240 (25%)
Query: 54 ENFNPDCLVGEGGYGRVYKGY-----------IEAVDQVVAVKQLDRSGNQGSREFFAEV 102
++ VG G +GRV+ + A+ +V+ +KQ N+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKR------- 53
Query: 103 LMLSLVQHQNLVNLIGYCADGDQRIL--VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI 160
+L V H ++ L + + DQR L + E++ G L F+ ++
Sbjct: 54 -VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGEL----------------FSYLRN 94
Query: 161 AGGAAKG------------LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208
+G + LEYLH ++YRD K NILLD E + KL+DFG AK
Sbjct: 95 SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-- 149
Query: 209 PTGGKDHVSTRVM-GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267
K T + GT Y APE + K D ++ G+++ E++ G + P
Sbjct: 150 ----KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 71/259 (27%), Positives = 104/259 (40%), Gaps = 44/259 (16%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS----GNQGSREFFAEVLMLSLVQ 109
++F ++G G +G V+ + QV A+K L +S NQ AE +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADAD 59
Query: 110 HQNLVNLIGYCADGDQRIL--VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
+V L Y + D+ L V E+M G L N + D P + R IA
Sbjct: 60 SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEET-ARFYIAELVL-A 113
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK-------------- 213
L+ +H + I+RD K NIL+DA+ + KL+DFGL K
Sbjct: 114 LDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 214 --------DHVSTRVM-----GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAI 260
DH RV GT Y APE + D +S GV+L E++ G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 261 DNSRPSEEQNLVT-WAKPL 278
+ E N + W + L
Sbjct: 231 YSDTLQETYNKIINWKESL 249
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLV-QHQNLVNL 116
++G+G +G+V ++ ++ A+K L + + E +L+L +H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 117 IGYCA--DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
+C + V E+++ G L H E F +I GL++LH
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII----CGLQFLHKK 115
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
+IYRD K N+LLD + + K++DFG+ K G + ++ GT Y APE +
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKASTFCGTPDYIAPE-ILK 169
Query: 235 GQLTKKS-DVYSFGVVLLELITGRS 258
GQ +S D +SFGV+L E++ G+S
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 15/197 (7%)
Query: 62 VGEGGYGRVYKGYIEA--VDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVNLI 117
+G G +G V KG + ++ VAVK L N + E E ++ + + +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G C + + +LV E G L N FL + + ++ + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPL-NKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY--GYCAPEYAMTG 235
++RD A N+LL + K+SDFGL+K +++ + G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 236 QLTKKSDVYSFGVVLLE 252
+ + KSDV+SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ----------- 109
++G G Y +V ++ ++ A+K + +E + + VQ
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVI-------KKELVNDDEDIDWVQTEKHVFETASN 54
Query: 110 HQNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFL---DLPPDQEPLDWFTRMKIAGGAA 165
H LV L C + R+ V EF+S G L H LP + + +
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-------YSAEIS 106
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
L +LH+ +IYRD K N+LLDAE + KL+D+G+ K G G D ST GT
Sbjct: 107 LALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST-FCGTPN 161
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAID--NSRPSEEQN 270
Y APE D ++ GV++ E++ GRS D + +QN
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 39/217 (17%)
Query: 62 VGEGGYGR--VYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVN---- 115
+GEG +G+ + K + V+ + + + E EV +LS ++H N+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 116 ---------LIGYCADGD--QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA 164
++ YC GD ++I N F P+ + LDWF ++ +A
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKI-------NAQRGVLF----PEDQILDWFVQICLA--- 113
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
L+++HD +++RD K+ NI L + KL DFG+A++ ++ +GT
Sbjct: 114 ---LKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTP 165
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAID 261
Y +PE KSD+++ G VL E+ T + A +
Sbjct: 166 YYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLML-SLVQHQNLVNLIG-- 118
+G+G YG+V+K + AVK LD + E AE +L +L H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 119 YCAD---GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
Y D GDQ LV E + GS+ + E ++ I A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-- 142
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEY-AM 233
I+RD K +NILL E KL DFG+ A+L T + + S +GT + APE A
Sbjct: 143 -NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPEVIAC 198
Query: 234 TGQL----TKKSDVYSFGVVLLELITGRSAIDNSRP 265
QL + DV+S G+ +EL G + + P
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 46/193 (23%), Positives = 83/193 (43%), Gaps = 19/193 (9%)
Query: 80 QVVAVKQLDRSGNQGSRE---FFAEVLMLSLVQHQNLVNLIGYCADGDQRIL-VYEFMSN 135
VA+K L + + F E + + + H N+V L+ + V+E++
Sbjct: 4 HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63
Query: 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL---D 192
+L ++ L ++ L H+ +++RD K NI++
Sbjct: 64 RTLR----EVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 193 AEFNPKLSDFGLAKLGPTGGKDHV-----STRVMGTYGYCAPEYAMTGQLTKKSDVYSFG 247
+ K+ DFG+ L P V +T V+GT YCAPE +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 248 VVLLELITGRSAI 260
++ LE +TG+ +
Sbjct: 177 LIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 5e-12
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 53/224 (23%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLVQHQNLVN 115
+G G YG V + + VA+K++ N A E+ +L ++H+N++
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 116 LIGYCADGDQR-----ILVYEFM---------SNGSLEN-HFLDLPPDQEPLDWFTRMKI 160
L+ +V E M S L + H +F +
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHI----------QYFLYQIL 113
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK------D 214
+GL+YLH A+ VI+RD K SNIL+++ + K+ DFGLA+ +
Sbjct: 114 -----RGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 215 HVSTRVMGTYGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELITGR 257
+V TR Y APE ++ TK D++S G + EL+T +
Sbjct: 166 YVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 17/232 (7%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
VG G YG VYK ++ AVK + E+ M+ +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
++ + E+ GSL+ D+ PL + +GL YLH ++
Sbjct: 77 SREKLWICMEYCGGGSLQ----DIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 182 RDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAM---TGQL 237
RD K +NILL + KL+DFG+ AK+ T K +GT + APE A G
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 238 TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT---WAKPLLRDKKKFT 286
+ D+++ G+ +EL + + + P L++ + P L+DK K++
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLV-QHQNLVNL 116
++G+G +G+V ++ D+V A+K L + + E +L+L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
D+ V E+++ G L EP F A L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF----YAAEVTLALMFLHRHG- 116
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
VIYRD K NILLDAE + KL+DFG+ K G G +T GT Y APE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELE 172
Query: 237 LTKKSDVYSFGVVLLELITGR 257
D ++ GV++ E++ G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 7e-12
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF-FAEVLMLSLVQHQNLVNLIGY 119
++G G Y +V ++ +++ A+K + + + + + Q N L+G
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 120 --CADGDQRIL-VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
C + R+ V E+++ G L H E F +I+ L YLH+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS----LALNYLHERG- 116
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
+IYRD K N+LLD+E + KL+D+G+ K G G ++ GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGED 172
Query: 237 LTKKSDVYSFGVVLLELITGRSAID--NSRPSEEQN 270
D ++ GV++ E++ GRS D S + +QN
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 60/234 (25%), Positives = 108/234 (46%), Gaps = 31/234 (13%)
Query: 39 KTPNVFKYQELADAT-------ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS- 90
K N F E+ D+T +N P +G G G V Y +++ VA+K+L R
Sbjct: 5 KRDNNFYSVEIGDSTFTVLKRYQNLKP---IGSGAQGIVCAAYDAILERNVAIKKLSRPF 61
Query: 91 GNQG-SREFFAEVLMLSLVQHQNLVNLIGY------CADGDQRILVYEFMSNGSLENHFL 143
NQ ++ + E++++ V H+N++ L+ + +V E M + +
Sbjct: 62 QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ--VI 119
Query: 144 DLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203
+ D E + + + G +++LH +I+RD K SNI++ ++ K+ DFG
Sbjct: 120 QMELDHERMSYLLYQMLCG-----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171
Query: 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
LA+ T G + T + T Y APE + + D++S G ++ E+I G
Sbjct: 172 LAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-12
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF--FAEVLMLSLVQ---H 110
+ P +G G YG VYK VA+K + N+ EV +L ++ H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 111 QNLVNLIGYCADG--DQRI---LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
N+V L+ CA D+ LV+E + L + +PP P + T +
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE--TIKDLMRQFL 118
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS-TRVMGTY 224
+GL++LH +++RD K NIL+ + KL+DFGLA++ ++ T V+ T
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC----QMALTPVVVTL 171
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLEL 253
Y APE + D++S G + E+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 71 YKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130
+ V +K L S FF ++S + H++LV L G C D+ I+V
Sbjct: 22 LDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCV-RDENIMVE 79
Query: 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL 190
E++ G L+ FL + L W + +A A L YL D +++ + NIL
Sbjct: 80 EYVKFGPLDV-FLHREKNNVSLHWK--LDVAKQLASALHYLEDKK---LVHGNVCGKNIL 133
Query: 191 L----DAEFNP---KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ--LTKKS 241
+ E KLSD G+ ++ R+ + APE GQ LT +
Sbjct: 134 VARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----PWIAPECIRNGQASLTIAA 187
Query: 242 DVYSFGVVLLELITGRSAIDNSRPSEEQ 269
D +SFG LLE+ + ++ S E+
Sbjct: 188 DKWSFGTTLLEICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEV-LMLSLVQHQNLVNL 116
++G+G +G+V + + AVK L + + + AE ++L V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
++ V +F++ G L H EP F +IA L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIA----SALGYLHSIN- 116
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
++YRD K NILLD++ + L+DFGL K G + +T GT Y APE
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 237 LTKKSDVYSFGVVLLELITG 256
D + G VL E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 59/199 (29%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQHQNLVNLIG 118
+G+G +G+V + ++ A+K + ++ E AE +L+ V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI-AGGAAKGLEYLHDVADP 177
++ LV F++ G L +H +E +R + LE LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYTAELLCALENLHKFN-- 113
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
VIYRD K NILLD + + L DFGL KL D + GT Y APE +
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 238 TKKSDVYSFGVVLLELITG 256
TK D ++ GV+L E++TG
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 29/207 (14%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---REFFAEVLMLSLVQHQNLVNLIG 118
+G G G VYK ++ A+K + GN R+ E+ +L V H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVI--YGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 119 -YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
+ +G+ ++L+ EFM GSLE + D++ L R ++G + YLH
Sbjct: 140 MFDHNGEIQVLL-EFMDGGSLEGTHIA---DEQFLADVARQILSG-----IAYLHRRH-- 188
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
+++RD K SN+L+++ N K++DFG+++ L T D ++ V GT Y +PE T
Sbjct: 189 -IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSV-GTIAYMSPERINT-D 243
Query: 237 LTK------KSDVYSFGVVLLELITGR 257
L D++S GV +LE GR
Sbjct: 244 LNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 47/234 (20%)
Query: 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAE 101
F ++L D E +G G +G V K + ++AVK++ RS + +
Sbjct: 1 FTAEDLKDLGE-------IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMD 52
Query: 102 --VLMLSLVQHQNLVNLIGYCA----DGDQRILVYEFMSNGSLENHF------LDLPPDQ 149
V+M S + ++ + +GD I + E M SL+ + L +
Sbjct: 53 LDVVMRS----SDCPYIVKFYGALFREGDCWICM-ELMDI-SLDKFYKYVYEVLKSVIPE 106
Query: 150 EPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209
E L KIA K L YL + + +I+RD K SNILLD N KL DFG++
Sbjct: 107 EILG-----KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS---- 155
Query: 210 TGGK--DHVS-TRVMGTYGYCAPEYAMTGQLTK---KSDVYSFGVVLLELITGR 257
G+ D ++ TR G Y APE +SDV+S G+ L E+ TG+
Sbjct: 156 --GQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)
Query: 60 CLVGEGGYGRVYKG-YIEA---VDQVVAVKQLDRSGNQGSREFF-AEVLMLSLVQHQNLV 114
L+ EG +GR++ G I+ ++ V VK + ++ E +L + HQN++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 115 NLIGYCA-DGDQRILVYEFMSNGSLENHFLD---LPPDQEPLDWFTR--MKIAGGAAKGL 168
++ C DG+ ++Y +M+ G+L+ FL L P T+ + +A A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKL-FLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPT-----GGKDHVSTRVMG 222
YLH VI++D A N ++D E K++D L++ L P G ++ + M
Sbjct: 131 SYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM- 186
Query: 223 TYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
A E + + + SDV+SFGV+L EL+T
Sbjct: 187 -----ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 35/104 (33%), Positives = 57/104 (54%), Gaps = 10/104 (9%)
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK--DHV 216
KI+ +GL YL + +++RD K SNIL+++ KL DFG++ G+ D +
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSM 154
Query: 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAI 260
+ +GT Y +PE T +SD++S G+ L+E+ GR I
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 65/229 (28%), Positives = 103/229 (44%), Gaps = 51/229 (22%)
Query: 46 YQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQ----LDRSGNQGS--REFF 99
Y+ELA +GEG YG VYK + VA+K+ L G S RE
Sbjct: 1 YEELA----------EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI- 49
Query: 100 AEVLMLSL--VQHQNLVNLIGYCA--DGDQRI---LVYEFMSNGSLENHFLD------LP 146
L+ L +H N+V L+ C D+ + LV+E + L +L LP
Sbjct: 50 --ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLAT-YLSKCPKPGLP 105
Query: 147 PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206
P+ + R + +G+++LH +++RD K NIL+ ++ K++DFGLA+
Sbjct: 106 PET--IKDLMRQLL-----RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155
Query: 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKS--DVYSFGVVLLEL 253
+ T V+ T Y APE + Q + + D++S G + EL
Sbjct: 156 ---IYSFEMALTSVVVTLWYRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLVQ 109
E+F L+ G YG VY + Q A+K++++ NQ ++ F E +L+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ-IQQVFVERDILTFAE 59
Query: 110 HQNLVNLIGYCADGDQRIL--VYEFMSNG---SLENHFLDLPPDQEPLDWFTRMKIAGGA 164
+ +V++ +C+ +R L V E++ G +L + LP D RM A
Sbjct: 60 NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD------MARMYFAE-T 110
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG-------GKDHVS 217
LEYLH+ +++RD K N+L+ + + KL+DFGL+K+G G
Sbjct: 111 VLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 218 TR------VMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG 256
TR V GT Y APE + K D ++ G++L E + G
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNLIGYC 120
+GEG Y V+KG + + +VA+K++ +G+ EV +L ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI-AGGAAKGLEYLHDVADPPV 179
LV+E++ + +LD + L +KI +GL Y H +
Sbjct: 73 HTERCLTLVFEYLDSDL--KQYLD---NCGNLMSMHNVKIFMFQLLRGLSYCHK---RKI 124
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-TGQLT 238
++RD K N+L++ + KL+DFGLA+ K + + V T Y P+ + + + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 239 KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV 272
D++ G +L E+ TGR S EE +L+
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 59/272 (21%), Positives = 111/272 (40%), Gaps = 22/272 (8%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQL---DRSGNQGSREFFAEVLMLSLVQ 109
NF + +G+G + VYK +VVA+K++ + + ++ E+ +L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
H N++ + + ++ +V E G L + + T K LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
++H +++RD K +N+ + A KL D GL + K + ++GT Y +P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289
E KSD++S G +L E+ +S ++ NL + K + +K +
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKI--EKCDYP--- 226
Query: 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
PL Y + + C+ D + RP
Sbjct: 227 -PLPADHYSE----ELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 33/210 (15%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDR------SGNQGSREFFAEVLMLSLVQHQNLVN 115
+G G G V Y Q VA+K+L R + RE VLM LV H+N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL---VLM-KLVNHKNIIG 79
Query: 116 LIGYCADGDQR--------ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
L+ Q+ LV E M + +DL D E + + + G
Sbjct: 80 LLN--VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDL--DHERMSYLLYQMLCG----- 130
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
+++LH +I+RD K SNI++ ++ K+ DFGLA+ T G + T + T Y
Sbjct: 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGR 257
APE + + D++S G ++ E+I G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 44/123 (35%), Positives = 57/123 (46%), Gaps = 25/123 (20%)
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG--------LAKLGPT 210
KIA K LEYLH + VI+RD K SN+L++ KL DFG +AK
Sbjct: 107 KIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTK----KSDVYSFGVVLLELITGRSAIDNSRPS 266
G K Y APE K KSDV+S G+ ++EL TGR D+ +
Sbjct: 165 GCKP-----------YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP 213
Query: 267 EEQ 269
+Q
Sbjct: 214 FQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRS-GNQG-SREFFAEVLMLSLVQHQNLVNLIGY 119
+G G G V + + VAVK+L R NQ ++ + E+++L V H+N+++L+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 120 ------CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
+ LV E M + ++L D E + + + G +++LH
Sbjct: 89 FTPQKSLEEFQDVYLVMELMDANLCQVIHMEL--DHERMSYLLYQMLCG-----IKHLHS 141
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
+I+RD K SNI++ ++ K+ DFGLA+ T + + T + T Y APE +
Sbjct: 142 AG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVIL 195
Query: 234 TGQLTKKSDVYSFGVVLLELITG 256
+ D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 33/218 (15%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLVQHQNLVNL 116
+G+G +G V+K + Q+VA+K++ N+ +E F E+ +L L++H+N+VNL
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV-LMENE--KEGFPITALREIKILQLLKHENVVNL 76
Query: 117 IGYC---ADGDQR-----ILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
I C A R LV+EF + G L N + + MK+
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIK----KVMKML---L 129
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK--LGPTGGKDHVSTRVMGT 223
GL Y+H +++RD KA+NIL+ + KL+DFGLA+ K + T + T
Sbjct: 130 NGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 224 YGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAI 260
Y PE + D++ G ++ E+ T RS I
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 62/236 (26%), Positives = 110/236 (46%), Gaps = 21/236 (8%)
Query: 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLS 106
EL D ++F +G G G V K + ++A K + R + E+ +L
Sbjct: 1 ELKD--DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 107 LVQHQNLVNLIG-YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
+V G + +DG+ I + E M GSL+ + + P + ++ IA
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKE--AKRIPEEILGKVSIA--VL 113
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK--DHVSTRVMGT 223
+GL YL + +++RD K SNIL+++ KL DFG++ G+ D ++ +GT
Sbjct: 114 RGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGT 165
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLL 279
Y +PE + +SD++S G+ L+EL GR I P ++ + +P++
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI--PPPDAKELEAIFGRPVV 219
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 19/216 (8%)
Query: 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA--EVLMLSLVQHQNLVNLI 117
+GEG Y VYKG + Q+VA+K++ +G+ F A E +L ++H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLH 69
Query: 118 GYCADGDQRILVYEFMSNG---SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
LV+E++ +++ L L F + +GL Y H
Sbjct: 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAYCHQR 122
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM- 233
V++RD K N+L+ KL+DFGLA+ K + + V T Y P+ +
Sbjct: 123 R---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLG 177
Query: 234 TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ 269
+ + + D++ G + E+ TGR S E+Q
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)
Query: 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA--EVLMLSL 107
AD+ E +GEG Y VYKG + ++VA+K + +G+ F A E +L
Sbjct: 4 ADSYEKLEK---LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKG 59
Query: 108 VQHQNLVNLIGYCADGDQRILVYEFMSNG---SLENHFLDLPPDQEPLDWFTRMKIAGGA 164
++H N+V L + LV+E++ ++ H L P+ L F ++
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR----- 114
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
GL Y+H +++RD K N+L+ KL+DFGLA+ H + + T
Sbjct: 115 --GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTL 167
Query: 225 GYCAPEYAM-TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ 269
Y P+ + + + + D++ G + +E+I G +A + ++Q
Sbjct: 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-11
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 62 VGEGGYGRVYKG-YIEAVDQV-VAVKQLDRSGNQGSREFFAEVLMLSLVQHQ----NLVN 115
+G G +G V KG Y Q+ VA+K L + R+ E++ + + HQ +V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD---EMMREAEIMHQLDNPYIVR 59
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
+IG C + + +LV E S G L N FL D+ + +++ + G++YL
Sbjct: 60 MIGVC-EAEALMLVMEMASGGPL-NKFLSGKKDEITVS--NVVELMHQVSMGMKYLEG-- 113
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD-HVSTRVMGTY--GYCAPEYA 232
++RD A N+LL + K+SDFGL+K G D + R G + + APE
Sbjct: 114 -KNFVHRDLAARNVLLVNQHYAKISDFGLSK--ALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 233 MTGQLTKKSDVYSFGVVLLE 252
+ + +SDV+S+G+ + E
Sbjct: 171 NFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 8e-11
Identities = 67/227 (29%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRS----GNQGSREFFAEVLMLSLVQHQNLVNLI 117
VG+GGYG+V+ + ++VA+K++ +S N+ R E +L+ + + LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTERDILTTTKSEWLVKLL 67
Query: 118 GYCADGDQRILVYEFMSNG---SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
D + L E++ G +L N+ L D + M A A L Y+H
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGYIH-- 124
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
RD K N L+DA + KL+DFGL+K T + V+G+ Y APE
Sbjct: 125 -------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRG 172
Query: 235 GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE-QNLVTWAKPLLR 280
D +S G +L E + G S P+E +NL W + L R
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 8e-11
Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 31/229 (13%)
Query: 36 KAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVD-QVVAVKQLDRSG--- 91
K K N KY E+FN +G G +GRV + D VA+K+ ++S
Sbjct: 19 KEPKRKNKMKY-------EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK 71
Query: 92 NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE- 150
+ F+E +L+ + H VNL G D LV EF+ G F L ++
Sbjct: 72 QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF---FTFLRRNKRF 128
Query: 151 PLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210
P D A EYL + ++YRD K N+LLD + K++DFG AK+
Sbjct: 129 PND--VGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--- 180
Query: 211 GGKDHVSTR---VMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG 256
V TR + GT Y APE + K +D ++ G+ + E++ G
Sbjct: 181 -----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 69/247 (27%), Positives = 114/247 (46%), Gaps = 24/247 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF-FAEVLMLSLVQHQNLVNLIGY 119
++G G Y +V ++ DQ+ A+K + + + + + Q + L+G
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 120 --CADGDQRI-LVYEFMSNGSLENHFLDLP--PDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
C R+ LV E+++ G L H P++ + + IA L +LH+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLHER 115
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
+IYRD K N+LLDA+ + KL+D+G+ K G G D ST GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST-FCGTPNYIAPEILRG 170
Query: 235 GQLTKKSDVYSFGVVLLELITGRSAI----DNSRPSEEQNL--VTWAKPLLRDKKKFTMM 288
+ D ++ GV++ E++ GRS DN + E L V KP +R + ++
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-IRIPRFLSVK 229
Query: 289 ADPLLEG 295
A +L+G
Sbjct: 230 ASHVLKG 236
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 36/99 (36%), Positives = 59/99 (59%), Gaps = 15/99 (15%)
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL-----GPTGG-KDHVSTR 219
+GL+Y+H A+ V++RD K SN+LL+ + K+ DFGLA++ TG ++V+TR
Sbjct: 117 RGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 220 VMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
Y APE + + TK D++S G +L E+++ R
Sbjct: 174 -----WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 35/91 (38%), Positives = 50/91 (54%)
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
+H V +I+RD K++NILL + KL DFG +K+ D V GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAID 261
+KK+D++S GV+L EL+T + D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 55 NFNPDCLVGEGGYGRVY-----------KGYIEAVDQVVAVKQLDRSGNQGSREFFAEVL 103
NF ++G G YG+V+ K Y V Q A+ Q ++ E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR----TERN 56
Query: 104 MLSLVQHQNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI-- 160
+L V+ + + Y + ++ L+ +++S G + H D F+ ++
Sbjct: 57 VLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-------DNFSEDEVRF 109
Query: 161 -AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR 219
+G LE+LH + ++YRD K NILLD+E + L+DFGL+K + K+ +
Sbjct: 110 YSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS- 165
Query: 220 VMGTYGYCAPEY--AMTGQLTKKSDVYSFGVVLLELITGRS 258
GT Y APE G K D +S G+++ EL+TG S
Sbjct: 166 FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGAS 205
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 13/214 (6%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNLIGYC 120
+GEG Y V+KG + + +VA+K++ +G+ EV +L ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI-AGGAAKGLEYLHDVADPPV 179
LV+E++ ++D D + +KI +GL Y H V
Sbjct: 74 HTDKSLTLVFEYLDKDL--KQYMD---DCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-TGQLT 238
++RD K N+L++ KL+DFGLA+ K + + V T Y P+ + + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183
Query: 239 KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV 272
+ D++ G + E+ +GR S +E +L+
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 24/219 (10%)
Query: 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLML 105
E+ + +N +P VG G YG V + VAVK+L R ++ + E+ +L
Sbjct: 14 EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 106 SLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFL-----DLPPDQEPLDWFTRMKI 160
++H+N++ L+ E ++ L H + ++ Q+ D + I
Sbjct: 71 KHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 126
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
+GL+Y+H AD +I+RD K SN+ ++ + K+ DFGLA+ +V+TR
Sbjct: 127 YQ-ILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 181
Query: 221 MGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRS 258
Y APE + + D++S G ++ EL+TGR+
Sbjct: 182 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNLIGYC 120
+GEG Y VYKG + D +VA+K++ +G+ EV +L ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI-AGGAAKGLEYLHDVADPPV 179
LV+E++ +LD D +K+ +GL Y H V
Sbjct: 74 HTEKSLTLVFEYLDKDL--KQYLD---DCGNSINMHNVKLFLFQLLRGLNYCHR---RKV 125
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-TGQLT 238
++RD K N+L++ KL+DFGLA+ K + + V T Y P+ + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYS 183
Query: 239 KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV 272
+ D++ G + E+ TGR S E+ + +
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (147), Expect = 2e-10
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 56/228 (24%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA--------EVLML-SLVQHQN 112
+G+G +G VY + ++VA+K++ ++F++ EV L L +H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE--PLDWFTRMKIAGGAAKGLEY 170
+V L + D+ V+E+M E + L D++ P I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK----DHVSTRVMGTYGY 226
+H +RD K N+L+ K++DFGLA+ + D+VSTR Y
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WY 164
Query: 227 CAPE-------YAMTGQLTKKSDVYSFGVVLLELIT------GRSAID 261
APE Y + D+++ G ++ EL T G S ID
Sbjct: 165 RAPEILLRSTSY------SSPVDIWALGCIMAELYTLRPLFPGSSEID 206
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 50/221 (22%)
Query: 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLVQHQNLV 114
VG G YG V + + VA+K+L R E FA E+ +L +QH+N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS---EIFAKRAYRELTLLKHMQHENVI 77
Query: 115 NLIGYCADGDQRILVYEFMSNGSL---ENHFLDLPPDQEPLDWFTRMKIAGG-------- 163
L+ F S S ++ +L +P Q L KI G
Sbjct: 78 GLLDV------------FTSAVSGDEFQDFYLVMPYMQTDLQ-----KIMGHPLSEDKVQ 120
Query: 164 -----AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
GL+Y+H +I+RD K N+ ++ + K+ DFGLA+ +V T
Sbjct: 121 YLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVT 177
Query: 219 RVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRS 258
R Y APE + + D++S G ++ E++TG++
Sbjct: 178 R-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA---EVLMLSLVQHQNLVN--- 115
VG+G YG V + +K+L+ N RE A E +LS ++H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLR-NASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 116 -----------LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA 164
++G+C GD +Y L+ L P+ + ++WF ++ +A
Sbjct: 67 SWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA--- 114
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
L+YLH+ +++RD K N+ L K+ D G+A++ + +++ ++GT
Sbjct: 115 ---LQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTP 166
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAID 261
Y +PE KSDV++ G + E+ T + A +
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDR---------SGNQGSREFFAEVLMLSLVQHQN 112
+G+G +G+VY+ + ++ A+K L + + G R L+ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLL---DESPF 57
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
+V L LV ++MS G L F L + + + IA LE+LH
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFSEDRAKFYIAE-LVLALEHLH 113
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
++YRD K NILLDA + L DFGL+K + + GT Y APE
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 233 MTGQ-LTKKSDVYSFGVVLLELITGRS 258
+ + TK D +S GV++ E+ G S
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWS 195
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 26/220 (11%)
Query: 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLML 105
E+ + +N P VG G YG V Y + Q VAVK+L R +R + E+ +L
Sbjct: 12 EVPERYQNLTP---VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 106 SLVQHQNLVNLIGY------CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK 159
++H+N++ L+ + ++ LV M G+ N+ + Q+ D +
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKC---QKLSDEHVQFL 123
Query: 160 IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR 219
I +GL+Y+H +I+RD K SN+ ++ + ++ DFGLA+ +V+TR
Sbjct: 124 IYQ-LLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR 179
Query: 220 VMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRS 258
Y APE + + D++S G ++ EL+ G++
Sbjct: 180 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 58/202 (28%), Positives = 91/202 (45%), Gaps = 15/202 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQHQNLVNLI 117
L+G+G +G+V +A + A+K L + E E +L +H L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA-AKGLEYLHDVAD 176
D+ V E+ + G L H +E + R + G L+YLH ++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLH--SE 114
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAPEYAMTG 235
V+YRD K N++LD + + K++DFGL K G KD + + GT Y APE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 236 QLTKKSDVYSFGVVLLELITGR 257
+ D + GVV+ E++ GR
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE---FFAEV-LMLSLVQHQNLVNL 116
++G+G +G+V ++ AVK L + +E AE ++L ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
++ V ++++ G L H EP F A A + YLH +
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF----YAAEVASAIGYLHSLN- 116
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
+IYRD K NILLD++ + L+DFGL K G + ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCGTPEYLAPEVLRKEP 172
Query: 237 LTKKSDVYSFGVVLLELITG 256
+ D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQHQNLVNLI 117
L+G+G +G+V +A + A+K L + E E +L +H L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA-AKGLEYLHDVAD 176
D+ V E+++ G L H +E + R + G L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHS--- 113
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAPEYAMTG 235
++YRD K N++LD + + K++DFGL K G T D + + GT Y APE
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT---DAATMKTFCGTPEYLAPEVLEDN 170
Query: 236 QLTKKSDVYSFGVVLLELITGR 257
+ D + GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 4e-10
Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 46/222 (20%)
Query: 62 VGEGGYGRVYKGYIEA--VDQVVAVKQLDRSGNQG---SREFFAEVLMLSLVQHQNLVNL 116
+G G YGRVYK + + A+K+ Q S+ E+ +L ++H+N+V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 117 IGYC-ADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK---IAGGAAK----- 166
+ D+ + L++++ E+ + + + + K I K
Sbjct: 68 VEVFLEHADKSVYLLFDYA-----EHDLWQI------IKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 167 ---GLEYLHDVADPPVIYRDFKASNILLDAEFNP----KLSDFGLAK-----LGPTGGKD 214
G+ YLH V++RD K +NIL+ E K+ D GLA+ L P D
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 215 HVSTRVMGTYGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELIT 255
V+ T Y APE + + TK D+++ G + EL+T
Sbjct: 174 ----PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 60/276 (21%), Positives = 120/276 (43%), Gaps = 34/276 (12%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQL---DRSGNQGSREFFAEVLMLSLVQHQ 111
NF + +G G + VY+ + VA+K++ + + ++ E+ +L + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLEN---HFLD---LPPDQEPLDWFTRMKIAGGAA 165
N++ + + ++ +V E G L +F L P++ +F ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL------C 116
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
+E++H V++RD K +N+ + A KL D GL + + K + ++GT
Sbjct: 117 SAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPY 171
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285
Y +PE KSD++S G +L E+ +A+ + ++ NL + +K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLC-------QKI 220
Query: 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
P L ++ + L + ++ MC+ D D RP
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVS---MCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVD---QVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVN 115
++G+G +G V + +++ D Q VAVK L S EF E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 116 LIGYC--ADGDQRI----LVYEFMSNGSLENHFLDLPPDQEP--LDWFTRMKIAGGAAKG 167
LIG + R+ ++ FM +G L L +EP L T ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
+EYL + I+RD A N +L+ ++DFGL+K +G +
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELIT 255
A E T SDV++FGV + E++T
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLENH---FLDLPPDQEPLDWFTRMKIAGGAAKGL 168
N+V L Y D LV + G L +H FL++P + W M +A L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAEMVVA------L 98
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG-LAKLGPTGGKDHVSTRVMGTYGYC 227
+ LH ++ RD +NILLD + +L+ F +++ + + V YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPS 266
APE + T+ D +S G +L EL+TG++ ++ PS
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPS 187
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 16/202 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQHQNLVNLI 117
L+G+G +G+V +A + A+K L + E E +L +H L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA-AKGLEYLHDVAD 176
D+ V E+ + G L H +E + R + G LEYLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHS--- 113
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAPEYAMTG 235
V+YRD K N++LD + + K++DFGL K G + D + + GT Y APE
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS---DGATMKTFCGTPEYLAPEVLEDN 170
Query: 236 QLTKKSDVYSFGVVLLELITGR 257
+ D + GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 64/276 (23%), Positives = 115/276 (41%), Gaps = 34/276 (12%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQL---DRSGNQGSREFFAEVLMLSLVQHQ 111
NF + +G G + VY+ VA+K++ D + + E+ +L + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLEN---HFLD---LPPDQEPLDWFTRMKIAGGAA 165
N++ + ++ +V E G L HF L P++ +F ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL------C 116
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
LE++H V++RD K +N+ + A KL D GL + + K + ++GT
Sbjct: 117 SALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPY 171
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285
Y +PE KSD++S G +L E+ +A+ + ++ NL + KK
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLC-------KKI 220
Query: 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
P L + + L Q + MC+ D + RP
Sbjct: 221 EQCDYPPLPSDHYSEELRQ---LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 52/236 (22%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVD----QVVAVKQLDRSGN--QGSREFFAEVLM 104
D + P +G G YG V A+D + VA+K++ + + ++ E+ +
Sbjct: 2 DVGSRYKPIENIGSGAYGVV----CSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKI 57
Query: 105 LSLVQHQNLVN----LIGYCADGDQRILVYEFM---------SNGSLE----NHFLDLPP 147
L +H N++ L AD +V + M S+ L +FL
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFL---- 113
Query: 148 DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207
+GL+Y+H A+ VI+RD K SN+L++ + ++ DFG+A+
Sbjct: 114 --------------YQLLRGLKYIHS-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARG 156
Query: 208 GPTGGKDH--VSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAI 260
+ +H T + T Y APE ++ + T D++S G + E++ GR +
Sbjct: 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 28/226 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGY-IEAVDQVVAVK----QLDRSGNQGS--REFFAEVLMLS 106
+ + +GEG YG+V+K ++ + VA+K Q G S RE A + L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLE 59
Query: 107 LVQHQNLVNLIGYCA----DGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIA 161
+H N+V L C D + ++ LV+E + L + +P P + M
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM 221
+GL++LH V++RD K NIL+ + KL+DFGLA++ T V+
Sbjct: 119 --LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVV 170
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLE------LITGRSAID 261
T Y APE + D++S G + E L G S +D
Sbjct: 171 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 62 VGEGGYGRVYKGYIEA---VDQVVAVKQLDRS-GNQGSREFFAEVLMLSLVQHQNLVNLI 117
+G G +G+V G + + QVV VK+L S Q +F E +QH NL+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDL-PPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
G C + +LV EF G L+ + + D T ++A A GL +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA--MT 234
I+ D N LL A+ K+ D+GL+ ++ + APE +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 235 GQL-----TKKSDVYSFGVVLLEL 253
G L TK+S+V+S GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGSREFFAEVLMLSLVQHQNLVNL--I 117
+GEG YG VYK ++ +A+K+ L++ E+ +L +QH N+V L +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 118 GYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
+ ++R+ LV+E++ + L+ H +D PD + + +G+ Y H
Sbjct: 70 VHS---EKRLYLVFEYL-DLDLKKH-MDSSPDFAKNPRLIKTYLY-QILRGIAYCH---S 120
Query: 177 PPVIYRDFKASNILLDAEFNP-KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-T 234
V++RD K N+L+D N KL+DFGLA+ G T + T Y APE + +
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 235 GQLTKKSDVYSFGVVLLELIT------GRSAID 261
+ D++S G + E++ G S ID
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211
|
Length = 294 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ----NLVNLI 117
+G+G YG VYK +A+K++ ++ F +++M + H+ +V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK---FNQIIMELDILHKAVSPYIVDFY 65
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G + E+M GSL+ + E + +I KGL++L + +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLY-AGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPEY----A 232
+I+RD K +N+L++ KL DFG++ L + K ++ G Y APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGG 177
Query: 233 MTGQLTK--KSDVYSFGVVLLELITGR 257
T +SDV+S G+ +LE+ GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLVQHQNLVNL 116
VG G YG V VA+K+L R E FA E+ +L ++H+N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS---ELFAKRAYRELRLLKHMKHENVIGL 79
Query: 117 IG-YCADGD-----QRILVYEFMSN--GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168
+ + D LV FM G L H E L + KGL
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLSEDRIQFLVYQMLKGL 131
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCA 228
+Y+H +I+RD K N+ ++ + K+ DFGLA+ + +V TR Y A
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRA 183
Query: 229 PEYAMTG-QLTKKSDVYSFGVVLLELITGR 257
PE + T+ D++S G ++ E++TG+
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQH 110
E+F+ ++G G +G V ++ QV A+K L + S F+ E +++
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 111 QNLVNLIGYCADGDQRIL--VYEFMSNGSLENHFLDLPPDQE-PLDWFTRMKIAGGAAKG 167
+ +V L + A D + L V E+M G L N L + + P W R A
Sbjct: 103 EWIVQL--HYAFQDDKYLYMVMEYMPGGDLVN----LMSNYDIPEKW-ARFYTAE-VVLA 154
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
L+ +H + I+RD K N+LLD + KL+DFG G T V GT Y
Sbjct: 155 LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYI 210
Query: 228 APEYAMT----GQLTKKSDVYSFGVVLLELITG 256
+PE + G ++ D +S GV L E++ G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 43/228 (18%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL--DRSGNQG-SREFFAEVLMLSLVQHQNLVNLI 117
L+G+GG G VY Y + VA+K++ D S N + F E + + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 118 GYCADGDQRILVYEFMS--NGSLENHFL-------DLPPD---QEPLDWFTRM--KIAGG 163
C+DGD VY M G L L + + + F + KI
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC-- 123
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA-------------KLGPT 210
+EY+H V++RD K NILL + D+G A +
Sbjct: 124 --ATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 211 GGKDHVST---RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
T +++GT Y APE + ++ +D+Y+ GV+L +++T
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 13/216 (6%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA--EVLMLSLVQHQNLVNLIGY 119
+GEG Y VYKG Q+VA+K + +G F A E +L ++H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
+ V+E+M L + + P P + +GL Y+H +
Sbjct: 72 IHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP---YNVRLFMFQLLRGLAYIHG---QHI 124
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-TGQLT 238
++RD K N+L+ KL+DFGLA+ + + S V T Y P+ + +
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYS 182
Query: 239 KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW 274
D++ G + +E++ G+ A EQ W
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
L YLH V+YRD K N++LD + + K++DFGL K G + G + T GT Y
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT-FCGTPEYL 162
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGR 257
APE + D + GVV+ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 8/107 (7%)
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
LE+LH + +IYRD K NILLD+ + L+DFGL+K + + GT Y
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-FCGTIEY 172
Query: 227 CAPEYAMTGQL--TKKSDVYSFGVVLLELITGRS--AIDNSRPSEEQ 269
AP+ G K D +S GV++ EL+TG S +D + S+ +
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 52/225 (23%), Positives = 84/225 (37%), Gaps = 32/225 (14%)
Query: 65 GGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD 124
G GRV+ V +K G +G+ E ++L V H +++ + G
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK----IGQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGA 130
Query: 125 QRILV--------YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
+V Y +++ S PL + I +GL YLH
Sbjct: 131 ITCMVLPHYSSDLYTYLTKRS------------RPLPIDQALIIEKQILEGLRYLHAQR- 177
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
+I+RD K NI ++ + D G A+ P + + GT APE +
Sbjct: 178 --IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAPEVLARDK 232
Query: 237 LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281
K+D++S G+VL E++ S I PS + V L
Sbjct: 233 YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277
|
Length = 357 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 59/267 (22%), Positives = 117/267 (43%), Gaps = 32/267 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G G V+ D+ VAVK++ + Q + E+ ++ + H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 122 DGDQRI--------------LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
+ +V E+M L N P +E F + +G
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLL-----RG 126
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGLAK-LGPT-GGKDHVSTRVMGTY 224
L+Y+H V++RD K +N+ ++ E K+ DFGLA+ + P K ++S ++ +
Sbjct: 127 LKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 225 GYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283
Y +P ++ TK D+++ G + E++TG+ + E+ L+ + P++R++
Sbjct: 184 -YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242
Query: 284 K---FTMMADPLLE-GQYPRKGLYQAL 306
+ ++ + G PR+ L L
Sbjct: 243 RNELLNVIPSFVRNDGGEPRRPLRDLL 269
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 6e-09
Identities = 59/237 (24%), Positives = 91/237 (38%), Gaps = 45/237 (18%)
Query: 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS----GNQGSREFFAEVLMLSLVQHQ 111
F L+G+G GRV+ ++ ++ A+K LD+ N+ R E +L+ + H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR-VLTEQEILATLDHP 61
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK---GL 168
L L LV ++ G L L P + + AA+ L
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGK----CLSEEVARFYAAEVLLAL 116
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK--------------- 213
EYLH + ++YRD K NILL + LSDF L+K
Sbjct: 117 EYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 214 ---------DHVSTRVM---GTYGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELITGR 257
+ S R GT Y APE ++G D ++ G++L E++ G
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 73/266 (27%), Positives = 110/266 (41%), Gaps = 32/266 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVL-MLSLVQH 110
++F+ LVG G +G V +A + A+K + +S Q + FF E +LS+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNG---SLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
+ L D D LV E+ G SL N + D E + F A+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFY-------LAEL 111
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG-LAKLGPTGGKDHVSTRVMGTYGY 226
+ +H V ++RD K N+L+D + KL+DFG A+L T K S +GT Y
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL--TANKMVNSKLPVGTPDY 169
Query: 227 CAPEYAMTGQLTKKS------DVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLR 280
APE T K D +S GV+ E+I GRS P E ++
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS------PFHEGTSAKTYNNIMN 223
Query: 281 DKKKFTMMADPLLEGQYPRKGLYQAL 306
++ DP + + L Q+L
Sbjct: 224 FQRFLKFPEDPKVSSDF--LDLIQSL 247
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 34/109 (31%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
+GL+YLH +++RD K N+L+++ K+ DFGLA++ H++ V+ Y
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 226 YCAPEYAMTGQ-LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT 273
Y APE M + T D++S G + EL+ R P ++ +L+T
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 58/278 (20%), Positives = 111/278 (39%), Gaps = 34/278 (12%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLI 117
L+ E +YKG ++ V ++ + E+ L + N++ +
Sbjct: 27 LIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84
Query: 118 GY----CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
G+ D + L+ E+ + G L LD D L + T++ +A KGL L+
Sbjct: 85 GFIIDIVDDLPRLSLILEYCTRGYLRE-VLDKEKD---LSFKTKLDMAIDCCKGLYNLYK 140
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
+ P Y++ + + L+ + K+ GL K+ + +V+ V +Y ++
Sbjct: 141 YTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS- 197
Query: 234 TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293
+ T K D+YS GVVL E+ TG+ +N E +L ++ + D L
Sbjct: 198 --EYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL------IINKNNSLKLPLDCPL 249
Query: 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
E + + C D+ RP + +++ L
Sbjct: 250 EIKC----------IVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 20/223 (8%)
Query: 43 VFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR---SGNQGSREFF 99
V K ++L E+++ ++G G +G V ++ +V A+K L + S F+
Sbjct: 32 VRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 100 AEVLMLSLVQHQNLVNLIGYCADGDQRIL--VYEFMSNGSLENHFLDLPPDQEPLDWFTR 157
E +++ +V L +CA D + L V E+M G L N + ++ ++T
Sbjct: 92 EERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA 149
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
+ L+ +H + +I+RD K N+LLD + KL+DFG G
Sbjct: 150 EVVLA-----LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201
Query: 218 TRVMGTYGYCAPEYAMT----GQLTKKSDVYSFGVVLLELITG 256
T V GT Y +PE + G ++ D +S GV L E++ G
Sbjct: 202 TAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVNLIG 118
++G+G YG V + VA+K+++ S E+ +L L++H ++V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 119 YCADGDQR-----ILVYEFMSNGSLENHFL-----DLPPDQEPLDWFTRMKIAGGAAKGL 168
+R +V+E M + + H + DL P+ + ++ L
Sbjct: 67 IMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQLLR-------AL 116
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL----GPTG--GKDHVSTRVMG 222
+Y+H V +RD K NIL +A+ K+ DFGLA++ PT D+V+TR
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR--- 170
Query: 223 TYGYCAPEY--AMTGQLTKKSDVYSFGVVLLELITGR 257
Y APE + + T D++S G + E++TG+
Sbjct: 171 --WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 34/104 (32%), Positives = 57/104 (54%), Gaps = 10/104 (9%)
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK--DHV 216
K++ KGL YL + +++RD K SNIL+++ KL DFG++ G+ D +
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSM 158
Query: 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAI 260
+ +GT Y +PE + +SD++S G+ L+E+ GR I
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 54/242 (22%), Positives = 102/242 (42%), Gaps = 48/242 (19%)
Query: 50 ADATENFNP-DCLVGEGGYGRVYKGYIEAVDQVVAVKQLD----RSGNQGSREFFA---- 100
+E + +GEG YG+V K Y ++VA+K++ + R+
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 101 ------EVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDW 154
E+ +++ ++H+N++ L+ +GD LV + M++ DL ++ +D
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS--------DL---KKVVDR 112
Query: 155 FTRMKIAGGAA------KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-- 206
R+ + GL LH ++RD +NI ++++ K++DFGLA+
Sbjct: 113 KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY 169
Query: 207 -----LGPTGGKDHVSTRVMGTYG-----YCAPEYAM-TGQLTKKSDVYSFGVVLLELIT 255
+ + R T Y APE M + D++S G + EL+T
Sbjct: 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
Query: 256 GR 257
G+
Sbjct: 230 GK 231
|
Length = 335 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 62 VGEGGYGRVYKG--YIEAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNLIG 118
+G G +G+V Y + V VK+L + + + EF + ++QH N++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
C + +LV+E+ G L+++ + ++A A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--- 119
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK-DHVST--RVMGTYGYCAPEYA--- 232
++ D N L ++ K+ D+G +GP+ K D++ T + APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 233 ----MTGQLTKKSDVYSFGVVLLEL 253
+T + TK S+V++ GV L EL
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVK--QLDRSGNQGSREF-FAEVLMLSLVQHQNLVNLIG 118
+GEG YG V+K ++VA+K +LD ++G E+ +L ++H+N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLD-DDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 119 YCADGDQRILVYEFMSNGSLENHF--LDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
+ LV+E+ + L+ +F + D E + F + KGL + H
Sbjct: 67 VLHSDKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLL-----KGLAFCHS--- 117
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
V++RD K N+L++ KL+DFGLA+ G + + T Y P+ +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 237 LTKKS-DVYSFGVVLLEL 253
L S D++S G + EL
Sbjct: 176 LYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK---LGPTGGKDHVSTRVMGT 223
GL+Y+H A+ V++RD K N+L++A+ K+ DFGLA+ P + T + T
Sbjct: 117 GLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 224 YGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELITGR 257
Y APE ++ Q TK DV+S G +L EL+ +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
+GL+Y+H A+ V++RD K SN+LL+A + K+ DFGLA+ T K T + T
Sbjct: 119 RGLKYIHS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 226 YCAPEYAMT-GQLTKKSDVYSFGVVLLELITGR 257
Y APE + + T DV+S G + EL+ +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 70/275 (25%), Positives = 107/275 (38%), Gaps = 85/275 (30%)
Query: 62 VGEGGYGRVYKGYIEAV-------DQV--VAVKQLDRSGNQGSRE-FFAEVLMLS-LVQH 110
+G G +G+V +EA D V VAVK L S + RE +E+ +LS L QH
Sbjct: 46 LGAGAFGKV----VEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101
Query: 111 QNLVNLIG-------------YCADGD--------QRILVYEFMS------------NGS 137
+N+VNL+G YC GD + M+ N +
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161
Query: 138 LENHFL---------------------------------DLPPDQEPLDWFTRMKIAGGA 164
LE ++ + D PLD ++ +
Sbjct: 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQV 221
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
A+G+++L A I+RD A N+LL K+ DFGLA+ V
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRS 258
+ APE T +SDV+S+G++L E+ + G+S
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 67/265 (25%), Positives = 107/265 (40%), Gaps = 77/265 (29%)
Query: 61 LVGEGGYGRVYKGYIEAVDQ-----VVAVKQLDRSGNQGS--REFFAEV-LMLSLVQHQN 112
++G G +G+V + +D+ VAVK L + G S + +E+ +++ + H N
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKML-KEGATASEHKALMSELKILIHIGNHLN 72
Query: 113 LVNLIGYCADGDQRILV------YEFMSN------------------------------- 135
+VNL+G C + ++V Y +SN
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 136 ----------GSLENHFL-----DLPPDQEPLD-WFTRMKI------AGGAAKGLEYLHD 173
L + F P QE D W + + + + A+G+E+L
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL-- 190
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV---STRVMGTYGYCAPE 230
A I+RD A NILL K+ DFGLA+ D+V S R+ + APE
Sbjct: 191 -ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPE 246
Query: 231 YAMTGQLTKKSDVYSFGVVLLELIT 255
T +SDV+SFGV+L E+ +
Sbjct: 247 SIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 19/148 (12%)
Query: 106 SLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
S ++ + YC D + E G + + +WF ++ +
Sbjct: 70 SFLERDAFCIITEYCEGRDLDCKLEELKHTG-------KTLSENQVCEWFIQLLL----- 117
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
G+ Y+H +++RD KA NI L K+ DFG+++L G ++T GT
Sbjct: 118 -GVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPY 170
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLEL 253
Y +PE KSD++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 3/156 (1%)
Query: 100 AEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK 159
+E+ L+ H +V D+ +L+ E+ S G L + P F +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP---FQEYE 170
Query: 160 IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR 219
+ + + L +V +++RD K++NI L KL DFG +K V++
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 220 VMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
GT Y APE + +KK+D++S GV+L EL+T
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 50/199 (25%), Positives = 81/199 (40%), Gaps = 32/199 (16%)
Query: 76 EAVDQVVAVKQ--LDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133
+ + +VAVK+ LD + + E++ +QH N++ + + +V M
Sbjct: 22 KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81
Query: 134 SNGS----LENHFLD-LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASN 188
+ GS L+ HF + LP E F I L+Y+H I+R KAS+
Sbjct: 82 AYGSCEDLLKTHFPEGLP---ELAIAF----ILKDVLNALDYIHSKG---FIHRSVKASH 131
Query: 189 ILLDAEFNPKLSDFGLAKLGPTGGKDHV--------STRVMGTYGYCAPEY---AMTGQL 237
ILL + LS + GK S + + + +PE + G
Sbjct: 132 ILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQQNLQG-Y 187
Query: 238 TKKSDVYSFGVVLLELITG 256
+KSD+YS G+ EL G
Sbjct: 188 NEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 58/197 (29%), Positives = 92/197 (46%), Gaps = 21/197 (10%)
Query: 82 VAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENH 141
V +K LD S + FF ++S V H +L + G C G + I+V EF+ +G L+
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV- 105
Query: 142 FLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL-----LDAEFN 196
L + P+ W ++ +A A L YL D +++ + A NIL L +
Sbjct: 106 CLRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTS 160
Query: 197 P--KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLEL 253
P KLSD G++ ++ V R+ + APE G L+ +D +SFG LLE+
Sbjct: 161 PFIKLSDPGVS-FTALSREERVE-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
Query: 254 -ITGRSAIDNSRPSEEQ 269
G + PSE++
Sbjct: 215 CFDGEVPLKERTPSEKE 231
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 62/248 (25%), Positives = 107/248 (43%), Gaps = 29/248 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQ 111
E+F ++G G +G V ++ D+V A+K L++ + F E + +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 112 NLVNLIGYCADGDQRI-LVYEFMSNG---SLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
+ + Y + + LV ++ G +L + F D P+ + M IA +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG-LAKLGPTGGKDHVSTRVMGTYGY 226
L Y+H RD K NIL+D + +L+DFG KL G S+ +GT Y
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ--SSVAVGTPDY 169
Query: 227 CAPEY--AM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281
+PE AM G+ + D +S GV + E++ G + P ++LV ++
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVETYGKIMNH 223
Query: 282 KKKFTMMA 289
K++F A
Sbjct: 224 KERFQFPA 231
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 51/170 (30%), Positives = 74/170 (43%), Gaps = 26/170 (15%)
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV---STRVM 221
A+G+E+L A I+RD A NILL K+ DFGLA+ D+V R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 237
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLR 280
+ APE T +SDV+SFGV+L E+ + G S + EE R
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---------FCR 287
Query: 281 DKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330
K+ T M P +Y +Y + C + + RP ++V L
Sbjct: 288 RLKEGTRMRAP----EYATPEIYSIMLD---CWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 55/189 (29%), Positives = 83/189 (43%), Gaps = 20/189 (10%)
Query: 73 GYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132
GY + V +K LD S S FF M+ V H+++V L G C + I+V EF
Sbjct: 26 GYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEF 85
Query: 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL- 191
+ G L+ L + + L + K+A A L YL D +++ + NILL
Sbjct: 86 VEFGPLD---LFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLA 139
Query: 192 ----DAEFNP--KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-TGQLTKKSDVY 244
D E P KLSD G+ + + R+ + APE + L+ +D +
Sbjct: 140 REGIDGECGPFIKLSDPGIPITVLS--RQECVERI----PWIAPECVEDSKNLSIAADKW 193
Query: 245 SFGVVLLEL 253
SFG L E+
Sbjct: 194 SFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 39/220 (17%)
Query: 60 CLVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
C VG G YG VYK + D+ A+KQ++ +G S E+ +L ++H N+++L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQ 64
Query: 118 G-YCADGDQRI-LVYEFMSNGSLENHFLDL----PPDQEPLDWFTRMKIAGGAAKGLEY- 170
+ + D+++ L++++ + H + +++P+ ++ G K L Y
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPV------QLPRGMVKSLLYQ 116
Query: 171 ----LHDVADPPVIYRDFKASNILLDAEFNP-----KLSDFGLAK-----LGPTGGKDHV 216
+H + V++RD K +NIL+ E P K++D G A+ L P D V
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 217 STRVMGTYGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELIT 255
T+ Y APE + + TK D+++ G + EL+T
Sbjct: 176 VV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 53/170 (31%), Positives = 73/170 (42%), Gaps = 26/170 (15%)
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV---STRVM 221
AKG+E+L A I+RD A NILL K+ DFGLA+ D+V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLR 280
+ APE T +SDV+SFGV+L E+ + G S + EE R
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------FCR 293
Query: 281 DKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330
K+ T M P Y +YQ + C + RP ++V L
Sbjct: 294 RLKEGTRMRAP----DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 65/272 (23%), Positives = 99/272 (36%), Gaps = 81/272 (29%)
Query: 62 VGEGGYGRV-----YKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLS-LVQHQNLV 114
+G G +G+V Y + VAVK L S + RE +E+ +LS L H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 115 NLIG-------------YCADGD-------------------------QRILVYEFMSNG 136
NL+G YC GD + L+++ +
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSC 162
Query: 137 SLENHFLDLPP---------------------------------DQEPLDWFTRMKIAGG 163
N ++D+ P D+ LD + +
Sbjct: 163 DSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQ 222
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
AKG+ +L A I+RD A NILL K+ DFGLA+ V
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE T +SDV+S+G++L E+ +
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 18/228 (7%)
Query: 36 KAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR---SGN 92
+ K T N K ++L E++ ++G G +G V ++ +V A+K L +
Sbjct: 27 RYKDTIN--KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR 84
Query: 93 QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPL 152
S F+ E +++ +V L D +V E+M G L N + ++
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA 144
Query: 153 DWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212
++T + L+ +H + I+RD K N+LLD + KL+DFG G
Sbjct: 145 RFYTAEVVLA-----LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196
Query: 213 KDHVSTRVMGTYGYCAPEYAMT----GQLTKKSDVYSFGVVLLELITG 256
T V GT Y +PE + G ++ D +S GV L E++ G
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 54/210 (25%), Positives = 90/210 (42%), Gaps = 25/210 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVK----QLDRSG--NQGSREFFAEVLMLSLVQHQNLVN 115
+GEG YG+VYK + ++VA+K ++D G RE L+ L + +V
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI---SLLQMLSESIYIVR 65
Query: 116 LIGY----CADGDQRI-LVYEFMSNGSLENHFLDL--PPDQEPLDWFTRMKIAGGAAKGL 168
L+ +G + LV+E++ S F+D PL T KG+
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLD--SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNP-KLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
+ H V++RD K N+L+D + K++D GL + K + T + T Y
Sbjct: 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYR 178
Query: 228 APEYAMTG-QLTKKSDVYSFGVVLLELITG 256
APE + + D++S G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 51/241 (21%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY- 119
++G G +G VY+ + VA+K++ + +R E+L++ + H N++ L Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYY 128
Query: 120 ---CADGDQRIL------------VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA 164
C +++ + V+++M + + NH L L F +
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL---------FLVKLYSYQL 179
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNP-KLSDFGLAKLGPTGGKDHVSTRVMGT 223
+ L Y+H + +RD K N+L+D + KL DFG AK G+ VS + +
Sbjct: 180 CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK-NLLAGQRSVS--YICS 233
Query: 224 YGYCAPEYAM-TGQLTKKSDVYSFGVVLLELI------TGRSAIDN--------SRPSEE 268
Y APE + T D++S G ++ E+I +G+S++D P+E+
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293
Query: 269 Q 269
Q
Sbjct: 294 Q 294
|
Length = 440 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 60 CLVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
C VG G YG VYK + ++ A+KQ++ +G S E+ +L ++H N++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQ 64
Query: 118 G-YCADGDQRI-LVYEFMSNGSLENHFLDL----PPDQEPLDWFTRMKIAGGAAKGLEYL 171
+ + D+++ L++++ + H + +++P+ R + + L+ +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQ-LPRSMVKSLLYQILDGI 121
Query: 172 HDVADPPVIYRDFKASNILLDAEFNP-----KLSDFGLAK-----LGPTGGKDHVSTRVM 221
H + V++RD K +NIL+ E P K++D G A+ L P D V
Sbjct: 122 HYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVV--- 177
Query: 222 GTYGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELIT 255
T+ Y APE + + TK D+++ G + EL+T
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 34/151 (22%), Positives = 57/151 (37%), Gaps = 17/151 (11%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLV--NLIG 118
L+ G RVY + D+ +K RE EV +L L+ + L ++
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLA 60
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
L+ E+ +E LD ++E D ++ A+ L LH +
Sbjct: 61 SGESDGWSYLLMEW-----IEGETLDEVSEEEKEDIAEQL------AELLAKLHQLPLLV 109
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209
+ + D NIL+D + D+ A GP
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 33/113 (29%), Positives = 48/113 (42%), Gaps = 36/113 (31%)
Query: 180 IYRDFKASNILLDAEFNPKLSDFGL----------------AKLGPTGGKDHVST----- 218
I+RD K N+LLDA+ + KLSDFGL + P+ D +S
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 219 ----------RVM-----GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG 256
R + GT Y APE + K+ D +S GV++ E++ G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE---FFAEVLMLSLVQH 110
++F ++G G +G V ++ QV A+K L++ E F E +L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNG---SLENHFLD-LPPDQEPLDWFTRMKIAGGAAK 166
+ + NL D + LV ++ G +L + F D LP D + M +A +
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVLAIDSVH 119
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG-LAKLGPTGGKDHVSTRVMGTYG 225
L Y+H RD K N+LLD + +L+DFG +L G S +GT
Sbjct: 120 QLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ--SNVAVGTPD 168
Query: 226 YCAPEY--AM---TGQLTKKSDVYSFGVVLLELITGRS 258
Y +PE AM G+ + D +S GV + E++ G +
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 36/109 (33%), Positives = 46/109 (42%), Gaps = 13/109 (11%)
Query: 150 EPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA-KLG 208
PL + I + L YLH +I+RD K NI LD N L DFG A KL
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 209 PTGGKDHVSTRV----MGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLEL 253
H T GT +PE K+D++S G+VL E+
Sbjct: 237 -----AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 36/134 (26%), Positives = 56/134 (41%), Gaps = 34/134 (25%)
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLA-------------------------------KLG 208
I+RD K N+LLDA+ + KLSDFGL +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 209 PTGGKD--HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPS 266
T K+ ++ +GT Y APE M K D +S GV++ E++ G + P
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 267 EE-QNLVTWAKPLL 279
E + ++ W + L+
Sbjct: 243 ETYRKVMNWKETLV 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 37/145 (25%), Positives = 56/145 (38%), Gaps = 46/145 (31%)
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLA---------------------KLGPTGGKDHVST 218
I+RD K NIL+D + + KL+DFGL + P+ D VS
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 219 ------------------------RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELI 254
++GT Y APE + T+ D +S GV+L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 255 TGRSAIDNSRPSEEQ-NLVTWAKPL 278
G+ P+E Q ++ W L
Sbjct: 243 VGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 16/95 (16%)
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK----DHVSTRVM 221
K L+++H + +RD K NIL+ + KL+DFG + K +++STR
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTR-- 162
Query: 222 GTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELIT 255
Y APE +T G K D+++ G V E+++
Sbjct: 163 ---WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 8e-05
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 22/155 (14%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIG 118
+ G +G+VY G + ++ AVK + ++ + AE L+L + +V+L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 119 YCADGDQRILVYEFMSNGSLEN------HFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
+ LV E++ G +++ +F D+E +K A L+YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYF-----DEE-----MAVKYISEVALALDYLH 121
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207
+I+RD K N+L+ E + KL+DFGL+K+
Sbjct: 122 RHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 40/177 (22%), Positives = 75/177 (42%), Gaps = 24/177 (13%)
Query: 89 RSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV--------YEFMSNGSLEN 140
++G++ + + E+L L + H+N++ + ++ Y FM +
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDE---- 256
Query: 141 HFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS 200
PL TR I +EY+HD +I+RD K NI L+ + L
Sbjct: 257 ---AFDWKDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLG 309
Query: 201 DFGLAKLGPTGGKDHVSTRV--MGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
DFG A K+ + +GT +PE + +D++S G++LL++++
Sbjct: 310 DFGTAM---PFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 1e-04
Identities = 38/155 (24%), Positives = 60/155 (38%), Gaps = 49/155 (31%)
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL----------------------- 204
+E +H + I+RD K NIL+D + + KL+DFGL
Sbjct: 114 IESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 205 -------AKLGPTGGK--------DHVSTRVM-----GTYGYCAPEYAMTGQLTKKSDVY 244
+++ K H R + GT Y APE + T+ D +
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQH--QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228
Query: 245 SFGVVLLELITGRSAIDNSRPSEEQ-NLVTWAKPL 278
S GV+L E++ G+ P+E Q ++ W L
Sbjct: 229 SVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 36/138 (26%), Positives = 55/138 (39%), Gaps = 42/138 (30%)
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD------------------------- 214
I+RD K N+LLD++ + KLSDFGL TG K
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLC----TGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 215 ------------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDN 262
++ +GT Y APE M K D +S GV++ E++ G +
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 263 SRPSEE-QNLVTWAKPLL 279
P E + ++ W + L+
Sbjct: 239 ETPQETYKKVMNWKETLI 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE---FFAEVLMLSLVQH 110
++F ++G G +G V ++ +++ A+K L++ E F E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNG---SLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
Q + L D + LV ++ G +L + F D P+ + M +A +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG-LAKLGPTGGKDHVSTRVMGTYGY 226
L Y+H RD K N+LLD + +L+DFG K+ G S+ +GT Y
Sbjct: 121 LHYVH---------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ--SSVAVGTPDY 169
Query: 227 CAPEY--AM---TGQLTKKSDVYSFGVVLLELITGRS 258
+PE AM G+ + D +S GV + E++ G +
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 51/177 (28%), Positives = 74/177 (41%), Gaps = 38/177 (21%)
Query: 101 EVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGS----LENHFLDLPPDQEPLDWFT 156
EV++ +H N++ G ++ FM+ GS L+ +F E +
Sbjct: 49 EVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF------PEGMSEAL 102
Query: 157 RMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG-LAKLGPTGGKDH 215
I GA +GL YLH I+R+ KAS+IL+ + LS L L G K
Sbjct: 103 IGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159
Query: 216 V-------STRVMGTYGYCAPE--------YAMTGQLTKKSDVYSFGVVLLELITGR 257
V ST V+ + +PE Y + KSD+YS G+ EL TGR
Sbjct: 160 VVYDFPQFSTSVL---PWLSPELLRQDLYGYNV------KSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST-RVMGT 223
A+G+E+L A ++RD A N+LL K+ DFGLA+ ++VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLP 302
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE T SDV+S+G++L E+ +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 50/225 (22%), Positives = 87/225 (38%), Gaps = 53/225 (23%)
Query: 100 AEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK 159
AE +L+ ++ +V L D D V +++ G + + + + E L F +
Sbjct: 50 AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE 109
Query: 160 IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA-------------- 205
+ +E +H + I+RD K NIL+D + + KL+DFGL
Sbjct: 110 LTCA----VESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 206 -------------------------KLGP---TGGKDH---VSTRVMGTYGYCAPEYAMT 234
+L P + H ++ ++GT Y APE +
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 235 GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ-NLVTWAKPL 278
T+ D +S GV+L E++ G+ P E Q ++ W L
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 10/110 (9%)
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
+ ++YLH+ +I+RD KA NI ++ + L DFG A P + GT
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTIA 248
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITG------RSAIDNSRPSEEQ 269
APE D++S G+VL E+ T + +D S+ Q
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQ 298
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 6e-04
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 5/92 (5%)
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST-RVMGT 223
A G+E+L A ++RD A N+L+ K+ DFGLA+ +++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLP 304
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE T SDV+SFG++L E+ T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 336 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.84 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.64 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.57 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.38 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.33 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.32 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.18 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.15 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.08 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.06 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.94 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.82 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.81 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.65 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.65 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.6 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.44 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.43 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.4 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.37 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.27 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.2 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.19 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.17 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.16 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.98 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.78 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.71 | |
| PLN02236 | 344 | choline kinase | 97.7 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.58 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.58 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.49 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.37 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.36 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.28 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.26 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.22 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.2 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.08 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.08 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.08 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.98 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.66 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.49 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.25 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.24 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.01 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.95 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-56 Score=373.17 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=212.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCC-eEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD-QRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 131 (336)
.+.+..+.||+|+.|+||++.|+.|++.+|+|++.... ....+++.+|+++++..+|||||.+|+.|.... ..+++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 35667778999999999999999999999999995543 344578999999999999999999999999988 5999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||++|||++++.. .+.+++.....++.++++||.|||. .+ ||||||||+||||+..|.|||||||.+..+..
T Consensus 159 YMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 159 YMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred hcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999875 3679999999999999999999996 66 99999999999999999999999999986543
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+... ........+ ++
T Consensus 232 S----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-~~~~Ll~~I----------v~ 296 (364)
T KOG0581|consen 232 S----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-DIFELLCAI----------VD 296 (364)
T ss_pred h----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-CHHHHHHHH----------hc
Confidence 2 56788999999999999999999999999999999999999999987622111 111111111 11
Q ss_pred CccCCCCcH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPR-KGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... ..+|. .++.+++.++..||+.||.+|||+.++++
T Consensus 297 ~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 297 EPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 12333 36779999999999999999999999986
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-57 Score=382.59 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=211.1
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-------cHHHHHHHHHHHhhccCCCccceEEEEEeCC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-------GSREFFAEVLMLSLVQHQNLVNLIGYCADGD 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 124 (336)
..+.|.+.+.||+|+||.|-+|..+.||+.||||++.+.... ......+|+++|+.|+|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 446789999999999999999999999999999999764211 2234679999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC---CceEEcc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---FNPKLSD 201 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~---~~~kl~D 201 (336)
..||||||++||.|.+.+.. .+.+.+.....++.|++.|+.|||+.| |+||||||+|||++.+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999876 567788888999999999999999999 9999999999999766 5699999
Q ss_pred ccccccCCCCCCcceeeeeccCccccCccccccCCC---CCccchhhHHHHHHHHHhCCCCCCCCCCcc-cccHHHHHHH
Q 036144 202 FGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL---TKKSDVYSFGVVLLELITGRSAIDNSRPSE-EQNLVTWAKP 277 (336)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~ 277 (336)
||+|+... ......++||||.|.|||++.++.+ ..++|+||+||+||-+++|.+||+...... ....+..++-
T Consensus 323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y 399 (475)
T KOG0615|consen 323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY 399 (475)
T ss_pred cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence 99999753 3455778999999999999987643 348899999999999999999998765433 2222211111
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. .........+++..+||.+||..||++|||+.|+|+
T Consensus 400 ~--------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 400 A--------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred c--------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 0 011223467889999999999999999999999885
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-54 Score=384.57 Aligned_cols=290 Identities=58% Similarity=0.952 Sum_probs=252.5
Q ss_pred CCCcccHHHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEE
Q 036144 40 TPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY 119 (336)
Q Consensus 40 ~~~~~~~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 119 (336)
....|.+.++..++++|.....||+|+||.||+|.... |..||||.+.........+|.+|+.++..++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 45679999999999999999999999999999999986 48999998866543214569999999999999999999999
Q ss_pred EEeCC-eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceE
Q 036144 120 CADGD-QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 120 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
|.+.+ ..+||+||+++|+|.+++...... .++|..+.+|+.++|+||+|||....++|+||||||+|||+|++.+.|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 599999999999999999873322 899999999999999999999998878899999999999999999999
Q ss_pred EccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 199 LSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 199 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
|+|||+|...+.. .....+...||.+|+|||++..+..+.++||||||++++||++|+.+.+...+.....++.|.++.
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999654331 111111117999999999999999999999999999999999999998877666666789999888
Q ss_pred hhcccccccccCCccC-CCCcH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 279 LRDKKKFTMMADPLLE-GQYPR-KGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
+.+. ....++|+.+. ..++. .....+..++.+|++.+|.+||+|.+|++.|+.+.
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 8776 88999999987 66665 57778999999999999999999999999997664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-56 Score=393.61 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=218.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.+|...++||+|+|+.||.+++..+|+.||+|++.+. .....+.+.+||++.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999999999999999999763 2344577999999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|+|..++|..++.. ++++++..++.++.||+.||.|||+.+ |+|||||..|+|++++.+|||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999864 688999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .....+.||||.|.|||++.....+..+||||+|||+|-|+.|++||+..+-.+....+....
T Consensus 171 ~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-------------- 234 (592)
T KOG0575|consen 171 D--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-------------- 234 (592)
T ss_pred c--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC--------------
Confidence 3 245678999999999999999999999999999999999999999998765433322222111
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
-.+|...+..+.+||.++|+.||.+|||+++||.
T Consensus 235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0234456678999999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=373.95 Aligned_cols=249 Identities=26% Similarity=0.384 Sum_probs=206.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
...+|.+.+.||.|+||+||+|+++.++..||||.+.+. .....+.+..|+.+|+.++|||||.+++++..++..|||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 346799999999999999999999999999999999876 344556688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC------CceEEcccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE------FNPKLSDFG 203 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~------~~~kl~Dfg 203 (336)
||||+||+|.+++.. ++.+++..++.++.||+.|+++||+++ ||||||||+|||++.. ..+||+|||
T Consensus 88 MEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999976 568999999999999999999999999 9999999999999765 458999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
+|+.+..+ ....+.||++-|||||++..+.|+.|+|+||+|+|+|+|++|++||......+..-.+.....
T Consensus 161 fAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~------ 231 (429)
T KOG0595|consen 161 FARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE------ 231 (429)
T ss_pred hhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc------
Confidence 99987643 346778999999999999999999999999999999999999999997776554332221111
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVD 325 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 325 (336)
....++...+..+.+|+...++.+|..|-+..+
T Consensus 232 ---------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 232 ---------IVPVLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred ---------ccCchhhhccCchhhhhhHHHhcCccccCchHH
Confidence 111222223334555666666666666655544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-57 Score=365.52 Aligned_cols=259 Identities=23% Similarity=0.324 Sum_probs=216.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEE-EEEeCCe-EEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIG-YCADGDQ-RIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~-~~l 128 (336)
..+|++.++||.|.||.||+|.+..+|..+|.|.+.-. .....+.+..|+.+|++|+|||||++++ .+.+++. +++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 35688999999999999999999999999999998643 2334567899999999999999999998 4444444 789
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD-PPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
|||||.+|+|.+.+......++.+++..+|+++.|++.||..+|++-. ..|+||||||.||+++.+|.|||+|||++++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999999888889999999999999999999999998431 2399999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
+.. ......+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+ +......+- ++ +
T Consensus 178 l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~KI~-qg-d--- 244 (375)
T KOG0591|consen 178 LSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKKIE-QG-D--- 244 (375)
T ss_pred hcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHHHH-cC-C---
Confidence 654 3445677899999999999999999999999999999999999999998763 222222211 11 0
Q ss_pred ccCCccCCCCc-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 288 MADPLLEGQYP-RKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 288 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
...+| ..++..+.+||..|+.+||+.||+...++..+
T Consensus 245 ------~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 245 ------YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred ------CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 01223 56788999999999999999999965555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=364.07 Aligned_cols=243 Identities=26% Similarity=0.355 Sum_probs=210.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.++||+|+||+|+.++.+.+++.+|+|++++.. ....+....|..+|..++||.||+++..|++...+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 478999999999999999999999999999999997653 33456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
+||+.||.|.-.|+. ...+++..++-++.+|+.||.|||++| ||||||||+|||+|.+|+++|+|||+|+...
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999875 577999999999999999999999999 9999999999999999999999999998543
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. .....++|||+.|||||++.+.+|+..+|.||||+++|+|++|.+||...+.....+.+...+
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------------- 241 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------------- 241 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------------
Confidence 32 223556899999999999999999999999999999999999999999876544333332111
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 321 (336)
....+...+..+.+++.++|..||+.|.
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1122333566899999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=349.22 Aligned_cols=266 Identities=26% Similarity=0.310 Sum_probs=217.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
+.|+.+.++|+|+||.||+++++.||+.||||++..+... ..+-.++|+++|++++|+|+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 5688889999999999999999999999999999765432 23457899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
||+. ++.+.+... ...++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9965 555555553 456888999999999999999999999 99999999999999999999999999997653
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH--------HHHHhhcc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW--------AKPLLRDK 282 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~ 282 (336)
.....+..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+.++.+....+.. -..++..+
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2344667889999999999988 6899999999999999999999999998776665444432 12333333
Q ss_pred cccccccCCccCC--CC---cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEG--QY---PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~--~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+..+.-|.... .. -+..+.-+.+++..||+.||.+|++.++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 3333333332221 11 1234558899999999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=364.06 Aligned_cols=257 Identities=32% Similarity=0.500 Sum_probs=212.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeE-EEEEeecCCCCcc--HHHHHHHHHHHhhccCCCccceEEEEEeCC-eEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQV-VAVKQLDRSGNQG--SREFFAEVLMLSLVQHQNLVNLIGYCADGD-QRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv 129 (336)
....+.+.||.|+||+||+|.+++ .. ||+|++....... .+.+.+|+.+|..++|||||+++|++.+.. ..++|
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 344555569999999999999984 45 9999997654322 458999999999999999999999999887 79999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEccccccccC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKLG 208 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 208 (336)
|||+++|+|.+++... ....+++..+..++.||++|++|||+.+. ||||||||+|||++.++ ++||+|||+++..
T Consensus 119 tEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999763 46789999999999999999999998764 89999999999999997 9999999999764
Q ss_pred CCCCCcceeeeeccCccccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAM--TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
.... ...+...||+.|||||++. ...|+.++||||||+++|||+||..||.+.........+
T Consensus 195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v-------------- 258 (362)
T KOG0192|consen 195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV-------------- 258 (362)
T ss_pred cccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--------------
Confidence 3321 2234468999999999999 569999999999999999999999999987652211111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+..++..++..+..|+.+||+.||+.||++.+++..|+.+.
T Consensus 259 --~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 259 --VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred --HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 1111222334446668999999999999999999999999998764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=365.42 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=213.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 127 (336)
...+|.+.+.||+|+|++|++|+.+.++..||||++.+.- ....+.+..|-.+|.+| .||.|++++..|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4468999999999999999999999999999999986532 22234567788889888 7999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+|+||+++|+|.+++.. -+.+++...+.++.+|+.||+|||++| ||||||||+|||++.+++++|+|||.|..
T Consensus 151 FvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999976 477999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCc-----------ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 036144 208 GPTGGKD-----------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 208 ~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 276 (336)
+...... ....+++||..|.+||++..+..++.+|+|+||||+|+|+.|.+||...++--....+.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--- 300 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--- 300 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH---
Confidence 6532221 11256999999999999999999999999999999999999999998866422211111
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ++. .|+...++.+.+||.+.|..||.+|+|+++|-+
T Consensus 301 ---~--------l~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 301 ---A--------LDY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ---H--------hcc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1 111 334444568999999999999999999988865
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=334.23 Aligned_cols=237 Identities=27% Similarity=0.347 Sum_probs=208.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|+..+.||.|+||.|.+++++.+|..+|+|++++.... ..+...+|..+|+.+.||.++++++.+.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 5688999999999999999999999999999999765432 2345678999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||++||.|..+++. .+++++..++-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||+|.....
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999976 578999999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
...+.||||.|+|||++..++|+.++|.||||+++|||+.|.+||...++...-..+. .
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~----------------~ 255 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL----------------E 255 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH----------------h
Confidence 2567899999999999999999999999999999999999999999877633222221 1
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCC
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSR 320 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 320 (336)
. .-.+|...+..+.+|+..+|+.|-.+|
T Consensus 256 ~--~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 G--KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred C--cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1 113566667789999999999999999
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=361.74 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=219.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
..|....+||+|+.|.||.|....+++.||||++........+.+.+|+.+|+..+|+|||.+++.|...+.+++||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 56888889999999999999999999999999998877666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+||+|.+.+.. ..+++.++..|+.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||+|.......
T Consensus 353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~- 423 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ- 423 (550)
T ss_pred CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc-
Confidence 99999999865 44899999999999999999999999 9999999999999999999999999998765432
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
....+.+|||.|||||++....|++++||||||++++||+-|.+||-+.++.....++. .+ ...
T Consensus 424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------~n--------g~P 487 (550)
T KOG0578|consen 424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------TN--------GTP 487 (550)
T ss_pred -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------hc--------CCC
Confidence 25677899999999999999999999999999999999999999998866544433332 11 111
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....+...+..+.+++.+||+.|+++||++.|+|+
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 12234556779999999999999999999999997
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=346.83 Aligned_cols=263 Identities=25% Similarity=0.348 Sum_probs=216.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
...|++..+||.|..++||+|+...+++.||||++.... ....+.+.+|+..|+.++||||++++..|..+..+++||+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467999999999999999999999999999999997543 3335889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
||.+||+.+.+.... ...+++..+..|+.++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999998754 345999999999999999999999999 999999999999999999999999998765544
Q ss_pred CCcc-ee-eeeccCccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 212 GKDH-VS-TRVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 212 ~~~~-~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
+... .. ..++||++|||||++.. ..|+.|+||||||++..||.+|..||....+....-... ......
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--------qn~pp~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--------QNDPPT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--------cCCCCC
Confidence 4222 22 56899999999999654 479999999999999999999999999877644211110 011111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+..+-....+..+.+++..||+.||.+|||++++++
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111111222334558999999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=359.98 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=212.3
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC----CC-ccHHHHHHHHHHHhhcc-CCCccceEEEEEeCC
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS----GN-QGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGD 124 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 124 (336)
....+|.+.+.||+|+||.|++|.+..++..||+|++... .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999999999999999987654 11 23456778999999999 999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-CceEEcccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFG 203 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-~~~kl~Dfg 203 (336)
..++||||+.||+|.+++.. ..++.+..+..++.|++.|++|+|+.| |+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999975 577888999999999999999999999 9999999999999999 999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCC-CC-CccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ-LT-KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
++.... .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||++.+...... .+...
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~------ki~~~ 238 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR------KIRKG 238 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH------HHhcC
Confidence 998763 2344567789999999999999987 86 88999999999999999999999844322111 11111
Q ss_pred ccccccccCCccCCCCcHHH-HHHHHHHHHhhcCCCCCCCCCHHHHH
Q 036144 282 KKKFTMMADPLLEGQYPRKG-LYQALAVAGMCLQEDADSRPFMVDVV 327 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~Rpt~~evl 327 (336)
.. .++... +..+..|+.+||..||.+|+|+.+++
T Consensus 239 ~~------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EF------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Cc------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 10 122223 67899999999999999999999998
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-51 Score=327.25 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=215.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc--HHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG--SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.+|...++||+|.||.||+|++..+|+.||||.++.....+ .....+|++.|+.++|+||+.++++|.......+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888889999999999999999999999999997653221 2457899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+ ..+|+..+.+ ....++...+..++.++++||+|+|+++ |+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 82 fm-~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FM-PTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ec-cccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 99 5699998876 5678899999999999999999999999 999999999999999999999999999986554
Q ss_pred CCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--HHH---------h
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--KPL---------L 279 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---------~ 279 (336)
. ...+..+-|.+|+|||.+.|. .|+..+|+||.|||+.||+.|.+-|.+.++.+....+-.+ .+. +
T Consensus 155 ~--~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 N--RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred C--cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 3 334445889999999998875 7999999999999999999999988887655543333211 111 1
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.+...+.....+.... +-...+.++.+|+..||..||.+|+|++++++.
T Consensus 233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111122222222222 223456677999999999999999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-51 Score=356.18 Aligned_cols=253 Identities=23% Similarity=0.316 Sum_probs=210.3
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
..++|+++++||+|+||.||+|+-+.||..+|+|+++++. ......+..|-.+|...++|+||+++..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999999999999999998764 3345668889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||++||++..+|.. ...|++..++.++.+++.||+.||+.| +|||||||+|+|||..|++||+|||+|.-+
T Consensus 219 iMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999975 678999999999999999999999999 999999999999999999999999998521
Q ss_pred CC----------------------CC-C-----c-----------------ceeeeeccCccccCccccccCCCCCccch
Q 036144 209 PT----------------------GG-K-----D-----------------HVSTRVMGTYGYCAPEYAMTGQLTKKSDV 243 (336)
Q Consensus 209 ~~----------------------~~-~-----~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 243 (336)
.. .. . . ......+|||.|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 00 0 0 00123579999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC
Q 036144 244 YSFGVVLLELITGRSAIDNSRPSEEQ-NLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF 322 (336)
Q Consensus 244 wslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt 322 (336)
||||||+||||.|.+||...++.+.- .++.|...+..+. ....+.++.+||.+||. ||++|..
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999988775543 3333332221110 11233689999999999 9999975
Q ss_pred ---HHHHH
Q 036144 323 ---MVDVV 327 (336)
Q Consensus 323 ---~~evl 327 (336)
++||-
T Consensus 436 ~~G~~EIK 443 (550)
T KOG0605|consen 436 SKGAEEIK 443 (550)
T ss_pred cccHHHHh
Confidence 55543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=355.55 Aligned_cols=267 Identities=22% Similarity=0.279 Sum_probs=216.7
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHH--HHHHHHHHhhcc-CCCccceEEEEEeCC-eE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE--FFAEVLMLSLVQ-HQNLVNLIGYCADGD-QR 126 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~~iv~~~~~~~~~~-~~ 126 (336)
...++|.+.+.||.|.||.||+|+.+.+|+.||||.++..-.. .++ -++|+..|++|+ |||||++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3457899999999999999999999999999999999764322 333 468999999999 999999999998887 99
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||| ..+|.+++.. .+..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+
T Consensus 86 ~fVfE~M-d~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeeHHhh-hhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccc
Confidence 9999999 6799999887 3788999999999999999999999999 9999999999999988899999999998
Q ss_pred cCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----Hhh
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-----LLR 280 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~ 280 (336)
.... ....+..+.|.+|+|||++.. +.|+.+.|+||+|||++|+.+-++.|.+.+..+....+..+.+ .+.
T Consensus 159 ev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 159 EVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 6533 234667889999999999875 5799999999999999999999999998876665444432210 011
Q ss_pred cccc--------cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 281 DKKK--------FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 281 ~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.+.. +....-..+..-+ +..+.++.+++.+||..||.+|||+.++|+.
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111 1111111111112 2377799999999999999999999999873
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=345.75 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=207.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCC--eEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD--QRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e 131 (336)
.+|...+.||+|+||.||++.+..+|...|||.+........+.+.+|+.+|+.++|||||++++...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45788889999999999999999999999999987654333667899999999999999999999755444 6889999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-CCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-EFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~ 210 (336)
|+++|+|.+++.... ..+++..++.+..|+++||.|||++| |+||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999998732 27999999999999999999999999 999999999999999 79999999999876542
Q ss_pred -CCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCC-CCcccccHHHHHHHHhhccccccc
Q 036144 211 -GGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNS-RPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
...........||+.|||||++..+ ...+++|||||||++.||+||.+||... ...+. .-.+.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~------~~~ig-------- 236 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA------LLLIG-------- 236 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH------HHHHh--------
Confidence 1122234457899999999999863 3346999999999999999999999874 11110 00000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
... ....++...+....+++.+|++.||+.|||++++|..-
T Consensus 237 -~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 237 -RED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -ccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 011 11145666777999999999999999999999999743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=346.68 Aligned_cols=268 Identities=24% Similarity=0.286 Sum_probs=212.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 128 (336)
.+.|+.+++||+|.||.||+|++..+|+.||+|.+.... .....-..+||.+|++|+||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 356888999999999999999999999999999987654 33345577999999999999999999988776 68999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
|+|||+ -+|..++.. ..-.+++.++..++.||+.||+|+|+.| |+|||||..|||||.+|.+||+|||+|+++
T Consensus 196 VFeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 999995 478777754 3567999999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc-cccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK-KKFT 286 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 286 (336)
.... ....++.+-|.+|+|||.+.|. .|+.++|+||+||||.||+.|++.|.+....+....+-.....-... +...
T Consensus 269 ~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 5433 3346777899999999999886 79999999999999999999999999877655443332111100000 0000
Q ss_pred cccC---CccCCCC-------cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMAD---PLLEGQY-------PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~---~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+.. ......+ -...+....+|+..+|..||.+|.|+.++|.
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1110 0000111 1233557889999999999999999999885
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=360.53 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=213.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.-|++.+.||.|+-|.|-+|+|..||+.+|||++.+.. ......+.+|+-+|+.+.||||+.+|+++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45888999999999999999999999999999997652 222356889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||++||.|.+++.. ++++++..+.+++.||+.|+.|+|..+ |+||||||+|+|++..+++||+|||+|..-..
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999976 688999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCcceeeeeccCccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLT-KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
+ ....+.||+|.|.|||++.|.+|+ .++||||+|+|||.|++|+.||++.+.......+. .. . .
T Consensus 165 g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~------~G--~-f--- 229 (786)
T KOG0588|consen 165 G---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ------RG--V-F--- 229 (786)
T ss_pred C---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH------cC--c-c---
Confidence 3 345677999999999999999985 89999999999999999999999654322211111 11 0 0
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
+.|...+.++.+|+.+||.+||++|.|++||++.
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 2245567789999999999999999999999873
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-50 Score=352.05 Aligned_cols=247 Identities=30% Similarity=0.390 Sum_probs=215.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|-+.+.||+|.||+||+|+.+.+.+.||+|.+.+.... ....+.+|+++++.++||||+.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5788889999999999999999999999999999876543 34568999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+.| +|..++.. .+.++++.+..++.+++.||.|||+.+ |.|||+||.|||++.++.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9965 99999875 688999999999999999999999999 99999999999999999999999999997644
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
.....+...|||.|||||...+++|+..+|+||+|||+|||+.|++||-.... ......+..+.
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~d~--------- 216 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILKDP--------- 216 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhcCC---------
Confidence 45567788999999999999999999999999999999999999999965332 22223333221
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
-..+...+..+.+++...|..||..|.|..+++.
T Consensus 217 ---v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 ---VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1234467779999999999999999999998875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=347.90 Aligned_cols=257 Identities=29% Similarity=0.425 Sum_probs=214.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
+.+...+.||+|.||.||+|.++. ...||+|.++.. ....+.+.+|+.+|+.|+|++||++++++..+.-.+|||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 345567789999999999999986 358999998764 334578889999999999999999999999988899999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+.|+|.++|.. ..+..+...+.+.++.||++|++||++++ +|||||-..||||+++..+||+|||+++...+ ..
T Consensus 284 ~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~ 357 (468)
T KOG0197|consen 284 PKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGD-DE 357 (468)
T ss_pred ccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCC-Cc
Confidence 99999999987 45778899999999999999999999999 99999999999999999999999999994322 22
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
........-...|.|||.+..+.++.+|||||||++||||+| |+.|+......+....+. .-
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-----------------~G 420 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-----------------RG 420 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-----------------cc
Confidence 222233334567999999999999999999999999999999 888888766443332222 11
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
.+-..|..++..+.+|+..||+.+|++|||++.+...|+.+..
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 2223455677799999999999999999999999999988753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=354.27 Aligned_cols=244 Identities=27% Similarity=0.437 Sum_probs=211.3
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 127 (336)
..++|.++++||+|+||+|++|..+.+++.+|||++++.. .++.+....|.+++...+ ||.++.++.+|++.+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578999999999999999999999999999999998763 445667888999988875 999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+.||++..+. ....+++..+.-+++.|+.||+|||+++ ||+||||.+|||+|.+|.+||+|||+|+.
T Consensus 446 fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999955443 3477999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
... ......++||||.|+|||++.+..|+.++|.|||||+||||+.|..||.+.+.++.-+.+.. +
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------d------ 583 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------D------ 583 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------C------
Confidence 432 22356789999999999999999999999999999999999999999998765443322221 1
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
.-.+|...+.+..+|++++|..+|++|..+
T Consensus 584 ------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 123566778899999999999999999866
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=342.70 Aligned_cols=250 Identities=27% Similarity=0.372 Sum_probs=214.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..|...+.||+|.||.||+|.+..+++.||+|++..... ....++.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 457777889999999999999999999999999976543 3457789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+.||++.+.+.. ...+++..+.-++.+++.|+.|||..+ .+|||||+.|||+..+|.+||+|||++......
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~- 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT- 164 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech-
Confidence 999999999865 344477788889999999999999999 999999999999999999999999999876443
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.....+++|||.|||||++....|+.++||||||++.+||.+|.+|+....+.....++. .-..|.
T Consensus 165 -~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------------k~~PP~ 230 (467)
T KOG0201|consen 165 -VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------------KSAPPR 230 (467)
T ss_pred -hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------------CCCCCc
Confidence 233477999999999999998899999999999999999999999999887644332221 111222
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
+ ..+.+..+.+++..||+.||+.||++.++|+.
T Consensus 231 L----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 L----DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred c----ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2 23566689999999999999999999999873
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=346.80 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=206.0
Q ss_pred hcCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeCC-
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADGD- 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~- 124 (336)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.++..+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467999999999999999999852 3456899999865432 2345688999999999 8999999999887644
Q ss_pred eEEEEEEcCCCCChhhhhccCCC---------------------------------------------------------
Q 036144 125 QRILVYEFMSNGSLENHFLDLPP--------------------------------------------------------- 147 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 147 (336)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998864211
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccc
Q 036144 148 -DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226 (336)
Q Consensus 148 -~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 226 (336)
....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++................++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1235788888999999999999999998 999999999999999999999999999754322211222334567889
Q ss_pred cCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHH
Q 036144 227 CAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQA 305 (336)
Q Consensus 227 ~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (336)
+|||++.+..++.++|||||||++|+|++ |..||......+. .. ..+..+.. ...+...+..+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~~~----------~~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDGTR----------MRAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcCCC----------CCCCCCCCHHH
Confidence 99999999999999999999999999997 9999976443211 00 11111100 01123345679
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 306 LAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 306 ~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=334.99 Aligned_cols=255 Identities=27% Similarity=0.348 Sum_probs=204.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--------------ccHHHHHHHHHHHhhccCCCccceE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--------------QGSREFFAEVLMLSLVQHQNLVNLI 117 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~iv~~~ 117 (336)
..++|++.+.||+|.||.|-+|++..+++.||||++.+... ...+...+|+.+|+++.|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 34789999999999999999999999999999999965321 1235788999999999999999999
Q ss_pred EEEEeC--CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC
Q 036144 118 GYCADG--DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF 195 (336)
Q Consensus 118 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~ 195 (336)
++..+. +..|||+|||..|.+... +.....+++.++++++.+++.||+|||.+| ||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 999765 578999999998887432 222333999999999999999999999999 99999999999999999
Q ss_pred ceEEccccccccCCCCC---CcceeeeeccCccccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 036144 196 NPKLSDFGLAKLGPTGG---KDHVSTRVMGTYGYCAPEYAMTGQ----LTKKSDVYSFGVVLLELITGRSAIDNSRPSEE 268 (336)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 268 (336)
+|||+|||.+.....+. ........+|||.|+|||...++. .+.+.||||+|++||+|+.|..||.+....+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 99999999998653321 122233468999999999988743 35789999999999999999999987543222
Q ss_pred ccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 269 QNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.. .+.+..+.-.-.+++.+.+.+||.+||++||+.|.++.+|...
T Consensus 328 ~~----------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 328 FD----------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HH----------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 11 1122222222223567789999999999999999999998654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=328.58 Aligned_cols=268 Identities=24% Similarity=0.334 Sum_probs=213.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecC--CCCccHHHHHHHHHHHhhccCCCccceEEEEEe-----CC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD-----GD 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 124 (336)
....|...+.||+|+||.|+.|.++.+|+.||||.+.. ......++..+|+++|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34567778899999999999999999999999999873 334456778999999999999999999998864 45
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..|+|+|+| +.+|.+.+.. ...++...+..++.|++.||.|+|+.+ |+||||||.|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 689999999 6788888865 455999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH-----
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL----- 278 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----- 278 (336)
|+...........+..+.|.+|.|||++.. ..|+.+.||||+|||+.||++|++.|.+.+......++....+.
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 997754433444577889999999998764 58999999999999999999999999987755544433211100
Q ss_pred ---hhccc------ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 ---LRDKK------KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ---~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+.... .........+...++ +.+..+.+|+.+||..||.+|+|++|+|+
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 000000001111122 45668999999999999999999999986
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=334.81 Aligned_cols=248 Identities=22% Similarity=0.343 Sum_probs=212.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccH---HHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---REFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
..+|++.+.||+|.||.|-+|+....|..||||.+++....+. -.+.+|++||+.|+||||+.++++|++.+..++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4679999999999999999999999999999999987654433 3578999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||..+|.|.+|+.. ++.+++..++.++.||..|+.|+|.++ ++|||||.+|||+|.|+++||+|||++..+.
T Consensus 132 MEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999976 688999999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCcceeeeeccCccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLT-KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
. .....++||+|.|.+||++.+.+|. +.+|.||||++||-|+.|..||++.+-.. ++.. + .. +. .
T Consensus 205 ~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQ---I-s~-Ga---Y 270 (668)
T KOG0611|consen 205 D---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQ---I-SR-GA---Y 270 (668)
T ss_pred c---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHH---h-hc-cc---c
Confidence 3 3456789999999999999999984 89999999999999999999999865321 1111 1 11 01 1
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
. .+..+.+..-||++||..||++|.|+++|...
T Consensus 271 r--------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 271 R--------EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred c--------CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1 11223367789999999999999999998753
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=309.97 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=216.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
..++|++.+.||+|-||.||+|+.+.++-.||+|++-+.. .....++.+|+++-+.|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 4578999999999999999999999999999999986543 2234678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
++||..+|+|...+... ....+++...+.+..|++.|+.|+|.++ ++||||||+|+|++.++.+||+|||.+...
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999863 3466888889999999999999999998 999999999999999999999999999764
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
+ .....+.|||..|.|||+..+..++..+|+|++|++.||++.|.+||+.....+....+..
T Consensus 175 p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k-------------- 236 (281)
T KOG0580|consen 175 P----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK-------------- 236 (281)
T ss_pred C----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH--------------
Confidence 3 3346778999999999999999999999999999999999999999987653222111111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..-.+|...+..+.++|.+||..+|.+|.+..|++..
T Consensus 237 ----~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 ----VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 0112345566789999999999999999999998863
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=337.75 Aligned_cols=246 Identities=25% Similarity=0.298 Sum_probs=205.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999999999999999986432 123456789999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999865 456889999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||........... ....
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~------i~~~--------- 213 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK------ILAG--------- 213 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhC---------
Confidence 1 2345799999999999999999999999999999999999999976543221111 1110
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVTA 329 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~~ 329 (336)
...++...+..+.+|+.+||+.||.+||+ ++++++.
T Consensus 214 ---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 ---KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 01223334568899999999999999995 8888753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=310.49 Aligned_cols=267 Identities=22% Similarity=0.271 Sum_probs=219.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeC-----CeE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG-----DQR 126 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 126 (336)
...+|.+.+.||+|+|+-||++++-.++..+|+|.+.....++.+..++|+..-++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 457899999999999999999999999999999999888777888899999999999999999998876433 348
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
|++++|+..|||.+.+.....+...+++.+++.|+.++.+||++||+.. ++++||||||.|||+++.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999988777788999999999999999999999986 579999999999999999999999999997
Q ss_pred cCCCCCCcc-------eeeeeccCccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 036144 207 LGPTGGKDH-------VSTRVMGTYGYCAPEYAMTG---QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 207 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 276 (336)
...-..... .......|.-|+|||.+.-+ ..+.++|||||||++|.|+.|..||+..-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 643221111 01123468899999988644 568999999999999999999999975322
Q ss_pred HHhhcccccc-cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 277 PLLRDKKKFT-MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 277 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+..+. .+.+....-.-....++.+.++|.+||+.||.+||++.+++..++.+.
T Consensus 247 ----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111 111212211112236789999999999999999999999999998764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=331.84 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=205.3
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37788899999999999999999999999999865321 223457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998887542 2346889999999999999999999998 999999999999999999999999999764322
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. ......||..|+|||++.+..++.++|||||||++|+|++|..||............. .....
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~---------- 219 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVKE---------- 219 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhhc----------
Confidence 1 2234579999999999999999999999999999999999999998654322111111 00000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
....++...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 011233345668999999999999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=340.62 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=218.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCe-EEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ-RILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 129 (336)
.++|..++++|+|+||.+++++++..+..+++|.+..... ...+...+|+.+++++.|||||.+.+.|..++. .++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 3679999999999999999999999999999999875432 233567899999999999999999999998888 9999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|+||+||++.+.+... +...+++..++.|+.|++.|++|||+.+ |+|||||+.|||++.++.|+|+|||+|+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999873 3577999999999999999999999888 9999999999999999999999999999764
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. .....+.+||+.|+.||++.+.+|+.++|||||||++|||++-+++|...+.......+. .
T Consensus 158 ~~--~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~------------~--- 220 (426)
T KOG0589|consen 158 PE--DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN------------R--- 220 (426)
T ss_pred Cc--hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh------------h---
Confidence 43 234667899999999999999999999999999999999999999998766433221111 0
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
......+..++.++..++..||..+|+.||++.++|..
T Consensus 221 --~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 221 --GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11234566778899999999999999999999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=339.64 Aligned_cols=242 Identities=26% Similarity=0.344 Sum_probs=200.6
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNG 136 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 136 (336)
+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999987532 223356778999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcce
Q 036144 137 SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV 216 (336)
Q Consensus 137 ~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 216 (336)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 99988864 457899999999999999999999998 999999999999999999999999998753221 122
Q ss_pred eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCC
Q 036144 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQ 296 (336)
Q Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (336)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... .... ...
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~------~~~~------------~~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL------ILME------------EIR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHH------HHcC------------CCC
Confidence 3446799999999999999999999999999999999999999976432211111 1100 012
Q ss_pred CcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 297 YPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 297 ~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
++...+..+.+++.+||+.||++|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2334566899999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=341.22 Aligned_cols=246 Identities=26% Similarity=0.334 Sum_probs=205.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.++.+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999986532 22345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+.+|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999998865 356888899999999999999999998 9999999999999999999999999997643
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+...
T Consensus 170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~-------- 230 (329)
T PTZ00263 170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY------EKILAG-------- 230 (329)
T ss_pred CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH------HHHhcC--------
Confidence 22 23457999999999999999999999999999999999999999765432111 111110
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
. ..++...+..+.+|+.+||+.||.+||+ +++++.
T Consensus 231 --~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 231 --R--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --C--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 0122234557899999999999999997 677764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=339.52 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=207.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36899999999999999999999999999999986532 223456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999864 356889999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+...... . ..
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~------~---~~ 219 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET------L---QR 219 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc------c---cC
Confidence 234567999999999999999999999999999999999999999875543221111110000 0 00
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
+.. .......+..+.+++.+||..+|.+||++.++++.
T Consensus 220 ~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000 00012345688999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=335.69 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=208.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999999999999999875432 234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999865 34688999999999999999999984 5 99999999999999999999999999875432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc------
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK------ 284 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 284 (336)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+...... .+.......
T Consensus 157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSIS 230 (331)
T ss_pred c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccC
Confidence 2 2334579999999999999899999999999999999999999997654322111100 000000000
Q ss_pred --------------------------cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 285 --------------------------FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 285 --------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
...+.............+..+.+|+.+||+.||++|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000111345689999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=317.25 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=211.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc--HHHHHHHHHHHhhccCCCccceEEEEEe--CCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG--SREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 128 (336)
.++|+.+..|++|+||.||+|+++.|++.||+|.++...... .-..++|+.+|..++|||||.+-.+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 466899999999999999999999999999999997654221 1245799999999999999999988764 457899
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
|||||+ -+|..++..+ .+++...++..++.|++.|++|||..+ |+||||||+|+|++..|.+||+|||+|+.+
T Consensus 155 VMe~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 999995 5899998874 478999999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----HHhhcc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-----PLLRDK 282 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~ 282 (336)
..+ ....+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++.+.|.+....+..+.+-... .++..-
T Consensus 228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 554 3446778899999999999875 79999999999999999999999999876655443332110 011110
Q ss_pred cccc--------cccCCccCCCCcHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFT--------MMADPLLEGQYPRK-GLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~--------~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+. ...-..+...|.-. .+..-.+|+..+|..||.+|.|++|.|+
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1111 11111112222222 4567889999999999999999999885
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=331.02 Aligned_cols=265 Identities=24% Similarity=0.379 Sum_probs=205.4
Q ss_pred cCCCCcccccccCceEEEEEEEcc----------------cCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccce
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEA----------------VDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNL 116 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~----------------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~ 116 (336)
++|.+.+.||+|+||.||+|.+.. ++..||+|++...... ....+.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578999999999999999998642 3457999998764322 34568899999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChhhhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 036144 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPP---------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181 (336)
Q Consensus 117 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H 181 (336)
++++.+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999998864211 1234678889999999999999999998 999
Q ss_pred CCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh--CCCC
Q 036144 182 RDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT--GRSA 259 (336)
Q Consensus 182 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~p 259 (336)
|||||+|||++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999976533322222333456789999999988899999999999999999987 5567
Q ss_pred CCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 260 IDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
|......+ ........+........ ...+...+..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQVY-------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhcccccc-------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76543322 12211111111100000 0112234568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=326.15 Aligned_cols=246 Identities=20% Similarity=0.339 Sum_probs=201.0
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCcc---HHHHHHHHHHHhhccCCCccceEEEEEe----CCeEEEEEEc
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG---SREFFAEVLMLSLVQHQNLVNLIGYCAD----GDQRILVYEF 132 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~ 132 (336)
..||+|++|.||+|... |+.||||.+....... .+.+.+|+.+++.++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 57999999999999984 7899999987654333 3567799999999999999999999876 3567899999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
+++|+|.+++.. ...+++.....++.+++.||.|||+. + ++||||||+||+++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999865 35688889999999999999999984 6 889999999999999999999999998754322
Q ss_pred CCcceeeeeccCccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|..||......+.... ....+.
T Consensus 177 -----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~------i~~~~~------ 239 (283)
T PHA02988 177 -----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL------IINKNN------ 239 (283)
T ss_pred -----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhcCC------
Confidence 123468899999999876 6899999999999999999999999986543221111 111110
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
...++...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 240 ----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 ----SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ----CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 011223456689999999999999999999999999988753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=329.81 Aligned_cols=266 Identities=22% Similarity=0.307 Sum_probs=204.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 579999999999999999999999999999999865432 2335678999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 96 589888764 2345788899999999999999999998 9999999999999999999999999987543221
Q ss_pred CcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHHhhccc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------KPLLRDKK 283 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 283 (336)
.......|++.|+|||++.+ ..++.++||||+||++|+|++|.+||......+....+... ++.+....
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 12234568999999998875 56899999999999999999999999875543322211110 00000001
Q ss_pred ccccccCCccCCC----CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLEGQ----YPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......+..... .....+.++.+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111111000 01123557899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=328.80 Aligned_cols=267 Identities=22% Similarity=0.264 Sum_probs=205.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|.+.+.||+|+||.||+|.++.+++.||+|++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999999999999999986542 2234567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|++++++..+.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 998877765432 2356889999999999999999999998 999999999999999999999999999765332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------HHhhccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK--------PLLRDKK 283 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 283 (336)
. ........||+.|+|||++.+..++.++|||||||++|+|++|.+||......+....+.... ..+....
T Consensus 154 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 S-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred c-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 1 112234578999999999999899999999999999999999999998754322211111000 0000000
Q ss_pred ccccccCCccC------CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLE------GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......+... ..+....+..+.+|+.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01111001000 1111234567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=351.75 Aligned_cols=255 Identities=22% Similarity=0.248 Sum_probs=210.3
Q ss_pred cCCCCcccccccCceEEEEEEEccc-CeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAV-DQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..|.+.+.||+|+||.||+|....+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3489999999999999999999877 788999987655444445678899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++|+|.+++........++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988654444567899999999999999999999998 9999999999999999999999999998654332
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.. ....... .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~------~~~~~~~------~--- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM------QQVLYGK------Y--- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC------C---
Confidence 222344567999999999999999999999999999999999999999764432111 1111100 0
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..++...+..+.+++.+||+.||++||++.+++.
T Consensus 289 --~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 --DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0122334568999999999999999999999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=340.86 Aligned_cols=262 Identities=25% Similarity=0.403 Sum_probs=206.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccC-----eEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVD-----QVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (336)
.++|++.+.||+|+||.||+|.+..+| ..||+|.+..... .....+.+|+.+++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 457999999999999999999875433 5799999875432 2345678999999999 89999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCC-----------------------------------------------------------
Q 036144 126 RILVYEFMSNGSLENHFLDLP----------------------------------------------------------- 146 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 146 (336)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999875321
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeee
Q 036144 147 -------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR 219 (336)
Q Consensus 147 -------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 219 (336)
....++++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01235788889999999999999999998 99999999999999999999999999976533322222223
Q ss_pred eccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCc
Q 036144 220 VMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298 (336)
Q Consensus 220 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
..++..|+|||++.+..++.++|||||||++|+|++ |..||........ ... ..... .....+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~----~~~~~----------~~~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYK----MVKRG----------YQMSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHH----HHHcc----------cCccCC
Confidence 345678999999998899999999999999999997 9999976433211 011 01110 001112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 299 RKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 299 ~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 22346899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=317.88 Aligned_cols=270 Identities=23% Similarity=0.286 Sum_probs=209.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCC-ccceEEEEEeCC------
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQN-LVNLIGYCADGD------ 124 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~------ 124 (336)
..|...++||+|+||+||+|+.+.+|+.||+|++...... ......+|+.+++.|+|+| |+.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4466667799999999999999999999999999765432 3355789999999999999 999999998877
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||+ .-+|..++.........++...+..++.||+.||+|||+++ |+||||||+||||+.+|.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 789999999 67999999875543356777899999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--H---H
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK--P---L 278 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~---~ 278 (336)
|+....+ ....+..++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+....+....+-... + .
T Consensus 167 Ara~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 167 ARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9865433 2335667899999999999987 79999999999999999999999998876533322221100 0 0
Q ss_pred hhcccccccccCCcc----CCCCcH---HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 279 LRDKKKFTMMADPLL----EGQYPR---KGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~----~~~~~~---~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
++..........+.. ...+.. .......+++.+||+.+|.+|.|+..+++.
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000000000000000 001111 112478899999999999999999999874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=330.84 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=217.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..-|.+.+.||+|.|+.|-+|+|.-||+.||||++.+.... ....+..|++.|+.++|||||++|++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 35588889999999999999999999999999999876433 3356889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-CCCCceEEccccccccCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL-DAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~-~~~~~~kl~Dfg~~~~~~ 209 (336)
|+-++|+|.+|+.+ ....+.+..+.+++.||+.||.|+|..+ +|||||||+||.+ ..-|-|||+|||++-.+.
T Consensus 97 ELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 99999999999987 4677999999999999999999999999 9999999999876 455779999999998776
Q ss_pred CCCCcceeeeeccCccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLT-KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
++. ..++.||+..|.|||++.+..|+ +++||||||+|||.|++|++||+..+..+....+.
T Consensus 171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmIm--------------- 232 (864)
T KOG4717|consen 171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIM--------------- 232 (864)
T ss_pred Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhh---------------
Confidence 554 36778999999999999999997 78999999999999999999999877655443332
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
|=. =..|...+.++.+||..||..||.+|.+.++|..
T Consensus 233 -DCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 -DCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -ccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 111 1346778889999999999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=339.27 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=205.9
Q ss_pred hcCCCCcccccccCceEEEEEEE-----cccCeEEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (336)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999975 3456789999986543 22345688999999999 89999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCC----------------------------------------------------------
Q 036144 126 RILVYEFMSNGSLENHFLDLPP---------------------------------------------------------- 147 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 147 (336)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998864211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 148 -------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 148 -------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1235788889999999999999999998 999999999999999999999999999765332221
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .... .+..+..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~--------- 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIKEGYR--------- 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHHhCcc---------
Confidence 22222345678999999999999999999999999999998 888887643221 1111 1111100
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
...+...+..+.+|+.+||+.||++|||+.++++.|+..
T Consensus 336 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 -MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011122345799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=320.63 Aligned_cols=254 Identities=24% Similarity=0.276 Sum_probs=210.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
+.|++++.||.|.-|+||++..++++..+|+|++.+.... ...+...|-+||+.++||.++.+|..|+.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 4588888999999999999999999999999999875432 3345778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|||+||+|..+.+.. ..+.+++..++-++.+++-||+|||-.| ||+|||||+||||.++|+|.|+||+++.....
T Consensus 157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999998874 4567999999999999999999999999 99999999999999999999999998643110
Q ss_pred ---------------------------------CCC---------------------cceeeeeccCccccCccccccCC
Q 036144 211 ---------------------------------GGK---------------------DHVSTRVMGTYGYCAPEYAMTGQ 236 (336)
Q Consensus 211 ---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 236 (336)
... ......++||-.|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 01223478999999999999999
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCC
Q 036144 237 LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQED 316 (336)
Q Consensus 237 ~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 316 (336)
.+.++|.|+||+.+|||+.|..||.+.+..+.... ++...+.-.-....+..+.+||+++|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N----------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN----------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH----------------HhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999999998765432211 11211111112255678999999999999
Q ss_pred CCCCCC----HHHHHH
Q 036144 317 ADSRPF----MVDVVT 328 (336)
Q Consensus 317 p~~Rpt----~~evl~ 328 (336)
|.+|.. ++||-+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999988 777654
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=334.21 Aligned_cols=242 Identities=25% Similarity=0.339 Sum_probs=200.0
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNG 136 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 136 (336)
+.||+|+||.||++.+..++..||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999986532 223456788999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcce
Q 036144 137 SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV 216 (336)
Q Consensus 137 ~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 216 (336)
+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99888754 356899999999999999999999998 999999999999999999999999998753221 112
Q ss_pred eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCC
Q 036144 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQ 296 (336)
Q Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (336)
....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ..... . ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~------~~~~~--------~----~~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------LILME--------D----IK 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH------HhccC--------C----cc
Confidence 334679999999999999999999999999999999999999997644321111 11100 0 12
Q ss_pred CcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 297 YPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 297 ~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 2334556889999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=333.38 Aligned_cols=240 Identities=27% Similarity=0.356 Sum_probs=197.5
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999998643 223345678899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence 998864 356889999999999999999999998 999999999999999999999999998753221 12234
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCc
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ....... ...++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~~------------~~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQE------------PLRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHcC------------CCCCC
Confidence 56799999999999999999999999999999999999999976432211 1111111 01223
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 036144 299 RKGLYQALAVAGMCLQEDADSRPF---MVDVVT 328 (336)
Q Consensus 299 ~~~~~~l~~li~~cl~~dp~~Rpt---~~evl~ 328 (336)
...+..+.+++.+||+.||.+||+ +.+++.
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 345568899999999999999985 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=321.41 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=209.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCC-----eEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD-----QRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 128 (336)
-.|...+++|.|+||.||.|....+++.||||..-.... .-.+|+++|+.++|||||++.-+|.... +..+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 357778899999999999999999999999999865433 2347999999999999999998886432 3458
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-CceEEcccccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGLAKL 207 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~ 207 (336)
||||+ ..+|.+++......+..++...+.-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 Vleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 99999 56999999876666788999999999999999999999998 9999999999999877 8899999999998
Q ss_pred CCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--HH----Hhh
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--KP----LLR 280 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~----~~~ 280 (336)
+..+.. ..+...|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+..+....+-.. .+ +..
T Consensus 176 L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 176 LVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 766544 4566789999999998875 8999999999999999999999999986654432222111 00 000
Q ss_pred c-----ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 281 D-----KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 281 ~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
- +.....+....+...+....+.++.+++.++|+.+|.+|.++.++++
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0 11112222222222244566779999999999999999999999885
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=333.35 Aligned_cols=242 Identities=26% Similarity=0.338 Sum_probs=199.3
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNG 136 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 136 (336)
+.||+|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999999999999999986532 223345678999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcce
Q 036144 137 SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV 216 (336)
Q Consensus 137 ~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 216 (336)
+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC--CCc
Confidence 99888754 356899999999999999999999998 999999999999999999999999998743221 112
Q ss_pred eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCC
Q 036144 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQ 296 (336)
Q Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (336)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+....... ..... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~------~~~~~------------~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ILMEE------------IR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HhcCC------------CC
Confidence 2346799999999999999999999999999999999999999976543221111 11000 11
Q ss_pred CcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 297 YPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 297 ~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2334456889999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=336.26 Aligned_cols=246 Identities=26% Similarity=0.342 Sum_probs=203.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccC-eEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVD-QVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 467999999999999999999976554 689999986432 2234567889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999865 456899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...++..... .+....
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~------~i~~~~------ 244 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ------KILEGI------ 244 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH------HHhcCC------
Confidence 321 234679999999999999899999999999999999999999998654321111 111100
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+++.+||+.||++|+ |++++++
T Consensus 245 ------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 ------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 012233455788999999999999995 8888875
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=312.58 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=209.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.+.|++.+.||+|.|+.|++..++.+|+.+|+|++... ...+.+++.+|+.|-+.|+||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 46788889999999999999999999999999988532 3446788999999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC---CceEEcccccccc
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---FNPKLSDFGLAKL 207 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~ 207 (336)
|+++|++|..-+.. +..+++..+...+.||++||.|+|..+ |||||+||+|+++... .-+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999776654 356788888999999999999999999 9999999999999433 3499999999987
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
+..+ .....++|||.|||||++...+|+..+|||+.|+|||-|+.|.+||.+.+.......+. ...
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~------~g~----- 228 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK------AGA----- 228 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh------ccc-----
Confidence 7532 33556789999999999999999999999999999999999999998755332211111 111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+...-+..+++..+|+++||..||.+|.|+.|.|.
T Consensus 229 ---yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 ---YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11112233456778999999999999999999998874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=339.86 Aligned_cols=266 Identities=26% Similarity=0.408 Sum_probs=216.5
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCC
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD 124 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 124 (336)
.++....+.+.+...||+|.||+||+|.|.+ .||||++..... ...+.|.+|+..+++-+|.||+-+.|++..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4555566778889999999999999999985 599999976543 34567999999999999999999999999888
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
. .+|+.+|+|.+|..++.. .+..++..+.+.|+.|+++|+.|||.++ |||||||..|||+.++++|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 7 899999999999999876 3467888999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG---QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
+..-..-..........|...|||||++..+ +|++.+||||||+++|||++|..||...........+-.+
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG------ 608 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG------ 608 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc------
Confidence 9754332222333445688899999998753 7899999999999999999999999955444333222111
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
.... +. ......++.++.+|+..||..++++||.+.+|+..|+.+.+
T Consensus 609 -~l~p---d~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 -YLMP---DL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -ccCc---cc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0000 10 01233566789999999999999999999999998887654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=331.38 Aligned_cols=252 Identities=24% Similarity=0.271 Sum_probs=216.3
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 127 (336)
....|++.+.||.|.||.||++..+.+|+.+|+|.+.+.... ....+.+|+.+|+.+. |||||.+++.|++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 456799999999999999999999999999999999765433 3357899999999998 999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC----CceEEcccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE----FNPKLSDFG 203 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~----~~~kl~Dfg 203 (336)
+|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.| |+||||||+|+|+... +.++++|||
T Consensus 113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 999999999999999874 3999999999999999999999999 9999999999999443 479999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...........+....
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~------- 254 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD------- 254 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC-------
Confidence 9987644 445777899999999999999999999999999999999999999999876443322221110
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......-...+..+.+++..||..||..|+|+.++|+
T Consensus 255 -------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 -------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 12222333456778999999999999999999999987
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=323.22 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=210.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccC-----eEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVD-----QVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
++|++.+.||+|+||.||+|.+...+ ..||+|.+..... .....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 46889999999999999999986554 6899999865432 22356889999999999999999999999988999
Q ss_pred EEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC
Q 036144 128 LVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF 195 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~ 195 (336)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865321 1156888899999999999999999998 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 036144 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 274 (336)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i-- 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-- 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999875433322223334567889999999988899999999999999999998 99999765432211111
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
... .....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 240 -----~~~----------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 -----RSR----------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred -----HcC----------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 000 01112344567899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=324.76 Aligned_cols=265 Identities=21% Similarity=0.272 Sum_probs=201.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 3679999999999999999999999999999999875432 223457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+ .++|.+++.. ....++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YV-HTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CC-CcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 99 5688777754 2456888899999999999999999998 999999999999999999999999998753222
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc--------
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK-------- 282 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 282 (336)
........||+.|+|||++.+ ..++.++||||+||++|+|++|..||........ ............
T Consensus 157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 --SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred --CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccch
Confidence 122334568999999998875 4688999999999999999999999986533211 111000000000
Q ss_pred cccccccCCccCCCCcH---------HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPR---------KGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...............+. ..+..+.+++.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000000000 12346889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=347.70 Aligned_cols=260 Identities=22% Similarity=0.261 Sum_probs=211.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEE-EEEe------C
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIG-YCAD------G 123 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~-~~~~------~ 123 (336)
...++++.+.|.+|+|+.||+|.+...|..||+|.+-.......+.+.+|+.+|++|+ |+|||.+++ .... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 3456888999999999999999999877999999987766667788999999999997 999999999 3321 1
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
....|.||||.||.|-+++..+.. ..|++.++++|+.++++|+.+||... ++|||||||-+||||+.+|+.||||||
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 346789999999999999987543 33999999999999999999999985 889999999999999999999999999
Q ss_pred ccccCCCCCCccee-------eeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 036144 204 LAKLGPTGGKDHVS-------TRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT 273 (336)
Q Consensus 204 ~~~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 273 (336)
.++--......... -...-|+.|+|||++. +.+.++|+|||+|||+||-|+....||+......
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------ 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------ 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------
Confidence 98643222111000 0123699999999874 6789999999999999999999999998753322
Q ss_pred HHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 274 WAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
+++....-.-.+.++..+.+||..||+.||.+||++-+++..+-.|.
T Consensus 266 --------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 266 --------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred --------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 12222222223467889999999999999999999999999887764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=335.68 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=210.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-C-----CCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-H-----QNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~ 126 (336)
..+|.+.++||+|+||.|.+|.+..|++.||||+++.. ..-.++...|+.+|..|+ | -|+|+++++|...++.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 34789999999999999999999999999999999654 344567788999999997 4 3899999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC--ceEEccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF--NPKLSDFGL 204 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~ 204 (336)
|||+|.+ +-+|.+++.. +.-..++...++.++.||+.||.+||+.+ |||+||||+|||+...+ .|||+|||+
T Consensus 264 ciVfELL-~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeeehhh-hhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999 7799999987 45567999999999999999999999999 99999999999996543 599999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-----HHHh
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA-----KPLL 279 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~ 279 (336)
+++... ...+.+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+....+... ..++
T Consensus 338 Sc~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 338 SCFESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred ccccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 987532 233678899999999999999999999999999999999999999887765543333211 0011
Q ss_pred hcccccccccCC----------------------------------------ccCCCCcHHHHHHHHHHHHhhcCCCCCC
Q 036144 280 RDKKKFTMMADP----------------------------------------LLEGQYPRKGLYQALAVAGMCLQEDADS 319 (336)
Q Consensus 280 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~ 319 (336)
..........+. .+...+.......+.+++.+||..||..
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 111110111100 0001112234557899999999999999
Q ss_pred CCCHHHHHH
Q 036144 320 RPFMVDVVT 328 (336)
Q Consensus 320 Rpt~~evl~ 328 (336)
|+|+.++|+
T Consensus 493 R~tp~qal~ 501 (586)
T KOG0667|consen 493 RITPAQALN 501 (586)
T ss_pred cCCHHHHhc
Confidence 999998875
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=321.86 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=208.9
Q ss_pred cCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568888999999999999998753 3578999998765443 3467899999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 128 LVYEFMSNGSLENHFLDLP----------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
+||||+++++|.+++.... .....+++..+..++.|++.|+.+||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999987532 23455788899999999999999999998 9999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 276 (336)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+. .....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHH
Confidence 9999999875422221122233446788999999999999999999999999999998 9999876543221 11110
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
.+ . ....+...+..+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 239 ----~~-~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ----QG-R---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----cC-C---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 00 0 011122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=319.84 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=205.6
Q ss_pred cCCCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.+|++.+.||+|+||.||+|.++ ..+..||+|.++.... .....+.+|+.+++.++||||+++++++......++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56889999999999999999875 4467899999876432 2235688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999865 2356899999999999999999999998 9999999999999999999999999876432
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... ........++..|+|||.+.+..++.++|||||||++|++++ |..||......+. ... .....
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~----~~~~~----- 225 (266)
T cd05064 159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA----VEDGF----- 225 (266)
T ss_pred ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH----HHCCC-----
Confidence 111 111112335678999999999999999999999999999775 9999976543221 110 11110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 226 -----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 -----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112334556899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=338.56 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=203.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999999999999999986532 223355778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999865 356899999999999999999999998 99999999999999999999999999865322
Q ss_pred CCCc------------------------------------ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHH
Q 036144 211 GGKD------------------------------------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELI 254 (336)
Q Consensus 211 ~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 254 (336)
.... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 0111346999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 036144 255 TGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF---MVDVVT 328 (336)
Q Consensus 255 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~evl~ 328 (336)
+|..||......+... ......... . . ......+..+.+++.+||. +|.+|++ +.++++
T Consensus 234 ~G~~Pf~~~~~~~~~~------~i~~~~~~~---~---~--~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQETYR------KIINWKETL---Q---F--PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHHHH------HHHcCCCcc---C---C--CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999998654322111 111000000 0 0 0011235578899999997 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=330.12 Aligned_cols=245 Identities=26% Similarity=0.404 Sum_probs=198.3
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHH---hhccCCCccceEEEEEeCCeEEEE
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLML---SLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+..|+.++ +.++||||+++++++......++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677889999999999999999999999999986532 22234566666555 556799999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|..++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999887743 46899999999999999999999998 9999999999999999999999999986432
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. ........|++.|+|||.+.+..++.++|||||||++|+|++|..||......+... ......
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------~i~~~~------- 217 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVNDE------- 217 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCC-------
Confidence 21 122345679999999999999999999999999999999999999997654322111 111100
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 012333456789999999999999999 5677665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=323.00 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=209.8
Q ss_pred cCCCCcccccccCceEEEEEEE-----cccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.+|.+.+.||+|+||.||++.. ..++..+|+|.+..........+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688999999999999999985 33456799999876555555678999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 129 VYEFMSNGSLENHFLDLP---------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
||||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 12345899999999999999999999998 999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .. ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~---~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE---CI 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HH
Confidence 99999875433222122223445778999999998899999999999999999998 8999876543221 11 11
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
. .+. . . ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 236 ~-~~~-~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 T-QGR-V-----L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred H-cCC-c-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 0 100 0 0 111223457999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=346.35 Aligned_cols=259 Identities=24% Similarity=0.261 Sum_probs=210.8
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCC---
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD--- 124 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 124 (336)
.....+|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.++..++|+||+++++.+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 445679999999999999999999999999999999986543 223456788999999999999999988765332
Q ss_pred -----eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 125 -----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 125 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 367999999999999998765555567999999999999999999999998 999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
+|||++...............+||+.|+|||++.+..++.++|||||||++|+|++|..||......+. .....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHh
Confidence 999999765433222334456799999999999999999999999999999999999999976432211 11111
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. . ...++...+..+.+++.+||+.||.+||++.+++.
T Consensus 259 ~~------~-----~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 259 AG------R-----YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred cC------C-----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 10 0 01123345568999999999999999999999986
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=335.49 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=200.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47899999999999999999999999999999986532 222356788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999865 457899999999999999999999998 99999999999999999999999999875422
Q ss_pred CCCc---------------------------------ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCC
Q 036144 211 GGKD---------------------------------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257 (336)
Q Consensus 211 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 257 (336)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0112457999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcC--CCCCCCCCHHHHHH
Q 036144 258 SAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQ--EDADSRPFMVDVVT 328 (336)
Q Consensus 258 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~Rpt~~evl~ 328 (336)
.||......+....+. ..... +. .... ...+..+.+++.+|+. .++..||+++|+++
T Consensus 234 ~Pf~~~~~~~~~~~i~------~~~~~---~~---~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 234 PPFCSETPQETYKKVM------NWKET---LI---FPPE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCCCCHHHHHHHHH------cCcCc---cc---CCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 9997654322211111 00000 00 0000 1234577888888664 23335689999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=329.31 Aligned_cols=265 Identities=20% Similarity=0.270 Sum_probs=205.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4789999999999999999999999999999998865422 233568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|+++++|.+++.. ...+++..+..++.+++.||.|||+. + ++||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999864 35688899999999999999999974 5 99999999999999999999999999865422
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH---HHH---------
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA---KPL--------- 278 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~--------- 278 (336)
. ......||..|+|||++.+..++.++|||||||++|+|++|..||............... ...
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 1 223457899999999999889999999999999999999999999764432211100000 000
Q ss_pred --------hhcc----cc----cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 --------LRDK----KK----FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 --------~~~~----~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... .. ...+.............+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000 00 00000000000000123457899999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=309.00 Aligned_cols=254 Identities=24% Similarity=0.315 Sum_probs=209.8
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC----ccH----HHHHHHHHHHhhc-cCCCccceEEEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN----QGS----REFFAEVLMLSLV-QHQNLVNLIGYCA 121 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~----~~~----~~~~~e~~~l~~l-~h~~iv~~~~~~~ 121 (336)
...+.|...+.||.|..+.|-++.++.+|..+|+|++..... +.. +.-..|+.+|+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 445678999999999999999999999999999999864321 112 2345799999997 4999999999999
Q ss_pred eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcc
Q 036144 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSD 201 (336)
Q Consensus 122 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~D 201 (336)
.+...++|+|.++.|.|.+++.+ .-.+++...+.|+.|+.+|++|||..+ ||||||||+|||++++-+++|+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 99999999999999999999975 567999999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeeeccCccccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 036144 202 FGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT------GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA 275 (336)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 275 (336)
||+++.+..+.+ ....||||+|+|||.+.- ..|+..+|+|++|+|+|-|+.|.+||......-....+.
T Consensus 167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im-- 241 (411)
T KOG0599|consen 167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM-- 241 (411)
T ss_pred cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH--
Confidence 999998876543 566899999999998752 468999999999999999999999997543221111111
Q ss_pred HHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 KPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... ...+--.+.+....+||.+||+.||.+|.|++|+|+
T Consensus 242 ----eGkyq--------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 ----EGKYQ--------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ----hcccc--------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11111 111112356678999999999999999999999986
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=333.03 Aligned_cols=260 Identities=18% Similarity=0.173 Sum_probs=199.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
.+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++||||+++++++......++|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999999999999999753 234678999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+++|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... .
T Consensus 166 -~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~ 236 (391)
T PHA03212 166 -KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-N 236 (391)
T ss_pred -CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc-c
Confidence 5788887754 356889999999999999999999998 999999999999999999999999998653221 1
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc----cHHHHHHHHhh---cc----
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ----NLVTWAKPLLR---DK---- 282 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~---~~---- 282 (336)
........||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........... ..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 12234467999999999999999999999999999999999999886543221110 00000000000 00
Q ss_pred --ccccc---------ccCCccCCCC--cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 --KKFTM---------MADPLLEGQY--PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 --~~~~~---------~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... ...+...... ....+..+.+|+.+||+.||++|||++|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0000000000 1124557899999999999999999999985
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=332.27 Aligned_cols=242 Identities=26% Similarity=0.341 Sum_probs=198.7
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNG 136 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 136 (336)
+.||+|+||.||+|.+..+|..||+|++.... ......+..|+.+++.++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999986532 223355678999999999999999999999999999999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 137 SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 137 ~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cc
Confidence 99888754 4568999999999999999999997 67 999999999999999999999999998643221 11
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------~~~------------~~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME------------EI 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------hcC------------CC
Confidence 233457999999999999999999999999999999999999999765432211111 000 01
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
.++...+..+.+++.+||+.||++|+ ++.++++
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 12333456889999999999999997 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=317.04 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=213.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999999999999999875432 222346788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988754444566899999999999999999999988 99999999999999999999999999876433
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.. .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ....... ...
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~-~~~-------- 223 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKI-EQC-------- 223 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHH-hcC--------
Confidence 21 11223568899999999988889999999999999999999999986543211 1111111 000
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..........+..+.+++.+||+.+|++|||+.++++.|+.++
T Consensus 224 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 -DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0011112234567999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=328.14 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=198.6
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCC-CccceEEEEEeCCeEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQ-NLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 130 (336)
+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+..|..++..+.|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5888999999999999999999999999999986532 23345677899999988764 6888999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999988864 356888999999999999999999998 99999999999999999999999999864322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .......+||+.|+|||++.+..++.++||||+||++|+|++|..||......+... .....
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~------~i~~~--------- 216 (324)
T cd05587 154 G--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ------SIMEH--------- 216 (324)
T ss_pred C--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHcC---------
Confidence 1 122345679999999999999999999999999999999999999997654322111 11100
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
...++...+..+.+++.+||+.||.+|++.
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 112233455688999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=336.47 Aligned_cols=253 Identities=23% Similarity=0.259 Sum_probs=200.1
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999999999999999986532 2234567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999865 356888999999999999999999998 999999999999999999999999997532110
Q ss_pred CC---------------------------------------------cceeeeeccCccccCccccccCCCCCccchhhH
Q 036144 212 GK---------------------------------------------DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSF 246 (336)
Q Consensus 212 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 246 (336)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 001123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhc--CCCCCCCCCHH
Q 036144 247 GVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCL--QEDADSRPFMV 324 (336)
Q Consensus 247 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dp~~Rpt~~ 324 (336)
||++|+|++|..||......+....+ ...... .........+..+.+++.+|+ ..+|..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i------~~~~~~--------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKV------INWENT--------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHH------Hccccc--------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 99999999999999875532211111 000000 000011123557888998854 55666699999
Q ss_pred HHHH
Q 036144 325 DVVT 328 (336)
Q Consensus 325 evl~ 328 (336)
+++.
T Consensus 301 ~~l~ 304 (381)
T cd05626 301 DIKA 304 (381)
T ss_pred HHhc
Confidence 9986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=322.50 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=211.7
Q ss_pred cCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+........+.+.+|+.+++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45888899999999999999864 3456799999876555555678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc
Q 036144 129 VYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN 196 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~ 196 (336)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999865321 2345889999999999999999999998 999999999999999999
Q ss_pred eEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHH
Q 036144 197 PKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWA 275 (336)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~ 275 (336)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. ...
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH-
Confidence 99999999975433322222334557889999999999999999999999999999998 9999876543221 111
Q ss_pred HHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 276 KPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
...+ ... ..+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 238 ---~~~~-~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 238 ---ITQG-RVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ---HhCC-CCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1110 000 1122245579999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=319.78 Aligned_cols=248 Identities=26% Similarity=0.357 Sum_probs=200.8
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
||+|+||+||++.+..+++.||+|.+..... ...+.+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 7999999999999999999999999865322 1234567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cccc
Confidence 9887654444567899999999999999999999998 9999999999999999999999999987543322 1233
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCc
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
...||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ....... .. ...++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~----------~~--~~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRIL----------ND--SVTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhc----------cc--CCCCc
Confidence 4578999999999999999999999999999999999999997643221110 0000110 00 01223
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 299 RKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 299 ~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
...+..+.+++.+||+.||++|| |++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 34566899999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.95 Aligned_cols=241 Identities=26% Similarity=0.404 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhh-ccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSL-VQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+..+++.||+|++.... ....+.+..|..++.. .+||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999986532 2223445566666664 4799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999988864 356899999999999999999999998 9999999999999999999999999997542221 2
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.. ..+... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~~------------~~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DSILND------------RP 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHcC------------CC
Confidence 334567999999999999999999999999999999999999999865432111 111100 01
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMV-DVV 327 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl 327 (336)
.++...+..+.+++.+||+.||.+||++. +++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12333456789999999999999999976 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=330.18 Aligned_cols=237 Identities=27% Similarity=0.387 Sum_probs=194.5
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.++.+++.||+|++.... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999986431 23345567888888776 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999988865 356889999999999999999999998 999999999999999999999999998753221 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.. ..+.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~------------~ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF------EAILNDE------------V 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HHHhcCC------------C
Confidence 234467999999999999999999999999999999999999999865432211 1111110 0
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
.++...+..+.+++.+||+.||.+||++
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1222345688999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=335.33 Aligned_cols=254 Identities=25% Similarity=0.300 Sum_probs=207.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46899999999999999999999999999999986532 233456888999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999875 367899999999999999999999988 99999999999999999999999999976543
Q ss_pred CC---------------------------CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 036144 211 GG---------------------------KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNS 263 (336)
Q Consensus 211 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 263 (336)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001223457999999999999999999999999999999999999999876
Q ss_pred CCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHH
Q 036144 264 RPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-MVDVVTA 329 (336)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~evl~~ 329 (336)
........+ ...... ...+ .....+..+.++|.+||. ||.+||+ ++++++.
T Consensus 234 ~~~~~~~~i------~~~~~~---~~~p-----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKI------INWKES---LRFP-----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHH------hccCCc---ccCC-----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 532211111 100000 0000 011145689999999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=317.52 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=212.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..+|.+.+.||.|+||.||+|.+.. +..+|+|.+..........+..|+.+++.++||||+++++++......++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4568899999999999999999988 889999999776655567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999763 3456889999999999999999999988 9999999999999999999999999997653321
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+. ..... ..
T Consensus 159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~----~~--------- 220 (261)
T cd05148 159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQIT----AG--------- 220 (261)
T ss_pred --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHH----hC---------
Confidence 11223346778999999988899999999999999999998 8999976542211 11110 00
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 -YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 01112334456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=329.62 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=199.2
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeC-----CeEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG-----DQRI 127 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 127 (336)
+|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999999999999999986432 22345688999999999999999999987543 3479
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 999999 5789888764 356899999999999999999999998 99999999999999999999999999975
Q ss_pred CCCCCC-cceeeeeccCccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------H
Q 036144 208 GPTGGK-DHVSTRVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------K 276 (336)
Q Consensus 208 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~ 276 (336)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+... .
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 422211 112234579999999998865 67899999999999999999999999765432211111000 0
Q ss_pred HHhhccc---ccccccCCccCCCC---cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 277 PLLRDKK---KFTMMADPLLEGQY---PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 277 ~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+.... ....+ .......+ .+..+..+.+++.+||+.||++|||++++++
T Consensus 233 ~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 00000 00000000 0123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=340.93 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=200.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeC--------C
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG--------D 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~ 124 (336)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999999999999999885432 2345799999999999999999887432 2
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEcccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFG 203 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg 203 (336)
..++||||++ ++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999995 5787777654445677999999999999999999999998 99999999999998665 69999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--H---
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK--P--- 277 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~--- 277 (336)
++....... ......||+.|+|||++.+. .|+.++|||||||++|+|++|.+||......+....+.... +
T Consensus 217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 997653322 22345789999999988764 68999999999999999999999998755432211111000 0
Q ss_pred H---hhcc---cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 278 L---LRDK---KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 278 ~---~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. .... ..+.......+...++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 0000 0000011111112233345568999999999999999999999985
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=320.33 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=198.4
Q ss_pred cCCCCcccccccCceEEEEEEEcc-cCeEEEEEeecCCCC--ccHHHHHHHHHHHhhc---cCCCccceEEEEE-----e
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEA-VDQVVAVKQLDRSGN--QGSREFFAEVLMLSLV---QHQNLVNLIGYCA-----D 122 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~-----~ 122 (336)
++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 468999999999999999999854 468899998865332 2234566777777665 6999999999885 2
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
....++||||+. ++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999995 6999988653 2345889999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
|++...... .......||+.|+|||.+.+..++.++|||||||++|+|++|.+||......+....+...... ...
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~-~~~ 230 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGE 230 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCC-CCh
Confidence 999764332 2234457899999999998889999999999999999999999999876543321111100000 000
Q ss_pred ccc-------ccccCCccCC---CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKF-------TMMADPLLEG---QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~-------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... .......... ...+..+..+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000000 111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=325.15 Aligned_cols=249 Identities=27% Similarity=0.363 Sum_probs=198.5
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
++||+|+||.||+|.+..+++.||+|+++... ......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999999999999999997532 22335577899999888 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999888754 357999999999999999999999998 999999999999999999999999998642221 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc--cccHHHHHHHHhhcccccccccCCcc
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE--EQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..||+...... ......+........ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------~- 221 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK---------Q- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC---------C-
Confidence 2344679999999999999999999999999999999999999997433221 111111111111110 0
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPF------MVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt------~~evl~ 328 (336)
..++...+..+.+++.+||+.||.+||| ++++++
T Consensus 222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1123334567899999999999999998 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=324.76 Aligned_cols=241 Identities=27% Similarity=0.417 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhh-ccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSL-VQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+..+++.||+|++.... .........|..++.. ++||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999999999999999986532 2233456677777775 5899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DA 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CC
Confidence 999998864 356888899999999999999999998 999999999999999999999999998743221 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
......||+.|+|||++.+..++.++||||+||++|+|++|..||......+....+. . ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-------~-------~~~---- 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-------M-------DNP---- 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------h-------CCC----
Confidence 2345679999999999999999999999999999999999999997654322111110 0 001
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMV-DVV 327 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl 327 (336)
.++...+..+.+++.+||+.||++||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 12223455789999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=315.27 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=208.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
.+|.+.+.||+|+||.||+|.++.+++.||+|.+... ......+.+|+.+++.++|+||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4578888999999999999999998999999998654 333567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998652 2456889999999999999999999988 99999999999999999999999999876533211
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. .. ....
T Consensus 160 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~------~~-~~~~---------- 221 (263)
T cd05052 160 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------EL-LEKG---------- 221 (263)
T ss_pred -eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HH-HHCC----------
Confidence 11112234668999999998899999999999999999998 89998754322111 11 1110
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01122333456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=313.00 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=199.4
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
+.||+|+||.||+|.+..+++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999999889999999876433 22345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999864 2346889999999999999999999998 9999999999999999999999999987543211111111
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCC
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQY 297 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (336)
...++..|+|||.+.++.++.++|||||||++|+|++ |..||.......... .... ......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~-------~~~~----------~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE-------AIEQ----------GVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHH-------HHHc----------CCCCCC
Confidence 1123457999999998899999999999999999998 888886543221111 0000 011122
Q ss_pred cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 298 PRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 298 ~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3334568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=319.46 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=204.6
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
+|++.++||+|+||.||++.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 47888999999999999999998999999999865321 122456789999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999887642 2356899999999999999999999998 999999999999999999999999998764322
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. ......|+..|+|||++.+..++.++||||+||++|+|++|..||...........+. ..+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~---------- 219 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKE---------- 219 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhh----------
Confidence 1 1234578999999999998899999999999999999999999998644321111110 00000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
....++...+..+.+|+.+||+.||.+|| +++++++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 01122334566889999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=327.54 Aligned_cols=242 Identities=26% Similarity=0.373 Sum_probs=197.4
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
++||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999986532 22334567788888765 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--~~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--GV 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC--Cc
Confidence 999988864 356888999999999999999999998 999999999999999999999999998753222 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.. ..+.... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------~~i~~~~------------~ 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------ESILHDD------------V 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH------HHHHcCC------------C
Confidence 234467999999999999999999999999999999999999999865432211 1111110 0
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCC-------CHHHHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRP-------FMVDVVT 328 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rp-------t~~evl~ 328 (336)
.++...+..+.+++.+||+.||++|| ++.++++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 12223456789999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=324.64 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=205.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe----EEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ----VVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.+|++.+.||+|+||.||+|.+..++. .||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 569999999999999999999865555 38999986543 23346788999999999999999999998764 5679
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
+++|+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999875 2346888899999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.............++..|+|||.+.+..++.++|||||||++|+|++ |..||......+... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~--- 229 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGER--- 229 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHhCCCC---
Confidence 43322222222345678999999999999999999999999999997 999997644322111 1111100
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
...+...+..+.+++.+||+.+|.+|||+.+++..|..+.
T Consensus 230 -------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 230 -------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0112223457899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=328.57 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=197.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..+|+..+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 3567788899999999999999999999999999865432 223568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+. ...++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 153 ~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999998643 23456778889999999999999998 999999999999999999999999998764322
Q ss_pred CCcceeeeeccCccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT-----GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
. .......||..|+|||++.. ...+.++|||||||++|+|++|+.||......+........ ...
T Consensus 222 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~----- 291 (353)
T PLN00034 222 M--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMS----- 291 (353)
T ss_pred c--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hcc-----
Confidence 1 12234579999999998743 23457899999999999999999999843322211111100 000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.....+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 292 ------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 ------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011223445689999999999999999999999874
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=335.95 Aligned_cols=254 Identities=21% Similarity=0.260 Sum_probs=200.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999999999999999986432 223356788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999865 356889999999999999999999999 99999999999999999999999999863211
Q ss_pred CCCc---------------------------------------------ceeeeeccCccccCccccccCCCCCccchhh
Q 036144 211 GGKD---------------------------------------------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYS 245 (336)
Q Consensus 211 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws 245 (336)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0011246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCC---CC
Q 036144 246 FGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSR---PF 322 (336)
Q Consensus 246 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt 322 (336)
|||++|+|++|..||......+... ........ +. +. -....+..+.+++.+||. +|.+| +|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~------~i~~~~~~---~~---~p--~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYR------KIINWRET---LY---FP--DDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHH------HHHccCCc---cC---CC--CCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 9999999999999997654322111 11100000 00 00 011245678999999998 66665 59
Q ss_pred HHHHHHH
Q 036144 323 MVDVVTA 329 (336)
Q Consensus 323 ~~evl~~ 329 (336)
+.+++..
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=325.24 Aligned_cols=241 Identities=27% Similarity=0.422 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhh-ccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSL-VQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.++.+|+.||+|++.... .........|..++.. ++||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999999999999999986532 2233456677777765 4899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence 999988864 356888999999999999999999998 999999999999999999999999998643221 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .. ... . ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~---~~~-~-------~~~---- 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FE---SIR-V-------DTP---- 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HH---HHH-h-------CCC----
Confidence 23456799999999999999999999999999999999999999976543211 11 000 0 001
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMV-DVV 327 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl 327 (336)
.++...+..+.+++.+||+.||++||++. +++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12223456789999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=336.41 Aligned_cols=252 Identities=22% Similarity=0.225 Sum_probs=199.4
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999999999999999986532 2223567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999998865 356888899999999999999999998 999999999999999999999999997532100
Q ss_pred C---------------------------------------------CcceeeeeccCccccCccccccCCCCCccchhhH
Q 036144 212 G---------------------------------------------KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSF 246 (336)
Q Consensus 212 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 246 (336)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC---H
Q 036144 247 GVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF---M 323 (336)
Q Consensus 247 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~ 323 (336)
||++|+|++|..||...++.+....+ .... ...........+..+.+++.+|+ .+|++|++ +
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i------~~~~--------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKV------INWQ--------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHH------HccC--------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 99999999999999865432211111 0000 00000111233557888888876 49999997 7
Q ss_pred HHHHH
Q 036144 324 VDVVT 328 (336)
Q Consensus 324 ~evl~ 328 (336)
.+++.
T Consensus 300 ~ei~~ 304 (382)
T cd05625 300 DEIKA 304 (382)
T ss_pred HHHhc
Confidence 77764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=337.27 Aligned_cols=252 Identities=22% Similarity=0.239 Sum_probs=201.0
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6899999999999999999999999999999986432 2234567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999865 356888899999999999999999998 999999999999999999999999997432100
Q ss_pred C-----------------------------------------CcceeeeeccCccccCccccccCCCCCccchhhHHHHH
Q 036144 212 G-----------------------------------------KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVL 250 (336)
Q Consensus 212 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 250 (336)
. ........+||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 00011235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC---CHHHHH
Q 036144 251 LELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP---FMVDVV 327 (336)
Q Consensus 251 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp---t~~evl 327 (336)
|+|++|..||......+....+. .. . ...........+..+.+++.+|+ .+|.+|+ |+.+++
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~-------~~-~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVI-------NW-E------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHh-------cc-C------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999998765432211110 00 0 00000111124557888888876 5999999 888887
Q ss_pred H
Q 036144 328 T 328 (336)
Q Consensus 328 ~ 328 (336)
+
T Consensus 300 ~ 300 (376)
T cd05598 300 A 300 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=326.95 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=198.0
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
+|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+..|..++..+ .|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5888999999999999999999999999999987532 12234466777887776 5899999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999988864 356888999999999999999999998 99999999999999999999999999874322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||........... +...
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~------i~~~--------- 216 (323)
T cd05616 154 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS------IMEH--------- 216 (323)
T ss_pred C--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH------HHhC---------
Confidence 1 1123446799999999999999999999999999999999999999986543221111 1100
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
...++...+..+.+++.+||+.||.+|++.
T Consensus 217 ---~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 ---NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 012333456688999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=330.63 Aligned_cols=253 Identities=24% Similarity=0.269 Sum_probs=204.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36889999999999999999999999999999987532 223456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999998752 357899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCcceeeeeccCccccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAM------TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
... .......||+.|+|||++. ...++.++|||||||++|+|++|..||......... ..+.... .
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~i~~~~-~ 226 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY------NNIMNFQ-R 226 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH------HHHHcCC-C
Confidence 222 2233457999999999986 456789999999999999999999999765432211 1111100 0
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ..-......+..+.+|+..||+ +|.+|||+.++++
T Consensus 227 ~-------~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 F-------LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred c-------cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 0000111245678999999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=326.30 Aligned_cols=244 Identities=26% Similarity=0.371 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999999999999999987542 22334577888888766 799999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence 999888754 356899999999999999999999998 999999999999999999999999998753221 11
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc--ccHHHHHHHHhhcccccccccCCcc
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE--QNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....+........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------- 220 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------- 220 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-----------
Confidence 23446799999999999999999999999999999999999999964322111 11111111111110
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
...++...+..+.+++.+||+.||++|||+
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 012334456688999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=332.65 Aligned_cols=253 Identities=23% Similarity=0.264 Sum_probs=203.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 467999999999999999999999999999999986431 22334577899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999998854 35788888999999999999999998 9999999999999999999999999997643
Q ss_pred CCCCcceeeeeccCccccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTG----QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||......... ..+.......
T Consensus 194 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~~~ 266 (370)
T cd05596 194 ANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKNSL 266 (370)
T ss_pred CCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCCcC
Confidence 221 1122346799999999988653 4789999999999999999999999865432111 1111100000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADS--RPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~ 328 (336)
. . ......+..+.+++.+||+.+|.+ |||+++++.
T Consensus 267 ~------~--~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 T------F--PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred C------C--CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 0 0 011134668999999999999988 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=325.97 Aligned_cols=242 Identities=29% Similarity=0.395 Sum_probs=196.9
Q ss_pred ccccccCceEEEEEEEc---ccCeEEEEEeecCCC----CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 60 CLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+.||+|+||.||++.+. .+++.||+|++.... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999873 468899999986431 12234567899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999998864 456788888999999999999999998 9999999999999999999999999986432211
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~~~~~---------- 216 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKILKGK---------- 216 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHHHcCC----------
Confidence 123345799999999999988999999999999999999999999976543211 11111110
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+++.+||+.||++|| ++.++++
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112333456789999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=326.30 Aligned_cols=264 Identities=26% Similarity=0.385 Sum_probs=206.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEe-CC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCAD-GD 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~ 124 (336)
.++|++.+.||+|+||.||+|.... +++.||+|++..... ...+.+..|+.++..+ +|+||+++++++.. ..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4579999999999999999997543 457899999865432 2235677899999999 79999999998764 45
Q ss_pred eEEEEEEcCCCCChhhhhccCCCC--------------------------------------------------------
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPD-------------------------------------------------------- 148 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 148 (336)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999988542210
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCcccc
Q 036144 149 -QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227 (336)
Q Consensus 149 -~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 227 (336)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 236889999999999999999999988 9999999999999999999999999998654332222233345677899
Q ss_pred CccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHH
Q 036144 228 APEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQAL 306 (336)
Q Consensus 228 aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 306 (336)
|||++.+..++.++|||||||++|+|++ |..||......+. .. ..+..... ...+...+..+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~----------~~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEGTR----------MRAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhccCC----------CCCCccCCHHHH
Confidence 9999999999999999999999999998 9999976432211 00 11111100 011223455799
Q ss_pred HHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 307 AVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 307 ~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
+++.+||+.+|++||++.++++.|+.+..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=317.65 Aligned_cols=261 Identities=24% Similarity=0.431 Sum_probs=204.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 35679999999999999999998752 356799998864322 233568899999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 126 RILVYEFMSNGSLENHFLDLPPD------QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 234677888999999999999999988 999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~------ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------ 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence 99999875433222111222345788999999998899999999999999999999 78888764432111110
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
... .. ...+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 235 -~~~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -MEG-GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HcC-Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 010 00 01122344579999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=326.05 Aligned_cols=252 Identities=27% Similarity=0.349 Sum_probs=200.6
Q ss_pred CCCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCC----CccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQR 126 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 126 (336)
+|++.+.||+|+||.||+|.+. .++..||+|++.+.. ....+.+..|+.+++.++ |+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999874 468999999986432 222355778999999995 89999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999998864 456889999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||............ ......
T Consensus 154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~----- 225 (332)
T cd05614 154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK----- 225 (332)
T ss_pred cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-----
Confidence 5432221 223346799999999998865 4789999999999999999999999754322211111 111110
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
.++ .++...+..+.+++.+||+.||++|| +++++++
T Consensus 226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 011 22333456789999999999999999 6777775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=331.71 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=208.0
Q ss_pred hcCCCCcccccccCceEEEEEEEccc-----CeEEEEEeecCCCC-ccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAV-----DQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 125 (336)
.++|.+.+.||+|+||.||+|.+... +..||||++..... ...+.+.+|+.+++.+. ||||+++++++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 46788999999999999999987433 35699999865432 22356889999999996 9999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCC----------------------------------------------------------
Q 036144 126 RILVYEFMSNGSLENHFLDLPP---------------------------------------------------------- 147 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 147 (336)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988754210
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC
Q 036144 148 ----------------------------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA 193 (336)
Q Consensus 148 ----------------------------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~ 193 (336)
....+++..+..++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 1234788888999999999999999988 999999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHH
Q 036144 194 EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLV 272 (336)
Q Consensus 194 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~ 272 (336)
++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 99999999999875433222222233456788999999998899999999999999999997 8899875432111 00
Q ss_pred HHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 273 TWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
. ...... ....+...+..+.+++.+||+.||++|||+.++.+.|+.+.+
T Consensus 351 ~----~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 N----KIKSGY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred H----HHhcCC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0 011100 011223445689999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=313.12 Aligned_cols=257 Identities=23% Similarity=0.398 Sum_probs=207.2
Q ss_pred cCCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
++|++.+.||+|+||.||+|.+..+ ...||+|.+..... .....+.+|+.+++.++||||+++++++......+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5689999999999999999998643 45799999865432 2345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999865 2347899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ... .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~----~~~~~----- 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKA----VEDGY----- 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHH----HHcCC-----
Confidence 2221112222345678999999998899999999999999999998 9999865432211 111 10100
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 226 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 -----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=324.69 Aligned_cols=242 Identities=28% Similarity=0.426 Sum_probs=198.0
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999987532 23345567888888877 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GV 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC--CC
Confidence 999988764 346899999999999999999999998 999999999999999999999999998642221 11
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...... ..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~------~~i~~~------------~~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF------QSILED------------EV 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH------HHHHcC------------CC
Confidence 233457999999999999999999999999999999999999999765422111 111100 01
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFM-----VDVVT 328 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~ 328 (336)
.++...+..+.+|+.+||+.||.+|||+ .++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1233345688999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=310.84 Aligned_cols=261 Identities=21% Similarity=0.311 Sum_probs=213.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||+|.+..+|+.||+|.++... ......+.+|+.+++.++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999999899999999886432 223457889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.........+++..++.++.+++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998765445567899999999999999999999998 99999999999999999999999999875433
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ..........
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~---------- 222 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEK---------- 222 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhhc----------
Confidence 21 1223456899999999998889999999999999999999999998654321 1111111000
Q ss_pred CccCCCCc-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYP-RKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
... ...+ ...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 223 ~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 CDY-PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCC-CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000 1111 245568999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=324.82 Aligned_cols=244 Identities=26% Similarity=0.340 Sum_probs=196.3
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+..+++.||+|++.... ....+.+..|+.++..+ +||||+.+++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999999999999999997542 22335577899998887 599999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence 999988754 356899999999999999999999998 999999999999999999999999998743221 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...................... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK-----------PI 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC-----------CC
Confidence 2345679999999999999999999999999999999999999997543322222221111111110 01
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
.++...+..+.+++.+||+.||.+|+++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1233445678999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=313.16 Aligned_cols=262 Identities=20% Similarity=0.277 Sum_probs=212.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++......+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468888999999999999999998899999998764322 22356789999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988754444567899999999999999999999998 99999999999999999999999999876433
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.. .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ....... ....
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~-------~~~~- 224 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKI-------EQCD- 224 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhhh-------hcCC-
Confidence 21 12234568999999999988889999999999999999999999986543211 1111100 0000
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.........+..+.+++.+||+.||++|||+.+|++.++.+.
T Consensus 225 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 --YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011112235568999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=331.24 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=202.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.+.. ......+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999999999999999986421 2233457789999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999998854 35788899999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCcceeeeeccCccccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTG----QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
.... .......+||+.|+|||++.+. .++.++||||+||++|+|++|..||......... ..+......
T Consensus 193 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~~~~ 265 (370)
T cd05621 193 DETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDHKNS 265 (370)
T ss_pred ccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCcc
Confidence 3221 1123456799999999998754 3789999999999999999999999765432111 111111000
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADS--RPFMVDVVTA 329 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~ 329 (336)
.. . ......+..+.+++..||..++.+ |+|+.++++.
T Consensus 266 ~~------~--p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LN------F--PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cC------C--CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 0 011134567889999999865544 8999998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=311.66 Aligned_cols=256 Identities=24% Similarity=0.334 Sum_probs=206.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..+|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999999988999999998765544556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998854 356889999999999999999999988 9999999999999999999999999997543221
Q ss_pred CcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.......|+..|+|||.+. ...++.++|+||+||++|+|++|..||....+....... ......
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----------~~~~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----------SKSNFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----------ecCCCC
Confidence 1123356889999999874 345788999999999999999999998654322111000 000000
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
.+.. ......+..+.+++.+||+.+|++|||++++++.|
T Consensus 228 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0111 01123456899999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=314.34 Aligned_cols=257 Identities=26% Similarity=0.406 Sum_probs=203.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe----EEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ----VVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.+|++.+.||+|+||.||+|.+..++. .+++|.+..... .....+..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 568888999999999999999977665 477787754322 223567788889999999999999998754 45788
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
++||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999865 3456899999999999999999999988 999999999999999999999999999765
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||........... +..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~--- 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGER--- 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCCc---
Confidence 43322222334557788999999998899999999999999999998 9999976543221111 111110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
... +...+..+.+++.+||..||..|||+.|+++.|..+.
T Consensus 230 ~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 LAQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 000 1113346788999999999999999999999997753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=324.57 Aligned_cols=238 Identities=27% Similarity=0.348 Sum_probs=192.2
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHH-HHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVL-MLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+..+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999999999999999986532 122234445544 56789999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 999988864 456889999999999999999999998 999999999999999999999999998643221 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+. ........ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~------------~ 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNILNKP------------L 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHHHcCC------------C
Confidence 23446799999999999999999999999999999999999999976543221 11111110 0
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMV 324 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ 324 (336)
..+...+..+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11223456889999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=315.35 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=205.6
Q ss_pred cCCCCcccccccCceEEEEEEE----cccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYI----EAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.+|++.+.||+|+||.||+|.+ ..++..+|+|.+..... .....+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999985 34567899999865332 233568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC
Q 036144 129 VYEFMSNGSLENHFLDLPP-------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF 195 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~ 195 (336)
||||+++++|.+++..... ....+++.....++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853211 1235788889999999999999999998 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 036144 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 274 (336)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR- 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 999999999976533322222333456778999999988889999999999999999998 988987643221111110
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
.... ...+...+..+.+++.+||+.||.+||++.++++.|.+
T Consensus 241 ------~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 ------KRQL----------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------cCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000 01222345578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=315.92 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=207.9
Q ss_pred hcCCCCcccccccCceEEEEEEEccc-----CeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAV-----DQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|.+.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 46789999999999999999998643 37899999865432 2335678999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPD------QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS 200 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~ 200 (336)
++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999998753322 234788899999999999999999988 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHh
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~------- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV------- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH-------
Confidence 9999875433222222233456789999999988889999999999999999998 99998764432211111
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
.... ....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0100 001222335689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=315.01 Aligned_cols=259 Identities=27% Similarity=0.447 Sum_probs=207.0
Q ss_pred cCCCCcccccccCceEEEEEEE-----cccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.+|...+.||+|+||.||+|.. ..++..+|+|.+..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4678889999999999999974 33567899999876655556789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 129 VYEFMSNGSLENHFLDLPP-----------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
+|||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 1135788999999999999999999998 9999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 276 (336)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--- 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH---
Confidence 9999999875433221112223345788999999999999999999999999999998 899986544322111110
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
.... ...+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus 239 ----~~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 ----QGRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ----cCcc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0000 01122344578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=316.18 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=206.8
Q ss_pred CCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... .....+.+|+.+++.++||||+++++.+......++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47888999999999999998753 235789998865432 234568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 036144 129 VYEFMSNGSLENHFLDLP--------------------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASN 188 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~N 188 (336)
+|||+.+++|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999876432 12245888999999999999999999988 9999999999
Q ss_pred eEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 036144 189 ILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSE 267 (336)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~ 267 (336)
|+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++++|++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875433222222233446778999999988899999999999999999998 999997654322
Q ss_pred cccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 268 EQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.... .... .....+...+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 238 ~~~~-------~~~~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 238 LFNL-------LKTG----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHHH-------HhCC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1111 1110 011112334568999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=317.72 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=209.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEccc-----CeEEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAV-----DQVVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGD 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 124 (336)
..++|++.+.||+|+||.||++.+... ...+|+|.+.... ......+.+|+.+++.+ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 346789999999999999999998643 3789999986542 22335688999999999 7999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC
Q 036144 125 QRILVYEFMSNGSLENHFLDLP------------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD 192 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~ 192 (336)
..+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 9999999999999999986421 23456889999999999999999999988 99999999999999
Q ss_pred CCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccH
Q 036144 193 AEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNL 271 (336)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~ 271 (336)
.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 999999999999976533222111222335678999999988899999999999999999997 8899876543221111
Q ss_pred HHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 272 VTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
. .... ....+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 247 ~-------~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 L-------KEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H-------HcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 0100 01122234568999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=311.58 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=203.6
Q ss_pred CCCcccccccCceEEEEEEEcc---cCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCe-----
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEA---VDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ----- 125 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 125 (336)
|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999999764 347899999875432 223568899999999999999999998865544
Q ss_pred -EEEEEEcCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 126 -RILVYEFMSNGSLENHFLDLP--PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 126 -~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
.+++|||+++|+|..++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999998885432 22356899999999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
|++................++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .... .. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~---~~-~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDY---LR-H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HH-c
Confidence 99976543322222222345678999999988899999999999999999999 888886543221 1111 11 0
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
+. ....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112234556899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=310.12 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=202.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
.+|++.+.||+|+||.||+|.++. +..+|+|.+.... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 458888999999999999998865 5679999876443 33567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999988652 245889999999999999999999998 99999999999999999999999999875432211
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......++..|+|||++.+..++.++|+||||+++|+|++ |..||......+....+ . .+. ..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i------~-~~~---~~---- 220 (256)
T cd05114 156 -TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI------S-RGF---RL---- 220 (256)
T ss_pred -eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------H-CCC---CC----
Confidence 11122335668999999988899999999999999999999 89999765432211111 1 100 00
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
..+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 221 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 ---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011123457899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=311.33 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=206.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 4678999999999999999999764 5679999876533 3356788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999998653 2456788889999999999999999988 9999999999999999999999999997653321
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ... +.... .
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~~~~------~- 222 (261)
T cd05072 158 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA----LQRGY------R- 222 (261)
T ss_pred e-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH----HHcCC------C-
Confidence 1 11223345678999999988889999999999999999998 9999975432221 111 11100 0
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.......+..+.+++.+||..+|++|||++++++.|+.+
T Consensus 223 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 ---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011122445789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=309.29 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=206.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|++|.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4568999999999999999999865 5789999986543 3356788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.... ...+++..+..++.|++.||.+||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999987632 356899999999999999999999998 9999999999999999999999999997654221
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. ........+..|+|||.+.+..++.++||||||+++|+|++ |..||......... .. .....
T Consensus 158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~----~~~~~-------- 221 (261)
T cd05068 158 Y-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---QQ----VDQGY-------- 221 (261)
T ss_pred c-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH----HHcCC--------
Confidence 1 11111223457999999988899999999999999999999 99999764322111 10 00000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 --RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0112233456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=309.10 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=205.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-----cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-----GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
++|.+.+.||+|++|.||.|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999989999999998643211 23467889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999998865 346888899999999999999999998 999999999999999999999999998754
Q ss_pred CCCCCcce-eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHV-STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~---~~~-------- 220 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---F---KIA-------- 220 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---H---HHh--------
Confidence 32211111 13356788999999999988999999999999999999999999764322110 0 000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.......++...+..+.+++.+||..+|.+|||+.++++.
T Consensus 221 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 --TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0001112333455688999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=312.23 Aligned_cols=258 Identities=27% Similarity=0.381 Sum_probs=201.1
Q ss_pred CCCcccccccCceEEEEEEEcccCe--EEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeC------Ce
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQ--VVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------DQ 125 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 125 (336)
|.+.+.||+|+||.||+|.+..++. .+|+|.++... ....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567789999999999999977665 69999886542 23346688899999999999999999977432 24
Q ss_pred EEEEEEcCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 126 RILVYEFMSNGSLENHFLDLP--PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
.+++|||+.+|+|.+++.... .....+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874321 23355899999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+. .. .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~----~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YD----YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHHcC
Confidence 9986543322112223346778999999999999999999999999999999 7888875432211 11 11111
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
... ..+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 100 11223445789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=315.14 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=205.3
Q ss_pred cCCCCcccccccCceEEEEEEEccc-----CeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAV-----DQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.+|.+.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 3477788899999999999987543 578999998754322 2356788999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC
Q 036144 128 LVYEFMSNGSLENHFLDLP------------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF 195 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~ 195 (336)
+++||+.+++|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 12345788889999999999999999998 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 036144 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 274 (336)
.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......+. ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~- 237 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---IE- 237 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-
Confidence 999999999876533322222233456789999999988899999999999999999998 8888876433211 11
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
...... ...++...+..+.+++..||+.+|.+||++.++++.|+.
T Consensus 238 --~i~~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 --MIRNRQ-----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred --HHHcCC-----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111100 011233455679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=316.40 Aligned_cols=260 Identities=24% Similarity=0.355 Sum_probs=207.3
Q ss_pred hcCCCCcccccccCceEEEEEEE-----cccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (336)
.++|.+.+.||+|+||.||+|.+ ..++..||+|.++.... ...+.+.+|+.+++.+ +||||+++++++.....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35799999999999999999985 33456899998875432 2345688999999999 79999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++||||+.+|+|.+++... ....+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999998652 2234899999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
................++..|+|||.+.+..++.++||||+||++|+|++ |..||......+.. .. .....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~----~~~~~-- 260 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YK----LIKEG-- 260 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HH----HHHcC--
Confidence 75543322112223456788999999999999999999999999999998 99998764432110 01 11111
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 261 --------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 --------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00011223345799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.75 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=201.9
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCC-----eEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD-----QRI 127 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 127 (336)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999899999999986432 223456889999999999999999999998776 789
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999995 678777754 457899999999999999999999998 99999999999999999999999999975
Q ss_pred CCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-----------
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA----------- 275 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 275 (336)
..... ........+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||......+....+...
T Consensus 153 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 43221 1222335689999999998874 5899999999999999999999999876543322111100
Q ss_pred -----HH-HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 -----KP-LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 -----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. +.......... . .........+..+.+|+.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 232 ACEGARAHILRGPHKPPSL-P--VLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hhHHHHHHHHhCCCCCCch-H--HhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00 00000000000 0 000112233567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=311.09 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=196.2
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
||+|+||.||++.++.+|+.||+|.+..... .....+..|+++++.++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999999999999999999864321 1233456799999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence 9887542 3345888899999999999999999998 999999999999999999999999998765332 1233
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCc
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
...|+..|+|||++.+..++.++||||+||++|+|++|..||........ ............ .. ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~----------~~-~~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE----------VK-FEH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc----------cc-ccc
Confidence 45689999999999988999999999999999999999999975432211 111111111100 00 001
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 299 RKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 299 ~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+..+.+|+.+||+.||++||++.|+++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 124557899999999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=323.68 Aligned_cols=241 Identities=26% Similarity=0.342 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHH-HHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEV-LMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+..+++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999986432 11223344444 456788999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence 999998864 356788888899999999999999998 999999999999999999999999998743221 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.. ....... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~~~------------~ 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNILNKP------------L 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH------HHHHhCC------------c
Confidence 234567999999999999999999999999999999999999999765432211 1111110 0
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl 327 (336)
.++...+..+.+++.+||+.||.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 12233456889999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=313.17 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=207.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccC----------------eEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccce
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVD----------------QVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNL 116 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~----------------~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~ 116 (336)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 57999999999999999999876543 5689999875532 234578899999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 036144 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPP-------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNI 189 (336)
Q Consensus 117 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Ni 189 (336)
++++......+++|||+.+++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 9999999999999999999999999876331 1236899999999999999999999998 99999999999
Q ss_pred EECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCcc
Q 036144 190 LLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT--GRSAIDNSRPSE 267 (336)
Q Consensus 190 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~p~~~~~~~~ 267 (336)
+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999875433322223334556789999999988889999999999999999998 667776543221
Q ss_pred cccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 268 EQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
........+... ........+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 242 ---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 ---VIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111000 001111122334568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=329.09 Aligned_cols=257 Identities=21% Similarity=0.241 Sum_probs=203.2
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
....++|++.+.||+|+||.||+|.++.+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 344578999999999999999999999999999999986422 22234577899999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999998854 34788889999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTG----QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
...... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.... ...+....
T Consensus 191 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~ 263 (371)
T cd05622 191 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNHK 263 (371)
T ss_pred EcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcCC
Confidence 653221 1223456799999999998754 378999999999999999999999986543211 11111110
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADS--RPFMVDVVTA 329 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~ 329 (336)
.. +.-......+..+.++|..||..++.+ |++++++++.
T Consensus 264 ~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 NS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred Cc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00 000111235668899999999844433 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=312.91 Aligned_cols=259 Identities=28% Similarity=0.419 Sum_probs=205.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678999999999999999999976 6789999988654322 235688999999999999999999999988899
Q ss_pred EEEEEcCCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC---ceEEc
Q 036144 127 ILVYEFMSNGSLENHFLDLPP---DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF---NPKLS 200 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~---~~kl~ 200 (336)
++||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++ .++|+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865321 1235889999999999999999999998 99999999999998654 59999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHh
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||...........+ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~------~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV------T 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------H
Confidence 9999976422211111122234568999999998899999999999999999997 99999765432211111 0
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
... ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 -~~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 -GGG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -cCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 100 01122334568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=312.28 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=204.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCe----EEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQ----VVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.++|++.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 3578899999999999999999876665 489999865432 2345688999999999999999999998754 477
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
++++|+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999865 2356899999999999999999999998 99999999999999999999999999976
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..............++..|+|||...+..++.++|||||||++|||++ |..||.......... .+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~-- 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-------LLEKGER-- 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-------HHHCCCc--
Confidence 543222111222335678999999998899999999999999999998 889987543222111 1111100
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
...+...+..+.+++.+||+.||+.||++.+++..|+.+.
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0112234557899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=311.52 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=201.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|++.++||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36888899999999999999999999999999986542 23345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|..+ ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 999998654 24677888999999999999999998 999999999999999999999999998754322
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccH-HHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNL-VTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 291 (336)
......||..|+|||++.+..++.++|+|||||++|+|++|..||........... ........ .. ..+
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~------~~~ 218 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV-DE------DPP 218 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh-cc------CCC
Confidence 23345789999999999999999999999999999999999999976432221111 11111100 00 000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
. ......+..+.+++.+||+.+|++||+++++++.
T Consensus 219 ~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 V---LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred C---CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0 0112234578999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=321.26 Aligned_cols=242 Identities=24% Similarity=0.374 Sum_probs=197.2
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 130 (336)
+|+..+.||+|+||.||+|.++.+|+.||+|++.... ......+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778889999999999999999999999999986532 223345677888888876 577888999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999998864 356899999999999999999999998 99999999999999999999999999874322
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ........||+.|+|||++.+..++.++||||+||++|+|++|..||........ . ..+...
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~---~~i~~~--------- 216 (323)
T cd05615 154 D--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---F---QSIMEH--------- 216 (323)
T ss_pred C--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---H---HHHHhC---------
Confidence 1 1123345699999999999999999999999999999999999999986543211 1 111110
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
...++...+..+.+++.+||+.+|.+|++.
T Consensus 217 ---~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 ---NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 012233445688999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=314.62 Aligned_cols=251 Identities=33% Similarity=0.524 Sum_probs=197.2
Q ss_pred CcccccccCceEEEEEEEc----ccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 58 PDCLVGEGGYGRVYKGYIE----AVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 58 ~~~~ig~G~~g~v~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+.+.||.|+||.||+|.+. ..+..|+||.+...... ..+.+.+|++.++.++||||+++++++......++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3567999999999999998 45678999999654332 357899999999999999999999999988889999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++|+|.+++... ....+++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999873 3567899999999999999999999998 9999999999999999999999999998653222
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
.........+...|+|||.+....++.++||||||+++|||++ |..||......+. .. .+ .....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~---~~---~~-~~~~~------- 223 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI---IE---KL-KQGQR------- 223 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH---HH---HH-HTTEE-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc---cc-ccccc-------
Confidence 2222333457788999999998889999999999999999999 6788876533221 11 11 11101
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
...+...+..+.+++..||..||++|||+.++++.|
T Consensus 224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112333456799999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=316.74 Aligned_cols=266 Identities=21% Similarity=0.316 Sum_probs=203.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 679999999999999999999999999999999865432 2234577899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
++ ++|.+++.. ....++...+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 96 588887765 2345788899999999999999999998 9999999999999999999999999987532221
Q ss_pred CcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHHhhccc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------KPLLRDKK 283 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 283 (336)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+... ++.+....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 12233568999999998865 46899999999999999999999999876543322211110 00000000
Q ss_pred ccccccCCccCC----CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLEG----QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......+.... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000 001124557889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=314.69 Aligned_cols=265 Identities=22% Similarity=0.362 Sum_probs=204.0
Q ss_pred cCCCCcccccccCceEEEEEEEccc--------------CeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAV--------------DQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIG 118 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~--------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~ 118 (336)
++|++.+.||+|+||.||++.+..+ ...||+|.+..... .....+.+|+++++.++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987643 23589999865432 23356889999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChhhhhccCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 036144 119 YCADGDQRILVYEFMSNGSLENHFLDLP--------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL 190 (336)
Q Consensus 119 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil 190 (336)
++......++||||+.+++|.+++.... .....+++..++.++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999885421 11124788889999999999999999998 999999999999
Q ss_pred ECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCccc
Q 036144 191 LDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT--GRSAIDNSRPSEE 268 (336)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~p~~~~~~~~~ 268 (336)
++.++.+||+|||++................++..|+|||.+.++.++.++|+|||||++|+|++ |..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 99999999999999875433322222223445778999999998899999999999999999988 567776544322
Q ss_pred ccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 269 QNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.+......+...... .....+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 241 --~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 --VIENTGEFFRNQGRQ-------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --HHHHHHHhhhhcccc-------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111110000 000112223458999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=329.47 Aligned_cols=253 Identities=22% Similarity=0.303 Sum_probs=200.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999999999999999986432 223456788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999864 456899999999999999999999998 99999999999999999999999999864322
Q ss_pred CCCc---------------------------------ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCC
Q 036144 211 GGKD---------------------------------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257 (336)
Q Consensus 211 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 257 (336)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 036144 258 SAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF---MVDVVT 328 (336)
Q Consensus 258 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt---~~evl~ 328 (336)
.||....+......+ ..... ... .... ...+..+.++|.+|+. ||.+|++ +.++++
T Consensus 234 ~Pf~~~~~~~~~~~i------~~~~~---~~~---~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQETYRKV------MNWKE---TLV---FPPE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHHHHHHHH------HcCCC---cee---cCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 999865543221111 10000 000 0000 1235578889988774 9999985 566554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=340.80 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=216.0
Q ss_pred cCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.+....+.||+|+||+||+|...+ ....||||.++..... ...+|.+|++++..++|||||+++|++..++-.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 445667789999999999998642 3467999999876555 5678999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 128 LVYEFMSNGSLENHFLDLPPD----------QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~----------~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
||+|||..|+|.++|....+. ..+++..+.+.|+.|||.|+.||-+++ +|||||-..|+||+++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 999999999999998763321 334889999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 276 (336)
||+|||+++..-..+-......-.-..+|||||.+..+.|+.+|||||+||+|||+++ |..|+.+....+....+...
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g- 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG- 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC-
Confidence 9999999985433322222222234678999999999999999999999999999998 88998876654433333211
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.+ -..|..++.++.+|+..||+.+|++||+++||-.+|+..
T Consensus 722 ---------------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 722 ---------------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ---------------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 11 245677888999999999999999999999999999864
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=313.08 Aligned_cols=251 Identities=25% Similarity=0.358 Sum_probs=207.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..+|.+.+.||+|+||.||+|.+..++..||+|.+..........+.+|+.+++.++|+||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35799999999999999999999988999999998766555567788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998853 35788899999999999999999998 9999999999999999999999999987543221
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+... ... .... ..
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~----~~~~---------~~ 233 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL----IATN---------GT 233 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH----HhcC---------CC
Confidence 122335689999999999888899999999999999999999999976543211 000 0000 00
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+...+..+.+++.+||..+|++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 001122344567899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=314.14 Aligned_cols=266 Identities=23% Similarity=0.384 Sum_probs=205.2
Q ss_pred cCCCCcccccccCceEEEEEEEcc----------------cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccce
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEA----------------VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNL 116 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~ 116 (336)
++|++.+.||+|+||.||++.+.. ++..+|+|.+..... .....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 569999999999999999986542 345799999875432 234678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChhhhhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 036144 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPD-------QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNI 189 (336)
Q Consensus 117 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Ni 189 (336)
++++......++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999998763321 234778889999999999999999998 99999999999
Q ss_pred EECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCcc
Q 036144 190 LLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT--GRSAIDNSRPSE 267 (336)
Q Consensus 190 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~--g~~p~~~~~~~~ 267 (336)
+++.++.++|+|||++................++..|+|||...++.++.++|+|||||++|+|++ |..||......+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875433222222223345678999999888899999999999999999998 778886544322
Q ss_pred cccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 268 EQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
. +......+..... .... ..+..++..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 242 ~---~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V---IENTGEFFRDQGR--QVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHhhccc--cccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111111000 0000 1122344689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=312.51 Aligned_cols=252 Identities=28% Similarity=0.406 Sum_probs=203.3
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.|+..+.||+|+||.||++.+..+++.||+|.+...... ....+.+|+.+++.++|++++.+++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999999999999999998654322 22456789999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999988652 2346889999999999999999999988 999999999999999999999999998754322
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. ......|+..|+|||.+.+..++.++||||+||++|+|++|..||............. .....
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~---------- 219 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKE---------- 219 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhh----------
Confidence 1 1233478999999999999999999999999999999999999997643221111111 00000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
....++...+..+.+|+..||+.||++||| ++++++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 001122334557899999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=308.48 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=206.4
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
+|++.+.||+|+||.||++.+..++..+|+|.++... ....+.+.+|+.+++.++|+||+++++.+......+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999999999999999986432 233467788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++++|.+++... ....+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 999999988642 3456788999999999999999999998 999999999999999999999999998754332
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||........ . ...... ..
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~---~~~~~~--~~-------- 217 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---I---LKVCQG--SY-------- 217 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---H---HHHhcC--CC--------
Confidence 1223345789999999999888899999999999999999999999976432111 0 011000 00
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
...+...+..+.+++.+||+.||++|||+.+++..
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01223345578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=327.36 Aligned_cols=265 Identities=20% Similarity=0.214 Sum_probs=200.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
....|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++|+||+++++++......++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3457999999999999999999999999999999642 2345689999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
++ .++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 241 ~~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KY-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 99 5788888764 2346899999999999999999999998 999999999999999999999999999765332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-cc----ccHHHHHHHHhhcccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPS-EE----QNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~----~~~~~~~~~~~~~~~~~~ 286 (336)
..........||..|+|||++.+..++.++|||||||++|||++|..++...... .. ..+.............+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 2222233467999999999999999999999999999999999988665332211 11 011111100000000000
Q ss_pred c----------------ccCCccCC-CCc--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 287 M----------------MADPLLEG-QYP--RKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 287 ~----------------~~~~~~~~-~~~--~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
. ...+.... .+. ...+..+.+||.+||+.||.+|||+.|+|+.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000000 000 0223478899999999999999999999874
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=312.73 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=197.6
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhc---cCCCccceEEEEEe-----CC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLV---QHQNLVNLIGYCAD-----GD 124 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~~ 124 (336)
+|++.+.||+|+||.||+|.++.+++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588899999999999999999999999999998653221 223456677777665 69999999998864 34
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..+++|||+. ++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999996 5888888653 2345899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH-HHH----HHh
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT-WAK----PLL 279 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~----~~~ 279 (336)
+....... ......||..|+|||++.+..++.++||||+||++|+|++|.+||......+....+. ... ..+
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 97643221 1234568999999999998899999999999999999999999997654322211111 000 000
Q ss_pred hcccc-cccccCCccC---CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 RDKKK-FTMMADPLLE---GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ~~~~~-~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... ......+... ....+..+..+.+++.+||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0000000000 0111234567899999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=307.25 Aligned_cols=252 Identities=30% Similarity=0.434 Sum_probs=207.7
Q ss_pred ccccccCceEEEEEEEccc---CeEEEEEeecCCCCcc-HHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSGNQG-SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+... +..|++|.+....... .+.+.+|+..++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 3699999999999999865 8899999987654433 56788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 136 GSLENHFLDLPPD-----QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 136 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
++|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999998764222 477999999999999999999999988 99999999999999999999999999987644
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
...........++..|+|||.+....++.++||||||+++|+|++ |..||......+..... . ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~-~~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL------R-KG------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------H-cC-------
Confidence 332223344567889999999988899999999999999999999 69999876332211111 0 00
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.....+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011223334668999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=324.18 Aligned_cols=239 Identities=26% Similarity=0.319 Sum_probs=195.0
Q ss_pred ccccccCceEEEEEEE---cccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 60 CLVGEGGYGRVYKGYI---EAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
+.||+|+||.||++.+ ..+|+.||+|++..... .....+..|+.+++.++||||+++++++.+....++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999886 35789999999875321 223456789999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
+|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~ 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--E 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCC--C
Confidence 9999998854 456899999999999999999999998 999999999999999999999999998754322 1
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (336)
.......||+.|+|||.+.+..++.++|||||||++|+|++|..||......+.. ..+....
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~i~~~~------------ 214 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TMILKAK------------ 214 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HHHHcCC------------
Confidence 2234467999999999999889999999999999999999999999765432111 1111100
Q ss_pred CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 036144 295 GQYPRKGLYQALAVAGMCLQEDADSRPFMVD 325 (336)
Q Consensus 295 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 325 (336)
..++...+..+.+++.+||+.||++|||+.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0122334567899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=320.25 Aligned_cols=238 Identities=26% Similarity=0.342 Sum_probs=191.7
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHH-HHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEV-LMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
++||+|+||.||+|.+..+++.||+|++.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999986432 12223445554 467889999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
++|...+.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999888754 456888899999999999999999998 999999999999999999999999998743221 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.... ....... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~------------~~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------YDNILHK------------PL 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------HHHHhcC------------CC
Confidence 23446799999999999988999999999999999999999999976542211 1111110 01
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMV 324 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ 324 (336)
.++...+..+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 22334456899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=321.88 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=199.7
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCC-----
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD----- 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 124 (336)
..++|++.+.||+|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986432 233456789999999999999999999986443
Q ss_pred -eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 125 -QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 125 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
..++||||++ ++|.+.+. ..++...+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 4789999995 46666553 24778889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHH-----------
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV----------- 272 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~----------- 272 (336)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+........
T Consensus 169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 98753221 1233457899999999999999999999999999999999999999865432210000
Q ss_pred -----HHHHHHhhcccc-----cccccCCcc---CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 273 -----TWAKPLLRDKKK-----FTMMADPLL---EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 273 -----~~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
............ ......... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000000 000000000 00111123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=312.95 Aligned_cols=265 Identities=25% Similarity=0.396 Sum_probs=207.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
..++|++.+.||+|+||.||+|.++. .+..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34789999999999999999997652 345799998764432 223457789999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 126 RILVYEFMSNGSLENHFLDLPP------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
.++||||+++|+|.+++..... .....+...+..++.|++.||.|||+.+ |+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999875321 1234566788899999999999999998 999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
+|||++................++..|+|||.+.++.++.++|+|||||++|+|++ |..||......+.. . ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~---~---~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL---K---FV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HH
Confidence 99999875433222122222345778999999998899999999999999999998 78888754332211 1 11
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccCC
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~~ 336 (336)
. .... ...+...+..+.+++.+||+.||++|||+.++++.|+...+|
T Consensus 235 ~-~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 235 M-DGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred H-cCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 1 0000 011222346899999999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=317.83 Aligned_cols=262 Identities=26% Similarity=0.376 Sum_probs=206.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcc-------cCeEEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA-------VDQVVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADG 123 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 123 (336)
.++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3679999999999999999998743 23569999987542 23345688899999999 799999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
...++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999976321 1235888999999999999999999988 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQN 270 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~ 270 (336)
+.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999875432211111222234578999999998899999999999999999998 888886543221111
Q ss_pred HHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
. .... .....+...+..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus 254 ~-------~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 254 L-------LKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred H-------HHcC----------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1 1010 011123344568899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=306.24 Aligned_cols=251 Identities=26% Similarity=0.354 Sum_probs=207.1
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|.+.+.||+|++|.||+|.+..+++.|++|.+... .......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477888999999999999999999999999998643 233456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++... ....+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999998763 2457889999999999999999999988 9999999999999999999999999987653321
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......|++.|+|||++.+..++.++|+||||+++++|++|..||........ . ......
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~~----------- 216 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---I---LKIIRG----------- 216 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHHHcC-----------
Confidence 122345689999999999999999999999999999999999999976542111 1 111000
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
....++...+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011222345689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=312.76 Aligned_cols=265 Identities=28% Similarity=0.362 Sum_probs=204.5
Q ss_pred cCCCCcccccccCceEEEEEEE----cccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYI----EAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 127 (336)
.+|++.+.||+|+||.||+|.. ..++..||+|.+........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999984 45688999999876655556678999999999999999999998753 34688
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999865 2346889999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCccee-eeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc---------cHHHHHHH
Q 036144 208 GPTGGKDHVS-TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ---------NLVTWAKP 277 (336)
Q Consensus 208 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~---------~~~~~~~~ 277 (336)
.......... ....++..|+|||++.+..++.++||||||+++|+|++|..++......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 5433221111 1122345699999998889999999999999999999987765433211000 00000000
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.. ........+...+..+.+|+.+||+.+|++|||+.++++.|+.++
T Consensus 238 ~~----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 LL----------KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HH----------hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00 000011112334568999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=323.05 Aligned_cols=239 Identities=26% Similarity=0.339 Sum_probs=192.4
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHH-HHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVL-MLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+..+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999999999999999986532 122334455554 56779999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999888754 457899999999999999999999998 999999999999999999999999998643221 12
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.. ....... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~~~~------------~ 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNILHKP------------L 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHHcCC------------c
Confidence 234567999999999999999999999999999999999999999765432211 1111100 0
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVD 325 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 325 (336)
..+...+..+.+++.+||+.+|.+||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 112234557889999999999999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=313.55 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=203.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe--EEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ--VVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 129 (336)
++|++.+.||+|+||.||+|....++. .+++|.++... ....+.+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999877664 47888876432 23345688999999999 799999999999999999999
Q ss_pred EEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 130 YEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999865321 1235888999999999999999999988 9999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 276 (336)
||+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......+.. .
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~---~--- 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY---E--- 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H---
Confidence 99999998632111 01111223557999999988899999999999999999997 99999765432211 1
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
... .. .....+...+..+.+|+.+||+.+|.+|||++++++.|+.+.
T Consensus 230 ~~~-~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 230 KLP-QG----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HHh-cC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 100 00 011122234568899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=310.36 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=205.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.+.|++.+.||.|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 36799999999999999999999999999999998766555567788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|..++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999887754 2356899999999999999999999988 999999999999999999999999998653221
Q ss_pred CcceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
........+++.|+|||.+. ...++.++|+|||||++|+|++|..||........ .. ..... .
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~--~--- 231 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----KIAKS--E--- 231 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HH----HHhcC--C---
Confidence 12233456889999999885 34578899999999999999999999876442111 01 01000 0
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+ ....+...+..+.+++.+||+.||++||+++++++
T Consensus 232 --~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 --PP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --Cc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 00112334557899999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=310.99 Aligned_cols=269 Identities=25% Similarity=0.373 Sum_probs=204.3
Q ss_pred CCCcccccccCceEEEEEEE----cccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEEE
Q 036144 56 FNPDCLVGEGGYGRVYKGYI----EAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRIL 128 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 128 (336)
|.+.+.||+|+||+||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 45678999999875432 2345678999999999999999999987653 46789
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999854 35899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCCcc-eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDH-VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ .......... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhhhh
Confidence 4322111 11223456779999999888999999999999999999999999865432110 0000000000 0000111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..+.......+...+..+.+++..||+.+|++|||++++++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112233445668999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=322.04 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=201.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeC------
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------ 123 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 123 (336)
..++|.+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999999999999999986542 22345677899999999999999999988643
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
...++||||++ ++|.+.+. ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 35789999995 46766653 24788889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHH-H---------
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-T--------- 273 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-~--------- 273 (336)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+..... .
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99754322 1233457899999999999999999999999999999999999999765432211100 0
Q ss_pred ------HHHHHhhcccccccccCC------cc--CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 274 ------WAKPLLRDKKKFTMMADP------LL--EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 274 ------~~~~~~~~~~~~~~~~~~------~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.................+ .. ....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000000000000 00 011122234578999999999999999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=310.10 Aligned_cols=252 Identities=29% Similarity=0.431 Sum_probs=204.0
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHH--HHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR--EFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
|++.+.||+|+||.||++.+..+++.||+|++......... ...+|+.+++.++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 56788999999999999999999999999999776533322 2356999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
.+++|.+++.. ...++...++.++.|+++||.+||+.+ ++|+||||+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 99999999872 467899999999999999999999998 999999999999999999999999999754 112
Q ss_pred cceeeeeccCccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-HhhcccccccccCC
Q 036144 214 DHVSTRVMGTYGYCAPEYAM-TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-LLRDKKKFTMMADP 291 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 291 (336)
........++..|+|||++. +..++.++||||||+++++|++|..||................. .....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 222 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS--------- 222 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------
Confidence 23445567899999999988 78899999999999999999999999987622222111111100 00000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..........+.+++.+||+.||++|||+.++++
T Consensus 223 ---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 223 ---SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ---TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ---ccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000011268999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=313.31 Aligned_cols=265 Identities=21% Similarity=0.260 Sum_probs=204.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+++++.++||||+++++++..+...++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468999999999999999999999999999999865432 2235688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999865 3568899999999999999999997 46 999999999999999999999999998654221
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc-------
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK------- 284 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 284 (336)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+....................
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 223457899999999998888999999999999999999999998654322111111000000000000
Q ss_pred -------------cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 285 -------------FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 285 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.................+..+.+++.+||..+|++|||+.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000001245579999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=347.34 Aligned_cols=264 Identities=20% Similarity=0.328 Sum_probs=206.6
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe--CCe
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQ 125 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 125 (336)
....++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+..|+.+++.++||||++++++|.. ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445578999999999999999999999999999999986542 2234568899999999999999999998854 356
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeCCCCCCCeEECC--------
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD----PPVIYRDFKASNILLDA-------- 193 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~----~~i~H~dikp~Nil~~~-------- 193 (336)
.++||||+++|+|.+++.........+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999987644445679999999999999999999998542 34999999999999954
Q ss_pred ---------CCceEEccccccccCCCCCCcceeeeeccCccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 036144 194 ---------EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELITGRSAIDN 262 (336)
Q Consensus 194 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~ 262 (336)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++||||||||+|+|++|..||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 234899999999754322 12334579999999999864 4589999999999999999999999975
Q ss_pred CCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcc
Q 036144 263 SRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT--ALEYL 333 (336)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~--~L~~i 333 (336)
..... .+. ..+. .. +.+. ....+..+.+||..||+.+|.+|||+.++|. .+..+
T Consensus 246 ~~~~~--qli---~~lk-~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 246 ANNFS--QLI---SELK-RG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCcHH--HHH---HHHh-cC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 43211 111 1111 00 0000 1123457999999999999999999999984 44433
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=314.39 Aligned_cols=263 Identities=25% Similarity=0.370 Sum_probs=208.3
Q ss_pred HhcCCCCcccccccCceEEEEEEEc-------ccCeEEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIE-------AVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCAD 122 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 122 (336)
..++|.+.+.||+|+||.||+|.+. ..+..||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567899999999999999999753 234579999886432 23346788999999999 79999999999999
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL 190 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil 190 (336)
....++||||+.+|+|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999875321 1245788889999999999999999998 999999999999
Q ss_pred ECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccc
Q 036144 191 LDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQ 269 (336)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~ 269 (336)
++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 249 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 99999999999999976543222222233446778999999988889999999999999999998 78888654322211
Q ss_pred cHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 270 NLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
. . +..... ...+...+..+.+++.+||+.+|.+|||+.++++.|+.|.
T Consensus 250 ~------~-~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 250 K------L-LKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred H------H-HHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1 1 111100 0112234568999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=315.22 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=202.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeE--EEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQV--VAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 129 (336)
++|++.+.||+|+||.||+|.+..++.. +|+|.+.... ......+.+|+.++..+ +||||+++++++......++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5788999999999999999999776654 5777765432 22345678899999999 899999999999999999999
Q ss_pred EEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 130 YEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999865321 1246889999999999999999999998 9999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 276 (336)
+|+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. ..
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~--- 234 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE--- 234 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HH---
Confidence 99999998532111 11112234667999999988889999999999999999998 9999975443211 11
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.. ... .....+...+..+.+|+.+||+.+|++||++.++++.|+.+.
T Consensus 235 ~~-~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 235 KL-PQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HH-hcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 000 000112223457899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=322.96 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=204.4
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
....++-||.|+.|.||+|+.+ ++.||||+++.- -..+|+-|+.|+||||+.|.++|...-.+++|||||.
T Consensus 125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HhhhhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 3344566999999999999998 789999987532 2357889999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
.|-|.++|.. ...+.......|..+||.|++|||.+. |||||||.-||||+.+..|||+|||.++.....
T Consensus 196 ~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--- 265 (904)
T KOG4721|consen 196 QGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--- 265 (904)
T ss_pred cccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence 9999999976 567888888999999999999999998 999999999999999999999999999754332
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (336)
.....++||..|||||++.+.+.+.|+|||||||+||||+||..||.+-+..... |+ +-...+.
T Consensus 266 STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wG------------VGsNsL~ 329 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WG------------VGSNSLH 329 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----Ee------------ccCCccc
Confidence 2345689999999999999999999999999999999999999999875432211 11 0111222
Q ss_pred CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 295 GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 295 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
...|..++..+.-|+..||+..|.+||++.+++..|+.
T Consensus 330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 23455666788999999999999999999999999864
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=306.46 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=202.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
.+|.+.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 458888999999999999998865 4569999886543 33467899999999999999999999999888899999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
.+++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+.......
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~- 154 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE- 154 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc-
Confidence 999999998652 236899999999999999999999998 9999999999999999999999999987543321
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+... ... .... .
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~------~~~-~~~~------~- 220 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE------KVS-QGLR------L- 220 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH------HHh-cCCC------C-
Confidence 111122345678999999988889999999999999999998 999987644322111 111 1000 0
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
..+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ---YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111123468999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=308.94 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=203.0
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
|++.+.||+|+||.||+|.+..++..+++|.+..........+.+|+++++.++|||++++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67788899999999999999999999999998765545556788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
++|..++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~ 158 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 158 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--cc
Confidence 999888754 2456899999999999999999999998 999999999999999999999999998654321 11
Q ss_pred eeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 216 VSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
......++..|+|||++. +..++.++|+|||||++|+|++|.+||........ ... .... . .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~----~~~~--~-----~ 225 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK----IAKS--E-----P 225 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH----Hhhc--C-----C
Confidence 233456899999999874 34678899999999999999999999876442111 011 0000 0 0
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+. ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus 226 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 226 PT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0112234568999999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=318.45 Aligned_cols=192 Identities=23% Similarity=0.318 Sum_probs=167.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..+|.+.+.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++......++|||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 45799999999999999999999999999999985432 235689999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+ .++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 139 ~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 139 Y-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred c-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 9 5688888764 3467899999999999999999999998 99999999999999999999999999874322
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAI 260 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~ 260 (336)
........||..|+|||++.+..++.++|||||||++|+|+++..++
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 -APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 11233457999999999999999999999999999999999865554
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=310.22 Aligned_cols=251 Identities=29% Similarity=0.392 Sum_probs=202.2
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
|+..+.||+|+||.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++|+||+.+.+.+...+..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 6677889999999999999999999999999865421 2234567899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888652 2346899999999999999999999998 9999999999999999999999999986543221
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+. ......
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~~~----------- 220 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLET----------- 220 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhhcc-----------
Confidence 1234578999999999998899999999999999999999999997654322111111 000000
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
...++...+..+.+|+..||+.||++||| +.+++.
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 221 -EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00122334557899999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=304.01 Aligned_cols=254 Identities=26% Similarity=0.373 Sum_probs=209.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|++.+.||.|+||.||+|.+..++..+++|++........+.+.+|+.+++.++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57899999999999999999999889999999997665556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999998865 2357899999999999999999999998 9999999999999999999999999987543221
Q ss_pred cceeeeeccCccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTG---QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||............. .. . ...
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~------~~--~---~~~ 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS------KS--N---FPP 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hc--c---CCC
Confidence 123345688999999998776 88999999999999999999999997654322111100 00 0 000
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+. .......+..+.+++.+||+.+|.+|||+.+++.
T Consensus 224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 1123345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=318.22 Aligned_cols=256 Identities=21% Similarity=0.245 Sum_probs=200.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||.||++.+..+++.||+|++.+. .......+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999999999999999998642 1223355788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999865 2456889999999999999999999999 99999999999999999999999999865433
Q ss_pred CCCcceeeeeccCccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMT-----GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
.. ........||+.|+|||++.. ..++.++|||||||++|+|++|..||......+.. ..+.......
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~ 227 (331)
T cd05597 155 DG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHF 227 (331)
T ss_pred CC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCcc
Confidence 22 112233569999999999863 45788999999999999999999999764432211 1111110000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADS--RPFMVDVVTA 329 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~ 329 (336)
. +. ......+..+.+++.+||..++++ ||++.++++.
T Consensus 228 ~------~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 Q------FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c------CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 00 011124567889999988654443 7899888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=323.60 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=207.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhcc-CCCccceEEEEEeCC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQ-HQNLVNLIGYCADGD 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 124 (336)
..++|.+.+.||+|+||.||+|.+. .++..||+|++...... ..+.+.+|+.++..+. ||||+++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888999999999999999964 34568999999754322 2346889999999997 999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCC---------------------------------------------------------
Q 036144 125 QRILVYEFMSNGSLENHFLDLPP--------------------------------------------------------- 147 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 147 (336)
..++||||+.+|+|.+++.....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999998864211
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 036144 148 -------------------------------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL 190 (336)
Q Consensus 148 -------------------------------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil 190 (336)
....+++...+.++.|++.||.|||+.+ ++||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1234677788899999999999999988 999999999999
Q ss_pred ECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccc
Q 036144 191 LDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQ 269 (336)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~ 269 (336)
++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 99999999999999975432221112223457889999999998889999999999999999998 88898654322210
Q ss_pred cHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 270 NLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
. . .+..+. ....+...+..+.+|+.+||+.+|..||++.+|+..|+.+
T Consensus 352 --~---~-~~~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 352 --Y---N-AIKRGY----------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred --H---H-HHHcCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 0 011110 0112233456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=308.77 Aligned_cols=257 Identities=24% Similarity=0.417 Sum_probs=204.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe---EEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ---VVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.+|++.+.||+|+||.||+|.+..++. .||+|.+.... ......+..|+.+++.++||||+++++++......++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 457889999999999999999876554 69999986542 23346788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998652 356889999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCcceeeeec---cCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 210 TGGKDHVSTRVM---GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 210 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
............ .+..|+|||.+.+..++.++|||||||++|||++ |..||........ .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i----~~~~-- 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAI----EQDY-- 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHH----HcCC--
Confidence 322111111111 2457999999998999999999999999999886 9999976543211 1111 0000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+++.+||+.+|.+||++.+++..|+.+
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0111223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.19 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=203.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|.+.+.||+|+||.||+|.+..+ ..||+|.+.... .....+.+|+.+++.++||||+++++++.. ...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 5699999999999999999998765 469999987533 234678899999999999999999998754 5578999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999998752 2345788999999999999999999988 99999999999999999999999999976533221
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......++..|+|||...+..++.++|||||||++|+|++ |..||......+... ... ...
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~------~~~-~~~--------- 220 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD------QVE-RGY--------- 220 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH------HHh-cCC---------
Confidence 11223346778999999988899999999999999999999 888887654322111 000 000
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 221 -~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0112234556889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=305.06 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=202.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
.+|.+.+.||+|+||.||+|.++. +..+|+|.+..... ....+.+|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 458888999999999999998864 66899999865432 3456888999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999998652 346899999999999999999999998 99999999999999999999999999875432211
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+.. . ... ..
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~---~~~-~~---------- 217 (256)
T cd05059 156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E---SVS-AG---------- 217 (256)
T ss_pred -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H---HHH-cC----------
Confidence 11111224457999999998899999999999999999999 88998764432211 1 100 00
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 218 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 218 YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 011122234668999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.88 Aligned_cols=246 Identities=29% Similarity=0.390 Sum_probs=209.7
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.|.-++.||.|+||.||.|++..+.+.||||.+..+. .+.++++..|+.+|++++|||+|.+.++|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3666677999999999999999999999999997654 3445778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|| -||-.+++.- .++++.+..+..|+.+.+.||.|||+.+ .||||||..|||+++.|.|||+|||.+....+
T Consensus 107 YC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 107 YC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 99 6787777764 4678999999999999999999999999 99999999999999999999999999976433
Q ss_pred CCcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
..+++|||.|||||++. .+.|+-++||||||++-.||.-.++|+.+.+.......+. ..
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-------------QN 240 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------------QN 240 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-------------hc
Confidence 56789999999999986 4789999999999999999999999987765322211111 11
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..|.+. ..+++..+++++..||+.-|.+|||.+++++.
T Consensus 241 esPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 241 ESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 222222 45778899999999999999999999999873
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=324.97 Aligned_cols=266 Identities=29% Similarity=0.428 Sum_probs=215.4
Q ss_pred ccHHHHHHHhcCCCCcccccccCceEEEEEEEcccCe---E-EEEEeecCC---CCccHHHHHHHHHHHhhccCCCccce
Q 036144 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQ---V-VAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNL 116 (336)
Q Consensus 44 ~~~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~---~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~ 116 (336)
...+.++-..++..+.++||+|+||.||+|..+..+. . ||+|..... ......++.+|+++|+.++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 3334445555677778999999999999999875422 3 899998752 24456779999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc
Q 036144 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN 196 (336)
Q Consensus 117 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~ 196 (336)
+|+.....-.++|||+|.||+|.++|.. ....++..+...++.+.+.||+|||+++ ++||||-..|+|++.++.
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGV 300 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCe
Confidence 9999999999999999999999999987 3347999999999999999999999999 999999999999999999
Q ss_pred eEEccccccccCCCCCCcceee-eeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 036144 197 PKLSDFGLAKLGPTGGKDHVST-RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 274 (336)
+||+|||+++... ...... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....+....+.
T Consensus 301 vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~- 376 (474)
T KOG0194|consen 301 VKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV- 376 (474)
T ss_pred EEeCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-
Confidence 9999999987542 111111 1234578999999999999999999999999999999 788988766443222221
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
. ...+...+...+..+..++..||..+|++|||+.++.+.|+.+.
T Consensus 377 -----~----------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 377 -----K----------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred -----h----------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 1 11122334455678899999999999999999999999998764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=307.99 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=204.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|.+.+.||+|+||.||+|.+..+++.||+|.++.........+.+|+.+++.++||||+++++++......++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46888889999999999999999999999999987655444566788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 99999998864 456899999999999999999999998 999999999999999999999999998654321
Q ss_pred cceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 214 DHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
........|+..|+|||.+. ...++.++|+|||||++|+|++|..||....+........ .. ....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~------~~-----~~~~ 228 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT------KS-----NFQP 228 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh------cc-----CCCC
Confidence 12233457899999999874 4568899999999999999999999986544321110000 00 0000
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+.... ....+..+.+++.+||+.+|++|||++++++
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 0123457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=309.65 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=206.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|++.+.||.|+||.||+|.+..++..+|+|.+..........+..|+.+++.++||||+++++++......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56899999999999999999998889999999987655555567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 156 (280)
T cd06611 85 DGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-- 156 (280)
T ss_pred CCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc--
Confidence 99999998865 2356899999999999999999999998 999999999999999999999999998654322
Q ss_pred cceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 214 DHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
........|++.|+|||.+. ...++.++|+||||+++|+|++|..||......... . .....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~~~------- 223 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--L----KILKS------- 223 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--H----HHhcC-------
Confidence 12234457899999999875 345788999999999999999999999765432111 0 11100
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..+.+ ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 224 EPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00000 1122345578999999999999999999999863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.61 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=203.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.+.. +..+|+|.+..... ..+.+.+|+.+++.++|+|++++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3578999999999999999998764 56799999865433 3567899999999999999999999875 4567899999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999998652 2345889999999999999999999998 9999999999999999999999999997643322
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+. ... . ...
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~---~-~~~--------- 219 (260)
T cd05070 157 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQ---V-ERG--------- 219 (260)
T ss_pred c-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH---H-HcC---------
Confidence 1 11122335668999999988899999999999999999999 8899976432211 111 1 000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
.....+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112233445689999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=306.78 Aligned_cols=257 Identities=25% Similarity=0.451 Sum_probs=205.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe---EEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ---VVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
++|...+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+..|+++++.++|||++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999999875554 79999986543 23345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999865 2356889999999999999999999998 9999999999999999999999999987653
Q ss_pred CCCCccee-eeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 210 TGGKDHVS-TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 210 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
........ .....+..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .. . +....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~---~~---~-i~~~~---- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV---MK---A-INDGF---- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HH---H-HhcCC----
Confidence 32211111 11223457999999988889999999999999999997 9999965443211 11 1 11100
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 228 ------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=340.66 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=204.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.++||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 579999999999999999999999999999999875422 22356889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 131 EFMSNGSLENHFLDLPP-------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
||++||+|.+++..... ....++...++.++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 1234566778899999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCC----------------cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 036144 204 LAKLGPTGGK----------------DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267 (336)
Q Consensus 204 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 267 (336)
++........ .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9975421100 001123569999999999999999999999999999999999999997633211
Q ss_pred cccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcc
Q 036144 268 EQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-FMVDVVTALEYL 333 (336)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~evl~~L~~i 333 (336)
.. ... .. ..+... ......+..+.+++.+||+.||++|| +++++++.|+..
T Consensus 239 i~----~~~-~i---------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 IS----YRD-VI---------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred hh----hhh-hc---------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 10 000 00 000000 00123445788999999999999996 566677766653
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=307.05 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=215.0
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
-|.+.++||+|+||.||+|.|+.+|+.+|+|.+... .+.+++..|+.+|++++.|++|++|+.+.....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 367778899999999999999999999999997543 356889999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
-|++.+.++. .++++++..+..++...++||+|||... -+|||||..|||++.+|..||+|||.+-.+.+. -
T Consensus 112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--M 183 (502)
T KOG0574|consen 112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--M 183 (502)
T ss_pred CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--H
Confidence 9999999876 5788999999999999999999999998 899999999999999999999999999765332 2
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (336)
....+..|||-|||||++..-.|+.++||||||++..||..|++||.+-.+......+. ..+...
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---------------T~PPPT 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---------------TKPPPT 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---------------CCCCCC
Confidence 23566889999999999999999999999999999999999999998866543322221 011111
Q ss_pred CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 295 GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 295 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
-.-|..++..+.++++.||..+|++|.|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12255678899999999999999999999988874
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=310.17 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=208.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..+|.+.+.||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++|+||+++++++......++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999999989999999998765555556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998854 45788899999999999999999998 9999999999999999999999999987543221
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+........ ....
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~---------------~~~~ 232 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---------------TNGT 232 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec---------------cCCC
Confidence 12234568999999999998889999999999999999999999997654322110000 0000
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001122334567889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=332.44 Aligned_cols=263 Identities=20% Similarity=0.258 Sum_probs=195.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC------CCccceEEEEEeC-C
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH------QNLVNLIGYCADG-D 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~~-~ 124 (336)
...+|.+.+.||+|+||.||+|.+..+++.||||+++... ........|+.+++.++| .+++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 4578999999999999999999999999999999986432 223445667777777654 4588888888764 5
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCC--------
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEF-------- 195 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~-------- 195 (336)
..++||+++ +++|.+++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred eEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 788999988 8889888864 3568999999999999999999997 47 99999999999998765
Q ss_pred --------ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 036144 196 --------NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267 (336)
Q Consensus 196 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 267 (336)
.+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999875421 12345689999999999999999999999999999999999999998765433
Q ss_pred cccHHHHHH-----------------HHhhcccccccccCCc-----cC-CCC-cHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 268 EQNLVTWAK-----------------PLLRDKKKFTMMADPL-----LE-GQY-PRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 268 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~-----~~-~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
....+.... .++..........++. .. ... .......+.+||.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 222211100 0000000000000000 00 000 00123468899999999999999999
Q ss_pred HHHHH
Q 036144 324 VDVVT 328 (336)
Q Consensus 324 ~evl~ 328 (336)
+|+|+
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99986
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=306.15 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=205.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccC---eEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVD---QVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999986443 4799999865432 2345788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++... ...+++.....++.|++.||.+||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998652 346888999999999999999999998 9999999999999999999999999997654
Q ss_pred CCCCcce-eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 210 TGGKDHV-STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 210 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
....... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||......+. ... . .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~---~-~~~~~--- 227 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKA---I-EEGYR--- 227 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHH---H-hCCCc---
Confidence 3221111 111223568999999998899999999999999999886 9999976543221 111 1 01000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011223455789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=310.22 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=207.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
.+|++.+.||.|++|.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46899999999999999999999999999999987655555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++++|..++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~- 169 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ- 169 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccc-
Confidence 99999998854 35889999999999999999999998 9999999999999999999999999987543221
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
.......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+....... .... . +
T Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~------~~~~--~-----~-- 233 (296)
T cd06655 170 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG--T-----P-- 233 (296)
T ss_pred -ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcC--C-----c--
Confidence 1223356899999999998888999999999999999999999999775532211110 0000 0 0
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....+...+..+.+++.+||..||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00112234557889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=302.45 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=201.0
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
++||.|+||.||+|.+.. ++.||+|.+...... ....+.+|+.+++.++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999999988 899999998765433 446788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++.. ....++...+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++.............
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999865 2346788899999999999999999998 9999999999999999999999999987543221111112
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCC
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQY 297 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (336)
...++..|+|||.+.++.++.++|+||||+++|+|++ |..||...........+. .. .....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-------~~----------~~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SG----------YRMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-------cC----------CCCCC
Confidence 2234667999999988899999999999999999999 888887654322111110 00 01112
Q ss_pred cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 298 PRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 298 ~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
+...+..+.+++.+||+.+|.+|||+.++++.|+.
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 23345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=309.48 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=208.5
Q ss_pred HhcCCCCcccccccCceEEEEEEEcc----cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEe-CCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEA----VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCAD-GDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 125 (336)
..++|.+.+.||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35679999999999999999999876 358899998865432 234568899999999999999999998765 467
Q ss_pred EEEEEEcCCCCChhhhhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPD----QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSD 201 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~D 201 (336)
.+++++|+.+++|.+++...... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998764322 156899999999999999999999988 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhh
Q 036144 202 FGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLR 280 (336)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 280 (336)
||+++.+.............++..|+|||.+.+..++.++|||||||++|++++ |..||...++.+. ..+ +.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAY----LK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHH----HH
Confidence 999975433222112223446778999999988899999999999999999998 9999976543221 111 11
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 281 DKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+... ..+...+..+.+++.+||..||++|||+.++++.|+.+.
T Consensus 234 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 234 DGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred cCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11000 011123457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=303.11 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=196.7
Q ss_pred cccccCceEEEEEEE--cccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCC
Q 036144 61 LVGEGGYGRVYKGYI--EAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNG 136 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 136 (336)
.||+|+||.||+|.+ ..++..+|+|++..... ...+.+.+|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 45678999999864432 23456889999999999999999999875 45678999999999
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcce
Q 036144 137 SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV 216 (336)
Q Consensus 137 ~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 216 (336)
+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||.||+++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999864 346889999999999999999999998 99999999999999999999999999976533221111
Q ss_pred -eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC
Q 036144 217 -STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294 (336)
Q Consensus 217 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (336)
.....++..|+|||.+....++.++|+|||||++|||++ |..||......+....+ .... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-------~~~~----------~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-------ESGE----------R 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HCCC----------C
Confidence 122234578999999988889999999999999999998 99999765432211111 1110 1
Q ss_pred CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 295 GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 295 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
...+...+..+.+++.+||+.||++||++.+|.+.|+.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11233455689999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=310.44 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=205.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3578999999999999999998753 578999999875432 2345688999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 036144 127 ILVYEFMSNGSLENHFLDLP------------------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASN 188 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~------------------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~N 188 (336)
+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986421 11234788889999999999999999988 9999999999
Q ss_pred eEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcc
Q 036144 189 ILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSE 267 (336)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~ 267 (336)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432211111222335667999999988899999999999999999997 888886543322
Q ss_pred cccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 268 EQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
. .. . +.... . ...+...+..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus 241 ~---~~---~-~~~~~-~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 V---IY---Y-VRDGN-V---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H---HH---H-HhcCC-C---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 11 1 11110 0 01122345689999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=303.27 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=199.2
Q ss_pred ccccccCceEEEEEEEcccC---eEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVD---QVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+...+ ..+|+|.+..... ...+.+.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36999999999999876544 7899999875543 23457889999999999999999999876 4567999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999865 236889999999999999999999998 9999999999999999999999999987653322211
Q ss_pred e-eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 216 V-STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 216 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+ ...... ...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~~----~~~---------- 215 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAMLE----SGE---------- 215 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH----cCC----------
Confidence 1 111223567999999998899999999999999999998 999997654321 111111 100
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01122334568899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=311.89 Aligned_cols=267 Identities=22% Similarity=0.310 Sum_probs=203.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|.+.+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 367999999999999999999999999999999986543 2233467789999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 995 689888765 2456888999999999999999999998 999999999999999999999999998753322
Q ss_pred CCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHHhhcc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------KPLLRDK 282 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 282 (336)
. .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+....+... ++.....
T Consensus 158 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 T--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred C--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 1 112334578999999988654 5789999999999999999999999865533221111100 0000000
Q ss_pred cccccccCCccCCC----CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQ----YPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........+..... .....+..+.+||.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000111000 11123557899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=303.44 Aligned_cols=251 Identities=27% Similarity=0.433 Sum_probs=206.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||.|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457899999999999999999886 78899999876543 456789999999999999999999999989999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~- 155 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG- 155 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence 9999999998652 2346899999999999999999999998 999999999999999999999999999764221
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
.....++..|+|||.+....++.++||||||+++|+|++ |..||......+..... ...
T Consensus 156 ----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~--------- 215 (256)
T cd05039 156 ----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV-------EKG--------- 215 (256)
T ss_pred ----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------hcC---------
Confidence 112334667999999988889999999999999999997 99998755332211111 000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00112233456899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=313.14 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=205.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcc-------cCeEEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA-------VDQVVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADG 123 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 123 (336)
.++|.+.+.||+|+||.||+|.+.. ....+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4678899999999999999998632 34579999886542 23345688999999999 599999999999998
Q ss_pred CeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
...+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 899999999999999999865321 1245888899999999999999999988 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQN 270 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~ 270 (336)
+.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999975432211111122234567999999998899999999999999999999 888886544322111
Q ss_pred HHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.. ..... ...+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 248 ~~-------~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 248 LL-------REGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred HH-------HcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 11100 0122334557889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=321.19 Aligned_cols=264 Identities=21% Similarity=0.213 Sum_probs=202.0
Q ss_pred hcCCCCcccccccCceEEEEEEEc--ccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..+|.+.+.||+|+||.||++... .++..||+|.+... ....+|+.+++.++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999764 35678999987543 23468999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|++ +++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 166 e~~-~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKY-KCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999 5788888733 467899999999999999999999998 99999999999999999999999999976544
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc-cccccc--
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD-KKKFTM-- 287 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-- 287 (336)
...........||+.|+|||++.+..++.++|||||||++|+|++|..||..................+.. ...+..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 33333334567999999999999999999999999999999999999999765543211111111000000 000000
Q ss_pred ---------ccCCccCCCC--c-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 288 ---------MADPLLEGQY--P-----RKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 288 ---------~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.........+ + ...+..+.++|.+||..||++|||+.+++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0 1234578899999999999999999999863
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=321.22 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=200.7
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeC------
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------ 123 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 123 (336)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999999999999999986532 23345678999999999999999999987543
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
...++||||++ ++|.+++.. .++...+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999995 577776632 4778889999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH---------
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW--------- 274 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~--------- 274 (336)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..
T Consensus 172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99754321 123345789999999999999999999999999999999999999976543222111100
Q ss_pred ---H----HHHhhccccc-----ccccCCcc---CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 275 ---A----KPLLRDKKKF-----TMMADPLL---EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 275 ---~----~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. .......... ........ ........+..+.+++.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0000000000 00000000 01111123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=303.83 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=205.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.++||+|+||.||+|.... ++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4679999999999999999998765 6789999986543 33567889999999999999999999874 4568999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+.+++|.+++... ....+++.....++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999988652 3456888999999999999999999988 9999999999999999999999999987653221
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..... ...
T Consensus 157 -~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~--------- 219 (260)
T cd05067 157 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-------ERG--------- 219 (260)
T ss_pred -cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-------HcC---------
Confidence 111223346778999999988899999999999999999998 99999765432211110 000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+++.+||+.+|++|||+++++..|+.+
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 220 -YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 00011223445799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=302.53 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=197.7
Q ss_pred cccccCceEEEEEEEc--ccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 61 LVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
.||+|+||.||+|.+. ..+..||+|++...... ..+.+.+|+.+++.++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999875 44567999998655332 2356889999999999999999999875 456889999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcce-
Q 036144 138 LENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV- 216 (336)
Q Consensus 138 L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~- 216 (336)
|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...........
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9998864 2457899999999999999999999998 99999999999999999999999999875433221111
Q ss_pred eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....+ ... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~----------~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-------EQG----------KRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-------HCC----------CCC
Confidence 111223578999999988889999999999999999996 99999765432211111 111 011
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.++...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22334566899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.97 Aligned_cols=263 Identities=27% Similarity=0.359 Sum_probs=202.8
Q ss_pred hcCCCCcccccccCceEEEEEEE-----cccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeC-C
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADG-D 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~ 124 (336)
.++|++.+.||+|+||.||+|.+ ..+++.||||.++.... .....+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36799999999999999999985 34578899999875432 2345688999999999 689999999987654 4
Q ss_pred eEEEEEEcCCCCChhhhhccCCC---------------------------------------------------------
Q 036144 125 QRILVYEFMSNGSLENHFLDLPP--------------------------------------------------------- 147 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 147 (336)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999998864211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeec
Q 036144 148 ------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM 221 (336)
Q Consensus 148 ------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 221 (336)
....+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0134678888999999999999999998 9999999999999999999999999987643222111222234
Q ss_pred cCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHH
Q 036144 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRK 300 (336)
Q Consensus 222 gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (336)
++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ... ....+.. ...+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~----------~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTR----------MRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----HHhccCC----------CCCCCC
Confidence 5678999999988899999999999999999997 8899875432211 110 1111100 011112
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 301 GLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 301 ~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+..+.+++..||+.||++|||+.++++.|+.+.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 3457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=303.46 Aligned_cols=250 Identities=24% Similarity=0.409 Sum_probs=203.6
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc---------HHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG---------SREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
+|.+...||+|++|.||+|.+..++..+|+|.+....... .+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788889999999999999998889999999886543221 1457789999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999865 356888899999999999999999988 999999999999999999999999998
Q ss_pred ccCCCCCC----cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 206 KLGPTGGK----DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 206 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
........ ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ +. ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~---~~~-- 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---IF---KIG-- 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---HH---HHh--
Confidence 76542111 1112234688999999999888899999999999999999999999976432111 00 000
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .....+...+..+.+++.+||+.||.+||++.++++
T Consensus 226 -----~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 -----EN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----cc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 111223345568999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=301.92 Aligned_cols=250 Identities=28% Similarity=0.376 Sum_probs=207.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|++.+.||+|+||.||+|.+..++..+++|.+..... ...+.+|+.+++.++||||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999999998899999999865432 578899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
.+++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~- 153 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM- 153 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCc-
Confidence 99999999864 3467899999999999999999999998 9999999999999999999999999987654322
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||............ .. ....
T Consensus 154 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------~~--------~~~~ 217 (256)
T cd06612 154 -AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------PN--------KPPP 217 (256)
T ss_pred -cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------cc--------CCCC
Confidence 1233455889999999998889999999999999999999999999764432211000 00 0000
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....+...+..+.+++.+||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11122344567999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=317.78 Aligned_cols=263 Identities=24% Similarity=0.352 Sum_probs=199.1
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeC-----
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADG----- 123 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 123 (336)
...++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345789999999999999999999999999999999865322 2335577899999999999999999887533
Q ss_pred -CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 124 -DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 124 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 8899887743 46899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK----- 276 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----- 276 (336)
|++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.........
T Consensus 163 g~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 163 GLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred ccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99975432 1234578999999999877 578999999999999999999999997654322111100000
Q ss_pred HH---hhcc------cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 277 PL---LRDK------KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 277 ~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. +... ..........+. ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000 000000000000 000112346789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=308.86 Aligned_cols=264 Identities=27% Similarity=0.352 Sum_probs=207.5
Q ss_pred HHHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEE---
Q 036144 46 YQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCA--- 121 (336)
Q Consensus 46 ~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~--- 121 (336)
++.+....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455567789999999999999999999999999999999876432 2245678899999998 6999999999874
Q ss_pred --eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 122 --DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 122 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
.+...++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 345789999999999999987654344567889999999999999999999988 999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-----GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 274 (336)
+|||++...... ........|++.|+|||.+.. ..++.++||||+||++|+|++|..||......... ..
T Consensus 166 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~- 240 (286)
T cd06638 166 VDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK- 240 (286)
T ss_pred ccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh-
Confidence 999998764322 112334568999999998753 45789999999999999999999999765432110 00
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
.... ..+. ...+...+..+.+++.+||+.||++|||+.|+++.+
T Consensus 241 ----~~~~------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 241 ----IPRN------PPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ----cccc------CCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0000 0000 011122345789999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=313.65 Aligned_cols=264 Identities=19% Similarity=0.226 Sum_probs=197.6
Q ss_pred Cccccccc--CceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 58 PDCLVGEG--GYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 58 ~~~~ig~G--~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
+.++||+| +|++||++.++.+|+.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 78999999999999999999986542 222356778999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998652 2345889999999999999999999998 99999999999999999999999987543221111
Q ss_pred c-----ceeeeeccCccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh------
Q 036144 214 D-----HVSTRVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLR------ 280 (336)
Q Consensus 214 ~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 280 (336)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|..||......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCcccccccc
Confidence 0 01122356778999999876 46899999999999999999999999764322110 000000000
Q ss_pred ---cc------------------cc---cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 281 ---DK------------------KK---FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 281 ---~~------------------~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .. ............+....+..+.+++.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 00 00000000001122234568999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=305.75 Aligned_cols=253 Identities=27% Similarity=0.358 Sum_probs=201.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeC------C
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADG------D 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~------~ 124 (336)
....|.+.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999999999999999986543 3346788999999988 699999999998753 4
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..+++|||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 678999999999999998752 2356889999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
+...... ........|+..|+|||++. +..++.++|+|||||++|+|++|..||....+.......
T Consensus 158 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------- 228 (272)
T cd06637 158 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------- 228 (272)
T ss_pred ceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------
Confidence 8754322 11234467899999999886 346888999999999999999999999754322111100
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ... ........+..+.+|+.+||+.+|.+|||+.++++
T Consensus 229 ~~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PR-NPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hc-CCC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 000 00111234457899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=326.63 Aligned_cols=252 Identities=22% Similarity=0.354 Sum_probs=213.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
+-|.++..||.|+||.||+|.++.++-..|.|++.-.+.....++.-|+.||..++||+||++++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44778888999999999999999999999999998777777888999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
.||-++..+.. -...+.+.++..++.|++.||.|||+++ |||||||..|||++-+|.++|+|||++.... ..
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--ST 183 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hH
Confidence 99999998876 4578999999999999999999999999 9999999999999999999999999986532 22
Q ss_pred cceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 214 DHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.....+++|||+|||||+.. ..+|+.++||||||++|.||..+.+|-...++... ++... .-
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKia-----------KS 250 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIA-----------KS 250 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHh-----------hc
Confidence 34467799999999999875 46899999999999999999999998766543221 11100 00
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..|.+ --|..++..+.+++.+||..||..||+++++++
T Consensus 251 ePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 01111 125677889999999999999999999999986
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=304.92 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=205.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999999999999999986543 33345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ..+++..++.++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999864 27899999999999999999999988 9999999999999999999999999997654321
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..||....+......+ ... ..+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~-------~~~------~~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-------PKN------NPPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-------hhc------CCCC
Confidence 2233456889999999999888999999999999999999999999765422111000 000 0111
Q ss_pred cCCCCcHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRK-GLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+.. .+..+.+++.+||..+|++|||++++++
T Consensus 218 ----~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 ----LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ----CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 4557899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=304.44 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=197.6
Q ss_pred cccccCceEEEEEEEcccCe--EEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEEcCCCC
Q 036144 61 LVGEGGYGRVYKGYIEAVDQ--VVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYEFMSNG 136 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g 136 (336)
.||+|+||.||+|.+..++. .+++|.+.... ....+.+.+|+.+++.+ +||||+++++++......++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 59999999999999987765 46888876432 23345788999999999 7999999999999999999999999999
Q ss_pred ChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 137 SLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 137 ~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 99999865321 1235788999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
+..... .........+..|+|||++....++.++|||||||++|+|++ |..||......+. .. .. ...
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~---~~-~~~- 227 (270)
T cd05047 159 SRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE---KL-PQG- 227 (270)
T ss_pred ccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---HH---HH-hCC-
Confidence 853211 111111234567999999988889999999999999999997 9999965432111 11 11 000
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.+|.+|||+.++++.|+.|.
T Consensus 228 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 ---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000112234457899999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=302.09 Aligned_cols=249 Identities=26% Similarity=0.383 Sum_probs=201.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEE-eCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA-DGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 132 (336)
.+|.+.+.||+|+||.||++... |..+|+|.+.... ..+.+.+|+.+++.++|+|++++++++. .....+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 57899999999999999999876 6789999986432 3457889999999999999999999764 55678999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 9999999998752 2345888999999999999999999998 999999999999999999999999998753221
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||......+. .. .+..+
T Consensus 156 ----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~----~~~~~--------- 215 (256)
T cd05082 156 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----RVEKG--------- 215 (256)
T ss_pred ----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHhcC---------
Confidence 122345668999999988899999999999999999997 9999875432111 11 11111
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.|
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 -YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01112233456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=307.26 Aligned_cols=267 Identities=22% Similarity=0.274 Sum_probs=201.7
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|.+.+.||+|++|.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 47888999999999999999998999999999865422 2235678999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+. ++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 96 68888876533 2356899999999999999999999998 999999999999999999999999998754322
Q ss_pred CcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHH-HHH----HHHhhcc---c
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWA----KPLLRDK---K 283 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-~~~----~~~~~~~---~ 283 (336)
........+++.|+|||.+.+. .++.++|||||||++|+|++|++||............ ... ...+... .
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 155 -VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1122334678999999988654 5789999999999999999999999764432111000 000 0000000 0
Q ss_pred ccccccCCccC---CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLE---GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........... .......+..+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0011124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=316.47 Aligned_cols=255 Identities=19% Similarity=0.235 Sum_probs=200.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||++.+..+++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999999999999999986421 222345778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999875 2356888999999999999999999998 99999999999999999999999999875433
Q ss_pred CCCcceeeeeccCccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMT-----GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
.. ........||+.|+|||++.+ +.++.++|||||||++|+|++|..||......+.. ..+.......
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~~ 227 (331)
T cd05624 155 DG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHEERF 227 (331)
T ss_pred CC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHcCCCcc
Confidence 21 112234579999999998875 46889999999999999999999999764432111 1111100000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADS--RPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~ 328 (336)
.+. ......+..+.+++.+||..++.+ |++++++++
T Consensus 228 ------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 ------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 000 111234568999999999876554 467888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=316.57 Aligned_cols=256 Identities=21% Similarity=0.247 Sum_probs=200.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||++.++.+++.+|+|++.+.. ......+.+|+.++..++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999999999999999986421 222345778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999865 2356889999999999999999999998 99999999999999999999999999865422
Q ss_pred CCCcceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
.. ........||+.|+|||++. ...++.++|||||||++|+|++|..||......+... .+.......
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~ 227 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKERF 227 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HHhCCCccc
Confidence 21 12233457999999999886 3468899999999999999999999997654322111 111100000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADS--RPFMVDVVTA 329 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~~ 329 (336)
... ......+..+.+++.+||..++.+ |++++++++.
T Consensus 228 ------~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ------QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000 111234568899999998665444 6889988764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=305.94 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=205.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe----EEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ----VVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.+|++.+.||+|+||.||+|.++.+|. .+|+|.+..... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568889999999999999999876654 589998865543 234568899999999999999999999887 78899
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 86 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999865 2345899999999999999999999988 999999999999999999999999999765
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.............++..|+|||.+....++.++|+||||+++|++++ |..||......+....+ ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~---- 228 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-------EKGE---- 228 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------hCCC----
Confidence 43322211222234568999999988899999999999999999998 99999765432211111 1100
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+++.+||..+|..|||+.++++.|+.+
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111222345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=307.37 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=203.5
Q ss_pred CCCCcccccccCceEEEEEEE----cccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYI----EAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRI 127 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 127 (336)
.|.+.+.||+|+||.||++.. ..++..||+|.+.... ......+.+|+.+++.++|||++++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478889999999999999984 4568899999986543 23345788999999999999999999998775 5688
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998652 345899999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc--------cccHHHHHHHH
Q 036144 208 GPTGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE--------EQNLVTWAKPL 278 (336)
Q Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~ 278 (336)
....... .......++..|+|||.+.+..++.++|||||||++|+|+++..|+....... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 5332211 11223557778999999988899999999999999999999876643321100 00000000011
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
..... ....+...+..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus 239 ~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11100 0111223456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=300.52 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=200.7
Q ss_pred ccccccCceEEEEEEEcc-cC--eEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEA-VD--QVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|++|.||+|.+.. .+ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999865 23 3699999877655 445678899999999999999999999988 889999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999876322 56899999999999999999999998 9999999999999999999999999997654322111
Q ss_pred -eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 216 -VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 216 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .... .... ..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~---~~~~---~~------ 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKI---DKEG---ER------ 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---HhcC---Cc------
Confidence 1223457788999999988899999999999999999998 9999975443221 1111 0000 00
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111233457999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=306.86 Aligned_cols=265 Identities=27% Similarity=0.406 Sum_probs=207.5
Q ss_pred cCCCCcccccccCceEEEEEEEc----ccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEe--CCeE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIE----AVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQR 126 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 126 (336)
..|.+.+.||+|+||.||+|.+. .++..+|+|.+...... ....+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46788889999999999999864 34789999998765443 35678999999999999999999999877 5678
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999998752 336899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCcce-eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc--------cHHHHHHH
Q 036144 207 LGPTGGKDHV-STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ--------NLVTWAKP 277 (336)
Q Consensus 207 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~ 277 (336)
.......... .....++..|+|||.+.+..++.++||||||+++++|++|..|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 6542221111 11234556799999998889999999999999999999999998654322110 00111111
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..... .....+...+..+.+++.+||+.+|.+|||+.++++.|+.|.
T Consensus 238 ~~~~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEG----------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcC----------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11111 011112234467999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.46 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=206.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45778889999999999999999889999999986543 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998854 45888899999999999999999988 9999999999999999999999999987543321
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+....... ...
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----------------~~~ 216 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-----------------PKN 216 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-----------------hcC
Confidence 1233356888999999998888999999999999999999999999765432211000 000
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.....+...+..+.+++.+||+.+|++||++.+++..
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1112334566789999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=301.23 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=203.8
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe-CCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD-GDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 131 (336)
+|++.+.||+|++|.||++.++.+++.||+|.+.... ....+.+.+|+.+++.++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999999889999999986533 2334568889999999999999999998764 446789999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++... ....+++.+++.++.+++.||.+||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998752 2456899999999999999999999998 999999999999999999999999998765322
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
........|++.|+|||++.+..++.++|+||||+++++|++|..||...+.... ....... ..
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~~--~~------ 219 (257)
T cd08223 156 --CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRIIEG--KL------ 219 (257)
T ss_pred --CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHhc--CC------
Confidence 1223445689999999999999999999999999999999999999875432111 1111100 00
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+...+..+.+++.+||+.+|++|||+.++++
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1123345568999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=300.76 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=207.9
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|++.+.||.|+||.||.+.+..+++.+++|.+.... ......+.+|+.+++.++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999999999999999876542 33446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999987532 456889999999999999999999998 9999999999999999999999999987653322
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.. ...... .. .
T Consensus 156 --~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~~~--~~----~-- 219 (256)
T cd08221 156 --SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKIVQG--NY----T-- 219 (256)
T ss_pred --ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHcC--CC----C--
Confidence 1234456899999999998888999999999999999999999999764432211 111110 00 0
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
..+...+..+.+++.+||+.+|.+||++.++++.+
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11133456799999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=312.96 Aligned_cols=262 Identities=26% Similarity=0.381 Sum_probs=205.8
Q ss_pred hcCCCCcccccccCceEEEEEEEccc-------CeEEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAV-------DQVVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADG 123 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 123 (336)
..+|.+.+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 35689999999999999999986432 2368999876432 22346788999999999 799999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
...+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 999999999999999999875321 2345788889999999999999999998 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQN 270 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~ 270 (336)
+.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~- 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF- 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH-
Confidence 9999999999999875433221111222334567999999999999999999999999999998 88888654322211
Q ss_pred HHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
... ... .....+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 247 -----~~~-~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 247 -----KLL-KEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -----HHH-HcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111 110 001112234557899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=300.11 Aligned_cols=255 Identities=25% Similarity=0.329 Sum_probs=193.7
Q ss_pred cccccCceEEEEEEEc--ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 61 LVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5999999999999864 3457799998865432 223468889999999999999999999999889999999999999
Q ss_pred hhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcce
Q 036144 138 LENHFLDLPP-DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV 216 (336)
Q Consensus 138 L~~~l~~~~~-~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 216 (336)
|.+++..... .....++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999875322 2234567778889999999999999998 99999999999999999999999999865332221122
Q ss_pred eeeeccCccccCccccccC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 217 STRVMGTYGYCAPEYAMTG-------QLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 217 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.....++..|+|||++.+. .++.++|+||||+++|+|++ |..||......+..... .. ......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~------~~--~~~~~~ 230 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT------VR--EQQLKL 230 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH------hh--cccCCC
Confidence 2335578889999988642 35789999999999999996 99999765432211110 00 011111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
..+.+. ...+..+.+++..|+ .+|++|||+.+|++.|+
T Consensus 231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 122211 123446888999998 68999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=300.29 Aligned_cols=253 Identities=28% Similarity=0.425 Sum_probs=202.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|.+...||+|++|.||+|.+..+ ..+|+|.+.... ...+.+.+|+.+++.++|+|++++++++. ....+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 5688999999999999999998765 468999876443 33467889999999999999999999875 45678999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999998752 2345788899999999999999999988 99999999999999999999999999976533221
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......++..|+|||...+..++.++||||||+++|+|++ |..||......+. ... ....
T Consensus 158 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~~---------- 219 (260)
T cd05069 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ----VERG---------- 219 (260)
T ss_pred -cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcC----------
Confidence 11222346678999999988899999999999999999999 8999876443211 111 0000
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
.....+...+..+.+++.+||..||++||+++++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011223445689999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=300.86 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=206.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|.+.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4789999999999999999999865 5779999987543 3456789999999999999999999999988899999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++... ....+++..+..++.+++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999998762 2346899999999999999999999998 9999999999999999999999999987643211
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||....... .... ... ..
T Consensus 158 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~---~~~---~~------ 221 (261)
T cd05034 158 -YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ---VER---GY------ 221 (261)
T ss_pred -hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH---HHc---CC------
Confidence 111122334668999999998899999999999999999998 999996543211 1111 000 00
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 --RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001112235579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.37 Aligned_cols=241 Identities=25% Similarity=0.402 Sum_probs=192.6
Q ss_pred ccccccCceEEEEEEEcccCeE-------EEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQV-------VAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~-------vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+.||.|+||.||+|.+...+.. +|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 3699999999999998665443 888887655444456788999999999999999999999998999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc--------eEEccccc
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN--------PKLSDFGL 204 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~--------~kl~Dfg~ 204 (336)
+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998752 346888999999999999999999998 999999999999987765 69999998
Q ss_pred cccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCC-CCCCCCCCcccccHHHHHHHHhhcc
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGR-SAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
+..... .....++..|+|||++.+ ..++.++||||||+++|+|++|. .||.......... ....
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~- 220 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED- 220 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc-
Confidence 864322 223568889999999876 45899999999999999999995 5555433211100 0100
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
...++...+..+.+++.+||+.||++|||++++++.|+
T Consensus 221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01122233457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=308.96 Aligned_cols=257 Identities=27% Similarity=0.426 Sum_probs=203.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe----EEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ----VVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
++|+..+.||+|+||.||+|.+..+|. .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 568888999999999999999877665 578898765432 2234678899999999999999999998754 4679
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
++||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999865 2346888999999999999999999988 999999999999999999999999999765
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......... ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~-------~~~~~~~~-- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD-------LLEKGERL-- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHHCCCCC--
Confidence 43222112223345778999999998999999999999999999997 889987643222111 11111000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..+...+..+.+++..||..+|++||++.++++.|+.+.
T Consensus 231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=303.72 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=200.2
Q ss_pred cccccCceEEEEEEEcccC------eEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 61 LVGEGGYGRVYKGYIEAVD------QVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
.||+|+||.||+|.+.... ..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 5999999999999986543 689999876543 233567889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-----ceEEcccccc
Q 036144 134 SNGSLENHFLDLPP---DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-----NPKLSDFGLA 205 (336)
Q Consensus 134 ~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-----~~kl~Dfg~~ 205 (336)
++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999865322 2245788899999999999999999988 99999999999998877 8999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~~----~~~~- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQHV----TAGG- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHHH----hcCC-
Confidence 75433222222223456788999999999999999999999999999998 9999875432211 1110 0000
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111233456688999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=318.47 Aligned_cols=241 Identities=24% Similarity=0.298 Sum_probs=189.4
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhc---cCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLV---QHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
||+|+||.||+|.+..+++.||+|++..... ........|..++..+ .||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999864321 1223345566666654 699999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--~~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD--NK 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC--CC
Confidence 999988864 456899999999999999999999998 999999999999999999999999998653221 12
Q ss_pred eeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC
Q 036144 216 VSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (336)
.....+||+.|+|||++.+. .++.++|||||||++|+|++|..||......+... .+.... ..+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~------~i~~~~--------~~~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR------NIAFGK--------VRFP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH------HHHcCC--------CCCC
Confidence 23446799999999998764 58999999999999999999999997644322111 111000 0000
Q ss_pred CCCcHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHH
Q 036144 295 GQYPRKGLYQALAVAGMCLQEDADSRP----FMVDVVT 328 (336)
Q Consensus 295 ~~~~~~~~~~l~~li~~cl~~dp~~Rp----t~~evl~ 328 (336)
....+..+.+++.+||+.||.+|| ++.++++
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 012345788999999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=304.83 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=203.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|++.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46889999999999999999999899999999886532 22345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
+++++|..++.... ....+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999988876521 23478999999999999999999996 46 999999999999999999999999998654221
Q ss_pred CCcceeeeeccCccccCccccccC------CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTG------QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||............ ....
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~------ 223 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL---SAIV------ 223 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH---HHHh------
Confidence 22334688899999988543 3588999999999999999999999754321111110 0000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus 224 ----~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 ----DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 00 011233446678999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.04 Aligned_cols=199 Identities=27% Similarity=0.364 Sum_probs=162.1
Q ss_pred ccccccCceEEEEEEEc--ccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 135 (336)
.+||+|+||.||+|.++ .++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....+++|||+ +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~ 83 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-E 83 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-C
Confidence 57999999999999975 467899999986542 23457889999999999999999998854 45678999998 5
Q ss_pred CChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----CCCCceEEccccccc
Q 036144 136 GSLENHFLDLP-----PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL----DAEFNPKLSDFGLAK 206 (336)
Q Consensus 136 g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~----~~~~~~kl~Dfg~~~ 206 (336)
++|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 68887765321 12235889999999999999999999998 9999999999999 456789999999997
Q ss_pred cCCCCCCc-ceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 036144 207 LGPTGGKD-HVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSR 264 (336)
Q Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~ 264 (336)
........ .......||+.|+|||++.+. .++.++||||+||++|+|++|.+||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 65332211 122346789999999998774 68999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=304.93 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=207.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56888899999999999999999999999999886543 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
+++++|.+++.. .+.+++..+..++.+++.||.|||+ .+ ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999988764 3568999999999999999999997 46 999999999999999999999999998643221
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc-----ccHHHHHHHHhhcccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE-----QNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 286 (336)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||........ ..............
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 12345789999999999888999999999999999999999999986543211 11111111111110
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
.+.+ .....+..+.+++.+||+.||.+|||+.|+++....
T Consensus 230 ---~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 230 ---PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred ---CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0000 011245578999999999999999999999986433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=303.07 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=204.2
Q ss_pred hcCCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|.+.+.||+|+||.||+|.+... ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688889999999999999987543 3468999886544 2344578899999999999999999998875 45789
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++... ...+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999998652 345899999999999999999999988 999999999999999999999999998765
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.... ........++..|+|||.+....++.++||||||+++|+|++ |..||......+..... .....
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~~~--- 226 (270)
T cd05056 158 EDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-------ENGER--- 226 (270)
T ss_pred cccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HcCCc---
Confidence 3321 111222334568999999988889999999999999999986 99999765432211111 01000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
...+...+..+.+++.+|+..+|.+|||+.++++.|+.+.
T Consensus 227 -------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 227 -------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0122334568999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=296.97 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=197.6
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
++||+|+||.||+|... ++..+|+|.+...... ....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36999999999999875 4789999998654322 234678999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++.. ....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .....
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~ 152 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSG 152 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc-cccCC
Confidence 998864 2345789999999999999999999988 9999999999999999999999999986532211 11111
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCC
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQY 297 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (336)
...++..|+|||++.+..++.++||||||+++|+|++ |..||........... .... .....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-------~~~~----------~~~~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-------VEKG----------YRMSC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-------HHcC----------CCCCC
Confidence 2234667999999988889999999999999999998 9999976533211110 1010 01112
Q ss_pred cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 298 PRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 298 ~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2334568999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=301.04 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=206.4
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQRILVY 130 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 130 (336)
+|++.+.||.|+||.||+|.+..++..+|+|.+.... ....+.+..|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999999999999999986532 2234567889999999999999999998754 45678999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH-----DVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh-----~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
||+++++|.+++.........+++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998765445678999999999999999999999 666 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
....... .......+++.|+|||.+.+..++.++|+||||+++++|++|..||....... .... . ..
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~---~-~~---- 224 (265)
T cd08217 158 KILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK---I-KE---- 224 (265)
T ss_pred ccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH---H-hc----
Confidence 8654322 11334568999999999998889999999999999999999999998654211 1111 0 00
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....++...+..+.+++.+||+.+|.+|||+.+|++
T Consensus 225 ------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 225 ------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0011233445668999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=303.67 Aligned_cols=266 Identities=26% Similarity=0.323 Sum_probs=204.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|++.+.||+|+||.||+|.++.+++.||+|++..... ...+.+.+|+.+++.++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468899999999999999999998999999998864422 223567899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888777643 346899999999999999999999988 999999999999999999999999999765432
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH-HHH-------Hhhcc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW-AKP-------LLRDK 282 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~-------~~~~~ 282 (336)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......+....... ... .+...
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1233457889999998876 4688999999999999999999999986554322111110 000 00000
Q ss_pred cccccccCCccCCC-----CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQ-----YPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........+..... .....+..+.+++.+||+.+|++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000011110000 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=322.58 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=197.9
Q ss_pred CcccccccCceEEEEEEEcccCeEEEEEeecCC----CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCe--EEEEEE
Q 036144 58 PDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS----GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ--RILVYE 131 (336)
Q Consensus 58 ~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e 131 (336)
...+||+|+|-+||+|.+..+|..||--.++.. .....+.+..|+.+|+.|+||||+++++++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 445699999999999999999988886654321 23345789999999999999999999999987665 778999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-CceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~ 210 (336)
.+..|+|..|+.+ .+.++...+..|+.||++||.|||++. ++|+|||||.+||||+++ |.|||+|+|+|+....
T Consensus 124 L~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999876 466788899999999999999999975 899999999999999765 7899999999987533
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .....+|||.|||||+.. ..|+..+||||||++++||.|+.+||..+...... -+... .
T Consensus 199 s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI-----YKKV~----------S 258 (632)
T KOG0584|consen 199 S----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI-----YKKVT----------S 258 (632)
T ss_pred c----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH-----HHHHH----------c
Confidence 2 244478999999999765 89999999999999999999999999876532211 11111 1
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+..+..-....+.++|.+||.. .++|||+.|+|.
T Consensus 259 GiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 259 GIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1111122222234789999999999 999999999986
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=313.05 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=204.4
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 128 (336)
....|++++.||+|+.+.||++...+ .+.||+|.+... ......-+.+|+..|.+|+ |.+||.+++|-..+..+||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 34679999999999999999999876 456777765432 3334567999999999996 8999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||- .-+|..+|... ....+...+..++.|++.|+.++|..| |||.||||.|+|+- .|.+||+|||.|...
T Consensus 438 vmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred Eeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99976 66899988763 233444578889999999999999999 99999999999984 569999999999887
Q ss_pred CCCCCcceeeeeccCccccCccccccCC-----------CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQ-----------LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 277 (336)
............+||..||+||.+.... .++++||||||||||+|+.|++||.... +..
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~----- 579 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI----- 579 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH-----
Confidence 7777777778899999999999885322 4689999999999999999999997532 111
Q ss_pred HhhcccccccccCCccCCCCcHHHHH-HHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLY-QALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+..+.+|....+|+..... .+.+++..||..||++|||+.++|+
T Consensus 580 -----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 -----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 133444555444444443222 3999999999999999999999986
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=306.00 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=204.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999999999999999986532 223456889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.. ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999865 357899999999999999999999988 99999999999999999999999999876433
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.......... ..... .
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~--------~ 214 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYE------KILEG--------K 214 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHhcC--------C
Confidence 2 234568999999999988889999999999999999999999997654211100 00000 0
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+++.+||..||.+|+ +++|+++
T Consensus 215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 112233456889999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=299.50 Aligned_cols=254 Identities=22% Similarity=0.361 Sum_probs=205.4
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc------cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ------GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
+|+..+.||+|++|.||+|.+..+++.||+|++...... ..+.+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478888999999999999999999999999998653311 23568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEcccccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKL 207 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~ 207 (336)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999998864 356888999999999999999999998 99999999999998776 599999999876
Q ss_pred CCCCCC--cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 208 GPTGGK--DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 208 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
...... ........|+..|+|||.+.+..++.++|+||+|+++++|++|..||............. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~------- 223 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KI------- 223 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HH-------
Confidence 543211 111223568899999999988899999999999999999999999997543221111110 00
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.........+...+..+.+++.+||+.+|.+|||+.+++.
T Consensus 224 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ---ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0001112344456678999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=304.52 Aligned_cols=264 Identities=28% Similarity=0.354 Sum_probs=207.4
Q ss_pred ccHHHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEe
Q 036144 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCAD 122 (336)
Q Consensus 44 ~~~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 122 (336)
+...++....++|.+.+.||+|+||.||+|....+++.+|+|.+.... .....+.+|+.+++.+ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344555566788999999999999999999999999999999986542 2345677899999988 79999999999865
Q ss_pred C-----CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 123 G-----DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 123 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
. ...++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999988654444567899999999999999999999988 9999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-----QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV 272 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~ 272 (336)
+|+|||++....... .......|+..|+|||.+... .++.++|||||||++|+|++|..||........ ..
T Consensus 168 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 999999987543221 112335688999999987543 368999999999999999999999976543211 11
Q ss_pred HHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 273 TWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. .... ....+ ..+...+..+.+++.+||+.+|++||++.++++
T Consensus 244 ~----~~~~--~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 K----IPRN--PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred H----HhcC--CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 0000 00000 112233457999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=298.82 Aligned_cols=240 Identities=25% Similarity=0.385 Sum_probs=189.8
Q ss_pred cccccCceEEEEEEEcc------------cCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 61 LVGEGGYGRVYKGYIEA------------VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.||+|+||.||+|.... ....|++|.+..........+.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998642 233689998866554445678889999999999999999999999889999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc-------eEEcc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN-------PKLSD 201 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~-------~kl~D 201 (336)
||||+++++|..++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. ++++|
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 82 VEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 9999999999888754 2356899999999999999999999998 999999999999976654 89999
Q ss_pred ccccccCCCCCCcceeeeeccCccccCccccc-cCCCCCccchhhHHHHHHHHH-hCCCCCCCCCCcccccHHHHHHHHh
Q 036144 202 FGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-TGQLTKKSDVYSFGVVLLELI-TGRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
||++..... .....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+.. ...
T Consensus 156 ~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~ 222 (262)
T cd05077 156 PGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY 222 (262)
T ss_pred CCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH
Confidence 999864322 12345788899999886 467899999999999999998 588887654322111 001
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
... . . ........+.+|+.+||+.||.+||++.++++.|+
T Consensus 223 ~~~--~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQ--C-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcC--c-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 0 0 01112357889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=300.53 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=202.0
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc----------cHHHHHHHHHHHhhccCCCccceEEEEEeCC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ----------GSREFFAEVLMLSLVQHQNLVNLIGYCADGD 124 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 124 (336)
+|.+.+.||.|+||.||+|.+..+|+.+|+|.+...... ..+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 577888999999999999999988999999987532110 1235778999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999865 256888999999999999999999988 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ--LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
+................|+..|+|||.+.... ++.++|+||||+++|+|++|..||........ .. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~----~~~~-- 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MF----KLGN-- 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HH----Hhhc--
Confidence 97543322122233456889999999987654 88999999999999999999999964332111 00 0000
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .............+..+.+++.+||..+|.+|||+.++++
T Consensus 227 ~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 KR----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cc----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 0111111222234568999999999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=300.17 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=201.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.+++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 34455556899999999999999988999999998766555567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-CCceEEccccccccCC
Q 036144 133 MSNGSLENHFLDLPPDQEPL--DWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-EFNPKLSDFGLAKLGP 209 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~ 209 (336)
+++++|.+++... ...+ +...+..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++....
T Consensus 87 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 87 VPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred CCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999998752 2334 77888899999999999999988 999999999999976 6789999999987543
Q ss_pred CCCCcceeeeeccCccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTG--QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
... .......|++.|+|||.+.+. .++.++|+||||+++|+|++|..||........ ..+.....
T Consensus 161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~-------- 227 (268)
T cd06624 161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF-------- 227 (268)
T ss_pred cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh--------
Confidence 211 122334589999999988654 378999999999999999999999965432111 11100000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....++...+..+.+++.+||+.+|.+|||+.++++
T Consensus 228 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 ----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0111233445568999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=299.15 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=199.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-----ccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-----QGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQR 126 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 126 (336)
.+|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368899999999999999999999999999998864321 123457889999999999999999998875 3577
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
+++|||+++++|.+++.. ...+++...+.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999865 345788899999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCC-cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 207 LGPTGGK-DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 207 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
....... ........++..|+|||.+.+..++.++||||+||++|+|++|..||......... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~------ 222 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIA------ 222 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHh------
Confidence 5432111 11122345889999999999888999999999999999999999999754321110 0000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......++...+..+.+++ .||..+|++|||++|+++
T Consensus 223 ----~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 ----TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00011223344556777888 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=308.08 Aligned_cols=254 Identities=24% Similarity=0.283 Sum_probs=205.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+..|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688899999999999999999999999999998764322 3456889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999988652 2457899999999999999999999998 99999999999999999999999999865432
Q ss_pred CCCc---------------------------ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 036144 211 GGKD---------------------------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNS 263 (336)
Q Consensus 211 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 263 (336)
.... .......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111346889999999999888999999999999999999999999765
Q ss_pred CCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC----HHHHHH
Q 036144 264 RPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF----MVDVVT 328 (336)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt----~~evl~ 328 (336)
+..... . ..... ...-......+..+.+++.+||+.||++||| +++++.
T Consensus 236 ~~~~~~--~----~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETF--S----NILKK----------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHH--H----HHhcC----------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 432111 0 00100 0000001114668999999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=305.32 Aligned_cols=263 Identities=20% Similarity=0.250 Sum_probs=199.4
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 48888999999999999999999999999999865322 2234577899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+. ++|.+++.. ....+++..++.++.||++||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 95 588887754 2456899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc-cHHH--------HHHHHhhcc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ-NLVT--------WAKPLLRDK 282 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~--------~~~~~~~~~ 282 (336)
.......++..|+|||++.+. .++.++|||||||++|+|++|..|+......... ..+. ...+.....
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 112334678999999988764 4789999999999999999999886543322110 0000 000000000
Q ss_pred cccccccCCccC-----CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLE-----GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... .-+... .......+..+.+++.+||+.||.+|||++++++
T Consensus 232 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYK--PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccc--ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 000000 0111234568899999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=300.63 Aligned_cols=256 Identities=28% Similarity=0.389 Sum_probs=204.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCC------
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGD------ 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~------ 124 (336)
..++|++.+.||+|++|.||+|.++.+++.+++|++..... ..+.+.+|+.+++.+ .|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35789999999999999999999998899999999865443 346788999999998 6999999999997644
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999988764434567899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-----GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
+...... ........|+..|+|||.+.. ..++.++||||||+++|+|++|..||......... . ...
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~----~~~ 231 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL--F----KIP 231 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH--H----Hhh
Confidence 8754322 122334568999999998753 35778999999999999999999999754321110 0 000
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .......+...+..+.+++.+||..||++|||+.++++
T Consensus 232 ~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RN---------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cc---------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00011112335668999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=303.75 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=202.8
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
.|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666678999999999999999889999999986443 233456889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999988753 46888999999999999999999988 9999999999999999999999999987543321
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
.......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....+..... ..... .
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~----------~ 217 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKN----------S 217 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcC----------C
Confidence 12233568899999999998899999999999999999999999987543321110 00000 0
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........+..+.+++.+||+.+|.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11122234567899999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=338.13 Aligned_cols=261 Identities=30% Similarity=0.418 Sum_probs=212.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe-----EEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ-----VVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.+......||+|+||.||.|...+... .||+|.+.+.. .....+|.+|..+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667789999999999999865433 39999987764 344567999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPP---DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
+++|||+||+|..+|++... ....++....+.++.+||+|+.||++++ +|||||...|+|++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987421 2456888999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
|+......-......-.-...|||||.+..+.++.++||||||+++||++| |..||...+..+....+. .+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~-------~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL-------EGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-------hCC
Confidence 984322221111111122358999999999999999999999999999999 889998766543322111 111
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
+-..|..++..+.+++..||+.+|++||++..+++.++.|.
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 22345667789999999999999999999999999888764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=298.73 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=204.7
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 35789999999999999999998764 5679999876432 234678899999999999999999999887 77899999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999998763 2456788889999999999999999988 999999999999999999999999998754332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.. .......++..|+|||.+....++.++|+|||||++|+|++ |..||........... +.....
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------~~~~~~------ 221 (260)
T cd05073 156 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-------LERGYR------ 221 (260)
T ss_pred Cc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HhCCCC------
Confidence 11 11222345678999999988889999999999999999998 8999976443221111 111000
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
...+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 222 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 222 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 011223455799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.77 Aligned_cols=240 Identities=26% Similarity=0.409 Sum_probs=189.1
Q ss_pred cccccCceEEEEEEEccc------------------------CeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccce
Q 036144 61 LVGEGGYGRVYKGYIEAV------------------------DQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNL 116 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 116 (336)
.||+|+||.||+|....+ ...||+|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999986322 24588998865544444568889999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-
Q 036144 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF- 195 (336)
Q Consensus 117 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~- 195 (336)
++++......++||||+++|+|..++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999988864 3456889999999999999999999988 99999999999997543
Q ss_pred ------ceEEccccccccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHH-hCCCCCCCCCCcc
Q 036144 196 ------NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELI-TGRSAIDNSRPSE 267 (336)
Q Consensus 196 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~-~g~~p~~~~~~~~ 267 (336)
.++++|||++..... .....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||....+.+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 389999998754321 122357788999998865 56899999999999999995 6899987654322
Q ss_pred cccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 268 EQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.... +.... ..+......+.+++.+||+.+|++|||+.++++.|.
T Consensus 230 ~~~~-------~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERF-------YEKKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH-------HHhcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111 00000 011112246889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=303.08 Aligned_cols=253 Identities=26% Similarity=0.334 Sum_probs=198.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHH-HhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLM-LSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|++.+.||+|+||.||+|.++.+|+.||+|.+..... .....+..|+.. ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468899999999999999999999999999999875432 223445556654 566789999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|++ |+|.+++.........+++..++.++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 788888766444456799999999999999999999986 7 99999999999999999999999999875432
Q ss_pred CCCcceeeeeccCccccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMT----GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
. .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||....... .. .. .....
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~-~~---~~~~~----- 223 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQ-LK---QVVEE----- 223 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HH-HH---HHHhc-----
Confidence 1 11233568899999998865 457899999999999999999999996532210 00 00 00000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+.. .....+..+.+++.+||..+|.+|||+.++++
T Consensus 224 --~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 --PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 01124567999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=299.58 Aligned_cols=255 Identities=23% Similarity=0.380 Sum_probs=204.4
Q ss_pred CCCCcccccccCceEEEEEEEcc-cCeEEEEEeecCCC----------CccHHHHHHHHHHHhh-ccCCCccceEEEEEe
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEA-VDQVVAVKQLDRSG----------NQGSREFFAEVLMLSL-VQHQNLVNLIGYCAD 122 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 122 (336)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ......+..|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888899999999999999987 67899999875321 1122446678887764 799999999999999
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEcc
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSD 201 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~D 201 (336)
....+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886544455679999999999999999999996 56 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 202 FGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......... ......
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~------~~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA------TKIVEA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH------HHHhhc
Confidence 99997643322 234456899999999999888999999999999999999999998654322111 011000
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.. .+.. ....+..+.+++.+||+.||++||++.|+.++++
T Consensus 229 --~~----~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 --VY----EPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --cC----CcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00 0100 1123457899999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=305.85 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=202.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468899999999999999999999999999999875432 22356778999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999865 356889999999999999999999988 99999999999999999999999998863211
Q ss_pred CCC-------------cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 036144 211 GGK-------------DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277 (336)
Q Consensus 211 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 277 (336)
... ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||......+.. . .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~---~---~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF---G---Q 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---H
Confidence 000 00112245788999999998889999999999999999999999999754322111 1 0
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.... ....+.. ....+..+.+++.+||+.||++||+..++++.|+
T Consensus 228 ~~~~-----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 228 VISD-----DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHhc-----ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 0000 0001110 1124457899999999999999999665555554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=303.20 Aligned_cols=266 Identities=23% Similarity=0.304 Sum_probs=204.1
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|++.+.||.|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999999889999999987543 22346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+ +++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999988652 366899999999999999999999998 9999999999999999999999999987654332
Q ss_pred CcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH--------HHHHhhccc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW--------AKPLLRDKK 283 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 283 (336)
. .......|+..|+|||.+.+. .++.++||||+||++++|++|.+||.............. .++....-.
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 122345689999999988654 568999999999999999999888865432211110000 000000000
Q ss_pred ccccccCCccC----CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLE----GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....+..+... .......+..+.+++.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0011233578999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=297.76 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=201.2
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC------ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN------QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
+|.+.+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+.+++.++|+||+++++++.+....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4788899999999999999874 588999998864321 112457889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
+|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999864 346788999999999999999999988 999999999999999999999999998754
Q ss_pred CCCC----CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 209 PTGG----KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 209 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
.... .........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+......... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------~~~- 224 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-------AHR- 224 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-------hcc-
Confidence 2211 1112234568999999999998889999999999999999999999997543221110000 000
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......+...+..+.+++.+||+.+|.+|||+.+++.
T Consensus 225 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 -------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0001123345568899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=300.13 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=204.5
Q ss_pred cCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
++|++.+.||.|+||.||+|..+. +...+++|.+...... ....+.+|+.+++.++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568899999999999999999754 3467999988654433 3467899999999999999999999999989999
Q ss_pred EEEEcCCCCChhhhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPD-----QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
+||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998763321 126899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
|++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..... . .
T Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~---~-~ 233 (275)
T cd05046 162 SLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRL---Q-A 233 (275)
T ss_pred ccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHH---H-c
Confidence 998643221 1112233456778999999988889999999999999999998 788886543221 11110 0 0
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.... ...+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 234 -~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000 0112234458999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=304.27 Aligned_cols=267 Identities=26% Similarity=0.348 Sum_probs=205.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999999999999999986532 2234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|++++.+..+... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9987666655432 355899999999999999999999998 999999999999999999999999998765433
Q ss_pred CCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------HHhhcc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK--------PLLRDK 282 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 282 (336)
.. .......++..|+|||++.+. .++.++|+||||+++|+|++|..||......+......... ..+...
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 21 123345788999999999888 88999999999999999999999997654322111111000 000000
Q ss_pred ccccc--ccCCc----cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTM--MADPL----LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~--~~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... ..... ....++...+..+.+++.+||+.+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00000 001122233678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=298.33 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=200.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-----ccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-----QGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQR 126 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 126 (336)
.+|.+.+.||+|+||.||.|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468899999999999999999999999999998753221 1234678899999999999999999988763 567
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
+++|||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999998864 345788889999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 207 LGPTGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
........ .......|+..|+|||.+.+..++.++|||||||++|+|++|..||......... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----~-~~~------ 222 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-----F-KIA------ 222 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-----H-HHh------
Confidence 54321111 1122346889999999998888999999999999999999999999754321110 0 000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........+...+..+.+++.+|+. +|++||+++++++
T Consensus 223 ----~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 ----TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0011122344556678899999995 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=296.71 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=202.7
Q ss_pred CCCcccccccCceEEEEEEEcccC----eEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVD----QVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
+.+.+.||.|+||.||++.+...+ ..||+|.+...... ....+..|+.+++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 456788999999999999998766 89999998665433 4567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.... ...+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999987522 122899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
..... .....+++.|+|||.+.+..++.++|+||+|+++++|++ |..||........ ... .. ...
T Consensus 156 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~---~~-~~~------ 221 (258)
T smart00219 156 DDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEY---LK-KGY------ 221 (258)
T ss_pred ccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---Hh-cCC------
Confidence 31111 112337789999999988889999999999999999998 7888875332111 111 00 000
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
....+...+..+.+++.+||+.||++|||+.++++.|
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011222456899999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=297.65 Aligned_cols=255 Identities=25% Similarity=0.316 Sum_probs=190.8
Q ss_pred cccccCceEEEEEEEcc--cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 61 LVGEGGYGRVYKGYIEA--VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
.||+|+||.||+|.... ....+|+|.+..... .....+.+|+..++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997532 346789998764432 223567889999999999999999999999999999999999999
Q ss_pred hhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcce
Q 036144 138 LENHFLDLPPD-QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV 216 (336)
Q Consensus 138 L~~~l~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 216 (336)
|.+++...... ....++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99998764322 234567788899999999999999998 99999999999999999999999999864322211111
Q ss_pred eeeeccCccccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 217 STRVMGTYGYCAPEYAMT-------GQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 217 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.....++..|+|||++.. ..++.++|||||||++|+|++ |..||......+. .. ..... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~~~~--~~~~~ 230 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LK---QVVRE--QDIKL 230 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HH---HHhhc--cCccC
Confidence 223345778999998642 356889999999999999999 7888875433211 10 00100 11111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
..+. .+...+..+.+++..|+ .||++|||+++|++.|.
T Consensus 231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1222 22334557778888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=319.34 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=208.7
Q ss_pred cccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCChhh
Q 036144 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLEN 140 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 140 (336)
+||+|.||+||-|++..|...+|||.+........+-+.+|+..-+.|+|.|||+++|.+..+.+.-++||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999999999999999977666666778999999999999999999999999998899999999999999
Q ss_pred hhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC-CCCceEEccccccccCCCCCCccee
Q 036144 141 HFLDLPPDQEPL--DWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD-AEFNPKLSDFGLAKLGPTGGKDHVS 217 (336)
Q Consensus 141 ~l~~~~~~~~~l--~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 217 (336)
++... =+++ .+.+.--+..||++||.|||+.. |||||||-+||||+ -.|.+||+|||.++.+. +-....
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~T 733 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCT 733 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccc
Confidence 99873 3455 67788889999999999999998 99999999999994 56889999999998653 334556
Q ss_pred eeeccCccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 218 TRVMGTYGYCAPEYAMTG--QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 218 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.++.||..|||||++..+ .|+.++|||||||++.||.||++||-........ +..+---....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---------------MFkVGmyKvHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---------------MFKVGMYKVHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---------------hhhhcceecCC
Confidence 778899999999999765 6999999999999999999999999654432221 11111112234
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..|.+.+..+..+|.+|+.+||.+||++.++|.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 567788999999999999999999999999986
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=298.59 Aligned_cols=253 Identities=28% Similarity=0.394 Sum_probs=193.5
Q ss_pred ccccccCceEEEEEEEcc---cCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEE-eCCeEEEEEEcCC
Q 036144 60 CLVGEGGYGRVYKGYIEA---VDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCA-DGDQRILVYEFMS 134 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 134 (336)
+.||+|+||.||+|.+.. .+..+|+|.+.... ......+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998743 34679999875432 233467888999999999999999999765 4556889999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
+++|.+++... ....++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998652 234667778889999999999999988 999999999999999999999999998754321110
Q ss_pred --ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 215 --HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG-RSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 215 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
.......++..|+|||.+.+..++.++|||||||++|+|++| .+||......+ ... ..... . ..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~---~~~~~-~------~~ 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITV---YLLQG-R------RL 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---HHhcC-C------CC
Confidence 011223467789999999888999999999999999999995 56665433211 111 11110 0 00
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
..+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1112234578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=296.55 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=209.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+|+..+..++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368889999999999999999999999999999876543 3456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
+++++|.+++.. ...+++...+.++.|+++|+.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999865 2678999999999999999999999 88 999999999999999999999999998765332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||................ .. ..
T Consensus 154 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~-------~~- 220 (264)
T cd06623 154 L--DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DG-------PP- 220 (264)
T ss_pred C--CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cC-------CC-
Confidence 2 12234568899999999998899999999999999999999999997765311111111111 00 00
Q ss_pred ccCCCCcHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 LLEGQYPRK-GLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+.. .+..+.+++.+||..+|++|||+.++++
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 112222 5568999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=306.32 Aligned_cols=250 Identities=24% Similarity=0.329 Sum_probs=202.9
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
.|.....||+|+||.||++.+..++..||+|.+..........+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 34445569999999999999998899999999876554455678899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... .
T Consensus 103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~ 172 (292)
T cd06658 103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--V 172 (292)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccc--c
Confidence 9999998743 45888999999999999999999998 999999999999999999999999998754322 1
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (336)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......... ..... ...+...
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~----------~~~~~~~ 239 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIRD----------NLPPRVK 239 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh----------cCCCccc
Confidence 1223456899999999998889999999999999999999999999764432111 10000 0011111
Q ss_pred CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 295 GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 295 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.....+..+.+++.+||..||.+|||++++++.
T Consensus 240 --~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 --DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111234578899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=296.93 Aligned_cols=258 Identities=29% Similarity=0.406 Sum_probs=208.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|++.+.||.|+||.||+|.+..++..+|+|++.... ....+.+.+|+.+++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46899999999999999999998889999999986543 23456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++..... ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999865321 256889999999999999999999998 9999999999999999999999999987654432
Q ss_pred Ccc--eeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 213 KDH--VSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 213 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
... ......|+..|+|||++... .++.++|+||||+++|+|++|..||........ ... .... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~~-------~ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQN-------D 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----HhcC-------C
Confidence 221 22345689999999998876 789999999999999999999999976543221 111 0000 0
Q ss_pred CCccCCC-CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQ-YPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+.+... .....+..+.+++.+||+.||++|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0111111 01234568899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=314.46 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=214.6
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
......|.+.+.||+|.|+.|.+|++..++..||||.+++.... ..+.+.+|+++|+.++|||||+++.+......+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 34457799999999999999999999999999999999876433 2356889999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+.+|.+.+++.. .....+..+..++.|++.|++|+|+++ |||||||++|||++.+-++||+|||++.+
T Consensus 132 lV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecccccee
Confidence 99999999999999986 455666888999999999999999999 99999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT-KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
+..+ ....+++|++.|.|||++.+..|+ +.+|+||+|+++|-|++|..||++..-.+....+...
T Consensus 205 ~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g----------- 270 (596)
T KOG0586|consen 205 FDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG----------- 270 (596)
T ss_pred eccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee-----------
Confidence 7543 346778999999999999998774 8999999999999999999999976644432222100
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .++.-.+.++.+||+++|..+|.+|++++++.+
T Consensus 271 -----k~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 271 -----KY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -----ee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 00 123334557889999999999999999999875
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=296.24 Aligned_cols=248 Identities=26% Similarity=0.365 Sum_probs=203.2
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-----CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-----NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
+|+..+.||+|+||.||+|.+..++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778889999999999999999889999999986533 12345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999865 345888999999999999999999998 9999999999999999999999999987643
Q ss_pred CCCCcceeeeeccCccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||........ ..... ....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~-----~~~~---- 219 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIG-----RSKE---- 219 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHH-----hccc----
Confidence 322 233456899999999987776 89999999999999999999999976542111 11000 0000
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...++...+..+.+++.+||+.+|.+|||+.+++.
T Consensus 220 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 -----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01122334568899999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=305.34 Aligned_cols=270 Identities=22% Similarity=0.287 Sum_probs=202.0
Q ss_pred CCCCcccccccCceEEEEEEEcc--cCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEA--VDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRI 127 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 127 (336)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47888999999999999999988 88999999987632 33346678899999999999999999999988 8899
Q ss_pred EEEEcCCCCChhhhhccCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC----CCceEEccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQ-EPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA----EFNPKLSDF 202 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~-~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~----~~~~kl~Df 202 (336)
+||||++ ++|.+++....... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999995 57777765433322 37899999999999999999999998 999999999999999 899999999
Q ss_pred cccccCCCCCC-cceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCccccc-------HHH
Q 036144 203 GLAKLGPTGGK-DHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQN-------LVT 273 (336)
Q Consensus 203 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~-------~~~ 273 (336)
|++........ ........++..|+|||.+.+. .++.++|||||||++++|++|.+||.......... ...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876533222 1122345688999999988764 68999999999999999999999998655432100 000
Q ss_pred HHHHH----------hhcccccccccCCccCCCCc---------H--HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 274 WAKPL----------LRDKKKFTMMADPLLEGQYP---------R--KGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 274 ~~~~~----------~~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....+ ...........+......++ . ..+..+.+++.+||+.||++|||+.+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000000000000001111 1 34457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=295.36 Aligned_cols=255 Identities=21% Similarity=0.300 Sum_probs=191.5
Q ss_pred cccccCceEEEEEEEccc--CeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 61 LVGEGGYGRVYKGYIEAV--DQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
.||+|+||.||+|..... ...+++|.+..... ...+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975432 34567777654432 334678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCccee
Q 036144 138 LENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217 (336)
Q Consensus 138 L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 217 (336)
|.+++..........+...+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99998764333455677788899999999999999988 999999999999999999999999997542221111122
Q ss_pred eeeccCccccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 218 TRVMGTYGYCAPEYAMT-------GQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 218 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
....++..|+|||++.. ..++.++||||||+++|+|++ |..||......+... ..... ......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------~~~~~--~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------HVIKD--QQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHhh--cccccC
Confidence 34568899999998743 245789999999999999997 566776543221111 11111 111122
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
++.+.. ..+..+.+++..|| .+|.+||++.++++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222222 23457888999999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=295.62 Aligned_cols=243 Identities=25% Similarity=0.325 Sum_probs=207.5
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
..++|..+++||+|.||.|.+++.+.+++.+|+|++++.-. .....-+.|-++|+..+||.+..+.-.|+..+++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 34789999999999999999999999999999999976532 223445678999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||..||.|.-.+.. ...+++...+-+-..|+.||.|||+.+ ||.||||.+|+|+|.+|++||+|||+|.-.
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999877754 567888888999999999999999988 999999999999999999999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... .....++||||.|+|||++....|+.++|.|.+|+++|||++|+.||.+.+......++...
T Consensus 319 I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------------- 383 (516)
T KOG0690|consen 319 IKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------------- 383 (516)
T ss_pred ccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------
Confidence 322 23466799999999999999999999999999999999999999999876544333222210
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 321 (336)
...||...+.++..|+...|..||.+|.
T Consensus 384 -----d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 -----DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -----hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1245666777899999999999999995
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=304.18 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=202.1
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
|.....||+|+||.||+|.+..++..||+|.+..........+.+|+.+++.++||||+++++++......++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33444699999999999999988999999998765444556788999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 999987643 45889999999999999999999998 9999999999999999999999999986543221 1
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||......+.. ... ... . .+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~----~~~-~-----~~~~-- 237 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRL----RDS-P-----PPKL-- 237 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----hcc-C-----CCCc--
Confidence 233457899999999999889999999999999999999999999754432211 110 000 0 0000
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
......+..+.+++.+||+.+|.+||+++++++.
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0112234578899999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=300.01 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=201.0
Q ss_pred CCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCC------
Q 036144 56 FNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD------ 124 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 124 (336)
|.+.+.||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567788999999999999864 457899999986543 223456889999999999999999999886532
Q ss_pred eEEEEEEcCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLP--PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
..+++++|+.+|+|.+++.... .....++......++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988865321 12235788899999999999999999988 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
|++................+++.|++||.+....++.++|||||||++|+|++ |.+||......+. ..+. . .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~---~-~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYL---I-K 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHH---H-c
Confidence 99876533222222233445678999999988899999999999999999999 8888875432211 1111 0 0
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.... ..+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~~ 273 (273)
T cd05074 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273 (273)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 0000 011234458999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=295.99 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=203.8
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|++.+.||+|+||.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++|||++++++.+......++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5888899999999999999999999999999986542 22346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEccccccccCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKLGPTG 211 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 211 (336)
+++++|.+++... ....+++..+..++.+++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999998752 2345889999999999999999999998 99999999999998654 5799999999765332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.... .. ..... .
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~---~~~~~--~------- 217 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VL---KIMSG--T------- 217 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HH---HHHhc--C-------
Confidence 2 22335689999999999988899999999999999999999999976543211 11 00000 0
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...++...+..+.+++.+||+.+|.+|||+.++++
T Consensus 218 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 218 --FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01122234557999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=298.27 Aligned_cols=262 Identities=24% Similarity=0.278 Sum_probs=205.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 130 (336)
++|...+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+++++.++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 367888899999999999999998999999999875433 2346688999999999999999999988653 4689999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.........++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987654445567889999999999999999999998 99999999999999999999999999865422
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||........ ........... .....+.+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~ 230 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYIVN--MPNPELKD 230 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHHHhc--CCchhhcc
Confidence 21 2234678899999999988999999999999999999999999986533111 11111111110 00000000
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. . ......+..+.+++.+||+.+|.+|||+.|+++
T Consensus 231 ~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 E-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred C-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 0 001124568999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=301.64 Aligned_cols=257 Identities=27% Similarity=0.341 Sum_probs=202.6
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEe----
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCAD---- 122 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---- 122 (336)
+.......|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 33345578999999999999999999999999999999986543 2345678899999888 69999999999853
Q ss_pred --CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEc
Q 036144 123 --GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS 200 (336)
Q Consensus 123 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~ 200 (336)
....+++|||+.+|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 457899999999999999987532 345788889999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA 275 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 275 (336)
|||++...... ........|+..|+|||.+. +..++.++|+|||||++|+|++|..||....+........
T Consensus 164 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-- 239 (282)
T cd06636 164 DFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-- 239 (282)
T ss_pred eCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh--
Confidence 99998754221 11223456899999999875 3468889999999999999999999997644321111000
Q ss_pred HHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 KPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ...........+..+.+++.+||+.||.+|||+.++++
T Consensus 240 -----~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 -----R---------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -----h---------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00000111234568999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=295.84 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=201.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+++++.++|||++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 467888999999999999998864 6789999886443 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++++|.+++.. ....+++..++.++.+++.|+++||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 154 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ- 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-
Confidence 99999998865 2346788999999999999999999998 9999999999999999999999999987543221
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
........++..|+|||.+.++.++.++||||||+++|+|++ |..||........ .. .. ..+ ...
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~---~~-~~~---~~~---- 220 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---VE---TI-NAG---FRL---- 220 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---HH---HH-hCC---CCC----
Confidence 111122335678999999988899999999999999999998 9999875432211 11 11 000 000
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
..+...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus 221 ---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 ---YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 011123467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=304.98 Aligned_cols=199 Identities=26% Similarity=0.361 Sum_probs=161.4
Q ss_pred ccccccCceEEEEEEEcc--cCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEA--VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 135 (336)
.+||+|+||.||+|.++. ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. ....++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 479999999999999754 56889999986543 23467889999999999999999998853 567789999985
Q ss_pred CChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----CCCCceEEccccccc
Q 036144 136 GSLENHFLDLP-----PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL----DAEFNPKLSDFGLAK 206 (336)
Q Consensus 136 g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~----~~~~~~kl~Dfg~~~ 206 (336)
++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57877764321 12345888999999999999999999998 9999999999999 566789999999997
Q ss_pred cCCCCCCc-ceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 036144 207 LGPTGGKD-HVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSR 264 (336)
Q Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 264 (336)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 65332211 12234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=301.48 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=199.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|++|.||+|.++.+++.||+|.+...... ....+.+|+.+++.++|+||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 36799999999999999999999988999999998654322 23456789999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+. ++|.+++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 996 5899887652 346889999999999999999999998 999999999999999999999999998653221
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc-ccHHHHH-----HHHhhcccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE-QNLVTWA-----KPLLRDKKK 284 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-----~~~~~~~~~ 284 (336)
. .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||........ ....... ...+.....
T Consensus 157 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 157 S--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred C--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1 11223356889999998875 4689999999999999999999999975542111 0000000 000000000
Q ss_pred ---ccccc-----CCccCCCCc-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 285 ---FTMMA-----DPLLEGQYP-RKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 285 ---~~~~~-----~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... ...+....+ ......+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 000000000 011257889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=298.44 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=205.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|+..+.||.|++|.||+|.++.+++.+|+|.+..... .....+.+|+.+++.++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 357788899999999999999999999999999876532 3345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999998753 2678899999999999999999999 88 999999999999999999999999998654221
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ............ ..+
T Consensus 155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~-------~~~ 222 (265)
T cd06605 155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE-------PPP 222 (265)
T ss_pred H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC-------CCC
Confidence 1 1126789999999999999999999999999999999999999976532111 111111111110 000
Q ss_pred ccCCCCcHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 LLEGQYPRK-GLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+.. .+..+.++|.+||..||++|||+.+++.
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 ----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred ----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11122 5567999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=296.88 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=204.7
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|++.+.||+|+||.||++.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5888999999999999999999899999999986432 22345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+.+++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988652 2345788999999999999999999988 9999999999999999999999999987543321
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......|++.|+|||++.+..++.++|+|||||++++|++|..||......+. ........ .
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~~~--~------- 218 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIRGS--Y------- 218 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhcCC--C-------
Confidence 112234688999999999888899999999999999999999999875432211 11111110 0
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+...+..+.+++.+||+.+|.+||++.++++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0122334567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=295.39 Aligned_cols=239 Identities=26% Similarity=0.416 Sum_probs=191.9
Q ss_pred ccccccCceEEEEEEEcccC----------eEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 60 CLVGEGGYGRVYKGYIEAVD----------QVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999998766 45888887654433 5778899999999999999999999888 778999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-------ceEEccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-------NPKLSDF 202 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-------~~kl~Df 202 (336)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998762 236889999999999999999999988 99999999999998887 7999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccC--CCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHh
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG--QLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
|++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||............
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~------- 219 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY------- 219 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-------
Confidence 99875422 2234567789999998876 78999999999999999999 57777665422111100
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.... ..+......+.+++.+||..+|.+|||+.++++.|+
T Consensus 220 ~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 220 QDQH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hcCC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 000111157899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=301.33 Aligned_cols=266 Identities=22% Similarity=0.245 Sum_probs=202.6
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-----cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-----GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478888999999999999999988999999998755322 234567899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+ +++|.+++... ...+++..++.++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 99999998652 236899999999999999999999998 9999999999999999999999999997653
Q ss_pred CCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-----HHHhhccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA-----KPLLRDKK 283 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 283 (336)
... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||......+........ ...+....
T Consensus 154 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 322 12233456888999998865 46789999999999999999998888765432211111000 00000000
Q ss_pred ccccccCCccC-----CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 284 KFTMMADPLLE-----GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 284 ~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
........... .......+..+.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 01112346689999999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=299.88 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=207.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..+|.+.+.||+|+||.||++.+..++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36899999999999999999999888999999998655444556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999998854 35788899999999999999999998 9999999999999999999999999886543322
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||............. . ...
T Consensus 170 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~---------~~~ 232 (293)
T cd06647 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------T---------NGT 232 (293)
T ss_pred --cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------c---------CCC
Confidence 12233568899999999988889999999999999999999999997654322111000 0 000
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.....+...+..+.+++.+||+.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011122345578899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=303.51 Aligned_cols=266 Identities=28% Similarity=0.371 Sum_probs=202.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688899999999999999999988999999987654322 23567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|..+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888876643 345899999999999999999999998 999999999999999999999999998764332
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHHhhcc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------KPLLRDK 282 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 282 (336)
. .......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||......+....+... ...+...
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 22234568899999998875 45788999999999999999999999754432211111100 0000000
Q ss_pred cccccccCCccCC-----CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEG-----QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........+.... ......+..+.+++.+||+.+|++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000110000 011234568999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=295.50 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=199.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|.+.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++|||++++++++... ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 5689999999999999999875 47889999986432 345788999999999999999999998654 479999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999998753 2346888999999999999999999988 999999999999999999999999998753221
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
......+..|+|||.+.+..++.++|+|||||++|+|++ |..||......+... ......
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~--------- 214 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE-------CVEKGY--------- 214 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH-------HHhCCC---------
Confidence 122234567999999988899999999999999999997 999997654322111 111110
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 215 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 -RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 011122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.43 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=202.8
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
.|...+.||+|++|.||++.+..+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 35555689999999999999988899999999865544445668899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
+++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 9999998864 45888899999999999999999998 9999999999999999999999999886543221
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (336)
.......|++.|+|||.+.+..++.++||||||+++|+|++|..||....+..... ..... . .+...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~------~~~~~--~-----~~~~~ 236 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK------RIRDN--L-----PPKLK 236 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH------HHHhc--C-----CCCCc
Confidence 12233568999999999988889999999999999999999999997643321111 11000 0 00110
Q ss_pred CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 295 GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 295 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+...+..+.+++.+||+.+|++|||+.++++
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11124458999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=297.46 Aligned_cols=248 Identities=24% Similarity=0.310 Sum_probs=205.7
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
+|++.+.||.|+||.||+|.+..++..||+|++..... ...+.+.+|+++++.++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48888999999999999999998999999999875432 335678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+.+++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999865 257889999999999999999999998 999999999999999999999999998765332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............. ....
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~---------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET---------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc----------
Confidence 2 2334568899999999988889999999999999999999999998765421111111 1000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH--HHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFM--VDVV 327 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~--~evl 327 (336)
....++...+..+.+++.+||+.||.+||++ .|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112233345689999999999999999999 6655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=292.01 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=203.7
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|.+.+.||+|+||.||+|.+..++..|++|.+...... ..+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588889999999999999999888999999998765443 456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999865 345788889999999999999999998 9999999999999999999999999987654332
Q ss_pred Ccce--eeeeccCccccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 213 KDHV--STRVMGTYGYCAPEYAMTGQ---LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 213 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.... .....++..|+|||.+.+.. ++.++||||||+++++|++|..||........ ..+. .. .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~--~~---~---- 221 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFH--VG---A---- 221 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHH--Hh---c----
Confidence 2111 12356889999999988766 88999999999999999999999975432111 0000 00 0
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+.+.. ....+..+.+++.+||+.+|.+|||+.+++.
T Consensus 222 ~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 GHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00111110 1122567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=292.25 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=210.0
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|.+.+.||.|+||.||++.+..++..||+|++..... .....+.+|+++++.++|||++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 57888999999999999999998899999999875433 3456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.........+++..+..++.+++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999998775444578999999999999999999999998 9999999999999999999999999997654332
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......|++.|+|||...+..++.++|+||+|+++++|++|..||........ . ...... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~---~~~~~~--~-------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---A---LKILKG--Q-------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---H---HHHhcC--C--------
Confidence 233445789999999999888899999999999999999999999976542211 1 111100 0
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....+...+..+.+++.+||..+|.+|||+.++++
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 220 -YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11122244568999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=299.79 Aligned_cols=266 Identities=23% Similarity=0.299 Sum_probs=203.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv 129 (336)
++|++.+.||.|+||.||+|.+..+++.+|+|.++..... ....+.+|+.+++.++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5788999999999999999999999999999998654322 223567899999999999999999998877 889999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+. ++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 5998888652 246899999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHHhh
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------KPLLR 280 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~ 280 (336)
... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+... ++.+.
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 321 122334578899999988754 4689999999999999999999999865543221111100 00000
Q ss_pred c-----ccccccccCCccCCCCcHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 281 D-----KKKFTMMADPLLEGQYPRK-GLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 281 ~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ...........+...++.. .+..+.+++.+||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000011111112222222 4667899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=294.80 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=201.5
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhcc---CCCccceEEEEEeCCeEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQ---HQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.|++.+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.+. |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999999999999999986542 334466888999999986 999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998754 36889999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||........... ... ..
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~------~~ 218 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------IPK------SK 218 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------ccc------CC
Confidence 32 22334568999999998865 4578999999999999999999999976432211100 000 00
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+.+.. ...+..+.+++.+||+.||++||++.+++.
T Consensus 219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111111 114457999999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=312.99 Aligned_cols=269 Identities=23% Similarity=0.312 Sum_probs=207.1
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeC------CeEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------DQRI 127 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~ 127 (336)
.|...+.||+|+||.||+|+++.+|+.||||.+.... ....+...+|+++|++++|+|||+++++-++. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4556678999999999999999999999999997643 34456788999999999999999999876543 3568
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE--CCCCc--eEEcccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL--DAEFN--PKLSDFG 203 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~--~~~~~--~kl~Dfg 203 (336)
+|||||.||||...+.. +.....+++.+.+.++.++..|+.|||+++ |+||||||.||++ ..+|+ .||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999876 455678999999999999999999999998 9999999999998 33344 7999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
.|+-.+.+. ...+++||+.|++||.+.. +.|+..+|.|||||++|+..||..||...........+.|.... .+.
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t-kkp 245 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT-KKP 245 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc-cCC
Confidence 999776544 5788999999999999985 88999999999999999999999999876544322222222111 111
Q ss_pred cccccccCCcc------------CCCCcHHHHHHHHHHHHhhcCCCCCCCC--CHHHHHHHHh
Q 036144 283 KKFTMMADPLL------------EGQYPRKGLYQALAVAGMCLQEDADSRP--FMVDVVTALE 331 (336)
Q Consensus 283 ~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dp~~Rp--t~~evl~~L~ 331 (336)
........+.- .....+.....+..++..+|..+|.+|. ...+.-+.+.
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~ 308 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD 308 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence 11111111111 1222334445677888899999999998 5444444433
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=298.03 Aligned_cols=263 Identities=24% Similarity=0.296 Sum_probs=200.2
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|+..+.||.|++|.||+|.+..++..||+|.+.... ......+.+|+++++.++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999999999999999886433 22235688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 6898888653 2456899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH----------hhc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL----------LRD 281 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~ 281 (336)
.......++..|+|||.+.+. .++.++||||||+++|+|++|..||........ ........ ...
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhH
Confidence 112334578899999988764 468899999999999999999999976443211 11100000 000
Q ss_pred ----ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 ----KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+......... ......+..+.++|.+||+.||.+|||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000000 001123457889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=296.03 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=198.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc-HHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG-SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..+|.+.+.||+|+||.||+|.+..++..||+|.+....... ...+.+|+.+++.++|+||+++++++......++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467999999999999999999999889999999986543222 3457789999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 994 777777654 2345778888999999999999999998 999999999999999999999999998753221
Q ss_pred CCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh--ccc-----
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLR--DKK----- 283 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~----- 283 (336)
. .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||........ ........+. .+.
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHHHHHcCCCChhhhhhh
Confidence 1 112334578999999988764 588999999999999999999999976543211 1100000000 000
Q ss_pred -ccccccCCcc----CCCC-----cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 -KFTMMADPLL----EGQY-----PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 -~~~~~~~~~~----~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......... .... ....+..+.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0000 0012457889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=294.67 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=203.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+-|++.+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 44778889999999999999999889999999986443 22345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~- 154 (277)
T cd06641 84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT- 154 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccc-
Confidence 999999998853 45889999999999999999999988 999999999999999999999999998654322
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
........++..|+|||.+.+..++.++|+|||||++|+|++|..||........... . ... . .
T Consensus 155 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------~-~~~-~-----~-- 218 (277)
T cd06641 155 -QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------I-PKN-N-----P-- 218 (277)
T ss_pred -hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH------H-hcC-C-----C--
Confidence 1122335688999999999888899999999999999999999999975432111100 0 000 0 0
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+...+..+.+++.+||+.+|.+||++.++++
T Consensus 219 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 219 --PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred --CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1122234567899999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=298.02 Aligned_cols=248 Identities=28% Similarity=0.389 Sum_probs=200.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
...|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++......++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 3568889999999999999999998899999999864432 2235688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99995 677777654 2356899999999999999999999998 9999999999999999999999999986542
Q ss_pred CCCCcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
. .....++..|+|||++. ...++.++||||||+++|+|++|..||........... .... .
T Consensus 167 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~------~~~~--~-- 230 (307)
T cd06607 167 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQN--D-- 230 (307)
T ss_pred C------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH------HhcC--C--
Confidence 2 22346888999999874 45688999999999999999999999976542221100 0000 0
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.+ ...+...+..+.+++.+||+.+|++||++.+++..
T Consensus 231 ---~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 ---SP---TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CC---CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 01122355679999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.19 Aligned_cols=245 Identities=29% Similarity=0.389 Sum_probs=197.2
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
||+|+||.||+|.+..+|+.||+|.+.... ......+..|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999999999999999986532 12234567899999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+...... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 9988653 2246899999999999999999999998 999999999999999999999999998754321 1223
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCc
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ... .....++
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~------------~~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--RTL------------EMAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--ccc------------cccccCC
Confidence 35678899999999888899999999999999999999999976543211111110 000 0011223
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 299 RKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 299 ~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
...+..+.+++.+||+.||.+|| ++.+++.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 34466899999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=294.70 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=207.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..+.|++.+.||+|++|.||+|.+..++..+++|++..... ....+.+|+.+++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45668888899999999999999998899999999976544 45678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999997622 47899999999999999999999988 999999999999999999999999998654332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+....... ... ...
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~------~~~--~~~----- 234 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI------TTK--GIP----- 234 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hhc--CCC-----
Confidence 1 1223345788999999998888999999999999999999999999764432111100 000 000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........+..+.+++.+||+.+|.+|||+.++++
T Consensus 235 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 --PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred --CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00111224567999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=299.08 Aligned_cols=268 Identities=22% Similarity=0.282 Sum_probs=201.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 128 (336)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ....+.+|+.+++.++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46799999999999999999999999999999998644321 123466899999999999999999998755 56899
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+. ++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999995 5888887652 356899999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----HHhhcc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-----PLLRDK 282 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~ 282 (336)
.... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||...+..+....+.... ..+...
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 4322 11223346888999998865 468999999999999999999999998655433221111100 000000
Q ss_pred ccc---cccc-CCccCCCC---cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 283 KKF---TMMA-DPLLEGQY---PRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 283 ~~~---~~~~-~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
... .... .......+ ....+..+.++|.+||+.||++|||+.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000 00000000 01135678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=293.47 Aligned_cols=250 Identities=24% Similarity=0.296 Sum_probs=208.1
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|++.+.||.|+||.||++.++.+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999999999999999986543 22345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998764444567899999999999999999999998 999999999999999999999999999765433
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+........ . . .
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~-~----------~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV------Q-R----------G 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------h-c----------C
Confidence 222346889999999999889999999999999999999999999765432111100 0 0 0
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+...+..+.+++.+||+.+|++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111223355678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=298.39 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=197.7
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|...+.||+|+||.||++.+..+++.+|+|.+..... .....+.+|+.++..+. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45666789999999999999999999999999875432 33456788999999886 99999999999999999999999
Q ss_pred CCCCChhhhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 133 MSNGSLENHFLDL-PPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 133 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
+. +++.++.... ......+++..+..++.+++.||.|||+. + ++||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 84 5666544321 12246789999999999999999999974 6 99999999999999999999999999875432
Q ss_pred CCCcceeeeeccCccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTG---QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.. ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||..... ...........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~------ 226 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG------ 226 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC------
Confidence 21 12334688999999998766 689999999999999999999999975431 11111111100
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+.+....+...+..+.+|+.+||+.+|++|||+.++++
T Consensus 227 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 227 -DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred -CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111112222335668999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=287.50 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=206.6
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
+|.+.+.||+|++|.||+|.+..++..+++|++..........+.+|+.+++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47788899999999999999998899999999876654456778999999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
+++|.+++... ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998762 257899999999999999999999988 99999999999999999999999999876543321
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (336)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||............. . .......
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~-----~~~~~~~----- 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T-----NGPPGLR----- 218 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h-----cCCCCcC-----
Confidence 344578999999999988889999999999999999999999997654221111100 0 0000000
Q ss_pred CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 295 GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 295 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+...+..+.+++.+||+.||++|||+.++++
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01112557999999999999999999999885
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=304.68 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=200.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeC------
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------ 123 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 123 (336)
...+|++.+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999999999999998643 223345677899999999999999999988643
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
...++||||+ .++|.+.+.. .++...+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||
T Consensus 94 ~~~~lv~e~~-~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELM-DANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEecc-CCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 3579999999 4688887743 2788899999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH---------H
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT---------W 274 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~---------~ 274 (336)
++....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||...+.......+. +
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 997643221 1233468899999999999999999999999999999999999997654221110000 0
Q ss_pred -------HHHHhhccc-----ccccccCCc----cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 275 -------AKPLLRDKK-----KFTMMADPL----LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 275 -------~~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......... .+....... .....+...+..+.+++.+||+.||++|||+.|+|.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000 000000000 001112234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=293.67 Aligned_cols=243 Identities=26% Similarity=0.350 Sum_probs=190.7
Q ss_pred cccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhh---ccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSL---VQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
.||+|+||.||+|.+..+++.+|+|.+...... ....+.+|..+++. ..||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999988654221 12233445444443 479999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--- 150 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---
Confidence 9999988864 456899999999999999999999998 999999999999999999999999998644221
Q ss_pred ceeeeeccCccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 215 HVSTRVMGTYGYCAPEYAM-TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
......|+..|+|||.+. +..++.++||||+||++|+|++|..||.......... .... .. ..
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~--~~------------~~ 214 (279)
T cd05633 151 -KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRM--TL------------TV 214 (279)
T ss_pred -CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHH--hh------------cC
Confidence 122346899999999886 4568999999999999999999999997644322111 1000 00 01
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVTA 329 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~ 329 (336)
....+...+..+.+++.+||+.||.+|| |++++++.
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1123334566899999999999999999 59888773
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=295.02 Aligned_cols=267 Identities=22% Similarity=0.289 Sum_probs=202.9
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
+|++.+.||.|++|.||+|.+..+|..||+|++..... .....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 58889999999999999999999999999999876532 23456778999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+ ++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 D-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred C-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 6 58888876532 2356899999999999999999999998 9999999999999999999999999997543221
Q ss_pred cceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH-HH-------HHHhhcccc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT-WA-------KPLLRDKKK 284 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~-~~-------~~~~~~~~~ 284 (336)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||......+....+. .. ...+.....
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 112334578899999988654 57899999999999999999999998765432211110 00 000000000
Q ss_pred cccccCC---ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 285 FTMMADP---LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 285 ~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....... ..........+..+.+++.+||+.||.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0001111234567899999999999999999999885
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=331.62 Aligned_cols=257 Identities=23% Similarity=0.281 Sum_probs=211.1
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeC
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG 123 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 123 (336)
..+....++|.++++||+|+||.|.+++++.|++.||+|++.+. ......-|..|-.+|.--+.+-|+.++-.|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34445568999999999999999999999999999999999773 234456788899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
.++|+||||++||+|..++..+ ..+++..++-++..|+.||..||+.| +|||||||+|||+|..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999763 37999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccc----c-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAM----T-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
.|..+...+ .......+|||.|.+||++. + +.|++..|.||+|+++|||+.|..||....-.+. +.+-
T Consensus 221 sClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT-----Y~KI- 293 (1317)
T KOG0612|consen 221 SCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET-----YGKI- 293 (1317)
T ss_pred hHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH-----HHHH-
Confidence 998775433 44566689999999999985 2 5699999999999999999999999965332111 1111
Q ss_pred hhcccccccccCCccCCCCc--HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHH
Q 036144 279 LRDKKKFTMMADPLLEGQYP--RKGLYQALAVAGMCLQEDADSRPF---MVDVVT 328 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rpt---~~evl~ 328 (336)
.+-.-.-.|| ...+..+.+||.+.+. +|+.|.. ++++-.
T Consensus 294 ----------m~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 294 ----------MNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred ----------hchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1110011222 3367789999998875 8888887 777654
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=297.98 Aligned_cols=269 Identities=23% Similarity=0.298 Sum_probs=198.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCC------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD------ 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 124 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4579999999999999999999999999999998864322 22234678999999999999999999886543
Q ss_pred --eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 125 --QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 125 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
..++||||+. ++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 4599999994 588887754 2346899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCc--ceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH--
Q 036144 203 GLAKLGPTGGKD--HVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-- 277 (336)
Q Consensus 203 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 277 (336)
|++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||...........+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999755332211 112334678899999987664 478999999999999999999999976554322222221110
Q ss_pred ---HhhcccccccccCCccCCCC---------cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 278 ---LLRDKKKFTMMADPLLEGQY---------PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 278 ---~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+.................. +...+..+.++|.+||+.||.+|||++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000000000000 0012346789999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=291.34 Aligned_cols=243 Identities=26% Similarity=0.356 Sum_probs=199.6
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
||.|++|.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999999999999999865432 2345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++.. ...++...+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999865 345889999999999999999999988 9999999999999999999999999997654321 223
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCc
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
...|++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ........ .......++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~----------~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDIL----------KGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHh----------ccCCCCCCC
Confidence 3568999999999988889999999999999999999999998655311 11111111 001111233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 299 RKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 299 ~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
...+..+.+++.+||+.+|.+||+ +.|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 334668999999999999999999 788776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=294.97 Aligned_cols=262 Identities=24% Similarity=0.278 Sum_probs=200.7
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
|++.+.||.|++|.||+|.+..+|..||+|++.... ......+.+|+.+++.++|||++++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 677889999999999999999899999999986543 222356788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 81 -DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred -CcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 578999886532 246899999999999999999999988 9999999999999999999999999987543221
Q ss_pred cceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc----------
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK---------- 282 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 282 (336)
.......++..|+|||++.+. .++.++|+||||+++|+|++|..||........... .........
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCCCChHHhhhhhhc
Confidence 112233568899999987664 578999999999999999999999976543221111 000000000
Q ss_pred ----cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 ----KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......... .........+..+.+++.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQ-DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhccccccc-chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000 001112234568899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=293.66 Aligned_cols=261 Identities=21% Similarity=0.227 Sum_probs=196.2
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhcc-CCCccceEEEEEeC--CeEEEEEE
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQ-HQNLVNLIGYCADG--DQRILVYE 131 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e 131 (336)
|.+.+.||+|+||.||+|.+..++..||+|.+..... .......+|+.++..+. |+|++++++++.+. ...++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6678899999999999999999999999999865422 22234457888888885 99999999999887 88999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+. ++|.+.+.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++. +.++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 588777754 2356899999999999999999999998 999999999999999 99999999999764322
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHHhhcc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------KPLLRDK 282 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 282 (336)
. ......++..|+|||.+.. +.++.++|||||||++|+|++|..||...+..+........ ...+...
T Consensus 153 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 P---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred C---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 1 1233468899999997654 56789999999999999999999999775543211111000 0000000
Q ss_pred cccccccCCc-cCC---CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPL-LEG---QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~-~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .....+. ... ......+..+.+++.+||+.+|++|||++++++
T Consensus 230 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RH-MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cc-ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 0000000 000 011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=288.00 Aligned_cols=252 Identities=26% Similarity=0.356 Sum_probs=207.7
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRILVY 130 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~ 130 (336)
+|...+.||+|++|.||+|.+..++..|++|++..... ...+.+.+|+.+++.++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47788899999999999999998899999999866542 3456788999999999999999999999988 8899999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++... ..+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998752 37899999999999999999999988 99999999999999999999999999986544
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
...........++..|+|||.+.+..++.++||||||+++++|++|..||..... ......... .
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~----------~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALYKIG----------S 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHHhcc----------c
Confidence 3221123345689999999999888899999999999999999999999976551 111111110 0
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......+...+..+.+++.+||+.||.+||++.+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111233344678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=296.34 Aligned_cols=267 Identities=20% Similarity=0.215 Sum_probs=199.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCe-----
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQ----- 125 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~----- 125 (336)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468899999999999999999999999999998765422 22356788999999995 6999999999887665
Q ss_pred EEEEEEcCCCCChhhhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-CCceEEcccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPD-QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-EFNPKLSDFG 203 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-~~~~kl~Dfg 203 (336)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 888887653322 456899999999999999999999998 999999999999998 8899999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc-
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD- 281 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 281 (336)
++....... .......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.......... .........
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL--HIFKLLGTPT 232 (295)
T ss_pred cceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHhCCCC
Confidence 987543221 11223357889999998865 467999999999999999999999997644322111 000000000
Q ss_pred ccc------ccccc-CCc----cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKK------FTMMA-DPL----LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~------~~~~~-~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... ..... .+. ......+..+..+.++|.+||+.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00000 000 000011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=288.59 Aligned_cols=247 Identities=19% Similarity=0.236 Sum_probs=194.9
Q ss_pred HHHhcCCCCcccc--cccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeE
Q 036144 50 ADATENFNPDCLV--GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 50 ~~~~~~y~~~~~i--g~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (336)
....++|.+.+.+ |.|+||.||++.++.++..+|+|.+........ |+.....+ +||||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3445677777776 999999999999999999999999865422211 22222222 699999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEcccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLA 205 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~ 205 (336)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 85 ~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 999999999999999865 347899999999999999999999998 99999999999999988 9999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
...... ....|+..|+|||++.+..++.++|+||+|+++|+|++|..||........ ....+....
T Consensus 158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~------- 223 (267)
T PHA03390 158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ------- 223 (267)
T ss_pred eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-------
Confidence 754321 234689999999999998999999999999999999999999985433221 111111100
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-MVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~evl~ 328 (336)
. .........+..+.+++.+||+.+|.+||+ ++++++
T Consensus 224 ----~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ----Q--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----c--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 001122345668999999999999999996 688874
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=290.99 Aligned_cols=251 Identities=20% Similarity=0.299 Sum_probs=203.5
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|.+.+.||+|+||.||+|.++.+|..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4788899999999999999999999999999986532 22345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc-eEEccccccccCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN-PKLSDFGLAKLGPTG 211 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~ 211 (336)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998652 2345789999999999999999999998 999999999999988865 699999998765332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. .......|++.|+|||++.+..++.++|+||||+++++|++|..||....... ........ . .
T Consensus 156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~--~----~-- 219 (257)
T cd08225 156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQG--Y----F-- 219 (257)
T ss_pred c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhcc--c----C--
Confidence 1 12233468999999999988889999999999999999999999987543211 11111100 0 0
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.......+..+.+++.+||+.+|++|||+.++++.
T Consensus 220 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 ---APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01122344579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=295.62 Aligned_cols=249 Identities=27% Similarity=0.383 Sum_probs=199.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..|...+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++|||++++++++......++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 347788889999999999999998899999999864422 22346888999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+. |+|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9996 577777654 2456899999999999999999999998 99999999999999999999999999865322
Q ss_pred CCCcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.....|+..|+|||.+. .+.++.++|||||||++|+|++|..||........... .....
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------~~~~~----- 240 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQNE----- 240 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HHhcc-----
Confidence 22346889999999874 45689999999999999999999999876432211110 00000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.........+..+.+++.+||+.+|.+||++.++++.+.
T Consensus 241 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 -----SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -----CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 000111234557899999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=293.66 Aligned_cols=245 Identities=25% Similarity=0.345 Sum_probs=199.6
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
...||+|+||.||++.+..+++.||+|.+..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35699999999999999999999999998655444456788999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 105 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~ 174 (292)
T cd06657 105 TDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRK 174 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cccc
Confidence 987643 35788999999999999999999998 9999999999999999999999999986543221 1233
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCc
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
...|++.|+|||.+.+..++.++|+||+|+++|+|++|..||............ .... .+.+. ..
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~~~~----------~~~~~--~~ 239 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNL----------PPKLK--NL 239 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhhC----------CcccC--Cc
Confidence 456899999999998888999999999999999999999999764332111111 0000 00000 01
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 299 RKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 299 ~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+..+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 123457889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=288.78 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=201.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-----CccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-----NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQR 126 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 126 (336)
.+|.+.+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999999999999999874321 22335688899999999999999999998764 467
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
+++|||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999998864 345788899999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCC-cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 207 LGPTGGK-DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 207 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
....... ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||........ ... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----~------- 221 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFK----I------- 221 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHH----H-------
Confidence 5432111 1112335689999999999888899999999999999999999999975432111 110 0
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........++...+..+.+++.+||+ +|..|||+.+++.
T Consensus 222 ---~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ---ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01111123445566789999999999 6799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.60 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=202.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe----CCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD----GDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 126 (336)
.++|++.+.||.|+||.||+|.+..+|..||+|.+.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999999999999999986542 2334567889999999999999999988753 3568
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~-~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehh-hhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 9999999 4689888754 355899999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCc--ceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----H
Q 036144 207 LGPTGGKD--HVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-----L 278 (336)
Q Consensus 207 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~ 278 (336)
........ .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 54332211 11234578999999998765 4689999999999999999999999976544322111110000 0
Q ss_pred hhc--cccccccc---CCccC---CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRD--KKKFTMMA---DPLLE---GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~--~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+.. ........ ..... .......+..+.+++.+||+.+|.+|||+++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 00000000 00000 0011234668999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=299.11 Aligned_cols=264 Identities=21% Similarity=0.255 Sum_probs=195.9
Q ss_pred cccccc--CceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEG--GYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G--~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
..||+| +||+||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++......++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 347777 999999999999999999999865432 2235678899999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999887632 345888999999999999999999988 9999999999999999999999998654322111110
Q ss_pred -----eeeeeccCccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-------------
Q 036144 216 -----VSTRVMGTYGYCAPEYAMTG--QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA------------- 275 (336)
Q Consensus 216 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------- 275 (336)
......++..|+|||++.+. .++.++|||||||++|+|++|..||...............
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 01112356679999998764 5789999999999999999999999765432110000000
Q ss_pred --HHH------hhc--------ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 --KPL------LRD--------KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 --~~~------~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... ... ......+....+........+..+.+|+.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 000 00000111111222223456778999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=297.49 Aligned_cols=249 Identities=28% Similarity=0.365 Sum_probs=209.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.+.|...++||+|+||.|+-++-+.||+.+|.|.+.+.. .......++|-.+|..++.+.||.+--.|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 367888999999999999999999999999999886532 22334578899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
+..|+||+|.=+|.... ...+++..++-++.+|+.||++||..+ ||.|||||+|||+|+.|+++|+|+|+|...+
T Consensus 264 LtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999998887743 367999999999999999999999998 9999999999999999999999999998775
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.+.. ....+||.+|||||++.++.|+...|.|||||++|+|+.|+.||...........+.. ..+.
T Consensus 339 ~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr--r~~~--------- 404 (591)
T KOG0986|consen 339 EGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR--RTLE--------- 404 (591)
T ss_pred CCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH--HHhc---------
Confidence 5433 3445899999999999999999999999999999999999999987554332211111 1111
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
....++...++++.+|.+..|..||++|...
T Consensus 405 ---~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 ---DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ---chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1234566677899999999999999999654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.27 Aligned_cols=266 Identities=23% Similarity=0.338 Sum_probs=201.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeC-----Ce
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG-----DQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 125 (336)
..+|.+.+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999999999999999998653 222345677899999999999999999987644 34
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++|+||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCC-CCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 79999999 5788888754 456899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-------- 276 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 276 (336)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+............
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7653321 22334568899999998765 468999999999999999999999997653221111110000
Q ss_pred HHhhcccc------cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 277 PLLRDKKK------FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 277 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
........ .......... ......+..+.+++.+||+.+|++|||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 0000000000 1112346678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.17 Aligned_cols=273 Identities=18% Similarity=0.207 Sum_probs=190.1
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccC-eEEEEEee--------------c---CCCCccHHHHHHHHHHHhhccCCC
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVD-QVVAVKQL--------------D---RSGNQGSREFFAEVLMLSLVQHQN 112 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~-~~vavK~~--------------~---~~~~~~~~~~~~e~~~l~~l~h~~ 112 (336)
...++|++.+.||+|+||.||++..+... ...+.|.+ . .........+.+|+.+++.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998765322 22222211 0 011122345789999999999999
Q ss_pred ccceEEEEEeCCeEEEEEEcCCCCChhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLP-PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 113 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
|+++++++...+..++|++++ +++|.+++.... ..........+..++.||+.||.|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 999999999999999999998 567777664321 11233445667889999999999999998 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCC-CCCCCCccccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSA-IDNSRPSEEQN 270 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p-~~~~~~~~~~~ 270 (336)
+.++.+||+|||++....... ........||..|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999997653321 1223346799999999999999999999999999999999998754 44332222211
Q ss_pred HHHHHHHHhhccccc-------ccccCC----ccCCCCc-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 271 LVTWAKPLLRDKKKF-------TMMADP----LLEGQYP-----RKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~-------~~~~~~----~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+......+-.....+ ....+. .....++ ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111111000000000 000000 0000000 012346778899999999999999999986
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=294.73 Aligned_cols=267 Identities=20% Similarity=0.238 Sum_probs=198.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|++.+.||+|++|.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 578999999999999999999998999999999865432 223567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-CCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-EFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~ 210 (336)
|++ ++|.+++... ....+++..++.++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 6888877542 2334678888899999999999999988 999999999999985 45799999999975432
Q ss_pred CCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--H---HHhhcccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--K---PLLRDKKK 284 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~---~~~~~~~~ 284 (336)
. ........+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||......+........ . ..+.....
T Consensus 156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 1 111233467889999998866 46789999999999999999999999765432211111000 0 00000000
Q ss_pred cccc---c---CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 285 FTMM---A---DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 285 ~~~~---~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... . ............+..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0 000000011234567899999999999999999999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=301.84 Aligned_cols=265 Identities=21% Similarity=0.289 Sum_probs=198.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeC-----CeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG-----DQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 126 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999999999999986432 22345678899999999999999999887644 357
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++++||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 89999995 588777643 46899999999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCc-ceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc--
Q 036144 207 LGPTGGKD-HVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK-- 282 (336)
Q Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-- 282 (336)
........ .......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+...... .....+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCCH
Confidence 54332111 11233568999999998654 568999999999999999999999997643221100 000000000
Q ss_pred cccccccC-----------CccCCC---CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 283 KKFTMMAD-----------PLLEGQ---YPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 283 ~~~~~~~~-----------~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.....+.+ ...... .....+..+.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000000 011235578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=335.76 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=209.7
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
....+|.-...||.|.||.||-|.+..+|+..|+|.+.-.. ......+.+|..++..++|||+|+++++-.+.+..++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34567888889999999999999999999999999886443 3334668899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
.||||++|+|.+++.. ....++.....+..|++.|+.|||+.| ||||||||+||+++.+|.+|++|||.|...
T Consensus 1312 FMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999865 344666667778899999999999999 999999999999999999999999999876
Q ss_pred CCCCCc--ceeeeeccCccccCccccccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 209 PTGGKD--HVSTRVMGTYGYCAPEYAMTG---QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 209 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
.....+ .......||+-|||||++.+. .-..+.|||||||++.||+||+.||...+.+= .+.+
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy--------- 1452 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMY--------- 1452 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHh---------
Confidence 543211 122346799999999999864 45689999999999999999999998755321 1111
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..... -..++|...+..-.+++..||+.||+.|.++.++++.
T Consensus 1453 ~V~~g----h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 HVAAG----HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHhcc----CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 01111 1124455577889999999999999999999988863
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.58 Aligned_cols=264 Identities=30% Similarity=0.494 Sum_probs=209.6
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.....|....+||+|+||.||+|.+..++..||+|.+...... ...|++.++.++||||+++++++.+....++||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3345688888999999999999999888999999998644322 235688999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. +++..+..++.|++.|++|||....++|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred eCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999843 7888999999999999999996544559999999999999998887765 555432211
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......|.+..... .......+
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~ 906 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWID 906 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhheeC
Confidence 1223688999999999999999999999999999999999999954322 223445555433322 23334445
Q ss_pred CccCC--CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEG--QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~--~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
+.+.. ..+......+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 54432 234456667899999999999999999999999999874
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=289.27 Aligned_cols=242 Identities=25% Similarity=0.351 Sum_probs=191.0
Q ss_pred cccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHH---HHhhccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVL---MLSLVQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~---~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
.||+|+||.||+|.+..+++.||+|.+...... ....+..|.. .++...||+|+++++++......++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999988999999998654321 1122334433 3444579999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
|++|..++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 9999988754 456899999999999999999999988 999999999999999999999999998754221
Q ss_pred ceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 215 HVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
......|+..|+|||.+.++ .++.++||||+|+++|+|++|..||............. ... ..
T Consensus 151 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~------------~~ 214 (278)
T cd05606 151 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTL------------TM 214 (278)
T ss_pred -CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH---Hhh------------cc
Confidence 12345789999999998754 68999999999999999999999998653322111110 000 00
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
...++...+..+.+++.+||..+|.+|| ++.++++
T Consensus 215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1122333456899999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=285.33 Aligned_cols=248 Identities=28% Similarity=0.413 Sum_probs=205.9
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|.+.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+|+++++.++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47888999999999999999998899999999876543 3446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999865 367899999999999999999999998 9999999999999999999999999998654322
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
. ......++..|+|||...+..++.++|+||+|+++|+|++|..||........ .+ . ....
T Consensus 154 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~-~-~~~~----------- 214 (254)
T cd06627 154 K--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LF-R-IVQD----------- 214 (254)
T ss_pred c--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HH-H-Hhcc-----------
Confidence 2 12345689999999998888889999999999999999999999975442111 00 0 0000
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....++...+..+.+++.+||..+|++|||+.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 011223334568899999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=281.09 Aligned_cols=254 Identities=22% Similarity=0.227 Sum_probs=201.5
Q ss_pred HhcCCCCc-ccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEe----CCe
Q 036144 52 ATENFNPD-CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCAD----GDQ 125 (336)
Q Consensus 52 ~~~~y~~~-~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 125 (336)
.+++|.+. ++||-|-.|.|..+.++.|++.+|+|++.. ....++|++.--.. .|||||.++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666654 479999999999999999999999999853 35667888876554 59999999998864 356
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC---CceEEccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---FNPKLSDF 202 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~---~~~kl~Df 202 (336)
+.+|||.++||.|.+.+++. ....+++.++..|+.||..|+.|||+.+ |.||||||+|+|.+.+ ..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 77999999999999999873 4577999999999999999999999999 9999999999999654 45999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
|+|+.... .....+.+.||.|.|||++....|+...|+||+|+++|-|++|.+||-....... ....+.-+..+
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---spgMk~rI~~g 282 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKRRIRTG 282 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---ChhHHhHhhcc
Confidence 99985432 2335667899999999999999999999999999999999999999965432111 11111111000
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+..+--...++...++|+.+|..+|.+|.|+.+++.
T Consensus 283 -------qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 -------QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -------CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 011111222356788999999999999999999999875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=290.57 Aligned_cols=259 Identities=16% Similarity=0.167 Sum_probs=189.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCCCccHH-----------HHHHHHHHHhhccCCCccceE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSGNQGSR-----------EFFAEVLMLSLVQHQNLVNLI 117 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~~iv~~~ 117 (336)
...+|.+.+.||+|+||.||+|.+..+ +..+|+|+.......... ....+...+..+.|+++++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999999877 667788764332211111 112233445567899999999
Q ss_pred EEEEeCC----eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC
Q 036144 118 GYCADGD----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA 193 (336)
Q Consensus 118 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~ 193 (336)
+++.... ..+++++++ ..++.+.+.. ....++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 8766543 446788877 4566666543 223567788899999999999999998 999999999999999
Q ss_pred CCceEEccccccccCCCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 036144 194 EFNPKLSDFGLAKLGPTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE 268 (336)
Q Consensus 194 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 268 (336)
++.++|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999765322111 112235699999999999999999999999999999999999999987633221
Q ss_pred c-cHH--HHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 269 Q-NLV--TWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 269 ~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
. ... .+...+.. ... .....+..+.+++..|+..+|++||++.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKCDFIKRLHE----------GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHHHHHHHhhh----------hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 100 11111110 000 01123467999999999999999999999998774
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.09 Aligned_cols=264 Identities=23% Similarity=0.272 Sum_probs=201.2
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEEEEEE
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRILVYE 131 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 131 (336)
|++.+.||.|+||.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999999999999999997653 23345688999999999999999999999888 88999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|++ ++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 996 5888887642 257899999999999999999999998 999999999999999999999999999765433
Q ss_pred CCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc--
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM-- 288 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 288 (336)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+....... ........
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP-TDENWPGVSK 231 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-chhhcccccc
Confidence 21 12233457889999997765 467899999999999999999999997655332211111000000 00000000
Q ss_pred ------------cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ------------ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ------------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....+...+....+..+.+++.+||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000111112668999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=298.31 Aligned_cols=269 Identities=24% Similarity=0.322 Sum_probs=201.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhc-cCCCccceEEEEEeC--CeE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADG--DQR 126 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 126 (336)
..++|.+.+.||+|+||.||+|.+..+++.+|+|.+... .......+.+|+.+++.+ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 356789999999999999999999988999999988542 222345577899999999 999999999988653 468
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+. ++|.+++.. ..+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 699888754 26788888999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCc---ceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----
Q 036144 207 LGPTGGKD---HVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP----- 277 (336)
Q Consensus 207 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----- 277 (336)
........ .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65332211 12334568999999998765 4678999999999999999999999976543322111100000
Q ss_pred ---Hhhcc---cccccccCCc--cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 278 ---LLRDK---KKFTMMADPL--LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 278 ---~~~~~---~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.+... .......... ......+..+..+.+++.+||+.||.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 0000000000 0001111245689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=300.71 Aligned_cols=265 Identities=25% Similarity=0.402 Sum_probs=216.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccH-HHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS-REFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
....+.++||+|.||.|.++.... +..||+|.++....... .+|.+|+++|.+|+||||++++++|..++-+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 456778899999999999998875 68999999987765554 7899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++|+|.+++.... ...+.......|+.||+.|++||.+.+ +|||||.+.|+|++.++++||+|||+++-+-.+.
T Consensus 617 mEnGDLnqFl~ahe--apt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHE--LPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhcc--CcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999998732 222455566789999999999999999 9999999999999999999999999998665555
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHH--hCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELI--TGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~--~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
-.......+-..+|||||.+..+.++.++|+|+||+++||++ +...||+....+ +.+.....++.....-.-+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l-- 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVL-- 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceec--
Confidence 444555566788999999999999999999999999999975 467888765433 2333333333332221111
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.-|.-++..+.+++.+||..+.++|||++++...|+...
T Consensus 767 -----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 767 -----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 123445668899999999999999999999999887643
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=288.74 Aligned_cols=242 Identities=23% Similarity=0.262 Sum_probs=189.9
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCcc---HHHHHHHHHHH-hhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG---SREFFAEVLML-SLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||.|+||.||+|.+..+++.||+|.+....... ...+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999999889999999986543211 12334454443 455899999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999865 356889999999999999999999998 99999999999999999999999999865322
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||............ ...... ...
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~~~--------~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI------LSRRIN--------WPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcccC--------CCC
Confidence 23346889999999998888999999999999999999999999765432211100 000000 011
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......+..+.+++.+||+.+|++||++.++.+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 112234568999999999999999997654444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=299.81 Aligned_cols=267 Identities=23% Similarity=0.290 Sum_probs=204.9
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCC-----eEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD-----QRI 127 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 127 (336)
+|.+.+.||.|++|.||+|.+..+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999999889999999987643 334467889999999999999999999987765 789
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
++|||+. ++|.+++.. ...+++..++.++.|++.||.+||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999996 588888754 347899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCc-ceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH-----hh
Q 036144 208 GPTGGKD-HVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL-----LR 280 (336)
Q Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~ 280 (336)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||......+....+...... +.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 5443210 122345688999999999887 8899999999999999999999999876543221111100000 00
Q ss_pred --cccccccccC---C---ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 281 --DKKKFTMMAD---P---LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 281 --~~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.......... . ..........+..+.+++.+||+.+|.+|||+++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000 0 00001112245678999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=291.27 Aligned_cols=261 Identities=23% Similarity=0.287 Sum_probs=203.1
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
|.+.+.||.|++|.||+|.+..+++.+++|.+...... ....+..|+.+++.++|+||+++++++......++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778899999999999999988999999998654322 3456888999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 D-TDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 6 588887765 2357899999999999999999999998 9999999999999999999999999987654332
Q ss_pred cceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc--cccccccc-
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD--KKKFTMMA- 289 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~- 289 (336)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+. ..+.. ........
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF---RTLGTPDPEVWPKFTS 228 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---HHcCCCchHhcccchh
Confidence 122334688899999998876 78999999999999999999999997655322211110 00000 00000000
Q ss_pred ------------CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 ------------DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
............+..+.+++.+||+.||.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000001112345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=291.28 Aligned_cols=245 Identities=29% Similarity=0.401 Sum_probs=196.9
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.|...+.||+|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++|||++++++++.+....++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 36777789999999999999998999999999865432 223467889999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-- 172 (313)
T cd06633 102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-- 172 (313)
T ss_pred cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC--
Confidence 994 677777654 2456899999999999999999999998 9999999999999999999999999986421
Q ss_pred CCcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
......|+..|+|||++. +..++.++|||||||++|+|++|..||............ ... ..
T Consensus 173 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~------~~~--~~--- 237 (313)
T cd06633 173 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQN--DS--- 237 (313)
T ss_pred ----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------Hhc--CC---
Confidence 123456889999999874 456889999999999999999999998765432211110 000 00
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+ .......+..+.+++.+||+.+|.+||++.+++.
T Consensus 238 --~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 --P---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred --C---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0111223456899999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=288.92 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=197.0
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
||.|+||.||+|.+..+|+.+++|.+..... .....+.+|+.+++.++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999865433 3345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC-----
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK----- 213 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 213 (336)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999865 236899999999999999999999998 99999999999999999999999999875433211
Q ss_pred -cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 -DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
........++..|+|||...+..++.++|+||||+++|+|++|..||......+... ..... ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~~~--~~------- 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ------NILNG--KI------- 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHhcC--Cc-------
Confidence 112234568889999999988889999999999999999999999997654322111 11000 00
Q ss_pred cCCCCcHH--HHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 293 LEGQYPRK--GLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 293 ~~~~~~~~--~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
..+.. .+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus 219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 01111 256889999999999999999995554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=291.95 Aligned_cols=248 Identities=28% Similarity=0.372 Sum_probs=198.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..|...+.||+|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677778999999999999999889999999986432 223356788999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+. |+|.+++.. ....+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9995 688777654 2356889999999999999999999988 99999999999999999999999999875422
Q ss_pred CCCcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.....|+..|+|||.+. ...++.++|||||||++|+|++|..||............ . ...
T Consensus 168 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~-~~~---- 230 (308)
T cd06634 168 ------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------A-QNE---- 230 (308)
T ss_pred ------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH------h-hcC----
Confidence 22346889999999874 356789999999999999999999998764322111100 0 000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
.+ .......+..+.+++.+||+.+|++||++.+++..-
T Consensus 231 --~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 231 --SP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred --CC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00 011223456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=284.68 Aligned_cols=273 Identities=21% Similarity=0.249 Sum_probs=202.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCe----EEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe-CCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQ----VVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD-GDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 125 (336)
...|+..+.||+|.||.||+|....++. .+|+|.++... ........+|+.+++.++|||++.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3569999999999999999997765543 68999986542 2233568899999999999999999998877 778
Q ss_pred EEEEEEcCCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC----CceEEc
Q 036144 126 RILVYEFMSNGSLENHFLDLPP-DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE----FNPKLS 200 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~----~~~kl~ 200 (336)
.+|++||.+. +|...+..... ....++...+..|+.||+.|+.|||++. |+||||||.||||..+ |.|||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999954 88887765332 3357899999999999999999999999 9999999999999888 899999
Q ss_pred cccccccCCCCCCcc-eeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCccccc---HHHHH
Q 036144 201 DFGLAKLGPTGGKDH-VSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQN---LVTWA 275 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~---~~~~~ 275 (336)
|||+++.+..+-... .....+-|.+|+|||.+.|. .|+.+.||||+|||+.||++..+.|......-... .....
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999765443322 33456789999999999875 79999999999999999999999887644221111 11111
Q ss_pred HHHh--------------hcccccccccCCccCCCCcH-----------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 276 KPLL--------------RDKKKFTMMADPLLEGQYPR-----------KGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 276 ~~~~--------------~~~~~~~~~~~~~~~~~~~~-----------~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..++ .+-......+.......+.. .-+....+|+.++|..||.+|.|+++.++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 1111 00000000000000000000 012347899999999999999999998873
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=292.04 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=205.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 129 (336)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999999999999999986532 222356788999999998 99999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
||++++++|.+++.. ...+++..++.++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999875 347999999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCC------------------cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccH
Q 036144 210 TGGK------------------DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNL 271 (336)
Q Consensus 210 ~~~~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~ 271 (336)
.... ........++..|+|||...+..++.++|+||||++++++++|..||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 3221 0222345688999999999888899999999999999999999999986542111
Q ss_pred HHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHH
Q 036144 272 VTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM----VDVVT 328 (336)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~----~evl~ 328 (336)
.. .... ....++...+..+.+++.+||+.+|.+|||+ +++++
T Consensus 231 ~~---~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQ---KILK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH---HHHh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 0000 0112233346689999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=290.47 Aligned_cols=268 Identities=25% Similarity=0.310 Sum_probs=199.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCC-----
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD----- 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 124 (336)
..++|++.+.||+|+||.||+|.++.+|+.||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45789999999999999999999998899999999865432 22346778999999999999999999887654
Q ss_pred -----eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 125 -----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 125 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
..++||||+++ ++.+.+.. ....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999965 77776654 2356899999999999999999999998 999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP- 277 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~- 277 (336)
+|||.+........ .......++..|+|||.+.+. .++.++|||||||++++|++|++||......+....+.....
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99999876533221 112223467889999987653 578999999999999999999999976443221111111000
Q ss_pred ----Hhhcccccccc--cC------CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 278 ----LLRDKKKFTMM--AD------PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 278 ----~~~~~~~~~~~--~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+......... .+ ......+ ...+..+.+++..||+.||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000 00 0000001 123557999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=278.61 Aligned_cols=254 Identities=23% Similarity=0.324 Sum_probs=203.8
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
+.||+|+|+.|.-+....+|..||||++.+........+.+|++++.+.+ |+||+.++++|+++...|||||-+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 36999999999999999999999999999887777788999999999986 99999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc---eEEccccccccCC-----C
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN---PKLSDFGLAKLGP-----T 210 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~~~-----~ 210 (336)
...+.+ +..+++..+.++..+|+.||.+||.+| |.||||||+|||-..... ||||||++..-.. .
T Consensus 164 LshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999876 677999999999999999999999999 999999999999966544 8999998864211 1
Q ss_pred CCCcceeeeeccCccccCccccc---c--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc-----cHHHHHHHHhh
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAM---T--GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ-----NLVTWAKPLLR 280 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~ 280 (336)
...+....+.+|+..|||||+.. + ..|+.+.|.||||+|+|-|++|.+||.+....+.. .-......++
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF- 315 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF- 315 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH-
Confidence 22223345678999999999763 2 35899999999999999999999999875543321 1111111111
Q ss_pred cccccccccCCccCCCCc----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 281 DKKKFTMMADPLLEGQYP----RKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+.+.+... +|| .+.+....+++..+|..|+..|.++..++.
T Consensus 316 -----esIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 316 -----ESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred -----HHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11111111 222 246778899999999999999998887765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=256.14 Aligned_cols=265 Identities=22% Similarity=0.265 Sum_probs=206.9
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+|...++||+|.||+||+|+++.+++.||+|.++.... .......+|+-+++.++|.|||+++++...+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45666789999999999999999999999999875432 2345688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
| ..+|..++.. .++.++...++.++.|+++||.++|+++ +.|||+||.|.+|+.+|.+||+|||+++.+.-
T Consensus 83 c-dqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi-- 153 (292)
T KOG0662|consen 83 C-DQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI-- 153 (292)
T ss_pred h-hHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC--
Confidence 9 6688888876 4677899999999999999999999999 99999999999999999999999999986533
Q ss_pred CcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHh--hcccccccc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLL--RDKKKFTMM 288 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 288 (336)
........+-|.+|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+..+....+-+..... ..-..+..+
T Consensus 154 pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 23334455779999999999875 68999999999999999987 556566655444332222221111 111123333
Q ss_pred cCCccCCCCcH---------HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPR---------KGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~---------~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.|......++. .....-++++.+.|.-+|..|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 33333332322 22234567888899999999999998875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=291.59 Aligned_cols=269 Identities=23% Similarity=0.266 Sum_probs=197.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCC------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGD------ 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 124 (336)
.++|.+.+.||+|+||.||+|.++.+++.+|+|.+...... ....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999999999999999998643322 2245678999999999999999999875433
Q ss_pred --eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 125 --QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 125 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
..++||||+. ++|.+.+.. ....+++..+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4689999985 567776654 2457999999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCc---------ceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHH
Q 036144 203 GLAKLGPTGGKD---------HVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV 272 (336)
Q Consensus 203 g~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~ 272 (336)
|++......... ...+...+++.|+|||.+.+. .++.++|||||||++|+|++|.+||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 998754322111 112334678899999987654 5899999999999999999999999765543221111
Q ss_pred HHHHH-----HhhcccccccccCCccCCCCc-------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 273 TWAKP-----LLRDKKKFTMMADPLLEGQYP-------RKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 273 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... .+..........+.......+ ......+.+++.+||+.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 10000 000000000000000000001 112357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=295.03 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=199.2
Q ss_pred hcCCCC-cccccccCceEEEEEEEcccCeEEEEEeecCCCCcc--------------HHHHHHHHHHHhhccCCCccceE
Q 036144 53 TENFNP-DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG--------------SREFFAEVLMLSLVQHQNLVNLI 117 (336)
Q Consensus 53 ~~~y~~-~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~iv~~~ 117 (336)
.++|.. .+.||.|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 356664 567999999999999999899999999986543221 12467899999999999999999
Q ss_pred EEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 118 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
+++......++||||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence 99999999999999995 689888854 456889999999999999999999998 9999999999999999999
Q ss_pred EEccccccccCCCCC------------CcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 036144 198 KLSDFGLAKLGPTGG------------KDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSR 264 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~ 264 (336)
+|+|||++....... .........++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999987543110 01112224568899999998764 47899999999999999999999998665
Q ss_pred CcccccHHHHHHHHhhcccc--ccc--------ccCCccC---CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 265 PSEEQNLVTWAKPLLRDKKK--FTM--------MADPLLE---GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~--~~~--------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+....+. ........ ... ....... .......+..+.+++.+||+.+|++|||+++++.
T Consensus 239 ~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLGRIF---ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHH---HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 432211110 00000000 000 0000000 0011123567899999999999999999999986
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=299.41 Aligned_cols=267 Identities=21% Similarity=0.298 Sum_probs=198.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeC---------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG--------- 123 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------- 123 (336)
..+|.+.+.||.|+||.||+|.+..+|..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999999999999999998766555567788999999999999999999776543
Q ss_pred -----CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-CCce
Q 036144 124 -----DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-EFNP 197 (336)
Q Consensus 124 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-~~~~ 197 (336)
...++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999995 688887743 45889999999999999999999998 999999999999974 5578
Q ss_pred EEccccccccCCCCCCc-ceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKD-HVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA 275 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 275 (336)
+|+|||++......... .......++..|+|||.+.. ..++.++|||||||++|+|++|..||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998754321111 11123457889999998754 56889999999999999999999999766543221111100
Q ss_pred HHHhhc---cc---cc-ccccCCccC-----CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 KPLLRD---KK---KF-TMMADPLLE-----GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 ~~~~~~---~~---~~-~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+.... .. .. ......... ..+....+..+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 00 00 000000000 0011124457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=290.20 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=192.0
Q ss_pred CceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCChhhhhc
Q 036144 66 GYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFL 143 (336)
Q Consensus 66 ~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 143 (336)
++|.||.+....+++.||+|++... .......+.+|+.+++.++|+||+++++++......+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4466666677778999999998754 23345678999999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC-----cceee
Q 036144 144 DLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK-----DHVST 218 (336)
Q Consensus 144 ~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~ 218 (336)
.. ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||.+........ .....
T Consensus 92 ~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 TH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 53 2345888999999999999999999998 99999999999999999999999998864432111 11123
Q ss_pred eeccCccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH----hhc------ccccc
Q 036144 219 RVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL----LRD------KKKFT 286 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~------~~~~~ 286 (336)
...++..|+|||++.. ..++.++|+||+||++|+|++|..||........ ........ +.. .....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcC
Confidence 3457788999999875 3688999999999999999999999986442211 11100000 000 00000
Q ss_pred c----ccC----CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 M----MAD----PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~----~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ..+ ...........+..+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 000 00111223345668999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=295.76 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=211.2
Q ss_pred CCCCcccccccCceEEEEEEEcc----cCeEEEEEeecCC-CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEA----VDQVVAVKQLDRS-GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.....++||.|.||.||.|.... ..-.||||..+.+ .....+.|+.|..+|+.++||||++++|++.+. -.++|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 34456689999999999998743 2345999999874 445578899999999999999999999999864 46899
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
||+++.|.|..+++. .+..++......++.||..||.|||+.. +|||||-..||||....-|||+|||+++.+.
T Consensus 469 mEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 469 MELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 999999999999987 5677999999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
+..-. ..+...-..-|||||.+....++.+||||.||+++||+++ |..||.+-...+..-.
T Consensus 543 d~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~----------------- 604 (974)
T KOG4257|consen 543 DDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH----------------- 604 (974)
T ss_pred ccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-----------------
Confidence 54332 2233334567999999999999999999999999999866 9999987543332111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
+...-+...|+.++..+..|..+||..+|.+||++.++...|..+.
T Consensus 605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 1112233567788889999999999999999999999999887653
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=274.07 Aligned_cols=250 Identities=27% Similarity=0.377 Sum_probs=198.5
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEEc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+.+.+..||.|..|.|+++..+.+|...|||.+....+. ...+++..+.++.... +|+||+.+++|..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 344556799999999999999999999999999876543 3355666776665544 89999999999999999999998
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
| +..++.++.. ..+++++..+-++...++.||.||.+++ +|+|||+||+|||+|+.|++||||||.+-.+.+.
T Consensus 173 M-s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS- 245 (391)
T KOG0983|consen 173 M-STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS- 245 (391)
T ss_pred H-HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc-
Confidence 8 5566666654 3567999999999999999999999854 4999999999999999999999999999765433
Q ss_pred CcceeeeeccCccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-cccHHHHHHHHhhcccccccc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMT---GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE-EQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 288 (336)
...+...|-+.|||||.+.. ..|+..+||||||++++||.||..||...+.+- ....+ +.+
T Consensus 246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv------ln~------- 310 (391)
T KOG0983|consen 246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV------LNE------- 310 (391)
T ss_pred --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH------Hhc-------
Confidence 33556679999999999864 368999999999999999999999999865421 11111 111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..|.+... ...+..+.+++..||..|+.+||...++++
T Consensus 311 ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 311 EPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11222211 125668999999999999999999999886
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=318.80 Aligned_cols=254 Identities=24% Similarity=0.323 Sum_probs=191.2
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEe------
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD------ 122 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 122 (336)
.....+|+.+..||+|+||.||+|+++-+|..||||+|.... ......+.+|++.+.+|+|||||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 345678999999999999999999999999999999997653 2234568899999999999999987643311
Q ss_pred --------------------------------------------------------------------------------
Q 036144 123 -------------------------------------------------------------------------------- 122 (336)
Q Consensus 123 -------------------------------------------------------------------------------- 122 (336)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------C--------CeEEEEEEcCCCCChhhhhccCCCCCCCC-CHHHHHHHHHHHHHHH
Q 036144 123 -------------------------G--------DQRILVYEFMSNGSLENHFLDLPPDQEPL-DWFTRMKIAGGAAKGL 168 (336)
Q Consensus 123 -------------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l-~~~~~~~i~~~l~~~l 168 (336)
. ..+|+-||||+..+|.+++... ... .....|.++.+|++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHH
Confidence 0 1146789999877777766541 111 3567899999999999
Q ss_pred HHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC----------------CCCCcceeeeeccCccccCcccc
Q 036144 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP----------------TGGKDHVSTRVMGTYGYCAPEYA 232 (336)
Q Consensus 169 ~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~ 232 (336)
.|+|+.| ||||||||.|||++.++.|||+|||+++... .+......+..+||.-|+|||++
T Consensus 711 aYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 9999999 9999999999999999999999999997611 11122245668999999999998
Q ss_pred ccC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC--CCCcHHHHHHHHH
Q 036144 233 MTG---QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE--GQYPRKGLYQALA 307 (336)
Q Consensus 233 ~~~---~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~ 307 (336)
.+. .|+.|+|+||||+|++||+. ||...- ..+..... + .+..++ ..+.......-..
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-----ERa~iL~~-L---------R~g~iP~~~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-----ERASILTN-L---------RKGSIPEPADFFDPEHPEEAS 849 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCchH-----HHHHHHHh-c---------ccCCCCCCcccccccchHHHH
Confidence 765 49999999999999999986 454321 11111111 1 111111 2233334445678
Q ss_pred HHHhhcCCCCCCCCCHHHHHH
Q 036144 308 VAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 308 li~~cl~~dp~~Rpt~~evl~ 328 (336)
+|++||+.||.+|||+.|+|.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 999999999999999999986
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=287.65 Aligned_cols=253 Identities=28% Similarity=0.393 Sum_probs=196.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+..|+.++..+ .||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678999999999999999999998899999999875432 2334566677766666 4999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
||+ +++|.+++.. ....+++..+..++.|++.|++|||+ .+ |+||||+|+||+++.++.++|+|||++....
T Consensus 94 e~~-~~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELM-STCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred ecc-CcCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 998 5677777654 23478999999999999999999997 47 9999999999999999999999999987543
Q ss_pred CCCCcceeeeeccCccccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQ----LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
... ......++..|+|||.+.+.. ++.++||||||+++|+|++|..||....... ... ....... .
T Consensus 167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~---~~~~~~~--~ 236 (296)
T cd06618 167 DSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--EVL---TKILQEE--P 236 (296)
T ss_pred CCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--HHH---HHHhcCC--C
Confidence 221 122345788999999987553 7899999999999999999999997532211 001 0111110 0
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
+.. ......+..+.+++.+||+.||.+|||+.+++..
T Consensus 237 -----~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 -----PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0011234579999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=291.72 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=195.3
Q ss_pred CCCCcccccccCceEEEEEEEccc--CeEEEEEeecCCC--CccHHHHHHHHHHHhhc-cCCCccceEEEEEe----CCe
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAV--DQVVAVKQLDRSG--NQGSREFFAEVLMLSLV-QHQNLVNLIGYCAD----GDQ 125 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~----~~~ 125 (336)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.+ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 478888999999999999999887 8899999986432 22245678899999998 59999999987543 245
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.+++++|+ +++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEecc-cCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 78899998 5789888754 456899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCc--ceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-------
Q 036144 206 KLGPTGGKD--HVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA------- 275 (336)
Q Consensus 206 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~------- 275 (336)
......... .......||..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...............
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 754332211 11233578999999998765 46899999999999999999999999765432111100000
Q ss_pred --HHHhhcc-----cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 --KPLLRDK-----KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 --~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....... ..........+. ......+..+.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 000000000000 011123557999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=290.89 Aligned_cols=264 Identities=21% Similarity=0.323 Sum_probs=200.3
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe-CCeEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD-GDQRI 127 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 127 (336)
...++|++.+.||.|+||.||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45688999999999999999999999999999999875432 2234667899999999999999999999865 56788
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
++|||+ +++|.+++.. ..++...+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+..
T Consensus 87 lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 6789887753 45788888899999999999999998 99999999999999999999999999874
Q ss_pred CCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH-H--------HHH
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT-W--------AKP 277 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~-~--------~~~ 277 (336)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+. . ...
T Consensus 158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 322 1233467889999998765 578999999999999999999999997654321111000 0 000
Q ss_pred HhhcccccccccCCccCCCCc-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 278 LLRDKKKFTMMADPLLEGQYP-----RKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.. .................+ ...+..+.+++.+||+.+|++|||+++++..
T Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 IC-SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cc-chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000000001111 1235689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=283.91 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=197.3
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhc---cCCCccceEEEEEeCCe-----
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLV---QHQNLVNLIGYCADGDQ----- 125 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~----- 125 (336)
|++.+.||+|+||.||+|.++.++..||+|.+...... ....+.+|+.+++.+ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67788999999999999999988999999998643222 123466777777665 59999999999988776
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999995 58988876532 236899999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh-----
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLR----- 280 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 280 (336)
....... ......++..|+|||.+.+..++.++|+|||||++|+|++|.+||......+....+ ......
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI--FDVIGLPSEEE 229 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH--HHHcCCCChHh
Confidence 7653322 122345788999999999889999999999999999999999999765433211111 000000
Q ss_pred --cc-----cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 281 --DK-----KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 281 --~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ........... .......+..+.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 00000000000 1112234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.19 Aligned_cols=252 Identities=26% Similarity=0.347 Sum_probs=198.0
Q ss_pred CCCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCC----CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (336)
+|++.+.||+|+||.||+|.+. .+|..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788899999999999999884 468999999986532 12235678899999999 589999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999865 356888899999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTG--QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
...... ........|+..|+|||.+.+. .++.++||||||+++|+|++|..||....... ............
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~--- 227 (290)
T cd05613 154 EFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS--- 227 (290)
T ss_pred eccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc---
Confidence 543221 1122345689999999998753 57889999999999999999999997533211 111111111110
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
...++...+..+.+++.+||+.||++|| ++.+++.
T Consensus 228 ---------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ---------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0112333456789999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=288.01 Aligned_cols=269 Identities=19% Similarity=0.252 Sum_probs=208.4
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-C-C----CccceEEEEE
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-H-Q----NLVNLIGYCA 121 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~iv~~~~~~~ 121 (336)
......++|.+...+|+|.||.|..+.+..++..||||+++..... .+...-|+.+++++. + | -++.+.++|.
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 3344578999999999999999999999999999999999754322 345667999999984 2 2 4778888999
Q ss_pred eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC--------
Q 036144 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-------- 193 (336)
Q Consensus 122 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-------- 193 (336)
..++.++|+|.+ |.|+.+++.. +.-.+++...++.++.|+++++++||+.+ ++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEec
Confidence 999999999988 8899999976 56678999999999999999999999999 999999999999822
Q ss_pred ------------CCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 036144 194 ------------EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAID 261 (336)
Q Consensus 194 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 261 (336)
+..|+++|||.|++.. ......+.|..|+|||++.+-+|+..+||||+||||+||.+|...|.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFq 310 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQ 310 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecc
Confidence 2358999999998632 22466789999999999999999999999999999999999999998
Q ss_pred CCCCcccccHHHHH--------------HHHhhcc----------cccccccCCccC----CCCcHHHHHHHHHHHHhhc
Q 036144 262 NSRPSEEQNLVTWA--------------KPLLRDK----------KKFTMMADPLLE----GQYPRKGLYQALAVAGMCL 313 (336)
Q Consensus 262 ~~~~~~~~~~~~~~--------------~~~~~~~----------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl 313 (336)
..+..+.....+.. ...+..+ ++.....++... -.....+...+.+|+.+||
T Consensus 311 tHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 311 THENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 87654421111100 0111111 000111111000 0112345568999999999
Q ss_pred CCCCCCCCCHHHHHH
Q 036144 314 QEDADSRPFMVDVVT 328 (336)
Q Consensus 314 ~~dp~~Rpt~~evl~ 328 (336)
..||.+|+|+.|+|.
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=284.45 Aligned_cols=251 Identities=21% Similarity=0.259 Sum_probs=200.8
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-----CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-----NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
+|.+.+.||+|+||.||++.+..++..+++|+++... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888899999999999999998777777777765322 12234567789999999999999999999988999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988764445567999999999999999999999998 999999999999975 579999999987643
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ........
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~~~~~-------- 220 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLRIVEG-------- 220 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHcC--------
Confidence 321 12334568899999999888889999999999999999999999996433111 11111100
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+...+..+.+++.+||+.+|++||++.++++
T Consensus 221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 ---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011123455668999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=290.44 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=200.7
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeC-
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG- 123 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 123 (336)
.++....++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 344556789999999999999999999999899999999986532 22235677899999999999999999988543
Q ss_pred -----CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceE
Q 036144 124 -----DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 124 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
...+++++++ +++|.+++.. ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888887 8899887753 45889999999999999999999998 99999999999999999999
Q ss_pred EccccccccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--
Q 036144 199 LSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA-- 275 (336)
Q Consensus 199 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-- 275 (336)
|+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+...
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999875322 1234568899999998766 56889999999999999999999999754432211111000
Q ss_pred ------HHHhhccc------ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 ------KPLLRDKK------KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 ------~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+.... ........... ......+..+.+++.+||+.||.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 00000000 00000000000 000123557899999999999999999999886
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=293.85 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=194.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeC------C
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------D 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 124 (336)
..+|.+.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999999889999999986532 22234578999999999999999999988654 3
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++|+||+. .+|..+. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999984 4776654 235888999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-------
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK------- 276 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------- 276 (336)
+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+....
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8753221 223467889999998876 468999999999999999999999998654322111111000
Q ss_pred -HHhhccccccccc---CCccCCCC---cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 277 -PLLRDKKKFTMMA---DPLLEGQY---PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 277 -~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... ....... .......+ .+..+..+.+++.+||+.||++||++++++.
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 239 VQKLED-KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHhcc-cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 0000000 00000000 1123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=283.15 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=199.2
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEEcC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
|.+.+.||.|++|.||+|....+++.|++|.+..... .......+|+..++.++ |+|++++++++......++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6678899999999999999998899999999865432 22234567899999999 999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 88998888652 2356899999999999999999999998 9999999999999999999999999987543221
Q ss_pred cceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH-HHH----HHhhccc----
Q 036144 214 DHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT-WAK----PLLRDKK---- 283 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~----~~~~~~~---- 283 (336)
......++..|+|||++.. ..++.++|+||||+++++|++|.+||......+...... ... ..+....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1233568899999998754 468999999999999999999999997664322211100 000 0000000
Q ss_pred ccccccCCccC---CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLE---GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........... .......+..+.+++.+||+.+|++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000 0001112467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=285.24 Aligned_cols=256 Identities=25% Similarity=0.318 Sum_probs=200.1
Q ss_pred CCCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCC----CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (336)
+|.+.+.||+|++|.||++.+. .++..||+|.+.... ......+.+|+.++..+ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778889999999999999864 457889999986432 12235678899999999 599999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999998854 356888999999999999999999988 9999999999999999999999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ--LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
...... ........|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||........ ...........
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS--- 227 (288)
T ss_pred cccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc---
Confidence 643321 11223356899999999987654 78899999999999999999999964322111 11111111110
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
. ...+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 228 -----~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -----K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 11222344578999999999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=287.08 Aligned_cols=244 Identities=26% Similarity=0.368 Sum_probs=203.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 127 (336)
...+|..+.+||+|+||.|.+|..+++.+.+|||++++.-. .+.+--..|-++|.... -|.+++++.+|+.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 34679999999999999999999999999999999976522 22233346777777664 678999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+.||+|--.++.. +.+.+..+.-++.+|+-||-+||++| |+.||||.+||+++.+|++||+|||++..
T Consensus 427 FVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 999999999998777653 44555667788999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
...+ .....+++|||.|+|||++..++|+..+|.||+|++||||+.|++||++.+..+....+.
T Consensus 500 ni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~-------------- 563 (683)
T KOG0696|consen 500 NIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM-------------- 563 (683)
T ss_pred cccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--------------
Confidence 3332 234567999999999999999999999999999999999999999999876544322221
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF 322 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt 322 (336)
+ ..-.+|...+.++..|....|...|.+|..
T Consensus 564 --e--hnvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 --E--HNVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --H--ccCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1 123577888889999999999999999964
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=292.63 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=198.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCC-----
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD----- 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 124 (336)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999999999999999985432 222346789999999999999999999987543
Q ss_pred -eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 125 -QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 125 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7899888743 46889999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-------
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA------- 275 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~------- 275 (336)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+...
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 98754221 233467899999998876 45889999999999999999999999765432110000000
Q ss_pred -HHHhhccc--ccccccCCccC---CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 -KPLLRDKK--KFTMMADPLLE---GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 -~~~~~~~~--~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+.... ........... .......+..+.+++.+||+.||++|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 00000000000 0111233457889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=297.52 Aligned_cols=243 Identities=25% Similarity=0.365 Sum_probs=210.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.+++.+..||-|+||.|-++..+.....+|+|++++.. ....+.+..|-.+|..+++|.||++|-.|.+..+.||.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999999988655568999987653 334456789999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|-|-||.|+..+.+ ++.++..+..-++..+++|+.|||+++ ||.|||||+|.+++.+|-+||.|||+|+....
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999875 678888899999999999999999999 99999999999999999999999999998766
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
+.+ .-++||||.|.|||++.++..+.++|.||||+++|||++|.+||...++....+.+..+-..+
T Consensus 573 g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------- 638 (732)
T KOG0614|consen 573 GRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------- 638 (732)
T ss_pred CCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh-----------
Confidence 544 456899999999999999999999999999999999999999999988766555544322211
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPF 322 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt 322 (336)
.+|........+|+.+.+..+|.+|..
T Consensus 639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -----EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 456677778999999999999999975
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=283.40 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=201.5
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
|++.+.||+|.+|.||+|.+..+++.||+|.+.... ......+..|+.+++.++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566778999999999999999999999999987653 233456788999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
. ++|.+++... ...+++..+..++.|++.||.+||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 6 6999998752 246899999999999999999999998 99999999999999999999999999876433221
Q ss_pred cceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH-H----HHHhhccccc--
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW-A----KPLLRDKKKF-- 285 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~-~----~~~~~~~~~~-- 285 (336)
......++..|+|||.+.+. .++.++|||||||++++|++|.+||......+....+.. . ...+......
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 22334567889999998776 889999999999999999999999976543221111100 0 0000000000
Q ss_pred -ccccCCccCC---CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 -TMMADPLLEG---QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 -~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......... ...+..+..+.+++.+||+.||++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 001122567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.44 Aligned_cols=264 Identities=26% Similarity=0.383 Sum_probs=218.4
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.++.-..+.....+||.|.||.||.|.|+.....||||.++... -...+|+.|+.+|+.++|||+|+++++|..+--.|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 34444455667789999999999999999999999999997553 45688999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+|.|||..|+|.+||... .+..++....+.++.||+.|+.||..++ +|||||-..|.||.++..||++|||++++
T Consensus 340 IiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999874 4566888888999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
+.. .............-|.|||-+....++.++|||+||++|||+.| |-.||.+-+..+ +..++..+..+
T Consensus 415 Mtg-DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkgyRM- 485 (1157)
T KOG4278|consen 415 MTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKGYRM- 485 (1157)
T ss_pred hcC-CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhccccc-
Confidence 643 22222233334667999999999999999999999999999988 778887654222 22333332222
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
.-+..+++.+.+|++.||+.+|.+||++.|+-+.+|.+.+
T Consensus 486 ---------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 486 ---------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ---------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 1234566689999999999999999999999999987643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.46 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=215.5
Q ss_pred CCCCcccccccCceEEEEEEEcccC---eEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVD---QVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
...+.++||.|.||.|++|..+..| ..||||.++.... ....+|+.|+.||-+.+||||+++.|+.....-..+|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4567889999999999999997665 5699999976543 34467999999999999999999999999988899999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|||++|+|+.+|+. ..+.++..+...++..|+.|+.||-+.+ +|||||-..||||+.+..+|++|||+++.+.+
T Consensus 710 EyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999987 4466999999999999999999999999 99999999999999999999999999998755
Q ss_pred CCCcceeeeecc--CccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 211 GGKDHVSTRVMG--TYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
+.. ...++..| ..+|.|||.+....++.+|||||+|++|||.++ |..||.+....+..+.+.
T Consensus 784 d~~-~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-------------- 848 (996)
T KOG0196|consen 784 DPE-AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-------------- 848 (996)
T ss_pred CCC-ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH--------------
Confidence 442 22222333 468999999999999999999999999999877 999988765433322222
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.-.+...|-+++..|.+|+..||+.|-.+||.+.+|+..|+++
T Consensus 849 ---~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 849 ---QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred ---hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 1122234557888999999999999999999999999999985
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=295.73 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=200.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCe----
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ---- 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 125 (336)
..++|.+.+.||+|++|.||+|.+..+++.||+|++.... ......+.+|+.+++.++|||++++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999999999999999986532 2234567789999999999999999988765544
Q ss_pred --EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 126 --RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 126 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 7799988854 46899999999999999999999998 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH----HH
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK----PL 278 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~ 278 (336)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.... +.
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99754322 233467889999998765 367899999999999999999999997654322111100000 00
Q ss_pred hhccc---ccccc---cCCccCCCC---cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRDKK---KFTMM---ADPLLEGQY---PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~~~---~~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+.... ..... ........+ ....+..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 00000 000000001 1123568999999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=292.66 Aligned_cols=245 Identities=23% Similarity=0.288 Sum_probs=201.3
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNG 136 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 136 (336)
.++||+|.||+||-|.++.+|+.||||++++- .......+.+|+.||+.+.||.||.+...|+..+..++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46899999999999999999999999999764 2344567899999999999999999999999999999999999554
Q ss_pred ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC---CceEEccccccccCCCCCC
Q 036144 137 SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---FNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 137 ~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~~~~~~~ 213 (336)
-|+-.+.. ..+.+++..-.-+..||+.||.|||.++ |+|+||||+|||+... .++||||||+|+....
T Consensus 649 MLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--- 719 (888)
T KOG4236|consen 649 MLEMILSS---EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--- 719 (888)
T ss_pred HHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch---
Confidence 45444443 6788999888889999999999999999 9999999999999554 4699999999997533
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
.....+.+|||.|+|||++.++.|+..-|+||.|+|+|--++|..||....+ ..+.+..+.-++
T Consensus 720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMy-------------- 783 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMY-------------- 783 (888)
T ss_pred hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhcccccc--------------
Confidence 3446678999999999999999999999999999999999999999975432 111121111111
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....-.+.+..+.+||...|+..-.+|.|+...+.
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 11223456678999999999999999999887654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=276.60 Aligned_cols=237 Identities=29% Similarity=0.369 Sum_probs=194.9
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
||.|+||.||++.+..+++.+|+|++...... ....+..|+.+++.++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999988999999998754322 345688999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceee
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 218 (336)
.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999865 346899999999999999999999988 9999999999999999999999999987643321 1234
Q ss_pred eeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCc
Q 036144 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298 (336)
Q Consensus 219 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
...++..|+|||...+..++.++|+||||+++|+|++|..||........ ....... ...++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~------------~~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI------YEKILKD------------PLRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHhcC------------CCCCC
Confidence 45688999999999888889999999999999999999999975442110 1111100 01122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 036144 299 RKGLYQALAVAGMCLQEDADSRPFMVD 325 (336)
Q Consensus 299 ~~~~~~l~~li~~cl~~dp~~Rpt~~e 325 (336)
...+..+.+++.+||..||++|||+.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 233568899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=299.25 Aligned_cols=256 Identities=27% Similarity=0.381 Sum_probs=216.2
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEE-----eC
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCA-----DG 123 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-----~~ 123 (336)
.+..+.|++.++||.|.+|.||+++++.+++..|+|+...... ..+++..|..+++.+ .|||++.++++|. .+
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 3456779999999999999999999999999999999876543 346788899999987 5999999999985 35
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
++++||||||.|||..+++.... ...+.+..+..|+..++.|+.+||... ++|||||=.|||++.++.|||+|||
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 78999999999999999998855 778999999999999999999999988 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-----QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
++..+.. ......+.+|||.|||||++... .|+..+|+||||++..||.-|.+|+-+..+......+
T Consensus 169 vSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I------ 240 (953)
T KOG0587|consen 169 VSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------ 240 (953)
T ss_pred eeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC------
Confidence 9987543 23445668899999999998643 5788999999999999999999999887654322111
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+|.....-+..++..+.++|..||..|-+.||++.++|+
T Consensus 241 ---------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 ---------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 12222222335678889999999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=308.49 Aligned_cols=147 Identities=28% Similarity=0.366 Sum_probs=132.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.+++.++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999865432 2235678899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||..+ |+||||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999864 345788899999999999999999988 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=294.63 Aligned_cols=240 Identities=25% Similarity=0.300 Sum_probs=199.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.+.|.+...+|.|+|+.|-.+.+..+++..++|++.... .+..+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 577899999999999999999999999999999997652 2334577666554 69999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-CCCCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL-DAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~-~~~~~~kl~Dfg~~~~~~~ 210 (336)
++.|+-+.+.+... +.....+..|+.+|+.|+.|||++| +|||||||+|||+ +..++++|+|||.+.....
T Consensus 397 ~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999888877652 2222677789999999999999999 9999999999999 6889999999999986543
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ..+.+-|..|.|||++...+|++++|+||||++||+|++|+.||...... +. +..
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~e--------------i~~ 524 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IE--------------IHT 524 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HH--------------HHH
Confidence 2 34456789999999999999999999999999999999999999875533 11 001
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....+.+....|..+.+|+.+||+.||.+||++.+++.
T Consensus 525 ~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 525 RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11122333566778999999999999999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=273.91 Aligned_cols=220 Identities=23% Similarity=0.228 Sum_probs=179.8
Q ss_pred cCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCChhhhhcc
Q 036144 65 GGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLD 144 (336)
Q Consensus 65 G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 144 (336)
|.+|.||+|.+..+++.||+|.+.... ....|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999986543 223455555556799999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCc
Q 036144 145 LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224 (336)
Q Consensus 145 ~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 224 (336)
...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 245899999999999999999999988 999999999999999999999999987654321 22345677
Q ss_pred cccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHH
Q 036144 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQ 304 (336)
Q Consensus 225 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (336)
.|+|||.+.+..++.++|+||+|+++|+|++|..|+........ ......++...+..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------------THTTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------------cccccCCcccCCHH
Confidence 89999999888899999999999999999999988754221100 00001123344568
Q ss_pred HHHHHHhhcCCCCCCCCCH
Q 036144 305 ALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 305 l~~li~~cl~~dp~~Rpt~ 323 (336)
+.+++.+||+.||++|||+
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 8999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=295.07 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=207.4
Q ss_pred cCCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
++....++||+|.||.|++|.|... .-.||||.++..... ...+|++|+.+|..|+|+|++++||+..+ .-..||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 4456677899999999999999643 246999999765443 56789999999999999999999999987 567799
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
||+++.|||.+.|.+ ..+..+.......++.||+.|+.||.+++ +|||||-..|+|+.....|||+|||+.+.+.
T Consensus 189 ~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999999999987 45677888899999999999999999999 9999999999999998899999999998765
Q ss_pred CCCCcceee-eeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 210 TGGKDHVST-RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 210 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.+....... ...-...|+|||.+....++.++|||++|+++|||++ |..||-+....+....+.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-------------- 329 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-------------- 329 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc--------------
Confidence 543332221 2233557999999999999999999999999999998 678887766433222221
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..-...-++.+++++.+++..||.++|.+|||+.+|.+.
T Consensus 330 ---~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 ---AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ---ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 111123356788999999999999999999999999754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=280.99 Aligned_cols=267 Identities=27% Similarity=0.419 Sum_probs=203.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhh--ccCCCccceEEEEEeCC----eEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSL--VQHQNLVNLIGYCADGD----QRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~----~~~ 127 (336)
...++.++||+|.||.||+|... ++.||||++... ..+.+.+|-.|.+. +.|+||+++++.-.... .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 44666778999999999999987 589999999753 34567788877775 57999999999876555 789
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeeeCCCCCCCeEECCCCceEEcc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA------DPPVIYRDFKASNILLDAEFNPKLSD 201 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~------~~~i~H~dikp~Nil~~~~~~~kl~D 201 (336)
||++|.+.|+|.+||.. ..++|....+++..+++||+|||+-. +++|+|||||..||||..+++..|+|
T Consensus 285 LVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999965 67999999999999999999999743 57899999999999999999999999
Q ss_pred ccccccCCCCCCcceeeeeccCccccCccccccCC-CC-----CccchhhHHHHHHHHHhCCCCCCCCCCcc-cccHH--
Q 036144 202 FGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ-LT-----KKSDVYSFGVVLLELITGRSAIDNSRPSE-EQNLV-- 272 (336)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~-- 272 (336)
||+|..+..+.........+||.+|||||++.+.. +. .+.||||+|.++|||++....+......+ ...+.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99999887666555555689999999999987642 22 46899999999999999765543211111 11110
Q ss_pred -------HHHHHHhhcccccccccCCccCCCCc-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 273 -------TWAKPLLRDKKKFTMMADPLLEGQYP-RKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 273 -------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
...+... .+....|.+..... .....-+.+.+..||+.||+.|.|+.=+-+++..+..
T Consensus 440 vG~hPt~e~mq~~V-----V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 440 VGNHPTLEEMQELV-----VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred hcCCCCHHHHHHHH-----HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111111 11111121111111 1234578999999999999999999988888877654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=288.89 Aligned_cols=246 Identities=24% Similarity=0.272 Sum_probs=197.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.-|..++.||-|+||.|.++...+|...||+|.+++.+.- .......|-.||...+++-||++|-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 4477888999999999999999999999999998765422 2345678999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC-
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP- 209 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~- 209 (336)
+|++||++-.+|.. .+.+++..++-++.++..|+++.|..| +|||||||+|||||.+|++||+|||+|+-+.
T Consensus 709 dYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999876 467888889999999999999999999 9999999999999999999999999986311
Q ss_pred --------CCCCc-------------------------------ceeeeeccCccccCccccccCCCCCccchhhHHHHH
Q 036144 210 --------TGGKD-------------------------------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVL 250 (336)
Q Consensus 210 --------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il 250 (336)
.+... ......+||+.|+|||++....|+...|.||.|+||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 11000 011236799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC
Q 036144 251 LELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321 (336)
Q Consensus 251 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 321 (336)
|||+.|++||-...+.+.+..+..+.. .++- .+..+.+.++.++|.+++. +++.|.
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw~~----------~l~~----~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINWRN----------FLHI----PYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeehhh----------cccc----ccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999998887665544332211 1121 2233445567777766443 555554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=267.26 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=202.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|.++.+||+|+|+.|.++.++.|.+.+|+|++++. ..++.+....|-.+..+. +||.+|-+..+|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 47899999999999999999999999999999998764 334455567777777665 69999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
|.||++||+|--.++. ...++++.++-+...|..||.|||+.| |+.||||.+|+|++..|++||+|+|+++..
T Consensus 329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999655543 567999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-cccccHHHH-HHHHhhcccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRP-SEEQNLVTW-AKPLLRDKKKFT 286 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~-~~~~~~~~~~~~ 286 (336)
..+ .....+++|||.|.|||++.+..|...+|.|+||++++||+.|+.||+.-.. ....+...+ ..-++
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil------- 472 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL------- 472 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-------
Confidence 332 2345679999999999999999999999999999999999999999975321 111111111 11111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF 322 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt 322 (336)
... ..+|...+-....++..-|+.||.+|..
T Consensus 473 ---ekq--iriprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 473 ---EKQ--IRIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred ---hhc--ccccceeehhhHHHHHHhhcCCcHHhcC
Confidence 111 1244555667778999999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=265.70 Aligned_cols=270 Identities=22% Similarity=0.309 Sum_probs=203.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEe--------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD-------- 122 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 122 (336)
...|+-..+||+|.||.||+|..+.+|+.||+|++-.. ...-.....+|+.+|..|+|+|++.+++.+..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 34566777899999999999999999999999976432 12223457899999999999999998877642
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
....|+||.+|+ -+|..++.. ....++...+..++.++..||.|+|... |+|||+||+|+||+.+|.+||+||
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecc
Confidence 234789999995 478777764 3467899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCc--ceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 036144 203 GLAKLGPTGGKD--HVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 203 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
|+++.+...... ...++.+-|.+|++||.+.+. .|+++.|||..|||+.+|+++.+.+.+........++......+
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 999765433222 234556779999999998874 89999999999999999999999998876555444443322111
Q ss_pred -----hcccc---cccccCC-ccCCCCc--------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 280 -----RDKKK---FTMMADP-LLEGQYP--------RKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 280 -----~~~~~---~~~~~~~-~~~~~~~--------~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.+-.. ...+-.+ ...+.+. .......++|+..+|..||.+|+++.+++..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111 1111111 1111111 1113378899999999999999999998864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=269.49 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=195.1
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhh-ccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSL-VQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
+-+..||.|+||+|++-.++.+|+..|||.++.... ....+++.|...... -+.||||+++|....+...++.||+|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM- 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM- 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-
Confidence 334569999999999999999999999999976543 445677888866544 56899999999999888899999999
Q ss_pred CCChhhhhcc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 135 NGSLENHFLD-LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 135 ~g~L~~~l~~-~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
.-||+.+... +.-....+++...-.|....+.||.||....+ |||||+||+|||++..|.|||||||.+-.+..
T Consensus 146 d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--- 220 (361)
T KOG1006|consen 146 DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--- 220 (361)
T ss_pred hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH---
Confidence 5677654322 11234668888888898889999999987543 99999999999999999999999999965432
Q ss_pred cceeeeeccCccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 214 DHVSTRVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
....+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||..|+...+. .......... ++...+..+
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~--gdpp~l~~~ 293 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI--GDPPILLFD 293 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc--CCCCeecCc
Confidence 222444568889999999864 4699999999999999999999999987653 1111111111 111111111
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.-..+.+..+..+|..||..|...||...++++
T Consensus 294 ----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 ----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111245678999999999999999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=265.76 Aligned_cols=269 Identities=23% Similarity=0.320 Sum_probs=205.3
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhh--ccCCCccceEEEEEeC----
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSL--VQHQNLVNLIGYCADG---- 123 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~---- 123 (336)
.....+..+.+.||+|.||.||+|.++ |+.||||++... +.+.+.+|.++.+. |+|+||+.+++.-..+
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 345577889999999999999999999 789999998643 34567888888875 6999999999875433
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeCCCCCCCeEECCCCceE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-----VADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-----~~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
.+++||++|.+.|||.|+|.. ..++....++++..++.||++||. +|++.|.|||||..||||..++...
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 367899999999999999964 678999999999999999999996 4688899999999999999999999
Q ss_pred EccccccccCCCCC--CcceeeeeccCccccCccccccCC----C--CCccchhhHHHHHHHHHhC----------CCCC
Q 036144 199 LSDFGLAKLGPTGG--KDHVSTRVMGTYGYCAPEYAMTGQ----L--TKKSDVYSFGVVLLELITG----------RSAI 260 (336)
Q Consensus 199 l~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslG~il~~l~~g----------~~p~ 260 (336)
|+|+|+|....... -....+..+||.+|||||++...- + -..+||||||.++||+... ++||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999997654332 223345578999999999986542 1 2468999999999999762 4666
Q ss_pred CCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 261 DNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+.-+.+-.... .+...+ .+.+.....+..........+.+|++.||..||.-|-|+--+-+.|.++.
T Consensus 437 yd~Vp~DPs~ee--MrkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 437 YDVVPSDPSFEE--MRKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ccCCCCCCCHHH--Hhccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 554332221110 111111 11111111122334456778999999999999999999999999888775
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=288.68 Aligned_cols=255 Identities=28% Similarity=0.394 Sum_probs=212.8
Q ss_pred CCCCcccccccCceEEEEEEEcccC----eEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVD----QVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.....++||+|+||+||+|.+-..| -+||+|++.... .....++++|+.+|..++|||++++++++.... .-||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3556678999999999999985434 468999886543 444678999999999999999999999998765 7789
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
++|+++|+|.++++. .+..+-....+.|..||++|+.|||.++ +|||||-..||||..-..+||.|||++..+.
T Consensus 776 tq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999987 5778888999999999999999999988 9999999999999999999999999999876
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
............-.+-|||-|.+....|+.++|||||||++||++| |..|++.....+..++......
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR----------- 918 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER----------- 918 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-----------
Confidence 6554443333344667999999999999999999999999999988 8899988765554433332111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
...|+.++.++..++.+||..|+..||+++++.+.+..+
T Consensus 919 ------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 919 ------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred ------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 133556777999999999999999999999999887654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=273.05 Aligned_cols=261 Identities=23% Similarity=0.347 Sum_probs=201.5
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc-------HHHHHHHHHHHhhccCCCccceEEEEEe
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG-------SREFFAEVLMLSLVQHQNLVNLIGYCAD 122 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 122 (336)
....++|-++.+||+|+|+.||+|.+......||+|+-..+..+. .+...+|..|-+.|+||.||++|++|.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 345578999999999999999999999889999999854332211 1346789999999999999999999964
Q ss_pred -CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---CCCCceE
Q 036144 123 -GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL---DAEFNPK 198 (336)
Q Consensus 123 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~---~~~~~~k 198 (336)
.+..+-|+|||+|.+|+-++.. .+.+++..++.|+.||+.||.||... +++|||-||||.|||+ +..|.+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred ccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 4567889999999999888865 67789999999999999999999987 4889999999999999 4457899
Q ss_pred EccccccccCCCCCCc-----ceeeeeccCccccCccccccC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc
Q 036144 199 LSDFGLAKLGPTGGKD-----HVSTRVMGTYGYCAPEYAMTG----QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ 269 (336)
Q Consensus 199 l~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 269 (336)
|+|||++..+...... .......||.+|++||++.-+ ..+.++||||+|+|+|+.+.|+.||.......
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-- 691 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-- 691 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--
Confidence 9999999987654332 123346799999999998643 46889999999999999999999998643221
Q ss_pred cHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 036144 270 NLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327 (336)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl 327 (336)
+++... ..+....... ..-+..+.+...+|++||+..-++|....++.
T Consensus 692 dILqeN-------TIlkAtEVqF---P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 DILQEN-------TILKATEVQF---PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHHhhh-------chhcceeccC---CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111 1111000000 01123455788999999999999998877664
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=287.19 Aligned_cols=262 Identities=17% Similarity=0.215 Sum_probs=171.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEccc----CeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEE------EE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAV----DQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY------CA 121 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~------~~ 121 (336)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .+....+ .++...+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 457899999999999999999999988 89999998754321 1111111 1122222222222221 23
Q ss_pred eCCeEEEEEEcCCCCChhhhhccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 036144 122 DGDQRILVYEFMSNGSLENHFLDLPP----------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFK 185 (336)
Q Consensus 122 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dik 185 (336)
.....++||||+.+++|.+++..... .........+..++.|++.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 55678999999999999998864210 0011123346679999999999999988 9999999
Q ss_pred CCCeEECC-CCceEEccccccccCCCCCCcceeeeeccCccccCccccccC----------------------CCCCccc
Q 036144 186 ASNILLDA-EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG----------------------QLTKKSD 242 (336)
Q Consensus 186 p~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 242 (336)
|+|||++. ++.+||+|||++.....+. ........+|+.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 5789999999997553322 2234456799999999965432 2345679
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc---ccccCCccC----C--CCcHHHHHHHHHHHHhhc
Q 036144 243 VYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF---TMMADPLLE----G--QYPRKGLYQALAVAGMCL 313 (336)
Q Consensus 243 vwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~----~--~~~~~~~~~l~~li~~cl 313 (336)
||||||++|||+++..+++... ......+...+... .....+... . ...........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL-------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH-------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999776543211 11110000000000 000010000 0 000111224568999999
Q ss_pred CCCCCCCCCHHHHHH
Q 036144 314 QEDADSRPFMVDVVT 328 (336)
Q Consensus 314 ~~dp~~Rpt~~evl~ 328 (336)
+.||++|||+.++++
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=263.29 Aligned_cols=264 Identities=19% Similarity=0.277 Sum_probs=201.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-----C---CCccceEEEEE----
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-----H---QNLVNLIGYCA---- 121 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~---- 121 (336)
.+|-+.++||.|.|++||++.+..+.+.||+|+.+.. ..-.+....||++|++++ | .+||++++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6788999999999999999999999999999998543 333466789999999884 2 37999999996
Q ss_pred eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-------
Q 036144 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE------- 194 (336)
Q Consensus 122 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~------- 194 (336)
++.+++||+|++ |.+|..+|.. ...+.++...+.+|+.||+.||.|||... +|||-||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence 457899999999 8899999877 35677999999999999999999999854 49999999999998211
Q ss_pred --------------------------------------------------------------------------------
Q 036144 195 -------------------------------------------------------------------------------- 194 (336)
Q Consensus 195 -------------------------------------------------------------------------------- 194 (336)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 036144 195 -------------------------------------------------------------------------------F 195 (336)
Q Consensus 195 -------------------------------------------------------------------------------~ 195 (336)
-
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc---ccHH
Q 036144 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE---QNLV 272 (336)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~---~~~~ 272 (336)
.+||+|||.|+.. ....+.-+.|..|+|||++.+..|++.+||||++|++|||.||...|+....... .+.+
T Consensus 392 ~vKIaDlGNACW~-----~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi 466 (590)
T KOG1290|consen 392 RVKIADLGNACWV-----HKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI 466 (590)
T ss_pred eEEEeeccchhhh-----hhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence 0344455544432 1123334578899999999999999999999999999999999999987553321 1111
Q ss_pred H------------------HHHHHhhcccccccccCCccC---------CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 036144 273 T------------------WAKPLLRDKKKFTMMADPLLE---------GQYPRKGLYQALAVAGMCLQEDADSRPFMVD 325 (336)
Q Consensus 273 ~------------------~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 325 (336)
. +.+.++...+.++.+..-..- =.++.+....+.+++.-||+.+|++|||+.+
T Consensus 467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~ 546 (590)
T KOG1290|consen 467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ 546 (590)
T ss_pred HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence 1 112233333333333222111 1356677889999999999999999999999
Q ss_pred HHH
Q 036144 326 VVT 328 (336)
Q Consensus 326 vl~ 328 (336)
.|+
T Consensus 547 cl~ 549 (590)
T KOG1290|consen 547 CLK 549 (590)
T ss_pred Hhc
Confidence 885
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=256.17 Aligned_cols=239 Identities=29% Similarity=0.393 Sum_probs=194.3
Q ss_pred CceEEEEEEEcccCeEEEEEeecCCCCcc-HHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCChhhhhcc
Q 036144 66 GYGRVYKGYIEAVDQVVAVKQLDRSGNQG-SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLD 144 (336)
Q Consensus 66 ~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 144 (336)
+||.||+|.+..+|+.+|+|++....... .+.+.+|++.++.++|+|++++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999987655444 67889999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCc
Q 036144 145 LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224 (336)
Q Consensus 145 ~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 224 (336)
. ..++...++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+....... ......++.
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 2 23888999999999999999999998 9999999999999999999999999997654321 234456889
Q ss_pred cccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHH
Q 036144 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQ 304 (336)
Q Consensus 225 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (336)
.|+|||.+.+..++.++|+||||+++++|++|..||....... .... ......... .......+..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~---~~~~~~~~~---------~~~~~~~~~~ 216 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFK---KIGKPKPPF---------PPPEWKISPE 216 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH---HHhccCCCC---------ccccccCCHH
Confidence 9999999988889999999999999999999999987632111 1111 000000000 0000004457
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 305 ALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 305 l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=268.87 Aligned_cols=270 Identities=21% Similarity=0.195 Sum_probs=209.0
Q ss_pred HHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC------CCccceEEEEEe
Q 036144 49 LADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH------QNLVNLIGYCAD 122 (336)
Q Consensus 49 ~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~ 122 (336)
.+....+|.+....|+|-|++|..|.+...|..||||+|..+..- ...=+.|+++|+.|+. -|++.++..|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 344557899999999999999999999988999999999866432 3445689999999962 389999999999
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc-eEEcc
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN-PKLSD 201 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~-~kl~D 201 (336)
.+++|||||-+ ..+|.++|..+. ..-.|....+..++.|+..||..|..++ |+|.||||+||||++..+ +||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeecc
Confidence 99999999988 779999998765 3566888899999999999999999999 999999999999987654 89999
Q ss_pred ccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-----H
Q 036144 202 FGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA-----K 276 (336)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~ 276 (336)
||.|...... ..+...-+.-|.|||++.|.+|+...|+||+||+||||.||+..|.+.....+..+..-. .
T Consensus 581 fGSA~~~~en----eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 581 FGSASFASEN----EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred Cccccccccc----cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 9999764332 233344566799999999999999999999999999999999999987765543332211 1
Q ss_pred HHhhcccccccccCCccC----------------------------------CCCcH---HHHHHHHHHHHhhcCCCCCC
Q 036144 277 PLLRDKKKFTMMADPLLE----------------------------------GQYPR---KGLYQALAVAGMCLQEDADS 319 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~----------------------------------~~~~~---~~~~~l~~li~~cl~~dp~~ 319 (336)
.++..+.-...-+|.-++ ..++. .....+.+|+..||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 111111111111111000 01222 23447889999999999999
Q ss_pred CCCHHHHHH
Q 036144 320 RPFMVDVVT 328 (336)
Q Consensus 320 Rpt~~evl~ 328 (336)
|.|+.++|+
T Consensus 737 Rit~nqAL~ 745 (752)
T KOG0670|consen 737 RITVNQALK 745 (752)
T ss_pred cCCHHHHhc
Confidence 999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=238.81 Aligned_cols=206 Identities=25% Similarity=0.303 Sum_probs=172.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhh-ccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSL-VQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++...+..||+|++|.|-+.++..+|...|+|.+...-+ ....+.++|+.+... ..+|.+|.+++........++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 445556679999999999999999999999999865432 334567778876654 469999999999988889999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
.| .-||+.+..........+++..+-+|+..++.||.|||++-+ ++|||+||.|||++.+|+||+||||.+-.+.+.
T Consensus 126 ~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 99 568887776666678899999999999999999999998654 999999999999999999999999999765432
Q ss_pred CCcceeeeeccCccccCcccccc----CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMT----GQLTKKSDVYSFGVVLLELITGRSAIDNSRP 265 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 265 (336)
- ..+...|-..|||||.+.. ..|+.++||||||+++.||.+++.||+....
T Consensus 203 i---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 203 I---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred h---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 2 1233457888999998864 3799999999999999999999999987543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=253.12 Aligned_cols=268 Identities=22% Similarity=0.310 Sum_probs=202.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCC-----eE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD-----QR 126 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 126 (336)
.+.+..+.||-|+||.||.+++..+|+.||+|++...- ....+.+.+|+.+|...+|.|++..++...-.. ..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 35667788999999999999999999999999986532 233467889999999999999999988775432 45
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
|++.|++ ..+|...+.. ...++...+.-++.||++||.|||+.+ |.||||||.|.|++.|..+||||||+++
T Consensus 133 YV~TELm-QSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHH-Hhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccc
Confidence 6788888 5677776654 678888899999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--H------H
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--K------P 277 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~------~ 277 (336)
...... ....+..+-|..|+|||+++|. .|+.+.||||.|||+.||+..+..|....+.+..+++... . .
T Consensus 205 vee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 205 TWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred ccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHH
Confidence 654322 2223445679999999999985 7999999999999999999999999877766554444211 0 0
Q ss_pred HhhcccccccccCCccCCC--------CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 278 LLRDKKKFTMMADPLLEGQ--------YPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
.-+.+-+.+.+..+..... -+.........++..+|..||..|.+.++.+..+
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0111111111111111111 1122334677888999999999999999887643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=268.33 Aligned_cols=263 Identities=19% Similarity=0.262 Sum_probs=180.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEc----------------ccCeEEEEEeecCCCCccHHHH--------------HHH
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIE----------------AVDQVVAVKQLDRSGNQGSREF--------------FAE 101 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e 101 (336)
..++|.+.++||+|+||.||+|... ..+..||||.+........+++ ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 2346799999865432222222 346
Q ss_pred HHHHhhccCCCc-----cceEEEEEe--------CCeEEEEEEcCCCCChhhhhccCCC--------------------C
Q 036144 102 VLMLSLVQHQNL-----VNLIGYCAD--------GDQRILVYEFMSNGSLENHFLDLPP--------------------D 148 (336)
Q Consensus 102 ~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~ 148 (336)
+.++..++|.++ +++++++.. ....++||||+++++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 666777766544 566776643 3467899999999999998864211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccC
Q 036144 149 QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCA 228 (336)
Q Consensus 149 ~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 228 (336)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....+.. .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123466778899999999999999988 99999999999999999999999999865433211 11112235889999
Q ss_pred ccccccCC--------------------CC--CccchhhHHHHHHHHHhCCC-CCCCCCCccc-----ccHHHHHHHHhh
Q 036144 229 PEYAMTGQ--------------------LT--KKSDVYSFGVVLLELITGRS-AIDNSRPSEE-----QNLVTWAKPLLR 280 (336)
Q Consensus 229 PE~~~~~~--------------------~~--~~~DvwslG~il~~l~~g~~-p~~~~~~~~~-----~~~~~~~~~~~~ 280 (336)
||.+.... |+ .+.|+||+||++|+|++|.. ||........ .+... .+....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~-~~r~~~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN-RWRMYK 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH-HHHhhc
Confidence 99875432 11 34799999999999999875 6654321110 00000 000000
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCC---CCCCCHHHHHH
Q 036144 281 DKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDA---DSRPFMVDVVT 328 (336)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~Rpt~~evl~ 328 (336)
. ....-......+....+|+.+||..+| .+|+|++|+|+
T Consensus 458 ~---------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 G---------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred c---------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 001111122345688999999999766 68999999986
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=278.27 Aligned_cols=261 Identities=27% Similarity=0.442 Sum_probs=204.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcc-------cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhcc-CCCccceEEEEEeC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA-------VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQ-HQNLVNLIGYCADG 123 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 123 (336)
.++..+.+.||+|+||.|++|.... ....||||.++.... ...+.+..|+.+|+.+. |+||+.+++++...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3445666799999999999997531 145799999876543 34567899999999985 99999999999998
Q ss_pred CeEEEEEEcCCCCChhhhhccCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLP---P-------DQ--EPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~---~-------~~--~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
...++|+||+..|+|.+++.... . .. ..++....+.++.||+.|++||++.. +|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 89999999999999999998744 0 01 24888999999999999999999988 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeecc--CccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMG--TYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEE 268 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~ 268 (336)
+.+..+||+|||+++......... .....| ...|||||.+....|+.++||||||+++||+++ |..||.+.....
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~- 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE- 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH-
Confidence 999999999999998543322221 111222 345999999999999999999999999999998 778887632111
Q ss_pred ccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 269 QNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.+.. .+..+ .+-..|..++.++.+++..||+.+|++||++.++.+.++.+
T Consensus 530 -~l~~----~l~~G----------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 -ELLE----FLKEG----------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -HHHH----HHhcC----------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1111 11111 11233455677899999999999999999999999998763
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=277.68 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=190.1
Q ss_pred CCCcccccccCceE-EEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEEcC
Q 036144 56 FNPDCLVGEGGYGR-VYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 56 y~~~~~ig~G~~g~-v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
|...+++|.|+.|+ ||+|... |+.||||.+-.. ....+.+|+..|+.-+ |||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 45556789999886 7999998 689999987543 2346789999999874 999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC---C--CceEEccccccccC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA---E--FNPKLSDFGLAKLG 208 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~---~--~~~kl~Dfg~~~~~ 208 (336)
..+|.+++...............+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+|||+|+.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 67999999763111111222455788999999999999999 999999999999965 3 45899999999987
Q ss_pred CCCCCcc-eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 209 PTGGKDH-VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG-RSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 209 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..+.... ...+..||.+|+|||++.....+.++||||+||++|+.++| .+||.+.-..+. + ++..+..+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-N-------Il~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-N-------ILTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-h-------hhcCcccee
Confidence 5543322 23456799999999999998888899999999999999886 899986432111 1 111222222
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+.. ..++ .+.+||.+|++++|..||++.+||.
T Consensus 734 ~L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 2111 1111 7889999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=236.82 Aligned_cols=260 Identities=20% Similarity=0.331 Sum_probs=199.8
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeC--CeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADG--DQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~l 128 (336)
..++|++.+++|+|.|+.||.|.+..+++.++||++++. ..+.+.+|+.+|+.|. ||||++++++..++ ....|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 347899999999999999999999999999999999764 3467899999999997 99999999998765 45679
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEcccccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKL 207 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~ 207 (336)
|+||+++.+...+. ..++...++.++.+++.||.|+|+.| |.|||+||.|++|+... .++|+|+|+|.+
T Consensus 113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 99999888877665 34777788999999999999999999 99999999999998764 599999999998
Q ss_pred CCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----HHhhc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-----PLLRD 281 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~ 281 (336)
.-.+.. ....+.+..|--||.+.. ..|+..-|+|||||++..|+..+-||........ +++..++ .+..-
T Consensus 183 YHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 183 YHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELYAY 258 (338)
T ss_pred cCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHHHH
Confidence 754433 334567888999998865 5789999999999999999999999876543322 1221111 11000
Q ss_pred ccccccccCCccCC----------------CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFTMMADPLLEG----------------QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~~~~~~~~~~----------------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
-......+++.... +-..-.+.++.+++.+.|..|-.+|+|+.|.++
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 01111112222211 111112458899999999999999999999764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=245.72 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=200.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeC------Ce
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------DQ 125 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~ 125 (336)
.+|.-++.+|.|+- .|..|.+.-++++||+|..... .....+...+|...+..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56777888999998 8888999888999999987543 233456788999999999999999999998533 35
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.|+|||++ ..+|.+.+. ..++-.++..++.|++.|+.|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 96 ~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 68999999 779988875 23566788899999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH------------
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT------------ 273 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------ 273 (336)
... ......+..+.|..|.|||++.+-.|.+.+||||+||++.||++|...|.+.+.-+.-..+.
T Consensus 166 r~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred ccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 753 23345667889999999999999889999999999999999999999998654322211110
Q ss_pred ----HHHHHhhcc------cccccccCCccCCC--CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 274 ----WAKPLLRDK------KKFTMMADPLLEGQ--YPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 274 ----~~~~~~~~~------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.++...... ...+...|..+... .++-....+.+++.+||..||++|.++.++|.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 111111100 01111122222111 12223446889999999999999999999885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=230.43 Aligned_cols=212 Identities=33% Similarity=0.520 Sum_probs=184.9
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCChhh
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLEN 140 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 140 (336)
||+|.+|.||++....+++.+++|++...... ....+.+|+..++.+.|++++++++++......+++||++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999988999999998755432 24678999999999999999999999999999999999999899999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-CCceEEccccccccCCCCCCcceeee
Q 036144 141 HFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-EFNPKLSDFGLAKLGPTGGKDHVSTR 219 (336)
Q Consensus 141 ~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 219 (336)
++... ...++...++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 98652 146888999999999999999999998 999999999999999 89999999999976533221 2333
Q ss_pred eccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCc
Q 036144 220 VMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298 (336)
Q Consensus 220 ~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (336)
..+...|++||..... .++.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5688899999998877 888999999999999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 299 RKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 299 ~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
..+.+++..|++.+|.+||++.++++.+
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2678899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=265.18 Aligned_cols=254 Identities=25% Similarity=0.320 Sum_probs=211.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|.....+|.|.||.||+++++.+++..|+|+++.....+..-+..|+-+++..+||||+.+++.+......++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46899999999999999999999999999999999988777778888999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
|.||+|.+... -..++++.++..++...+++++|||+.+ =+|||||=.||++++.|.+|++|||.+... +.
T Consensus 94 cgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi--ta 164 (829)
T KOG0576|consen 94 CGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI--TA 164 (829)
T ss_pred cCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh--hh
Confidence 99999987654 3678999999999999999999999999 899999999999999999999999998653 22
Q ss_pred CcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.-.....+.||+.|||||+.. .+.|+..+|||++|++..|+---++|..+..+.....+.. + ...
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--k----------S~~ 232 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--K----------SGF 232 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--c----------cCC
Confidence 334567789999999999874 5689999999999999999998888866554432221111 0 001
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
++... .-....+..+.++++.+|-.+|++|||++-+|.
T Consensus 233 qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111 112345678999999999999999999988764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=255.97 Aligned_cols=199 Identities=23% Similarity=0.309 Sum_probs=172.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--------cHHHHHHHHHHHhhcc---CCCccceEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--------GSREFFAEVLMLSLVQ---HQNLVNLIGYC 120 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~---h~~iv~~~~~~ 120 (336)
...+|...+.+|.|+||.|++|.++.....|+||.+.+...- ..-.+..|+.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 345699999999999999999999999999999998654211 1112457999999997 99999999999
Q ss_pred EeCCeEEEEEEcC-CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 121 ADGDQRILVYEFM-SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 121 ~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
++++++|++||-. +|-+|.+++.. +..+++..+..|+.|++.|+++||+.+ |||||||-+|+.++.+|-+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence 9999999999964 56688888865 567899999999999999999999999 999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCC
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAID 261 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~ 261 (336)
+|||.+.... ......++||..|.|||++.|..| +..-|||++|++||-++....||.
T Consensus 712 idfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999997643 334677899999999999998877 567899999999999998887774
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=229.26 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=188.9
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEE-EEeCCeEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGY-CADGDQRIL 128 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~~~~~~l 128 (336)
...+.|.+.+.||+|.||.+.++.|++++..+++|.+.... ....+|.+|...--.|. |.||+..|++ |+..+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 34578999999999999999999999999999999986543 44678999987766664 8999998875 567778889
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC--CCCceEEccccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD--AEFNPKLSDFGLAK 206 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~--~~~~~kl~Dfg~~~ 206 (336)
++||++.|+|.+-+.. ..+-+.....++.|++.||.|||+++ +||||||.+||||- +..+|||||||...
T Consensus 100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999999988754 45778888999999999999999999 99999999999992 23479999999987
Q ss_pred cCCCCCCcceeeeeccCccccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTG-----QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
..... .....-+..|.|||..... ..++.+|+|.||+++|.+++|..||.... ........|..-....
T Consensus 172 k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 172 KVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRK 245 (378)
T ss_pred ccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhccc
Confidence 53221 1223346679999976432 34788999999999999999999998433 2233333332211111
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVD 325 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 325 (336)
.. .+...|. ..++.+..+.++-|.+++++|=-+.+
T Consensus 246 ~~--------~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 246 NP--------ALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred Cc--------cCchhhc-ccCHHHHHHHHHhcCCcccccchhHH
Confidence 11 1111111 23457888999999999999943333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=239.67 Aligned_cols=269 Identities=22% Similarity=0.322 Sum_probs=201.1
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcc---cCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeC
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEA---VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADG 123 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 123 (336)
.+....+.|.+.++||+|.|++||++.+.. ....||+|.+...+ ....+.+|+++|..+. +.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 344566789999999999999999999876 78899999987654 3467899999999985 89999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-CceEEccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDF 202 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-~~~kl~Df 202 (336)
++..+|+||++..+..++... ++...+..++..++.||.++|.+| ||||||||.|+|.+.. +.-.|+||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEec
Confidence 999999999999998888755 667888999999999999999999 9999999999999654 56899999
Q ss_pred cccccCC-----------------C-------------------------CCCcceeeeeccCccccCcccccc-CCCCC
Q 036144 203 GLAKLGP-----------------T-------------------------GGKDHVSTRVMGTYGYCAPEYAMT-GQLTK 239 (336)
Q Consensus 203 g~~~~~~-----------------~-------------------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ 239 (336)
|++.... . ...........||++|.|||++.. ...++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9987100 0 000011223569999999999876 46899
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCCCccc--ccHHH-HHH------HHhhcc----------------ccccccc-CC--
Q 036144 240 KSDVYSFGVVLLELITGRSAIDNSRPSEE--QNLVT-WAK------PLLRDK----------------KKFTMMA-DP-- 291 (336)
Q Consensus 240 ~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~-~~~------~~~~~~----------------~~~~~~~-~~-- 291 (336)
++||||.|+|+..+++++.||......-. ..++. +++ ..+... ..+..+. ..
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 99999999999999999999876543221 01110 000 000000 0011110 00
Q ss_pred ------ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 ------LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..........+..+.+++.+||..||.+|.|+++.|+
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0111112223447899999999999999999999886
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=236.80 Aligned_cols=267 Identities=24% Similarity=0.343 Sum_probs=213.5
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEcccC-----eEEEEEeecCC-CCccHHHHHHHHHHHhhccCCCccceEEEE
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAVD-----QVVAVKQLDRS-GNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 120 (336)
+++.....+++...++-+|.||.||.|.++... +.|-+|.++.. +.-....++.|...+..+.|||+.++.++.
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 455555677888889999999999999776432 33556666443 223345688899999999999999999987
Q ss_pred Ee-CCeEEEEEEcCCCCChhhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC
Q 036144 121 AD-GDQRILVYEFMSNGSLENHFLDL----PPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF 195 (336)
Q Consensus 121 ~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~ 195 (336)
.+ ....++++.++.-|+|..++... +...+.++..+...++.|++.|+.|||+.+ +||.||-..|.+|++..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 54 46778899999999999999832 234456788888999999999999999999 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 036144 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 274 (336)
+|||+|=.+++.+-+++-.....+......||+||.+.+..|+.++|+||||+++|||+| |+.|+..-++.+....+..
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 999999999987655544444444455678999999999999999999999999999998 8899988777665444432
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
+. . ..-|.+++.++..++.-||..+|++||++++++.-|...
T Consensus 514 Gy-------R----------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 514 GY-------R----------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred cc-------e----------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 21 1 122456777999999999999999999999999877653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=225.73 Aligned_cols=200 Identities=31% Similarity=0.431 Sum_probs=174.0
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ..+.+.+|+..++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56677899999999999999988999999999766544 56788899999999999999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
+++|.+++.... ..+++.....++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 999999987522 12788899999999999999999998 99999999999999999999999999886543320
Q ss_pred ceeeeeccCccccCcccc-ccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 036144 215 HVSTRVMGTYGYCAPEYA-MTGQLTKKSDVYSFGVVLLELITGRSAIDN 262 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 262 (336)
.......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122345688899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=258.53 Aligned_cols=196 Identities=17% Similarity=0.213 Sum_probs=138.0
Q ss_pred hccC-CCccceEEEE-------EeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 036144 107 LVQH-QNLVNLIGYC-------ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178 (336)
Q Consensus 107 ~l~h-~~iv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~ 178 (336)
.++| +||+++++++ ......+++||++ +++|.+++.. ....+++..++.++.||++||.|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 5777888876 2234567788987 7799999964 2456899999999999999999999998
Q ss_pred eeeCCCCCCCeEECCCC-------------------ceEEccccccccCCCCCC--------------cceeeeeccCcc
Q 036144 179 VIYRDFKASNILLDAEF-------------------NPKLSDFGLAKLGPTGGK--------------DHVSTRVMGTYG 225 (336)
Q Consensus 179 i~H~dikp~Nil~~~~~-------------------~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~ 225 (336)
|+||||||+||||+..+ .+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 455556665542110000 000112458999
Q ss_pred ccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHH
Q 036144 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQA 305 (336)
Q Consensus 226 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 305 (336)
|+|||++.+..|+.++|||||||++|||++|.+|+..... ........ ...+.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~---------~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHR---------VLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHh---------hcChhh-----hhcCHHH
Confidence 9999999999999999999999999999998887653211 00000000 000100 0112345
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHH
Q 036144 306 LAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 306 ~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+++.+||+.+|.+|||+.++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 68889999999999999999986
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=218.64 Aligned_cols=260 Identities=20% Similarity=0.209 Sum_probs=197.9
Q ss_pred CCCCcccccccCceEEEEEEEcccC-eEEEEEeecCCCCccHHHHHHHHHHHhhccC----CCccceEEEE-EeCCeEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVD-QVVAVKQLDRSGNQGSREFFAEVLMLSLVQH----QNLVNLIGYC-ADGDQRIL 128 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~~iv~~~~~~-~~~~~~~l 128 (336)
+|.+.+.||+|+||.||+|.+..++ ..+|+|............+..|+.++..+.. +++..+++.+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999998764 6789998765433333367788888888862 6899999999 57788999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-----CceEEcccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-----FNPKLSDFG 203 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-----~~~kl~Dfg 203 (336)
||+.+ |.+|.++..... ...++..+...++.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 999999876543 578999999999999999999999999 9999999999999765 359999999
Q ss_pred ccccCC--CCCC---cc--e-eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 036144 204 LAKLGP--TGGK---DH--V-STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA 275 (336)
Q Consensus 204 ~~~~~~--~~~~---~~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 275 (336)
+++... .... .. . ...+.||..|+++....+...+++.|+||++.++.+++.|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998322 1111 11 1 23456999999999999999999999999999999999999999765543322111111
Q ss_pred HHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 276 KPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.... .... +....+..+.++...+-..+...+|....+...|...
T Consensus 253 ~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 253 PRKL--------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred hhhh--------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1000 0000 1122234555666666668999999999998887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=208.30 Aligned_cols=207 Identities=21% Similarity=0.306 Sum_probs=180.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.+-.|.+.++||+|+||.++.|++--++++||||.-.. .....++..|.+..+.|. .++|...+-+..++.+-.|||
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 45679999999999999999999999999999997433 334567889999999886 699999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-----ceEEcccccc
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-----NPKLSDFGLA 205 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-----~~kl~Dfg~~ 205 (336)
|++ |.||++++.- ....++..++..++.|++.-++++|++. +|.|||||+|+||...+ .+.++|||+|
T Consensus 104 dLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999 9999999876 4567999999999999999999999999 99999999999996543 3899999999
Q ss_pred ccCCCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 036144 206 KLGPTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267 (336)
Q Consensus 206 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 267 (336)
..+.++... ....+..||.+||+--...+.+.+...|+-|||-++++.+-|..||.+.....
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 877654432 34556789999999999999999999999999999999999999999866443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=201.25 Aligned_cols=167 Identities=20% Similarity=0.151 Sum_probs=126.2
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|||.+++.. ....+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 688888865 2456999999999999999999999865 999999999999999 9998764322
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
...||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......... . . .+ ...
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~-~---~----~~-~~~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMP-A---D----DP-RDR 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhc-c---C----Cc-ccc
Confidence 12689999999999999999999999999999999999999975432111 0111111100 0 0 00 000
Q ss_pred CCcHHHHH--HHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 296 QYPRKGLY--QALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 296 ~~~~~~~~--~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
..+...+. .+.+++.+||+.+|.+|||+.++++.+..+
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 11222333 699999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=201.35 Aligned_cols=209 Identities=22% Similarity=0.285 Sum_probs=177.7
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC-CCccceEEEEEeCCeEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH-QNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 130 (336)
...+|.++++||+|+||.+|+|.+..+|+.||||+-+.. ....++.-|..+.+.|++ ..|..+..++.+..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 357899999999999999999999999999999985433 233567889999999975 78888888899999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC---CceEEcccccccc
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---FNPKLSDFGLAKL 207 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~~ 207 (336)
+.+ |.||++++.- ....++..+++-++.|++.-++|+|..+ ++||||||+|+|..-+ ..+.|+|||++..
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 998 9999999876 3567888999999999999999999999 9999999999999544 4589999999986
Q ss_pred CCCCCC-----cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc
Q 036144 208 GPTGGK-----DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ 269 (336)
Q Consensus 208 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 269 (336)
+.+... ........||..|.+--...+...+...|+-|+|.++.++--|..||.+.......
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 543222 22345578999999988888888999999999999999999999999987665443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=214.57 Aligned_cols=168 Identities=17% Similarity=0.135 Sum_probs=130.9
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcc-cCeEEEEEeecCCC-----CccHHHHHHHHHHHhhccCCCccceEEEEEeC
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEA-VDQVVAVKQLDRSG-----NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG 123 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 123 (336)
.....+|.+.+.||+|+||+||+|.+.. +++.+|||++.... ......+.+|+++|+.++|+|++..+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 4556889999999999999999999876 67888999865321 1123568899999999999999863322 2
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCeEECCCCceEEccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDF-KASNILLDAEFNPKLSDF 202 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~di-kp~Nil~~~~~~~kl~Df 202 (336)
...++||||++|++|... .. .. ...++.++++||.|||+.| |+|||| ||+|||++.++.++|+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~----~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP----HG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc----cc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999632 11 11 1467889999999999998 999999 999999999999999999
Q ss_pred cccccCCCCCCcce------eeeeccCccccCcccccc
Q 036144 203 GLAKLGPTGGKDHV------STRVMGTYGYCAPEYAMT 234 (336)
Q Consensus 203 g~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 234 (336)
|++......+.... .++..++..|+|||.+..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99986654332111 135678899999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=232.13 Aligned_cols=255 Identities=19% Similarity=0.230 Sum_probs=192.7
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccH----HHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGS----REFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
....++|.|++|.|+.+......+.++.|.+... ..... ..+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4566899999998888888766666666654311 11111 12556777888899999988877766655555559
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|||++ +|...+.. ...+....+..++.|++.|+.|||+.| |.|||+||+|++++.+|.+||+|||.+.....
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99998 99998865 246778888999999999999999999 99999999999999999999999999987655
Q ss_pred CCCc--ceeeeeccCccccCccccccCCCCC-ccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 211 GGKD--HVSTRVMGTYGYCAPEYAMTGQLTK-KSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
+... ......+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+...... ....-..
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~~~~~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYSDQRN 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------ccccccc
Confidence 4444 5567789999999999999999985 5899999999999999999998766554432000 0000000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+.. -...+....+.....++.+||++||.+|.|+++|++
T Consensus 546 ~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 001122344557888999999999999999999986
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-25 Score=195.60 Aligned_cols=260 Identities=29% Similarity=0.411 Sum_probs=197.3
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCC-CccceEEEEEeCCeEEEEEE
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQ-NLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 131 (336)
|.+...||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 667788999999999999998 67899998765433 256788999999999988 79999999977777899999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~ 210 (336)
++.++++.+++...... ..++......++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999766542211 36888999999999999999999999 99999999999999998 699999999975433
Q ss_pred CCCcc----eeeeeccCccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-ccccHHHHHHHHhhcc
Q 036144 211 GGKDH----VSTRVMGTYGYCAPEYAMT---GQLTKKSDVYSFGVVLLELITGRSAIDNSRPS-EEQNLVTWAKPLLRDK 282 (336)
Q Consensus 211 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~ 282 (336)
..... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ........... ..
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE---LP 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh---cC
Confidence 32221 3466789999999999987 57899999999999999999999997655431 00111111111 10
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .................+.+++..++..+|..|.+..+...
T Consensus 232 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 232 TP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred Cc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 00 00000000000222357889999999999999999887665
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=184.84 Aligned_cols=173 Identities=12% Similarity=0.080 Sum_probs=134.4
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHH---------HHHHHHHHhhccCCCccceEEEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE---------FFAEVLMLSLVQHQNLVNLIGYCA 121 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~iv~~~~~~~ 121 (336)
....+|.+.+++|.|+||.||++.. ++..+|+|++.+........ +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3568999999999999999999766 36689999997554333222 578999999999999999998866
Q ss_pred eC--------CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC
Q 036144 122 DG--------DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA 193 (336)
Q Consensus 122 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~ 193 (336)
.. ...+++|||++|.+|.++.. ++. ....+++.++..+|..| ++|||+||.||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 43 35789999999999987631 222 24568999999999999 999999999999998
Q ss_pred CCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh
Q 036144 194 EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255 (336)
Q Consensus 194 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 255 (336)
+| ++|+|||.......... . ........|+.++|+||||+++..+..
T Consensus 171 ~g-i~liDfg~~~~~~e~~a---~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA---K-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccchhh---H-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 88 99999998864321110 0 113445567789999999999876643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-26 Score=218.02 Aligned_cols=253 Identities=21% Similarity=0.197 Sum_probs=185.5
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHH---HHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREF---FAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
+|...+.||.+.|=+|.+|++.+ |. |+||++-+.. .-..+.+ ..|++ ...+++||++++.-+.......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 57777889999999999999986 44 8999986543 2223333 34444 55678999999988888888889999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc--C
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL--G 208 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~--~ 208 (336)
+|+ .-+|.|.+.. +.-+...+..-|+-|++.||..+|..| |+|||||.+||||+...-+.|+||..-+. +
T Consensus 101 qyv-khnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHH-hhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 998 5588888754 556777888889999999999999999 99999999999999999999999987643 2
Q ss_pred CCCCC---cceeeeeccCccccCccccccC----------C-CCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 036144 209 PTGGK---DHVSTRVMGTYGYCAPEYAMTG----------Q-LTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVT 273 (336)
Q Consensus 209 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~ 273 (336)
+.... .....+...-.+|.|||.+... . .+++.||||+||+++||++ |++||+.. ++..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh
Confidence 21111 1122233344579999987542 1 5688999999999999988 57777642 1222
Q ss_pred HHHH-HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccCC
Q 036144 274 WAKP-LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336 (336)
Q Consensus 274 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~~ 336 (336)
+... ....+..++.+. ...+++++..|++.||+.|.++++.|+....+..|
T Consensus 247 Yr~~~~~~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP 298 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFP 298 (1431)
T ss_pred HhccCccCHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHhhhccccH
Confidence 1111 000011111121 22688999999999999999999999988777655
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=189.53 Aligned_cols=234 Identities=19% Similarity=0.247 Sum_probs=152.0
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhcc----------CCCccceEEEEE-
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQ----------HQNLVNLIGYCA- 121 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~~- 121 (336)
+.....||.|+++.||.+++..||+.+|+|++.... ....+.+.+|......+. |-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445668999999999999999999999999985433 223455666665554432 212222222221
Q ss_pred --------eC---C-----eEEEEEEcCCCCChhhhhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 036144 122 --------DG---D-----QRILVYEFMSNGSLENHFLD---LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYR 182 (336)
Q Consensus 122 --------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~ 182 (336)
.. . ..+++|+-+ .++|.+++.. .......+.......+..|+++.+++||+.| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 1 236788877 6788777543 1122233445556777899999999999999 9999
Q ss_pred CCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccC--------CCCCccchhhHHHHHHHHH
Q 036144 183 DFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG--------QLTKKSDVYSFGVVLLELI 254 (336)
Q Consensus 183 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslG~il~~l~ 254 (336)
||+|+|++++.+|.++|+||+....... . ......+..|.|||..... .++.+.|.|+||+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~-~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----R-YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----E-EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----e-eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999998764211 1 1113456789999976432 4788999999999999999
Q ss_pred hCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCC
Q 036144 255 TGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSR 320 (336)
Q Consensus 255 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 320 (336)
+|..||....+...... .-..+. +.++.+..||..+|+.||.+|
T Consensus 245 C~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999987543322111 112344 778899999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-26 Score=185.36 Aligned_cols=249 Identities=20% Similarity=0.321 Sum_probs=196.1
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
..+..+|.+...|..|+|++.+ ..++.|++.-. .....++|..|.-.|+-..||||+.+++.+..+..+.++..|+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 4455678999999999999985 45667776432 3333467889999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEc--cccccccCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS--DFGLAKLGPTG 211 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~--Dfg~~~~~~~~ 211 (336)
+.|||.+++... ..-.++-.++.+++.++++|++|||+.. +-|----|....++||++.+.+|+ |--++-.
T Consensus 270 p~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq---- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---- 342 (448)
T ss_pred cchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee----
Confidence 999999999873 3445677789999999999999999975 223344688899999998876653 3322211
Q ss_pred CCcceeeeeccCccccCccccccCCCC---CccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLT---KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.....-.|.|++||.+..++-+ .++|+|||++++|||.|...||.+..+.+..-.+.
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------------- 402 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------------- 402 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh---------------
Confidence 1122357889999999876543 57999999999999999999999887755433221
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
-+.++..+|+..+..+.+|+.-|++.||.+||.+..++-.||++.
T Consensus 403 -leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 -LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 223444667778889999999999999999999999999999864
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=177.87 Aligned_cols=139 Identities=15% Similarity=0.097 Sum_probs=108.2
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCc--c-------H-----------------HHHHHHHHHHhhccCCC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--G-------S-----------------REFFAEVLMLSLVQHQN 112 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~~ 112 (336)
...||+|+||.||+|.+. +|+.||+|+++..... . . .....|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 7999999998654211 0 0 11235999999998887
Q ss_pred ccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCCeEE
Q 036144 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL-HDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 113 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~l-h~~~~~~i~H~dikp~Nil~ 191 (336)
+.....+... ..++||||++|+++...... ...++......++.|++.+|.++ |+.| |+||||||+||++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 6444333222 23899999988776544322 35688889999999999999999 6888 9999999999999
Q ss_pred CCCCceEEccccccccC
Q 036144 192 DAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~ 208 (336)
+ ++.++|+|||++...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=171.44 Aligned_cols=140 Identities=17% Similarity=0.112 Sum_probs=110.3
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCc---------------------c-----HHHHHHHHHHHhhccCCC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---------------------G-----SREFFAEVLMLSLVQHQN 112 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~~ 112 (336)
.+.||+|++|.||+|.+. +|+.||||+++..... . ......|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 7999999998764211 0 112357889999999998
Q ss_pred ccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEE
Q 036144 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILL 191 (336)
Q Consensus 113 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~ 191 (336)
+.....+.... .++||||++|+++...... ...++......++.|++.++.++|+ .| |+||||||+||++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 75544443332 4899999988765433221 2456778889999999999999999 88 9999999999999
Q ss_pred CCCCceEEccccccccCC
Q 036144 192 DAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~ 209 (336)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 8 7899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=203.51 Aligned_cols=198 Identities=19% Similarity=0.187 Sum_probs=160.7
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc---CCCccceEEEEEeCCeE
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ---HQNLVNLIGYCADGDQR 126 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~ 126 (336)
....+.|.|.+.||+|+||.||+|.+.. |+.||+|+-++......--. .+++.+|+ -+.|..+...+...+..
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~---~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC---LQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh---HHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3455789999999999999999999988 99999999876655432111 12233333 34566666666777788
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC-------CCCceEE
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD-------AEFNPKL 199 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~-------~~~~~kl 199 (336)
++|+||.+.|||.+++. ..+.+++..+..++.|++..|..||..+ |||+||||+|+++. .+..++|
T Consensus 770 ~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999986 4677888899999999999999999999 99999999999992 2345999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 258 (336)
+|||.+..+..-.........++|-.+-.+|+..|.+|+..+|.|.|+.+++.|+.|++
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999875433222234566789999999999999999999999999999999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-25 Score=197.28 Aligned_cols=226 Identities=27% Similarity=0.363 Sum_probs=180.6
Q ss_pred cccccCceEEEEEEE---cccCeEEEEEeecCCCCcc--HHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEEcCC
Q 036144 61 LVGEGGYGRVYKGYI---EAVDQVVAVKQLDRSGNQG--SREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYEFMS 134 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~---~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~ 134 (336)
++|+|+||.|+++.- ...|..+|+|+..+..... ......|..++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998654 3457789999987653221 123456777888876 9999999999999999999999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 214 (336)
||.|...+.. ...+.+.....+...++-|+.++|+.+ ++|||+|++||+++.+|.+++.|||.++..-....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 9999877654 445666777778888999999999999 99999999999999999999999999976433221
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccC
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (336)
.|||..|||||++. .....+|.||+|+++++|++|..||.. +....+ . ...
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I------l------------~~~ 203 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI------L------------KAE 203 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH------h------------hhc
Confidence 18999999999987 668899999999999999999999986 111111 0 011
Q ss_pred CCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 295 GQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 295 ~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
...|...+..+.+++..++..+|.+|...
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 24566777889999999999999999755
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=163.94 Aligned_cols=186 Identities=16% Similarity=0.111 Sum_probs=138.0
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc----HHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEE
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG----SREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.+...|++|+||+|+++.. .+..++.+.+....... ...+.+|+++|++|. |+++++++++ +..+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3456799999999998776 36788877776544321 124789999999996 4889999886 34689999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCeEECCCCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDF-KASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~di-kp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|+.|.+|...... ....++.|++.+|.++|+.| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999988653311 11357788999999999999 999999 79999999999999999999985443
Q ss_pred CCCc----ce-------eeeeccCccccCccccccC-CCC-CccchhhHHHHHHHHHhCCCCCCC
Q 036144 211 GGKD----HV-------STRVMGTYGYCAPEYAMTG-QLT-KKSDVYSFGVVLLELITGRSAIDN 262 (336)
Q Consensus 211 ~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwslG~il~~l~~g~~p~~~ 262 (336)
.... .. ......++.|++|+...-- ..+ ...+.++-|+-+|.++|+..++..
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 3210 00 0112367788888754322 233 566888999999999999987644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-23 Score=175.42 Aligned_cols=197 Identities=20% Similarity=0.187 Sum_probs=140.0
Q ss_pred cCCCccceEEEEEe---------------------------CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHH
Q 036144 109 QHQNLVNLIGYCAD---------------------------GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIA 161 (336)
Q Consensus 109 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 161 (336)
.|||||.++.+|.+ +...|+||..+ ..+|.+++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999887743 23568999988 5699999865 445666778899
Q ss_pred HHHHHHHHHHHhCCCCCeeeCCCCCCCeEE--CCC--CceEEccccccccCCCCCCcce----eeeeccCccccCccccc
Q 036144 162 GGAAKGLEYLHDVADPPVIYRDFKASNILL--DAE--FNPKLSDFGLAKLGPTGGKDHV----STRVMGTYGYCAPEYAM 233 (336)
Q Consensus 162 ~~l~~~l~~lh~~~~~~i~H~dikp~Nil~--~~~--~~~kl~Dfg~~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~ 233 (336)
.|+++|+.|||.+| |.|||+|.+|||+ +++ ..+.|+|||+|--....+.... .-...|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999999 333 3589999999854322111111 12245788899999876
Q ss_pred cCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHH
Q 036144 234 TGQ------LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALA 307 (336)
Q Consensus 234 ~~~------~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 307 (336)
..+ --.++|.|+.|.+.||+++...||........ +.. ..++-.-| ..+...+..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r-----------~Yqe~qLP----alp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTR-----------TYQESQLP----ALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chh-----------hhhhhhCC----CCcccCChHHHH
Confidence 432 12589999999999999999999975221111 111 11111122 233445558999
Q ss_pred HHHhhcCCCCCCCCCHHHHHHHH
Q 036144 308 VAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 308 li~~cl~~dp~~Rpt~~evl~~L 330 (336)
++...|+.||++|++..=....|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 99999999999999876544443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-22 Score=163.85 Aligned_cols=136 Identities=18% Similarity=0.185 Sum_probs=106.9
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-----cCCCccceEEEEEeCC---eEE-
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-----QHQNLVNLIGYCADGD---QRI- 127 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~~~- 127 (336)
.-.+.||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ .||||+++++++.++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3456799999999995 6666665 69998765444567799999999999 5799999999998874 333
Q ss_pred EEEEc--CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeCCCCCCCeEECC----CCceEEc
Q 036144 128 LVYEF--MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL-EYLHDVADPPVIYRDFKASNILLDA----EFNPKLS 200 (336)
Q Consensus 128 lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l-~~lh~~~~~~i~H~dikp~Nil~~~----~~~~kl~ 200 (336)
+|+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||+.+ |+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557999999964 235544 35577777777 9999999 999999999999964 3479999
Q ss_pred ccccc
Q 036144 201 DFGLA 205 (336)
Q Consensus 201 Dfg~~ 205 (336)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-23 Score=193.71 Aligned_cols=213 Identities=24% Similarity=0.313 Sum_probs=151.1
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
...+|..++.|..|+||.||+++|+.+.+.+|+|+ .+.. .+.+- ++....+|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-----lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-----LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-----hhhhc--cccccCCccee-----------------
Confidence 45789999999999999999999999999999954 3321 11111 33333444444
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+-...+.. -++++.. ++.|++|||+.+ |+|||+||+|.+|+.=|++|++|||++......
T Consensus 136 ----gDc~tllk~----~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ----GDCATLLKN----IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ----chhhhhccc----CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 232333322 2334333 267899999999 999999999999999999999999998642111
Q ss_pred CCc-------------ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 212 GKD-------------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 212 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
... -.....+||+.|.|||++..+.|+..+|.|++|+|+|+.+-|..||.+..+++....+......
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~ 276 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 276 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence 100 1123468999999999999999999999999999999999999999988766543222111111
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
+ .+- ......++.+++..+|+.+|..|--.
T Consensus 277 w------pE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 277 W------PEE---------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred c------ccc---------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 1 000 11223478999999999999999543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=175.71 Aligned_cols=217 Identities=27% Similarity=0.412 Sum_probs=163.8
Q ss_pred HhhccCCCccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 036144 105 LSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDF 184 (336)
Q Consensus 105 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~di 184 (336)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+.. ....+++.....+..+++.|++|||... -..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 4678999999999999999999999999999999999876 4677899999999999999999999855 2399999
Q ss_pred CCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCC-------CCCccchhhHHHHHHHHHhCC
Q 036144 185 KASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ-------LTKKSDVYSFGVVLLELITGR 257 (336)
Q Consensus 185 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwslG~il~~l~~g~ 257 (336)
+..|.+++....+||+|||+.................-..-|.|||.+.+.. .+.+.|+||+|++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987653311111222223456799999887631 466799999999999999999
Q ss_pred CCCCCCCCcccc-cHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 258 SAIDNSRPSEEQ-NLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 258 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.||......... ..+..... .......|.+... .+....+..++..||..+|.+||+++.+-..++.+.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred CccccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 999875443322 22222111 0111111111100 023337899999999999999999999998887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7e-21 Score=160.28 Aligned_cols=144 Identities=15% Similarity=0.105 Sum_probs=111.1
Q ss_pred cCCCCcccccccCceEEEEEE-EcccCeEEEEEeecCCCCc-------------------c-----HHHHHHHHHHHhhc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGY-IEAVDQVVAVKQLDRSGNQ-------------------G-----SREFFAEVLMLSLV 108 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~-~~~~~~~vavK~~~~~~~~-------------------~-----~~~~~~e~~~l~~l 108 (336)
.-|.+.+.||+|+||.||+|. +..+|+.||+|++...... . ...+..|+.+++.+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358888999999999999999 6678999999998654211 0 02256899999999
Q ss_pred cCC--CccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 036144 109 QHQ--NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKA 186 (336)
Q Consensus 109 ~h~--~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp 186 (336)
.+. .+.+++++ ...++||||++|++|...... ...+.......++.|++.++.+||+.+. ++||||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp 177 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSE 177 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCCh
Confidence 753 33444442 235899999999888665422 2345566678899999999999997653 99999999
Q ss_pred CCeEECCCCceEEccccccccC
Q 036144 187 SNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 187 ~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
+||+++ ++.++|+|||.+...
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhcc
Confidence 999999 889999999998743
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-20 Score=153.59 Aligned_cols=134 Identities=19% Similarity=0.260 Sum_probs=111.8
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCcc--------HHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG--------SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
+.||+|++|.||+|.+ .|..+++|+........ ...+.+|+.++..+.|+++.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 4699999999999988 46789999865432111 1346789999999999998887777777788899999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
|++|++|.+++... .. ....++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999988542 11 67889999999999999998 99999999999999 78899999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=173.96 Aligned_cols=174 Identities=22% Similarity=0.338 Sum_probs=128.8
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
+.|+.|++|...+|.+|+.... .....++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5689999999999999997533 34567778889999999999999 66 99999999999999999999999999
Q ss_pred cccCCCCC----CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHHh
Q 036144 205 AKLGPTGG----KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG-RSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 205 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
........ .....+...||..||+||++.+..|+.++||||||++|+||+.- ..+|+..
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------------- 466 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------------- 466 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------------
Confidence 87654433 12235567899999999999999999999999999999999982 2222111
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVD 325 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 325 (336)
..+..+.+..+...+-.+ -+.-..++.+++...|.+||++.+
T Consensus 467 ---~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 467 ---ATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---HhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHH
Confidence 011111111111111001 113457899999999999994433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=148.79 Aligned_cols=143 Identities=15% Similarity=0.079 Sum_probs=110.5
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc----------------------cHHHHHHHHHHH
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ----------------------GSREFFAEVLML 105 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l 105 (336)
.+......|.+.+.||+|+||.||++.+. +|+.||||++...... .......|+.++
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34444445888899999999999999885 6899999987543210 011256788889
Q ss_pred hhccCC--CccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 036144 106 SLVQHQ--NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRD 183 (336)
Q Consensus 106 ~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~d 183 (336)
..+.|+ .+++.++. ...++||||++|++|...... .....++.+++.++.++|+.+ ++|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 888877 44555442 345899999999998765321 234578899999999999988 99999
Q ss_pred CCCCCeEECCCCceEEccccccccC
Q 036144 184 FKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 184 ikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
|||+||+++.++.++|+|||.+...
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.1e-19 Score=148.36 Aligned_cols=130 Identities=20% Similarity=0.290 Sum_probs=104.8
Q ss_pred cccccCceEEEEEEEcccCeEEEEEeecCCCC-c-------cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-Q-------GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.||+|+||.||+|.+. +..+++|....... . ....+.+|+.++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999854 67899998643221 1 114467899999999988766555555666777999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
++|++|.+++... . ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~----~-------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEG----N-------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhc----H-------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998877541 1 078899999999999998 99999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.2e-19 Score=167.54 Aligned_cols=137 Identities=20% Similarity=0.285 Sum_probs=110.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecC--CCC------ccHHHHHHHHHHHhhccCCCccceEEEEEeCC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGN------QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~--~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 124 (336)
...|...+.||+|+||.||+|.+... .+++|+... ... .....+.+|+.+++.++|++++....+.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 34567788999999999999988653 344443211 111 11245788999999999999998887777777
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++.++|+|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 7899999999999998874 34678999999999999998 9999999999999 677999999999
Q ss_pred ccc
Q 036144 205 AKL 207 (336)
Q Consensus 205 ~~~ 207 (336)
+..
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 974
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.2e-21 Score=179.13 Aligned_cols=257 Identities=23% Similarity=0.269 Sum_probs=196.0
Q ss_pred hcCCCCcccccccCceEEEEEEEc-ccCeEEEEEeecCCC--CccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIE-AVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l 128 (336)
...|.+.+.||+|+|+.|-+.... .....+|+|.+.... .........|..+-+.+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 456888888999999999998874 344567777765543 222344556787877777 9999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCCeEECCCC-ceEEccccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH-DVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAK 206 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh-~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~ 206 (336)
++++..|+++.+.+.. ......+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||++.
T Consensus 99 ~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999887731 12224555667788999999999999 777 99999999999999999 99999999998
Q ss_pred cCCC-CCCcceeeeecc-CccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 207 LGPT-GGKDHVSTRVMG-TYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 207 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
.... .+........+| ++.|+|||...+. ...+..|+||+|+++..+++|..|+.......... ..|... .
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~-----~ 247 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSN-----K 247 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeeccc-----c
Confidence 8766 555555666788 9999999998885 45688999999999999999999998766544211 111000 0
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl 327 (336)
...........+....+++.+++..+|..|.+.+++-
T Consensus 248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -------cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0000111223344678899999999999999988764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=5e-18 Score=138.66 Aligned_cols=135 Identities=19% Similarity=0.145 Sum_probs=97.3
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCcc--HHH----------------------HHHHHHHHhhccCC--C
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG--SRE----------------------FFAEVLMLSLVQHQ--N 112 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~--~ 112 (336)
.+.||+|+||.||+|.+. +++.||||++....... ... ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 68999999986532211 111 13456666666543 3
Q ss_pred ccceEEEEEeCCeEEEEEEcCCCCChhhh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeE
Q 036144 113 LVNLIGYCADGDQRILVYEFMSNGSLENH-FLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNIL 190 (336)
Q Consensus 113 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil 190 (336)
+.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. .+ |+|+||||+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4455543 235899999988554321 11100 01 4567899999999999999 88 999999999999
Q ss_pred ECCCCceEEccccccccC
Q 036144 191 LDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~ 208 (336)
++ ++.++|+|||.+...
T Consensus 148 i~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EE-CCcEEEEECcccccc
Confidence 99 889999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-17 Score=130.88 Aligned_cols=135 Identities=19% Similarity=0.148 Sum_probs=113.2
Q ss_pred CcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC--CCccceEEEEEeCCeEEEEEEcCCC
Q 036144 58 PDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH--QNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 58 ~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.+.||.|.++.||++.... ..+++|....... ...+..|+.+++.+.| .++++++.+....+..+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 34679999999999999864 6799998865433 4578899999999986 5899999988888889999999988
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+++..+ +......++.+++.++..||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777543 4456678899999999999986445599999999999999988999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.2e-17 Score=137.62 Aligned_cols=134 Identities=22% Similarity=0.228 Sum_probs=102.6
Q ss_pred cccc-ccCceEEEEEEEcccCeEEEEEeecCCC-------------CccHHHHHHHHHHHhhccCCCc--cceEEEEEeC
Q 036144 60 CLVG-EGGYGRVYKGYIEAVDQVVAVKQLDRSG-------------NQGSREFFAEVLMLSLVQHQNL--VNLIGYCADG 123 (336)
Q Consensus 60 ~~ig-~G~~g~v~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~ 123 (336)
..|| .|+.|+||.+... +..++||.+.... ......+.+|+.++..|.|+++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 7888889988776 6788999874321 1122457789999999998775 6677664432
Q ss_pred C----eEEEEEEcCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceE
Q 036144 124 D----QRILVYEFMSN-GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 124 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
. ..++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+.| |+||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 2 23599999987 688888754 234443 3567899999999999 99999999999999988999
Q ss_pred Ecccccccc
Q 036144 199 LSDFGLAKL 207 (336)
Q Consensus 199 l~Dfg~~~~ 207 (336)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-16 Score=143.39 Aligned_cols=250 Identities=23% Similarity=0.231 Sum_probs=186.6
Q ss_pred cCCCCcccccc--cCceEEEEEEE--cccCeEEEEEeecCCC--CccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeE
Q 036144 54 ENFNPDCLVGE--GGYGRVYKGYI--EAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQR 126 (336)
Q Consensus 54 ~~y~~~~~ig~--G~~g~v~~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 126 (336)
..|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+... ......=.+|+...+.++ |++.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45778888999 99999999998 8889999999843322 222223345666666664 89999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeeeCCCCCCCeEECCC-CceEEcc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK----GLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSD 201 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~----~l~~lh~~~~~~i~H~dikp~Nil~~~~-~~~kl~D 201 (336)
++-.|++ +.+|..+... ....++....+..+.+... ||.++|+.+ ++|-|+||+||+...+ ...+++|
T Consensus 194 fiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 9999998 6888888765 3344777788888888888 999999988 9999999999999999 8899999
Q ss_pred ccccccCCCCCCcc---eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 202 FGLAKLGPTGGKDH---VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 202 fg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
||+......+.... ......|...|++||. ..+.++..+|+|++|.++.+..++..+....-.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------------- 332 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKN------------- 332 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCC-------------
Confidence 99998765544222 1233468889999995 566789999999999999999998765543210
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+....+..++....+.++...+..|++.+|..|++.+.+..
T Consensus 333 ----~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 ----SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0111111112233344344556777999999999999998876653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-16 Score=133.36 Aligned_cols=205 Identities=23% Similarity=0.293 Sum_probs=144.6
Q ss_pred HHHhhccCCCccceEEEEEeCC-----eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 036144 103 LMLSLVQHQNLVNLIGYCADGD-----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177 (336)
Q Consensus 103 ~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~ 177 (336)
..|-++.|.|+++++.|+.+.. ...++.||+..|++..+|+........+....-.+|+-||+.||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3445567999999999886543 467999999999999999987777788888888999999999999999984 8
Q ss_pred CeeeCCCCCCCeEECCCCceEEcccccc--ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh
Q 036144 178 PVIYRDFKASNILLDAEFNPKLSDFGLA--KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255 (336)
Q Consensus 178 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 255 (336)
+|+|+++..+.|++..+|-+|++----. ...-............+.++|.|||.=.....+.++|||+||....+|.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 8999999999999999988887532111 10000111112223457889999997666677889999999999999988
Q ss_pred CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 256 GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 256 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+..-..+...... ........ ...+-+.. =+.++..|++..|..||++.+++.
T Consensus 278 lEiq~tnseS~~~-~ee~ia~~-------i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 278 LEIQSTNSESKVE-VEENIANV-------IIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred heeccCCCcceee-hhhhhhhh-------eeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 7654333221111 00000000 01111111 124778999999999999998875
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-14 Score=131.02 Aligned_cols=170 Identities=17% Similarity=0.149 Sum_probs=130.2
Q ss_pred EEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCC
Q 036144 72 KGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEP 151 (336)
Q Consensus 72 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 151 (336)
.|..+.++.+|.|...+...........+-++.|+.++||||+++++.++.....|+|+|-+ -.|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------
Confidence 57778889999999987665544566788899999999999999999999999999999987 366767655
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccc
Q 036144 152 LDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231 (336)
Q Consensus 152 l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 231 (336)
+.......-+.||+.||.|||..+. ++|++|.-+.|+|+..|..||++|.++........ ......--..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 2255666778999999999985332 99999999999999999999999999865432211 1111222234556654
Q ss_pred cccCCCCCccchhhHHHHHHHHHhC
Q 036144 232 AMTGQLTKKSDVYSFGVVLLELITG 256 (336)
Q Consensus 232 ~~~~~~~~~~DvwslG~il~~l~~g 256 (336)
+.... -..|.|.|||++++++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 33222 345999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.9e-15 Score=134.68 Aligned_cols=141 Identities=18% Similarity=0.120 Sum_probs=96.0
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccH----------------------------------------HHH
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS----------------------------------------REF 98 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 98 (336)
.+.||+|++|.||+|+.+ +|+.||||+.++...... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 357999999999999986 489999999865421100 013
Q ss_pred HHHHHHHhhcc----CCCccceEEEE-EeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHH
Q 036144 99 FAEVLMLSLVQ----HQNLVNLIGYC-ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK-GLEYLH 172 (336)
Q Consensus 99 ~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~-~l~~lh 172 (336)
.+|...+..+. |.+-+.+-.++ ......++||||++|++|.++.... ....+ ...++..++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHH
Confidence 34555555542 22222222222 2234578999999999998875431 11122 2345555555 467889
Q ss_pred hCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 173 ~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
..| ++|+|++|.||+++.++.++++|||++....
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 888 9999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.3e-15 Score=139.46 Aligned_cols=147 Identities=14% Similarity=0.065 Sum_probs=95.8
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc----------------------------------HH-
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG----------------------------------SR- 96 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~- 96 (336)
....|+. +.||+|++|.||+|+.+.+|+.||||++++.-... .+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456777 78999999999999999889999999997542110 01
Q ss_pred -----HHHHHHHHHhhcc----CCCccceEEEEEe-CCeEEEEEEcCCCCChhhhh--ccCCCCCCCCCHHHHHHHHHHH
Q 036144 97 -----EFFAEVLMLSLVQ----HQNLVNLIGYCAD-GDQRILVYEFMSNGSLENHF--LDLPPDQEPLDWFTRMKIAGGA 164 (336)
Q Consensus 97 -----~~~~e~~~l~~l~----h~~iv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~~l 164 (336)
++.+|+..+.++. +.+.+.+-.++.+ ....++||||++|+++.+.- .........+....+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 1334444444442 3333443343332 45578999999999997742 2111011123333333333333
Q ss_pred HHHHHHHHhCCCCCeeeCCCCCCCeEECCCC----ceEEccccccccCC
Q 036144 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEF----NPKLSDFGLAKLGP 209 (336)
Q Consensus 165 ~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~----~~kl~Dfg~~~~~~ 209 (336)
...| ++|+|+||.||+++.++ .++++|||++...+
T Consensus 277 -------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 -------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3456 99999999999999888 89999999987653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=114.98 Aligned_cols=130 Identities=20% Similarity=0.172 Sum_probs=96.8
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCcc-ceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLV-NLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
+.|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 46899999999999876 67899998754432 123467899999988765544 455443 3345799999999887
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA--DPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
.+. . .....++.+++++|..||..+ ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~--~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--D----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--c----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 543 0 011345678999999999887 23359999999999999 66899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.9e-13 Score=108.13 Aligned_cols=138 Identities=12% Similarity=0.092 Sum_probs=99.2
Q ss_pred cccccccCceEEEEEEEcc------cCeEEEEEeecCCCC---------------------cc-HHH----HHHHHHHHh
Q 036144 59 DCLVGEGGYGRVYKGYIEA------VDQVVAVKQLDRSGN---------------------QG-SRE----FFAEVLMLS 106 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~------~~~~vavK~~~~~~~---------------------~~-~~~----~~~e~~~l~ 106 (336)
...||.|--+.||.|.... .+..+|||+.+.... .. ... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998653 357899998742110 01 112 237999999
Q ss_pred hccC--CCccceEEEEEeCCeEEEEEEcCCCCChhh-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeC
Q 036144 107 LVQH--QNLVNLIGYCADGDQRILVYEFMSNGSLEN-HFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL-HDVADPPVIYR 182 (336)
Q Consensus 107 ~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~l-h~~~~~~i~H~ 182 (336)
++.. -++...+++ ..-++||||+.+..+.. .+. ...++......+..+++.++..| |..+ +||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9863 566777764 45689999996543321 121 12344455667889999999998 8888 9999
Q ss_pred CCCCCCeEECCCCceEEccccccccCC
Q 036144 183 DFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 183 dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
||+|.||+++ ++.+.|+|||.+....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4689999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.9e-14 Score=128.40 Aligned_cols=250 Identities=20% Similarity=0.200 Sum_probs=176.9
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEc-ccCeEEEEEeecCCCCccHHH--HHHHHHHHhhc-cCCCccceEEEEEeCCe
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIE-AVDQVVAVKQLDRSGNQGSRE--FFAEVLMLSLV-QHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (336)
.....+|..+..||.|.|+.|+.+..+ .++..|++|...+.......+ -..|+-+...+ .|.+++.....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344567889999999999999998866 678889999876554333333 24566666665 48888888877777777
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-CceEEccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGL 204 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~ 204 (336)
.|+--|||+++++..... ....+++...+.+..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||+
T Consensus 341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccc
Confidence 889999999998876652 2344666778899999999999999988 9999999999999876 7789999999
Q ss_pred cccCCCCCCcceeeeeccCcccc--CccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYC--APEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
+..+... .....+.-++. +|.......+..+.|++|||..+.+.+++....+.....
T Consensus 414 ~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---------------- 472 (524)
T KOG0601|consen 414 WTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---------------- 472 (524)
T ss_pred cccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc----------------
Confidence 8642111 11222333444 444444567889999999999999999987543321110
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
..+...... ..+.....+..+...+...++..||.+.++....+.
T Consensus 473 ---~~i~~~~~p--~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 473 ---LTIRSGDTP--NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ---eeeeccccc--CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 000000000 011122567778899999999999999887765443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.9e-12 Score=98.16 Aligned_cols=131 Identities=20% Similarity=0.257 Sum_probs=100.1
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC--CccH------HHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGS------REFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~------~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..+++|+-+.++.+.+. |..+++|.=.+.. .... ..-.+|+.++..+.--.|.-..=+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35899999999999775 4457777532211 1111 234579999999876666666666677788889999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
|++|..|.+.+... ...++..+-..+.-||..| |+|+||.++||++...+ +.++|||++.+
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888662 1456677777888999999 99999999999997764 99999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=6e-14 Score=133.98 Aligned_cols=251 Identities=18% Similarity=0.171 Sum_probs=175.0
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
...+.+.+.+-+-+|.++.++.+.-..+|...+.|+...... ...+....+-.++-...+|-++...-.+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345678888889999999999998888887777776543221 11222222222222234455555544444556788
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
|+++|+.+++|...+.... ..+....+.....+..++++||... +.|+|++|.|+++..++..+++|||....
T Consensus 881 L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred hhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccc
Confidence 9999999999988887632 3444455666677888999999887 99999999999999999999999984321
Q ss_pred CCC------C-------------------C----CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCC
Q 036144 208 GPT------G-------------------G----KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258 (336)
Q Consensus 208 ~~~------~-------------------~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~ 258 (336)
... . . .........||+.|.+||...+......+|.|++|+++++.++|.+
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 100 0 0 0011234679999999999999999999999999999999999999
Q ss_pred CCCCCCCcccccHHHHHHHHhhcccccccccCCcc-CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 036144 259 AIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL-EGQYPRKGLYQALAVAGMCLQEDADSRPFMV 324 (336)
Q Consensus 259 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ 324 (336)
||....+.... +.+..... ...-+...+..+.+++...+..+|..|..+.
T Consensus 1034 p~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99886654321 11111100 0112334566788899999999999997765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.1e-12 Score=104.39 Aligned_cols=142 Identities=18% Similarity=0.240 Sum_probs=107.9
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccC--CCccceEEEEEeCC---eEEEEEEcC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQH--QNLVNLIGYCADGD---QRILVYEFM 133 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~---~~~lv~e~~ 133 (336)
+.|+.|..+.||++.... |..+++|....... .....+..|+++++.+.+ .++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 468999999999998754 57899998754332 134568899999999975 44677777766532 568999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA-------------------------------------- 175 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~-------------------------------------- 175 (336)
+|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888765421 34666677778888888888888531
Q ss_pred ---------------CCCeeeCCCCCCCeEECC--CCceEEcccccccc
Q 036144 176 ---------------DPPVIYRDFKASNILLDA--EFNPKLSDFGLAKL 207 (336)
Q Consensus 176 ---------------~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~~ 207 (336)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999988 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.1e-11 Score=107.91 Aligned_cols=219 Identities=14% Similarity=0.170 Sum_probs=156.2
Q ss_pred CceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEE----eCCeEEEEEEcCCC-CChhh
Q 036144 66 GYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA----DGDQRILVYEFMSN-GSLEN 140 (336)
Q Consensus 66 ~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~lv~e~~~~-g~L~~ 140 (336)
.-.+.|++...-+|..|++|.+.............-+++++++.|+|+|++.++|. .+..+++|++|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 44678999999999999999995443333445566788999999999999998876 45678899999875 46666
Q ss_pred hhccC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 141 HFLDL-----------PPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 141 ~l~~~-----------~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
+.-.- ......+++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++++.+++|...|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 53321 223455788999999999999999999999 9999999999999999999999888876543
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
... .+| +.. -.+-|.=.||.+++.|.||.......+. .......
T Consensus 445 ~d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-~~~s~~~---------------- 488 (655)
T KOG3741|consen 445 EDP--------------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRTDS-TQSSHLT---------------- 488 (655)
T ss_pred CCC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccccc-hHHHHHH----------------
Confidence 321 001 111 2356888999999999999643211110 0000011
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
.+-...+.++.+++.-....++++ -++.+++.++
T Consensus 489 ------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 489 ------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 112345567778888887777776 6777777643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.7e-11 Score=94.53 Aligned_cols=143 Identities=21% Similarity=0.251 Sum_probs=105.6
Q ss_pred CcccccccCceEEEEEEEcccCeEEEEEee-cCCC-------CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 58 PDCLVGEGGYGRVYKGYIEAVDQVVAVKQL-DRSG-------NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 58 ~~~~ig~G~~g~v~~~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
....|-+|+-+.|+++.+. |+.+.||.- .+.- .-......+|++.+.++.--.|.-..-++.+.+.-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5667999999999999887 678788852 1111 01123466899999988765665555566777778899
Q ss_pred EEcCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc---eEEcccccc
Q 036144 130 YEFMSN-GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN---PKLSDFGLA 205 (336)
Q Consensus 130 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~ 205 (336)
|||++| .++.+++.... ...........++..+-+.+.-||..+ |+|+||..+||++..++. +.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999976 47888877632 222333333678888999999999998 999999999999965553 589999998
Q ss_pred cc
Q 036144 206 KL 207 (336)
Q Consensus 206 ~~ 207 (336)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.1e-10 Score=100.38 Aligned_cols=264 Identities=14% Similarity=0.128 Sum_probs=161.6
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHh-hccCCCccceEEE------EEeC-CeEE
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLS-LVQHQNLVNLIGY------CADG-DQRI 127 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~------~~~~-~~~~ 127 (336)
......||+|+-+.+|-.-.- ...+.|++.........+ .+..|. .-.||-+-.-+.+ .-+. ...-
T Consensus 13 i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred cCCCccccCCccceeeecchh---hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 345567999999999965332 124567765544332222 222232 2345533321111 1112 2255
Q ss_pred EEEEcCCCCC-hhhhhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 128 LVYEFMSNGS-LENHFLD--LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 128 lv~e~~~~g~-L~~~l~~--~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
+.|+.+.+.. +..++.- ...+.....|...+.++..++.+.+.||..| .+-+|++++|+|+++++.|.|.|=+.
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence 7888876642 2222111 1223345678889999999999999999999 99999999999999999999998766
Q ss_pred cccCCCCCCcceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCc-----ccccHHH
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITG-RSAIDNSRPS-----EEQNLVT 273 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g-~~p~~~~~~~-----~~~~~~~ 273 (336)
-... .........+|.+.|.+||.-. +..-+..+|.|.||+++++++.| ++||++-... ....-+.
T Consensus 164 fqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 164 FQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred eeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 5433 1223344568999999999654 33557889999999999999887 8999863311 1111111
Q ss_pred HHHHHhhcccccccccCCccCCCCcHH-HHHHHHHHHHhhcCC--CCCCCCCHHHHHHHHhccc
Q 036144 274 WAKPLLRDKKKFTMMADPLLEGQYPRK-GLYQALAVAGMCLQE--DADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~--dp~~Rpt~~evl~~L~~i~ 334 (336)
.. .+....+-+.-.. ......+.. .+.++..+..+|+.. ++.-|||++.++..|..+.
T Consensus 241 ~g--~f~ya~~~~~g~~-p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 241 HG--RFAYASDQRRGLK-PPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred cc--eeeechhccCCCC-CCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 11 1111111000001 111122222 244677888888875 3668999999999987653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.4e-10 Score=94.67 Aligned_cols=140 Identities=14% Similarity=0.098 Sum_probs=99.1
Q ss_pred cccccCceEEEEEEEcccCeEEEEEeecCCCCc-----------cHHHHHHHHHHHhhccCC--CccceEEEEEe-----
Q 036144 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-----------GSREFFAEVLMLSLVQHQ--NLVNLIGYCAD----- 122 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~----- 122 (336)
.+-......|+++... |+.|.||........ ....+.+|...+..|..- .++..+.++..
T Consensus 29 ~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3444444556676554 678999976432210 111367899888888533 34455556543
Q ss_pred CCeEEEEEEcCCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-------C
Q 036144 123 GDQRILVYEFMSNG-SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-------E 194 (336)
Q Consensus 123 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-------~ 194 (336)
....++|||++++. +|.+++.... ....+......++.+++..+.-||..| |+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23578999999876 7888875422 234456677789999999999999999 999999999999974 4
Q ss_pred CceEEcccccccc
Q 036144 195 FNPKLSDFGLAKL 207 (336)
Q Consensus 195 ~~~kl~Dfg~~~~ 207 (336)
..+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.5e-10 Score=90.60 Aligned_cols=125 Identities=19% Similarity=0.165 Sum_probs=78.8
Q ss_pred EEEEEEEcccCeEEEEEeecCCCCc---------------------c-----HHHHHHHHHHHhhccCC--CccceEEEE
Q 036144 69 RVYKGYIEAVDQVVAVKQLDRSGNQ---------------------G-----SREFFAEVLMLSLVQHQ--NLVNLIGYC 120 (336)
Q Consensus 69 ~v~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~--~iv~~~~~~ 120 (336)
.||.|.... |..+|+|+.+..... . .....+|.+.|..+..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 388888854 789999987432100 0 12356899999999765 566776553
Q ss_pred EeCCeEEEEEEcCC--CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 121 ADGDQRILVYEFMS--NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY-LHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 121 ~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~-lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
.-++||||++ |..+..+... .++......++.+++..+.. +|..| |+|+||.+.||+++.+ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 2469999997 5455433221 11122345667777775544 57888 9999999999999887 99
Q ss_pred EEccccccccC
Q 036144 198 KLSDFGLAKLG 208 (336)
Q Consensus 198 kl~Dfg~~~~~ 208 (336)
.|+|||.+...
T Consensus 146 ~iIDf~qav~~ 156 (188)
T PF01163_consen 146 YIIDFGQAVDS 156 (188)
T ss_dssp EE--GTTEEET
T ss_pred EEEecCcceec
Confidence 99999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.5e-11 Score=110.41 Aligned_cols=151 Identities=22% Similarity=0.263 Sum_probs=104.9
Q ss_pred HHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCccee-------eeeccCccccCcccccc
Q 036144 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS-------TRVMGTYGYCAPEYAMT 234 (336)
Q Consensus 162 ~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~ 234 (336)
.+++.|+.|+|. ..++||++|.|++|.++.++..||+.|+++.....+...... .-..-...|.|||.+.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999997 445999999999999999999999999998754332221111 11234668999999999
Q ss_pred CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhc
Q 036144 235 GQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCL 313 (336)
Q Consensus 235 ~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 313 (336)
...+.++|+||+|+++|.+.. |+.-+......... ......+..-...+....+.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------------SFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh--------------hhhhcccccccccccccCcHHHHHHHHHHh
Confidence 888999999999999999994 54444433221111 111111111112233456668888999999
Q ss_pred CCCCCCCCCHHHHHH
Q 036144 314 QEDADSRPFMVDVVT 328 (336)
Q Consensus 314 ~~dp~~Rpt~~evl~ 328 (336)
..++.-||++..++.
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999997766653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.2e-09 Score=89.31 Aligned_cols=135 Identities=17% Similarity=0.101 Sum_probs=98.5
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC----------------------ccHHHHHHHHHHHhhccCC--
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN----------------------QGSREFFAEVLMLSLVQHQ-- 111 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~-- 111 (336)
+.+...||-|--|.||.|.+.. |..+|||.=+.... .......+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 4566789999999999999975 78999996422100 0112356899999999754
Q ss_pred CccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 112 NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 112 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
.+.+.+++ +.-.+|||+++|-.|...- ++......++..|++-+..+-..| +||+|+.+-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 67777753 4457999999886664321 123334455566666666666777 9999999999999
Q ss_pred CCCCceEEcccccccc
Q 036144 192 DAEFNPKLSDFGLAKL 207 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~ 207 (336)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.6e-08 Score=83.63 Aligned_cols=106 Identities=20% Similarity=0.198 Sum_probs=83.2
Q ss_pred HHHHHHHHHHhhccC--CCccceEEEEEeC----CeEEEEEEcCCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 036144 96 REFFAEVLMLSLVQH--QNLVNLIGYCADG----DQRILVYEFMSNG-SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168 (336)
Q Consensus 96 ~~~~~e~~~l~~l~h--~~iv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l 168 (336)
....+|...+..|.. -.+.+.+++.... ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 457788888887753 3455666666543 2458999999874 7888886522 255566788999999999
Q ss_pred HHHHhCCCCCeeeCCCCCCCeEECCCC---ceEEccccccccC
Q 036144 169 EYLHDVADPPVIYRDFKASNILLDAEF---NPKLSDFGLAKLG 208 (336)
Q Consensus 169 ~~lh~~~~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~ 208 (336)
.-||..| |+|+|++|.|||++.++ .+.++||+.+...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999998887 7999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.8e-08 Score=80.80 Aligned_cols=138 Identities=14% Similarity=0.114 Sum_probs=101.8
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCC------CccHHHHHHHHHHHhhccC--CCccceEEEEE-e----CCeEEE
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSG------NQGSREFFAEVLMLSLVQH--QNLVNLIGYCA-D----GDQRIL 128 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~-~----~~~~~l 128 (336)
-|.|+-+.|+..... |..+-+|...... +-....+.+|+..+..|.. -.+.+.. ++. . ....+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 467888899998776 3468888764211 2245678999999999863 2344544 332 1 234679
Q ss_pred EEEcCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc--eEEcccccc
Q 036144 129 VYEFMSN-GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN--PKLSDFGLA 205 (336)
Q Consensus 129 v~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~ 205 (336)
|+|-+.| -+|.+++... ...+.+......++.+++.++.-||+.| +.|+|+.+.||+++.++. +.++||.-+
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9997743 5888887552 2235567777899999999999999999 999999999999986667 999999887
Q ss_pred cc
Q 036144 206 KL 207 (336)
Q Consensus 206 ~~ 207 (336)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 64
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.8e-08 Score=79.25 Aligned_cols=137 Identities=12% Similarity=0.096 Sum_probs=91.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHH---------HHHHHHHhhccCC---CccceEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---------FAEVLMLSLVQHQ---NLVNLIGY 119 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~h~---~iv~~~~~ 119 (336)
...+|.+.+++-......|.+.... |+.+++|..+.......+.+ .+.+..+..+... ....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4577888888888887777776665 68899998765433322222 2344444444322 22332322
Q ss_pred EE-----eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC
Q 036144 120 CA-----DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE 194 (336)
Q Consensus 120 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~ 194 (336)
.. .....+++|||++|..|.+... +++ .+...+++++.-||..| ++|+|..|.|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 22 2234568999999988865421 222 24456778899999999 9999999999999855
Q ss_pred CceEEccccccc
Q 036144 195 FNPKLSDFGLAK 206 (336)
Q Consensus 195 ~~~kl~Dfg~~~ 206 (336)
.++++||+...
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 59999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-08 Score=94.44 Aligned_cols=145 Identities=17% Similarity=0.154 Sum_probs=91.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccH------------------------------H-------
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS------------------------------R------- 96 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~------------------------------~------- 96 (336)
..|+. ..|+.++-|.||+|+.+. |+.||||+.++.-.... +
T Consensus 126 ~eF~~-~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 126 SEFEP-EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHcCC-CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 34443 479999999999999987 99999999865321100 0
Q ss_pred ---HHHHHHHHHhhcc----CCCccceEEEE-EeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHH-
Q 036144 97 ---EFFAEVLMLSLVQ----HQNLVNLIGYC-ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKG- 167 (336)
Q Consensus 97 ---~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~- 167 (336)
++.+|...+.++. ...-+.+-.++ +-....+|+|||++|-.+.+...- ....++... ++..++++
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~---ia~~~~~~f 277 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKE---LAELLVRAF 277 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHH---HHHHHHHHH
Confidence 1234555555442 22222222222 234567899999999888887422 112333222 22222222
Q ss_pred HHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 168 l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
+..+-..| ++|.|..|.||+++.+|.+.+.|||+....+
T Consensus 278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 22222345 9999999999999999999999999987643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.1e-07 Score=78.03 Aligned_cols=140 Identities=16% Similarity=0.174 Sum_probs=86.0
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC--CccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ--NLVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
..||+|..+.||+.. +..+++|...... ......+|.++++.+..- .+.+.+++........+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 358999999999831 4467889875432 345578999999998643 35778888877778889999998863
Q ss_pred -hhhhh---------------------ccCCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHhC-CCCCeeeCC
Q 036144 138 -LENHF---------------------LDLPPDQEPLDWFTRMKIAGG----------AAK-GLEYLHDV-ADPPVIYRD 183 (336)
Q Consensus 138 -L~~~l---------------------~~~~~~~~~l~~~~~~~i~~~----------l~~-~l~~lh~~-~~~~i~H~d 183 (336)
+...+ .........++... ..+..+ +.. ...+|... ....++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 11100111111000 000000 000 11222211 134579999
Q ss_pred CCCCCeEECCCCceEEcccccccc
Q 036144 184 FKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 184 ikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+.|.||+++.++ +.++||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999887 99999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3e-09 Score=97.72 Aligned_cols=187 Identities=18% Similarity=0.091 Sum_probs=136.8
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCC-ccceEEEEEeCCeEEEEEEcC
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN-LVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~ 133 (336)
-+....-.++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..+....++|+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 3445556899999999998877654444 6665432 34566889999999999 777777777778888999999
Q ss_pred CCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 134 SNG-SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 134 ~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
.++ +..... ......+...+...+...-.++++++|+.- =+|+| ||+.++ +..+..||+....+....
T Consensus 317 s~~rs~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEM---TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccC---ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 776 222111 112233334444556666678899999865 58888 777765 589999999987654432
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAID 261 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 261 (336)
......+|+.++|||+.....+....|+|++|.-..+|--|.+|-.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3556789999999999999999999999999988888877776643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.6e-07 Score=74.87 Aligned_cols=148 Identities=19% Similarity=0.160 Sum_probs=96.7
Q ss_pred HHHHHHhcCCCCcc---cccccCceEEEEEEEcccCeEEEEEeecCCCCc-------------------cHH-----HHH
Q 036144 47 QELADATENFNPDC---LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-------------------GSR-----EFF 99 (336)
Q Consensus 47 ~~~~~~~~~y~~~~---~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-------------------~~~-----~~~ 99 (336)
..+.....+..+.. .|++|--+.||+|... .+..+|+|++...... ... ...
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 33344445554444 4566777789998874 3789999998543211 111 134
Q ss_pred HHHHHHhhcc--CCCccceEEEEEeCCeEEEEEEcCCCCCh-hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 036144 100 AEVLMLSLVQ--HQNLVNLIGYCADGDQRILVYEFMSNGSL-ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VA 175 (336)
Q Consensus 100 ~e~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~ 175 (336)
+|+..|+++. +-.+.+-+.+.. -.|||||+....+ .-.|. .-++.......+..++++.+.-|-. .+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 6888888774 455666666554 4699999844311 11111 1222333566677778888877776 56
Q ss_pred CCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 176 ~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
+||+||..-|||+. ++.+.|+|||-+...
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 99999999999999 789999999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.3e-07 Score=71.67 Aligned_cols=129 Identities=17% Similarity=0.173 Sum_probs=92.5
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCcc-ceEEEEEeCCeEEEEEEcCCC
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLV-NLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~ 135 (336)
.+.+.|++|.+|.||++.+. |..+|+|+-..+++ ...+..|+++|..+...++. +++.+..+ ++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcC
Confidence 45567999999999999998 56899998765433 46788999999999876654 45544443 355999998
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC-CCCeEECCCCceEEcccccccc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFK-ASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dik-p~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
.+|.++.... + .+-...++++---|...| |-|+.|. |...++..++.+.|+||..|+.
T Consensus 97 ~~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIGG-------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhcc-------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8887765421 1 223334566656677777 9999987 5544444555899999999974
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.1e-07 Score=75.61 Aligned_cols=141 Identities=21% Similarity=0.170 Sum_probs=85.7
Q ss_pred ccccCc-eEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEEcCCCCChh
Q 036144 62 VGEGGY-GRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYEFMSNGSLE 139 (336)
Q Consensus 62 ig~G~~-g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 139 (336)
|..|.. ..||++... +..+.+|...... ...+.+|+.+++.+. +-.+.+++++.......++||++++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 445555 788998765 3678889865432 345678999998885 445667888777766789999999998876
Q ss_pred hhhc-------------------cCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHh----C
Q 036144 140 NHFL-------------------DLPPDQEPLDWF--TRMKIAG--------------------GAAKGLEYLHD----V 174 (336)
Q Consensus 140 ~~l~-------------------~~~~~~~~l~~~--~~~~i~~--------------------~l~~~l~~lh~----~ 174 (336)
.... .......++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4421 111101111100 0000000 01111122211 1
Q ss_pred CCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 175 ~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
....++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 134599999999999999877788999998853
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.3e-07 Score=76.52 Aligned_cols=143 Identities=17% Similarity=0.246 Sum_probs=83.7
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC--CccceEEEEEe---CCeEEEEEEcCC
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ--NLVNLIGYCAD---GDQRILVYEFMS 134 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~~ 134 (336)
+.|+.|..+.||++.... ..+++|..... .....+..|..+++.+... .+.+++.+... ....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 468999999999999875 48899987543 3456788899999888633 35666664432 335689999999
Q ss_pred CCChhh----------------hhc---cCCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 036144 135 NGSLEN----------------HFL---DLPPDQEPLDWFTR---------MKI------------AGGAAK-GLEYLHD 173 (336)
Q Consensus 135 ~g~L~~----------------~l~---~~~~~~~~l~~~~~---------~~i------------~~~l~~-~l~~lh~ 173 (336)
|.++.. .+. .............. ... ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988776 111 11001111111110 000 111222 2333332
Q ss_pred ----CCCCCeeeCCCCCCCeEEC-CCCceEEccccccc
Q 036144 174 ----VADPPVIYRDFKASNILLD-AEFNPKLSDFGLAK 206 (336)
Q Consensus 174 ----~~~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~ 206 (336)
.....++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1234599999999999999 66667899999875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.5e-05 Score=64.60 Aligned_cols=104 Identities=27% Similarity=0.281 Sum_probs=82.0
Q ss_pred HHHHHHHhhccC-CCccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 036144 99 FAEVLMLSLVQH-QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177 (336)
Q Consensus 99 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~ 177 (336)
..|..+++.+.+ +++++++|++- .++|.||...+++....... ..-...+|..+.+|+.++++.+.+++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888888876 69999999984 46799999776664321000 1123468899999999999999999986555
Q ss_pred CeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 178 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
.+.-.|++|+|+-+++++++|++|.+.+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 588999999999999999999999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.43 E-value=6.7e-06 Score=82.01 Aligned_cols=80 Identities=11% Similarity=0.186 Sum_probs=57.1
Q ss_pred cccccccCceEEEEEEEcccC--eEEEEEeecCCC-CccHHHHHHHHHHHhhcc-CCCc--cceEEEEEeC---CeEEEE
Q 036144 59 DCLVGEGGYGRVYKGYIEAVD--QVVAVKQLDRSG-NQGSREFFAEVLMLSLVQ-HQNL--VNLIGYCADG---DQRILV 129 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv 129 (336)
...++.|.+..+|+......+ ..+++|+..... ......+.+|+.+++.+. |.++ .+++.++.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 456899999999998775432 467788754332 123356889999999995 6654 7778877654 467899
Q ss_pred EEcCCCCCh
Q 036144 130 YEFMSNGSL 138 (336)
Q Consensus 130 ~e~~~~g~L 138 (336)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.40 E-value=4.1e-06 Score=70.86 Aligned_cols=73 Identities=14% Similarity=0.161 Sum_probs=46.5
Q ss_pred ccccccCce-EEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC---CccceEEEEEeCC---eEEEEEEc
Q 036144 60 CLVGEGGYG-RVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ---NLVNLIGYCADGD---QRILVYEF 132 (336)
Q Consensus 60 ~~ig~G~~g-~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~---~~~lv~e~ 132 (336)
+.|+.|+.. .||+. +..+++|..... .....+.+|.+++..+... .+.++++.....+ ..+++|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 357766666 58876 234778875432 2345788999999888632 3445554443322 34789999
Q ss_pred CCCCChh
Q 036144 133 MSNGSLE 139 (336)
Q Consensus 133 ~~~g~L~ 139 (336)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.5e-05 Score=64.94 Aligned_cols=128 Identities=19% Similarity=0.225 Sum_probs=87.8
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCC----------------CccHHHHHHHHHHHhhcc------CCCccce
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG----------------NQGSREFFAEVLMLSLVQ------HQNLVNL 116 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~iv~~ 116 (336)
...||+|+.-.||.--+ +...+||+..... ....++..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 34699999999996332 4457899987654 112345566666555554 7899999
Q ss_pred EEEEEeCCeEEEEEEcCCC------CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 036144 117 IGYCADGDQRILVYEFMSN------GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL 190 (336)
Q Consensus 117 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil 190 (336)
+|+.+++....+|+|.+.+ .||.+++.. ..++. ...+. +-+-..+|-+.+ |+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999997532 367777743 34554 33333 344456677777 999999999999
Q ss_pred ECCCC----ceEEcc
Q 036144 191 LDAEF----NPKLSD 201 (336)
Q Consensus 191 ~~~~~----~~kl~D 201 (336)
+.... .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 94332 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.2e-06 Score=78.39 Aligned_cols=138 Identities=14% Similarity=0.118 Sum_probs=86.8
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCccH---------------------------H----------HHHHHH
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---------------------------R----------EFFAEV 102 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~---------------------------~----------~~~~e~ 102 (336)
+.||.-+.|.|++|+.+. |+.||||+.++.-.... + +|..|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 469999999999999988 99999999755321100 0 123444
Q ss_pred HHHhh----ccCCC------ccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHH
Q 036144 103 LMLSL----VQHQN------LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL-EYL 171 (336)
Q Consensus 103 ~~l~~----l~h~~------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l-~~l 171 (336)
+...+ +.|-+ |.+++-. .....+|+|||++|..+.+.-.- ....++...+.. .+.++. .-|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~---~l~~~~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILN---KLVEAYLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHH---HHHHHHHHHH
Confidence 43333 23444 3333322 23457899999999988776322 123344443333 232222 112
Q ss_pred HhCCCCCeeeCCCCCCCeEECC----CCceEEccccccccCC
Q 036144 172 HDVADPPVIYRDFKASNILLDA----EFNPKLSDFGLAKLGP 209 (336)
Q Consensus 172 h~~~~~~i~H~dikp~Nil~~~----~~~~kl~Dfg~~~~~~ 209 (336)
=..| ++|.|=.|.||++.. ++.+.+-|||+.....
T Consensus 318 f~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 318 FKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HhcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2234 999999999999983 6679999999987543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.6e-05 Score=67.12 Aligned_cols=75 Identities=17% Similarity=0.149 Sum_probs=48.7
Q ss_pred ccccccCceEEEEEEEcc-cCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCC-ccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 60 CLVGEGGYGRVYKGYIEA-VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN-LVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
+.|..|-...+|++.... .+..|++|+....... .-...+|+.+++.+...+ .++++.... ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457888888999987653 3467889976543221 123357888888885433 344444332 247999999877
Q ss_pred hh
Q 036144 138 LE 139 (336)
Q Consensus 138 L~ 139 (336)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.6e-05 Score=68.40 Aligned_cols=144 Identities=16% Similarity=0.167 Sum_probs=84.8
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC--CccceEE------EEEeCCeEEEEE
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ--NLVNLIG------YCADGDQRILVY 130 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~------~~~~~~~~~lv~ 130 (336)
.+.|..|....+|++... +..+++|+... .....+..|+.++..+.+. .+.+++. +....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 345778888899998654 34688998754 2345677788888887532 2444433 123345668999
Q ss_pred EcCCCCChhh----h----------hc----cCCCC---CCCCCHHHHH----------HHHHHHHHHHHHHHhC----C
Q 036144 131 EFMSNGSLEN----H----------FL----DLPPD---QEPLDWFTRM----------KIAGGAAKGLEYLHDV----A 175 (336)
Q Consensus 131 e~~~~g~L~~----~----------l~----~~~~~---~~~l~~~~~~----------~i~~~l~~~l~~lh~~----~ 175 (336)
++++|.++.. . +. ..... .....+.... .....+..++.++... -
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998877532 0 00 00000 0001111100 0111123344444431 1
Q ss_pred CCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 176 ~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
..+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 24599999999999999876678999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.20 E-value=7.7e-06 Score=80.70 Aligned_cols=194 Identities=24% Similarity=0.224 Sum_probs=134.9
Q ss_pred HHHHHHHhhccCCCccceEEEEEeCCeEE----EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 036144 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRI----LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174 (336)
Q Consensus 99 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~ 174 (336)
..|...+..+.|+|++.++.|........ +..+++..-++...+.. ...++....+.+..++.+|+.++|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 45666777789999999999887654433 34577878788777754 56788889999999999999999997
Q ss_pred CCCCeeeCCCCCC---CeEECCCCceEEc--cccccccCCCCCCcceeeeeccCccccCccccccCCCCC--ccchhhHH
Q 036144 175 ADPPVIYRDFKAS---NILLDAEFNPKLS--DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTK--KSDVYSFG 247 (336)
Q Consensus 175 ~~~~i~H~dikp~---Nil~~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwslG 247 (336)
. ..|.-+... +.-++..+.+.++ ||+.+..+.... ......-+..+.|||......++. ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 666555544 4445666667766 998887654322 223334566678888776665544 47999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 036144 248 VVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327 (336)
Q Consensus 248 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl 327 (336)
..+..+..|..+-..... ....+...+.. ...+...+|+..++++|+++.+++
T Consensus 380 ll~~~~~~~~~i~~~~~~-----------------------~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSAV-----------------------PVSLLDVLSTS----ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCcccccccc-----------------------hhhhhccccch----hhhhhhhhhcchhhhhccchhhhh
Confidence 999999998754332110 00011111111 466788899999999999999998
Q ss_pred HH
Q 036144 328 TA 329 (336)
Q Consensus 328 ~~ 329 (336)
+.
T Consensus 433 ~~ 434 (1351)
T KOG1035|consen 433 TH 434 (1351)
T ss_pred hc
Confidence 74
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.19 E-value=4e-05 Score=65.71 Aligned_cols=139 Identities=13% Similarity=0.024 Sum_probs=79.7
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCc-cceEEEEEeCCeEEEEEEcCCCCChhh
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL-VNLIGYCADGDQRILVYEFMSNGSLEN 140 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~L~~ 140 (336)
+..|-...+|+... ++..+++|..........-...+|..+++.+....+ .+++.... .++||||++|.++..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 56788889998874 366888997644322211235779999998864433 34444332 368999999877642
Q ss_pred h-----------------hccCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHhC-----CCCCeeeCCCCCCC
Q 036144 141 H-----------------FLDLPPDQEPLDWFT-RMKIAGGA---------AKGLEYLHDV-----ADPPVIYRDFKASN 188 (336)
Q Consensus 141 ~-----------------l~~~~~~~~~l~~~~-~~~i~~~l---------~~~l~~lh~~-----~~~~i~H~dikp~N 188 (336)
. +........+++... ...+..++ ...+..+-.. ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 111111112222211 11111111 1112212111 12348999999999
Q ss_pred eEECCCCceEEcccccccc
Q 036144 189 ILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~ 207 (336)
|+++.++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 88999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.3e-05 Score=62.54 Aligned_cols=125 Identities=24% Similarity=0.342 Sum_probs=86.4
Q ss_pred cCCCCcccccccCc-eEEEEEEEcccCeEEEEEeecC---CCC------------------ccHHHHHHHHHHHhhcc--
Q 036144 54 ENFNPDCLVGEGGY-GRVYKGYIEAVDQVVAVKQLDR---SGN------------------QGSREFFAEVLMLSLVQ-- 109 (336)
Q Consensus 54 ~~y~~~~~ig~G~~-g~v~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~-- 109 (336)
.+++.++.||.|.- |.||++... |..+|+|++.. ... ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78899999999999 999999998 67999999421 100 01123567777666664
Q ss_pred -CCCc--cceEEEEEeC------------------CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 036144 110 -HQNL--VNLIGYCADG------------------DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168 (336)
Q Consensus 110 -h~~i--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l 168 (336)
+.++ ++.+||..-. ....+|.||++... .+... -+.+|.+-+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHH
Confidence 4556 8888887322 11346777664432 22222 244566677
Q ss_pred HHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 169 ~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8899998 999999999986 3578999865
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.16 E-value=8.6e-05 Score=65.00 Aligned_cols=76 Identities=13% Similarity=0.082 Sum_probs=55.7
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC---CCccceEEEEEe---CCeEEEEEEc
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH---QNLVNLIGYCAD---GDQRILVYEF 132 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~~lv~e~ 132 (336)
.+.||.|..+.||.....+ + .+.+|..+.. .....+..|...|+.|.. -.+.++++++.. ....++|||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3469999999999986543 3 4667774321 123578899999998853 468888887754 3568999999
Q ss_pred CCCCCh
Q 036144 133 MSNGSL 138 (336)
Q Consensus 133 ~~~g~L 138 (336)
++|+++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.10 E-value=0.00014 Score=65.76 Aligned_cols=76 Identities=18% Similarity=0.114 Sum_probs=53.8
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCC-------CccHHHHHHHHHHHhhcc---CCCccceEEEEEeCCeEEEE
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-------NQGSREFFAEVLMLSLVQ---HQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv 129 (336)
+.||.|.+..||++.....++.++||+-.+.. +...+....|.+.|+.+. ..++++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 46999999999999987544689999854221 123456777888888763 2456777766 34557899
Q ss_pred EEcCCCCC
Q 036144 130 YEFMSNGS 137 (336)
Q Consensus 130 ~e~~~~g~ 137 (336)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.0003 Score=62.02 Aligned_cols=145 Identities=16% Similarity=0.177 Sum_probs=82.0
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC--CccceEEE------EEeCCeEEEEE
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ--NLVNLIGY------CADGDQRILVY 130 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~------~~~~~~~~lv~ 130 (336)
.+.++.|....+|++... +..+++|+..... ....+..|+.++..|... .+.+++.. .......++++
T Consensus 27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 445777877899998654 3367889865421 234556777777777432 23444431 12245678999
Q ss_pred EcCCCCChhhh--------------hc----cCCCCCC---CCC-HHH--HH----------HHHHHHHHHHHHHHh---
Q 036144 131 EFMSNGSLENH--------------FL----DLPPDQE---PLD-WFT--RM----------KIAGGAAKGLEYLHD--- 173 (336)
Q Consensus 131 e~~~~g~L~~~--------------l~----~~~~~~~---~l~-~~~--~~----------~i~~~l~~~l~~lh~--- 173 (336)
+|++|.++... +. ....... ..+ |.. .. .....+...+.++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99988554210 11 0100000 000 000 00 011122334554532
Q ss_pred -CCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 174 -VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 174 -~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
.-..+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 1135599999999999999887678999999863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00028 Score=62.58 Aligned_cols=143 Identities=13% Similarity=0.137 Sum_probs=77.1
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC--CccceEE------EEEeCCeEEEEEE
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ--NLVNLIG------YCADGDQRILVYE 131 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~------~~~~~~~~~lv~e 131 (336)
+.|+.|....+|++.... ..+++|++.. .....+..|+.++..|... .+.+.+. +.......+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~--g~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQ--GEYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCC--CcEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456778778899987653 3688998752 1234445566666665321 2333332 1233456789999
Q ss_pred cCCCCChhh-----h---------h----ccCCCC---CCCCCHH-HHH------------HHHHH-HHHHHHHHHhC--
Q 036144 132 FMSNGSLEN-----H---------F----LDLPPD---QEPLDWF-TRM------------KIAGG-AAKGLEYLHDV-- 174 (336)
Q Consensus 132 ~~~~g~L~~-----~---------l----~~~~~~---~~~l~~~-~~~------------~i~~~-l~~~l~~lh~~-- 174 (336)
|++|..+.. . + ...... ...+.+. ... ..+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 0 0 000000 0011111 100 01111 11122333211
Q ss_pred --CCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 175 --ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 175 --~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
-..++||+|+.|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 134599999999999998665558999999864
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00032 Score=61.25 Aligned_cols=139 Identities=17% Similarity=0.224 Sum_probs=88.0
Q ss_pred CcccccccCceEEEEEEEcccCeEEEEEeecC--CCCccHHHHHHHHHHHhhccC--CCccceEEEEEeCC--eEEEEEE
Q 036144 58 PDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGNQGSREFFAEVLMLSLVQH--QNLVNLIGYCADGD--QRILVYE 131 (336)
Q Consensus 58 ~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e 131 (336)
+...+..|..-.+|..... ++.+++. ... ..........+|..+++.+.- -.+...++++.++. ..+.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 3344544554555655554 6778888 321 222334556778888887653 34455666776665 6799999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHH-HHHHHHHHHHHhC------------------------------------
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIA-GGAAKGLEYLHDV------------------------------------ 174 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~-~~l~~~l~~lh~~------------------------------------ 174 (336)
|++|..+.+.+... ... .+++ ..++..|..||+.
T Consensus 106 ~veGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 106 WVEGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred EecceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 99886554433221 011 1222 2555666666651
Q ss_pred -------------------CCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 175 -------------------ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 175 -------------------~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
+...++|+|+.+.|++++.++-+=+.||+++...
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 1245999999999999998888999999999754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00037 Score=61.26 Aligned_cols=142 Identities=19% Similarity=0.173 Sum_probs=83.4
Q ss_pred cccccCceEEEEEEEcc------cCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCc-cceEEEEEeCCeEEEEEEcC
Q 036144 61 LVGEGGYGRVYKGYIEA------VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL-VNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~ 133 (336)
.+..|-...+|++.... .++.+++|+..... .......+|..++..+....+ .+++.++.. .+|++|+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 46667777899887643 25789999875543 223456788888888864333 455555532 3689999
Q ss_pred CCCChhhh-----------------hccCCCC--C---CCCCHH--HHHH--------------------------HHHH
Q 036144 134 SNGSLENH-----------------FLDLPPD--Q---EPLDWF--TRMK--------------------------IAGG 163 (336)
Q Consensus 134 ~~g~L~~~-----------------l~~~~~~--~---~~l~~~--~~~~--------------------------i~~~ 163 (336)
+|.++... +...... . ...+.. .... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88776431 1111111 0 011110 1000 1112
Q ss_pred HHHHHHHHHh------CCCCCeeeCCCCCCCeEECCC----CceEEcccccccc
Q 036144 164 AAKGLEYLHD------VADPPVIYRDFKASNILLDAE----FNPKLSDFGLAKL 207 (336)
Q Consensus 164 l~~~l~~lh~------~~~~~i~H~dikp~Nil~~~~----~~~kl~Dfg~~~~ 207 (336)
+...+..+-. .....++|+|+.|.||+++.+ +.+.++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2222333432 123459999999999999875 7899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=4.7e-05 Score=65.58 Aligned_cols=138 Identities=13% Similarity=0.042 Sum_probs=96.3
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-----------------CccH-----HHHHHHHHHHhhcc-C-
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-----------------NQGS-----REFFAEVLMLSLVQ-H- 110 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-----------------~~~~-----~~~~~e~~~l~~l~-h- 110 (336)
-+.+...||-|--+.||.+-+.. |.+.++|.-+... ...+ -...+|...|+.|. |
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 36788899999999999999876 7788888532110 0001 12457899998885 3
Q ss_pred CCccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 036144 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL 190 (336)
Q Consensus 111 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil 190 (336)
-.+.+.+++ +.-++|||++.|-.|.+.-.- . ....+...+..-|.-|-..| +||+|..--||+
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~---d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------E---DPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec-------C---ChHHHHHHHHHHHHHHHHcC---ceecccchheeE
Confidence 345555544 345789999988887554211 1 12334455555566677777 999999999999
Q ss_pred ECCCCceEEccccccccCCC
Q 036144 191 LDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~~~ 210 (336)
+++++.++++||--+...+.
T Consensus 235 v~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred EecCCCEEEeechHhhccCC
Confidence 99999999999987654433
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00069 Score=60.65 Aligned_cols=142 Identities=16% Similarity=0.156 Sum_probs=82.2
Q ss_pred cccccCceEEEEEEEcc----cCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCc-cceEEEEEeCCeEEEEEEcCCC
Q 036144 61 LVGEGGYGRVYKGYIEA----VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL-VNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~ 135 (336)
.|..|-.-.+|++.... .++.|++|+.........+ -..|..+++.+..-++ .++++.+..+ .|.+|+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 45567788899987532 2468999987655433222 3678999888865444 3556655432 58999987
Q ss_pred CChhhh-----------------hccCC--CCCCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-C
Q 036144 136 GSLENH-----------------FLDLP--PDQEPLDWFTRMKIAGGA-----------------AKGLEYL----HD-V 174 (336)
Q Consensus 136 g~L~~~-----------------l~~~~--~~~~~l~~~~~~~i~~~l-----------------~~~l~~l----h~-~ 174 (336)
.+|... +.... .......+..+..+..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776421 11111 011111122222332111 1112222 11 1
Q ss_pred CCCCeeeCCCCCCCeEECC-CCceEEcccccccc
Q 036144 175 ADPPVIYRDFKASNILLDA-EFNPKLSDFGLAKL 207 (336)
Q Consensus 175 ~~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~ 207 (336)
....++|+|+++.||+++. ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1234899999999999976 46799999999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=3.9e-06 Score=84.77 Aligned_cols=159 Identities=13% Similarity=0.020 Sum_probs=116.8
Q ss_pred HHHHHHhhccCCCccceEEEEEe--CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 036144 100 AEVLMLSLVQHQNLVNLIGYCAD--GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA-- 175 (336)
Q Consensus 100 ~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~-- 175 (336)
.|..-++...|+++.....-... ....+.+++|+.+|.+.+.+.+...+...+...-+.....+.+.+..-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 34444555678887766654432 34567899999999999999886666666665555544444455555555432
Q ss_pred CCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh
Q 036144 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255 (336)
Q Consensus 176 ~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 255 (336)
..-.+|+++|+.|.+|..+.+++++++|+.+...+ .........+++.|++|++...-.++.++|+|+.|+-+|.+..
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 34479999999999999999999999999983211 1223445678889999998888888989999999999999988
Q ss_pred CCCCC
Q 036144 256 GRSAI 260 (336)
Q Consensus 256 g~~p~ 260 (336)
|..+|
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 87665
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0016 Score=56.37 Aligned_cols=31 Identities=26% Similarity=0.414 Sum_probs=26.0
Q ss_pred CCeeeCCCCCCCeEECCCCc-eEEcccccccc
Q 036144 177 PPVIYRDFKASNILLDAEFN-PKLSDFGLAKL 207 (336)
Q Consensus 177 ~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~ 207 (336)
..++|+|+.|.||+++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999987565 46999999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0028 Score=56.32 Aligned_cols=73 Identities=21% Similarity=0.121 Sum_probs=48.2
Q ss_pred cccccCceEEEEEEEcccCeEEEEEeecCC-------CCccHHHHHHHHHHHhhcc--CCC-ccceEEEEEeCCeEEEEE
Q 036144 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS-------GNQGSREFFAEVLMLSLVQ--HQN-LVNLIGYCADGDQRILVY 130 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv~ 130 (336)
.||.|....||++.....++.|+||+-.+. -+-...+..-|.+.|+... .|. +++++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 489999999999998654468999975321 1233455667888887664 343 444443 3344556899
Q ss_pred EcCCC
Q 036144 131 EFMSN 135 (336)
Q Consensus 131 e~~~~ 135 (336)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0052 Score=55.66 Aligned_cols=73 Identities=12% Similarity=0.076 Sum_probs=50.4
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCC-------ccHHHHHHHHHHHhhcc---CCCccceEEEEEeCCeEEE
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-------QGSREFFAEVLMLSLVQ---HQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~l 128 (336)
.+.||.|....||++.+. +..++||+-..... ........|...|+.+. ..++.+++.+.. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 456899999999998874 45689998652111 13344556677776664 247778888776 34678
Q ss_pred EEEcCCC
Q 036144 129 VYEFMSN 135 (336)
Q Consensus 129 v~e~~~~ 135 (336)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0024 Score=56.26 Aligned_cols=142 Identities=14% Similarity=0.083 Sum_probs=90.4
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---------------------CccHH-----HHHHHHHHHhhcc
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---------------------NQGSR-----EFFAEVLMLSLVQ 109 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---------------------~~~~~-----~~~~e~~~l~~l~ 109 (336)
-.+-..|..|--+.||.|.... |..+|||+++-+- ....+ ....|++.|++|+
T Consensus 146 ~~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred eecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 3455678899999999988765 7789999874210 00111 2457888888887
Q ss_pred CCCccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 036144 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNI 189 (336)
Q Consensus 110 h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Ni 189 (336)
...|.-.--+.. ..-+|||+|+. .+= |-.- .-..-.++...+..+-.+++.-+.-|.... ++||.||.--|+
T Consensus 225 ~aGIP~PePIlL--k~hVLVM~FlG-rdg--w~aP-kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~ 296 (520)
T KOG2270|consen 225 NAGIPCPEPILL--KNHVLVMEFLG-RDG--WAAP-KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNL 296 (520)
T ss_pred hcCCCCCCceee--ecceEeeeecc-CCC--CcCc-ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhh
Confidence 555432111111 12469999983 321 1110 112344565666777777777766665533 299999999999
Q ss_pred EECCCCceEEcccccccc
Q 036144 190 LLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 190 l~~~~~~~kl~Dfg~~~~ 207 (336)
|+. +|.+.|+|.+-+.-
T Consensus 297 Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred eEE-CCEEEEEEcccccc
Confidence 994 56899999987753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00078 Score=61.70 Aligned_cols=166 Identities=24% Similarity=0.268 Sum_probs=94.0
Q ss_pred HHHHHHHHHHHhhccCCCccceEEEEEeC-CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 036144 95 SREFFAEVLMLSLVQHQNLVNLIGYCADG-DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173 (336)
Q Consensus 95 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~ 173 (336)
..++..-..+++.+.|+|....+++.... ....+|||++ +.||.+.+.... +.... ++ .|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-----l~~~s----------~~--~~- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-----LKDES----------LL--AH- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-----cchhh----------hc--cc-
Confidence 35677788899999999999999887643 4577899999 789998876522 11110 00 11
Q ss_pred CCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHH
Q 036144 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLEL 253 (336)
Q Consensus 174 ~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l 253 (336)
+ +.|- |+ ++.+| -++... |- +..+++||||+|.++.++
T Consensus 87 -~---~~~~-----~~-------~~~td-~~~t~~--------------------~~-----~~~pKsdVwsl~~i~~el 124 (725)
T KOG1093|consen 87 -G---VLHL-----NI-------IYITD-HFLTKY--------------------PS-----PIGPKSDVWSLGFIILEL 124 (725)
T ss_pred -c---ccee-----hh-------hhccc-cccccC--------------------CC-----CCCcchhhhhHHHHHHHH
Confidence 1 3321 22 23333 111100 00 112499999999999999
Q ss_pred HhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 036144 254 ITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327 (336)
Q Consensus 254 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl 327 (336)
.-|...+...... ............+.....+.. ...+....+..++++...|+-..|..||...++.
T Consensus 125 ~L~~~l~~~~~~s---~~l~~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 125 YLGISLEAELTES---EYLEILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHhhHHHHHHHHH---HHHHHHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 9987654432211 111111111111111100000 0123345566888999999999999999665543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0021 Score=53.35 Aligned_cols=30 Identities=30% Similarity=0.380 Sum_probs=21.4
Q ss_pred CeeeCCCCCCCeEE-CCCCceEEcccccccc
Q 036144 178 PVIYRDFKASNILL-DAEFNPKLSDFGLAKL 207 (336)
Q Consensus 178 ~i~H~dikp~Nil~-~~~~~~kl~Dfg~~~~ 207 (336)
.++|+|+.|.||++ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999999853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0042 Score=55.28 Aligned_cols=142 Identities=16% Similarity=0.258 Sum_probs=79.9
Q ss_pred cccccCceEEEEEEEccc---CeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCc-cceEEEEEeCCeEEEEEEcCCCC
Q 036144 61 LVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL-VNLIGYCADGDQRILVYEFMSNG 136 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g 136 (336)
.|..|-...+|++...+. +..|++|+....... .-.-.+|..+++.+..-++ .++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 455577778898875432 237899987654332 2234678889988875555 3556555322 588998877
Q ss_pred Chhhh-----------------hccCC-C-CCCCCCHHHHHHHHHHH----------------------HHHHHHHHh--
Q 036144 137 SLENH-----------------FLDLP-P-DQEPLDWFTRMKIAGGA----------------------AKGLEYLHD-- 173 (336)
Q Consensus 137 ~L~~~-----------------l~~~~-~-~~~~l~~~~~~~i~~~l----------------------~~~l~~lh~-- 173 (336)
+|... +.... . ....-.+..+..+..++ ..-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 66321 11111 0 11111122222222111 111222111
Q ss_pred --CC-CCCeeeCCCCCCCeEECC-CCceEEcccccccc
Q 036144 174 --VA-DPPVIYRDFKASNILLDA-EFNPKLSDFGLAKL 207 (336)
Q Consensus 174 --~~-~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~ 207 (336)
.+ ...++|+|+.|.||+++. ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 223899999999999974 56899999999864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0037 Score=54.23 Aligned_cols=73 Identities=21% Similarity=0.198 Sum_probs=48.3
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc---CCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ---HQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
.+.++.|....+|... .+++.+.||+-.. .....+..|..-|+.|. .-.+.+++++....+..+|||||++.
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 3458889999999987 4578899998652 23456888998888883 34678899998888788999999976
Q ss_pred C
Q 036144 136 G 136 (336)
Q Consensus 136 g 136 (336)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0055 Score=54.07 Aligned_cols=31 Identities=16% Similarity=0.205 Sum_probs=28.2
Q ss_pred CCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 177 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
.+++|+|+.++|++++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 4599999999999999998999999999874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0052 Score=55.37 Aligned_cols=75 Identities=20% Similarity=0.191 Sum_probs=49.8
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCC------CCccHHHHHHHHHHHhhcc--CCC-ccceEEEEEeCCeEEEE
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS------GNQGSREFFAEVLMLSLVQ--HQN-LVNLIGYCADGDQRILV 129 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~lv 129 (336)
.+.||.|.-..||++.+...+..|+||+-.+. -+-..++..-|.+.|+... .|. +++++.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 34689999999999998533567999975321 1233466777888888764 353 4445433 34445688
Q ss_pred EEcCCC
Q 036144 130 YEFMSN 135 (336)
Q Consensus 130 ~e~~~~ 135 (336)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.011 Score=52.22 Aligned_cols=141 Identities=16% Similarity=0.232 Sum_probs=80.6
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC---CCccc---e----EEEEEeCCeEEEEEE
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH---QNLVN---L----IGYCADGDQRILVYE 131 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~---~----~~~~~~~~~~~lv~e 131 (336)
|.+ .-..+|+..... | .+++|+.... ....++..|...+..|.- +-.++ . +.......+.+-+++
T Consensus 34 l~s-~eN~~f~~~~~~-g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTED-G-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecC-C-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 445688888765 3 3489987654 445677888888888742 21122 1 112222236778999
Q ss_pred cCCCCChhh-h------------------hccCC----CCCCCCCHHH-------------HHHHHHHHHHHHHHHHhC-
Q 036144 132 FMSNGSLEN-H------------------FLDLP----PDQEPLDWFT-------------RMKIAGGAAKGLEYLHDV- 174 (336)
Q Consensus 132 ~~~~g~L~~-~------------------l~~~~----~~~~~l~~~~-------------~~~i~~~l~~~l~~lh~~- 174 (336)
|++|..+.. . ....+ +......|.. ......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887762 1 01111 1111122220 001222333334433332
Q ss_pred ---CCCC---eeeCCCCCCCeEECCCCc-eEEcccccccc
Q 036144 175 ---ADPP---VIYRDFKASNILLDAEFN-PKLSDFGLAKL 207 (336)
Q Consensus 175 ---~~~~---i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~ 207 (336)
-... +||+|+.|+||+++.+.. +-++||+-+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1223 899999999999999875 88999998863
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0028 Score=55.75 Aligned_cols=75 Identities=21% Similarity=0.175 Sum_probs=57.9
Q ss_pred eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcc
Q 036144 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSD 201 (336)
Q Consensus 122 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~D 201 (336)
+..+.|++|++- |+++. ..+.-.+.++..++.+.+..+.-+...- ++-|||+.-+||+|+ +|+|-|+|
T Consensus 297 e~~y~yl~~kdh-gt~is--------~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLID 364 (488)
T COG5072 297 ETLYLYLHFKDH-GTPIS--------IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLID 364 (488)
T ss_pred CceEEEEEEecC-Cceee--------eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEE
Confidence 344567888876 66653 1234566788889888888777776643 489999999999999 99999999
Q ss_pred ccccccC
Q 036144 202 FGLAKLG 208 (336)
Q Consensus 202 fg~~~~~ 208 (336)
|-+++..
T Consensus 365 fklsRl~ 371 (488)
T COG5072 365 FKLSRLS 371 (488)
T ss_pred eeeeecc
Confidence 9999843
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.011 Score=52.13 Aligned_cols=30 Identities=23% Similarity=0.311 Sum_probs=25.9
Q ss_pred CCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 177 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 45999999999999987 6789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.025 Score=51.33 Aligned_cols=75 Identities=16% Similarity=0.216 Sum_probs=45.7
Q ss_pred ccccccCceEEEEEEEcccC-e-----EEEEEeecCCCCccHHHHHHHHHHHhhccCCCc-cceEEEEEeCCeEEEEEEc
Q 036144 60 CLVGEGGYGRVYKGYIEAVD-Q-----VVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL-VNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~-~-----~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~ 132 (336)
+.|..|-...+|++...... . .|.++...... ...-.-.+|+.+++.+...++ .++++.+.. .++.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 35666888899998754321 2 25555432221 111223578999999876555 455555542 589999
Q ss_pred CCCCChh
Q 036144 133 MSNGSLE 139 (336)
Q Consensus 133 ~~~g~L~ 139 (336)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987764
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.048 Score=50.49 Aligned_cols=76 Identities=8% Similarity=0.097 Sum_probs=47.5
Q ss_pred cccccccCceEEEEEEEcc--------cCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCcc-ceEEEEEeCCeEEEE
Q 036144 59 DCLVGEGGYGRVYKGYIEA--------VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLV-NLIGYCADGDQRILV 129 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv 129 (336)
.+.|..|-.-.+|++.... .++.|.+++.......-. .-..|..+++.+...+|. ++++.+. -..|
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 3456667777888887542 146788998755433222 345688888887654444 4555543 2467
Q ss_pred EEcCCCCChh
Q 036144 130 YEFMSNGSLE 139 (336)
Q Consensus 130 ~e~~~~g~L~ 139 (336)
.+|++|.+|.
T Consensus 185 ~efi~g~~l~ 194 (442)
T PTZ00296 185 EEWLYGDPLR 194 (442)
T ss_pred EEeeCCccCC
Confidence 8999887553
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.037 Score=45.59 Aligned_cols=103 Identities=16% Similarity=0.082 Sum_probs=64.0
Q ss_pred EEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHH
Q 036144 81 VVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK 159 (336)
Q Consensus 81 ~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~ 159 (336)
+..+|++....-. ....+..+..++.++. .|+++..= +...+-++.|.|-.... .. .-.
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~---~N~ 146 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NF---SNF 146 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------ch---hHH
Confidence 3445555432222 3345677888887664 35666521 33345688898832111 11 111
Q ss_pred HHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 160 IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 160 i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
|... +.+|.-.|+.. .+.+|+|-.|+||+-|..|.+||.|=++.
T Consensus 147 i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 147 ITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 1111 46677888543 55999999999999999999999998765
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.17 Score=44.99 Aligned_cols=71 Identities=14% Similarity=0.070 Sum_probs=43.0
Q ss_pred CceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC--CccceE---E--EEEeCCeEEEEEEcCCCCCh
Q 036144 66 GYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ--NLVNLI---G--YCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 66 ~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~---~--~~~~~~~~~lv~e~~~~g~L 138 (336)
.-..||++.... +..+++|+..... .....+..|+..+..|... .++... + +...+...+.++++++|...
T Consensus 37 ~eN~vy~v~~~~-~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 37 YENRVYQFGDED-GRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred ccceEEEEecCC-CCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 445688887643 5678999875332 3456677888888777421 122211 1 22334567789999987643
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.19 Score=41.76 Aligned_cols=74 Identities=23% Similarity=0.248 Sum_probs=52.3
Q ss_pred cccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc---CCCccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ---HQNLVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
.+..|.--..|.+.+. ..++-+|+-. ......+..|+.-|..|. .-++.+++.+..+..+.|+||||++-+.
T Consensus 23 ~v~gG~inea~~v~dg--~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 23 EVSGGDINEAWRLRDG--TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred ccCCccccceeEeecC--CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3555555555655554 3568888632 233456788888777764 4568889999999999999999998877
Q ss_pred hh
Q 036144 138 LE 139 (336)
Q Consensus 138 L~ 139 (336)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 64
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.15 Score=44.53 Aligned_cols=31 Identities=32% Similarity=0.375 Sum_probs=25.6
Q ss_pred CCeeeCCCCCCCeEECCC--C---ceEEcccccccc
Q 036144 177 PPVIYRDFKASNILLDAE--F---NPKLSDFGLAKL 207 (336)
Q Consensus 177 ~~i~H~dikp~Nil~~~~--~---~~kl~Dfg~~~~ 207 (336)
.-++|||+.+.|||+..+ | .+++.||-++..
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 349999999999999654 3 589999998864
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 336 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-61 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-60 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-53 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-46 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-44 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-21 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-15 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-15 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-15 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-13 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-13 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-13 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-12 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 8e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 517 bits (1335), Expect = 0.0
Identities = 112/305 (36%), Positives = 169/305 (55%), Gaps = 20/305 (6%)
Query: 41 PNVFKYQELADATENFNPDC------LVGEGGYGRVYKGYIEAVDQVVAVKQL----DRS 90
+ F + EL + T NF+ +GEGG+G VYKGY+ + VAVK+L D +
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDIT 69
Query: 91 GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE 150
+ ++F E+ +++ QH+NLV L+G+ +DGD LVY +M NGSL +
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTP 128
Query: 151 PLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210
PL W R KIA GAA G+ +LH+ I+RD K++NILLD F K+SDFGLA+
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQN 270
+ +++R++GT Y APE + G++T KSD+YSFGVVLLE+ITG A+D R Q
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQL 242
Query: 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330
L+ + + ++K D + + +VA CL E + RP + V L
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 331 EYLSS 335
+ +++
Sbjct: 302 QEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 510 bits (1316), Expect = 0.0
Identities = 120/315 (38%), Positives = 171/315 (54%), Gaps = 5/315 (1%)
Query: 18 KRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEA 77
+ S I + +L +AT NF+ L+G G +G+VYKG +
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 78 VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGS 137
VA+K+ +QG EF E+ LS +H +LV+LIG+C + ++ IL+Y++M NG+
Sbjct: 63 -GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 138 LENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197
L+ H + W R++I GAA+GL YLH +I+RD K+ NILLD F P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVP 178
Query: 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
K++DFG++K G + H+ST V GT GY PEY + G+LT+KSDVYSFGVVL E++ R
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 258 SAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDA 317
SAI S P E NL WA + + DP L + + L + A CL +
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSS 297
Query: 318 DSRPFMVDVVTALEY 332
+ RP M DV+ LEY
Sbjct: 298 EDRPSMGDVLWKLEY 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 499 bits (1287), Expect = e-180
Identities = 130/295 (44%), Positives = 184/295 (62%), Gaps = 8/295 (2%)
Query: 41 PNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVD-QVVAVKQLDRSGNQGS-REF 98
F +EL A++NF+ ++G GG+G+VYKG + D +VAVK+L QG +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQF 74
Query: 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
EV M+S+ H+NL+ L G+C +R+LVY +M+NGS+ + + P Q PLDW R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
+IA G+A+GL YLHD DP +I+RD KA+NILLD EF + DFGLAKL HV+T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVTT 193
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ--NLVTWAK 276
V GT G+ APEY TG+ ++K+DV+ +GV+LLELITG+ A D +R + + L+ W K
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
LL++ KK + D L+G Y + + Q + VA +C Q RP M +VV LE
Sbjct: 254 GLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 4e-88
Identities = 75/313 (23%), Positives = 115/313 (36%), Gaps = 29/313 (9%)
Query: 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVL 103
+ L + + G +G V+K + ++ VAVK Q S + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ-SWQNEYEVY 70
Query: 104 MLSLVQHQNLVNLIGYCADGD----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK 159
L ++H+N++ IG G L+ F GSL FL + W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLS-DFLK----ANVVSWNELCH 125
Query: 160 IAGGAAKGLEYLH-------DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212
IA A+GL YLH D P + +RD K+ N+LL ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 213 KDHVSTRVMGTYGYCAPEYAMTG-----QLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267
+ +GT Y APE + D+Y+ G+VL EL + +A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 268 EQNL--VTWAKPLLRDKKKF--TMMADPLLEGQYPRKGLYQALA-VAGMCLQEDADSRPF 322
P L D ++ P+L + + L C DA++R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 323 MVDVVTALEYLSS 335
V + +
Sbjct: 306 AGCVGERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-67
Identities = 71/327 (21%), Positives = 121/327 (37%), Gaps = 46/327 (14%)
Query: 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAE-- 101
E + +N L+G G YG VYKG ++ ++ VAVK + F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSF---ANRQNFINEKN 57
Query: 102 VLMLSLVQHQNLVNLIGYCADGD-----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFT 156
+ + L++H N+ I + +LV E+ NGSL + DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVS 112
Query: 157 RMKIAGGAAKGLEYLH------DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK---- 206
++A +GL YLH D P + +RD + N+L+ + +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 207 --LGPTGGKDHVSTRVMGTYGYCAPEYAM-------TGQLTKKSDVYSFGVVLLELITGR 257
L G +D+ + +GT Y APE K+ D+Y+ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 258 SAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPR---------KGLYQALAV 308
+ + E + + + M E Q P+ +
Sbjct: 233 TDLFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 309 AGMCLQEDADSRPFMVDVVTALEYLSS 335
C +DA++R + L
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMM 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 5e-62
Identities = 76/276 (27%), Positives = 121/276 (43%), Gaps = 24/276 (8%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVNLIGY 119
+G G +G V++ VAVK L EF EV ++ ++H N+V +G
Sbjct: 45 IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
+V E++S GSL L +E LD R+ +A AKG+ YLH+ +PP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTK 239
++R+ K+ N+L+D ++ K+ DFGL++L + S GT + APE +
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 240 KSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPR 299
KSDVYSFGV+L EL T + +P N + K+ +
Sbjct: 219 KSDVYSFGVILWELATLQ------QPWGNLNPAQVVAAVGFKCKR------LEIPRNLNP 266
Query: 300 KGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
+ A+ C + RP ++ L L
Sbjct: 267 Q--VAAIIE--GCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 9e-61
Identities = 75/287 (26%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS-------REFFAEVLMLSLVQHQNLV 114
+G+GG+G V+KG + VVA+K L ++G +EF EV ++S + H N+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV 174
L G + +V EF+ G L H L P+ W ++++ A G+EY+ +
Sbjct: 87 KLYGLMHN--PPRMVMEFVPCGDL-YHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQN- 140
Query: 175 ADPPVIYRDFKASNILLD-----AEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
+PP+++RD ++ NI L A K++DFGL++ H + ++G + + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAP 195
Query: 230 EYAMTGQL---TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286
E + + T+K+D YSF ++L ++TG D + + + + LR
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR------ 248
Query: 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
P + P + + + +C D RP +V L L
Sbjct: 249 ----PTIPEDCPPR--LRNVIE--LCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 2e-59
Identities = 73/288 (25%), Positives = 113/288 (39%), Gaps = 58/288 (20%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
VG G +G V K + VA+KQ++ + + F E+ LS V H N+V L G C
Sbjct: 16 VGRGAFGVVCKAKWR--AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
+ LV E+ GSL + L M ++G+ YLH + +I+
Sbjct: 72 N--PVCLVMEYAEGGSL-YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 182 RDFKASNILLDAEFN-PKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK 240
RD K N+LL A K+ DFG A T G+ + APE ++K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 241 SDVYSFGVVLLELITGR---------------SAIDNSRPSEEQNLVTWAKPLLRDKKKF 285
DV+S+G++L E+IT R + + +RP +NL + L+
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR---- 239
Query: 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
C +D RP M ++V + +L
Sbjct: 240 --------------------------CWSKDPSQRPSMEEIVKIMTHL 261
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-58
Identities = 70/297 (23%), Positives = 116/297 (39%), Gaps = 38/297 (12%)
Query: 56 FNPDCLV-----GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH 110
F P L+ G+G +G+ K +V+ +K+L R + R F EV ++ ++H
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
N++ IG + + E++ G+L + W R+ A A G+ Y
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGI---IKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL------------GPTGGKDHVST 218
LH + +I+RD + N L+ N ++DFGLA+L
Sbjct: 124 LHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278
V+G + APE +K DV+SFG+VL E+I +A + P +
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------ 234
Query: 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
+ + F P P + + C D + RP V + LE L
Sbjct: 235 --NVRGFLDRYCP---PNCPPS-FFP---ITVRCCDLDPEKRPSFVKLEHWLETLRM 282
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-57
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS----REFFAEVLMLSLVQHQNLVNLI 117
+G GG+G+VY+ + VAVK ++ E + ++++H N++ L
Sbjct: 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G C LV EF G L N L + + + A A+G+ YLHD A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPL-NRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 178 PVIYRDFKASNILLDAEFNP--------KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
P+I+RD K+SNIL+ + K++DFGLA+ G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAP 183
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGR 257
E +K SDV+S+GV+L EL+TG
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 8e-57
Identities = 58/295 (19%), Positives = 107/295 (36%), Gaps = 65/295 (22%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGY 119
+ E G ++KG + + VK L + SR+F E L + H N++ ++G
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 120 CAD--GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
C L+ +M GSL N + +D +K A A+G+ +LH +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT-LEP 132
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ- 236
+ + ++++D + ++S + S M + APE A+ +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPE-ALQKKP 184
Query: 237 ---LTKKSDVYSFGVVLLELITGRS--------------AIDNSRPSEEQNLVTWAKPLL 279
+ +D++SF V+L EL+T A++ RP+ + L+
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLM 244
Query: 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
+ C+ ED RP +V LE +
Sbjct: 245 KI------------------------------CMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-54
Identities = 59/286 (20%), Positives = 105/286 (36%), Gaps = 40/286 (13%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVNLIGY 119
+G+G +G+VY G VA++ +D + + F EV+ +H+N+V +G
Sbjct: 41 IGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
C ++ +L + + + LD +IA KG+ YLH +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSV---VRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKL---GPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
+++D K+ N+ D ++DFGL + G ++ G + APE
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 237 L---------TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287
+K SDV++ G + EL P + Q + K
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE------WPFKTQPAEAIIWQMGTGMKP--- 261
Query: 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
L + K + L C + + RP ++ LE L
Sbjct: 262 ---NLSQIGMG-KEISDILL---FCWAFEQEERPTFTKLMDMLEKL 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-54
Identities = 65/296 (21%), Positives = 114/296 (38%), Gaps = 29/296 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
+G+G YG V+ G + VAVK + + S E+ L++H+N++ I
Sbjct: 44 QIGKGRYGEVWMGKWR--GEKVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 121 ADGDQRI----LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH---- 172
G L+ ++ NGSL +L LD + +K+A + GL +LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLY-DYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 173 -DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK--DHVSTRVMGTYGYCAP 229
P + +RD K+ NIL+ ++D GLA + D +GT Y P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 230 E------YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE-QNLVTWAKPLLRDK 282
E Q +D+YSFG++L E+ + + + + + P D
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 283 KKF--TMMADPLLEGQYPRKGLYQALA-VAGMCLQEDADSRPFMVDVVTALEYLSS 335
++ P ++ + + + C + SR + V L +S
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-54
Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 27/278 (9%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVNLIGY 119
+G G +G VYKG VAVK L+ + + F EV +L +H N++ +GY
Sbjct: 32 IGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
I V ++ SL +H L + + + IA A+G++YLH +
Sbjct: 89 STAPQLAI-VTQWCEGSSLYHH---LHASETKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE---YAMTGQ 236
I+RD K++NI L + K+ DFGLA H ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 237 LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQ 296
+ +SDVY+FG+VL EL+TG+ N ++ + + R ++ D
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM--VGRG----SLSPDLSKVRS 252
Query: 297 YPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
K + + +A CL++ D RP ++ +E L+
Sbjct: 253 NCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEELA 287
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-51
Identities = 62/300 (20%), Positives = 116/300 (38%), Gaps = 41/300 (13%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAE--VLMLSLVQHQNLVNLIG 118
VG+G YG V++G + + VAVK ++ + +F E + +++H+N++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ--GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 119 YCADGD----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH-- 172
Q L+ + GSL + +L LD + ++I A GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYD-YLQ----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 173 ---DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK--DHVSTRVMGTYGYC 227
P + +RD K+ NIL+ ++D GLA + D + +GT Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 228 APE------YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281
APE K+ D+++FG+VL E+ + + + + D
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK----PPFYDVVPND 240
Query: 282 KKKFTMMADPLLEGQYP--RKGLYQALAVAGM------CLQEDADSRPFMVDVVTALEYL 333
M ++ Q P + + + C ++ +R + + L +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-50
Identities = 64/300 (21%), Positives = 123/300 (41%), Gaps = 37/300 (12%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAE--VLMLSLVQHQNLVNLIG 118
+G+G +G V++G + VAVK ++ R +F E + +++H+N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR--GEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 119 YCADGDQRI----LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH-- 172
+ LV ++ +GSL +L+ + + +K+A A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLF-DYLN----RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 173 ---DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG--KDHVSTRVMGTYGYC 227
P + +RD K+ NIL+ ++D GLA + D +GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 228 APEYAMTGQL-------TKKSDVYSFGVVLLELITGRSAIDNSRPSEE--QNLVTWAKPL 278
APE + + K++D+Y+ G+V E+ S + +LV + P
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV-PSDPS 276
Query: 279 LRDKKKF--TMMADPLLEGQYPRKGLYQALA-VAGMCLQEDADSRPFMVDVVTALEYLSS 335
+ + +K P + ++ + +A + C + +R + + L LS
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 15/198 (7%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
G G +G V+ G + A + +VAVK + +F E +L H N+V LIG C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
+V E + G L + L T +++ G AA G+EYL I+
Sbjct: 183 QKQPIYIVMELVQGGDFLTF---LRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIH 236
Query: 182 RDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY----CAPEYAMTGQL 237
RD A N L+ + K+SDFG+++ D V G APE G+
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSRE----EADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 238 TKKSDVYSFGVVLLELIT 255
+ +SDV+SFG++L E +
Sbjct: 293 SSESDVWSFGILLWETFS 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 71/290 (24%), Positives = 120/290 (41%), Gaps = 48/290 (16%)
Query: 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVNL 116
D +G G + VYKG VA +L S + F E ML +QH N+V
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 117 IGYCADGDQR----ILVYEFMSNGSLENHFLDLPPDQEPL--DWFTRMKIAGGAAKGLEY 170
+ +LV E M++G+L+ + + + W ++ KGL++
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQF 144
Query: 171 LHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
LH PP+I+RD K NI + + K+ D GLA L + + V+GT + AP
Sbjct: 145 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAP 199
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRP-SEEQNLVTWAKPLLRDKKKFTM- 287
E + + DVY+FG+ +LE+ T P SE QN + + K +
Sbjct: 200 EM-YEEKYDESVDVYAFGMCMLEMATSE------YPYSECQNAAQIYRRVTSGVKPASFD 252
Query: 288 -MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+A P + ++ + C++++ D R + + L+
Sbjct: 253 KVAIPEV-----KEIIEG-------CIRQNKDERY------SIKDLLNHA 284
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-37
Identities = 70/219 (31%), Positives = 105/219 (47%), Gaps = 21/219 (9%)
Query: 50 ADATENFNPDCLV-----GEGGYGRVYKGY----IEAVDQVVAVKQLDRSGNQGSREFFA 100
+D T+ F L G+G +G V + +VVAVK+L S + R+F
Sbjct: 2 SDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 101 EVLMLSLVQHQNLVNLIGYCADGDQR--ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
E+ +L +QH N+V G C +R L+ E++ GSL ++ L +E +D +
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY---LQKHKERIDHIKLL 117
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
+ KG+EYL I+RD NIL++ E K+ DFGL K+ P K+
Sbjct: 118 QYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKV 173
Query: 219 RVMGTY--GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ G + APE + + SDV+SFGVVL EL T
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 71/228 (31%), Positives = 107/228 (46%), Gaps = 21/228 (9%)
Query: 41 PNVFKYQELADATENFNPDCLV-----GEGGYGRVYKGY----IEAVDQVVAVKQLDRSG 91
+ E D T+ F L G+G +G V + +VVAVK+L S
Sbjct: 24 GAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 82
Query: 92 NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR--ILVYEFMSNGSLENHFLDLPPDQ 149
+ R+F E+ +L +QH N+V G C +R L+ E++ GSL ++ L +
Sbjct: 83 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY---LQKHK 139
Query: 150 EPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209
E +D ++ KG+EYL I+RD NIL++ E K+ DFGL K+ P
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196
Query: 210 TGGKDHVSTRVMGTY--GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
K++ + G + APE + + SDV+SFGVVL EL T
Sbjct: 197 Q-DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-36
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 51 DATENFNPDCLV-----GEGGYGRVYKGY----IEAVDQVVAVKQL-DRSGNQGSREFFA 100
D T F L GEG +G+V + + VAVK L SG +
Sbjct: 14 DPTH-FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK 72
Query: 101 EVLMLSLVQHQNLVNLIGYCADGDQR--ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM 158
E+ +L + H+N+V G C + L+ EF+ +GSL+ + LP ++ ++ ++
Sbjct: 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY---LPKNKNKINLKQQL 129
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
K A KG++YL ++RD A N+L+++E K+ DFGL K T K++ +
Sbjct: 130 KYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD-KEYYTV 185
Query: 219 RVMGTY--GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ + APE M + SDV+SFGV L EL+T
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 70/218 (32%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 51 DATENFNPDCLV-----GEGGYGRVYKGYI----EAVDQVVAVKQLDRSGNQGSREFFAE 101
D T F L G+G +G V + +VAVKQL SG R+F E
Sbjct: 16 DPTI-FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE 74
Query: 102 VLMLSLVQHQNLVNLIGYCADGDQR--ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK 159
+ +L + +V G ++ LV E++ +G L + L + LD +
Sbjct: 75 IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF---LQRHRARLDASRLLL 131
Query: 160 IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR 219
+ KG+EYL ++RD A NIL+++E + K++DFGLAKL P KD+ R
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVR 187
Query: 220 VMGTY--GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
G + APE +++SDV+SFGVVL EL T
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 12/223 (5%)
Query: 38 KKTPNVFKYQELADATENFNPDCLV-----GEGGYGRVYKGYIEAVDQVVAVKQLDRSGN 92
K+ + G G YG VY+G + VAVK L +
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDT 257
Query: 93 QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPL 152
EF E ++ ++H NLV L+G C ++ EFM+ G+L + +L +++ +
Sbjct: 258 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD-YL-RECNRQEV 315
Query: 153 DWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212
+ +A + +EYL I+R+ A N L+ K++DFGL++L TG
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL-MTGD 371
Query: 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE + + KSDV++FGV+L E+ T
Sbjct: 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 63 GEGGYGRVYKGYI-----EAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
G+G +G VY+G + + VA+K + + + + EF E ++ ++V L
Sbjct: 34 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFL-------DLPPDQEPLDWFTRMKIAGGAAKGLE 169
+G + G +++ E M+ G L +L P P +++AG A G+
Sbjct: 94 LGVVSQGQPTLVIMELMTRGDL-KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT------GGKDHVSTRVMGT 223
YL ++RD A N ++ +F K+ DFG+ + GGK + R M
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+PE G T SDV+SFGVVL E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 59/196 (30%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G G +G V+ GY D+V A+K + R G +F E ++ + H LV L G C +
Sbjct: 17 GSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYR 182
LV EFM +G L + +L + M +G+ YL + VI+R
Sbjct: 75 QAPICLVTEFMEHGCLSD-YLRTQRGLFAAETLLGM--CLDVCEGMAYL---EEACVIHR 128
Query: 183 DFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQLTK 239
D A N L+ K+SDFG+ + D T GT + +PE + +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 240 KSDVYSFGVVLLELIT 255
KSDV+SFGV++ E+ +
Sbjct: 185 KSDVWSFGVLMWEVFS 200
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 13/196 (6%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G G YG VY+G + VAVK L + EF E ++ ++H NLV L+G C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYR 182
++ EFM+ G+L + +L +++ + + +A + +EYL I+R
Sbjct: 81 EPPFYIITEFMTYGNLLD-YL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 183 DFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQLTK 239
D A N L+ K++DFGL++L T G + APE + +
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRL----MTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 240 KSDVYSFGVVLLELIT 255
KSDV++FGV+L E+ T
Sbjct: 192 KSDVWAFGVLLWEIAT 207
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 68/224 (30%), Positives = 102/224 (45%), Gaps = 24/224 (10%)
Query: 46 YQELADATENFNPDCLV-----GEGGYGRVYKGYI----EAVDQVVAVKQL-DRSGNQGS 95
+Q D T F+ L GEG +G+V + ++VAVK L +G Q
Sbjct: 19 FQGPGDPTV-FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR 77
Query: 96 REFFAEVLMLSLVQHQNLVNLIGYCADGDQR--ILVYEFMSNGSLENHFLDLPPDQEPLD 153
+ E+ +L + H++++ G C D LV E++ GSL +L + +
Sbjct: 78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL-RDYLP----RHSIG 132
Query: 154 WFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213
+ A +G+ YLH I+RD A N+LLD + K+ DFGLAK P G
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG-H 188
Query: 214 DHVSTRVMGTY--GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
++ R G + APE + SDV+SFGV L EL+T
Sbjct: 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 63/300 (21%), Positives = 105/300 (35%), Gaps = 38/300 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
+++ +GEGG+ V A+K++ Q E E M L H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 114 VNLIGYCADGDQR----ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
+ L+ YC L+ F G+L N L L + + G +GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-------G 222
+H +RD K +NILL E P L D G + +
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 223 TYGYCAPE------YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK 276
T Y APE + + + ++DV+S G VL ++ G D +
Sbjct: 206 TISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV------ 256
Query: 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
L + + ++ P ++ + + D RP + +++ LE L P
Sbjct: 257 -ALAVQNQLSIPQSP----RHSS----ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 39/239 (16%)
Query: 45 KYQELADATENFNPDCLV-----GEGGYGRVYKGYIEAV-----DQVVAVKQLDRSGNQG 94
+Y A +V GEG +G+V+ + +VAVK L +
Sbjct: 28 QYFSDACVHH-IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA 86
Query: 95 SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFL----------- 143
++F E +L+++QHQ++V G C +G ++V+E+M +G L N FL
Sbjct: 87 RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLA 145
Query: 144 -DLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202
PL + +A A G+ YL A ++RD N L+ K+ DF
Sbjct: 146 GGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDF 202
Query: 203 GLAKLGPT------GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
G+++ + GG+ + R M PE + + T +SDV+SFGVVL E+ T
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 40/215 (18%)
Query: 63 GEGGYGRVYKG-------YIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVN 115
G+G + +++KG Y + + V +K LD++ S FF M+S + H++LV
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
G C GD+ ILV EF+ GSL + +L + + W + A A + +L
Sbjct: 77 NYGVCVCGDENILVQEFVKFGSL-DTYLKKNKNCINILWKLEV--AKQLAAAMHFL---E 130
Query: 176 DPPVIYRDFKASNILLDAEFNP--------KLSDFGLAKLGPTGGKDHVSTRVMGTYGY- 226
+ +I+ + A NILL E + KLSD G++ V+
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDILQ 178
Query: 227 -----CAPEYAMTGQL-TKKSDVYSFGVVLLELIT 255
PE + +D +SFG L E+ +
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 68/289 (23%), Positives = 100/289 (34%), Gaps = 45/289 (15%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEV-LMLSLVQH 110
++F +G G YG V+K + ++ AVK+ G + AEV + QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLP---PDQEPLDWFTRMKIAGGAAKG 167
V L +G L E SL+ H P+ + +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDT------LLA 169
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
L +LH +++ D K +NI L KL DFGL T G V G Y
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYM 223
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287
APE + G +DV+S G+ +LE+ P + W + LR
Sbjct: 224 APE-LLQGSYGTAADVFSLGLTILEVACNMEL-----PHGGEG---WQQ--LRQGY---- 268
Query: 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
P + +V M L+ D R TA L+ P
Sbjct: 269 -LPPEFTAGLSS----ELRSVLVMMLEPDPKLRA------TAEALLALP 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-34
Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 42/245 (17%)
Query: 36 KAKKTPNVFKYQELADATENFNPDCLV-----GEGGYGRVYKGYI--EAVDQVVAVKQL- 87
K P+ Y + + + GEG +G+V K I + + A+K++
Sbjct: 9 HGKNNPDPTIYPV-------LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK 61
Query: 88 DRSGNQGSREFFAEV-LMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFL--- 143
+ + R+F E+ ++ L H N++NL+G C L E+ +G+L FL
Sbjct: 62 EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL-LDFLRKS 120
Query: 144 ----------DLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA 193
L + A A+G++YL + I+RD A NIL+
Sbjct: 121 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGE 177
Query: 194 EFNPKLSDFGLAKLGP---TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVL 250
+ K++DFGL++ + R M A E T SDV+S+GV+L
Sbjct: 178 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLL 231
Query: 251 LELIT 255
E+++
Sbjct: 232 WEIVS 236
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 39/229 (17%)
Query: 56 FNPDCLV-----GEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQGSREFFAEVLML 105
+V GEG +G+V+ +VAVK L ++F E +L
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71
Query: 106 SLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFL-------------DLPPDQEPL 152
+ +QH+++V G C DGD I+V+E+M +G L N FL + L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 153 DWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG---- 208
+ IA A G+ YL A ++RD N L+ A K+ DFG+++
Sbjct: 131 GLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
Query: 209 --PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
GG + R M PE M + T +SDV+SFGV+L E+ T
Sbjct: 188 YYRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 46 YQELADATENFNPDCLV-----GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA 100
E + N L G+G +G V G + VAVK + ++ ++ F A
Sbjct: 8 QDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCI-KNDAT-AQAFLA 63
Query: 101 EVLMLSLVQHQNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMK 159
E +++ ++H NLV L+G + + +V E+M+ GSL + +L + L +K
Sbjct: 64 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLR-SRGRSVLGGDCLLK 121
Query: 160 IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR 219
+ + +EYL ++RD A N+L+ + K+SDFGL K + ST+
Sbjct: 122 FSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQ 171
Query: 220 VMGTYGY--CAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRS 258
G APE + + KSDV+SFG++L E+ + GR
Sbjct: 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G+G +G V G + VAVK + ++ ++ F AE +++ ++H NLV L+G +
Sbjct: 202 GKGEFGDVMLG--DYRGNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 123 GDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
+ +V E+M+ GSL + +L + L +K + + +EYL ++
Sbjct: 258 EKGGLYIVTEYMAKGSLVD-YL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 312
Query: 182 RDFKASNILLDAEFNPKLSDFGLAK---LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
RD A N+L+ + K+SDFGL K GK + + APE + +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--LPVKWT------APEALREKKFS 364
Query: 239 KKSDVYSFGVVLLELIT-GRS 258
KSDV+SFG++L E+ + GR
Sbjct: 365 TKSDVWSFGILLWEIYSFGRV 385
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-33
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G G +G V G V A+K + + G+ EF E ++ + H+ LV L G C
Sbjct: 33 GTGQFGVVKYGKWRGQYDV-AIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYR 182
++ E+M+NG L N+ L + +++ + +EYL ++R
Sbjct: 91 QRPIFIITEYMANGCLLNY---LREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHR 144
Query: 183 DFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQLTK 239
D A N L++ + K+SDFGL++ D T +G+ + PE M + +
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRY----VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 240 KSDVYSFGVVLLELIT 255
KSD+++FGV++ E+ +
Sbjct: 201 KSDIWAFGVLMWEIYS 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 64/209 (30%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 62 VGEGGYGRVYKGYIEAVDQV---VAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
+G G +G VY G + D AVK L + +F E +++ H N+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 118 GYCADGDQRIL-VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
G C + L V +M +G L +F+ + AKG++YL A
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDL-RNFIRNETHN--PTVKDLIGFGLQVAKGMKYL---AS 146
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLA----------KLGPTGGKDHVSTRVMGTYGY 226
++RD A N +LD +F K++DFGLA TG K V + M
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV--KWM----- 199
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
A E T + T KSDV+SFGV+L EL+T
Sbjct: 200 -ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 15/196 (7%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G G +G V G + V AVK + + G+ EFF E + + H LV G C+
Sbjct: 17 GSGQFGVVKLGKWKGQYDV-AVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYR 182
+V E++SNG L N+ L + L+ +++ +G+ +L I+R
Sbjct: 75 EYPIYIVTEYISNGCLLNY---LRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 183 DFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQLTK 239
D A N L+D + K+SDFG+ + D +GT + APE + +
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRY----VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 240 KSDVYSFGVVLLELIT 255
KSDV++FG+++ E+ +
Sbjct: 185 KSDVWAFGILMWEVFS 200
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 63 GEGGYGRVYKGY----IEAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
G G +G VYKG E V VA+K+L + + + ++E E +++ V + ++ L+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G C L+ + M G L ++ D + AKG+ YL D
Sbjct: 84 GICL-TSTVQLITQLMPFGCL-LDYVREHKDNIGSQYLLNW--CVQIAKGMNYLEDRR-- 137
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGP--------TGGKDHVSTRVMGTYGYCAP 229
+++RD A N+L+ + K++DFGLAKL GGK + + A
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--------WMAL 188
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELIT 255
E + T +SDV+S+GV + EL+T
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-33
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 52/228 (22%)
Query: 63 GEGGYGRVYKGYIEAVD-------QVVAVKQL-DRSGNQGSREFFAEV-LMLSLVQHQNL 113
GEG +G+V +D VAVK L D + + + +E+ +M + +H+N+
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENHFL-------------DLPPDQEPLDWFTRMKI 160
+NL+G C ++ E+ S G+L +L +E + + +
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNL-REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A+G+EYL A I+RD A N+L+ K++DFGLA R
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------------RD 206
Query: 221 MGTYGYC-------------APEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ Y APE T +SDV+SFGV++ E+ T
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-33
Identities = 67/315 (21%), Positives = 116/315 (36%), Gaps = 65/315 (20%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN 112
+F ++G+G +G+V K + A+K++ + + +EV++L+ + HQ
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 113 LVNLIGYCADGDQRI-------------LVYEFMSNGSLENHFLDLPPDQEP---LDWFT 156
+V + + + E+ NG+L + +Q+ F
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 157 RMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL--------- 207
++ + L Y+H +I+RD K NI +D N K+ DFGLAK
Sbjct: 124 QI------LEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 208 ---GPTGGKDHVSTRVMGTYGYCAPE-YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNS 263
G T +GT Y A E TG +K D+YS G++ E+I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP------- 227
Query: 264 RPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPR--KGLYQALAVAGMCLQEDADSRP 321
S V K L +F P + + K + + + + D + RP
Sbjct: 228 -FSTGMERVNILKKLRSVSIEF----PPDFDDNKMKVEKKIIR------LLIDHDPNKRP 276
Query: 322 FMVDVVTALEYLSSP 336
A L+S
Sbjct: 277 ------GARTLLNSG 285
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 35/289 (12%)
Query: 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ 109
D + + +G+G G VY A Q VA++Q++ E+L++ +
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
+ N+VN + GD+ +V E+++ GSL D+ + +D + + LE
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSL----TDV-VTETCMDEGQIAAVCRECLQALE 130
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCA 228
+LH VI+RD K+ NILL + + KL+DFG A++ P K + ++GT + A
Sbjct: 131 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMA 184
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAKPLLRDKKKFTM 287
PE K D++S G++ +E+I G N P L+ T P L++ +K +
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS- 243
Query: 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
L CL+ D + R +A E L
Sbjct: 244 ------------AIFRDFLNR---CLEMDVEKRG------SAKELLQHQ 271
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 54/237 (22%)
Query: 56 FNPDCLV-----GEGGYGRVYKGYIEAV-----DQVVAVKQL-DRSGNQGSREFFAEVLM 104
+ + GE +G+VYKG++ Q VA+K L D++ EF E ++
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65
Query: 105 LSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFL-------------DLPPDQEP 151
+ +QH N+V L+G +++ + S+G L + FL D +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL-HEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 152 LDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211
L+ + + A G+EYL + V+++D N+L+ + N K+SD GL
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF------ 175
Query: 212 GKDHVSTRVMGTYGYC-------------APEYAMTGQLTKKSDVYSFGVVLLELIT 255
R + Y APE M G+ + SD++S+GVVL E+ +
Sbjct: 176 -------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 63 GEGGYGRVYKGY---IEAVDQVVAVKQL--DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
GEG +G V +G + VAVK + D S + EF +E + H N++ L+
Sbjct: 43 GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102
Query: 118 GYCADGDQRI-----LVYEFMSNGSLENHFL---DLPPDQEPLDWFTRMKIAGGAAKGLE 169
G C + + ++ FM G L + +L L + + T +K A G+E
Sbjct: 103 GVCIEMSSQGIPKPMVILPFMKYGDL-HTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT------GGKDHVSTRVMGT 223
YL ++ ++RD A N +L + ++DFGL+K + G + + +
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
A E T KSDV++FGV + E+ T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 62/206 (30%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 63 GEGGYGRVYKGYIEAVDQ---VVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLIG 118
G+G +G VY G Q A+K L + Q F E L++ + H N++ LIG
Sbjct: 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 119 YCADGDQRIL-VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
+ + +M +G L F+ P Q + A+G+EYL A+
Sbjct: 90 IMLPPEGLPHVLLPYMCHGDL-LQFIRSP--QRNPTVKDLISFGLQVARGMEYL---AEQ 143
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKL----GPTGGKDHVSTRV----MGTYGYCAP 229
++RD A N +LD F K++DFGLA+ + H R+ A
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT------AL 197
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELIT 255
E T + T KSDV+SFGV+L EL+T
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 15/210 (7%)
Query: 51 DATENFNPDCLV-----GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLML 105
DA E + L G+G +G V+ G +V A+K L + G F E ++
Sbjct: 177 DAWE-IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVM 233
Query: 106 SLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
++H+ LV L + +V E+MS GSL + + L + +A A
Sbjct: 234 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIA 290
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
G+ Y+ + ++RD +A+NIL+ K++DFGLA+L +
Sbjct: 291 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIK 346
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE A+ G+ T KSDV+SFG++L EL T
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 62/223 (27%), Positives = 95/223 (42%), Gaps = 42/223 (18%)
Query: 63 GEGGYGRVYKGYIEAVD-----QVVAVKQLDRSGNQGSR-EFFAEV-LMLSLVQHQNLVN 115
G G +G+V + + VAVK L S + R +E+ ++ L H N+VN
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFL---------------DLPPDQEPLDWFTRMKI 160
L+G C G +++ E+ G L +FL + D+ LD +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDL-LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK--------LGPTGG 212
+ AKG+ +L A I+RD A NILL K+ DFGLA+ +
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ V + M APE T +SDV+S+G+ L EL +
Sbjct: 208 RLPV--KWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 71/289 (24%), Positives = 115/289 (39%), Gaps = 35/289 (12%)
Query: 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ 109
D + +GEG G V + + VAVK +D Q F EV+++ Q
Sbjct: 41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
H N+V + G++ ++ EF+ G+L D+ Q L+ + + L
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGAL----TDI-VSQVRLNEEQIATVCEAVLQALA 155
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCA 228
YLH VI+RD K+ +ILL + KLSDFG A++ K ++GT + A
Sbjct: 156 YLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMA 209
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAKPLLRDKKKFTM 287
PE + D++S G++++E++ G + P + + P L++ K +
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVS- 268
Query: 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
L L L D R TA E L P
Sbjct: 269 ------------PVLRDFLER---MLVRDPQERA------TAQELLDHP 296
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 15/230 (6%)
Query: 31 IRKFGKAKKTPNVFKYQELADATENFNPDCLV-----GEGGYGRVYKGYIEAVDQVVAVK 85
+ T DA E + L G+G +G V+ G +V A+K
Sbjct: 240 CHRLTTVCPTSKPQTQGLAKDAWE-IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIK 297
Query: 86 QLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDL 145
L + G F E ++ ++H+ LV L + +V E+MS GSL +
Sbjct: 298 TL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG- 354
Query: 146 PPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205
+ L + +A A G+ Y+ + ++RD +A+NIL+ K++DFGLA
Sbjct: 355 -ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410
Query: 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+L + + APE A+ G+ T KSDV+SFG++L EL T
Sbjct: 411 RL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 52/228 (22%)
Query: 63 GEGGYGRVYKGYIEAVD-------QVVAVKQL-DRSGNQGSREFFAEV-LMLSLVQHQNL 113
GEG +G+V +D VAVK L D + + + +E+ +M + +H+N+
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENHFL-------------DLPPDQEPLDWFTRMKI 160
+NL+G C ++ E+ S G+L +L +E + + +
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNL-REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A+G+EYL A I+RD A N+L+ K++DFGLA R
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA-------------RD 252
Query: 221 MGTYGYC-------------APEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ Y APE T +SDV+SFGV++ E+ T
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 63 GEGGYGRVYKGY----IEAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
G G +G V+KG E++ V +K + D+SG Q + +L + + H ++V L+
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G C G LV +++ GSL +H + + L + AKG+ YL +
Sbjct: 82 GLCP-GSSLQLVTQYLPLGSLLDH---VRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-- 135
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
+++R+ A N+LL + +++DFG+A L P K + + + A E G+
Sbjct: 136 -MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 238 TKKSDVYSFGVVLLELIT 255
T +SDV+S+GV + EL+T
Sbjct: 195 THQSDVWSYGVTVWELMT 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-32
Identities = 66/196 (33%), Positives = 102/196 (52%), Gaps = 15/196 (7%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G G +G V+ GY +V AVK L + G+ F AE ++ +QHQ LV L
Sbjct: 22 GAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T 78
Query: 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYR 182
+ ++ E+M NGSL + FL P L + +A A+G+ ++ + I+R
Sbjct: 79 QEPIYIITEYMENGSLVD-FLK-TPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHR 133
Query: 183 DFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAMTGQLTK 239
D +A+NIL+ + K++DFGLA+L +D+ T G + APE G T
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI----EDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 240 KSDVYSFGVVLLELIT 255
KSDV+SFG++L E++T
Sbjct: 190 KSDVWSFGILLTEIVT 205
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 57/277 (20%), Positives = 104/277 (37%), Gaps = 34/277 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE---FFAEVLMLSLVQH 110
NF + +G G + VY+ VA+K++ ++ E+ +L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEP------LDWFTRMKIAGGA 164
N++ + ++ +V E G L + +F ++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL------ 145
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
LE++H V++RD K +N+ + A KL D GL + + + V GT
Sbjct: 146 CSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTP 200
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284
Y +PE KSD++S G +L E+ +S ++ NL + K + +
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKKIEQCD-- 254
Query: 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
PL Y + + MC+ D + RP
Sbjct: 255 ----YPPLPSDHYS----EELRQLVNMCINPDPEKRP 283
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 64/212 (30%), Positives = 91/212 (42%), Gaps = 29/212 (13%)
Query: 63 GEGGYGRVYKGYI-----EAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
G G +G VY+G + + VAVK L + Q +F E L++S HQN+V
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFL----DLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
IG R ++ E M+ G L FL P L + +A A G +YL
Sbjct: 99 IGVSLQSLPRFILMELMAGGDL-KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 173 DVADPPVIYRDFKASNILLDAEFNP---KLSDFGLAKLGPT------GGKDHVSTRVMGT 223
+ I+RD A N LL K+ DFG+A+ GG + + M
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM-- 212
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
PE M G T K+D +SFGV+L E+ +
Sbjct: 213 ----PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-32
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 28/212 (13%)
Query: 63 GEGGYGRVYKGYIEAVDQ---VVAVKQL--DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
G+G +G V + ++ D VAVK L D + EF E + H ++ L+
Sbjct: 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 118 GYCADGDQRI------LVYEFMSNGSLENHFLDLPPDQEP--LDWFTRMKIAGGAAKGLE 169
G + ++ FM +G L L + P L T ++ A G+E
Sbjct: 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT------GGKDHVSTRVMGT 223
YL + I+RD A N +L + ++DFGL++ + G + + +
Sbjct: 152 YL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL-- 206
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
A E T SDV++FGV + E++T
Sbjct: 207 ----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-32
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 51 DATENFNPDCLV-----GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLML 105
DA E + L G G +G V+ +V AVK + + G+ F AE ++
Sbjct: 181 DAWE-IPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVM 237
Query: 106 SLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
+QH LV L + ++ EFM+ GSL + FL + + + A
Sbjct: 238 KTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLD-FL-KSDEGSKQPLPKLIDFSAQIA 294
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT-- 223
+G+ ++ I+RD +A+NIL+ A K++DFGLA++ +D+ T G
Sbjct: 295 EGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAKF 347
Query: 224 -YGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE G T KSDV+SFG++L+E++T
Sbjct: 348 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 47/228 (20%)
Query: 63 GEGGYGRVYKGYIEAVD-----QVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
GEG +G+V K + VAVK L + + R+ +E +L V H +++ L
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFL---------------------DLPPDQEPLDWF 155
G C+ +L+ E+ GSL FL PD+ L
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSL-RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 156 TRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL-------- 207
+ A ++G++YL A+ +++RD A NIL+ K+SDFGL++
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ G+ V + M A E T +SDV+SFGV+L E++T
Sbjct: 208 KRSQGRIPV--KWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-32
Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 21/222 (9%)
Query: 46 YQELADATENFNPDCLV------GEGGYGRVYKGYIEAVDQV--VAVKQL--DRSGNQGS 95
+E+ + L G G +G V KGY + V VAVK L + +
Sbjct: 3 LEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 62
Query: 96 REFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWF 155
E AE ++ + + +V +IG C + + +LV E G L N +L +
Sbjct: 63 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPL-NKYLQ---QNRHVKDK 117
Query: 156 TRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215
+++ + G++YL + ++RD A N+LL + K+SDFGL+K +++
Sbjct: 118 NIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENY 173
Query: 216 VSTRVMGTY--GYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ G + + APE + + KSDV+SFGV++ E +
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 56/223 (25%), Positives = 90/223 (40%), Gaps = 46/223 (20%)
Query: 63 GEGGYGRVYKGYIEAVDQ-----VVAVKQL-DRSGNQGSREFFAEV-LMLSLVQHQNLVN 115
G G +G+V + + + VAVK L + +E+ +M L QH+N+VN
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFL-----------DLPPDQEPLDWFTRMKIAGGA 164
L+G C G +++ E+ G L +FL + +
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
A+G+ +L A I+RD A N+LL K+ DFGLA+ +M
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDS 218
Query: 225 GYC------------APEYAMTGQLTKKSDVYSFGVVLLELIT 255
Y APE T +SDV+S+G++L E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 33/232 (14%)
Query: 47 QELADATENFNPDCLV-----GEGGYGRVYKGYI-----EAVDQVVAVKQL-DRSGNQGS 95
++D E + G G +G VY+G + + VAVK L + Q
Sbjct: 60 SSISDLKE-VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 118
Query: 96 REFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWF 155
+F E L++S HQN+V IG R ++ E M+ G L++ + P
Sbjct: 119 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL 178
Query: 156 TR---MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP---KLSDFGLAKLGP 209
+ +A A G +YL + I+RD A N LL K+ DFG+A+
Sbjct: 179 AMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235
Query: 210 T------GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
GG + + M PE M G T K+D +SFGV+L E+ +
Sbjct: 236 RAGYYRKGGCAMLPVKWM------PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-31
Identities = 79/292 (27%), Positives = 117/292 (40%), Gaps = 42/292 (14%)
Query: 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLD-RSGNQGSREFFAEVLMLSLV 108
AD E F +G+G +G V+KG +VVA+K +D + E+ +LS
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG---GAA 165
+ G + ++ E++ GS L+ P E +IA
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDET-------QIATILREIL 129
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTY 224
KGL+YLH I+RD KA+N+LL KL+DFG+ +L T K +GT
Sbjct: 130 KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK---RNTFVGTP 183
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284
+ APE K+D++S G+ +EL G P + L+ P
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------- 236
Query: 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
P LEG Y K L + + CL ++ RP TA E L
Sbjct: 237 ------PTLEGNYS-KPLKEFVE---ACLNKEPSFRP------TAKELLKHK 272
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 63 GEGGYGRVYKGYIEAVDQ---VVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLIG 118
G G G V G + Q VA+K L + R+F +E ++ H N++ L G
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
G ++V E+M NGSL + FL Q + M G G+ YL D+
Sbjct: 118 VVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGM--LRGVGAGMRYLSDLG--- 171
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG-----YCAPEYAM 233
++RD A N+L+D+ K+SDFGL+++ +D T G + APE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRV----LEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 234 TGQLTKKSDVYSFGVVLLELIT 255
+ SDV+SFGVV+ E++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 62 VGEGGYGRVYKGYIEAVDQV---VAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
+G G +G VY G + D AVK L + +F E +++ H N+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 118 GYCADGDQRIL-VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
G C + L V +M +G L +F+ + AKG+++L A
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDL-RNFIRNETHN--PTVKDLIGFGLQVAKGMKFL---AS 210
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKL----------GPTGGKDHVSTRVMGTYGY 226
++RD A N +LD +F K++DFGLA+ TG K V + M
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV--KWM----- 263
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
A E T + T KSDV+SFGV+L EL+T
Sbjct: 264 -ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 63 GEGGYGRVYKGYIEAVDQV--VAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY 119
G G +G V +G + VA+K L + + E E ++ + + +V LIG
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
C + +LV E G L + FL ++ + ++ + G++YL +
Sbjct: 79 C-QAEALMLVMEMAGGGPL-HKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKNF 131
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY--GYCAPEYAMTGQL 237
++RD A N+LL K+SDFGL+K + + R G + + APE +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 238 TKKSDVYSFGVVLLELIT 255
+ +SDV+S+GV + E ++
Sbjct: 191 SSRSDVWSYGVTMWEALS 208
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-31
Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 63 GEGGYGRVYKGY----IEAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
G G +G VYKG E V VA+K+L + + + ++E E +++ V + ++ L+
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G C L+ + M G L ++ + ++ + + AKG+ YL D
Sbjct: 84 GICL-TSTVQLITQLMPFGCLLDY---VREHKDNIGSQYLLNWCVQIAKGMNYLEDRR-- 137
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
+++RD A N+L+ + K++DFGLAKL K++ + + A E +
Sbjct: 138 -LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196
Query: 238 TKKSDVYSFGVVLLELIT 255
T +SDV+S+GV + EL+T
Sbjct: 197 THQSDVWSYGVTVWELMT 214
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 49/298 (16%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREF-FAEVLMLSLVQHQ 111
E++ +G G YGR K ++ +++ K+LD + ++ +EV +L ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 112 NLVNLIGYCADGDQRIL--VYEFMSNGSLENHFLDLPPDQEPL------DWFTRMKIAGG 163
N+V D L V E+ G L + +++ L T++
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL----- 120
Query: 164 AAKGLEYLHDVADPP--VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM 221
L+ H +D V++RD K +N+ LD + N KL DFGLA++ T V
Sbjct: 121 -TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV- 177
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281
GT Y +PE +KSD++S G +L EL P + L
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKE-----LAG 226
Query: 282 KKKFTMMADPLLEGQYPR-KGLY--QALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
K + EG++ R Y + + L RP + E L +P
Sbjct: 227 K---------IREGKFRRIPYRYSDELNEIITRMLNLKDYHRP------SVEEILENP 269
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 60/202 (29%), Positives = 84/202 (41%), Gaps = 18/202 (8%)
Query: 63 GEGGYGRVYKGYIEAVDQV---VAVKQL---DRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
G+G +G V +G +A VAVK L S + +F EV + + H+NL+ L
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
G +V E GSL L L +R A A+G+ YL
Sbjct: 87 YGVVL-TPPMKMVTELAPLGSL-LDRLRKHQGHFLLGTLSRY--AVQVAEGMGYLESKR- 141
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT---YGYCAPEYAM 233
I+RD A N+LL K+ DFGL + P +V + +CAPE
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLK 197
Query: 234 TGQLTKKSDVYSFGVVLLELIT 255
T + SD + FGV L E+ T
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 52/205 (25%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
++G+G YG VY G + +A+K++ ++ S+ E+ + ++H+N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 121 ADGDQRILVYEFMSNGS----LENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
++ + E + GS L + + L +++ + ++T+ + +GL+YLHD
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDNQ- 142
Query: 177 PPVIYRDFKASNILLDAEF-NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE---YA 232
+++RD K N+L++ K+SDFG +K + GT Y APE
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKG 198
Query: 233 MTGQLTKKSDVYSFGVVLLELITGR 257
G K +D++S G ++E+ TG+
Sbjct: 199 PRG-YGKAADIWSLGCTIIEMATGK 222
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-31
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREF-FAEVLMLSLVQHQ 111
E + +GEG +G+ + +K+++ S + RE EV +L+ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLENHFLD----LPPDQEPLDWFTRMKIAGGAAKG 167
N+V + +V ++ G L L + + LDWF ++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLA 137
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
L+++HD +++RD K+ NI L + +L DFG+A++ + + GT Y
Sbjct: 138 LKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYL 192
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGRSA 259
+PE KSD+++ G VL EL T + A
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-31
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 63 GEGGYGRVYKGY----IEAVDQVVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLI 117
G G +G VYKG + VA+K L + +F E ++ H N++ L
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G + +++ E+M NG+L + FL + + M G A G++YL ++
Sbjct: 113 GVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGM--LRGIAAGMKYLANMN-- 167
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKL---------GPTGGKDHVSTRVMGTYGYCA 228
++RD A NIL+++ K+SDFGL+++ +GGK + R A
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK--IPIRWT------A 218
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELIT 255
PE + T SDV+SFG+V+ E++T
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-31
Identities = 76/301 (25%), Positives = 120/301 (39%), Gaps = 44/301 (14%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLD-RSGNQGSREFFAEVLMLSLVQHQN 112
+++ ++G G V Y + VA+K+++ E E+ +S H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDL-----PPDQEPLDWFTRMKIAG---GA 164
+V+ D+ LV + +S GS+ LD+ + IA
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTR--VM 221
+GLEYLH I+RD KA NILL + + +++DFG+ A L G R +
Sbjct: 131 LEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 222 GTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLR 280
GT + APE + K+D++SFG+ +EL TG + P + L P
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP--- 244
Query: 281 DKKKFTMMADPLLEGQYPRKGLYQALAVA-----GMCLQEDADSRPFMVDVVTALEYLSS 335
P LE K + + + +CLQ+D + RP TA E L
Sbjct: 245 ----------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP------TAAELLRH 288
Query: 336 P 336
Sbjct: 289 K 289
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-31
Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 40/222 (18%)
Query: 63 GEGGYGRVYKGYIEAVDQ-------VVAVKQL-DRSGNQGSREFFAEV-LMLSLVQHQNL 113
GEG +G+V +D+ VAVK L + + + +E+ +M + +H+N+
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 114 VNLIGYCADGDQRILVYEFMSNGSL------------ENHFLDLPPDQEPLDWFTRMKIA 161
+NL+G C ++ E+ S G+L E + +E L + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL--------GPTGGK 213
A+G+EYL A I+RD A N+L+ + K++DFGLA+ T G+
Sbjct: 198 YQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
V + M APE T +SDV+SFGV+L E+ T
Sbjct: 255 LPV--KWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 41/222 (18%)
Query: 63 GEGGYGRVYKGYIEAVD-----QVVAVKQL-DRSGNQGSREFFAEV-LMLSLVQHQNLVN 115
G G +G+V + +D + VAVK L + + + R +E+ +++ + H N+VN
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 116 LIGYCADGDQRILV-YEFMSNGSLENHFL-------------DLPPDQEPLDWFTRMKIA 161
L+G C ++V EF G+L + +L ++ L + +
Sbjct: 96 LLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL--------GPTGGK 213
AKG+E+L A I+RD A NILL + K+ DFGLA+ +
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ + M APE T +SDV+SFGV+L E+ +
Sbjct: 212 LPL--KWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-31
Identities = 47/224 (20%), Positives = 80/224 (35%), Gaps = 22/224 (9%)
Query: 48 ELADATENFNPDCLVGEG--GYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGSREFFAEVL 103
+ ++G+G V + + V V++ L+ N+ E+
Sbjct: 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELH 78
Query: 104 MLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG- 162
+ L H N+V ++ +V FM+ GS DL D + IA
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA----KDLICTHFM-DGMNELAIAYI 133
Query: 163 --GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG-LAKLGPTGGK----DH 215
G K L+Y+H + ++R KAS+IL+ + LS + G +
Sbjct: 134 LQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 216 VSTRVMGTYGYCAPEYAMTGQL--TKKSDVYSFGVVLLELITGR 257
+ + +PE KSD+YS G+ EL G
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 26/205 (12%)
Query: 61 LVGEGGYGRVYKGYIEAVD-QVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNLIG 118
+ GG G +Y V+ + V +K L SG+ ++ AE L+ V H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 119 YCADGDQRI-----LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
+ D+ +V E++ SL+ + L + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGKDHVSTRVMGTYGYCAPEYA 232
+ ++Y D K NI+L E KL D G + G + GT G+ APE
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YLYGTPGFQAPEIV 249
Query: 233 MTGQLTKKSDVYSFGVVLLELITGR 257
T +D+Y+ G L L
Sbjct: 250 -RTGPTVATDIYTVGRTLAALTLDL 273
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 63 GEGGYGRVYKGYIEAVDQ---VVAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLIG 118
G G +G V G ++ + VA+K L + R+F E ++ H N++ L G
Sbjct: 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
++V E+M NGSL + FL Q + + G A G++YL D+
Sbjct: 114 VVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLSDMG--- 167
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG-----YCAPEYAM 233
++RD A NIL+++ K+SDFGL ++ +D G + +PE
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRV----LEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 234 TGQLTKKSDVYSFGVVLLELIT 255
+ T SDV+S+G+VL E+++
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-31
Identities = 57/314 (18%), Positives = 109/314 (34%), Gaps = 68/314 (21%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQN 112
+F P +G GG+G V++ + D A+K++ + +RE EV L+ ++H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 113 LVNLIGYCADGD---------QRILVY---EFMSNGSL-----ENHFLDLPPDQEPLDWF 155
+V + + ++ +Y + +L ++ L F
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 156 TRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL-------- 207
++ A+ +E+LH +++RD K SNI + K+ DFGL
Sbjct: 125 LQI------AEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175
Query: 208 --GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRP 265
T +GT Y +PE + K D++S G++L EL+
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---------- 225
Query: 266 SEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPR--KGLYQALA-VAGMCLQEDADSRPF 322
P ++ + D + ++P Y + L RP
Sbjct: 226 -----------PFSTQMERVRTLTD-VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP- 272
Query: 323 MVDVVTALEYLSSP 336
A+ + +
Sbjct: 273 -----EAINIIENA 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 60/293 (20%), Positives = 106/293 (36%), Gaps = 63/293 (21%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGSREFFAEVLMLSLVQHQNLVNLIG 118
VG G +G V++ + AVK+ L+ + E++ + + +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYG 117
Query: 119 YCADGDQRILVYEFMSNGSLE---NHFLDLPPDQEPL-DWFTRMKIAGGAAKGLEYLHDV 174
+G + E + GSL LP E ++ A +GLEYLH
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYLGQ-----ALEGLEYLHTR 169
Query: 175 ADPPVIYRDFKASNILLDAEFNP-KLSDFGLAK-LGPTGGKDHVSTR--VMGTYGYCAPE 230
+++ D KA N+LL ++ + L DFG A L P G + T + GT + APE
Sbjct: 170 R---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRP-SEEQNL------VTWAKPLLRDKK 283
M K D++S ++L ++ G P ++ + P+
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGC------HPWTQYFRGPLCLKIASEPPPIREIPP 280
Query: 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+ ++ L+++ R +A+E
Sbjct: 281 SCAPLTAQAIQ----------------EGLRKEPVHRA------SAMELRRKV 311
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 52/226 (23%), Positives = 98/226 (43%), Gaps = 17/226 (7%)
Query: 38 KKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE 97
+K+ + D E + +G+G +G+VYK + + A K ++ + +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED 62
Query: 98 FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDL-PPDQEPLDWFT 156
+ E+ +L+ H +V L+G + ++ EF G++ + L
Sbjct: 63 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV----DAIMLELDRGLTEPQ 118
Query: 157 RMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDH 215
+ + L +LH +I+RD KA N+L+ E + +L+DFG+ AK T K
Sbjct: 119 IQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK-- 173
Query: 216 VSTRVMGTYGYCAPEYAMTGQLTK-----KSDVYSFGVVLLELITG 256
+GT + APE M + K+D++S G+ L+E+
Sbjct: 174 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 54/281 (19%)
Query: 15 FKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLV-----GEGGYGR 69
+K + R Q ++ + +Y E E F + L G G +G+
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREY-EYDLKWE-FPRENLEFGKVLGSGAFGK 60
Query: 70 VYKGYIEAVD-----QVVAVKQL-DRSGNQGSREFFAEV-LMLSLVQHQNLVNLIGYCAD 122
V + VAVK L +++ + +E+ +M L H+N+VNL+G C
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120
Query: 123 GDQRILVYEFMSNGSLENHFL--------------------DLPPDQEPLDWFTRMKIAG 162
L++E+ G L ++L + D L + + A
Sbjct: 121 SGPIYLIFEYCCYGDL-LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 163 GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK--------LGPTGGKD 214
AKG+E+L ++RD A N+L+ K+ DFGLA+ + +
Sbjct: 180 QVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
V + M APE G T KSDV+S+G++L E+ +
Sbjct: 237 PV--KWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 48/209 (22%), Positives = 85/209 (40%), Gaps = 36/209 (17%)
Query: 63 GEGGYGRVYKGY---IEAVDQVVAVKQLDRSGNQGSR-EFFAEVLMLSLVQHQNLVNLIG 118
GEG +G VY+G + VAVK + ++ +F +E +++ + H ++V LIG
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
+ + ++ E G L H+L+ + + + K + YL
Sbjct: 81 II-EEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLY--SLQICKAMAYL---ESIN 133
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY------------ 226
++RD NIL+ + KL DFGL+ R + Y
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVTRLPIKW 180
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+PE + T SDV+ F V + E+++
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 61/238 (25%), Positives = 103/238 (43%), Gaps = 48/238 (20%)
Query: 56 FNPDCLV-----GEGGYGRVYKGYIEAVD-----QVVAVKQL-DRSGNQGSREFFAEVLM 104
+ + + GEG +GRV++ + +VAVK L + + +F E +
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 105 LSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFL--------------------- 143
++ + N+V L+G CA G L++E+M+ G L N FL
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 144 DLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203
P PL ++ IA A G+ YL ++ ++RD N L+ K++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 219
Query: 204 LAKLGPT------GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
L++ + G D + R M PE + T +SDV+++GVVL E+ +
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 41/223 (18%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----------------EVLML 105
+G + ++ E ++ A+K+ ++S + R+F E+ ++
Sbjct: 40 NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 106 SLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
+ ++++ + G + D+ ++YE+M N S+ L LD I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNYTCFIPIQVI 153
Query: 166 K--------GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
K Y+H+ + + +RD K SNIL+D KLSDFG ++ +
Sbjct: 154 KCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIK 208
Query: 218 TRVMGTYGYCAPEYAMTGQLT---KKSDVYSFGVVLLELITGR 257
GTY + PE + + + K D++S G+ L +
Sbjct: 209 G-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-30
Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 26/204 (12%)
Query: 63 GEGGYGRVYKGYIEAVDQV---VAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLIG 118
GEG +G V++G + + VA+K + + + +F E L + H ++V LIG
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
+ ++ E + G L FL + L A + L YL
Sbjct: 84 VI-TENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILY--AYQLSTALAYL---ESKR 136
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKL-------GPTGGKDHVSTRVMGTYGYCAPEY 231
++RD A N+L+ + KL DFGL++ + GK + + APE
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK--------WMAPES 188
Query: 232 AMTGQLTKKSDVYSFGVVLLELIT 255
+ T SDV+ FGV + E++
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILM 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-30
Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 30/247 (12%)
Query: 14 SFKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKG 73
S + + + RR ++ + E F+ +GEG YG VYK
Sbjct: 1 SLETVQLRNPPRRQLKKLDED------------SLTKQPEEVFDVLEKLGEGSYGSVYKA 48
Query: 74 YIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133
+ Q+VA+KQ+ +E E+ ++ ++V G +V E+
Sbjct: 49 IHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106
Query: 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAG---GAAKGLEYLHDVADPPVIYRDFKASNIL 190
GS+ D+ + T +IA KGLEYLH + I+RD KA NIL
Sbjct: 107 GAGSV----SDIIRLRNKT--LTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNIL 157
Query: 191 LDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVV 249
L+ E + KL+DFG+ +L T K V+GT + APE +D++S G+
Sbjct: 158 LNTEGHAKLADFGVAGQLTDTMAK---RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGIT 214
Query: 250 LLELITG 256
+E+ G
Sbjct: 215 AIEMAEG 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-30
Identities = 50/200 (25%), Positives = 79/200 (39%), Gaps = 11/200 (5%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGNQGSRE-FFAEVLMLSLVQHQNLVNLI 117
LVG GG G VY+ +++VA+K + S + R E +Q ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
+ Q + ++ L + Q PL + I L+ H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLA----AMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG-- 154
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
+RD K NIL+ A+ L DFG+A + +GT Y APE
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHA 212
Query: 238 TKKSDVYSFGVVLLELITGR 257
T ++D+Y+ VL E +TG
Sbjct: 213 TYRADIYALTCVLYECLTGS 232
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-30
Identities = 59/241 (24%), Positives = 95/241 (39%), Gaps = 43/241 (17%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
+F L+G GG+G+V+K + +K++ + + + EV L+ + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 114 VNLIGYCADGDQRI----------------LVYEFMSNGSL----ENHFLDLPPDQEPLD 153
V+ G D + EF G+L E + L+
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 154 WFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGG 212
F ++ KG++Y+H +I RD K SNI L K+ DFGL L G
Sbjct: 127 LFEQI------TKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV 272
+ TR GT Y +PE + K+ D+Y+ G++L EL+ E
Sbjct: 178 R----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC-----DTAFETSKFF 228
Query: 273 T 273
T
Sbjct: 229 T 229
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 63 GEGGYGRVYKGYIEAVDQV--VAVKQL-DRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY 119
G G +G V +G + VA+K L + + E E ++ + + +V LIG
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
C + +LV E G L + FL ++ + ++ + G++YL +
Sbjct: 405 C-QAEALMLVMEMAGGGPL-HKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKNF 457
Query: 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY--CAPEYAMTGQL 237
++R+ A N+LL K+SDFGL+K + + R G + APE +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPECINFRKF 516
Query: 238 TKKSDVYSFGVVLLELIT 255
+ +SDV+S+GV + E ++
Sbjct: 517 SSRSDVWSYGVTMWEALS 534
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 54/235 (22%), Positives = 90/235 (38%), Gaps = 31/235 (13%)
Query: 37 AKKTPNVFKYQELADATENFNPDCLV-----GEGGYGRVYKGY---IEAVDQVVAVKQL- 87
A+ Y + + + GEG +G V++G E VA+K
Sbjct: 368 AEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK 427
Query: 88 DRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPP 147
+ + + +F E L + H ++V LIG + ++ E + G L FL +
Sbjct: 428 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGEL-RSFLQVRK 485
Query: 148 DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207
L A + L YL ++RD A N+L+ + KL DFGL++
Sbjct: 486 FSLDLASLILY--AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
Query: 208 -------GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ GK + + APE + T SDV+ FGV + E++
Sbjct: 541 MEDSTYYKASKGKLPIK--------WMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL--DRSGNQGSRE-FFAEVLMLSLVQHQNLVNLI 117
+G GG VY ++ VA+K + + + + F EV S + HQN+V++I
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
+ D LV E++ +L + PL T + G+++ HD+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLS----EYIESHGPLSVDTAINFTNQILDGIKHAHDMR-- 131
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
+++RD K NIL+D+ K+ DFG+AK + V+GT Y +PE A
Sbjct: 132 -IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEAT 189
Query: 238 TKKSDVYSFGVVLLELITGR 257
+ +D+YS G+VL E++ G
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 37/303 (12%), Positives = 79/303 (26%), Gaps = 73/303 (24%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS-------REFFAE------------ 101
++G+ + + + V + S E
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 102 ------VLMLSLVQHQNLVNLIGYCADGDQRILVYEF-------MSNGSLENHFLDLPPD 148
+ LV+ +I D ++ F + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 149 QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208
+ L R+++ + L LH +++ + +I+LD L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 209 PTGGKDHVSTRVMGTYGYCAPEY----------AMTGQLTKKSDVYSFGVVLLELITGRS 258
+D S G+ PE +T D ++ G+ + +
Sbjct: 260 ----RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 259 AIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDAD 318
P+ + + ++ + R K LLEG L+ +
Sbjct: 316 ------PNTDDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYPKE 353
Query: 319 SRP 321
R
Sbjct: 354 DRL 356
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 20/214 (9%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLM-----LSLV 108
++ P +G G YG V K Q++AVK++ + N ++ +LM + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK---RLLMDLDISMRTV 63
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168
V G + E M + SL+ + + + + KIA K L
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYC 227
E+LH VI+RD K SN+L++A K+ DFG+ L K G Y
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYM 176
Query: 228 APE----YAMTGQLTKKSDVYSFGVVLLELITGR 257
APE + KSD++S G+ ++EL R
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-29
Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 23/224 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV-LMLSLVQHQNLVNLIGY 119
++ EGG+ VY+ + A+K+L + + +R EV M L H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 120 CADGDQR-------ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
+ G + L+ + G L + + PL T +KI + ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLA---KLGPTGGKDHVSTRVM-------G 222
PP+I+RD K N+LL + KL DFG A P ++
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 223 TYGYCAPE---YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNS 263
T Y PE + +K D+++ G +L L + ++
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 74/288 (25%), Positives = 104/288 (36%), Gaps = 42/288 (14%)
Query: 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLM-- 104
Q + +G G G+V+K V+AVKQ+ RSGN+ E +LM
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK---EENKRILMDL 74
Query: 105 ---LSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIA 161
L +V G + E M + Q P+ K+
Sbjct: 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE----KLKKRMQGPIPERILGKMT 130
Query: 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRV 220
K L YL + VI+RD K SNILLD KL DFG+ +L K R
Sbjct: 131 VAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK----DRS 184
Query: 221 MGTYGYCAPE-----YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ--NLVT 273
G Y APE ++DV+S G+ L+EL TG+ N + E ++
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
Query: 274 WAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
PLL F+ ++ CL +D RP
Sbjct: 245 EEPPLLPGHMGFSGDFQSFVK----------------DCLTKDHRKRP 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 25/212 (11%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNL--VNL 116
+G GG +V++ E Q+ A+K ++ + E+ L+ +Q + + L
Sbjct: 35 QIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
Y +V E N L N +L ++ +D + R + + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDL-NSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG- 147
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE------ 230
+++ D K +N L+ + KL DFG+A V +GT Y PE
Sbjct: 148 --IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 231 -----YAMTGQLTKKSDVYSFGVVLLELITGR 257
+++ KSDV+S G +L + G+
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 25/212 (11%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNL--VNL 116
+G GG +V++ E Q+ A+K ++ NQ + E+ L+ +Q + + L
Sbjct: 16 QIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
Y +V E N L N +L ++ +D + R + + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDL-NSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG- 128
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE------ 230
+++ D K +N L+ + KL DFG+A V +GT Y PE
Sbjct: 129 --IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 231 -----YAMTGQLTKKSDVYSFGVVLLELITGR 257
+++ KSDV+S G +L + G+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 39/319 (12%), Positives = 86/319 (26%), Gaps = 80/319 (25%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE----------------------- 97
++G+ + + + V + S
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 98 -----FFAEVLMLSLVQHQNLVNLIGYCADGD--QRILVYEFM--SNGSLENHFLDLPPD 148
F ++ Q + ++ + D R +Y M + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 149 QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208
+ L R+++ + L LH +++ + +I+LD L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 209 PTGGKDHVSTRVMGTYGYCAPEYAMT-----------GQLTKKSDVYSFGVVLLELITGR 257
+D + G+ PE +T D ++ G+V+ +
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 258 SAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDA 317
P + + ++ + R K LLEG L+
Sbjct: 311 ------LPITKDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYPK 348
Query: 318 DSRPFMVDVVTALEYLSSP 336
+ R L+ + +P
Sbjct: 349 EDRL------LPLQAMETP 361
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 19/214 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLM-----LSLV 108
E+ +G G YG V K + Q++AVK++ + ++ + ++LM +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE---KEQKQLLMDLDVVMRSS 78
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168
+V G + E MS + + + + KI K L
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYC 227
+L + + +I+RD K SNILLD N KL DFG+ +L + K TR G Y
Sbjct: 139 NHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYM 192
Query: 228 APE----YAMTGQLTKKSDVYSFGVVLLELITGR 257
APE A +SDV+S G+ L EL TGR
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 40/237 (16%), Positives = 71/237 (29%), Gaps = 20/237 (8%)
Query: 38 KKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGY-----IEAVDQVVAVKQLDRSGN 92
K P + E ++ L+GEG + +VY+ Q +K +
Sbjct: 49 CKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP 108
Query: 93 QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHF-LDLPPDQEP 151
+ L + + +LV E S G+L N L ++
Sbjct: 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168
Query: 152 LDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL-----------DAEFNPKLS 200
+ + A +E +HD +I+ D K N +L D L
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225
Query: 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
D G + K + T T G+ E + D + + ++ G
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-28
Identities = 70/224 (31%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLS- 106
L D F LVG G YG+VYKG Q+ A+K +D +G E E+ ML
Sbjct: 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKK 76
Query: 107 LVQHQNLVNLIG------YCADGDQRILVYEFMSNGSLENHFLDL--PPDQEPLDWFTRM 158
H+N+ G DQ LV EF GS+ DL L
Sbjct: 77 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----TDLIKNTKGNTLKEEWIA 132
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVS 217
I +GL +LH VI+RD K N+LL KL DFG+ A+L T G+
Sbjct: 133 YICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR---R 186
Query: 218 TRVMGTYGYCAPEYAMTGQLTK-----KSDVYSFGVVLLELITG 256
+GT + APE + KSD++S G+ +E+ G
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF-FAEVLMLSLVQHQN 112
++F +G G G V+K + V+A K + R E+ +L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 113 LVNLIG-YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL 171
+V G + +DG+ I E M GSL+ + + K++ KGL YL
Sbjct: 93 IVGFYGAFYSDGEISI-CMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPE 230
+ +++RD K SNIL+++ KL DFG++ +L + V GT Y +PE
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPE 200
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGR 257
+ +SD++S G+ L+E+ GR
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNLI---- 117
G GG+G V + + + VA+KQ + + +RE + E+ ++ + H N+V+
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 118 --GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
A D +L E+ G L +L+ + L + + L YLH+
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRK-YLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 176 DPPVIYRDFKASNILLDAEFNP---KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
+I+RD K NI+L K+ D G AK G + V GT Y APE
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFV-GTLQYLAPELL 195
Query: 233 MTGQLTKKSDVYSFGVVLLELITGR 257
+ T D +SFG + E ITG
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 24/276 (8%), Positives = 54/276 (19%), Gaps = 43/276 (15%)
Query: 17 DKRRSSKQRRIAAEIRKFGKAKKTPN--VFKYQELADATENFNPDCLVGEGGYGRVYKGY 74
R + AA + N L+ + G V+
Sbjct: 23 GYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVR 82
Query: 75 IEAVDQVVAVKQLDRSGNQGSRE---FFAEVLMLSLVQHQNLVNLIGYC----------- 120
+ A+K E + + ++
Sbjct: 83 DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142
Query: 121 ---------------ADGDQRILVYEFM--SNGSLENHFLDLPPDQEPLDWFTRMKIAGG 163
+L+ L + + + +
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQ 202
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
+ L +++ F N+ + + L D T G
Sbjct: 203 LIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SSVP 254
Query: 224 YGYCAPEYAM--TGQLTKKSDVYSFGVVLLELITGR 257
Y E+ T T + + G+ + +
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 51/201 (25%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS----GNQGSREFFAEVLMLSLVQHQNLVNL 116
+G+G +G VY + ++A+K L ++ + EV + S ++H N++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRL 74
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
GY D + L+ E+ G++ + +L + + T A L Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTV---YRELQKLSKFDEQRTA-TYITELANALSYCHSKR- 129
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
VI+RD K N+LL + K++DFG + P+ + + GT Y PE
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---D-LCGTLDYLPPEMIEGRM 183
Query: 237 LTKKSDVYSFGVVLLELITGR 257
+K D++S GV+ E + G+
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGK 204
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 25/212 (11%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNL--VNL 116
+G GG +V++ E Q+ A+K ++ NQ + E+ L+ +Q + + L
Sbjct: 63 QIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
Y +V E N L N +L ++ +D + R + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDL-NSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG- 175
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE------ 230
+++ D K +N L+ + KL DFG+A V +G Y PE
Sbjct: 176 --IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 231 -----YAMTGQLTKKSDVYSFGVVLLELITGR 257
+++ KSDV+S G +L + G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL--DRSGNQGSRE-FFAEVLMLSLVQHQNLVNL- 116
++G GG V+ + VAVK L D + + F E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 117 -IGYCADGDQRILVY---EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
G A+ L Y E++ +L D+ + P+ +++ A + L + H
Sbjct: 79 DTG-EAETPAGPLPYIVMEYVDGVTLR----DIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST-RVMGTYGYCAPEY 231
+I+RD K +NI++ A K+ DFG+A+ G T V+GT Y +PE
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 232 AMTGQLTKKSDVYSFGVVLLELITGR 257
A + +SDVYS G VL E++TG
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 50/202 (24%), Positives = 87/202 (43%), Gaps = 18/202 (8%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS----GNQGSREFFAEVLMLSLVQHQNLVNL 116
+G+G +G VY + ++A+K L +S + E+ + S ++H N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRM 79
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
Y D + L+ EF G L + +L + + + A L Y H+
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGEL---YKELQKHGRFDEQRSATFMEE-LADALHYCHERK- 134
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAPEYAMTG 235
VI+RD K N+L+ + K++DFG + P+ R M GT Y PE
Sbjct: 135 --VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIEGK 187
Query: 236 QLTKKSDVYSFGVVLLELITGR 257
+K D++ GV+ E + G
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGM 209
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSRE-FFAEVLMLSLVQHQNLVNLI 117
+G+GG+ + ++ +V A K + +S RE E+ + + HQ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G+ D D +V E SL EP R + G +YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQ-IVLGCQYLHRNR-- 161
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAPEYAMTGQ 236
VI+RD K N+ L+ + K+ DFGLA G+ +V+ GT Y APE
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKG 217
Query: 237 LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT 273
+ + DV+S G ++ L+ G+ P E L
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKP------PFETSCLKE 248
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 20/217 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSRE-FFAEVLMLSLVQHQNLVNLI 117
+G+GG+ + ++ +V A K + +S RE E+ + + HQ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
G+ D D +V E SL EP R + G +YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQ-IVLGCQYLHRNR-- 135
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
VI+RD K N+ L+ + K+ DFGLA K+ G + V GT Y APE
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKG 191
Query: 237 LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT 273
+ + DV+S G ++ L+ G+ P E L
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKP------PFETSCLKE 222
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 49/308 (15%), Positives = 103/308 (33%), Gaps = 60/308 (19%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVD-QVVAVKQLDR--SGNQGSREFFAEV-LMLSLV 108
T F+ +G G +G V+K ++ +D + A+K+ + +G+ + EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKC-VKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168
QH ++V A+ D ++ E+ + GSL + + + +GL
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNP-------------------KLSDFGLAKLGP 209
Y+H ++ +++ D K SNI + P K+ D G
Sbjct: 129 RYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-- 183
Query: 210 TGGKDHVSTRVMGTYGYCAPE-YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE 268
G + A E K+D+++ + ++ N
Sbjct: 184 ---ISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236
Query: 269 QNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328
W + +R + P + + + + + + D + RP +
Sbjct: 237 -----WHE--IRQGRL------PRIPQVLSQ----EFTELLKVMIHPDPERRP------S 273
Query: 329 ALEYLSSP 336
A+ +
Sbjct: 274 AMALVKHS 281
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-26
Identities = 45/219 (20%), Positives = 84/219 (38%), Gaps = 22/219 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQN 112
+ ++G+G V++G + + A+K + + E +L + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 113 LVNLIGYCADGDQR--ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
+V L + R +L+ EF GSL L+ P + L + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 171 LHDVADPPVIYRDFKASNILL----DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
L + +++R+ K NI+ D + KL+DFG A+ + + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLY-GTEEY 181
Query: 227 CAPE--------YAMTGQLTKKSDVYSFGVVLLELITGR 257
P+ + D++S GV TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 65/257 (25%), Positives = 100/257 (38%), Gaps = 22/257 (8%)
Query: 8 KADHSLSFKDKRRSSKQRRIA-AEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGG 66
H Q + + K P+V + D + F+ +G G
Sbjct: 7 HHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGS 66
Query: 67 YGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFF---AEVLMLSLVQHQNLVNLIGYCADG 123
+G VY +VVA+K++ SG Q + ++ EV L ++H N + G
Sbjct: 67 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126
Query: 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRD 183
LV E+ + + L ++PL + GA +GL YLH +I+RD
Sbjct: 127 HTAWLVMEYCLGSASD----LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 179
Query: 184 FKASNILLDAEFNPKLSDFGL-AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT---K 239
KA NILL KL DFG + + P +GT + APE +
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDG 232
Query: 240 KSDVYSFGVVLLELITG 256
K DV+S G+ +EL
Sbjct: 233 KVDVWSLGITCIELAER 249
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 45/219 (20%), Positives = 84/219 (38%), Gaps = 22/219 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQN 112
+ ++G+G V++G + + A+K + + E +L + H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 113 LVNLIGYCADGDQR--ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
+V L + R +L+ EF GSL L+ P + L + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYT-VLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 171 LHDVADPPVIYRDFKASNILL----DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
L + +++R+ K NI+ D + KL+DFG A+ + + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLY-GTEEY 181
Query: 227 CAPE--------YAMTGQLTKKSDVYSFGVVLLELITGR 257
P+ + D++S GV TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 21/212 (9%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV-LMLSLVQHQNL 113
+F P ++G G G + + ++ VAVK++ + EV L+ +H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADR---EVQLLRESDEHPNV 80
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
+ D + + E + +L+ + L+ T ++ GL +LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHS 136
Query: 174 VADPPVIYRDFKASNILL-----DAEFNPKLSDFGLAK-LGPTGGKDHVSTRVMGTYGYC 227
+ +++RD K NIL+ + +SDFGL K L + V GT G+
Sbjct: 137 LN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 228 APEY---AMTGQLTKKSDVYSFGVVLLELITG 256
APE T D++S G V +I+
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 54/212 (25%), Positives = 84/212 (39%), Gaps = 39/212 (18%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSRE-FFAEVLMLSLVQHQNLVNLIGY 119
G+G + VY+ VA+K +D+ G + EV + ++H +++ L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA-------------AK 166
D + LV E NG + +K
Sbjct: 80 FEDSNYVYLVLEMCHNGEM----------------NRYLKNRVKPFSENEARHFMHQIIT 123
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA-KLGPTGGKDHVSTRVMGTYG 225
G+ YLH +++RD SN+LL N K++DFGLA +L K + GT
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPN 177
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
Y +PE A +SDV+S G + L+ GR
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 16/212 (7%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQH 110
+ F ++G GG+G V+ ++A ++ A K+L++ +G + E +L+ V
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 111 QNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFT--RMKI-AGGAAK 166
+ +V+L Y + + LV M+ G + H + E F R
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYH---IYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
GLE+LH +IYRD K N+LLD + N ++SD GLA G GT G+
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYA-GTPGF 355
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
APE + + D ++ GV L E+I R
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARG 387
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 58/256 (22%), Positives = 95/256 (37%), Gaps = 40/256 (15%)
Query: 19 RRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAV 78
+ G + TP +F + +E + +G G YG V +
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 79 DQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNG 136
A+K + ++ + + EV +L L+ H N++ L + D LV E G
Sbjct: 62 HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 137 SLENHFLDLPPDQEPLDWFTRMKIAG-----GAAK-------GLEYLHDVADPPVIYRDF 184
L F + AA G+ YLH +++RD
Sbjct: 122 EL----------------FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDL 162
Query: 185 KASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKS 241
K N+LL + + K+ DFGL+ + +GT Y APE + + +K
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPE-VLRKKYDEKC 218
Query: 242 DVYSFGVVLLELITGR 257
DV+S GV+L L+ G
Sbjct: 219 DVWSIGVILFILLAGY 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQH 110
F ++G+GG+G V + A ++ A K+L++ +G E +L V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 111 QNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFT--RMKI-AGGAAK 166
+ +V+L Y + + LV M+ G L+ H F R A
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHI-----YHMGQAGFPEARAVFYAAEICC 297
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
GLE LH ++YRD K NILLD + ++SD GLA P G + RV GT GY
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GTVGY 351
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
APE + T D ++ G +L E+I G+S
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-23
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 34/219 (15%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQH 110
E+F ++GEG + V A + A+K L++ + E ++S + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG----GAAK 166
V L D ++ + NG L ++ G +
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGEL----------------LKYIRKIGSFDETCTR 133
Query: 167 --------GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
LEYLH +I+RD K NILL+ + + +++DFG AK+ K +
Sbjct: 134 FYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 219 RVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
+GT Y +PE K SD+++ G ++ +L+ G
Sbjct: 191 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 9e-23
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 41/238 (17%)
Query: 38 KKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE 97
TP +F A ++ + ++G+G +G V + Q AVK + + + +
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 98 ---FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDW 154
EV +L + H N++ L + D LV E + G L
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL---------------- 113
Query: 155 FTRMKIAG-----GAAK-------GLEYLHDVADPPVIYRDFKASNILL---DAEFNPKL 199
F + AA+ G+ Y+H +++RD K N+LL + N ++
Sbjct: 114 FDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI 170
Query: 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
DFGL+ +GT Y APE + G +K DV+S GV+L L++G
Sbjct: 171 IDFGLSTHFEAS---KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 2e-22
Identities = 71/261 (27%), Positives = 104/261 (39%), Gaps = 34/261 (13%)
Query: 7 CKADHSLSFKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGG 66
C+ F+ S K R T N F + +G GG
Sbjct: 154 CQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRI------------IGRGG 201
Query: 67 YGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQN---LVNLIGYC 120
+G VY ++ A+K LD+ QG E +MLSLV + +V + Y
Sbjct: 202 FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YA 260
Query: 121 ADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI-AGGAAKGLEYLHDVADPP 178
++ + + M+ G L H E M+ A GLE++H+
Sbjct: 261 FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEHMHNRF--- 312
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL- 237
V+YRD K +NILLD + ++SD GLA K V GT+GY APE G
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASV-GTHGYMAPEVLQKGVAY 368
Query: 238 TKKSDVYSFGVVLLELITGRS 258
+D +S G +L +L+ G S
Sbjct: 369 DSSADWFSLGCMLFKLLRGHS 389
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 60/250 (24%), Positives = 96/250 (38%), Gaps = 51/250 (20%)
Query: 36 KAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS 95
P ++ ++ E++ +G G YG V + A+K + +S
Sbjct: 18 GIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKG 77
Query: 96 R-------------EFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHF 142
R E + E+ +L + H N++ L D LV EF G L
Sbjct: 78 RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL---- 133
Query: 143 LDLPPDQEPLDWFTRMKIAG-----GAAK-------GLEYLHDVADPPVIYRDFKASNIL 190
F ++ AA G+ YLH +++RD K NIL
Sbjct: 134 ------------FEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENIL 178
Query: 191 L---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFG 247
L ++ N K+ DFGL+ KD+ +GT Y APE + + +K DV+S G
Sbjct: 179 LENKNSLLNIKIVDFGLSSF---FSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCG 234
Query: 248 VVLLELITGR 257
V++ L+ G
Sbjct: 235 VIMYILLCGY 244
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 6e-22
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNLIGY 119
+GEG YG V ++ VAVK +D E E+ + ++ H+N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 120 CADGDQRILVYEFMSNGSLENHFLD---LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
+G+ + L E+ S G L + +P + +F ++ +A G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-DAQRFFHQL-MA-----GVVYLHGIG- 125
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE------ 230
+ +RD K N+LLD N K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGR 257
+ + DV+S G+VL ++ G
Sbjct: 184 FH--A---EPVDVWSCGIVLTAMLAGE 205
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 57/339 (16%), Positives = 103/339 (30%), Gaps = 51/339 (15%)
Query: 15 FKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGY 74
F+ K + IR + V + + E+ K
Sbjct: 23 FEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82
Query: 75 IEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL--VYEF 132
E + + + D + S V + + + + L +
Sbjct: 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQL 142
Query: 133 MSNGSL-----ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKAS 187
+L L+ L F ++ A+ +E+LH +++RD K S
Sbjct: 143 CRKENLKDWMNRRCSLEDREHGVCLHIFIQI------AEAVEFLHS---KGLMHRDLKPS 193
Query: 188 NILLDAEFNPKLSDFGLAK----------LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
NI + K+ DFGL + T +GT Y +PE
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253
Query: 238 TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQY 297
+ K D++S G++L EL+ S E ++T +R KF L +Y
Sbjct: 254 SHKVDIFSLGLILFELLYSFST-----QMERVRIIT----DVR-NLKF----PLLFTQKY 299
Query: 298 PRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
P+ + + L RP A + + +
Sbjct: 300 PQ--EHMMVQ---DMLSPSPTERP------EATDIIENA 327
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 18/83 (21%), Positives = 34/83 (40%), Gaps = 1/83 (1%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQN 112
+F P +G GG+G V++ + D A+K++ + +RE EV L+ ++H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 113 LVNLIGYCADGDQRILVYEFMSN 135
+V + E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEI 88
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNLIGY 119
+GEG YG V ++ VAVK +D E E+ + ++ H+N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 120 CADGDQRILVYEFMSNGSLENHFLD---LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
+G+ + L E+ S G L + +P + +F ++ +A G+ YLH +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-DAQRFFHQL-MA-----GVVYLHGIG- 125
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE------ 230
+ +RD K N+LLD N K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGR 257
+ + DV+S G+VL ++ G
Sbjct: 184 FH--A---EPVDVWSCGIVLTAMLAGE 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 30/213 (14%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS----GNQGSREFFAEVLMLSLVQHQNLVNL 116
L+GEG YG+V + AVK L + G E+ +L ++H+N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 117 --IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK-------- 166
+ Y + + +V E+ G QE LD + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGM-----------QEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
GLEYLH ++++D K N+LL K+S G+A+ D G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 227 CAPEYAMTGQL--TKKSDVYSFGVVLLELITGR 257
PE A K D++S GV L + TG
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 19/231 (8%)
Query: 38 KKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGS 95
P K +++ E+F ++G G +G V ++ D+V A+K L++ +
Sbjct: 58 WAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE 117
Query: 96 REFF-AEVLMLSLVQHQNLVNLIGYCA--DGDQRILVYEFMSNGSLENHFLDLPPDQEPL 152
F E +L + + L + A D + LV ++ G L L D+ P
Sbjct: 118 TACFREERDVLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTL-LSKFEDRLPE 174
Query: 153 DWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212
+ R +A ++ +H + ++RD K NIL+D + +L+DFG G
Sbjct: 175 EM-ARFYLAE-MVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229
Query: 213 KDHVSTRVMGTYGYCAPE-----YAMTGQLTKKSDVYSFGVVLLELITGRS 258
S V GT Y +PE G+ + D +S GV + E++ G +
Sbjct: 230 TVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-21
Identities = 54/206 (26%), Positives = 83/206 (40%), Gaps = 25/206 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNLIGYC 120
+G G +G V+ + +K +++ +Q E AE+ +L + H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK-------GLEYLHD 173
D +V E G L + Q + A+ L Y H
Sbjct: 90 EDYHNMYIVMETCEGGEL---LERIVSAQARGKALSEGY----VAELMKQMMNALAYFHS 142
Query: 174 VADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
V+++D K NIL K+ DFGLA+L D ST GT Y APE
Sbjct: 143 QH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPE 196
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITG 256
+T K D++S GVV+ L+TG
Sbjct: 197 -VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 47/228 (20%), Positives = 82/228 (35%), Gaps = 36/228 (15%)
Query: 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV-LMLSLVQHQNLV 114
+ ++G G G V + VAVK++ + E+ L+ H N++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVI 72
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG---GAAKGLEYL 171
+ E N +L++ E L A G+ +L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 172 HDVADPPVIYRDFKASNILLDAE-------------FNPKLSDFGLAKL---GPTGGKDH 215
H + +I+RD K NIL+ +SDFGL K G + + +
Sbjct: 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 216 VSTRVMGTYGYCAPE-------YAMTGQLTKKSDVYSFGVVLLELITG 256
++ GT G+ APE +LT+ D++S G V +++
Sbjct: 189 LNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-20
Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 28/209 (13%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRS--------GNQGSREFFAEVLMLSLVQHQNLV 114
G G +G V+ + ++ V VK + + + + E+ +LS V+H N++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 115 NLIGYCADGDQRILVYEFMSNGS-LENHFLDLPPDQEPLDWFTRMK---IAGGAAKGLEY 170
++ + LV E +G L P EPL + + Y
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL---ASYIFRQLVSA----VGY 145
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
L +I+RD K NI++ +F KL DFG A G + GT YCAPE
Sbjct: 146 LRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPE 199
Query: 231 YAMTGQL--TKKSDVYSFGVVLLELITGR 257
+ G + +++S GV L L+
Sbjct: 200 -VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 55/250 (22%), Positives = 102/250 (40%), Gaps = 28/250 (11%)
Query: 22 SKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQV 81
++ + +A ++ P V + +E+ ++F ++G G + V ++ QV
Sbjct: 34 AQDKYVADFLQWA-----EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88
Query: 82 VAVKQLDRSG----NQGSREFFAEVLMLSLVQHQNLVNLIGYCA--DGDQRILVYEFMSN 135
A+K +++ + S F E +L + + L + A D + LV E+
Sbjct: 89 YAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQL--HFAFQDENYLYLVMEYYVG 145
Query: 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF 195
G L L ++ P + R +A ++ +H + ++RD K NILLD
Sbjct: 146 GDLLTL-LSKFGERIPAEM-ARFYLAE-IVMAIDSVHRLG---YVHRDIKPDNILLDRCG 199
Query: 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE-------YAMTGQLTKKSDVYSFGV 248
+ +L+DFG G V GT Y +PE TG + D ++ GV
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258
Query: 249 VLLELITGRS 258
E+ G++
Sbjct: 259 FAYEMFYGQT 268
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 40/212 (18%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
G+G +G V K Q AVK ++++ N+ + EV +L + H N++ L
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG-----GAAK-------GL 168
D +V E + G L F + AA+ G+
Sbjct: 91 EDSSSFYIVGELYTGGEL----------------FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 169 EYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
Y+H +++RD K NILL + + + K+ DFGL+ ++ +GT
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAY 188
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
Y APE + G +K DV+S GV+L L++G
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
G+G + +V + VA+K +D++ ++ F EV ++ ++ H N+V L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 121 ADGDQRILVYEFMSNGSL-----ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
L+ E+ S G + + + ++E F ++ ++Y H
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGRM---KEKEARSKFRQI------VSAVQYCHQKR 134
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG 235
+++RD KA N+LLDA+ N K++DFG + GGK G Y APE G
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPE-LFQG 187
Query: 236 QL--TKKSDVYSFGVVLLELITGR 257
+ + DV+S GV+L L++G
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-20
Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 51/231 (22%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA---------------------- 100
G+G YG V Y E + A+K L + F
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 101 ----EVLMLSLVQHQNLVNL--IGYCADGDQRILVYEFMSNGSLENHFLDLP-----PDQ 149
E+ +L + H N+V L + + D +V+E ++ G + +++P +
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSED 137
Query: 150 EPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209
+ +F + I G+EYLH +I+RD K SN+L+ + + K++DFG++
Sbjct: 138 QARFYF-QDLIK-----GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-F 187
Query: 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLT---KKSDVYSFGVVLLELITGR 257
G +S V GT + APE + K DV++ GV L + G+
Sbjct: 188 KGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-19
Identities = 46/204 (22%), Positives = 75/204 (36%), Gaps = 38/204 (18%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V + A K++ + + F E+ ++ + H N++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG-----GAAK-------GLE 169
D LV E + G L F R+ AA+ +
Sbjct: 77 DNTDIYLVMELCTGGEL----------------FERVVHKRVFRESDAARIMKDVLSAVA 120
Query: 170 YLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
Y H + V +RD K N L + KL DFGLA G + +GT Y
Sbjct: 121 YCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYY 174
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVL 250
+P+ + G + D +S GV++
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 38/203 (18%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G G + V+ ++ A+K + +S E+ +L ++H+N+V L
Sbjct: 18 GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77
Query: 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG-----AAK-------GLEY 170
LV + +S G L F R+ G A+ ++Y
Sbjct: 78 TTHYYLVMQLVSGGEL----------------FDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 171 LHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
LH+ +++RD K N+L + ++DFGL+K+ ++ + + GT GY
Sbjct: 122 LHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYV 174
Query: 228 APEYAMTGQLTKKSDVYSFGVVL 250
APE +K D +S GV+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVIT 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 54/260 (20%), Positives = 108/260 (41%), Gaps = 24/260 (9%)
Query: 5 HCCKADHSLSFKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGE 64
H D + + + +I K K P K + + ++ +G
Sbjct: 7 HHHHGSKVRGKYDGPKINDYDKFYEDIWK--KYVPQPVEVKQGSV---YDYYDILEELGS 61
Query: 65 GGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD 124
G +G V++ +A +V K ++ E+ +++ + H L+NL D
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA---AKGLEYLHDVADPPVIY 181
+ +L+ EF+S G L F + + + ++ +GL+++H+ + +++
Sbjct: 122 EMVLILEFLSGGEL---FDRIAAEDYK---MSEAEVINYMRQACEGLKHMHEHS---IVH 172
Query: 182 RDFKASNILLDAEFNP--KLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
D K NI+ + + K+ DFGLA KL P D + T + APE +
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNP----DEIVKVTTATAEFAAPEIVDREPVG 228
Query: 239 KKSDVYSFGVVLLELITGRS 258
+D+++ GV+ L++G S
Sbjct: 229 FYTDMWAIGVLGYVLLSGLS 248
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 17/211 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQH 110
F L+G+G +G+V +A + A+K L + E E +L +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 111 QNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI-AGGAAKGL 168
L L Y R+ V E+ + G L H E R + L
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSAL 261
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYC 227
+YLH + V+YRD K N++LD + + K++DFGL K G G + + GT Y
Sbjct: 262 DYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYL 316
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
APE + D + GVV+ E++ GR
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 347
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 54/269 (20%), Positives = 87/269 (32%), Gaps = 50/269 (18%)
Query: 36 KAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS----G 91
+ + F+ L + + ++ +G+G YG V + A+K ++++
Sbjct: 8 SSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI 67
Query: 92 NQGSRE-FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL------ENHFLD 144
N E EV ++ + H N+ L D LV E G L
Sbjct: 68 NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDST 127
Query: 145 LPPDQEPLDWFTRMKIAGG-----------------------AAK-------GLEYLHDV 174
+ + + L YLH+
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ 187
Query: 175 ADPPVIYRDFKASNILL--DAEFNPKLSDFGLAKL--GPTGGKDHVSTRVMGTYGYCAPE 230
+ +RD K N L + F KL DFGL+K G+ + T GT + APE
Sbjct: 188 G---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
Query: 231 --YAMTGQLTKKSDVYSFGVVLLELITGR 257
K D +S GV+L L+ G
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-19
Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 22/254 (8%)
Query: 9 ADHSLSFKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYG 68
+ + + K + S + +A F K +TP+ Q + F+ +G G +G
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQ-----LDQFDRIKTLGTGSFG 55
Query: 69 RVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQHQNLVNLIGYCADGDQ 125
RV + A+K LD+ ++ E +L V LV L D
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFK 185
+V E+++ G + +H + EP F A EYLH + +IYRD K
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARF----YAAQIVLTFEYLHSLD---LIYRDLK 168
Query: 186 ASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYCAPEYAMTGQLTKKSDVY 244
N+L+D + +++DFG AK + T + GT APE ++ K D +
Sbjct: 169 PENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWW 222
Query: 245 SFGVVLLELITGRS 258
+ GV++ E+ G
Sbjct: 223 ALGVLIYEMAAGYP 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 4e-19
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA--EVLMLSLVQHQ 111
E + LVGEG YG V K + ++VA+K+ S + + A E+ +L ++H+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 112 NLVNLIGYCADGDQRILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168
NLVNL+ C + LV+EF+ + LE L + + I G+
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQV--VQKYLFQII-----NGI 137
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK---DHVSTRVMGTYG 225
+ H +I+RD K NIL+ KL DFG A+ G+ D V+TR
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----W 189
Query: 226 YCAPEYAM-TGQLTKKSDVYSFGVVLLELITGR 257
Y APE + + K DV++ G ++ E+ G
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-19
Identities = 52/263 (19%), Positives = 91/263 (34%), Gaps = 51/263 (19%)
Query: 16 KDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYI 75
+ ++ + + E F + + + + ++P ++G G V +
Sbjct: 56 AEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVH 115
Query: 76 EAVDQVVAVKQLDRSGNQGSREFFAEVL---------MLSLVQHQNLVNLIGYCADGDQR 126
A AVK ++ + + S E EV + + H +++ LI
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175
Query: 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG------AAK-------GLEYLHD 173
LV++ M G L F + + +LH
Sbjct: 176 FLVFDLMRKGEL----------------FDYL-TEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE--- 230
+++RD K NILLD +LSDFG + G K + GT GY APE
Sbjct: 219 NN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELC-GTPGYLAPEILK 272
Query: 231 ---YAMTGQLTKKSDVYSFGVVL 250
K+ D+++ GV+L
Sbjct: 273 CSMDETHPGYGKEVDLWACGVIL 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 5e-19
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA--EVLMLSLVQHQ 111
E + +GEG YG V+K Q+VA+K+ S + + A E+ ML ++H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 112 NLVNLIGYCADGDQRILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168
NLVNL+ + LV+E+ + L+ + +P + T + + +
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL--VKSITWQTL-----QAV 115
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK---DHVSTRVMGTYG 225
+ H I+RD K NIL+ KL DFG A+L D V+TR
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----W 167
Query: 226 YCAPE-------YAMTGQLTKKSDVYSFGVVLLELITGR 257
Y +PE Y DV++ G V EL++G
Sbjct: 168 YRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-19
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 54 ENFNPDCLVGEGGYGRVY---KGYIEAVDQVVAVKQLDRS---GNQGSREF-FAEVLMLS 106
E F ++G+GGYG+V+ K ++ A+K L ++ N AE +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 107 LVQHQNLVNLIGYCADGDQRI-LVYEFMSNGSL------ENHFLDLPPDQEPLDWFTRMK 159
V+H +V+LI Y ++ L+ E++S G L E F E
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIF------MED-----TAC 124
Query: 160 I-AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVST 218
+ L +LH +IYRD K NI+L+ + + KL+DFGL K G T
Sbjct: 125 FYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---VT 178
Query: 219 RVM-GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
GT Y APE M + D +S G ++ +++TG
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 6e-19
Identities = 54/253 (21%), Positives = 97/253 (38%), Gaps = 23/253 (9%)
Query: 16 KDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNP----DCLVGEGGYGRVY 71
D++ + + + Q + ++ +G G +G V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 72 KGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131
+ A A K + E+ +S+++H LVNL D ++ +++YE
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA---AKGLEYLHDVADPPVIYRDFKASN 188
FMS G L F + + + + KGL ++H+ ++ D K N
Sbjct: 235 FMSGGEL---FEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPEN 285
Query: 189 ILLDAEFNP--KLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYS 245
I+ + + KL DFGL L P GT + APE A + +D++S
Sbjct: 286 IMFTTKRSNELKLIDFGLTAHLDP----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 246 FGVVLLELITGRS 258
GV+ L++G S
Sbjct: 342 VGVLSYILLSGLS 354
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-19
Identities = 51/218 (23%), Positives = 83/218 (38%), Gaps = 40/218 (18%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS------GNQGSREFFAEVLMLSLV----QH 110
L+G+GG+G V+ G+ VA+K + R+ S EV +L V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFT---RM------KIA 161
++ L+ + + +LV E Q+ D+ T +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA------------QDLFDYITEKGPLGEGPSRCFF 145
Query: 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP-KLSDFGLAKLGPTGGKDHVSTRV 220
G +++ H V++RD K NIL+D KL DFG L
Sbjct: 146 GQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDFD-- 199
Query: 221 MGTYGYCAPEYAMTGQLT-KKSDVYSFGVVLLELITGR 257
GT Y PE+ Q + V+S G++L +++ G
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 8e-19
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 54 ENFNPDCLVGEGGYGRVY---KGYIEAVDQVVAVKQL--DRSGNQGSREFFAEVLMLSLV 108
F ++G+G +G+V+ K Q+ A+K L + E +L V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 109 QHQNLVNLIGYCADGDQRI-LVYEFMSNGSL------ENHFLDLPPDQEPLDWFTRMKI- 160
H +V L Y + ++ L+ +F+ G L E F E +K
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT------EE-----DVKFY 131
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A L++LH + +IYRD K NILLD E + KL+DFGL+K K
Sbjct: 132 LAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYS 185
Query: 221 M-GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
GT Y APE T+ +D +SFGV++ E++TG
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 40/205 (19%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
G+G +G V K Q AVK ++++ N+ + EV +L + H N++ L
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL 90
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG-----GAAK-------GL 168
D +V E + G L F + AA+ G+
Sbjct: 91 EDSSSFYIVGELYTGGEL----------------FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 169 EYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
Y+H +++RD K NILL + + + K+ DFGL+ ++ +GT
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAY 188
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVL 250
Y APE + G +K DV+S GV+L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 52/249 (20%), Positives = 94/249 (37%), Gaps = 46/249 (18%)
Query: 37 AKKTPNVFKYQELADATENFNPDCL---------VGEGGYGRVYKGYIEAVDQVVAVKQL 87
+ VF + +L ++ P L +G G G V + + VA++ +
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168
Query: 88 DRSGNQGSRE--------FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL- 138
+ E+ +L + H ++ + + D + +V E M G L
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELF 227
Query: 139 -----ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA 193
+ +F +M ++YLH+ +I+RD K N+LL +
Sbjct: 228 DKVVGNKRL----KEATCKLYFYQM------LLAVQYLHENG---IIHRDLKPENVLLSS 274
Query: 194 EFNP---KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE---YAMTGQLTKKSDVYSFG 247
+ K++DFG +K+ G + T GT Y APE T + D +S G
Sbjct: 275 QEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 248 VVLLELITG 256
V+L ++G
Sbjct: 332 VILFICLSG 340
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSRE-FFAEVLMLSLVQHQNLVNLIGY 119
G G +G+V G + VAVK L+R + E+ L L +H +++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 120 CADGDQRILVYEFMSNGSLENHFLD---LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
+ +V E++S G L ++ + E F + ++ ++Y H
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-EARRLF-QQILS-----AVDYCHRHM- 131
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE------ 230
V++RD K N+LLDA N K++DFGL+ + G S G+ Y APE
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 186
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGR 257
YA G + D++S GV+L L+ G
Sbjct: 187 YA--GP---EVDIWSCGVILYALLCGT 208
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 63/276 (22%), Positives = 120/276 (43%), Gaps = 44/276 (15%)
Query: 4 FHCCKADHSLSFKDKRRSSKQRRIAAEIRKFGKAK-KTPNVFKYQELADAT----ENFNP 58
++C + + + KQ ++ + + +K K N F E+ D+T + +
Sbjct: 7 YYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQN 66
Query: 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---------FAEVLMLSLVQ 109
+G G G V Y +D+ VA+K+L SR F + E++++ V
Sbjct: 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVN 119
Query: 110 HQNLVNLIG-YCADGDQR-----ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG 163
H+N+++L+ + LV E M + + + D E + + +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYLLYQML--- 174
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK--DHVSTRVM 221
G+++LH A +I+RD K SNI++ ++ K+ DFGLA+ T +V TR
Sbjct: 175 --CGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 228
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
Y APE + + D++S G ++ E++ +
Sbjct: 229 ----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 48/216 (22%), Positives = 84/216 (38%), Gaps = 38/216 (17%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRS------GNQGSREFFAEVLMLSLVQHQ--N 112
L+G GG+G VY G + + VA+K +++ EV++L V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFT---RM------KIAGG 163
++ L+ + D +L+ E P Q+ D+ T +
Sbjct: 110 VIRLLDWFERPDSFVLILERPE------------PVQDLFDFITERGALQEELARSFFWQ 157
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGLAKLGPTGGKDHVSTRVMG 222
+ + + H+ V++RD K NIL+D KL DFG L G
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDFD---G 210
Query: 223 TYGYCAPEYAMTGQLT-KKSDVYSFGVVLLELITGR 257
T Y PE+ + + + V+S G++L +++ G
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 60/248 (24%), Positives = 102/248 (41%), Gaps = 31/248 (12%)
Query: 23 KQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVV 82
K + I + ++ + K ++L E++ ++G G +G V ++ +V
Sbjct: 43 KNKNIDNFLSRY-----KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVY 97
Query: 83 AVKQLDRSG----NQGSREFFAEVLMLSLVQHQNLVNLIGYCA--DGDQRILVYEFMSNG 136
A+K L + + + F+ E +++ +V L + A D +V E+M G
Sbjct: 98 AMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGG 154
Query: 137 SLENHF--LDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE 194
L N D+P R A L+ +H + I+RD K N+LLD
Sbjct: 155 DLVNLMSNYDVPEKW------ARFYTAEVVL-ALDAIHSMG---FIHRDVKPDNMLLDKS 204
Query: 195 FNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE----YAMTGQLTKKSDVYSFGVVL 250
+ KL+DFG G T V GT Y +PE G ++ D +S GV L
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 263
Query: 251 LELITGRS 258
E++ G +
Sbjct: 264 YEMLVGDT 271
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 53/204 (25%), Positives = 77/204 (37%), Gaps = 40/204 (19%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G G Y + +A + AVK +D+S + E ++L QH N++ L D
Sbjct: 31 GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLKDVYDD 87
Query: 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG-----AAK-------GLEY 170
G +V E M G L ++ A+ +EY
Sbjct: 88 GKYVYVVTELMKGGEL----------------LDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 171 LHDVADPPVIYRDFKASNILL-DAEFNP---KLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
LH V++RD K SNIL D NP ++ DFG AK + T T +
Sbjct: 132 LHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG-LLMTPC-YTANF 186
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVL 250
APE D++S GV+L
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLL 210
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 4e-18
Identities = 62/275 (22%), Positives = 98/275 (35%), Gaps = 78/275 (28%)
Query: 56 FNPDCLV-----GEGGYGRVYKGYIEAVDQ-----VVAVKQL-DRSGNQGSREFFAEV-L 103
F D L G G +G+V + +D+ VAVK L + + + R +E+ +
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 104 MLSLVQHQNLVNLIG--------------YCADGD------------------------- 124
++ + H N+VNL+G +C G+
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
Query: 125 -----------QRILVYEFMSNGS-------------LENHFLDLPPDQEPLDWFTRMKI 160
+R L S S +E ++ L +
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
+ AKG+E+L A I+RD A NILL + K+ DFGLA+
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 221 MGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT 255
+ APE T +SDV+SFGV+L E+ +
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 45/214 (21%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV-LMLSLVQHQNLVNLIGYCA 121
GEG + RV Q AVK +++ F EV ++ H+N++ LI +
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG-----AAK-------GLE 169
+ D+ LV+E M GS+ + + A+ L+
Sbjct: 82 EEDRFYLVFEKMRGGSI----------------LSHIHKRRHFNELEASVVVQDVASALD 125
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNP---KLSDFGLAK-LGPTGGKDHVSTRVM---- 221
+LH+ + +RD K NIL + K+ DF L + G +ST +
Sbjct: 126 FLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 222 GTYGYCAPE--YAMTGQLT---KKSDVYSFGVVL 250
G+ Y APE A + + + K+ D++S GV+L
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-18
Identities = 50/238 (21%), Positives = 93/238 (39%), Gaps = 35/238 (14%)
Query: 38 KKTPNVFKYQELADATENFN------PDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG 91
P F ++ + N ++G G +G+V+K A +A K + G
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG 126
Query: 92 NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL------ENHFLDL 145
+ E E+ +++ + H NL+ L + +LV E++ G L E++
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--- 183
Query: 146 PPDQEPLDWFTRMKIAGGA---AKGLEYLHDVADPPVIYRDFKASNILLDAEFNP--KLS 200
T + +G+ ++H + +++ D K NIL K+
Sbjct: 184 ---------LTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKII 231
Query: 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
DFGLA+ GT + APE ++ +D++S GV+ L++G S
Sbjct: 232 DFGLARR---YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 7e-18
Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQHQNLVNLI 117
+G+G +G+V ++ A+K +++ E F E+ ++ ++H LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFT--RMKI-AGGAAKGLEYLHDV 174
D + +V + + G L H Q F +K+ L+YL +
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVH--FKEETVKLFICELVMALDYLQNQ 134
Query: 175 ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
+I+RD K NILLD + ++DF +A + P + T + GT Y APE +
Sbjct: 135 R---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSS 188
Query: 235 GQL---TKKSDVYSFGVVLLELITGRS 258
+ + D +S GV EL+ GR
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 54 ENFNPDCLVGEGGYGRVY---KGYIEAVDQVVAVKQLDRS---GNQGSREF-FAEVLMLS 106
ENF ++G G YG+V+ K ++ A+K L ++ + E E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 107 LVQHQN-LVNLIGYCADGDQRI-LVYEFMSNGSL------ENHFLDLPPDQEPLDWFTRM 158
++ LV L Y + ++ L+ ++++ G L F E +
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERF------TEH-----EV 161
Query: 159 KI-AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
+I G LE+LH + +IYRD K NILLD+ + L+DFGL+K +
Sbjct: 162 QIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 218 TRVMGTYGYCAPEYAMTGQL--TKKSDVYSFGVVLLELITGRS 258
GT Y AP+ G K D +S GV++ EL+TG S
Sbjct: 219 DFC-GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 260
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 59 DCLVGEGGYGRVYKGYIEAV--DQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNL 116
C VG G YG VYK + D+ A+KQ++ +G S E+ +L ++H N+++L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISL 83
Query: 117 IG-YCADGDQRI-LVYEFM---------SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
+ + D+++ L++++ + + + + + + + +
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL----- 138
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNP----KLSDFGLAKL--GPTGGKDHVSTR 219
G+ YLH V++RD K +NIL+ E K++D G A+L P +
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 220 VMGTYGYCAPE-------YAMTGQLTKKSDVYSFGVVLLELITGR 257
V+ T+ Y APE Y TK D+++ G + EL+T
Sbjct: 196 VV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 40/204 (19%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV-LMLSLVQHQNLVNLIGYCA 121
GEG + K + +Q AVK + + +++ E+ + H N+V L
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVFH 76
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG-----AAK-------GLE 169
D LV E ++ G L F R+K A+ +
Sbjct: 77 DQLHTFLVMELLNGGEL----------------FERIKKKKHFSETEASYIMRKLVSAVS 120
Query: 170 YLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
++HDV V++RD K N+L + K+ DFG A+L P + + T T Y
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKTPC-FTLHY 175
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVL 250
APE + D++S GV+L
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVIL 199
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-17
Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSRE-FFAEVLMLSLVQHQNLVNLIGY 119
G G +G+V G E VAVK L+R + E+ L L +H +++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 120 CADGDQRILVYEFMSNGSLENHFLD---LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
+ +V E++S G L ++ L E F + ++ G++Y H
Sbjct: 85 ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-ESRRLF-QQILS-----GVDYCHRHM- 136
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE------ 230
V++RD K N+LLDA N K++DFGL+ + G S G+ Y APE
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 191
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGR 257
YA G + D++S GV+L L+ G
Sbjct: 192 YA--GP---EVDIWSSGVILYALLCGT 213
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-17
Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 57/229 (24%)
Query: 54 ENFNPDCLVGEGGYGRVY------KGYIEAV-----DQVVAVKQLDRSGNQGSREFFAEV 102
++F +G G +GRV+ G A+ + VV +KQ++ + E
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT--------NDER 57
Query: 103 LMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG 162
LMLS+V H ++ + G D Q ++ +++ G L F+ ++ +
Sbjct: 58 LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----------------FSLLRKSQ 101
Query: 163 ----GAAK--------GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210
AK LEYLH +IYRD K NILLD + K++DFG AK P
Sbjct: 102 RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 211 GGKDHVSTRVM-GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
T + GT Y APE T K D +SFG+++ E++ G +
Sbjct: 159 ------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 201
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 45/233 (19%), Positives = 83/233 (35%), Gaps = 39/233 (16%)
Query: 35 GKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG 94
G+ + F ++N++ +G+G + V + + A K ++
Sbjct: 10 GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA 69
Query: 95 SRE--FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPL 152
E + +QH N+V L + LV++ ++ G L
Sbjct: 70 RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-------------- 115
Query: 153 DWFTRMKIAGG-----AAK-------GLEYLHDVADPPVIYRDFKASNILLDAEFNP--- 197
F + A+ + Y H +++R+ K N+LL ++
Sbjct: 116 --FEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV 170
Query: 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVL 250
KL+DFGLA GT GY +PE +K D+++ GV+L
Sbjct: 171 KLADFGLAIEVNDSEA--WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLVQHQNLVNL 116
+G+G +G V+K Q VA+K++ N+ +E F E+ +L L++H+N+VNL
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV-LMENE--KEGFPITALREIKILQLLKHENVVNL 81
Query: 117 IGYCADGDQRI--------LVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
I C LV++F + G L N + + + +M +
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQMLL----- 134
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL--GPTGGKDHVSTRVMGT 223
GL Y+H +++RD KA+N+L+ + KL+DFGLA+ + + T + T
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 224 YGYCAPEYAM-TGQLTKKSDVYSFGVVLLELITGR 257
Y PE + D++ G ++ E+ T
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 44/265 (16%), Positives = 78/265 (29%), Gaps = 54/265 (20%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQHQNLVNLI 117
G + ++ A+D+ VA+ +D G +E + L LS + + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADP 177
++V E++ GSL+ D P P+ ++ A + H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ-EVADTSPS--PVG---AIRAMQSLAAAADAAHRA--- 148
Query: 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
V S + + S G L
Sbjct: 149 GVALSIDHPSRVRV--------SIDGDVVLA--------------YPATMPDA------- 179
Query: 238 TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQY 297
+ D+ G L L+ R P E + + P RD A +E
Sbjct: 180 NPQDDIRGIGASLYALLVNR------WPLPEAGVRSGLAPAERD------TAGQPIEPAD 227
Query: 298 PRKGLYQAL-AVAGMCLQEDADSRP 321
+ + + AVA +Q D R
Sbjct: 228 IDRDIPFQISAVAARSVQGDGGIRS 252
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 26/209 (12%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR------EFFAEVLMLSLVQHQNLVNL 116
G G + V K ++ A K + + ++ SR E EV +L V H N++ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA---AKGLEYLHD 173
+ +L+ E +S G L F L + + + G+ YLH
Sbjct: 81 HDVYENRTDVVLILELVSGGEL---FDFLAQK----ESLSEEEATSFIKQILDGVNYLHT 133
Query: 174 VADPPVIYRDFKASNILLDAEFNP----KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
+ + D K NI+L + P KL DFGLA G + + GT + AP
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAP 187
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRS 258
E L ++D++S GV+ L++G S
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 48/203 (23%), Positives = 81/203 (39%), Gaps = 27/203 (13%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR-----EFFAEVLMLSLVQHQNLVNLI 117
G+G + V + Q AVK +D + S + E + +++H ++V L+
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK-------GLEY 170
+ +V+EFM L ++ + ++ A+ L Y
Sbjct: 93 ETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAV----ASHYMRQILEALRY 145
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNP---KLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
HD +I+RD K +LL ++ N KL FG+A G V+ +GT +
Sbjct: 146 CHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFM 200
Query: 228 APEYAMTGQLTKKSDVYSFGVVL 250
APE K DV+ GV+L
Sbjct: 201 APEVVKREPYGKPVDVWGCGVIL 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS-----REFFAEVLMLSLV 108
E + +GEG Y VYKG + D +VA+K++ +G+ RE V +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDL 57
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
+H N+V L LV+E++ L++ + + F +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN--VKLFLFQLL----- 110
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
+GL Y H V++RD K N+L++ KL+DFGLA+ + T
Sbjct: 111 RGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLW 165
Query: 226 YCAPEYAM-TGQLTKKSDVYSFGVVLLELITGR 257
Y P+ + + + + D++ G + E+ TGR
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-17
Identities = 51/223 (22%), Positives = 83/223 (37%), Gaps = 44/223 (19%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE---------FFAEV- 102
EN+ P ++G G V + + + AVK +D +G EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 103 LMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRM---- 158
++ + H N++ L LV++ M G L D+ T
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLS 122
Query: 159 -KIAGGAAK----GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213
K + + LH + +++RD K NILLD + N KL+DFG +
Sbjct: 123 EKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPG 177
Query: 214 DHVSTRVMGTYGYCAPE------YAMTGQLTKKSDVYSFGVVL 250
+ + GT Y APE K+ D++S GV++
Sbjct: 178 EKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 5e-17
Identities = 42/205 (20%), Positives = 73/205 (35%), Gaps = 39/205 (19%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE--FFAEVLMLSLVQHQNLVNLIGYC 120
G+G + V + + A K ++ E + +QH N+V L
Sbjct: 15 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 74
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG-----AAK-------GL 168
+ LV++ ++ G L F + A+ +
Sbjct: 75 QEESFHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCIQQILESI 118
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNP---KLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
Y H +++R+ K N+LL ++ KL+DFGLA GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFA-GTPG 172
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVL 250
Y +PE +K D+++ GV+L
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 37/213 (17%), Positives = 84/213 (39%), Gaps = 40/213 (18%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G V++ + + K + G E+ +L++ +H+N+++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG------AAK-------GL 168
++ ++++EF+S + F R+ + L
Sbjct: 72 SMEELVMIFEFISGLDI----------------FERINTSAFELNEREIVSYVHQVCEAL 115
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNP--KLSDFGLA-KLGPTGGKDHVSTRVMGTYG 225
++LH + + D + NI+ + K+ +FG A +L P +
Sbjct: 116 QFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP----GDNFRLLFTAPE 168
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
Y APE ++ +D++S G ++ L++G +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-17
Identities = 51/233 (21%), Positives = 89/233 (38%), Gaps = 48/233 (20%)
Query: 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR------EFFAEVL 103
+ +++ +G G + V K + + A K + + SR E EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 104 MLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG 163
+L ++H N++ L + +L+ E +S G L F +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----------------FDFL-AEKE 103
Query: 164 ------AAK-------GLEYLHDVADPPVIYRDFKASNILLDAEFNP----KLSDFGLAK 206
A + G+ YLH + + D K NI+L + P KL DFG+A
Sbjct: 104 SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
Query: 207 -LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
+ + + GT + APE L ++D++S GV+ L++G S
Sbjct: 161 KIEA----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-17
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGNQGSREFFAEVLMLSLVQHQNLVNLIG- 118
+G G G V Y +++ VA+K+L R ++ + E++++ V H+N++ L+
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 119 YCADGDQRI-----LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
+ +V E M +L + + D E + + + G+++LH
Sbjct: 93 FTPQKSLEEFQDVYIVMELMDA-NL-CQVIQMELDHERMSYLLYQML-----CGIKHLHS 145
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK--DHVSTRVMGTYGYCAPEY 231
A +I+RD K SNI++ ++ K+ DFGLA+ T +V TR Y APE
Sbjct: 146 -AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEV 197
Query: 232 AMTGQLTKKSDVYSFGVVLLELITGR 257
+ + D++S G ++ E+I G
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 18/211 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQH 110
+F+ L+G+G +G+V +A + A+K L + E E +L +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 111 QNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI-AGGAAKGL 168
L L Y R+ V E+ + G L H E R + L
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGAEIVSAL 118
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGYC 227
EYLH V+YRD K N++LD + + K++DFGL K G + G + + GT Y
Sbjct: 119 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYL 172
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
APE + D + GVV+ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-17
Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 28/199 (14%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV-LMLSLVQHQNLVNLIGYCA 121
G G G+V + + Q A+K L S + EV ++V ++
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYE 92
Query: 122 DGDQRI----LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA---AKGLEYLHDV 174
+ ++ E M G L + + FT + A +++LH
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQ-----ERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 175 ADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
+ +RD K N+L + + KL+DFG AK + T T Y APE
Sbjct: 148 N---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPC-YTPYYVAPEV 200
Query: 232 AMTGQLTKKSDVYSFGVVL 250
+ K D++S GV++
Sbjct: 201 LGPEKYDKSCDMWSLGVIM 219
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY-C 120
+G G +G VY+ + ++VA+K++ Q R E+ ++ + H N+V L +
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 121 ADGDQRI-----LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA---------- 165
+ G+++ LV +++ + ++R K
Sbjct: 118 SSGEKKDEVYLNLVLDYVP--------ETV---YRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNP-KLSDFGLAKLGPTGGK--DHVSTRVMG 222
+ L Y+H + +RD K N+LLD + KL DFG AK G ++ +R
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 220
Query: 223 TYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
Y Y APE T DV+S G VL EL+ G+
Sbjct: 221 -Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLV 108
E + VGEG YG VYK ++ ++VA+K++ R + E E+ +L +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRI-RLDAE--DEGIPSTAIREISLLKEL 76
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
H N+V+LI LV+EFM L+ + L Q + + +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQ--IKIYLYQLL----- 129
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
+G+ + H +++RD K N+L++++ KL+DFGLA+ G T + T
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA--FGIPVRSYTHEVVTLW 184
Query: 226 YCAPEYAM-TGQLTKKSDVYSFGVVLLELITGR 257
Y AP+ M + + + D++S G + E+ITG+
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 8e-17
Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 28/210 (13%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR------EFFAEVLMLSLVQHQNLVNL 116
G G + V K ++ A K + + ++ SR E EV +L V H N++ L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA---AKGLEYLHD 173
+ +L+ E +S G L F L + + + G+ YLH
Sbjct: 81 HDVYENRTDVVLILELVSGGEL---FDFLAQK----ESLSEEEATSFIKQILDGVNYLHT 133
Query: 174 VADPPVIYRDFKASNILLDAEFNP----KLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCA 228
+ + D K NI+L + P KL DFGLA ++ + GT + A
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED----GVEFKNIFGTPEFVA 186
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
PE L ++D++S GV+ L++G S
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGAS 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 53/215 (24%), Positives = 81/215 (37%), Gaps = 48/215 (22%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122
G G +G + ++VAVK ++R E++ ++H N+V
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVILT 87
Query: 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG-----AAK-------GLEY 170
++ E+ S G L + R+ AG A G+ Y
Sbjct: 88 PTHLAIIMEYASGGEL----------------YERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNP--KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCA 228
H + + +RD K N LLD P K+ DFG +K + + V GT Y A
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIA 185
Query: 229 PE------YAMTGQLTKKSDVYSFGVVLLELITGR 257
PE Y G K +DV+S GV L ++ G
Sbjct: 186 PEVLLRQEYD--G---KIADVWSCGVTLYVMLVGA 215
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGNQGSREFFAEVLMLSLVQH 110
+ + VG G YG V + + VA+K+L R ++ + E+L+L +QH
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 111 QNLVNLI-----GYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA 164
+N++ L+ LV FM + + L +E + + +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM--QTDLQKIMGLKFSEEKIQYLVYQML---- 136
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
KGL+Y+H A V++RD K N+ ++ + K+ DFGLA+ +V TR
Sbjct: 137 -KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW---- 188
Query: 225 GYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
Y APE ++ + D++S G ++ E++TG+
Sbjct: 189 -YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQL---------DRSGNQGSREFFAEVLM 104
+FN ++G+G +G+V + D++ AVK L D + A
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-- 398
Query: 105 LSLVQHQNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG 163
+ L L C R+ V E+++ G L H + +EP F A
Sbjct: 399 ---GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF----YAAE 450
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-G 222
A GL +L +IYRD K N++LD+E + K++DFG+ K G +T+ G
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCG 504
Query: 223 TYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
T Y APE K D ++FGV+L E++ G++
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 540
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLV 108
+ + +GEG YG V+K ++VA+K++ R + E E+ +L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDD--DEGVPSSALREICLLKEL 58
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
+H+N+V L + LV+EF ++ DL P+ + F +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI--VKSFLFQLL----- 111
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
KGL + H V++RD K N+L++ KL++FGLA+ G + + T
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA--FGIPVRCYSAEVVTLW 166
Query: 226 YCAPEYAM-TGQLTKKSDVYSFGVVLLELITGRSAI 260
Y P+ + D++S G + EL +
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 31/207 (14%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAEVLMLSLVQHQNLVNLIGY 119
GEG +G+V Q VA+K + R + S E+ L L++H +++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 120 CADGDQRILVYEFMSNGSLENHFLD---LPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
++V E+ + G L ++ ++ + D E +F + I +EY H
Sbjct: 78 ITTPTDIVMVIEY-AGGELFDYIVEKKRMTED-EGRRFF-QQIICA-----IEYCHRHK- 128
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE------ 230
+++RD K N+LLD N K++DFGL+ + G S G+ Y APE
Sbjct: 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVINGKL 183
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGR 257
YA G + DV+S G+VL ++ GR
Sbjct: 184 YA--GP---EVDVWSCGIVLYVMLVGR 205
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 37/219 (16%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLV 108
E ++ +GEG YG VYK + A+K++ R + E E+ +L +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKA-QNNYGETFALKKI-RLEKE--DEGIPSTTIREISILKEL 57
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
+H N+V L + +LV+E + L+ L F +
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT--AKSFLLQLL----- 110
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
G+ Y HD V++RD K N+L++ E K++DFGLA+ G T + T
Sbjct: 111 NGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA--FGIPVRKYTHEIVTLW 165
Query: 226 YCAPE-------YAMTGQLTKKSDVYSFGVVLLELITGR 257
Y AP+ Y + D++S G + E++ G
Sbjct: 166 YRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 48/205 (23%), Positives = 84/205 (40%), Gaps = 39/205 (19%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
+G G VY+ + + A+K L ++ ++ + E+ +L + H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG-----AAK-------GL 168
+ LV E ++ G L F R+ G AA +
Sbjct: 118 ETPTEISLVLELVTGGEL----------------FDRIVEKGYYSERDAADAVKQILEAV 161
Query: 169 EYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
YLH+ +++RD K N+L + K++DFGL+K+ + T GT G
Sbjct: 162 AYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVC-GTPG 215
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVL 250
YCAPE + D++S G++
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 30/223 (13%)
Query: 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQL----DRSGNQGS-----REFFAEV 102
AT + P +G G YG VYK VA+K + G G RE A +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV-ALL 65
Query: 103 LMLSLVQHQNLVNLI----GYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLD---W 154
L +H N+V L+ D + ++ LV+E + L + PP P +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 155 FTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD 214
R + +GL++LH +++RD K NIL+ + KL+DFGLA+ +
Sbjct: 125 LMRQFL-----RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQM 174
Query: 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
++ V+ T Y APE + D++S G + E+ +
Sbjct: 175 ALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 28/210 (13%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR------EFFAEVLMLSLVQHQNLVNL 116
G G + V K ++ A K + + + SR + EV +L +QH N++ L
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA---AKGLEYLHD 173
+ IL+ E ++ G L F L + T + G+ YLH
Sbjct: 80 HEVYENKTDVILILELVAGGEL---FDFLAEK----ESLTEEEATEFLKQILNGVYYLHS 132
Query: 174 VADPPVIYRDFKASNILLDAEFNP----KLSDFGLA-KLGPTGGKDHVSTRVMGTYGYCA 228
+ + + D K NI+L P K+ DFGLA K+ + + GT + A
Sbjct: 133 LQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF----GNEFKNIFGTPEFVA 185
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
PE L ++D++S GV+ L++G S
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGAS 215
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLD--RSGNQGSREFFAEVLMLSLVQHQ-NLVNLIGY 119
G G + V + ++ Q A K L R G E E+ +L L + ++NL
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA---AKGLEYLHDVAD 176
+ + IL+ E+ + G + + L E + + + +G+ YLH
Sbjct: 98 YENTSEIILILEYAAGGEIFSLCLP-----ELAEMVSENDVIRLIKQILEGVYYLHQNN- 151
Query: 177 PPVIYRDFKASNILL---DAEFNPKLSDFGLAK-LGPTGGKDHVSTRVMGTYGYCAPEYA 232
+++ D K NILL + K+ DFG+++ +G +MGT Y APE
Sbjct: 152 --IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH----ACELREIMGTPEYLAPEIL 205
Query: 233 MTGQLTKKSDVYSFGVVLLELITGRS 258
+T +D+++ G++ L+T S
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTS 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 45/214 (21%), Positives = 79/214 (36%), Gaps = 49/214 (22%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE--------FFAEVLMLSLVQHQNLV 114
G G G V + + VA+K + + E+ +L + H ++
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 115 NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG-----AAK--- 166
+ + D + +V E M G L F ++
Sbjct: 79 KIKNFF-DAEDYYIVLELMEGGEL----------------FDKVVGNKRLKEATCKLYFY 121
Query: 167 ----GLEYLHDVADPPVIYRDFKASNILLDAEFNP---KLSDFGLAKLGPTGGKDHVSTR 219
++YLH+ +I+RD K N+LL ++ K++DFG +K+ G+ +
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRT 175
Query: 220 VMGTYGYCAPE---YAMTGQLTKKSDVYSFGVVL 250
+ GT Y APE T + D +S GV+L
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 48/247 (19%), Positives = 90/247 (36%), Gaps = 36/247 (14%)
Query: 15 FKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGY 74
Q+ ++ + KK + Y+ + ++G G G+V + +
Sbjct: 32 PAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIF 82
Query: 75 IEAVDQVVAVKQLDRSGNQGSREFFAEV-LMLSLVQHQNLVNLIGYCADGDQRI----LV 129
+ + A+K L + EV L Q ++V ++ + +V
Sbjct: 83 NKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137
Query: 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA---AKGLEYLHDVADPPVIYRDFKA 186
E + G L + FT + + + ++YLH + + +RD K
Sbjct: 138 MECLDGGELFSRIQ-----DRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKP 189
Query: 187 SNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDV 243
N+L KL+DFG AK + ++T T Y APE + K D+
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDM 246
Query: 244 YSFGVVL 250
+S GV++
Sbjct: 247 WSLGVIM 253
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 52/236 (22%), Positives = 84/236 (35%), Gaps = 56/236 (23%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVD---QVVAVKQLDR--SGNQGSREF--------- 98
+ + G YG V VD VA+K++ S +
Sbjct: 21 QSPYTVQRFISSGSYGAVCA----GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 99 FAEVLMLSLVQHQNLVNL----IGYCADGDQRI-LVYEFMSNGSLENHFLDL----PPDQ 149
E+ +L+ H N++ L + + ++ LV E M DL +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT--------DLAQVIHDQR 128
Query: 150 EPLD-----WFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204
+ +F + GL LH+ A V++RD NILL + + DF L
Sbjct: 129 IVISPQHIQYFMYHIL-----LGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNL 180
Query: 205 AKLGPTGGK--DHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGR 257
A+ +V+ R Y APE M TK D++S G V+ E+ +
Sbjct: 181 AREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 18/153 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLVQHQNLVNL 116
+GEG + VYK + +Q+VA+K++ +++ E+ +L + H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 117 IGYCADGDQRILVYEFMSN---GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
+ LV++FM ++++ L L P + + M + +GLEYLH
Sbjct: 78 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH--IKAYMLMTL-----QGLEYLHQ 130
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206
+++RD K +N+LLD KL+DFGLAK
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 7e-16
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAE--VLMLSLV 108
+F+ ++G+G +G+V +A + AVK L + +E +E VL+ + V
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-V 96
Query: 109 QHQNLVNLIGYCADGDQRI-LVYEFMSNGSL------ENHFLDLPPDQEPLDWFTRMKI- 160
+H LV L + ++ V ++++ G L E FL EP R +
Sbjct: 97 KHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL------EP-----RARFY 144
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A A L YLH + ++YRD K NILLD++ + L+DFGL K +T
Sbjct: 145 AAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTST 198
Query: 221 M-GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
GT Y APE + D + G VL E++ G
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 41/205 (20%), Positives = 76/205 (37%), Gaps = 38/205 (18%)
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLD-RSGNQGSRE-FFAEVLMLSLVQHQNLVNLIGYC 120
G+G + V + Q A ++ + + + E + L++H N+V L
Sbjct: 20 GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI 79
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG-----AAK-------GL 168
++ L+++ ++ G L F + A+ +
Sbjct: 80 SEEGHHYLIFDLVTGGEL----------------FEDIVAREYYSEADASHCIQQILEAV 123
Query: 169 EYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
+ H + V++R+ K N+LL KL+DFGLA + GT G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPG 178
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVL 250
Y +PE K D+++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 54 ENFNPDCLVGEGGYGRVYKGY-IEAVDQVVAVKQL----DRSG--NQGSREFFAEVLMLS 106
+ + +GEG YG+V+K ++ + VA+K++ G RE A + L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLE 69
Query: 107 LVQHQNLVNLI----GYCADGDQRI-LVYEFMSN---GSLENH-FLDLPPDQEPLDWFTR 157
+H N+V L D + ++ LV+E + L+ +P + +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET--IKDMMF 127
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
+ +GL++LH V++RD K NIL+ + KL+DFGLA+ + ++
Sbjct: 128 QLL-----RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALT 177
Query: 218 TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
+ V+ T Y APE + D++S G + E+ +
Sbjct: 178 SVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREF---FAE--VLMLSLV 108
E+F ++G+G +G+V+ + +Q A+K L + + E VL L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-W 75
Query: 109 QHQNLVNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
+H L ++ + + V E+++ G L H F A G
Sbjct: 76 EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF----YAAEIILG 130
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYGY 226
L++LH ++YRD K NILLD + + K++DFG+ K G T GT Y
Sbjct: 131 LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCGTPDY 184
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
APE + + D +SFGV+L E++ G+S
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 216
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-15
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS-----REFFAEVLML 105
++ F +G G Y VYKG + VA+K++ +G+ RE + ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLM 57
Query: 106 SLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
++H+N+V L ++ LV+EFM N L+ ++D +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDN-DLK-KYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 166 ---KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL--GPTGGKDHVSTRV 220
+GL + H+ +++RD K N+L++ KL DFGLA+ P S+ V
Sbjct: 116 QLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN---TFSSEV 169
Query: 221 MGTYGYCAPE-------YAMTGQLTKKSDVYSFGVVLLELITGR 257
+ T Y AP+ Y + D++S G +L E+ITG+
Sbjct: 170 V-TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 7/93 (7%)
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYG 225
GL +L +IYRD K N++LD+E + K++DFG+ K G +T+ GT
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPD 186
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
Y APE K D ++FGV+L E++ G++
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 48/212 (22%), Positives = 87/212 (41%), Gaps = 37/212 (17%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLML-SLVQHQNLVNLIGYC 120
+G G Y V++ ++ V VK L ++ E+ +L +L N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 121 ADGDQR--ILVYEFMSNGSLENHFLDLPPDQ------EPLDWFTRMKIAGGAAKGLEYLH 172
D R LV+E ++N + + L E L K L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 173 DVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKLGPTGGK--DHVSTRVMGTYGYCAP 229
+ +++RD K N+++D E +L D+GLA+ G + V++R + P
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 230 EYAMTGQL-TKKSDVYSFGVVLLELITGRSAI 260
E + Q+ D++S G +L +I +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-15
Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 28/217 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLV 108
+ + +GEG YG VYK ++ VA+K++ R ++ E EV +L +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHE--EEGVPGTAIREVSLLKEL 90
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLD--WFTRMKIAGGAAK 166
QH+N++ L + L++E+ N L+ ++D PD F I
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLK-KYMDKNPDVSMRVIKSFLYQLI-----N 143
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNP-----KLSDFGLAKLGPTGGKDHVSTRVM 221
G+ + H ++RD K N+LL K+ DFGLA+ G T +
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEI 198
Query: 222 GTYGYCAPEYAM-TGQLTKKSDVYSFGVVLLELITGR 257
T Y PE + + + D++S + E++
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGNQGSREFFAEVLMLSLV 108
+ + VG G YG V VA+K+L R ++ + E+ +L +
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 81
Query: 109 QHQNLVNLIG-YCADGDQRI-----LVYEFMSNGSLENHFLDLPP--DQEPLDWFTRMKI 160
+H+N++ L+ + D LV FM DL E L +
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--------DLGKLMKHEKLGEDRIQFL 133
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
KGL Y+H A +I+RD K N+ ++ + K+ DFGLA+ + +V TR
Sbjct: 134 VYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW 190
Query: 221 MGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
Y APE + T+ D++S G ++ E+ITG+
Sbjct: 191 -----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 4e-15
Identities = 55/233 (23%), Positives = 91/233 (39%), Gaps = 53/233 (22%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQ--LDRSGNQGSREFFAEVLMLSLVQH 110
+ F + + G+G +G V G ++ VA+K+ D +RE + L+++ H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNREL-QIMQDLAVLHH 78
Query: 111 QNLVNL--IGYCADGDQR-----ILVYEFMS------NGSLENHFLDLPPD-------QE 150
N+V L Y R +V E++ + + PP Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ- 137
Query: 151 PLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP-KLSDFGLAK-LG 208
+ + LH + V +RD K N+L++ KL DFG AK L
Sbjct: 138 -------------LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 209 PTGGKDHVS---TRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
P + +V+ +R Y Y APE Q T D++S G + E++ G
Sbjct: 184 P--SEPNVAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 7e-15
Identities = 35/93 (37%), Positives = 48/93 (51%), Gaps = 7/93 (7%)
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYG 225
L +LHD +IYRD K N+LLD E + KL+DFG+ K G G +T GT
Sbjct: 136 ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATFCGTPD 189
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
Y APE D ++ GV+L E++ G +
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHA 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 8e-15
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYG 225
L YLH+ +IYRD K N+LLD+E + KL+D+G+ K G G +T GT
Sbjct: 122 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPN 175
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
Y APE D ++ GV++ E++ GRS
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 9e-15
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 37/212 (17%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDR--SGNQGSREFFAEVLMLSLVQHQNLVNLI-- 117
VG G YG V + VAVK+L R ++ + E+ +L ++H+N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 118 ---GYCADGDQRI-LVYEFMSNGSLENHFLDL-------PPDQEPLDWFTRMKIAGGAAK 166
+ + LV M DL + + + + +
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHVQFLIYQIL-----R 143
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY 226
GL+Y+H AD +I+RD K SN+ ++ + K+ DFGLA+ +V+TR Y
Sbjct: 144 GLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----Y 195
Query: 227 CAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
APE + + D++S G ++ EL+TGR
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM-GTYG 225
L YLH+ +IYRD K N+LLD+E + KL+D+G+ K G G +T GT
Sbjct: 165 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPN 218
Query: 226 YCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
Y APE D ++ GV++ E++ GRS
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 53/234 (22%), Positives = 97/234 (41%), Gaps = 59/234 (25%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG-SREFFAEVLMLSLVQHQ 111
+ +GEG YG V Y VA+K++ +Q + E+ +L +H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 112 NLVNLIG----YCADGDQRI-LVYEFM---------SNGSLENHF-------LDLPPDQE 150
N++ + + + + +V + M + +H L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL------- 138
Query: 151 PLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210
+GL+Y+H A+ V++RD K SN+LL+ + K+ DFGLA++
Sbjct: 139 ---------------RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 211 GGK------DHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
++V+TR Y APE + + TK D++S G +L E+++ R
Sbjct: 181 DHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 56/238 (23%), Positives = 101/238 (42%), Gaps = 60/238 (25%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSL 107
+ +F L+GEG YG V + ++VA+K+++ FA E+ +L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP----LFALRTLREIKILKH 65
Query: 108 VQHQNLVNLI----GYCADGDQRI-LVYEFM--------SNGSLEN-HFLDLPPDQEPLD 153
+H+N++ + + + ++ E M S L + H Q
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHI------Q---- 115
Query: 154 WFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213
+F + + ++ LH ++ VI+RD K SN+L+++ + K+ DFGLA++
Sbjct: 116 YFIYQTL-----RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 214 -------------DHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
+ V+TR Y APE +T ++ DV+S G +L EL R
Sbjct: 168 DNSEPTGQQSGMVEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 44/216 (20%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGY-C 120
+G G +G V++ VA+K++ Q R E+ ++ +V+H N+V+L +
Sbjct: 48 IGNGSFGVVFQA-KLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 121 ADGDQRI-----LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA---------- 165
++GD++ LV E++ + + ++K
Sbjct: 103 SNGDKKDEVFLNLVLEYVP--------ETV---YRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNP-KLSDFGLAKLGPTGGK--DHVSTRVMG 222
+ L Y+H + + +RD K N+LLD KL DFG AK+ G ++ +R
Sbjct: 152 RSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR--- 205
Query: 223 TYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
Y Y APE T D++S G V+ EL+ G+
Sbjct: 206 -Y-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 45/246 (18%), Positives = 92/246 (37%), Gaps = 53/246 (21%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN 112
++ ++ +G G +G V + + + A+K++ + +RE + ++ ++ H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61
Query: 113 LVNLIGY---------CADGDQRILVYEFMSNGSLENHFLDLPPDQE------------P 151
++ L+ Y N + NH + + P
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 152 LDWFTRMKIAGGAA----------------KGLEYLHDVADPPVIYRDFKASNILLDAEF 195
+K + + + ++H + + +RD K N+L++++
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKD 178
Query: 196 NP-KLSDFGLAKLGPTGGK--DHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLL 251
N KL DFG AK ++ +R + Y APE + T D++S G V
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 252 ELITGR 257
ELI G+
Sbjct: 234 ELILGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 54/236 (22%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN 112
+ +G GG G V+ D+ VA+K++ + Q + E+ ++ + H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 113 LVNLIG-YCADGDQRI-------------LVYEFM---------SNGSLENHFLDLPPDQ 149
+V + G Q +V E+M LE H
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA------- 122
Query: 150 EPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKLG 208
F + +GL+Y+H A+ V++RD K +N+ ++ E K+ DFGLA++
Sbjct: 123 ---RLFMYQLL-----RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 209 PTGGK------DHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGR 257
+ + T+ Y +P ++ TK D+++ G + E++TG+
Sbjct: 172 DPHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 57/305 (18%), Positives = 102/305 (33%), Gaps = 94/305 (30%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSL 107
+N+ L+G G YG VY Y + ++ VA+K+++ E+ +L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN---RMFEDLIDCKRILREITILNR 81
Query: 108 VQHQNLVNL----IGYCADGDQRI-LVYEFM---------SNGSLEN-HF-------LDL 145
++ ++ L I + +V E + L H L
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL-- 139
Query: 146 PPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205
G ++H+ + +I+RD K +N LL+ + + K+ DFGLA
Sbjct: 140 --------------------LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 206 KLGPTGGK-------------------------DHVSTRVMGTYGYCAPEYAMTGQL-TK 239
+ + HV TR Y APE + + TK
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTK 231
Query: 240 KSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPR 299
D++S G + EL+ + N + PL F + D + + +
Sbjct: 232 SIDIWSTGCIFAELLNMLQSHINDPTNR--------FPLFPGSSCFPLSPDRNSKKVHEK 283
Query: 300 KGLYQ 304
Q
Sbjct: 284 SNRDQ 288
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 56/322 (17%), Positives = 105/322 (32%), Gaps = 97/322 (30%)
Query: 9 ADHSLSFKDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFN------PDCLV 62
+ H + + S Q ++ ++ + K+ + + ++ L+
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61
Query: 63 GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA-----EVLMLSLVQHQNLVNL- 116
G G YG V + Y + +VVA+K++ E+ +L+ + H ++V +
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIKKIL---RVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 117 ---IGYCADGDQRI-LVYEFM---------SNGSLEN-HF-------LDLPPDQEPLDWF 155
I + + +V E + L H L
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL------------ 166
Query: 156 TRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA---------- 205
G++Y+H A +++RD K +N L++ + + K+ DFGLA
Sbjct: 167 ----------VGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 206 ----------------KLGPTGGK----DHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVY 244
K HV TR Y APE + + T+ DV+
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTR-----WYRAPELILLQENYTEAIDVW 268
Query: 245 SFGVVLLELITGRSAIDNSRPS 266
S G + EL+
Sbjct: 269 SIGCIFAELLNMIKENVAYHAD 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 65/247 (26%), Positives = 107/247 (43%), Gaps = 68/247 (27%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS-GNQGS-----REFFAEVLMLS 106
+ +G+G YG V+K +VVAVK++ + N RE +++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREI---MILTE 64
Query: 107 LVQHQNLVNLIG-YCADGDQRI-LVYEFM---------SNGSLENHFLDLPPDQEPLDWF 155
L H+N+VNL+ AD D+ + LV+++M +N H Q +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHK------Q----YV 114
Query: 156 TRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK-- 213
I K ++YLH +++RD K SNILL+AE + K++DFGL++ +
Sbjct: 115 VYQLI-----KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 214 ----------------------DHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVL 250
D+V+TR Y APE + TK D++S G +L
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATR-----WYRAPEILLGSTKYTKGIDMWSLGCIL 221
Query: 251 LELITGR 257
E++ G+
Sbjct: 222 GEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 44/243 (18%), Positives = 83/243 (34%), Gaps = 79/243 (32%)
Query: 30 EIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDR 89
++ + KK + Y+ + ++G G G+V + + + + A+K L
Sbjct: 3 HVKSGLQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKMLQD 53
Query: 90 SGNQGSREFFAEV-LMLSLVQHQNLVNLIGYCADGDQRI----LVYEFMSNGSLENHFLD 144
+ EV L Q ++V ++ + +V E + G L
Sbjct: 54 -----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL------ 102
Query: 145 LPPDQEPLDWFTRMKIAGG-------AA-------KGLEYLHDVADPPVIYRDFKASNIL 190
F+R++ G A+ + ++YLH + + +RD K N+L
Sbjct: 103 ----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLL 149
Query: 191 L---DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFG 247
KL+DFG AK + Y K D++S G
Sbjct: 150 YTSKRPNAILKLTDFGFAK--------ETTGE---KYD-------------KSCDMWSLG 185
Query: 248 VVL 250
V++
Sbjct: 186 VIM 188
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 48/208 (23%), Positives = 78/208 (37%), Gaps = 22/208 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G G +G + G ++ VA+K L + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIPQVYYFGP 75
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
G +V E + SLE+ F DL L T + IA +EY+H +IY
Sbjct: 76 CGKYNAMVLELLGP-SLEDLF-DLCDRTFSLK--TVLMIAIQLISRMEYVHSKN---LIY 128
Query: 182 RDFKASNILLDAEFNPK-----LSDFGLAK--LGPTGGKDHVSTR----VMGTYGYCAPE 230
RD K N L+ N + DF LAK + P K H+ R + GT Y
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK-HIPYREHKSLTGTARY-MSI 186
Query: 231 YAMTG-QLTKKSDVYSFGVVLLELITGR 257
G + +++ D+ + G + + + G
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 43/208 (20%), Positives = 81/208 (38%), Gaps = 22/208 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+GEG +G +++G +Q VA+K R + L L + N+ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL-LAGCTGIPNVYYFGQ 76
Query: 122 DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181
+G +LV + + SLE+ T A ++ +H+ + ++Y
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEKS---LVY 129
Query: 182 RDFKASNILLDAEFNPK-----LSDFGLAK--LGPTGGKDHVSTR----VMGTYGYCAPE 230
RD K N L+ + + DFG+ K P + H+ R + GT Y
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ-HIPYREKKNLSGTARY-MSI 187
Query: 231 YAMTG-QLTKKSDVYSFGVVLLELITGR 257
G + +++ D+ + G V + + G
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 8e-09
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 22/207 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH-QNLVNLIGYC 120
+G G +G +Y G A + VA+K + E + ++Q + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
A+GD ++V E + SLE+ F T + +A +EY+H I
Sbjct: 75 AEGDYNVMVMELLGP-SLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN---FI 127
Query: 181 YRDFKASNILLDAEFNPK---LSDFGLAK--LGPTGGKDHVSTR----VMGTYGYCAPEY 231
+RD K N L+ + DFGLAK + H+ R + GT Y A
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ-HIPYRENKNLTGTARY-ASIN 185
Query: 232 AMTG-QLTKKSDVYSFGVVLLELITGR 257
G + +++ D+ S G VL+ G
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 43/223 (19%), Positives = 88/223 (39%), Gaps = 42/223 (18%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ----------- 109
+G G + V+ + VA+K + R + E+ +L V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 110 HQNLVNLIGY----CADGDQRILVYEFMSNGSL-----ENHFLDLPPDQEPLDWFTRMKI 160
+++ L+ + +G ++V+E + +L + +P + +I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIY------VK-QI 136
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP------KLSDFGLAKLGPTGGKD 214
+ GL+Y+H +I+ D K N+L++ +P K++D G A +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
H + + T Y +PE + +D++S ++ ELITG
Sbjct: 191 HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLV-NLIGYC 120
+G G +G +Y G ++ VA+K + + E + ++Q + N+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLE--NVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
+GD +LV + + SLE+ F L T + +A +E++H + +
Sbjct: 73 VEGDYNVLVMDLLGP-SLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS---FL 125
Query: 181 YRDFKASNILLDAEFNPK---LSDFGLAKL--GPTGGKDHVSTR----VMGTYGYCAPEY 231
+RD K N L+ + DFGLAK + + H+ R + GT Y A
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-HIPYRENKNLTGTARY-ASVN 183
Query: 232 AMTG-QLTKKSDVYSFGVVLLELITGR 257
G + +++ D+ S G VL+ + G
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 1e-08
Identities = 44/254 (17%), Positives = 70/254 (27%), Gaps = 68/254 (26%)
Query: 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--------QGSREFFAEVL 103
TE +GEG +G V++ + VA+K + G + E E++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 104 MLSLVQ---------HQNLVNLIG-YCADG-----------------------------D 124
+ + + + L +C G D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDF 184
Q +V EF G + T I L +RD
Sbjct: 136 QLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEAS--LRFEHRDL 188
Query: 185 KASNILLDAEFNPKLSDFGLAKLG--PTGGK-----DHVSTRVM--GTYGYC---APEYA 232
N+LL KL K P+ G D+ +R+ G +C E
Sbjct: 189 HWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL 248
Query: 233 MTGQLTKKSDVYSF 246
TG + D+Y
Sbjct: 249 FTGDGDYQFDIYRL 262
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 9e-07
Identities = 47/271 (17%), Positives = 80/271 (29%), Gaps = 78/271 (28%)
Query: 54 ENFNPDCLV----GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ 109
+ FN V G G + V+ + + VA+K + +S + E+ +L V+
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVR 91
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHF-LDLPPDQEPLDWFTRM---------- 158
+ + N L+ +F +G H + L +
Sbjct: 92 NSD-PNDPNREM---VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPC 147
Query: 159 --KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---------------------- 194
KI +GL+YLH +I+ D K NILL
Sbjct: 148 VKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205
Query: 195 ---------------------------FNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
K++D G A H + + T Y
Sbjct: 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQ-TRQYR 260
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
+ E + +D++S + EL TG
Sbjct: 261 SLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 44/217 (20%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ------NLV 114
++G+G +G+V K Y V Q VA+K + R+ + R+ E+ +L ++ Q N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 115 NLIGY-------CADGDQRILVYEFMSNGSL-----ENHFLDLPPDQEPLDWFTRMKIAG 162
+++ C + +E +S +L +N F R K A
Sbjct: 163 HMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKFQGFSLPL------VR-KFAH 207
Query: 163 GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP--KLSDFGLAKLGPTGGKDHVSTRV 220
+ L+ LH +I+ D K NILL + K+ DFG + V T +
Sbjct: 208 SILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYI 260
Query: 221 MGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
+ Y APE + + D++S G +L EL+TG
Sbjct: 261 QSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 52/220 (23%), Positives = 86/220 (39%), Gaps = 48/220 (21%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQL---DRSGNQGSREFFAEVLMLSLVQHQ------ 111
L+G+G +G+V K Y + VA+K + NQ EV +L L+
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKY 116
Query: 112 NLVNLIGY-------CADGDQRILVYEFMSNGSL-----ENHFLDLPPDQEPLDWFTRMK 159
+V+L + C LV+E +S +L +F + + TR K
Sbjct: 117 YIVHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNFRGVSLNL------TR-K 161
Query: 160 IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP--KLSDFGLAKLGPTGGKDHVS 217
A L +L + +I+ D K NILL K+ DFG + +
Sbjct: 162 FAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIY 216
Query: 218 TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257
+ + Y +PE + D++S G +L+E+ TG
Sbjct: 217 QYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 42/229 (18%), Positives = 78/229 (34%), Gaps = 46/229 (20%)
Query: 62 VGEGGYGRVYKGY--------IEAVDQVVAVKQLDRSGNQGSREF-----FAEVLMLSLV 108
G +Y+ Q ++K LD + E A+ L ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 109 QHQNLVNLIG-----YC--ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIA 161
+ L+ R LV + SL++ P + L + +++A
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSP--KHVLSERSVLQVA 165
Query: 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK--LSDFGLAKLGPTGGKDHVSTR 219
LE+LH+ ++ + A NI +D E + L+ +G A GK HV+
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK-HVAYV 221
Query: 220 ------VMGTYGYCAPEYA-----MTGQLTKKSDVYSFGVVLLELITGR 257
G E+ +++SD+ S G +L+ + G
Sbjct: 222 EGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 39/229 (17%), Positives = 78/229 (34%), Gaps = 44/229 (19%)
Query: 61 LVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGNQGSREF-----FAEVLMLSLVQH 110
+G+GG+G +Y + D VK E A+ +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 111 QNLVNLIG----------YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI 160
+ +G R ++ + + L+ + + T +++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEANA---KRFSRKTVLQL 157
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK--LSDFGLAKL-GPTGGKDHVS 217
+ LEY+H+ ++ D KASN+LL+ + + L D+GLA P G +
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA 214
Query: 218 TR----VMGTYGYCAPEYA-----MTGQLTKKSDVYSFGVVLLELITGR 257
GT E+ +++ D+ G +++ +TG
Sbjct: 215 ADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 43/227 (18%), Positives = 81/227 (35%), Gaps = 43/227 (18%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVN----- 115
+G GG+G +Y + + A + + Q + F+E+ V ++ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 116 ----------LIGY----CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTR---M 158
G R +V E + L+ F + +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGT-------FKKSTVL 154
Query: 159 KIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK--LSDFGLAKL-GPTGGKDH 215
++ LEY+H+ ++ D KA+N+LL + + L+D+GL+ P G
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 216 VSTRV----MGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGR 257
GT + A G L+++SDV G +L + G+
Sbjct: 212 YQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 336 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.55 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.4 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.32 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.98 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.81 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.79 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.67 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.62 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.57 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.39 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.3 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.14 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.93 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.9 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.9 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.89 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.85 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.83 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.81 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.63 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.59 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.57 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.65 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.54 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.79 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.51 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.92 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-65 Score=440.39 Aligned_cols=250 Identities=23% Similarity=0.304 Sum_probs=215.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+.+.+|+.+|+.++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999999653 2234567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999975 467999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
........+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||...+..+... .+....
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~------~i~~~~-------- 250 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA------KIIKLE-------- 250 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHTC--------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHcCC--------
Confidence 444445667899999999999999999999999999999999999999998654322211 111111
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
-.++...+..+.+||.+||+.||++|||++|++.
T Consensus 251 ----~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ----CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1233345668999999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-63 Score=435.47 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=214.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
..|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999997665555667899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+||+|.+++.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|......
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--
Confidence 99999999864 46999999999999999999999999 999999999999999999999999999875432
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||...+..+....+. .. ..+
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------~~------~~~-- 288 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------DN------LPP-- 288 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HS------SCC--
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------cC------CCC--
Confidence 223456799999999999999999999999999999999999999998754332211111 10 001
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........+..+.+||.+||+.||++|||++|+++
T Consensus 289 ~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 289 RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11223455678999999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-63 Score=432.51 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=216.3
Q ss_pred cCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
++|.+.+.||+|+||.||+|.+. .++..||||+++.......+.+.+|+.+|+.++|||||++++++.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888999999999999999875 3578999999987665556789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 129 VYEFMSNGSLENHFLDLP---------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
||||+++|+|.+++.... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 23467999999999999999999999998 999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...+..+....+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~----- 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT----- 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-----
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----
Confidence 99999986543332223334579999999999999999999999999999999998 899998765432211111
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+. ....|..++..+.+|+.+||+.||++|||+++|++.|+.+.
T Consensus 245 --~~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 245 --QGR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp --HTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 110 01233455668999999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-63 Score=436.91 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=207.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|+.|+|||||++++++.+.+..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 3689999999999999999999999999999999975432 23467899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|||+||+|.+++... ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 103 Ey~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999999752 3456799999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ....+..+||+.|||||++.+..|+.++|||||||++|||++|..||...+..+... .+.... .
T Consensus 178 ~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~i~~~~--~----- 242 (350)
T 4b9d_A 178 T--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------KIISGS--F----- 242 (350)
T ss_dssp H--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHTC--C-----
T ss_pred C--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHHcCC--C-----
Confidence 1 122345789999999999999999999999999999999999999998754322211 111110 0
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+ ..+...+..+.+||.+||+.||++|||++|+++
T Consensus 243 ~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 123345668999999999999999999999986
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-62 Score=432.89 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=210.4
Q ss_pred cCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
++|.+.+.||+|+||.||+|.++ .++..||||+++.......+.|.+|+.+|+.++|||||++++++.+....++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 56778889999999999999875 3688999999987665556789999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 129 VYEFMSNGSLENHFLDLPP-----------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
||||+++|+|.+++..... ...++++..++.|+.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999876432 2356999999999999999999999998 9999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 276 (336)
||+|||+++...........+..+||+.|||||++.+..|+.++|||||||++|||+| |+.||......+....+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~--- 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT--- 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH---
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH---
Confidence 9999999986544433344456789999999999999999999999999999999999 899998765432211111
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+. ....+..++..+.+|+.+||+.||++|||++||++.|+.|.
T Consensus 275 ----~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 275 ----QGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ----HTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----cCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 111 11233445668999999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-62 Score=423.30 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=208.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.+++.+.+.||+|+||+||+|+++. .||||+++... ....+.+.+|+.+++.++|||||++++++.+ +..++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 4678889999999999999998764 48999986543 2334678999999999999999999998764 5689999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|||++|+|.+++.. ....+++..+..|+.|++.||+|||+.+ ||||||||+|||++.++.+||+|||+|+....
T Consensus 111 Ey~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 111 QWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp ECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 99999999999975 3467999999999999999999999998 99999999999999999999999999987554
Q ss_pred CCCcceeeeeccCccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMT---GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
..........+||+.|||||++.+ +.|+.++|||||||++|||+||+.||...+....... ....+
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~------~~~~~----- 253 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF------MVGRG----- 253 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH------HHHTT-----
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH------HHhcC-----
Confidence 333344556789999999999864 4689999999999999999999999986543221111 11111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccCC
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~~ 336 (336)
...+.+ ...+..++..+.+|+.+||+.||++|||+.+|++.|+.|++|
T Consensus 254 ~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 254 YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 011111 123345567899999999999999999999999999998875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-62 Score=429.21 Aligned_cols=252 Identities=21% Similarity=0.210 Sum_probs=209.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
+.|.+.++||+|+||.||+|+++.+|+.||||+++.... ..+|+.+++.++|||||++++++.+.+..|+||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 457788899999999999999999999999999975432 246999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEccccccccCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 212 (336)
+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+| .+||+|||+|+......
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999975 457999999999999999999999998 99999999999999987 59999999998764332
Q ss_pred Cc---ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 213 KD---HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 213 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|.+||......+....+.. .....
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~~~~~---- 275 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------EPPPI---- 275 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------SCCGG----
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------CCCCc----
Confidence 21 123346899999999999999999999999999999999999999987655443222211 11000
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
..++...+..+.++|.+||+.||.+|||+.|+++.|..
T Consensus 276 -----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 -----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp -----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 12334556789999999999999999999999887653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-61 Score=436.99 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=214.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
..|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998766666677899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+||+|.+++.. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|......
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-- 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--
Confidence 99999999864 45999999999999999999999999 999999999999999999999999999875432
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
.......+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+....+. .+ ..+.+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------~~------~~~~~ 367 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------DN------LPPRL 367 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HS------CCCCC
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------cC------CCCCC
Confidence 223456789999999999999999999999999999999999999998754332221111 10 00111
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......+..+.+||.+||+.||++|||++|+|+
T Consensus 368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122345668999999999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=415.43 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=196.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999999999999999996542 233457899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+ +|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 7899999875 467999999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
. ....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||...+..... ..+....
T Consensus 165 ~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~------~~i~~~~------- 228 (275)
T 3hyh_A 165 G---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF------KNISNGV------- 228 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHTC-------
T ss_pred C---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHcCC-------
Confidence 2 23456789999999999998876 57999999999999999999999865432211 1111110
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..++...+..+.+|+.+||+.||++|||++|+++
T Consensus 229 -----~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 -----YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1123345668999999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-61 Score=422.76 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=214.9
Q ss_pred cCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.++++.+.||+|+||.||+|.+. .+++.||||+++... ....+.|.+|+.+++.++|||||++++++.+....+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45677889999999999999864 357899999997543 234577999999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC
Q 036144 128 LVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF 195 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~ 195 (336)
+||||+++|+|.+++..... ....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 1356899999999999999999999998 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHH
Q 036144 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 274 (336)
.+||+|||+++...........+..+||+.|||||++.++.|+.++|||||||++|||+| |..||......+....+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i-- 260 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI-- 260 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--
Confidence 999999999976543333333455689999999999999999999999999999999998 89999876543221111
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..+. ....+..++..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 261 -----~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 261 -----RNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -----HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----HcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1111 11234456678999999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-61 Score=413.55 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=201.0
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe----CCeEEEEE
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD----GDQRILVY 130 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 130 (336)
++.+.||+|+||.||+|.++.++..||+|++.... ....+.+.+|+.+++.++|||||++++++.+ ....|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999999999999999986532 2334668999999999999999999999865 34579999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-CCceEEccccccccCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-EFNPKLSDFGLAKLGP 209 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~ 209 (336)
||++||+|.+++.. ...+++..+..++.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999975 467999999999999999999999865 45999999999999974 7899999999998643
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
. ....+.+||+.|||||++.+ .|+.++|||||||++|||+||..||........ ....+. .+
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-----~~~~i~-~~------- 245 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVT-SG------- 245 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHT-TT-------
T ss_pred C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-----HHHHHH-cC-------
Confidence 2 23456789999999998865 699999999999999999999999976443211 111111 10
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....++...+..+.+||.+||+.||++|||++|+++
T Consensus 246 --~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 --VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011122233457899999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-61 Score=418.32 Aligned_cols=248 Identities=25% Similarity=0.328 Sum_probs=202.0
Q ss_pred cCCCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
++|++.+.||+|+||+||+|++. .+++.||||++.+.. ......+.+|+.+|+.++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999983 468899999997542 1223467889999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||++||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999975 457999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... .....+.+||+.|||||++.+..|+.++|||||||++|+|++|..||...+..+....+ ....
T Consensus 177 ~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~------ 242 (304)
T 3ubd_A 177 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LKAK------ 242 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC------
T ss_pred cCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------HcCC------
Confidence 332 22345578999999999999999999999999999999999999999875543221111 1110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM-----VDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~ 328 (336)
..++...+..+.+||.+||+.||++|||+ +|+++
T Consensus 243 ------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 ------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 12334456789999999999999999984 67764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=417.79 Aligned_cols=268 Identities=25% Similarity=0.339 Sum_probs=218.6
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEccc-----CeEEEEEeecCCCCc-cHHHHHHHHHHHhhccC-CCccceEEE
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAV-----DQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQH-QNLVNLIGY 119 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h-~~iv~~~~~ 119 (336)
..++...++|++.+.||+|+||.||+|.+..+ ++.||||.+...... ..+.+.+|+.+|+.++| ||||+++++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 33444567899999999999999999998654 368999999765432 34568999999999976 899999999
Q ss_pred EEeC-CeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 036144 120 CADG-DQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKA 186 (336)
Q Consensus 120 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp 186 (336)
+... ...++|||||++|+|.+++..... ....+++..+..++.||+.||+|||+++ ||||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence 8764 568999999999999999975321 2356899999999999999999999999 99999999
Q ss_pred CCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 036144 187 SNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRP 265 (336)
Q Consensus 187 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~ 265 (336)
+|||++.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |..||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654444444556789999999999999999999999999999999998 9999987553
Q ss_pred cccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 266 SEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.+. ... .+..+. ....+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 294 ~~~--~~~----~i~~g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 294 DEE--FCR----RLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp SHH--HHH----HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH--HHH----HHHcCC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 321 111 111111 1123344566899999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=402.33 Aligned_cols=252 Identities=20% Similarity=0.303 Sum_probs=190.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCC--------
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGD-------- 124 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-------- 124 (336)
++|++.+.||+|+||.||+|.++.+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4589999999999999999999999999999999754432 3456889999999999999999999987544
Q ss_pred ----eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEc
Q 036144 125 ----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS 200 (336)
Q Consensus 125 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~ 200 (336)
..|+|||||++|+|.+++..... ....++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999976321 233556678899999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCc----------ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccccc
Q 036144 201 DFGLAKLGPTGGKD----------HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQN 270 (336)
Q Consensus 201 Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 270 (336)
|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||.... .
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----E 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----H
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----H
Confidence 99999865432211 12344689999999999999999999999999999999996 665311 1
Q ss_pred HHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........ .. .... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~-~~---------~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRTLTDV-RN---------LKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHHH-HT---------TCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHH-hc---------CCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11101000 00 0000 111233456788999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-58 Score=399.65 Aligned_cols=268 Identities=22% Similarity=0.287 Sum_probs=199.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCC----eEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD----QRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 129 (336)
.+|.+.+.||+|+||.||+|++. |+.||||++..... .......|+..+..++|||||++++++.+++ ..++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45778889999999999999985 78999999865321 1122345666667889999999999997654 57999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA-----DPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~-----~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+.. .++|+||||||+|||++.++++||+|||+
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 999999999999965 46899999999999999999999861 23499999999999999999999999999
Q ss_pred cccCCCCCCc--ceeeeeccCccccCccccccC------CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc-------
Q 036144 205 AKLGPTGGKD--HVSTRVMGTYGYCAPEYAMTG------QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ------- 269 (336)
Q Consensus 205 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~------- 269 (336)
++........ ......+||+.|||||++.+. .|+.++|||||||++|||+||.+||......+..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 9765433221 123346899999999998764 3678999999999999999998887543321110
Q ss_pred -cHHHHHHHHhhcccccccccCCccCCCC-cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 270 -NLVTWAKPLLRDKKKFTMMADPLLEGQY-PRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 270 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
............ ...++.+.... +.+.+..+.+|+.+||+.||++|||+.+|++.|+.|.
T Consensus 235 ~~~~~~~~~~~~~-----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 235 DPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SCCHHHHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhc-----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 001111111110 11112121111 2245668999999999999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=404.36 Aligned_cols=267 Identities=21% Similarity=0.271 Sum_probs=206.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEe------CC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCAD------GD 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 124 (336)
.++|++.+.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 3679999999999999999999999999999999975432 233567899999999999999999998764 36
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..|+||||++ |+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999995 679998865 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC--CcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 205 AKLGPTGG--KDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 205 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
++...... ......+.+||+.|+|||++.+. .|+.++||||+||++|||++|.+||.+.+..+....+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98653321 12234567999999999998875 5799999999999999999999999876544332222111000000
Q ss_pred ccccc--------c---ccCCccCCC---CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFT--------M---MADPLLEGQ---YPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~--------~---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... . ...+..... ..+..+..+.+||.+||+.||++|||++|+|+
T Consensus 285 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 -AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp -GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0 000000000 01123567899999999999999999999886
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=393.11 Aligned_cols=266 Identities=19% Similarity=0.228 Sum_probs=201.2
Q ss_pred HHhcCCCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (336)
...++|++.+.||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.+|+.+ +||||+++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999875 467899999986543 345688999999988 699999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-CceEEcccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGLA 205 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~ 205 (336)
|+||||++||+|.+++. .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999883 3889999999999999999999999 9999999999999876 79999999999
Q ss_pred ccCCCCCC--------------------------cceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCC
Q 036144 206 KLGPTGGK--------------------------DHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRS 258 (336)
Q Consensus 206 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~ 258 (336)
+....... ....+..+||+.|+|||++.+. .|+.++||||+||++|+|++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 75432211 1122346899999999999875 58999999999999999999999
Q ss_pred CCCCCCCccc-ccHHHHHH---H------Hhhcc-----------------------ccccc----ccCCccCCCCcHHH
Q 036144 259 AIDNSRPSEE-QNLVTWAK---P------LLRDK-----------------------KKFTM----MADPLLEGQYPRKG 301 (336)
Q Consensus 259 p~~~~~~~~~-~~~~~~~~---~------~~~~~-----------------------~~~~~----~~~~~~~~~~~~~~ 301 (336)
||........ ...+.... . ..... ..... ..............
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 9975543211 11110000 0 00000 00000 00000000111234
Q ss_pred HHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 302 LYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 302 ~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+..+.+|+.+||+.||++|||++|+|+
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 567899999999999999999999986
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=414.56 Aligned_cols=253 Identities=22% Similarity=0.270 Sum_probs=214.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.++.+|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+....|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999999999999999999766555567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC--CceEEccccccccCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE--FNPKLSDFGLAKLGPT 210 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~--~~~kl~Dfg~~~~~~~ 210 (336)
++||+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++.....
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999865 3467999999999999999999999999 9999999999999754 7899999999987643
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+....+ .....
T Consensus 310 ~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i------~~~~~------- 373 (573)
T 3uto_A 310 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDW------- 373 (573)
T ss_dssp T---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HTTCC-------
T ss_pred C---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------HhCCC-------
Confidence 2 2345678999999999999999999999999999999999999999876543221111 11110
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..........+..+.+||.+||+.||.+|||+.|+|+
T Consensus 374 -~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 374 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111112234668999999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-55 Score=411.20 Aligned_cols=250 Identities=24% Similarity=0.327 Sum_probs=205.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHH---HHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFA---EVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|++.++||+|+||.||+|+++.+|+.||||++.+.. ........+ ++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999999999999999986431 122223333 45667778999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|.
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999975 467999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
..... ...+.+||+.|||||++.+ ..|+.++|+|||||++|||++|.+||......+...... .....
T Consensus 341 ~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~---- 409 (689)
T 3v5w_A 341 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTM---- 409 (689)
T ss_dssp ECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHC----
T ss_pred ecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCC----
Confidence 65432 2345789999999999975 589999999999999999999999997644332211111 11111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
...++...+..+.+||.+||+.||.+|++ ++||++
T Consensus 410 --------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred --------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11234455678999999999999999998 677764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=377.21 Aligned_cols=283 Identities=42% Similarity=0.693 Sum_probs=242.6
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++....++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 344556789999999999999999999975 5889999998776666667899999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999999999999765444557999999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
...............||+.|+|||++.+..++.++|||||||++|+|++|..||....+.+......+..... ......
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 266 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLE 266 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TTTCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-ccccHH
Confidence 6543333333445679999999999999999999999999999999999999998877666666665554332 233455
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
...++......+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 666666667778889999999999999999999999999999998753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=361.13 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=213.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
..+|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999999999999999998766555667789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999865 35899999999999999999999998 9999999999999999999999999987654322
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||............ .... .
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~---------~ 233 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNG---------T 233 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHC---------S
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC---------C
Confidence 2344567999999999999999999999999999999999999999765432211111 0000 0
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+...+..+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011223455668999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=366.72 Aligned_cols=291 Identities=44% Similarity=0.722 Sum_probs=241.8
Q ss_pred CCCcccHHHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEE
Q 036144 40 TPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIG 118 (336)
Q Consensus 40 ~~~~~~~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~ 118 (336)
....+.+.++....++|.+.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456788899999999999999999999999999865 588999999875432 22346889999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceE
Q 036144 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 119 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
++......++||||+++|+|.+++.........+++..++.++.|++.||.|||+....+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999988766667799999999999999999999999222299999999999999999999
Q ss_pred EccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--cccccHHHHHH
Q 036144 199 LSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRP--SEEQNLVTWAK 276 (336)
Q Consensus 199 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~ 276 (336)
|+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........+..
T Consensus 175 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999998654322 2334456699999999999988999999999999999999999999963221 12223333433
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
... .........+......++...+..+.+++.+||+.||.+|||+.++++.|+..
T Consensus 254 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 332 23455666677777788889999999999999999999999999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=365.33 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=216.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|.+.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 36789999999999999999999999999999998766656667899999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999976 3467999999999999999999999999 9999999999999999999999999997654322
Q ss_pred Ccc------------eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc---cHHHHHHH
Q 036144 213 KDH------------VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ---NLVTWAKP 277 (336)
Q Consensus 213 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~ 277 (336)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......... ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 211 112467999999999999999999999999999999999999998765443221 11111110
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..+...+..+.+++.+||+.||++|||+.++++.|+.++
T Consensus 243 ------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 ------------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ------------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 112233447889999999999999999999999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=367.33 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=210.5
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
...+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3468999999999999999999999999999999986542 23345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999865 356899999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCCcceeeeeccCccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLT-KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+ ....
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~------ 230 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------LRGK------ 230 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC------
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC------
Confidence 332 23456899999999999988775 7999999999999999999999875532221111 1110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+...+..+.+|+.+||+.||.+|||++++++
T Consensus 231 ------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 231 ------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0122334568999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=362.17 Aligned_cols=249 Identities=25% Similarity=0.332 Sum_probs=210.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 36799999999999999999999999999999998653 223456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999998865 356899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. .......+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..... ..+....
T Consensus 157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~~~------- 221 (337)
T 1o6l_A 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELILMEE------- 221 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC-------
T ss_pred cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH------HHHHcCC-------
Confidence 22 12345578999999999999999999999999999999999999999765432211 1111110
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+||.+||+.||++|| +++++++
T Consensus 222 -----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 123334566899999999999999999 8999876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=365.02 Aligned_cols=253 Identities=22% Similarity=0.270 Sum_probs=210.5
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc------cHHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ------GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
..++|.+.+.||+|+||.||+|.++.+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 346799999999999999999999999999999998754321 34678999999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC----ceEEcc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF----NPKLSD 201 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~----~~kl~D 201 (336)
.++||||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999864 457999999999999999999999999 99999999999998877 799999
Q ss_pred ccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 202 FGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.... +...
T Consensus 163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~------i~~~ 233 (361)
T 2yab_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN------ITAV 233 (361)
T ss_dssp CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH------HHTT
T ss_pred cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhc
Confidence 99998654432 23456799999999999999999999999999999999999999977543221111 1111
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... ....+....+..+.+||.+||..||.+|||+.++++
T Consensus 234 ~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SYD--------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC--------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 000111234567999999999999999999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=365.71 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=214.9
Q ss_pred hcCCCCcccccccCceEEEEEEEc-------ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIE-------AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADG 123 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 123 (336)
.++|.+.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367899999999999999999974 3467899999976532 2345688999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
...++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 1345899999999999999999999999 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQN 270 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~ 270 (336)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986544332222334567889999999999999999999999999999999 999998754332211
Q ss_pred HHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+ ..+ .....+...+..+.+++.+||+.||.+|||+.++++.|+.|.
T Consensus 317 ~~-------~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 317 LL-------KEG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HH-------HTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-------hcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 111 011223345668999999999999999999999999998864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=348.13 Aligned_cols=287 Identities=38% Similarity=0.627 Sum_probs=231.6
Q ss_pred CCCCcccHHHHHHHhcCCCCc------ccccccCceEEEEEEEcccCeEEEEEeecCCC----CccHHHHHHHHHHHhhc
Q 036144 39 KTPNVFKYQELADATENFNPD------CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLV 108 (336)
Q Consensus 39 ~~~~~~~~~~~~~~~~~y~~~------~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l 108 (336)
.+...|.+.++...+.+|... +.||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.+++.+
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l 87 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence 345678888999888888877 89999999999999874 7899999986532 23346788999999999
Q ss_pred cCCCccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 036144 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASN 188 (336)
Q Consensus 109 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~N 188 (336)
+||||+++++++.+....++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~N 163 (307)
T 2nru_A 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSAN 163 (307)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 99999999999999999999999999999999986532 2456899999999999999999999998 9999999999
Q ss_pred eEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 036144 189 ILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE 268 (336)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 268 (336)
|+++.++.++|+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|..||........
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 242 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB
T ss_pred EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH
Confidence 9999999999999999986544333333445679999999998764 589999999999999999999999987654432
Q ss_pred ccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 269 QNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
...+. .........+....+..+ ...+...+..+.+++.+||+.||.+|||+.++++.|+.|..
T Consensus 243 ~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 LLDIK--EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTHHH--HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHH--HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 22211 111112222333333333 24566778899999999999999999999999999998763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=361.75 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=209.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCC----eEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD----QRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~l 128 (336)
..+|++.+.||+|+||.||+|.+. ++.||||++.... ........|+.+++.++||||+++++++.... ..++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 468999999999999999999887 7899999986543 22345567899999999999999999998744 4699
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeCCCCCCCeEECCCCceE
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV----------ADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~----------~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999965 3589999999999999999999998 7 99999999999999999999
Q ss_pred EccccccccCCCCCCcceeeeeccCccccCccccccC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 036144 199 LSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-----QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT 273 (336)
Q Consensus 199 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 273 (336)
|+|||++................||+.|+|||++.+. .++.++|||||||++|+|++|..||.............
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 9999999765443333334446799999999998863 45678999999999999999999998755433221111
Q ss_pred ----------HHHHHhhcccccccccCCccCCCC-cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 274 ----------WAKPLLRDKKKFTMMADPLLEGQY-PRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 274 ----------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
...... .....+.+...+ ....+..+.+|+.+||+.||++|||+.++++.|+.|.
T Consensus 252 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 252 EIGQHPSLEDMQEVVV------HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHCSSCCHHHHHHHHT------TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccCCchhhhhhhhh------cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111110 001111111111 1235667999999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=352.20 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=209.7
Q ss_pred CCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 56 FNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
|...+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++......++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 66777899999999999999989999999999776666677899999999999999999999999999999999999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 127 ~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 196 (321)
T 2c30_A 127 GALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 196 (321)
T ss_dssp CBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--c
Confidence 999998854 46899999999999999999999998 9999999999999999999999999987654322 2
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
......||+.|+|||++.+..++.++||||||+++|+|++|..||......... . .+... ..+.+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~---~---~~~~~-------~~~~~-- 261 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---K---RLRDS-------PPPKL-- 261 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H---HHHHS-------SCCCC--
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HHhcC-------CCCCc--
Confidence 234567999999999999999999999999999999999999999765432211 1 11100 01111
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
......+..+.+++.+||+.||++|||+.++++.
T Consensus 262 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123345689999999999999999999999873
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=359.57 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=211.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccC---eEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVD---QVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
..+|.+.+.||+|+||.||+|.+..++ ..||||++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467899999999999999999997544 4599999976432 334568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999865 3457999999999999999999999999 999999999999999999999999999875
Q ss_pred CCCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 209 PTGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~---- 270 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-------EG---- 270 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TT----
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------cC----
Confidence 433221 12233456888999999999999999999999999999999 999997654322111110 00
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111223345568999999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=357.71 Aligned_cols=252 Identities=16% Similarity=0.236 Sum_probs=210.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468999999999999999999999999999999986543 3446688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC--CCceEEccccccccCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA--EFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~ 210 (336)
+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999865 3456999999999999999999999999 999999999999987 78999999999987643
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+.... .........
T Consensus 157 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------i~~~~~~~~---- 223 (321)
T 1tki_A 157 G---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------IMNAEYTFD---- 223 (321)
T ss_dssp T---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHTCCCCC----
T ss_pred C---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH------HHcCCCCCC----
Confidence 3 234556799999999999988899999999999999999999999986543221111 111100000
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......+..+.+++.+||+.||.+|||+.|+++
T Consensus 224 ----~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 ----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001134568999999999999999999999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=357.68 Aligned_cols=255 Identities=25% Similarity=0.370 Sum_probs=208.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 4789999999999999999999999999999999865432 223568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999998864 456999999999999999999999999 999999999999999999999999999765433
Q ss_pred CCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ...+.. .
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~----~--------- 224 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE----K--------- 224 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHT----T---------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhc----c---------
Confidence 33333445789999999999988775 78999999999999999999999865432211 111100 0
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 -KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00001123345678999999999999999999999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=353.89 Aligned_cols=261 Identities=30% Similarity=0.420 Sum_probs=205.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
...+|++.+.||+|+||.||+|.+. |..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3578999999999999999999874 78899999875542 2235688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999987521 1224899999999999999999999865 349999999999999999999999999997543
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. ..
T Consensus 191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~------~~-------- 254 (309)
T 3p86_A 191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG------FK-------- 254 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH------HS--------
T ss_pred cc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hc--------
Confidence 22 122345679999999999999999999999999999999999999998755332211110 00
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....++...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 255 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 255 --CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp --CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111233445568999999999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=349.58 Aligned_cols=275 Identities=17% Similarity=0.193 Sum_probs=218.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCC--eEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD--QRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999999999999999987543 233567889999999999999999999998765 78999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----CCCCceEEcccccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL----DAEFNPKLSDFGLA 205 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~----~~~~~~kl~Dfg~~ 205 (336)
|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997632 2234899999999999999999999999 9999999999999 77888999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccc--------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHH-HHHH
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAM--------TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAK 276 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~ 276 (336)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||............ ....
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 8654432 234467999999999886 578899999999999999999999999765443322111 1111
Q ss_pred HHhhccccc-----------ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 277 PLLRDKKKF-----------TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 277 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
... ..... ...........++...+..+.+++.+||+.||++|||++|+++......+
T Consensus 241 ~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 241 TGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cCC-CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 100 00000 00001112234567788899999999999999999999999998876554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=364.76 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=204.8
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 127 (336)
..++|++.+.||+|+||.||+|.++.+|+.||||++.+. .......+.+|..+++.+ +||||+++++++.+....+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 357899999999999999999999999999999998653 122345678899999987 6999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999875 356999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+.... +...
T Consensus 174 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------i~~~------ 239 (353)
T 3txo_A 174 GICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA------ILND------ 239 (353)
T ss_dssp SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHC------
T ss_pred cccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH------HHcC------
Confidence 3222 2234557899999999999999999999999999999999999999987553322111 1111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM------VDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~------~evl~ 328 (336)
...++...+..+.+|+.+||+.||.+||++ .++++
T Consensus 240 ------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 ------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 012233455689999999999999999998 67664
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=352.10 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=210.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.+..++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999999999999999998544322 235688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999875 356899999999999999999999999 9999999999999999999999999997653
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
... ........||+.|+|||++.+..++.++||||||+++|+|++|..||......... ....... .
T Consensus 163 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~--~---- 229 (294)
T 4eqm_A 163 ETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQDS--V---- 229 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSSC--C----
T ss_pred ccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhcc--C----
Confidence 321 12234467999999999999999999999999999999999999999875432210 0111000 0
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcccC
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-FMVDVVTALEYLSS 335 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~evl~~L~~i~~ 335 (336)
+......+...+..+.+++.+||+.||.+|| +++++++.|+.+..
T Consensus 230 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 230 -PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0000112233456899999999999999998 99999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=356.29 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=209.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc------cHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ------GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|.+.+.||+|+||.||+|.+..+|..||+|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35699999999999999999999999999999998654321 356789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC----ceEEccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF----NPKLSDF 202 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~----~~kl~Df 202 (336)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999864 467999999999999999999999999 99999999999998887 7999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+ ....
T Consensus 163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~------~~~~ 233 (326)
T 2y0a_A 163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------SAVN 233 (326)
T ss_dssp TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHTC
T ss_pred CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------HhcC
Confidence 9998654322 234467999999999999999999999999999999999999999765432211111 0000
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .........+..+.+|+.+||+.||.+|||+.++++
T Consensus 234 ~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 234 YE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CC--------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC--------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 000111233557899999999999999999999987
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=359.65 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=210.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999999999999999986432 23456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+.||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999875 456999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcceeeeeccCccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMT---GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||................. .
T Consensus 167 ~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~----- 235 (384)
T 4fr4_A 167 RE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---T----- 235 (384)
T ss_dssp TT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---C-----
T ss_pred CC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---c-----
Confidence 32 23456789999999999864 4689999999999999999999999986554333222221111 0
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-MVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~evl~ 328 (336)
...++...+..+.+||.+||+.||.+||+ ++++++
T Consensus 236 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 -------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11233445668999999999999999998 666654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=363.62 Aligned_cols=272 Identities=25% Similarity=0.338 Sum_probs=218.9
Q ss_pred ccHHHHHHHhcCCCCcccccccCceEEEEEE-----EcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccce
Q 036144 44 FKYQELADATENFNPDCLVGEGGYGRVYKGY-----IEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNL 116 (336)
Q Consensus 44 ~~~~~~~~~~~~y~~~~~ig~G~~g~v~~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~ 116 (336)
+....+....++|.+.+.||+|+||.||+|. +..+++.||||++..... ...+.+.+|+.+++.+ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4445555567899999999999999999999 456679999999976433 2335689999999999 78999999
Q ss_pred EEEEEeCCe-EEEEEEcCCCCChhhhhccCCCC-----------------------------------------------
Q 036144 117 IGYCADGDQ-RILVYEFMSNGSLENHFLDLPPD----------------------------------------------- 148 (336)
Q Consensus 117 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------- 148 (336)
++++..... .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987554 89999999999999999764321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 149 ---------------QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 149 ---------------~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 222889999999999999999999999 99999999999999999999999999986544444
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
........||+.|+|||++.+..++.++|||||||++|+|++ |..||......... ... ....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~----~~~~---------- 312 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR----LKEG---------- 312 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHH----HHHT----------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHH----HHcC----------
Confidence 444555678999999999999999999999999999999998 99999875533211 110 1010
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 011122334567999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=359.91 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=204.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|++.++||+|+||.||+|.++.+++.||+|++.+.. ......+..|..++..+ +||||+++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999999999999999987542 22335578899999877 89999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999998875 356999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc--ccHHH-HHHHHhhccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE--QNLVT-WAKPLLRDKKKF 285 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~ 285 (336)
... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+. ..... ....+...
T Consensus 204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---- 277 (396)
T 4dc2_A 204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---- 277 (396)
T ss_dssp CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----
T ss_pred ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----
Confidence 222 2234567899999999999999999999999999999999999999975432211 11111 11111111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
...++...+..+.+||.+||+.||.+||++
T Consensus 278 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 278 --------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 112344456689999999999999999995
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=353.68 Aligned_cols=246 Identities=27% Similarity=0.366 Sum_probs=209.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999999999999999986531 23346678999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999975 356899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
. .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..... ..+....
T Consensus 158 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~------- 219 (318)
T 1fot_A 158 D-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------EKILNAE------- 219 (318)
T ss_dssp S-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHCC-------
T ss_pred C-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC-------
Confidence 2 234568999999999999999999999999999999999999999765432211 1111110
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+++.+||+.||++|| +++++++
T Consensus 220 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 122334556899999999999999999 8888875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=369.01 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=213.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++......++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 34678899999999999999999998899999999875432 22346789999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 192 e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 192 ELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp ECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999875 2346899999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
...........++..|+|||.+.+..++.++|||||||++|||++ |..||......+.... ...+.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~------ 332 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-------VEKGG------ 332 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-------HHTTC------
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC------
Confidence 211111112335778999999998999999999999999999998 9999987543221111 11111
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....+...+..+.+|+.+||+.||++|||+.++++.|+.|.
T Consensus 333 ----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 333 ----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11223334568999999999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=367.16 Aligned_cols=254 Identities=19% Similarity=0.215 Sum_probs=208.7
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 45779999999999999999999999999999999875432 2345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC---CCCceEEccccccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD---AEFNPKLSDFGLAK 206 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~ 206 (336)
|||++||+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999876 456999999999999999999999999 99999999999998 46789999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
...... .......||+.|+|||++.+..|+.++|||||||++|+|++|.+||......+....+ ......
T Consensus 162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~~-- 231 (444)
T 3soa_A 162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI------KAGAYD-- 231 (444)
T ss_dssp CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHTCCC--
T ss_pred EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHH------HhCCCC--
Confidence 654322 2234568999999999999999999999999999999999999999765432211111 111000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ........+..+.+|+.+||+.||.+|||+.++|+
T Consensus 232 -~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 -F-----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -C-----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 01111234568999999999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=359.35 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=211.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999999999999999999765544556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC--CCceEEccccccccCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA--EFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~ 210 (336)
+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999998865 3456899999999999999999999999 999999999999974 46799999999987543
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+... .+.....
T Consensus 204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~------~i~~~~~------- 267 (387)
T 1kob_A 204 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------NVKRCDW------- 267 (387)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHHCCC-------
T ss_pred C---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC-------
Confidence 2 22345679999999999999999999999999999999999999998754322111 1111100
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..........+..+.++|.+||+.||.+|||+.++++
T Consensus 268 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 268 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0111122234568999999999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=360.27 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=208.4
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 126 (336)
...++|.+.+.||+|+||.||+|.++.+|+.||+|++.... ......+..|..++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999999999999999986532 23445678899999876 899999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||++||+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999875 356899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..... .......+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+.... +...
T Consensus 167 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~~~----- 233 (345)
T 1xjd_A 167 ENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS------IRMD----- 233 (345)
T ss_dssp CCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHC-----
T ss_pred hcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH------HHhC-----
Confidence 54322 1234567899999999999999999999999999999999999999986543221111 1111
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHH-HHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMV-DVV 327 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl 327 (336)
. ..++...+..+.+|+.+||+.||++||++. +++
T Consensus 234 ---~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 ---N----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---C----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---C----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 122334556899999999999999999997 554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=358.72 Aligned_cols=256 Identities=22% Similarity=0.284 Sum_probs=208.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC-----CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS-----GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.++|++.+.||+|+||.||+|.++.+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46799999999999999999999999999999998532 1224567899999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc---eEEccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN---PKLSDFGL 204 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~ 204 (336)
+||||+++++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998887654334456899999999999999999999999 999999999999977655 99999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
+....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ... .........
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~---~~i~~~~~~ 250 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLF---EGIIKGKYK 250 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHH---HHHHHTCCC
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHH---HHHHcCCCC
Confidence 98654322 223456799999999999999999999999999999999999999976321 111 111111000
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. + ......+..+.+|+.+||+.||++|||+.++++
T Consensus 251 ~~----~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 MN----P----RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC----H----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC----c----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0 000123568999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=365.34 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=210.6
Q ss_pred hcCCCCcccccccCceEEEEEE-----EcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGY-----IEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|.+.+.||+|+||.||+|. +..++..||||++.... ......+.+|+.+++.++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4679999999999999999999 44567899999986543 23345688999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC---ceEEc
Q 036144 127 ILVYEFMSNGSLENHFLDLP---PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF---NPKLS 200 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~---~~kl~ 200 (336)
++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999987632 22356899999999999999999999999 99999999999998555 49999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHh
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~------ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------ 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------
Confidence 9999974322222223344568999999999999999999999999999999998 999998754322111111
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
... ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 301 -~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 -SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp -TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 110 11122344567999999999999999999999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=358.96 Aligned_cols=253 Identities=19% Similarity=0.236 Sum_probs=209.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
..++|.+.+.||+|+||.||+|.++.+|..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45679999999999999999999999999999999965432 2345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC---ceEEccccccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF---NPKLSDFGLAK 206 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~ 206 (336)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999998864 456899999999999999999999999 99999999999997654 59999999998
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... +......
T Consensus 180 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~------i~~~~~~-- 248 (362)
T 2bdw_A 180 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ------IKAGAYD-- 248 (362)
T ss_dssp CCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHTCCC--
T ss_pred EecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhCCCC--
Confidence 654322 23456799999999999999999999999999999999999999976543221111 1111000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.........+..+.+||.+||+.||++|||+.++++
T Consensus 249 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 ------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 001111234568999999999999999999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=355.50 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=205.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeE----EEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQV----VAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+.... ......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 46799999999999999999999877765 5788775432 334567899999999999999999999998765 77
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+|++|+.+|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 89999999999999876 3467999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...........+. ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~---- 235 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KG---- 235 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TT----
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cC----
Confidence 654443333444567889999999999999999999999999999999 999998765433221111 10
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 236 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 236 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 011223345568999999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=352.61 Aligned_cols=263 Identities=26% Similarity=0.380 Sum_probs=216.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
...+|.+.+.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3577999999999999999999983 4458999999875432 334678899999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 036144 126 RILVYEFMSNGSLENHFLDLPP--------------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFK 185 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dik 185 (336)
.++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976432 1234899999999999999999999999 9999999
Q ss_pred CCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 036144 186 ASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSR 264 (336)
Q Consensus 186 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~ 264 (336)
|+||+++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986544333223344567889999999999999999999999999999999 999998765
Q ss_pred CcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 265 PSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.......+. .. .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 258 ~~~~~~~~~-------~~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PERLFNLLK-------TG----------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGGHHHHHH-------TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhh-------cC----------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 433221111 10 011223345568999999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=356.93 Aligned_cols=246 Identities=24% Similarity=0.292 Sum_probs=209.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.++.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999986432 23356788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999875 356899999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......+.. ..+....
T Consensus 193 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~~~------- 254 (350)
T 1rdq_E 193 GR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------EKIVSGK------- 254 (350)
T ss_dssp SC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC-------
T ss_pred CC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH------HHHHcCC-------
Confidence 21 34567999999999999999999999999999999999999999865432211 1111110
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
..++...+..+.++|.+||+.||.+||+ ++++++
T Consensus 255 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 -----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1223345668999999999999999998 888875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=344.41 Aligned_cols=264 Identities=20% Similarity=0.246 Sum_probs=205.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 579999999999999999999999999999999875432 223678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++ +|.+.+.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9965 66666554 3467999999999999999999999999 999999999999999999999999999865322
Q ss_pred CCcceeeeeccCccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc--cc---c
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK--KK---F 285 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---~ 285 (336)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||........ ............ .. .
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhh
Confidence 22334567899999999988765 89999999999999999998888654332211 111111110000 00 0
Q ss_pred cccc---------CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMA---------DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... ............+..+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0000 000111222345668999999999999999999999987
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=356.56 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=207.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999999999999999986431 22235788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+ +|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 7899988865 356999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.+. .....+||+.|+|||++.+..+ ++++|||||||++|+|++|..||.......... .+
T Consensus 160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~i 220 (336)
T 3h4j_B 160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------KV 220 (336)
T ss_dssp TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------CC
T ss_pred CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------HH
Confidence 322 2345679999999999988776 689999999999999999999997654322110 00
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .....+...+..+.+|+.+||+.||.+|||++|+++
T Consensus 221 ~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 NS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred Hc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 00 011233445668999999999999999999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=342.55 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=213.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4679999999999999999998875 6789999997544 3456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999875 2346899999999999999999999999 9999999999999999999999999998654332
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............ . ...
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~-~~~-------- 222 (268)
T 3sxs_A 159 -YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV------S-QGH-------- 222 (268)
T ss_dssp -EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------H-TTC--------
T ss_pred -hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH------H-cCC--------
Confidence 222333456778999999999899999999999999999999 99999765433211111 0 000
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
....+...+..+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus 223 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 223 --RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 011122234579999999999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=349.54 Aligned_cols=261 Identities=18% Similarity=0.195 Sum_probs=213.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.+ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4689999999999999999999999999999999865432 34578999999999 89999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc-----eEEccccccc
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN-----PKLSDFGLAK 206 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~-----~kl~Dfg~~~ 206 (336)
|+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999998763 467999999999999999999999998 999999999999998887 9999999998
Q ss_pred cCCCCCCcc-----eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 207 LGPTGGKDH-----VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 207 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 654332211 124578999999999999999999999999999999999999999876544332222211110000
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.... .+ ....+ .+.+++..||+.||.+||++.++++.|+.+
T Consensus 239 -~~~~-----~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 -TPIE-----VL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp -SCHH-----HH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -CCHH-----HH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0000 00 01123 799999999999999999999999999765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=356.55 Aligned_cols=250 Identities=25% Similarity=0.359 Sum_probs=208.7
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 127 (336)
..++|++.+.||+|+||.||+|.++.+|+.||+|++... .......+..|..++..+ +||+|+++++++.+....+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 357899999999999999999999999999999998653 123446678899999887 7999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999875 356899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.. ..+....
T Consensus 171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~~~----- 237 (353)
T 2i0e_A 171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIMEHN----- 237 (353)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC-----
T ss_pred cccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH------HHHHhCC-----
Confidence 3222 12345578999999999999999999999999999999999999999865432211 1111110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
..++...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 238 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 238 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred -------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1233445668999999999999999995 567664
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=345.77 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=200.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--------------------------ccHHHHHHHHHHHh
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--------------------------QGSREFFAEVLMLS 106 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 106 (336)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999999999999999865421 11346889999999
Q ss_pred hccCCCccceEEEEEe--CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 036144 107 LVQHQNLVNLIGYCAD--GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDF 184 (336)
Q Consensus 107 ~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~di 184 (336)
.++||||+++++++.+ ....++||||+++++|.+++. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999986 568899999999999987643 357999999999999999999999998 999999
Q ss_pred CCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCC
Q 036144 185 KASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ---LTKKSDVYSFGVVLLELITGRSAID 261 (336)
Q Consensus 185 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~g~~p~~ 261 (336)
||+|||++.++.+||+|||++...... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999999999999999999999865432 22344567999999999987765 4788999999999999999999997
Q ss_pred CCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 262 NSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....... ........ . ........+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~------~~~~~~~~--~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCL------HSKIKSQA--L--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHH------HHHHHHCC--C--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHH------HHHHhccc--C--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 6432211 11111110 0 00011234557999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=357.09 Aligned_cols=264 Identities=24% Similarity=0.405 Sum_probs=215.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
..++|.+.+.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999997 3558999999976533 234668899999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 036144 126 RILVYEFMSNGSLENHFLDLPPD--------------------QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFK 185 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dik 185 (336)
.++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 99999999999999999764221 267999999999999999999999999 9999999
Q ss_pred CCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 036144 186 ASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSR 264 (336)
Q Consensus 186 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~ 264 (336)
|+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999975433222223344578999999999999999999999999999999999 999997654
Q ss_pred CcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 265 PSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
..+.... . ..+ .. ...+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 282 ~~~~~~~------~-~~~-~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 HEEVIYY------V-RDG-NI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HHHHHHH------H-HTT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hHHHHHH------H-hCC-Cc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 3221111 1 111 00 11233455689999999999999999999999999998753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=342.98 Aligned_cols=256 Identities=28% Similarity=0.507 Sum_probs=208.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc-------HHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG-------SREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 478999999999999999999999999999999986543221 156889999999999999999999987665
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc-----eEEc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN-----PKLS 200 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~-----~kl~ 200 (336)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ .+|+||||||+||+++.++. +||+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999988865 3467999999999999999999999865 45999999999999988776 9999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccc--cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM--TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|..||............. .
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~ 242 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM----I 242 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH----H
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH----H
Confidence 9999974322 244567999999999984 4567899999999999999999999998655432211111 1
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.. ......++...+..+.+++.+||+.||.+|||+.++++.|+.|
T Consensus 243 ~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 RE----------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH----------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hc----------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 10 1111223344566899999999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=352.28 Aligned_cols=263 Identities=23% Similarity=0.351 Sum_probs=197.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCe---EEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQ---VVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
..++|.+.+.||+|+||.||+|.+..++. .||+|++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34689999999999999999999987665 8999998754 233456789999999999999999999999877655
Q ss_pred ------EEEEEcCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceE
Q 036144 127 ------ILVYEFMSNGSLENHFLDLP--PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 127 ------~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 89999999999999986422 22336899999999999999999999999 99999999999999999999
Q ss_pred EccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHH
Q 036144 199 LSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKP 277 (336)
Q Consensus 199 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 277 (336)
|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+....+.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---- 253 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI---- 253 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh----
Confidence 999999986544333333444567889999999999999999999999999999999 999998765433221111
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.. . ....+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 254 --~~-~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 254 --GG-N----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp --TT-C----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cC-C----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 0 01123344568999999999999999999999999998763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=343.68 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=212.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 3678999999999999999999975 6789999997543 3456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999865 3456899999999999999999999999 9999999999999999999999999997643221
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ . ..
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~------~-~~--------- 223 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------S-TG--------- 223 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------H-TT---------
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------h-cC---------
Confidence 112233457788999999999999999999999999999999 99999865432211111 1 00
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 011122334567999999999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=365.23 Aligned_cols=256 Identities=21% Similarity=0.240 Sum_probs=209.5
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
....++|++.+.||+|+||.||+|.++.+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+....
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 344578999999999999999999999999999999986421 12234578999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||++||+|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 145 ~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999865 35899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ----LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
...... .......+||+.|+|||++.+.. |+.++|||||||++|+|++|..||...+.......+......+
T Consensus 217 ~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--- 292 (410)
T 3v8s_A 217 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--- 292 (410)
T ss_dssp ECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---
T ss_pred eeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc---
Confidence 654322 22334678999999999998765 8899999999999999999999998655332221111110000
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADS--RPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~ 328 (336)
.-+ .....+..+.+||.+||+.+|.+ ||+++|+++
T Consensus 293 ------~~p-----~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 293 ------TFP-----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ------CCC-----TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ------cCC-----CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 000 01124568999999999999988 999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=349.92 Aligned_cols=266 Identities=27% Similarity=0.375 Sum_probs=210.0
Q ss_pred hcCCCCcccccccCceEEEEEE----EcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGY----IEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 126 (336)
.++|++.+.||+|+||.||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4789999999999999999998 566799999999987665556778999999999999999999999854 3568
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999762 345899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc---------cccHHHHHH
Q 036144 207 LGPTGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE---------EQNLVTWAK 276 (336)
Q Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~ 276 (336)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|..||....... .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 65432211 12233457788999999999999999999999999999999999886532110 000000011
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.... .......+...+..+.+++.+||+.||++|||+.++++.|+.|.
T Consensus 243 ~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 243 ELLK----------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHH----------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHh----------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111 11111233445668999999999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=358.56 Aligned_cols=263 Identities=26% Similarity=0.370 Sum_probs=215.7
Q ss_pred HhcCCCCcccccccCceEEEEEEEcc-------cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEA-------VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCAD 122 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 122 (336)
..++|.+.+.||+|+||.||+|.+.. .+..||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 34789999999999999999999753 336899999876533 2336688999999999 89999999999999
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL 190 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil 190 (336)
....++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999976431 1356999999999999999999999998 999999999999
Q ss_pred ECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccc
Q 036144 191 LDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQ 269 (336)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~ 269 (336)
++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~ 303 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986544333333444567899999999999999999999999999999999 99999765432211
Q ss_pred cHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 270 NLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.. +... .....+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 304 ~~-------~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 304 KL-------LKEG----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HH-------HHTT----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-------HHcC----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1111 011122334568999999999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=355.00 Aligned_cols=265 Identities=25% Similarity=0.365 Sum_probs=213.6
Q ss_pred HhcCCCCcccccccCceEEEEEEE-----cccCeEEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGD 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 124 (336)
..++|.+.+.||+|+||.||+|.+ ..++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++....
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357899999999999999999997 3457789999997542 23346789999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPD-------------------QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFK 185 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dik 185 (336)
..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999763221 134789999999999999999999998 9999999
Q ss_pred CCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCC
Q 036144 186 ASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSR 264 (336)
Q Consensus 186 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~ 264 (336)
|+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999976544333333445668899999999999999999999999999999998 999998755
Q ss_pred CcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 265 PSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
..... .. ..... .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 280 ~~~~~--~~----~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 280 VDANF--YK----LIQNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CSHHH--HH----HHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cHHHH--HH----HHhcC----------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 32211 11 11111 1112233345689999999999999999999999999988653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-49 Score=350.60 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=204.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|++.+.||+|+||.||+|.++.+++.||+|++.+... ...+.+.+|..+++.+ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3679999999999999999999999999999999975432 2335578899999887 89999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 88 v~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999865 356899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc---cHHHHHHHHhhccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ---NLVTWAKPLLRDKKKF 285 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 285 (336)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........+...
T Consensus 161 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---- 234 (345)
T 3a8x_A 161 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---- 234 (345)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC----
T ss_pred cCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC----
Confidence 222 12345578999999999999999999999999999999999999999753322110 111111111111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
...++...+..+.+|+.+||+.||.+||++
T Consensus 235 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 235 --------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 012334456689999999999999999996
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=364.83 Aligned_cols=262 Identities=20% Similarity=0.217 Sum_probs=211.9
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeC
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG 123 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 123 (336)
..+....++|++.++||+|+||.||+|.++.+++.||+|++.+.. ......+.+|+.++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 334445678999999999999999999999999999999986421 11223478899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
...++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 999999999999999999975 2467999999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
++....... .......+||+.|+|||++. ...|+.++|||||||++|||++|..||...+..+....+......
T Consensus 221 la~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 221 SCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 997653322 22334468999999999987 467899999999999999999999999875543322222111000
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHH
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADS--RPFMVDVVT 328 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--Rpt~~evl~ 328 (336)
+ .-+. .....+..+.+||.+||+.+|++ ||+++|+++
T Consensus 300 ~---------~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 300 F---------QFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp C---------CCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred c---------cCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0 0010 11124568999999999988888 999999986
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=348.20 Aligned_cols=270 Identities=22% Similarity=0.271 Sum_probs=195.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4679999999999999999999999999999999865432 334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 132 FMSNGSLENHFLDLP--PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|++ |+|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 996 69998876421 22356899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----Hhhccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-----LLRDKK 283 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~ 283 (336)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+..... .+....
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 221 22344578999999999876 4689999999999999999999999987654332211111000 000000
Q ss_pred cccc---ccCCcc--------CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTM---MADPLL--------EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~---~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... ...... ........+..+.+|+.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 000000 00011123558999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=358.80 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=200.4
Q ss_pred hcCCCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
..+|.+.+.||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999986 4577899999875432 234578999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999975 3456999999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 209 PTGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+ ...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i-------~~~---- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-------DEG---- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-------HTT----
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC----
Confidence 432211 11222345788999999999999999999999999999998 99999765432211111 110
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 01112234456899999999999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=344.42 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=218.4
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|++.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 4578999999999999999999999999999999986543 345778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999763 3466899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||............. .
T Consensus 165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-------~--------- 227 (288)
T 3kfa_A 165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------K--------- 227 (288)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------T---------
T ss_pred c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------c---------
Confidence 2 223344567889999999999999999999999999999999 999998765433211111 0
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
......+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 228 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 228 -DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 0111223344568999999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=339.94 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=199.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC----ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN----QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|++.+.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 367899999999999999999986 78999999865432 224678899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC--------CCceEEc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA--------EFNPKLS 200 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~--------~~~~kl~ 200 (336)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+|+||||||+||+++. ++.++|+
T Consensus 84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999998853 57899999999999999999999987555889999999999986 6789999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLR 280 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 280 (336)
|||++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......... ...
T Consensus 159 Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~- 227 (271)
T 3dtc_A 159 DFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------GVA- 227 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHH-
T ss_pred cCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------hhh-
Confidence 99999754332 1234579999999999999999999999999999999999999998654322111 000
Q ss_pred cccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 281 DKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
........+...+..+.+++.+||+.||.+|||+.++++.|+.|
T Consensus 228 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 ---------MNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ---------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ---------cCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 01111123344556899999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=354.13 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=208.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeE----EEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQV----VAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+.... ......+.+|+.+++.++||||+++++++. ....+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 36799999999999999999999877765 7788775432 233356778999999999999999999886 45688
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+.+|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999875 2456888899999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..............||..|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~--- 234 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-------KGE--- 234 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-------TTC---
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCC---
Confidence 655544444556678899999999999999999999999999999999 999998765433222211 100
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112223346788999999999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=355.10 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=198.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 35789999999999999999999999999999999975433 34668899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc--eEEccccccccCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN--PKLSDFGLAKLGP 209 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~ 209 (336)
|+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++....
T Consensus 97 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 97 YASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999865 356999999999999999999999999 999999999999987765 9999999987432
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCc-cchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKK-SDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
. ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||......... ...........
T Consensus 170 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~------ 238 (361)
T 3uc3_A 170 L---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVK------ 238 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTC------
T ss_pred c---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCC------
Confidence 2 122345679999999999988887655 89999999999999999999875543221 11111111111
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.........+..+.+|+.+||+.||++|||+.++++
T Consensus 239 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 239 ----YSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ----CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ----CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 000011123457899999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=343.51 Aligned_cols=263 Identities=16% Similarity=0.187 Sum_probs=214.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 467999999999999999999999999999999986443 234578899999999 79999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc-----eEEccccccc
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN-----PKLSDFGLAK 206 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~-----~kl~Dfg~~~ 206 (336)
|+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++.
T Consensus 87 ~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 99999999762 356999999999999999999999998 999999999999987776 9999999998
Q ss_pred cCCCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 207 LGPTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 207 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 65433221 1234567999999999999999999999999999999999999999876543332222211110000
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..... .....+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 240 -~~~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 240 -TPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp -SCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -ccHHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 00000 01123458999999999999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=348.76 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=207.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccC-------eEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVD-------QVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467999999999999999999998776 5799999977665666789999999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc--------e
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN--------P 197 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~--------~ 197 (336)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999976 2344899999999999999999999999 999999999999988887 9
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCC-CCCCCCCcccccHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRS-AIDNSRPSEEQNLVTWA 275 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~-p~~~~~~~~~~~~~~~~ 275 (336)
||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|.. ||........ ..
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~-- 229 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---LQ-- 229 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HH--
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH---HH--
Confidence 9999999864322 233568999999999987 679999999999999999999654 4443322111 10
Q ss_pred HHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccCC
Q 036144 276 KPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336 (336)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~~ 336 (336)
...... ..+...+..+.+++.+||+.||.+|||+.++++.|+.+..|
T Consensus 230 --~~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 230 --FYEDRH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --HHHTTC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --HhhccC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 011100 11111234688999999999999999999999999998776
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=349.14 Aligned_cols=264 Identities=26% Similarity=0.366 Sum_probs=215.9
Q ss_pred HhcCCCCcccccccCceEEEEEEE-----cccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeCC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADGD 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 124 (336)
..++|.+.+.||+|+||.||+|.+ ..++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999985 45678999999976543 2346788999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeE
Q 036144 125 QRILVYEFMSNGSLENHFLDLPP--------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNIL 190 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil 190 (336)
..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999876421 1235899999999999999999999998 999999999999
Q ss_pred ECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccc
Q 036144 191 LDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQ 269 (336)
Q Consensus 191 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~ 269 (336)
++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999987654433333444567889999999999999999999999999999999 99999775532211
Q ss_pred cHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 270 NLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..... .. .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 258 --~~~~~----~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 --YKMIK----EG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp --HHHHH----HT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHhc----cC----------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11111 00 001112334568999999999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=342.66 Aligned_cols=263 Identities=22% Similarity=0.299 Sum_probs=201.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|.+.+.||+|+||.||+|.+ .+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5789999999999999999999 5689999999865432 223678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLD-QDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCS-EEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 996 499888865 3466899999999999999999999998 999999999999999999999999999764322
Q ss_pred CCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc-ccc---c
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK-KKF---T 286 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~---~ 286 (336)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+. ...-... ... .
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF--RILGTPNSKNWPNVT 229 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HHHCCCCTTTSTTGG
T ss_pred --ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--HHHCCCChhhchhhh
Confidence 1223445789999999998764 58999999999999999999999998754322211111 0000000 000 0
Q ss_pred c--ccCCcc-------CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 M--MADPLL-------EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~--~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ..++.. ...+....+..+.+|+.+||+.||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 000000 01112234668899999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=346.56 Aligned_cols=264 Identities=23% Similarity=0.300 Sum_probs=204.7
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
..++|++.+.||+|+||.||+|.+.. |+.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 45789999999999999999999964 89999999865432 2235688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 98 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 98 FEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 99996 588888765 3456999999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc--cccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK--KKFT 286 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 286 (336)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.. ..... ....
T Consensus 171 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~---~~~~~~~~~~~ 245 (311)
T 3niz_A 171 IP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS---ILGTPNPREWP 245 (311)
T ss_dssp SC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH---HHCCCCTTTSG
T ss_pred CC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH---HHCCCChHHhh
Confidence 32 222344678999999999876 5689999999999999999999999987654433222211 00000 0000
Q ss_pred cc------cC---CccCC----CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MM------AD---PLLEG----QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~------~~---~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .. ..... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 00 00000 011223457899999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=351.52 Aligned_cols=266 Identities=23% Similarity=0.277 Sum_probs=211.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe----CCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD----GDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 128 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 4789999999999999999999999999999999876555556778999999999999999999999862 347889
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998765445678999999999999999999999998 999999999999999999999999998754
Q ss_pred CCCCCcc-------eeeeeccCccccCccccccCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 209 PTGGKDH-------VSTRVMGTYGYCAPEYAMTGQ---LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 209 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
....... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||........ .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~---- 259 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVALA---- 259 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHHH----
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhHH----
Confidence 2111000 012245799999999987654 68999999999999999999999853211110 00000
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccCC
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~~ 336 (336)
... ......+...+..+.+++.+||+.||.+|||+.++++.|+.+..|
T Consensus 260 ~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 VQN----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHC----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred hhc----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 000 001111233456899999999999999999999999999998765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=368.27 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=216.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
...+|.+.+.||+|+||.||+|.++.++..||||.+.... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 3467888999999999999999999999999999987543 346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 297 ~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999763 3456899999999999999999999999 999999999999999999999999999865332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ........++..|+|||++.+..++.++|||||||++|+|++ |..||......+....+ ...
T Consensus 372 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~-------- 435 (495)
T 1opk_A 372 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKD-------- 435 (495)
T ss_dssp C-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-------HTT--------
T ss_pred c-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC--------
Confidence 1 112223456789999999999999999999999999999999 99999876543221111 111
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 436 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 436 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 111223445668999999999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=350.48 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=205.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeE----EEEEeecCC-CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQV----VAVKQLDRS-GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
.++|++.+.||+|+||.||+|.+..+++. ||+|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 46799999999999999999999877765 477766543 2344577899999999999999999999998765 78
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+|++|+.+|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 99999999999999876 3456999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~---- 235 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KG---- 235 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TT----
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cC----
Confidence 544333333444567889999999999999999999999999999999 999998765433221111 10
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 236 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 236 ------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011223345568999999999999999999999999998865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=362.34 Aligned_cols=261 Identities=21% Similarity=0.217 Sum_probs=209.1
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeC
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG 123 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 123 (336)
.+.....++|++.+.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 333445688999999999999999999999999999999986432 12234578899999999999999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFG 203 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg 203 (336)
...|+||||++||+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999752 346899999999999999999999999 9999999999999999999999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccc-------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-------TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 276 (336)
++....... .......+||+.|+|||++. ...|+.++|||||||++|||++|..||...+..+....+....
T Consensus 208 la~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 208 SCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 998654322 22233468999999999987 3578999999999999999999999998755432221111110
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHH
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSR---PFMVDVVT 328 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---pt~~evl~ 328 (336)
.. ...+. .+...+..+.+||.+||+ +|.+| |+++|+++
T Consensus 287 ~~---------~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 EH---------LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HH---------CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cC---------cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00 00011 122345689999999999 99998 58999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=363.73 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=209.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999999999999999986432 22345788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999864 467999999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.+. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... .+....
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~------~i~~~~------ 232 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK------KICDGI------ 232 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH------HHHTTC------
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH------HHhcCC------
Confidence 322 2345689999999999988776 689999999999999999999998654322111 111100
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 233 ------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 ------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0112234557999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=342.42 Aligned_cols=262 Identities=22% Similarity=0.327 Sum_probs=203.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhh--ccCCCccceEEEEEe----CCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSL--VQHQNLVNLIGYCAD----GDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~----~~~~ 126 (336)
.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 47899999999999999999988 4889999998643 34456667777666 789999999998654 3457
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCCeEECCCCceE
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH--------DVADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh--------~~~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 899999999999999953 46999999999999999999999 777 99999999999999999999
Q ss_pred EccccccccCCCCCCcc--eeeeeccCccccCccccccC------CCCCccchhhHHHHHHHHHhC----------CCCC
Q 036144 199 LSDFGLAKLGPTGGKDH--VSTRVMGTYGYCAPEYAMTG------QLTKKSDVYSFGVVLLELITG----------RSAI 260 (336)
Q Consensus 199 l~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g----------~~p~ 260 (336)
|+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997543322211 12335799999999999876 455799999999999999999 7888
Q ss_pred CCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 261 DNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
............. ......... ........++...+..+.+|+.+||+.||++|||+.++++.|+.|
T Consensus 234 ~~~~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDM--RKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHH--HHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhh--hHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 6644332211111 111111000 011111122345678899999999999999999999999999876
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=355.89 Aligned_cols=272 Identities=19% Similarity=0.237 Sum_probs=208.1
Q ss_pred HhcCCCCccccccc--CceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 52 ATENFNPDCLVGEG--GYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 52 ~~~~y~~~~~ig~G--~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
...+|++.+.||+| +||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 35789999999999 99999999999999999999987543 223456788999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999998763 2356999999999999999999999999 99999999999999999999999998864
Q ss_pred CCCCCC-----cceeeeeccCccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH-HHHHHh
Q 036144 208 GPTGGK-----DHVSTRVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT-WAKPLL 279 (336)
Q Consensus 208 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~ 279 (336)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............. ...+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 322111 111223478999999999987 679999999999999999999999998755433211100 000000
Q ss_pred -hcc----cc-------------ccc---------ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 -RDK----KK-------------FTM---------MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 -~~~----~~-------------~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... .. ... .........++...+..+.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 00 000 00000011233445668999999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=366.40 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=200.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999998643 223345678899999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||++...
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999998865 4578999999999999999999998 88 999999999999999999999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ....
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~------ 365 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEE------ 365 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC------
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhCC------
Confidence 222 22344578999999999999999999999999999999999999999765432221111 1110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+||.+||+.||.+|| |++++++
T Consensus 366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 112334556899999999999999999 9999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=366.81 Aligned_cols=254 Identities=27% Similarity=0.383 Sum_probs=211.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999999999999999986431 23345688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||++||+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999998763 2345999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+. ......
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~--~~i~~~-------- 404 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--RLVKEV-------- 404 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH--HHHHHC--------
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH--HHhhcc--------
Confidence 332 2345689999999999999999999999999999999999999998754322211111 111110
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
...++...+..+.+||.+||+.||.+|| +++|+++
T Consensus 405 ----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 ----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1123344566899999999999999999 7888875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=341.74 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=209.4
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 34689999999999999999998874 7789999997543 335678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999875 2456999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+. ..
T Consensus 174 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~-------- 237 (283)
T 3gen_A 174 E-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QG-------- 237 (283)
T ss_dssp H-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------TT--------
T ss_pred c-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-------cc--------
Confidence 1 111223456788999999999999999999999999999998 999998755332211111 00
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 238 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 238 --LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 011122233458999999999999999999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=341.68 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=203.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-----CccHHHHHHHHHHHhhcc---CCCccceEEEEEeC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-----NQGSREFFAEVLMLSLVQ---HQNLVNLIGYCADG 123 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~ 123 (336)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999999999999999986432 112346677888877765 99999999999876
Q ss_pred C-----eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceE
Q 036144 124 D-----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 124 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
. ..++||||+. ++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 5789999995 6999998763 2345999999999999999999999999 99999999999999999999
Q ss_pred EccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 199 LSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 199 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+......
T Consensus 161 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999765332 2234567999999999999999999999999999999999999999875543322111110000
Q ss_pred hhccccccc-------ccCCccC---CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRDKKKFTM-------MADPLLE---GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~~~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ....... ...+... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 P-PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp C-CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 0 0000000 0000000 0011234568899999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=348.59 Aligned_cols=253 Identities=26% Similarity=0.302 Sum_probs=205.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..++|++.+.||+|+||.||+|.++.+|+.||+|++...... ..+|++++..+ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 356799999999999999999999999999999999765432 34688888877 7999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC----CceEEccccccc
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE----FNPKLSDFGLAK 206 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~----~~~kl~Dfg~~~ 206 (336)
||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+..+ +.+||+|||++.
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 99999999999865 456999999999999999999999999 9999999999998443 349999999998
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.............. +....
T Consensus 169 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---i~~~~---- 239 (342)
T 2qr7_A 169 QLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR---IGSGK---- 239 (342)
T ss_dssp ECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH---HHHCC----
T ss_pred cCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH---HccCC----
Confidence 653322 223456899999999999888899999999999999999999999986433222222211 11110
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......+....+..+.+|+.+||+.||++|||+.++++
T Consensus 240 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 240 ----FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ----CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ----cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111223345668999999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=348.29 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=183.0
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
.+.||+|+||.||+|.++.+++.||+|++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999999999999999998643 3456789999999997 9999999999999999999999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC---ceEEccccccccCCCCCCc
Q 036144 138 LENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF---NPKLSDFGLAKLGPTGGKD 214 (336)
Q Consensus 138 L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~---~~kl~Dfg~~~~~~~~~~~ 214 (336)
|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||++...... .
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~ 163 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--N 163 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC--C
Confidence 9999976 467999999999999999999999999 99999999999997665 7999999999865332 2
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc-cHHHHHHHHhhcccccccccCCcc
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ-NLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........+.... ...
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--------~~~ 235 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--------FSF 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC--------CCC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC--------CCC
Confidence 2334567899999999999999999999999999999999999999875432211 1111111111110 001
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........+..+.+|+.+||+.||.+|||++++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11111234668999999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=346.92 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=209.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc------cHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ------GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999999999999999998654321 356789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC----ceEEccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF----NPKLSDF 202 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~----~~kl~Df 202 (336)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .++|+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999865 456899999999999999999999998 99999999999999888 7999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+... .+....
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NITSVS 234 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHTTC
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhcc
Confidence 9998654322 2344579999999999999999999999999999999999999997654322111 111000
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ....+....+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 YD--------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC--------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc--------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000111233557899999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=348.88 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=194.4
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4577999999999999999999999999999999987543 34567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC---CCceEEccccccccC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA---EFNPKLSDFGLAKLG 208 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~~ 208 (336)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999865 456899999999999999999999998 999999999999975 889999999999764
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ . ...+.....
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~~i~~~~~----- 268 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---FRRILNCEY----- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---HHHHHTTCC-----
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---HHHHHhCCC-----
Confidence 322 223456799999999999999999999999999999999999999976543221 0 111111100
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..........+..+.+|+.+||+.||++|||+.++++
T Consensus 269 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 ---YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111122344568999999999999999999999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=355.37 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=200.7
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
.+.||+|+||.||+|.+..+|..||+|++........+.+.+|+.+++.++||||+++++++.+....++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999999999999999999776555567789999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE--CCCCceEEccccccccCCCCCCcce
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL--DAEFNPKLSDFGLAKLGPTGGKDHV 216 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~~~ 216 (336)
.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++....... .
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~ 244 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---K 244 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---B
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---c
Confidence 998865 3456899999999999999999999999 9999999999999 667889999999998654332 2
Q ss_pred eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCC
Q 036144 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQ 296 (336)
Q Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (336)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||......+.. ..+....... ...
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~~~~~--------~~~ 310 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL------NNILACRWDL--------EDE 310 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTCCCS--------CSG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhccCCC--------Chh
Confidence 33457999999999999889999999999999999999999999865432211 1111111000 001
Q ss_pred CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 297 YPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 297 ~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+..+.+||.+||+.||.+|||+.++++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11234568999999999999999999999987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=347.68 Aligned_cols=249 Identities=27% Similarity=0.349 Sum_probs=198.8
Q ss_pred hcCCCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCC----CccHHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
.++|++.+.||+|+||.||+|.+. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999999999999985 679999999997642 2233557889999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999865 356889999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
...... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+....
T Consensus 169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~~~--- 237 (327)
T 3a62_A 169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DKILKCK--- 237 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHTC---
T ss_pred cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhCC---
Confidence 753222 12234467999999999999999999999999999999999999999865432211 1111110
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 238 ---------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ---------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 112334456899999999999999999 7788876
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=339.86 Aligned_cols=267 Identities=25% Similarity=0.306 Sum_probs=204.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++......++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36799999999999999999999999999999998654332 2356789999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999888764 456899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHHhhc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------KPLLRD 281 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~ 281 (336)
. ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+....+... ...+..
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 155 P--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 2 122345679999999999876 57899999999999999999999999876543332221110 001111
Q ss_pred ccccccccCCccCCCC-----cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFTMMADPLLEGQY-----PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.........+...... ....+..+.+|+.+||+.||.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1111111000000000 0234557899999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=341.05 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=200.0
Q ss_pred hcCCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 46899999999999999999998643 56799999875433 23456889999999999999999999984 567889
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999975 2456899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...
T Consensus 167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------~~~---- 234 (281)
T 1mp8_A 167 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGE---- 234 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC----
T ss_pred Cccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------cCC----
Confidence 3322 112233457889999999999999999999999999999996 999998755433211111 100
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 235 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 235 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01123345568999999999999999999999999998763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=363.95 Aligned_cols=256 Identities=26% Similarity=0.369 Sum_probs=212.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|.+.+.||+|+||.||+|.++.+|+.||+|++.+.. ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67899999999999999999999999999999986432 233467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||++||+|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999998875545667999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.. ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......... ...........
T Consensus 342 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~~~~-------- 409 (543)
T 3c4z_A 342 GQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVLEQA-------- 409 (543)
T ss_dssp TC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHHHCC--------
T ss_pred CC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHhhcc--------
Confidence 32 1234468999999999999999999999999999999999999999875432211 11111111110
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM-----VDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~ 328 (336)
..++...+..+.+||.+||+.||.+||++ +++++
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 12334456689999999999999999975 66653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=336.97 Aligned_cols=248 Identities=21% Similarity=0.276 Sum_probs=209.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|.+.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 34679999999999999999999999999999999977655667889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---CCCCceEEccccccccC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 208 (336)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999998865 356899999999999999999999999 9999999999999 78889999999999765
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......+....+ .....
T Consensus 160 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~----- 224 (277)
T 3f3z_A 160 KPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI------REGTF----- 224 (277)
T ss_dssp CTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC-----
T ss_pred cCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhCCC-----
Confidence 4322 2344679999999998765 4999999999999999999999999875432211111 11000
Q ss_pred cCCccCCCCcH----HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPR----KGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.++. ..+..+.+++.+||+.||.+|||+.++++
T Consensus 225 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 225 -------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 23568999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=356.51 Aligned_cols=246 Identities=26% Similarity=0.327 Sum_probs=197.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHH-HhhccCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLM-LSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|++.+.||+|+||.||+|.++.+++.||+|++.+... .....+..|..+ ++.++||||+++++++.+....|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4689999999999999999999999999999999865432 223445667766 567899999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999865 356889999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... .......+||+.|+|||++.+..++.++|+|||||++|+|++|..||...+..+.. ..+....
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~~~------ 255 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNILNKP------ 255 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH------HHHHHSC------
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHHhcc------
Confidence 221 12345578999999999999999999999999999999999999999765432211 1111110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVD 325 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~e 325 (336)
..++...+..+.+||.+||+.||.+||++.+
T Consensus 256 ------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 ------LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1123345568999999999999999999853
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=352.39 Aligned_cols=264 Identities=22% Similarity=0.239 Sum_probs=206.4
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC-----CCccHHHHHHHHHHHhhccCCCccceEEEEEe
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS-----GNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 122 (336)
++....++|.+.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4456678899999999999999999999999999999998643 23445678999999999999999999999999
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPD------------------------------------QEPLDWFTRMKIAGGAAK 166 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~l~~ 166 (336)
....++||||+++|+|.+++...... ...+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999988531111 122456778899999999
Q ss_pred HHHHHHhCCCCCeeeCCCCCCCeEECCCC--ceEEccccccccCCCCC--CcceeeeeccCccccCcccccc--CCCCCc
Q 036144 167 GLEYLHDVADPPVIYRDFKASNILLDAEF--NPKLSDFGLAKLGPTGG--KDHVSTRVMGTYGYCAPEYAMT--GQLTKK 240 (336)
Q Consensus 167 ~l~~lh~~~~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 240 (336)
||.|||+.+ |+||||||+||+++.++ .+||+|||++....... .........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 99999999999998776 89999999997543211 1122345679999999999875 678999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCC
Q 036144 241 SDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSR 320 (336)
Q Consensus 241 ~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 320 (336)
+|||||||++|+|++|..||......+... ........ .........+..+.+|+.+||+.||.+|
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~~~~------~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKKLC--------FENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCC--------TTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcccc--------cCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 999999999999999999997655322111 11111100 0011112345689999999999999999
Q ss_pred CCHHHHHH
Q 036144 321 PFMVDVVT 328 (336)
Q Consensus 321 pt~~evl~ 328 (336)
||+.++++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=336.15 Aligned_cols=255 Identities=26% Similarity=0.371 Sum_probs=209.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467999999999999999999999999999999986443 233467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999998864 456899999999999999999999998 99999999999999999999999999976533
Q ss_pred CCCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
...........||+.|+|||.+.+..+ +.++||||||+++|+|++|..||......... ...+. ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~----~~~------- 225 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK----EKK------- 225 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHH----TTC-------
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhh----hcc-------
Confidence 322233445679999999999987765 78999999999999999999999875432211 11110 000
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.........+..+.+++.+||+.||.+|||+.++++
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 ---TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000112334568899999999999999999999986
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=347.87 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=212.1
Q ss_pred hcCCCCcccccccCceEEEEEEEc-------ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIE-------AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADG 123 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 123 (336)
.++|.+.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999985 3567899999875432 2346688999999999 899999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
...++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999976432 1235899999999999999999999998 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQN 270 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~ 270 (336)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 9999999999999986544332223344567889999999998899999999999999999999 999997654322111
Q ss_pred HHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+ . ... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 271 ~~------~-~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 271 LL------K-EGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HH------H-HTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH------h-cCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 1 100 01122344568999999999999999999999999998763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=341.20 Aligned_cols=266 Identities=25% Similarity=0.332 Sum_probs=211.0
Q ss_pred hcCCCCcccccccCceEEEEEE----EcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeC--Ce
Q 036144 53 TENFNPDCLVGEGGYGRVYKGY----IEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 125 (336)
...|++.+.||+|+||.||+|. +..+++.||+|++.... ......+.+|+.+++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3568999999999999999999 56789999999987543 33457789999999999999999999999876 67
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp EEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence 8999999999999999865 2456899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc--------ccccHHHHHH
Q 036144 206 KLGPTGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPS--------EEQNLVTWAK 276 (336)
Q Consensus 206 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~ 276 (336)
......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+...... ..........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 875443221 2233456888999999999999999999999999999999999886532110 0000000001
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
... ........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 254 ~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTL----------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHH----------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHH----------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111 111112234455678999999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=340.32 Aligned_cols=254 Identities=24% Similarity=0.308 Sum_probs=203.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|.+.+.||+|+||.||+|.+..++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999999999999999986543 3345778999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---CCCCceEEccccccccC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 208 (336)
|+++|+|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988653334567999999999999999999999999 9999999999999 55678999999999754
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... .......||+.|+|||++. ..++.++||||||+++|+|++|..||......+....... ......
T Consensus 178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------~~~~~~-- 245 (285)
T 3is5_A 178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------KEPNYA-- 245 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCCCC--
T ss_pred CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------CCcccc--
Confidence 332 2234567999999999875 5789999999999999999999999987543222111110 000000
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 246 ---~----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 ---V----ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---C------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---c----ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00113457889999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=339.03 Aligned_cols=262 Identities=27% Similarity=0.444 Sum_probs=198.4
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
..++|.+.+.||+|+||.||+|.+.. .||+|++..... ...+.+.+|+.+++.++||||++++++. .....++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 35789999999999999999998764 499999865432 2346688999999999999999999965 45668999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999865 3467999999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCCcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
............||+.|+|||++. +..++.++||||||+++|+|++|..||......+. ..... ... ..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~----~~~-~~- 243 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMV----GRG-SL- 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHH----HHT-SC-
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHh----ccc-cc-
Confidence 333333344567999999999986 56788999999999999999999999987543221 11111 010 00
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
.+. ........+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 244 ---~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 ---SPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---CCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---Ccc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 000 011223445689999999999999999999999999998753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=358.56 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=208.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCC-eEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD-QRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 467889999999999999999986 6799999997543 4577999999999999999999999987665 7899999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999762 2344789999999999999999999999 999999999999999999999999999754221
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.....++..|+|||++.+..++.++|||||||++|||++ |..||......+....+ ..+
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~~-------- 402 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKG-------- 402 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-------HTT--------
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC--------
Confidence 222367889999999999999999999999999999998 99999876543321111 111
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+..++..+.+|+.+||+.||.+|||+.++++.|+.|.
T Consensus 403 --~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 403 --YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011233445668999999999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=350.60 Aligned_cols=253 Identities=19% Similarity=0.248 Sum_probs=195.8
Q ss_pred hcCCCCc-ccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHh-hccCCCccceEEEEEe----CCeE
Q 036144 53 TENFNPD-CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLS-LVQHQNLVNLIGYCAD----GDQR 126 (336)
Q Consensus 53 ~~~y~~~-~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~----~~~~ 126 (336)
.++|.+. +.||+|+||.||+|.++.+|+.||||++.. ...+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3566665 689999999999999999999999999853 245678888874 4589999999999875 5678
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC---CCceEEcccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA---EFNPKLSDFG 203 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~---~~~~kl~Dfg 203 (336)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999762 2356999999999999999999999998 999999999999987 7889999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccccc-HHHHHHHHhhcc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQN-LVTWAKPLLRDK 282 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~ 282 (336)
++...... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......... ...... ...
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~ 283 (400)
T 1nxk_A 210 FAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQ 283 (400)
T ss_dssp TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTC
T ss_pred cccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCc
Confidence 99864322 22345689999999999999999999999999999999999999998755433211 111110 000
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.. .........+..+.+||.+||+.||++|||+.++++.
T Consensus 284 ~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 YE--------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC--------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc--------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0001112345689999999999999999999999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=339.12 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=205.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 478999999999999999999999999999999985432 12245688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999865 356899999999999999999999988 9999999999999999999999999986432
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
. .......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+....+. ..
T Consensus 161 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~-------- 222 (279)
T 3fdn_A 161 S----SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------RV-------- 222 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HT--------
T ss_pred c----ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH------hC--------
Confidence 2 22345679999999999999999999999999999999999999998654322111111 00
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...++...+..+.+|+.+||+.||.+|||+.++++
T Consensus 223 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 223 ----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11223334567899999999999999999999997
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=347.09 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=200.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCC-------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD------- 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 124 (336)
.++|++.+.||+|+||.||+|.++.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4679999999999999999999999999999999875432 34567899999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEcCCCCChhhhhccCCCCCCCCCH
Q 036144 125 --------------------------------------------------QRILVYEFMSNGSLENHFLDLPPDQEPLDW 154 (336)
Q Consensus 125 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~ 154 (336)
..++||||+++++|.+++.... .....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3789999999999999997643 2344566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc----------ceeeeeccCc
Q 036144 155 FTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD----------HVSTRVMGTY 224 (336)
Q Consensus 155 ~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~ 224 (336)
..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 778999999999999999999 999999999999999999999999999875443211 1223457999
Q ss_pred cccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHH
Q 036144 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQ 304 (336)
Q Consensus 225 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (336)
.|+|||++.+..++.++|||||||++|+|++|..|+... ..... ... . . .........+..
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~---~~~-~---------~-~~~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIIT---DVR-N---------L-KFPLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHH---HHH-T---------T-CCCHHHHHHCHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHH---Hhh-c---------c-CCCcccccCChh
Confidence 999999999999999999999999999999987654210 00000 000 0 0 000112334557
Q ss_pred HHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 305 ALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 305 l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+.+++.+||+.||++|||+.++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCCCcCCCHHHHhh
Confidence 899999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=343.74 Aligned_cols=246 Identities=24% Similarity=0.216 Sum_probs=196.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||+||+|.+..+|+.||||++...... .......|+..+..+ +||||+++++++.+....++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 36799999999999999999999999999999998654322 223445566555554 899999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 136 ~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred Eecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 9999 7899988876 2456999999999999999999999998 9999999999999999999999999987653
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|..|+..... . ..+..
T Consensus 209 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------~----~~~~~-------- 266 (311)
T 3p1a_A 209 TA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------W----QQLRQ-------- 266 (311)
T ss_dssp ---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------H----HHHTT--------
T ss_pred cC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------H----HHHhc--------
Confidence 32 22344579999999998875 799999999999999999999776643211 0 00100
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......++...+..+.+++.+||+.||++|||++++++
T Consensus 267 -~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 267 -GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00111112234568999999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=356.80 Aligned_cols=269 Identities=24% Similarity=0.335 Sum_probs=196.6
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhcc-CCCccceEEEEEeCC--e
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGD--Q 125 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~ 125 (336)
...++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34678999999999999999999999999999999986432 233456789999999997 999999999997554 6
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999996 689988865 46889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCC-------------------CcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 036144 206 KLGPTGG-------------------KDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRP 265 (336)
Q Consensus 206 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 265 (336)
....... .....+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 7643211 1122344689999999999886 6799999999999999999999999987654
Q ss_pred cccccHHHHHHHHhhccccccccc------------------CCccCCCCc------------HHHHHHHHHHHHhhcCC
Q 036144 266 SEEQNLVTWAKPLLRDKKKFTMMA------------------DPLLEGQYP------------RKGLYQALAVAGMCLQE 315 (336)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~------------~~~~~~l~~li~~cl~~ 315 (336)
......+..... .........+. .......++ ...+..+.+|+.+||+.
T Consensus 237 ~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 237 MNQLERIIGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 332221110000 00000000000 000000000 12355799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 036144 316 DADSRPFMVDVVTA 329 (336)
Q Consensus 316 dp~~Rpt~~evl~~ 329 (336)
||++|||++|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=341.53 Aligned_cols=257 Identities=25% Similarity=0.324 Sum_probs=202.7
Q ss_pred hcCCCCc-ccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPD-CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~-~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.+.|.+. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++..+ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678884 7899999999999999999999999999776555667899999999885 7999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc---eEEcccccccc
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN---PKLSDFGLAKL 207 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~ 207 (336)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 99999999999875 356899999999999999999999998 999999999999988776 99999999875
Q ss_pred CCCCCC-----cceeeeeccCccccCcccccc-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHH-----
Q 036144 208 GPTGGK-----DHVSTRVMGTYGYCAPEYAMT-----GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV----- 272 (336)
Q Consensus 208 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~----- 272 (336)
...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 432211 111234569999999999875 56899999999999999999999999876543211000
Q ss_pred ----HHHHHHhhcccccccccCCccCCCCc----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 273 ----TWAKPLLRDKKKFTMMADPLLEGQYP----RKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 273 ----~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......... . .++ ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~i~~~~----------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 244 ACQNMLFESIQEGK----------Y--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHHCC----------C--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHHhccC----------c--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0001111000 0 111 123568999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=345.99 Aligned_cols=271 Identities=25% Similarity=0.344 Sum_probs=217.4
Q ss_pred cHHHHHHHhcCCCCcccccccCceEEEEEEE-----cccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhc-cCCCccceE
Q 036144 45 KYQELADATENFNPDCLVGEGGYGRVYKGYI-----EAVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLV-QHQNLVNLI 117 (336)
Q Consensus 45 ~~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~ 117 (336)
.........++|.+.+.||+|+||.||+|.+ ..+++.||+|++...... ....+.+|+.+++.+ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444445568899999999999999999985 356789999999765432 335688999999999 689999999
Q ss_pred EEEEeCC-eEEEEEEcCCCCChhhhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC
Q 036144 118 GYCADGD-QRILVYEFMSNGSLENHFLDLPPD------------QEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDF 184 (336)
Q Consensus 118 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~di 184 (336)
+++.... ..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9987754 489999999999999999764321 223889999999999999999999998 999999
Q ss_pred CCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 036144 185 KASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNS 263 (336)
Q Consensus 185 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~ 263 (336)
||+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986544433334445678999999999999999999999999999999998 99999765
Q ss_pred CCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 264 RPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..... .... +.... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 255 ~~~~~--~~~~----~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 255 KIDEE--FCRR----LKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCSHH--HHHH----HHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHH--HHHH----hccCc----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 43221 1111 10100 01122334567999999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=343.18 Aligned_cols=264 Identities=20% Similarity=0.293 Sum_probs=203.8
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
...+|++.+.||+|+||.||+|.+..+|..||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467999999999999999999999899999999987532 2234568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999998754444567899999999999999999999998 999999999999999999999999998764
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ........ .. ..
T Consensus 187 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~-~~-~~--- 255 (310)
T 2wqm_A 187 SSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKIE-QC-DY--- 255 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHHHHHH-TT-CS---
T ss_pred cCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHHHHhh-cc-cC---
Confidence 332 122334579999999999999999999999999999999999999997543221 11111111 00 00
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+ ......+..+.+++.+||+.||.+|||+.++++.|+.|.
T Consensus 256 -~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 256 -PP----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp -CC----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CC----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00 111234558999999999999999999999999998874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=353.29 Aligned_cols=274 Identities=18% Similarity=0.220 Sum_probs=216.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCC--eEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD--QRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999999999999999987543 233567789999999999999999999998765 77999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----CCCCceEEcccccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL----DAEFNPKLSDFGLA 205 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~----~~~~~~kl~Dfg~~ 205 (336)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999987532 2234899999999999999999999999 9999999999999 77788999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCcccccc--------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMT--------GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 277 (336)
...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||............. ..
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~--~~ 238 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM--YK 238 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH--HH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH--HH
Confidence 865332 22344679999999998865 567889999999999999999999997644322211111 11
Q ss_pred Hhhcc--cc-----------cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 278 LLRDK--KK-----------FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 278 ~~~~~--~~-----------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
..... .. ............++...+..+.+++.+||+.||++|||+.++++.++.+.+
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 11110 00 000001111224457788899999999999999999999999999887643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=349.27 Aligned_cols=273 Identities=23% Similarity=0.230 Sum_probs=210.7
Q ss_pred ccHHHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-----CCCccceEE
Q 036144 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-----HQNLVNLIG 118 (336)
Q Consensus 44 ~~~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~ 118 (336)
+.+.+.....++|.+.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 33444445568999999999999999999999999999999998643 233456778999999886 999999999
Q ss_pred EEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-----
Q 036144 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA----- 193 (336)
Q Consensus 119 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~----- 193 (336)
++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 999999999999999 99999999763 2346899999999999999999999999 999999999999975
Q ss_pred --------------------CCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHH
Q 036144 194 --------------------EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLEL 253 (336)
Q Consensus 194 --------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l 253 (336)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 788999999999864322 3346799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCcccccHHHHHHH-----Hh---hcccccccccCCcc----CCC----------------CcHHHHHHH
Q 036144 254 ITGRSAIDNSRPSEEQNLVTWAKP-----LL---RDKKKFTMMADPLL----EGQ----------------YPRKGLYQA 305 (336)
Q Consensus 254 ~~g~~p~~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~~~~~~----~~~----------------~~~~~~~~l 305 (336)
++|..||......+....+..... .. .............. ... +....+..+
T Consensus 253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l 332 (360)
T 3llt_A 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF 332 (360)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence 999999987554332222111100 00 00000000000000 000 001112578
Q ss_pred HHHHHhhcCCCCCCCCCHHHHHH
Q 036144 306 LAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 306 ~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+|+.+||+.||.+|||++|+|+
T Consensus 333 ~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 333 CDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCChhhCCCHHHHhc
Confidence 89999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=347.53 Aligned_cols=270 Identities=23% Similarity=0.413 Sum_probs=216.7
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEE
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYC 120 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 120 (336)
.++....++|.+.+.||+|+||.||+|.+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344455688999999999999999999887 4678999999875432 2335688999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCChhhhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC
Q 036144 121 ADGDQRILVYEFMSNGSLENHFLDLP------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE 194 (336)
Q Consensus 121 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~ 194 (336)
.+....++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999986521 11245789999999999999999999998 9999999999999999
Q ss_pred CceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHH
Q 036144 195 FNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVT 273 (336)
Q Consensus 195 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~ 273 (336)
+.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-- 252 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-- 252 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH--
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHH--
Confidence 9999999999975432222222233457899999999999999999999999999999999 8899976543221111
Q ss_pred HHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccCC
Q 036144 274 WAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336 (336)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~~ 336 (336)
.. .. .. ...+...+..+.+++.+||+.||.+|||+.++++.|+.+..|
T Consensus 253 ----~~-~~-~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 253 ----VM-EG-GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ----HH-TT-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----HH-cC-Cc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11 10 00 112234456899999999999999999999999999987543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=348.51 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=198.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccC--CCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQH--QNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~l 128 (336)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.+++.++| |||+++++++......++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 467999999999999999999985 488999999865432 233668899999999986 999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
|||+ .+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||++...
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9995 58899999976 457899999999999999999999998 99999999999997 678999999999866
Q ss_pred CCCCCcceeeeeccCccccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMT-----------GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 277 (336)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~ 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHH
Confidence 44333333456689999999999865 67899999999999999999999999754321 111111
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..++.....++...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 233 ----------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 ----------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ----------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111222223333445678999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=350.20 Aligned_cols=274 Identities=25% Similarity=0.320 Sum_probs=214.8
Q ss_pred hcCCCCcccccccCceEEEEEE----EcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEE--eCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGY----IEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA--DGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 126 (336)
.++|++.+.||+|+||.||+|. +..++..||+|++........+.+.+|+.+++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 3679999999999999999999 46778999999998766555677899999999999999999999886 45678
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 999999999999999875 2346899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCcc-eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 207 LGPTGGKDH-VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............. . .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~-~~~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC-E-RDVPALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc-c-cccccHHHH
Confidence 764332221 2233568889999999999999999999999999999999999986533211000000 0 000000000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
............+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0011111122234455678999999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=342.53 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=202.4
Q ss_pred HhcCCCCcccccccCceEEEEEEEcc---cCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCC--
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEA---VDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD-- 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 124 (336)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45789999999999999999998864 567899999875432 23456889999999999999999999997655
Q ss_pred ---eEEEEEEcCCCCChhhhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 125 ---QRILVYEFMSNGSLENHFLDLP--PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 125 ---~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence 3499999999999999985322 23467999999999999999999999998 999999999999999999999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.............
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----- 263 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL----- 263 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-----
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-----
Confidence 99999976544332233344567889999999999999999999999999999999 889997755432211111
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.. .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 264 --~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 264 --HG----------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp --TT----------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cC----------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 011223345568999999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=340.77 Aligned_cols=260 Identities=21% Similarity=0.207 Sum_probs=202.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++......++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 357899999999999999999999999999999998654322 23668899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999875 356899999999999999999999999 999999999999999999999999998764
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+......
T Consensus 185 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~--- 253 (309)
T 2h34_A 185 TDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQAIPR--- 253 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSCCCC---
T ss_pred cccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccCCCC---
Confidence 3321 122334579999999999999999999999999999999999999997643211 11111110000
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhccc
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-FMVDVVTALEYLS 334 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~evl~~L~~i~ 334 (336)
....+...+..+.+++.+||+.||++|| |++++++.|+...
T Consensus 254 -----~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 254 -----PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp -----GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred -----ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 0112233445799999999999999999 9999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=360.26 Aligned_cols=268 Identities=20% Similarity=0.282 Sum_probs=188.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEe-----CCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCAD-----GDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 125 (336)
.++|++.+.||+|+||.||+|.++.+++.||||++..... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4789999999999999999999999999999999865432 234668899999999999999999999843 357
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 6799998865 467999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-------------------------ceeeeeccCccccCcccc-ccCCCCCccchhhHHHHHHHHHh----
Q 036144 206 KLGPTGGKD-------------------------HVSTRVMGTYGYCAPEYA-MTGQLTKKSDVYSFGVVLLELIT---- 255 (336)
Q Consensus 206 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~---- 255 (336)
......... ...+..+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 865422110 123456889999999976 45679999999999999999999
Q ss_pred -------CCCCCCCCCCccc-----------------ccHHHHHHHHhhccc--c-----------cccccCCccC---C
Q 036144 256 -------GRSAIDNSRPSEE-----------------QNLVTWAKPLLRDKK--K-----------FTMMADPLLE---G 295 (336)
Q Consensus 256 -------g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~--~-----------~~~~~~~~~~---~ 295 (336)
|.++|.+...... ..........+.... . .......... .
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 6666655331100 000000000000000 0 0000000000 0
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+..+..+.+|+.+||+.||++|||++|+|+
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 011233668999999999999999999999997
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=345.71 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=206.1
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--------cHHHHHHHHHHHhhccCCCccceEEEEEeC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--------GSREFFAEVLMLSLVQHQNLVNLIGYCADG 123 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 123 (336)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999999999999999998764321 223567899999999999999999999999
Q ss_pred CeEEEEEEcCCCC-ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 124 DQRILVYEFMSNG-SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 124 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
...++||||+.+| +|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999998766 99998865 456999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
|++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 175 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------- 237 (335)
T 3dls_A 175 GSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------- 237 (335)
T ss_dssp TTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------
T ss_pred ccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------
Confidence 9998654432 2345679999999999988877 789999999999999999999996522100
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
... ...+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 238 ----~~~------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----EAA------IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----hhc------cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01122245679999999999999999999999973
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=348.84 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=197.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc---HHHHHHHHHHHhhccCCCccceEEEEEeCC----e
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG---SREFFAEVLMLSLVQHQNLVNLIGYCADGD----Q 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 125 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 478999999999999999999999999999999997653322 346789999999999999999999987654 3
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999865 356899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 206 KLGPTGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 206 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCCCC
Confidence 765432221 2233467999999999999999999999999999999999999999765432211 111111000
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .......+..+.+++.+||+.||++||+..+++.
T Consensus 238 ~~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 238 PP--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CH--------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred Cc--------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00 0001124557999999999999999997766554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=334.43 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=208.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeC--CeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADG--DQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~l 128 (336)
.++|.+.+.||+|+||.||+|.+. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 467999999999999999999996 7889999987643 23345688999999999999999999999877 78899
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999762 2346899999999999999999999764 45999999999999999999999999887542
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCC---ccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTK---KSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
.. ....||+.|+|||++.+..++. ++|||||||++|+|++|..||.......... .....
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~---- 226 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM------KVALE---- 226 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH------HHHHS----
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH------HHHhc----
Confidence 22 2346899999999998766554 7999999999999999999998654322111 11111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
......+...+..+.+++.+||+.||++|||++++++.|+.|..
T Consensus 227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 ------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11112333455689999999999999999999999999998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=351.15 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=214.5
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCe-----EEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEe
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQ-----VVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCAD 122 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 122 (336)
....++|.+.+.||+|+||.||+|.+..++. .||+|.+..... ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3345789999999999999999999976654 799999876532 2346688999999999 89999999999999
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPP----------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD 192 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~ 192 (336)
....++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 9999999999999999999864210 1346899999999999999999999998 99999999999999
Q ss_pred CCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccH
Q 036144 193 AEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNL 271 (336)
Q Consensus 193 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~ 271 (336)
.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-- 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-- 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--
Confidence 999999999999976543333333344567889999999999999999999999999999998 99999765433211
Q ss_pred HHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 272 VTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.. ..... .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 277 ~~----~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 277 YK----LVKDG----------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HH----HHHHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHhcC----------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11 11110 001112233568999999999999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=336.89 Aligned_cols=252 Identities=19% Similarity=0.245 Sum_probs=208.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999999999999999986543 223466889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc---eEEcccccccc
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN---PKLSDFGLAKL 207 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~ 207 (336)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999888865 356899999999999999999999999 999999999999976655 99999999976
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+ ......
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~------~~~~~~--- 225 (284)
T 3kk8_A 158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI------KAGAYD--- 225 (284)
T ss_dssp CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCCC---
T ss_pred cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH------Hhcccc---
Confidence 54322 233467999999999999999999999999999999999999999765432211111 100000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ........+..+.+++.+||+.||++|||+.++++
T Consensus 226 ~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 Y-----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp C-----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C-----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 00111234557999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=344.77 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=209.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEE--EEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVV--AVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~v--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 129 (336)
++|++.+.||+|+||.||+|.+..++..+ |+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+....++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999999888765 999886532 33446788999999999 899999999999999999999
Q ss_pred EEcCCCCChhhhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 130 YEFMSNGSLENHFLDLP------------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
|||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997642 23457999999999999999999999999 9999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 276 (336)
||+|||++..... ........+++.|+|||++.+..++.++|||||||++|+|++ |..||......+.. .
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E 252 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------H
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH------H
Confidence 9999999874321 112233457889999999998899999999999999999998 99999765432211 1
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
. +... .....+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 253 ~-~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 253 K-LPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp H-GGGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-hhcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1110 011223345568999999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=335.35 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=188.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 467999999999999999999999899999999986432 22346788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999875 3467899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||........... ..
T Consensus 164 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------------~~ 225 (278)
T 3cok_A 164 MPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----------------VV 225 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CC
T ss_pred CCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH----------------Hh
Confidence 321 123345799999999999998999999999999999999999999976543221100 00
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ....+...+..+.+++.+||+.||++|||++++++
T Consensus 226 ~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 226 LA--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SS--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hc--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 01123334568999999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=351.94 Aligned_cols=251 Identities=21% Similarity=0.330 Sum_probs=198.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhcc--CCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQ--HQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~l 128 (336)
..+|.+.+.||+|+||.||+|.+.. ++.||||++..... ...+.+.+|+.+++.++ ||||+++++++......++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3569999999999999999999876 89999999865432 23467889999999997 5999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++...
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 558899999876 347888999999999999999999998 99999999999995 579999999999865
Q ss_pred CCCCCcceeeeeccCccccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMT-----------GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 277 (336)
............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ......
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~ 279 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA 279 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHH
Confidence 44333333455689999999999865 46899999999999999999999999754321 111111
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ++.....++...+..+.+|+.+||+.||.+|||+.++++
T Consensus 280 ~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 280 II----------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HH----------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hh----------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 11 111112223333567999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=363.68 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=212.5
Q ss_pred HHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 49 LADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 49 ~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
+....++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++. ....++
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 34456789999999999999999999975 6789999997643 45678999999999999999999999986 567899
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 260 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999999999999752 1235788899999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.... ........+|..|+|||++....++.++|||||||++|||++ |..||......+....+ ..+.
T Consensus 335 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~~~---- 402 (454)
T 1qcf_A 335 EDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ERGY---- 402 (454)
T ss_dssp CCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------HHTC----
T ss_pred CCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC----
Confidence 3211 111223456788999999999999999999999999999999 99999865432221111 1110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....+...+..+.+|+.+||+.||++|||+++|++.|+.+.
T Consensus 403 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 403 ------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 01123345568999999999999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=345.19 Aligned_cols=268 Identities=19% Similarity=0.236 Sum_probs=198.2
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
....++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 34567899999999999999999999999999999998654322 2345779999999999999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-----CCCCceEEccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL-----DAEFNPKLSDF 202 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~-----~~~~~~kl~Df 202 (336)
+||||++ |+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 110 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 9999996 599999876 346899999999999999999999999 9999999999999 44556999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
|++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+..... ...
T Consensus 182 g~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~ 258 (329)
T 3gbz_A 182 GLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG-LPD 258 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCC
T ss_pred CCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC-CCc
Confidence 999764322 1223445789999999999874 589999999999999999999999987553322111110000 000
Q ss_pred ccccc------cc-------cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFT------MM-------ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~------~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... .. ....+...++...+..+.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 00 0000000011124568899999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=334.61 Aligned_cols=263 Identities=20% Similarity=0.259 Sum_probs=207.4
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEE-EeCCeEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC-ADGDQRILVY 130 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 130 (336)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45789999999999999999999999999999998754332 23578899999999988766666554 6778889999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---CCCCceEEcccccccc
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKL 207 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~ 207 (336)
||+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999875 2456999999999999999999999999 9999999999999 7888999999999986
Q ss_pred CCCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-HHhhc
Q 036144 208 GPTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-PLLRD 281 (336)
Q Consensus 208 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 281 (336)
....... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||................ .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 5433221 12335679999999999999999999999999999999999999998765544333332211 11100
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
. .. . .....+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 238 ~--~~-----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 238 P--IE-----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp C--HH-----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred h--hh-----h----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0 00 0 01122458999999999999999999999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=335.12 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=211.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 367899999999999999999997 478899999976543 356789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~- 157 (267)
T 3t9t_A 85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD- 157 (267)
T ss_dssp CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-
T ss_pred CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc-
Confidence 999999999976 3456899999999999999999999999 999999999999999999999999999764321
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||......+... .+. ..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~i~-~~--------- 221 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE------DIS-TG--------- 221 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHH-TT---------
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHH------HHh-cC---------
Confidence 1111233457889999999998999999999999999999999 899998654322111 111 10
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 222 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001122234568999999999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=341.32 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=207.1
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 34679999999999999999999999999999999976554445678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---CCCCceEEccccccccC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 208 (336)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999998865 356899999999999999999999998 9999999999999 78889999999998754
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ..+.....
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~i~~~~~----- 224 (304)
T 2jam_A 160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF------EKIKEGYY----- 224 (304)
T ss_dssp CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHCCC-----
T ss_pred CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHcCCC-----
Confidence 221 223456999999999999999999999999999999999999999765432211 11111100
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+....+..+.+++.+||+.||++|||+.++++
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 225 ---EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111222345568999999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=358.01 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=198.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeC------C
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------D 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 124 (336)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 47899999999999999999999999999999998654 223346688999999999999999999999654 4
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||+++ +|.+.+.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 57999999965 56666532 4889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH---------
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------- 275 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 275 (336)
+...... ...+..+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9864332 2345578999999999999999999999999999999999999999876533221111100
Q ss_pred -------HHHhhccccc-----ccccCCc-c--CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 -------KPLLRDKKKF-----TMMADPL-L--EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 -------~~~~~~~~~~-----~~~~~~~-~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......... ....... . ........+..+.+|+.+||+.||++|||++|+++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0000000 0 00011123668999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=332.88 Aligned_cols=262 Identities=20% Similarity=0.259 Sum_probs=210.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEE-EeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC-ADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 131 (336)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 5789999999999999999999999999999999865432 34688999999999988766655544 67778899999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC---CCCceEEccccccccC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD---AEFNPKLSDFGLAKLG 208 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~ 208 (336)
|+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 9999999975 2456999999999999999999999999 99999999999994 7889999999999865
Q ss_pred CCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-HHhhcc
Q 036144 209 PTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-PLLRDK 282 (336)
Q Consensus 209 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 282 (336)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||................ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 433221 11345679999999999999999999999999999999999999998765443332222111 111000
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.. . .....+..+.+++.+||+.||.+|||++++++.|+.+.
T Consensus 239 --~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 239 --IE-----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp --HH-----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred --hH-----H----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 00 0 01123457999999999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=346.53 Aligned_cols=247 Identities=28% Similarity=0.375 Sum_probs=203.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++......++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588999999999999999999999999999998754322 2356889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+. |+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9996 688887754 2467899999999999999999999998 99999999999999999999999999976432
Q ss_pred CCCcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.....||+.|+|||++. +..++.++|||||||++|+|++|..||......... .......
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~----- 269 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE----- 269 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC-----
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC-----
Confidence 23457999999999985 567899999999999999999999999765432211 1111110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
.+. ..+...+..+.+++.+||+.||++|||++++++.
T Consensus 270 --~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 --SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 010 1122345578999999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=337.39 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=207.2
Q ss_pred hcCCCCcc-cccccCceEEEEEEE--cccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 53 TENFNPDC-LVGEGGYGRVYKGYI--EAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 53 ~~~y~~~~-~ig~G~~g~v~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
..+|.+.+ .||+|+||.||+|.+ ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++ .....+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788888 999999999999954 56688999999875432 2246788999999999999999999999 566789
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 99999999999999976 356899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCcc-eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 208 GPTGGKDH-VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 208 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+ ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------~~~~-- 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGE-- 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTC--
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCC--
Confidence 54432211 1223456789999999998899999999999999999999 99999875432211111 1110
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
...++...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 238 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 238 --------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11223345668999999999999999999999999998763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=343.28 Aligned_cols=262 Identities=20% Similarity=0.251 Sum_probs=211.1
Q ss_pred cHHHHHHHhcCCCCc-ccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhcc-CCCccceEEEE
Q 036144 45 KYQELADATENFNPD-CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQ-HQNLVNLIGYC 120 (336)
Q Consensus 45 ~~~~~~~~~~~y~~~-~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 120 (336)
.++......++|.+. +.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+. ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 455566677888887 89999999999999999999999999987532 233567889999999985 69999999999
Q ss_pred EeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC---CCce
Q 036144 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA---EFNP 197 (336)
Q Consensus 121 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~---~~~~ 197 (336)
.+....++||||+++|+|.+++.. .....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999999865 23467999999999999999999999999 999999999999987 7899
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 277 (336)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.
T Consensus 174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---- 246 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS---- 246 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----
T ss_pred EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH----
Confidence 999999998653321 2344679999999999999999999999999999999999999997654322111111
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ............+..+.+++.+||+.||.+|||++++++
T Consensus 247 --~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 247 --QV--------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --HT--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --hc--------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00 001111122334568999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=345.35 Aligned_cols=267 Identities=16% Similarity=0.169 Sum_probs=201.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcc---cCeEEEEEeecCCCCcc-----------HHHHHHHHHHHhhccCCCccceEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA---VDQVVAVKQLDRSGNQG-----------SREFFAEVLMLSLVQHQNLVNLIG 118 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~iv~~~~ 118 (336)
.++|.+.+.||+|+||.||+|.+.. ++..+|+|++....... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999986 78899999987553221 123567888899999999999999
Q ss_pred EEEe----CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC
Q 036144 119 YCAD----GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE 194 (336)
Q Consensus 119 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~ 194 (336)
++.. ....++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9987 77899999999 9999999875 237999999999999999999999998 9999999999999887
Q ss_pred C--ceEEccccccccCCCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 036144 195 F--NPKLSDFGLAKLGPTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267 (336)
Q Consensus 195 ~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 267 (336)
+ .+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999765322111 11244579999999999999999999999999999999999999996532221
Q ss_pred cccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 268 EQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
... .......... .......... ....+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 268 ~~~-~~~~~~~~~~---~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 268 VAV-QTAKTNLLDE---LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHH-HHHHHHHHHT---TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHH-HHHHHhhccc---ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111 1100110000 0000000000 0134458999999999999999999999999998765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=345.31 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=199.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc-HHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG-SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
++|.+.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999986543221 12345799999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
++ |+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 96 689888876 3456899999999999999999999999 999999999999999999999999999754322
Q ss_pred CcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc---
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM--- 288 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 288 (336)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+...... .........
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 231 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT-PTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CCTTTSTTGGGC
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CChHhchhhhcc
Confidence 222344578999999999876 57899999999999999999999999876543322221110000 000000000
Q ss_pred ------cCCccCC----CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ------ADPLLEG----QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ------~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+.... ......+..+.+|+.+||+.||.+|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 001123557899999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=337.41 Aligned_cols=267 Identities=24% Similarity=0.309 Sum_probs=203.7
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhh--ccCCCccceEEEEEeC--
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSL--VQHQNLVNLIGYCADG-- 123 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~-- 123 (336)
......++|++.+.||+|+||.||+|.+. ++.||||++... .......|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 33445678999999999999999999986 889999998543 23344556666555 4899999999999887
Q ss_pred --CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeeCCCCCCCeEECC
Q 036144 124 --DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV--------ADPPVIYRDFKASNILLDA 193 (336)
Q Consensus 124 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~--------~~~~i~H~dikp~Nil~~~ 193 (336)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKK 177 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECT
T ss_pred CCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECC
Confidence 788999999999999999965 3689999999999999999999988 6 999999999999999
Q ss_pred CCceEEccccccccCCCCCCcc--eeeeeccCccccCccccccCCCCCc------cchhhHHHHHHHHHhC---------
Q 036144 194 EFNPKLSDFGLAKLGPTGGKDH--VSTRVMGTYGYCAPEYAMTGQLTKK------SDVYSFGVVLLELITG--------- 256 (336)
Q Consensus 194 ~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwslG~il~~l~~g--------- 256 (336)
++.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|+|++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999997653322211 1234579999999999988776665 9999999999999999
Q ss_pred -CCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC-CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 257 -RSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG-QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 257 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..||............ ....... .. ..+.... ......+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 258 ~~~p~~~~~~~~~~~~~--~~~~~~~----~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYED--MREIVCI----KK-LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CCCTTTTTSCSSCCHHH--HHHHHTT----SC-CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccHhhhcCCCCchhh--hHHHHhh----hc-cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 5666544332211111 1111100 00 0111111 112367788999999999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=335.10 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=209.2
Q ss_pred cCCCCcc-cccccCceEEEEEEEc--ccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDC-LVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~-~ig~G~~g~v~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
++|.+.+ .||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++ .....++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5566666 8999999999999864 4678899999976532 3346788999999999999999999999 45668999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999864 3466999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 210 TGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
..... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+ ...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i-------~~~----- 229 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQG----- 229 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-------HTT-----
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-------hcC-----
Confidence 33221 11223456899999999998899999999999999999998 99999875543221111 111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....++...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 230 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 230 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 011233445668999999999999999999999999998763
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=334.06 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=208.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999999999999999985431 22346788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999875 346899999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+.. ......
T Consensus 166 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~-------- 227 (284)
T 2vgo_A 166 SL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIVNV-------- 227 (284)
T ss_dssp SS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTT--------
T ss_pred cc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHhcc--------
Confidence 22 233467999999999999999999999999999999999999999765432211 111110
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+ ..++...+..+.+++.+||+.||.+|||+.++++
T Consensus 228 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 0 1223345568999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=336.56 Aligned_cols=257 Identities=21% Similarity=0.330 Sum_probs=206.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcc---cCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA---VDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4679999999999999999998753 34579999987653 23456788999999999999999999998654 5689
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999875 3456899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+. ....
T Consensus 164 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-------~~~~--- 232 (281)
T 3cc6_A 164 EDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-------KGDR--- 232 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-------HTCC---
T ss_pred cccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-------cCCC---
Confidence 3321 112334557889999999998999999999999999999998 999997654433211111 0000
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 233 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 233 -------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 0112234567999999999999999999999999998763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=342.81 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=203.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccC----eEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVD----QVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.+|.+.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||+++++++......++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 56778899999999999999986543 4699999875432 234568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 124 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 9999999999999875 3467899999999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 209 PTGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+.. . . +....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~---~---~-~~~~~--- 267 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---K---A-INDGF--- 267 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---H---H-HHTTC---
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH---H---H-HHCCC---
Confidence 432211 11223456889999999999999999999999999999999 99999765432211 1 1 11110
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 268 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 -------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp -------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01122334568999999999999999999999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=344.47 Aligned_cols=263 Identities=27% Similarity=0.404 Sum_probs=206.5
Q ss_pred HhcCCCCcccccccCceEEEEEE-----EcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGY-----IEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
..++|.+.+.||+|+||.||+|. +..++..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 34789999999999999999999 55678899999986543 2334568899999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC---CceEE
Q 036144 126 RILVYEFMSNGSLENHFLDLPP---DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---FNPKL 199 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~---~~~kl 199 (336)
.++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ ..++|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976432 2245899999999999999999999998 9999999999999844 45999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHH
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~------ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV------ 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH------
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH------
Confidence 99999875433222223344568999999999999999999999999999999998 99999765432211111
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 259 -~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 259 -TSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp -HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 1100 01122334568999999999999999999999999998764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=359.73 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=206.3
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC--CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS--GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
..++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 457799999999999999999999999999999998543 223456789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC---CCCceEEccccccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD---AEFNPKLSDFGLAK 206 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~ 206 (336)
|||+.+|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 999999999998865 356899999999999999999999999 99999999999995 45679999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||......+....+. .....
T Consensus 173 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~~~-- 240 (486)
T 3mwu_A 173 CFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE------TGKYA-- 240 (486)
T ss_dssp TBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCCC--
T ss_pred ECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCC--
Confidence 65332 22345679999999998875 59999999999999999999999998754322211111 11000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.........+..+.++|.+||+.||.+|||+.++++
T Consensus 241 ------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 ------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp ------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000111234668999999999999999999999987
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=344.14 Aligned_cols=267 Identities=27% Similarity=0.391 Sum_probs=205.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 47899999999999999999999999999999998654332 2345779999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999988887654 456999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH--------HHHHhhc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW--------AKPLLRD 281 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~ 281 (336)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+.. ....+..
T Consensus 177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 2 1223446799999999998875 789999999999999999999999987654332211110 0011111
Q ss_pred ccccccccCCccCCCC-----cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFTMMADPLLEGQY-----PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.........+...... ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111111 1134668999999999999999999999886
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=348.85 Aligned_cols=268 Identities=16% Similarity=0.195 Sum_probs=204.5
Q ss_pred HhcCCCCcccccccCceEEEEEEEccc-----CeEEEEEeecCCCCccH-----------HHHHHHHHHHhhccCCCccc
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAV-----DQVVAVKQLDRSGNQGS-----------REFFAEVLMLSLVQHQNLVN 115 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~-----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~iv~ 115 (336)
..++|.+.+.||+|+||.||+|.+..+ ++.||||++........ .....|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999999764 57899999865432111 12334566677788999999
Q ss_pred eEEEEEeC----CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 116 LIGYCADG----DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 116 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99998764 4589999999 9999999876 3467999999999999999999999998 9999999999999
Q ss_pred C--CCCceEEccccccccCCCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 036144 192 D--AEFNPKLSDFGLAKLGPTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSR 264 (336)
Q Consensus 192 ~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 264 (336)
+ .++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 8899999999999765332111 11234569999999999999999999999999999999999999998643
Q ss_pred CcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 265 PSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.... .......... .....+.+..+. ....+..+.+++..||+.||.+|||+.++++.|+.+
T Consensus 266 ~~~~--~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 266 KDPK--YVRDSKIRYR--ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TCHH--HHHHHHHHHH--HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCHH--HHHHHHHHhh--hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 2221 1111111110 111111111111 112345799999999999999999999999998865
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=361.75 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=209.1
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999999999999999986542 3345778999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---CCCCceEEcccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLA 205 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~ 205 (336)
||||+.+|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999998865 456999999999999999999999999 9999999999999 56788999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||......+....+ ......
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~~~- 245 (484)
T 3nyv_A 177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV------EKGKYT- 245 (484)
T ss_dssp HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCC-
T ss_pred EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HcCCCC-
Confidence 8654332 2344679999999998865 7999999999999999999999999875533221111 111000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.........+..+.+||.+||+.||.+|||+.++++
T Consensus 246 -------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 -------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000111245668999999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=333.33 Aligned_cols=252 Identities=22% Similarity=0.279 Sum_probs=205.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC------ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN------QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3569999999999999999999999999999999865421 1356789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC----ceEEccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF----NPKLSDF 202 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~----~~kl~Df 202 (336)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .++|+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999865 356899999999999999999999998 99999999999998877 7999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+.... .....
T Consensus 157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~ 227 (283)
T 3bhy_A 157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN------ISAVN 227 (283)
T ss_dssp TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHTTC
T ss_pred ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH------hHhcc
Confidence 9998653322 23345799999999999999999999999999999999999999976543221111 10000
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ..........+..+.+++.+||+.||.+|||+.++++
T Consensus 228 ~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 Y--------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C--------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c--------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 0000111223557899999999999999999999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=360.28 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=202.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
..++|++.+.||+|+||.||+|.++.++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999999999999999987543 23356789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC---CceEEccccccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---FNPKLSDFGLAK 206 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~~ 206 (336)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999999998865 356899999999999999999999999 9999999999999764 459999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..... ......+||+.|+|||++. +.|+.++|||||||++|+|++|..||......+....+. ......
T Consensus 188 ~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~~~~- 256 (494)
T 3lij_A 188 VFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE------KGKYTF- 256 (494)
T ss_dssp ECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCCCC-
T ss_pred ECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCCC-
Confidence 65432 2234567999999999875 579999999999999999999999998755432211111 110000
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ......+..+.+|+.+||+.||.+|||+.++++
T Consensus 257 --~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 --DS-----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --CS-----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --Cc-----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00 011234568999999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=349.21 Aligned_cols=265 Identities=20% Similarity=0.255 Sum_probs=207.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4679999999999999999999999999999999876532 234668899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999875 34689999999999999999999985 8 99999999999999999999999999864321
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH---------HHhh-
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK---------PLLR- 280 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~- 280 (336)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||......+......... ....
T Consensus 185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 12344679999999999999999999999999999999999999998755332211110000 0000
Q ss_pred ------------ccc----ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 281 ------------DKK----KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 281 ------------~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... ....+.............+..+.+|+.+||+.||++|||++++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 000000000111111234568999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=335.68 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=205.1
Q ss_pred CCCCcccccccCceEEEEEEEcccCe---EEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE-EEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQ---VVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR-ILV 129 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-~lv 129 (336)
.|.+.+.||+|+||.||+|.+..++. .||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667899999999999999755443 799999875433 2346788999999999999999999999876655 999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+.+|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999976 3467899999999999999999999998 9999999999999999999999999997543
Q ss_pred CCCC--cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCC-CCCCCCcccccHHHHHHHHhhcccccc
Q 036144 210 TGGK--DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSA-IDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 210 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
.... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |......+....+. ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-------~~---- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-------QG---- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-------TT----
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-------cC----
Confidence 3211 1123345688999999999999999999999999999999995555 44433322111111 00
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 245 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 245 ------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011122334568999999999999999999999999998763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=336.08 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=204.9
Q ss_pred hcCCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEE-eCCeEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCA-DGDQRI 127 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 127 (336)
..+|++.+.||+|+||.||+|.+..+ ...+|+|.+..... ...+.+.+|+.+++.++||||+++++++. .....+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 45688999999999999999997543 34689999875433 23466889999999999999999999864 556789
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 99999999999999975 3466899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCC--cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 208 GPTGGK--DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 208 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
...... ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+...... ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~------~~--- 248 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QG--- 248 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH------TT---
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh------cC---
Confidence 533221 112334567889999999999999999999999999999999 566666544332211111 00
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 249 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 249 --------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 001112233457999999999999999999999999998864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=354.10 Aligned_cols=201 Identities=25% Similarity=0.376 Sum_probs=169.5
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeC-----C
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADG-----D 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 124 (336)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 35789999999999999999999999999999999975432 2346788999999999999999999999766 5
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence 7899999984 699999865 466999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCc--------------------ceeeeeccCccccCcccc-ccCCCCCccchhhHHHHHHHHHhCCCCC
Q 036144 205 AKLGPTGGKD--------------------HVSTRVMGTYGYCAPEYA-MTGQLTKKSDVYSFGVVLLELITGRSAI 260 (336)
Q Consensus 205 ~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~~g~~p~ 260 (336)
+......... ...+..+||+.|+|||++ ....|+.++|||||||++|+|++|..||
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9865432211 123567899999999986 4567999999999999999999854444
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=347.08 Aligned_cols=268 Identities=18% Similarity=0.249 Sum_probs=203.4
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe-------
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD------- 122 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 122 (336)
.....+|.+.+.||+|+||.||+|.+..+|+.||+|++...... ..+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999999999999999998654322 2479999999999999999999843
Q ss_pred -------------------------------CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 036144 123 -------------------------------GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL 171 (336)
Q Consensus 123 -------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~l 171 (336)
....++||||++ |+|.+.+.........+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999996 688877765444567899999999999999999999
Q ss_pred HhCCCCCeeeCCCCCCCeEEC-CCCceEEccccccccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHH
Q 036144 172 HDVADPPVIYRDFKASNILLD-AEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVV 249 (336)
Q Consensus 172 h~~~~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~i 249 (336)
|+.+ |+||||||+||+++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++||||+||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9998 99999999999997 68899999999998654332 23445789999999998875 58999999999999
Q ss_pred HHHHHhCCCCCCCCCCcccccHHHHH------HHHhhcccccccc-----cCCccCCCCcHHHHHHHHHHHHhhcCCCCC
Q 036144 250 LLELITGRSAIDNSRPSEEQNLVTWA------KPLLRDKKKFTMM-----ADPLLEGQYPRKGLYQALAVAGMCLQEDAD 318 (336)
Q Consensus 250 l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 318 (336)
+|+|++|..||......+....+... ............. ....+...++...+..+.+|+.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999876543322111100 0000000000111 111111113334566899999999999999
Q ss_pred CCCCHHHHHH
Q 036144 319 SRPFMVDVVT 328 (336)
Q Consensus 319 ~Rpt~~evl~ 328 (336)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=369.73 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=210.3
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 127 (336)
..++|++.+.||+|+||.||+|.++.+++.||||++.+. .......+..|..++..+ +||+|+.+++++.+....|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999999999999999998643 223346678899999887 6999999999999999999
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999875 356999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...+..+.. ..+...
T Consensus 492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~------ 557 (674)
T 3pfq_A 492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIMEH------ 557 (674)
T ss_dssp CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHSS------
T ss_pred cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHH------HHHHhC------
Confidence 43222 2345678999999999999999999999999999999999999999875432211 111111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFM-----VDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~-----~evl~ 328 (336)
...++...+..+.+||.+||+.||.+||++ +||++
T Consensus 558 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 ------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 112344566789999999999999999997 67664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=336.42 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=207.5
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe---------
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD--------- 122 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--------- 122 (336)
...+|++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999999899999999986543 356789999999999999999998864
Q ss_pred -------CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC
Q 036144 123 -------GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF 195 (336)
Q Consensus 123 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~ 195 (336)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 34578999999999999999752 2357899999999999999999999998 99999999999999999
Q ss_pred ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 036144 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA 275 (336)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 275 (336)
.++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+.... ...
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~ 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFF 228 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHH
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHH
Confidence 99999999997654332 2334569999999999999999999999999999999999998764210 000
Q ss_pred HHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 276 KPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
.. +. ... ++...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 229 ~~-~~---------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 229 TD-LR---------DGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HH-HH---------TTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HH-hh---------ccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 11 10 111 122334578999999999999999999999999987753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=340.99 Aligned_cols=266 Identities=27% Similarity=0.383 Sum_probs=212.2
Q ss_pred hcCCCCcccccccCceEEEEEE----EcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCC--eE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGY----IEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD--QR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 126 (336)
..+|++.+.||+|+||.||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4679999999999999999998 45679999999998766666678999999999999999999999986543 68
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 999999999999999976 2356899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCcc-eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc---------cccHHHHHH
Q 036144 207 LGPTGGKDH-VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE---------EQNLVTWAK 276 (336)
Q Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~ 276 (336)
......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... .........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 764432211 1223457788999999998899999999999999999999999886431100 000000001
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..+.. ......+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 274 ~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 274 ELLKN----------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHT----------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhc----------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 1111223345668999999999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=342.53 Aligned_cols=269 Identities=22% Similarity=0.266 Sum_probs=201.6
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-----cHHHHHHHHHHHhhccCCCccceEEEEEeCC
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-----GSREFFAEVLMLSLVQHQNLVNLIGYCADGD 124 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 124 (336)
....++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 34457899999999999999999999999999999998653221 1246789999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||+++ +|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999965 88888765 3456888899999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc-c
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD-K 282 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~ 282 (336)
+...... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||......+....+. ...-.. .
T Consensus 159 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~--~~~~~~~~ 234 (346)
T 1ua2_A 159 AKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF--ETLGTPTE 234 (346)
T ss_dssp GSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HHHCCCCT
T ss_pred ceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--HHcCCCCh
Confidence 9865332 2223456799999999998764 58999999999999999999999997754332211111 100000 0
Q ss_pred c---ccccccCCccCCC---C-----cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 283 K---KFTMMADPLLEGQ---Y-----PRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 283 ~---~~~~~~~~~~~~~---~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
. ......+...... . ....+..+.+||.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0000000000000 0 12345689999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=359.76 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=205.6
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-------------ccHHHHHHHHHHHhhccCCCccceE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-------------QGSREFFAEVLMLSLVQHQNLVNLI 117 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~iv~~~ 117 (336)
...++|.+.+.||+|+||.||+|.++.++..||+|++..... ...+.+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 356789999999999999999999999999999999865421 2346788999999999999999999
Q ss_pred EEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC--
Q 036144 118 GYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-- 195 (336)
Q Consensus 118 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-- 195 (336)
+++.+....++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999998865 356999999999999999999999999 99999999999998776
Q ss_pred -ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 036144 196 -NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 196 -~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 274 (336)
.+||+|||++...... .......||+.|+|||++. +.++.++||||+||++|+|++|..||......+....+.
T Consensus 186 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~- 260 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE- 260 (504)
T ss_dssp SSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-
T ss_pred ccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence 6999999999865432 2234567999999999876 569999999999999999999999998755432211111
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...... ........+..+.+|+.+||+.||.+|||++++++
T Consensus 261 -----~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 261 -----KGKYYF--------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -----HCCCCC--------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----cCCCCC--------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 110000 00001123568999999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=341.43 Aligned_cols=268 Identities=21% Similarity=0.269 Sum_probs=204.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEe--------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCAD-------- 122 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 122 (336)
..+|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4689999999999999999999999999999999865432 224567899999999999999999999987
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
....++||||++ ++|.+.+.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 346899999996 577777765 3456999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCC--cceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 036144 203 GLAKLGPTGGK--DHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 203 g~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99976543221 122345678999999998876 468999999999999999999999998765433222222111000
Q ss_pred hccccccccc-----C----CccCCCCcH------HHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 RDKKKFTMMA-----D----PLLEGQYPR------KGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ~~~~~~~~~~-----~----~~~~~~~~~------~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ....... . ......... ..+..+.+|+.+||+.||++|||++|+++
T Consensus 249 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CT-TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ch-hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00 0000000 0 000000000 01346889999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=337.47 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=204.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|++.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++++......++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45789999999999999999999999999999999977666667889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK- 169 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH-
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc-
Confidence 9999999998865 2456899999999999999999999998 99999999999999999999999998753211
Q ss_pred CCcceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
.........||+.|+|||++. +..++.++||||||+++|+|++|..||......... .......
T Consensus 170 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~---- 238 (302)
T 2j7t_A 170 -TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSD---- 238 (302)
T ss_dssp -HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC----
T ss_pred -cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhccC----
Confidence 011223457999999999883 667899999999999999999999999865432211 1111110
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......+...+..+.+++.+||+.||.+|||+.++++
T Consensus 239 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 239 -----PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001123345668999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=334.44 Aligned_cols=248 Identities=17% Similarity=0.240 Sum_probs=202.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 128 (336)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467999999999999999999999999999999987543 23346688899999998 89999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC--------------
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-------------- 194 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-------------- 194 (336)
||||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999763333367899999999999999999999999 9999999999999844
Q ss_pred -----CceEEccccccccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 036144 195 -----FNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE 268 (336)
Q Consensus 195 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 268 (336)
..++|+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 47999999999865432 224599999999998876 667899999999999999999887643211
Q ss_pred ccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 269 QNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ... .. . ...++...+..+.+++.+||+.||++|||+.++++
T Consensus 237 ---~~---~~~-~~-~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 ---WH---EIR-QG-R---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp ---HH---HHH-TT-C---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HH---HHH-cC-C---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00 000 00 0 01223344568999999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=334.45 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=210.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..+.|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 3467999999999999999999999999999999987543 334577899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 100 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp ECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence 99999999999853 56899999999999999999999999 99999999999999999999999999976533
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ........||+.|+|||++.+..++.++||||||+++|+|++|..||...........+ . .. ..
T Consensus 172 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~-~~------~~ 236 (303)
T 3a7i_A 172 T--QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI------P-KN------NP 236 (303)
T ss_dssp T--BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------H-HS------CC
T ss_pred c--ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh------h-cC------CC
Confidence 2 12234567999999999999999999999999999999999999999765432211111 0 00 01
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
+ .++...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 237 ~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 237 P----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp C----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred C----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1 1222345579999999999999999999999874
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=334.46 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=204.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999999999999999986543 34678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999863 2467899999999999999999999999 999999999999999999999999999764332
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
........||+.|+|||.+.+..++.++||||||+++|+|++|..||........... ..... .
T Consensus 179 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~-------~- 242 (314)
T 3com_A 179 --MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM------IPTNP-------P- 242 (314)
T ss_dssp --BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHHSC-------C-
T ss_pred --ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH------HhcCC-------C-
Confidence 1223445799999999999999999999999999999999999999976543221100 00000 0
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 243 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 -PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 001123344568999999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=349.06 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=195.4
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--------CccHHHHHHHHHHHhhccCCCccceEEEEEe
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--------NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 122 (336)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999999999999999986431 1112347899999999999999999999754
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC---ceEE
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF---NPKL 199 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~---~~kl 199 (336)
...++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 557999999999999988864 467999999999999999999999998 99999999999997554 4999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT---GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 276 (336)
+|||++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .....
T Consensus 284 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i- 357 (419)
T 3i6u_A 284 TDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI- 357 (419)
T ss_dssp CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH-
T ss_pred eecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH-
Confidence 99999986533 223445689999999999863 5788999999999999999999999976543221 11100
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. .. ... .........+..+.+|+.+||+.||++|||++++++
T Consensus 358 --~-~~-~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 --T-SG-KYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --H-TT-CCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --h-cC-CCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 00 000 000001123568999999999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=335.94 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=209.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
...+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3477999999999999999999999999999999986542 2234568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 93 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999998865 356899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+.. .......
T Consensus 166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~------ 231 (294)
T 2rku_A 166 EYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKKNE------ 231 (294)
T ss_dssp CSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTTC------
T ss_pred ccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhhcc------
Confidence 4322 2234467999999999999989999999999999999999999999765432211 1111100
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..++...+..+.+++.+||+.||++|||++++++
T Consensus 232 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 232 ------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 0122334567899999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=356.22 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=206.9
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
...++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ ...++||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 345678899999999999999999986 4679999987543 345789999999999999999999999876 6789999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 258 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999998641 2345899999999999999999999999 99999999999999999999999999976533
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. ........++..|+|||++.+..++.++||||||+++|+|++ |..||......+....+ ..+
T Consensus 333 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~~------- 397 (452)
T 1fmk_A 333 NE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERG------- 397 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTT-------
T ss_pred Cc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC-------
Confidence 21 112233457889999999999999999999999999999999 99999865432211111 111
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+|+.+||+.||++|||++++++.|+.+.
T Consensus 398 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 398 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 011223445668999999999999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=334.02 Aligned_cols=253 Identities=20% Similarity=0.241 Sum_probs=203.7
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC----CccHHHHHHHHHHHhhccCCCccceEEEEE--eCCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLVQHQNLVNLIGYCA--DGDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~ 125 (336)
..++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999999999999999986532 233467899999999999999999999984 4567
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++||||++++ |.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999766 77777653 3467899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ--LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
................||+.|+|||++.+.. ++.++||||||+++|+|++|..||......... ..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~i~~~~- 229 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF------ENIGKGS- 229 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCC-
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH------HHHhcCC-
Confidence 8764433334445567999999999987644 478999999999999999999999865422111 1111100
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..++...+..+.+++.+||+.||.+|||+.++++
T Consensus 230 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 230 -----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp -----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0122334568899999999999999999999996
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=345.08 Aligned_cols=261 Identities=23% Similarity=0.310 Sum_probs=199.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCC------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD------ 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 124 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4679999999999999999999999999999999865432 22456889999999999999999999997653
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999865 46899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----H
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-----L 278 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~ 278 (336)
+..... .....+||+.|+|||++.+ ..++.++||||+||++|+|++|..||...+..+....+..... .
T Consensus 175 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 986432 1344678999999999887 6899999999999999999999999987654322111110000 0
Q ss_pred hhc---c------cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRD---K------KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~---~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... . ..........+ .......+..+.+|+.+||+.||.+|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 0 00000000000 0112234568999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=334.91 Aligned_cols=257 Identities=28% Similarity=0.413 Sum_probs=209.0
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. +..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 45789999999999999999999864 6789999986543 345788999999999999999999999864 56899999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999998641 1236899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. ........++..|+|||++.+..++.++||||||+++|+|++ |..||......+.. . .. ...
T Consensus 163 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~---~~-~~~-------- 226 (279)
T 1qpc_A 163 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---Q---NL-ERG-------- 226 (279)
T ss_dssp C-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---H---HH-HTT--------
T ss_pred c-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---H---HH-hcc--------
Confidence 2 112233457889999999998899999999999999999999 99999765432211 1 11 110
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 227 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 227 --YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 011122344568999999999999999999999999998763
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=338.04 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=209.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 128 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4689999999999999999999999999999999875432 234568899999999999999999998754 568899
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA--DPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998764444566999999999999999999999865 2349999999999999999999999999997
Q ss_pred cCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+.. . .+. .+ ..
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~i~-~~-~~- 233 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---G---KIR-EG-KF- 233 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHH-HT-CC-
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH---H---HHh-hc-cc-
Confidence 653321 1223457899999999999999999999999999999999999999875432211 1 111 10 00
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~ 332 (336)
..++...+..+.+++.+||+.||++|||+.++++.+..
T Consensus 234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 234 --------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 11233445689999999999999999999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=342.14 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=209.8
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
...+|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4578999999999999999999999999999999986542 2234568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 119 v~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 119 VLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999998865 356899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+.. .......
T Consensus 192 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~------ 257 (335)
T 2owb_A 192 EYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKKNE------ 257 (335)
T ss_dssp CSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTC------
T ss_pred ccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHhcCC------
Confidence 4322 2234467999999999999999999999999999999999999999765432211 1111110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..++...+..+.+|+.+||+.||++|||+.++++
T Consensus 258 ------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 258 ------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0122334557899999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=337.12 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=200.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeC-CeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG-DQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.+. |+.||+|++.... ..+.+.+|+.+++.++||||+++++++... ...++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 478999999999999999999886 7899999986543 456789999999999999999999987654 47899999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999998652 1223788899999999999999999998 999999999999999999999999998754321
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.. .. ....
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~----~~~~-------- 230 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PR----VEKG-------- 230 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HH----HTTT--------
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH----HhcC--------
Confidence 223467899999999999999999999999999999998 99999765432211 10 1010
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 231 --YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 111223345568999999999999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=331.17 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=202.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe----CCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD----GDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 126 (336)
...|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345888889999999999999999999999999986532 2334668899999999999999999999875 4568
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC-CCCceEEcccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD-AEFNPKLSDFGLA 205 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~ 205 (336)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ .+|+||||||+||+++ .++.+||+|||++
T Consensus 105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999999965 356899999999999999999999865 3599999999999997 7889999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
...... ......||+.|+|||++. +.++.++|||||||++|+|++|..||......... ..... ..
T Consensus 180 ~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~-~~--- 245 (290)
T 1t4h_A 180 TLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVT-SG--- 245 (290)
T ss_dssp GGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHHHT-TT---
T ss_pred cccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HHHHh-cc---
Confidence 754322 234567999999999876 46999999999999999999999999764432211 11111 00
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....++...+..+.+++.+||+.||.+|||++++++
T Consensus 246 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 ------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0011122233457999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=343.72 Aligned_cols=254 Identities=17% Similarity=0.147 Sum_probs=205.2
Q ss_pred HhcCCCCcccccccCceEEEEEE-----EcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc---CCCccceEEEEEeC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGY-----IEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ---HQNLVNLIGYCADG 123 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~ 123 (336)
..++|.+.+.||+|+||.||+|. +..+++.||+|++... ....+..|+.+++.++ |+||+.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45679999999999999999994 6677899999998754 3456777888877776 99999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC---------
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPP-DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA--------- 193 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~--------- 193 (336)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 999999999999999999874222 2467999999999999999999999998 999999999999988
Q ss_pred --CCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccH
Q 036144 194 --EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNL 271 (336)
Q Consensus 194 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~ 271 (336)
++.+||+|||++...............+||+.|+|||++.+..|+.++|||||||++|+|++|..||........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999754333333445667899999999999999999999999999999999999999864322110
Q ss_pred HHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCC-CCHHHHHHHHhcc
Q 036144 272 VTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSR-PFMVDVVTALEYL 333 (336)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-pt~~evl~~L~~i 333 (336)
. ....+.. + ..+..+.+++..||+.+|.+| |++.++.+.|+.+
T Consensus 294 ------------~----~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 ------------K----PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ------------E----ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ------------e----echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0 0111111 1 124578899999999999999 6788888777654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=342.54 Aligned_cols=255 Identities=23% Similarity=0.335 Sum_probs=206.8
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--------cHHHHHHHHHHHhhc-cCCCccceEEEE
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--------GSREFFAEVLMLSLV-QHQNLVNLIGYC 120 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 120 (336)
....++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 34457799999999999999999999989999999998654321 134577899999999 799999999999
Q ss_pred EeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEc
Q 036144 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS 200 (336)
Q Consensus 121 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~ 200 (336)
......++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.| |+||||||+||+++.++.++|+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999875 356899999999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT------GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 274 (336)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+
T Consensus 243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i-- 317 (365)
T 2y7j_A 243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI-- 317 (365)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--
T ss_pred ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH--
Confidence 999998654332 2345679999999998863 36889999999999999999999999764422111111
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........ .+. ....+..+.+++.+||+.||++|||+.++++
T Consensus 318 ----~~~~~~~~---~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 ----MEGQYQFS---SPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----HHTCCCCC---HHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HhCCCCCC---Ccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10000000 000 0123457999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=340.45 Aligned_cols=269 Identities=26% Similarity=0.355 Sum_probs=207.7
Q ss_pred CCCcccccccCceEEEEEEE----cccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeEEE
Q 036144 56 FNPDCLVGEGGYGRVYKGYI----EAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQRIL 128 (336)
Q Consensus 56 y~~~~~ig~G~~g~v~~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 128 (336)
|++.+.||+|+||.||++.. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48999999999999988754 45789999999976532 334668899999999999999999999987 467899
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999865 34899999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....+..... .......
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~ 262 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQM-TVLRLTE 262 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHH-HHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccch-hHHHHHH
Confidence 543322 223345688899999999999999999999999999999999999875321100 0000000000 0000011
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11111122334455668999999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=336.98 Aligned_cols=267 Identities=26% Similarity=0.388 Sum_probs=190.7
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34678999999999999999999998889999999986543 23346688999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 130 YEFMSNGSLENHFLDL----PPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
|||+++++|.+++... ......+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988641 123456899999999999999999999998 999999999999999999999999998
Q ss_pred ccCCCCCC---cceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 206 KLGPTGGK---DHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 206 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............ ...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~~~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT------LQN 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------HTS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH------hcc
Confidence 76543221 112334679999999999876 57899999999999999999999999876543221110 000
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..................+..+.+++.+||+.||.+|||+.++++
T Consensus 243 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 --DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp --SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000011111111122234557999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=346.67 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=197.2
Q ss_pred CCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEe-CCeEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD-GDQRILV 129 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 129 (336)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 466778999999999999997543 3568999986543 2345678999999999999999999998754 5678999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999975 3456889999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCc--ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 210 TGGKD--HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 210 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..... .......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||......+....+. .+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-------~~~--- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGR--- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-------TTC---
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-------cCC---
Confidence 32211 12234567889999999999999999999999999999999 677887655433221111 100
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 314 -------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 314 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00112234558999999999999999999999999998763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=335.11 Aligned_cols=255 Identities=28% Similarity=0.398 Sum_probs=199.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.+. ++.||+|++... ...+.+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 357889999999999999999986 688999998643 345678999999999999999999998764 47899999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc-eEEccccccccCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN-PKLSDFGLAKLGPTG 211 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~-~kl~Dfg~~~~~~~~ 211 (336)
+++|+|.+++.... ....++...++.++.|++.||.|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 81 AEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999997532 1234788899999999999999999933233999999999999988887 799999999754221
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||......... ..+ ... ..
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~--~~~-~~--------- 220 (307)
T 2eva_A 160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMW--AVH-NG--------- 220 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHH--HHH-TT---------
T ss_pred -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHH--HHh-cC---------
Confidence 23456999999999999999999999999999999999999999764432111 111 110 00
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 221 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 221 -TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp -CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred -CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 011122334567999999999999999999999999998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=330.31 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=199.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++......++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999999899999999986432 23346788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999865 346899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||......... . ......
T Consensus 163 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~---~~~~~~------ 227 (276)
T 2h6d_A 163 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF---K---KIRGGV------ 227 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---H---HHHHCC------
T ss_pred CCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---H---HhhcCc------
Confidence 321 2334578999999999987765 68999999999999999999999764322111 1 111000
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 228 --~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 228 --F----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp --C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --c----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0 112234457899999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=333.30 Aligned_cols=259 Identities=20% Similarity=0.283 Sum_probs=204.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEe--CCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCAD--GDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999999999999999998643 3567899999999997 9999999999987 6678999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEccccccccC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKLG 208 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 208 (336)
|||+.+++|.+++.. +++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999998743 788899999999999999999999 99999999999999776 8999999999865
Q ss_pred CCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----H---Hh
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-----P---LL 279 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~---~~ 279 (336)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... ...... . .+
T Consensus 182 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHH
T ss_pred CCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHH
Confidence 4332 2344579999999999877 67999999999999999999999999654432111 110000 0 00
Q ss_pred hc-cc------------ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 RD-KK------------KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ~~-~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. .. ..............+...+..+.+||.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 00 000000111122223335678999999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=329.05 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=203.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|....+||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555668999999999999999999999999997766555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-CCceEEccccccccCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-EFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~ 212 (336)
++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 9999999987632 2345678889999999999999999998 999999999999987 889999999999765332
Q ss_pred CcceeeeeccCccccCccccccCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQ--LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
........||+.|+|||++.+.. ++.++||||||+++|+|++|..||........ ........
T Consensus 177 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~----------- 241 (295)
T 2clq_A 177 -NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGMF----------- 241 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHHH-----------
T ss_pred -CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhccc-----------
Confidence 12234467999999999987653 88999999999999999999999975432211 00000000
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....++...+..+.+++.+||+.||++|||+.++++
T Consensus 242 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 -KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111233345568999999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=335.25 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=191.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc--HHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG--SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.++|++.+.||+|+||.||+|.+..+|+.||+|++....... .+.+.++...++.++||||+++++++.+....++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 478999999999999999999999999999999987543221 223445555678889999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
||++ |+|.+++.........+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 588887765444567899999999999999999999997 8 9999999999999999999999999997653
Q ss_pred CCCCcceeeeeccCccccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYA----MTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
.. .......||+.|+|||++ .+..++.++|||||||++|+|++|..||........ .........
T Consensus 162 ~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~--- 230 (290)
T 3fme_A 162 DD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-----QLKQVVEEP--- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-----HHHHHHHSC---
T ss_pred cc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-----HHHHHhccC---
Confidence 32 223345799999999996 456789999999999999999999999975432211 011111110
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.........+..+.+++.+||+.||++|||+.++++
T Consensus 231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 -------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 001111234567999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=341.41 Aligned_cols=260 Identities=21% Similarity=0.273 Sum_probs=191.3
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEE--------e
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCA--------D 122 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--------~ 122 (336)
...+|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.+. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4568999999999999999999999999999999986665555677899999999996 999999999994 3
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
....++||||+ +|+|.+++.... ....+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+||+||
T Consensus 106 ~~~~~lv~e~~-~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELC-KGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SEEEEEEEECC-SEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CceEEEEEEec-CCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 34578999999 579988876422 2456999999999999999999999864 34999999999999999999999999
Q ss_pred cccccCCCCCCcc----------eeeeeccCccccCcccc---ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc
Q 036144 203 GLAKLGPTGGKDH----------VSTRVMGTYGYCAPEYA---MTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ 269 (336)
Q Consensus 203 g~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~ 269 (336)
|++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 9998654322111 11245699999999998 566789999999999999999999999975432111
Q ss_pred cHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 270 NLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
... ..........+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 262 ---------~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 ---------VNG----------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------hcC----------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 0000111122235789999999999999999999999998763
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=353.30 Aligned_cols=244 Identities=14% Similarity=0.150 Sum_probs=192.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHH---HHhhccCCCccceE-------EE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVL---MLSLVQHQNLVNLI-------GY 119 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~iv~~~-------~~ 119 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||||++... .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36688899999999999999999989999999998743 2334567889994 55556799999998 77
Q ss_pred EEeCCe-----------------EEEEEEcCCCCChhhhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 036144 120 CADGDQ-----------------RILVYEFMSNGSLENHFLDLP---PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179 (336)
Q Consensus 120 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i 179 (336)
+...+. .++||||+ +|+|.+++.... .....+++..++.++.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665542 78999999 689999987521 11223445788889999999999999999 9
Q ss_pred eeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccC-----------CCCCccchhhHHH
Q 036144 180 IYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-----------QLTKKSDVYSFGV 248 (336)
Q Consensus 180 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslG~ 248 (336)
+||||||+|||++.++.+||+|||++.... ......+| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 999999999999999999999999998532 23455678 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 249 VLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 249 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
++|+|++|..||........... +... ....+..+.+|+.+||+.||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~----------------~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEW----------------IFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGG----------------GGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhh----------------hhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999976543221110 0000 1123457999999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=362.67 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=201.6
Q ss_pred cccccCceEEEEEEEc--ccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 61 LVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
.||+|+||.||+|.++ .++..||||+++... ....+.+.+|+.+++.++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 356789999997653 3345789999999999999999999999976 56899999999999
Q ss_pred hhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc-ce
Q 036144 138 LENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD-HV 216 (336)
Q Consensus 138 L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~ 216 (336)
|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ..
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999865 3567999999999999999999999998 999999999999999999999999999865332211 11
Q ss_pred eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCC
Q 036144 217 STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295 (336)
Q Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (336)
.....+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+ ..+. ..
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~~~----------~~ 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGK----------RM 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH-------HTTC----------CC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-------HcCC----------CC
Confidence 222346789999999999999999999999999999998 99999876543322111 1110 11
Q ss_pred CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 296 ~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.++..++..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 23344566899999999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=349.09 Aligned_cols=203 Identities=22% Similarity=0.298 Sum_probs=176.8
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc------cCCCccceEEEEEeCCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV------QHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~ 125 (336)
...+|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 346799999999999999999999999999999998653 23345677888888887 56799999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc--eEEcccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN--PKLSDFG 203 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~--~kl~Dfg 203 (336)
.++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELL-SMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEecc-CCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999 57999988763 3345899999999999999999999998 999999999999999887 9999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPS 266 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 266 (336)
++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||......
T Consensus 248 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 248 SSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 9975432 233467999999999999999999999999999999999999999876543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=342.85 Aligned_cols=256 Identities=27% Similarity=0.359 Sum_probs=206.3
Q ss_pred hcCCCCcccccccCceEEEEEEEc---ccCeEEEEEeecCCC----CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIE---AVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGD 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 124 (336)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... ......+.+|+.+++.+ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 578999999986532 12335567899999999 5999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999875 356899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG--QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
+...... ........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... .........
T Consensus 206 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~- 281 (355)
T 1vzo_A 206 SKEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS- 281 (355)
T ss_dssp EEECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC-
T ss_pred CeecccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhcc-
Confidence 9764322 12223446799999999999863 57899999999999999999999997654332211 111111111
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVTAL 330 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~~L 330 (336)
...++...+..+.+||.+||+.||.+|| |+.++++..
T Consensus 282 -----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 -----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1123334556889999999999999999 999998743
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=331.81 Aligned_cols=254 Identities=23% Similarity=0.284 Sum_probs=208.1
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---------ccHHHHHHHHHHHhhcc-CCCccceEEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---------QGSREFFAEVLMLSLVQ-HQNLVNLIGYC 120 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~iv~~~~~~ 120 (336)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 445789999999999999999999999999999999865431 11345778999999995 99999999999
Q ss_pred EeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEc
Q 036144 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS 200 (336)
Q Consensus 121 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~ 200 (336)
......++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999875 356899999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccc------cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM------TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 274 (336)
|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.........
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----- 238 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML----- 238 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH-----
Confidence 999997654322 234467999999999885 456889999999999999999999999765432211
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..+..... ..........+..+.+++.+||+.||.+|||+.++++
T Consensus 239 -~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 -RMIMSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHHHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHhcCCc--------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111100 0111112345668999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=344.12 Aligned_cols=264 Identities=19% Similarity=0.215 Sum_probs=207.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc--------CCCccceEEEEE---
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ--------HQNLVNLIGYCA--- 121 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~--- 121 (336)
.++|.+.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 47899999999999999999999999999999998643 233467889999999986 788999999987
Q ss_pred -eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCC----
Q 036144 122 -DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEF---- 195 (336)
Q Consensus 122 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~---- 195 (336)
.....++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 556789999999 67777776552 335699999999999999999999998 8 99999999999998775
Q ss_pred ---------------------------------------------ceEEccccccccCCCCCCcceeeeeccCccccCcc
Q 036144 196 ---------------------------------------------NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230 (336)
Q Consensus 196 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 230 (336)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999865322 33457999999999
Q ss_pred ccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH---hh------------------ccccccccc
Q 036144 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL---LR------------------DKKKFTMMA 289 (336)
Q Consensus 231 ~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~------------------~~~~~~~~~ 289 (336)
++.+..++.++|||||||++|+|++|..||.................+ .. .......+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999876544322111111110 00 000000000
Q ss_pred CCcc---------CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLL---------EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... ....+...+..+.+|+.+||+.||++|||++|+++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000 01345677889999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=340.96 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=197.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHH--HhhccCCCccceEEEEEe-----CCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLM--LSLVQHQNLVNLIGYCAD-----GDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~~iv~~~~~~~~-----~~~ 125 (336)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..|.++ +..++||||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 47899999999999999999977 47999999986432 3344444444 556899999999986542 235
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeCCCCCCCeEECCCCc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV---------ADPPVIYRDFKASNILLDAEFN 196 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~---------~~~~i~H~dikp~Nil~~~~~~ 196 (336)
.++||||+++|+|.+++.. ...++..++.++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 6899999999999999965 3358889999999999999999998 7 999999999999999999
Q ss_pred eEEccccccccCCCCCC------cceeeeeccCccccCcccccc-------CCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 036144 197 PKLSDFGLAKLGPTGGK------DHVSTRVMGTYGYCAPEYAMT-------GQLTKKSDVYSFGVVLLELITGRSAIDNS 263 (336)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~g~~p~~~~ 263 (336)
+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999976543211 122334579999999999876 35678899999999999999997776543
Q ss_pred CCccc-ccHHH----------HHHHHhhcccccccccCCccCCC--CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHH
Q 036144 264 RPSEE-QNLVT----------WAKPLLRDKKKFTMMADPLLEGQ--YPRKGLYQALAVAGMCLQEDADSRPFMVDVVTAL 330 (336)
Q Consensus 264 ~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L 330 (336)
..... ..... .......... ..+.+... .....+..+.+|+.+||+.||++|||+.|+++.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 32211 11100 0001111100 11111111 1234677899999999999999999999999999
Q ss_pred hcccC
Q 036144 331 EYLSS 335 (336)
Q Consensus 331 ~~i~~ 335 (336)
+.|.+
T Consensus 314 ~~ll~ 318 (336)
T 3g2f_A 314 AELMM 318 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=331.64 Aligned_cols=272 Identities=22% Similarity=0.311 Sum_probs=211.4
Q ss_pred cccHHHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhh--ccCCCccceEEEE
Q 036144 43 VFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSL--VQHQNLVNLIGYC 120 (336)
Q Consensus 43 ~~~~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~ 120 (336)
...........++|.+.+.||+|+||.||+|.+. |+.||+|++... ....+.+|++++.. ++||||+++++++
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 3344444556789999999999999999999984 899999998643 34567788888887 7899999999999
Q ss_pred EeCC----eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCC
Q 036144 121 ADGD----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH--------DVADPPVIYRDFKASN 188 (336)
Q Consensus 121 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh--------~~~~~~i~H~dikp~N 188 (336)
.... ..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~N 177 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKN 177 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGG
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHH
Confidence 8876 78999999999999999965 35899999999999999999999 777 9999999999
Q ss_pred eEECCCCceEEccccccccCCCCCCcc--eeeeeccCccccCccccccC------CCCCccchhhHHHHHHHHHhC----
Q 036144 189 ILLDAEFNPKLSDFGLAKLGPTGGKDH--VSTRVMGTYGYCAPEYAMTG------QLTKKSDVYSFGVVLLELITG---- 256 (336)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~~g---- 256 (336)
|+++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 999999999999999997654332211 22445799999999998765 234789999999999999999
Q ss_pred ------CCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCC-CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 257 ------RSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQ-YPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 257 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..||......... ........... ...+.+... .....+..+.+|+.+||+.||++|||+.++++.
T Consensus 258 ~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDPS-VEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TBCCCCCCTTTTTSCSSCC-HHHHHHHHTTS------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccccccCccccCcCccc-HHHHHHHHHHH------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6777654432211 11111111110 011111111 123567789999999999999999999999999
Q ss_pred Hhccc
Q 036144 330 LEYLS 334 (336)
Q Consensus 330 L~~i~ 334 (336)
|+.|.
T Consensus 331 L~~i~ 335 (342)
T 1b6c_B 331 LSQLS 335 (342)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=347.85 Aligned_cols=262 Identities=19% Similarity=0.257 Sum_probs=210.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC-CCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH-QNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| +++..+..++......++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4789999999999999999999999999999998765433 2357889999999987 566666777788889999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE---CCCCceEEccccccccC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL---DAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 208 (336)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++...
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999975 2457999999999999999999999999 9999999999999 58889999999999865
Q ss_pred CCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 209 PTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 209 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..................... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-T 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-S
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-c
Confidence 443221 1223568999999999999999999999999999999999999999876554333222211110000 0
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.... +....+..+.+|+..||+.||++||++.+|++.|+.+
T Consensus 236 ~~~~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 236 SIEA---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp CHHH---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cHHH---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 0000 0112345899999999999999999999999999876
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=337.90 Aligned_cols=255 Identities=28% Similarity=0.378 Sum_probs=201.3
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEe------
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCAD------ 122 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~------ 122 (336)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 345678999999999999999999999999999999986543 3456788999999998 79999999999987
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence 46789999999999999998763 2356899999999999999999999998 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 277 (336)
|++...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||...........
T Consensus 174 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------ 245 (326)
T 2x7f_A 174 GVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------ 245 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------
T ss_pred cCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH------
Confidence 998764322 11234457999999999987 56789999999999999999999999976543221110
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... . + ...+...+..+.+++.+||..||.+|||+.++++
T Consensus 246 ~~~~~--~-----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 246 IPRNP--A-----P---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSC--C-----C---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhcCc--c-----c---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11000 0 0 0112233558999999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=347.54 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=199.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeC------CeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------DQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~ 127 (336)
.+|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 469999999999999999999999999999999865422 234799999999999999999988532 2367
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-CceEEccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGLAK 206 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~ 206 (336)
+||||+++ +|.+.+.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+|||++.
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999964 676666543334577999999999999999999999998 9999999999999865 568999999998
Q ss_pred cCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-----HHHh-
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA-----KPLL- 279 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~- 279 (336)
...... ......||+.|+|||++.+. .|+.++|||||||++|||++|..||......+....+... ...+
T Consensus 206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 654322 23446799999999998765 7999999999999999999999999875533221111100 0000
Q ss_pred hcccccccccCCccC-----CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 RDKKKFTMMADPLLE-----GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...........+.+. ..++...+..+.+||.+||+.||.+|||+.|+++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000011111111111 1122344568999999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=339.27 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=196.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCC------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD------ 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 124 (336)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999999999999999999865422 23456889999999999999999999997654
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||++ ++|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999995 578887742 4888999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH----------
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW---------- 274 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~---------- 274 (336)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..
T Consensus 174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9754321 223456799999999999999999999999999999999999999987553221111100
Q ss_pred ------HHHHhhcccc-----cccccCCcc---CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 275 ------AKPLLRDKKK-----FTMMADPLL---EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 275 ------~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......... ......... ........+..+.+|+.+||+.||++|||++++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000000 000000000 00112234678999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=337.52 Aligned_cols=268 Identities=21% Similarity=0.270 Sum_probs=205.8
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeC-----Ce
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADG-----DQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 125 (336)
...+|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 356899999999999999999999999999999999754322 236688999999999999999999999755 36
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999995 699998865 45899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCc-ceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----H
Q 036144 206 KLGPTGGKD-HVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-----L 278 (336)
Q Consensus 206 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~ 278 (336)
......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+..... .
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 865432111 11244689999999998654 5689999999999999999999999987664443222211000 0
Q ss_pred hhcc------cccccccCCcc--CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRDK------KKFTMMADPLL--EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~~------~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+... ........... ...+....+..+.+|+.+||+.||++|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00000000000 00011233567999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=343.18 Aligned_cols=264 Identities=17% Similarity=0.197 Sum_probs=207.0
Q ss_pred hcCCCCcccccccCceEEEEEEEccc--------CeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccc---------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAV--------DQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVN--------- 115 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~--------- 115 (336)
.++|.+.+.||+|+||.||+|.+..+ ++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 47899999999999999999999874 789999998643 35789999999999999887
Q ss_pred ------eEEEEEe-CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 036144 116 ------LIGYCAD-GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASN 188 (336)
Q Consensus 116 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~N 188 (336)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6777776 77889999999 99999999762 2367999999999999999999999998 9999999999
Q ss_pred eEECCCC--ceEEccccccccCCCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 036144 189 ILLDAEF--NPKLSDFGLAKLGPTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAID 261 (336)
Q Consensus 189 il~~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 261 (336)
||++.++ .+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999765332111 11234579999999999999999999999999999999999999998
Q ss_pred CCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 262 NSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....... ............ ...+..... .....+..+.+|+.+||+.||++|||++++++.|+.+.
T Consensus 270 ~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 270 NCLPNTE-DIMKQKQKFVDK---PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GGTTCHH-HHHHHHHHHHHS---CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCcCHH-HHHHHHHhccCC---hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 6542221 111111111111 111111100 01123468999999999999999999999999998763
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=362.38 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=200.7
Q ss_pred ccccccCceEEEEEEE--cccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYI--EAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.+ +.++..||||+++.... ...+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 3699999999999965 45678999999975432 335679999999999999999999999965 458899999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCc-
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD- 214 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 214 (336)
|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999965 456899999999999999999999999 999999999999999999999999999865433221
Q ss_pred ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 215 HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
.......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+....+. .+ .
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~~----------~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------KG----------E 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------TT----------C
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cC----------C
Confidence 22333457889999999999999999999999999999998 999998765432211111 11 1
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+|+..||+.||++|||+++|++.|+.+
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1123334566899999999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=339.80 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=187.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeC------C
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADG------D 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 124 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999999999999999865422 2345688999999999999999999998654 5
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++|||++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 7899888753 56999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----HH
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-----PL 278 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~ 278 (336)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... ..
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 975422 2345679999999999887 689999999999999999999999998765432221111100 00
Q ss_pred hhcc--cccccccC---CccCCCC---cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRDK--KKFTMMAD---PLLEGQY---PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~~--~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+..- ........ ......+ ....+..+.+|+.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000 00000000 0000000 0123457899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=332.24 Aligned_cols=260 Identities=25% Similarity=0.329 Sum_probs=200.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcc-cC--eEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA-VD--QVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~-~~--~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4679999999999999999998743 23 369999986542 234567889999999999999999999998765 8
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999875 2356899999999999999999999998 9999999999999999999999999998
Q ss_pred cCCCCCCcc-eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 207 LGPTGGKDH-VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||......+.. .......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~-- 241 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEG-- 241 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSC--
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------HHHHccC--
Confidence 754432211 2234567889999999998899999999999999999999 99999765432211 1111110
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 242 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0111223445689999999999999999999999999988753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=344.90 Aligned_cols=255 Identities=11% Similarity=0.014 Sum_probs=185.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhc--cCCCccceE-------EEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLV--QHQNLVNLI-------GYC 120 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~iv~~~-------~~~ 120 (336)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3458999999999999999999999999999999976543 2234567786555555 599988755 555
Q ss_pred EeC-----------------CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCC
Q 036144 121 ADG-----------------DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTR------MKIAGGAAKGLEYLHDVADP 177 (336)
Q Consensus 121 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~l~~~l~~lh~~~~~ 177 (336)
... ...++||||++ |+|.+++... ...++...+ +.++.||+.||.|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 433 33799999997 8999999752 122344445 677799999999999999
Q ss_pred CeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCcccccc--CCCCCccchhhHHHHHHHHHh
Q 036144 178 PVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELIT 255 (336)
Q Consensus 178 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~ 255 (336)
|+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999986422 1224567799999999987 689999999999999999999
Q ss_pred CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 256 GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 256 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
|..||............ . ...................+..+.+|+.+||+.||++|||+.++++
T Consensus 289 g~~Pf~~~~~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWK--------R-PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTCCC--------B-CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccchh--------h-hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999876432211000 0 0000000111111112245668999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=332.49 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=200.4
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--------ccHHHHHHHHHHHhhccCCCccceEEEEEeC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--------QGSREFFAEVLMLSLVQHQNLVNLIGYCADG 123 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 123 (336)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 45679999999999999999999999999999999865321 1123478999999999999999999998766
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc---eEEc
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN---PKLS 200 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~---~kl~ 200 (336)
. .++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 5 8999999999999998864 467899999999999999999999999 999999999999987665 9999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 277 (336)
|||++...... .......||+.|+|||++. ...++.++|||||||++|+|++|..||........ .......
T Consensus 160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~ 234 (322)
T 2ycf_A 160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS 234 (322)
T ss_dssp CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH
T ss_pred cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh
Confidence 99999865322 1223457999999999874 46789999999999999999999999976543221 1111100
Q ss_pred HhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ... .........+..+.+++.+||+.||++|||+.++++
T Consensus 235 ---~--~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 ---G--KYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---T--CCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---C--ccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0 000 000001123568999999999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=358.80 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=210.8
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
...++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|+.++||||+++++++.+ ...++||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 345678899999999999999999986 4679999997644 345789999999999999999999999876 6789999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 341 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999999641 2345889999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
. .........++..|+|||++.+..++.++|||||||++|||++ |..||......+....+ ..+
T Consensus 416 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-------~~~------- 480 (535)
T 2h8h_A 416 N-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERG------- 480 (535)
T ss_dssp H-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-------HTT-------
T ss_pred C-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC-------
Confidence 1 1111223456789999999999999999999999999999999 99999765432211111 111
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+..++..+.+|+.+||+.||++|||+++|++.|+.+.
T Consensus 481 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 481 ---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011223345668999999999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=339.18 Aligned_cols=272 Identities=20% Similarity=0.228 Sum_probs=200.4
Q ss_pred HHHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-----------cHHHHHHHHHHHhhccCCCcc
Q 036144 46 YQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-----------GSREFFAEVLMLSLVQHQNLV 114 (336)
Q Consensus 46 ~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv 114 (336)
..++....++|.+.+.||+|+||.||+|.+.. |..||||++...... ..+.+.+|+.+++.++||||+
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 44566778999999999999999999999876 899999998643221 126788999999999999999
Q ss_pred ceEEEEEe-----CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 036144 115 NLIGYCAD-----GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNI 189 (336)
Q Consensus 115 ~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Ni 189 (336)
++++++.. ....++||||+. |+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 99999854 336799999996 688888765 3457999999999999999999999999 99999999999
Q ss_pred EECCCCceEEccccccccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 036144 190 LLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE 268 (336)
Q Consensus 190 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 268 (336)
+++.++.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+.
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999743222 22345679999999999877 6799999999999999999999999987653322
Q ss_pred ccHHHHHH--------HHhhccc---ccccccCCccC---CCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 269 QNLVTWAK--------PLLRDKK---KFTMMADPLLE---GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 269 ~~~~~~~~--------~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+.... ..+.... ........... .......+..+.+|+.+||+.||.+|||+.++++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111000 0000000 00000000000 0111233557999999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=334.60 Aligned_cols=273 Identities=19% Similarity=0.216 Sum_probs=195.7
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCe--
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ-- 125 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 125 (336)
......++|.+.+.||+|+||.||+|.+..+|+.||||++.... .......+++..++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34556789999999999999999999999999999999886543 233456788888899999999999999865433
Q ss_pred -----EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeCCCCCCCeEECC-CCce
Q 036144 126 -----RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH--DVADPPVIYRDFKASNILLDA-EFNP 197 (336)
Q Consensus 126 -----~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh--~~~~~~i~H~dikp~Nil~~~-~~~~ 197 (336)
.++||||+++ +|...+.........+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999965 555554433335677899999999999999999999 888 999999999999986 8999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA- 275 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~- 275 (336)
||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+...
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 999999998654322 23446789999999998765 4899999999999999999999999876543322111100
Q ss_pred -------HHHhhcccccccccCC------ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 -------KPLLRDKKKFTMMADP------LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 -------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..............+. ..........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000000000 0001112235678999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=344.44 Aligned_cols=264 Identities=20% Similarity=0.286 Sum_probs=196.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCC------eE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD------QR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~ 126 (336)
..+|.+.+.||+|+||.||+|.+..++. ||+|++...... ..+|+.+++.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4579999999999999999999988666 788877543221 236999999999999999999986543 37
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC-CCCceEEcccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD-AEFNPKLSDFGLA 205 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~ 205 (336)
++||||++++ +...+.........+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 8999999664 44443322233567999999999999999999999999 99999999999998 7899999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH--------
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-------- 276 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 276 (336)
....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||......+....+....
T Consensus 190 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 190 KILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266 (394)
T ss_dssp EECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 8654332 23456789999999998765 58999999999999999999999998765432211111000
Q ss_pred HHhhcc---cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 277 PLLRDK---KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 277 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...... ..+.......+...++...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000 0000000001111122335568999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=331.03 Aligned_cols=264 Identities=19% Similarity=0.254 Sum_probs=206.6
Q ss_pred hcCCCCcccccccCceEEEEEEE-cccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCC------ccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYI-EAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN------LVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~ 125 (336)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.++|++ ++++++++.....
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999998 567899999998643 233466889999999987654 9999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC------------
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA------------ 193 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~------------ 193 (336)
.++||||+ +++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 89999998763 2346899999999999999999999998 999999999999987
Q ss_pred -------CCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 036144 194 -------EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPS 266 (336)
Q Consensus 194 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 266 (336)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999764321 33457999999999999999999999999999999999999999876543
Q ss_pred ccccHHHHHHH-----Hhhccccccc--------------------ccCCc-cCCCCcHHHHHHHHHHHHhhcCCCCCCC
Q 036144 267 EEQNLVTWAKP-----LLRDKKKFTM--------------------MADPL-LEGQYPRKGLYQALAVAGMCLQEDADSR 320 (336)
Q Consensus 267 ~~~~~~~~~~~-----~~~~~~~~~~--------------------~~~~~-~~~~~~~~~~~~l~~li~~cl~~dp~~R 320 (336)
+.......... .......... ...+. .........+..+.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 32221111100 0000000000 00000 0011233567789999999999999999
Q ss_pred CCHHHHHH
Q 036144 321 PFMVDVVT 328 (336)
Q Consensus 321 pt~~evl~ 328 (336)
||+.|+++
T Consensus 321 pt~~ell~ 328 (339)
T 1z57_A 321 ITLREALK 328 (339)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=332.67 Aligned_cols=260 Identities=18% Similarity=0.249 Sum_probs=205.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc-----------------HHHHHHHHHHHhhccCCCccc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG-----------------SREFFAEVLMLSLVQHQNLVN 115 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~iv~ 115 (336)
.++|.+.+.||+|+||.||+|.+ +|+.||+|++....... .+.+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 69999999986432111 177899999999999999999
Q ss_pred eEEEEEeCCeEEEEEEcCCCCChhhh------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCC
Q 036144 116 LIGYCADGDQRILVYEFMSNGSLENH------FLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASN 188 (336)
Q Consensus 116 ~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~N 188 (336)
+++++.+.+..++||||+++++|.++ +.. .....+++..++.++.|++.||.|||+ .+ |+||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999998 433 225779999999999999999999998 88 9999999999
Q ss_pred eEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccC-CCCC-ccchhhHHHHHHHHHhCCCCCCCCCCc
Q 036144 189 ILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTK-KSDVYSFGVVLLELITGRSAIDNSRPS 266 (336)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwslG~il~~l~~g~~p~~~~~~~ 266 (336)
|+++.++.++|+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999764332 34556799999999999887 6766 999999999999999999999875542
Q ss_pred ccccHHHHHHHHhhccccccc----ccCCcc---CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 267 EEQNLVTWAKPLLRDKKKFTM----MADPLL---EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ... .+......... ...+.. ........+..+.+|+.+||+.||.+|||+.++++
T Consensus 259 ~~--~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VE--LFN---NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH--HHH---HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH--HHH---HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 111 11111000000 000000 00111345668999999999999999999999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=333.76 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=198.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEE-----------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA----------- 121 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----------- 121 (336)
.++|.+.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 478999999999999999999999999999999987665555677899999999999999999999873
Q ss_pred ---eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC-CCCce
Q 036144 122 ---DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD-AEFNP 197 (336)
Q Consensus 122 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~-~~~~~ 197 (336)
.....++||||++ |+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 3467899999996 699998853 56899999999999999999999999 99999999999997 56789
Q ss_pred EEccccccccCCCCCC-cceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH
Q 036144 198 KLSDFGLAKLGPTGGK-DHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA 275 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 275 (336)
||+|||++........ ........+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||......+....+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999986532211 112234567999999998865 67899999999999999999999999876543221111100
Q ss_pred HHHhhcc------ccc----c-cccCCcc-CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 276 KPLLRDK------KKF----T-MMADPLL-EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 276 ~~~~~~~------~~~----~-~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+..... ... . ....+.. ........+..+.+++.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000 000 0 0000000 00011234568999999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=332.70 Aligned_cols=260 Identities=21% Similarity=0.321 Sum_probs=200.4
Q ss_pred ccHHHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhcc--CCCccceEEE
Q 036144 44 FKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQ--HQNLVNLIGY 119 (336)
Q Consensus 44 ~~~~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~iv~~~~~ 119 (336)
+.++.+....++|.+.+.||+|+||.||+|.+.. ++.||+|++..... ...+.+.+|+.+++.++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 3334444556789999999999999999999865 88999999865432 23467889999999997 5999999999
Q ss_pred EEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 120 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
+......++||| +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. +.+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEE
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEE
Confidence 999999999999 558899999876 357899999999999999999999998 999999999999964 79999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCcccccc-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCccc
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-----------GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE 268 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 268 (336)
+|||++................||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI- 246 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-
Confidence 99999986544333223345679999999999865 478889999999999999999999997643211
Q ss_pred ccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 269 QNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....... ++.....++...+..+.+++.+||+.||.+|||+.++++
T Consensus 247 ----~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 247 ----SKLHAII----------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp ----HHHHHHH----------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHHHH----------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 1111111 111112223333568999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=332.40 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=199.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCeE----
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR---- 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---- 126 (336)
.++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46899999999999999999999999999999999764322 246688999999999999999999999877654
Q ss_pred --EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 127 --ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 127 --~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
++||||+. ++|.+++. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999995 68887763 34899999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----HH
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-----PL 278 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~ 278 (336)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......+....+.... ..
T Consensus 191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 975422 2344678999999999887 689999999999999999999999998755332211111000 00
Q ss_pred hhc--c---cccccccCCccCCC---CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRD--K---KKFTMMADPLLEGQ---YPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~--~---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... . .............. .....+..+.+|+.+||+.||++|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000 0 00000000000000 11234568999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=335.61 Aligned_cols=264 Identities=17% Similarity=0.207 Sum_probs=202.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-----------CCCccceEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-----------HQNLVNLIGYCA 121 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~ 121 (336)
..+|.+.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999999999999999998643 233466788999998886 889999999987
Q ss_pred eCC----eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEEC----
Q 036144 122 DGD----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLD---- 192 (336)
Q Consensus 122 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~---- 192 (336)
... ..++|||++ +++|.+++... ....+++..++.++.||+.||.|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 654 789999999 99999998763 235589999999999999999999997 8 99999999999994
Q ss_pred --CCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCccccc
Q 036144 193 --AEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQN 270 (336)
Q Consensus 193 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~ 270 (336)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4447999999999765321 334579999999999999999999999999999999999999998654322111
Q ss_pred HHHHHHHHh---------------------hcccccccccCCc---------cCCCCcHHHHHHHHHHHHhhcCCCCCCC
Q 036144 271 LVTWAKPLL---------------------RDKKKFTMMADPL---------LEGQYPRKGLYQALAVAGMCLQEDADSR 320 (336)
Q Consensus 271 ~~~~~~~~~---------------------~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~R 320 (336)
.......+. ........+.... ....++...+..+.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111110000 0000000000000 0123556788899999999999999999
Q ss_pred CCHHHHHH
Q 036144 321 PFMVDVVT 328 (336)
Q Consensus 321 pt~~evl~ 328 (336)
||++++++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=332.25 Aligned_cols=205 Identities=23% Similarity=0.307 Sum_probs=175.3
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CC-----CccceEEEEEeC
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQ-----NLVNLIGYCADG 123 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~ 123 (336)
....++|.+.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 33467899999999999999999999999999999999643 223456778888888885 44 499999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeeCCCCCCCeEEC--CCCceEE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD--VADPPVIYRDFKASNILLD--AEFNPKL 199 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~--~~~~~i~H~dikp~Nil~~--~~~~~kl 199 (336)
...++||||+. ++|.+++... ....+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred CceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence 99999999995 6999998763 23568999999999999999999995 45 99999999999994 4778999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPS 266 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 266 (336)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999865322 33467999999999999999999999999999999999999999876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=335.94 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=202.6
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeC-----Ce
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADG-----DQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 125 (336)
..++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 35789999999999999999999999999999999965432 2335678999999999999999999988654 67
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999995 699998865 46899999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCcc--------eeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 036144 206 KLGPTGGKDH--------VSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 206 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 276 (336)
.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--- 236 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF--- 236 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---
Confidence 8654322111 1223578999999998765 678999999999999999999999998755322111110
Q ss_pred HHhhccc---ccc--------cccC--CccC-C---CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 277 PLLRDKK---KFT--------MMAD--PLLE-G---QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 277 ~~~~~~~---~~~--------~~~~--~~~~-~---~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....... ... .... +... . ......+..+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 000 0000 0000 0 001234568899999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=324.05 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=205.7
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++......++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999999899999999986532 3345778999999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC---CceEEcccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---FNPKLSDFGLA 205 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~---~~~kl~Dfg~~ 205 (336)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999998865 346899999999999999999999998 9999999999999764 46999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
....... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||......+... .+.......
T Consensus 172 ~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK------RVETGKYAF 241 (287)
T ss_dssp GTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCC
T ss_pred eeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHcCCCCC
Confidence 7653322 1234468999999998765 58999999999999999999999998754322111 111110000
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+ .......+..+.+++.+||+.||++|||+.++++
T Consensus 242 ----~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 ----D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ----C----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----C----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 0001233557999999999999999999999997
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=329.75 Aligned_cols=254 Identities=18% Similarity=0.212 Sum_probs=176.8
Q ss_pred HhcCCCCcc-cccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe----CCeE
Q 036144 52 ATENFNPDC-LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD----GDQR 126 (336)
Q Consensus 52 ~~~~y~~~~-~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 126 (336)
..++|.+.+ +||+|+||.||+|.++.+|+.||+|++... .....+....++.+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 457899855 699999999999999999999999998642 1222233344567789999999999876 4558
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC---CceEEcccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE---FNPKLSDFG 203 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~---~~~kl~Dfg 203 (336)
++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 9999999999999999763 2357999999999999999999999998 9999999999999764 459999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............. .... .
T Consensus 177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~-~-- 247 (336)
T 3fhr_A 177 FAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RRIR-L-- 247 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hhhh-c--
Confidence 99764322 2344678999999999988899999999999999999999999997654322110000 0000 0
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.............+..+.+|+.+||+.||.+|||+.++++
T Consensus 248 -----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 248 -----GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000011111234568999999999999999999999997
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=327.01 Aligned_cols=267 Identities=22% Similarity=0.286 Sum_probs=204.1
Q ss_pred HhcCCCCcccccccCceEEEEEEEc-ccCeEEEEEeecCCC--CccHHHHHHHHHHHhhc---cCCCccceEEEEE----
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIE-AVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLV---QHQNLVNLIGYCA---- 121 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~---- 121 (336)
..++|++.+.||+|+||.||+|.+. .+|+.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 678999999986432 12223566788777766 8999999999987
Q ss_pred -eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEc
Q 036144 122 -DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS 200 (336)
Q Consensus 122 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~ 200 (336)
.....++||||+. |+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999996 6999998763 2345899999999999999999999999 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhh
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLR 280 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 280 (336)
|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+..... ..
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~ 238 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LP 238 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC-CC
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC-CC
Confidence 9999975432 1223456789999999999999999999999999999999999999987653322111110000 00
Q ss_pred cccccc-------cccC---CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 281 DKKKFT-------MMAD---PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 281 ~~~~~~-------~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...... .... ......+....+..+.+|+.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000 00011122345668999999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=332.65 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=203.4
Q ss_pred HHHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCC
Q 036144 47 QELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGD 124 (336)
Q Consensus 47 ~~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 124 (336)
++.....++|++.+.||+|+||.||+|.+.. .+|+|++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3334456889999999999999999999864 38999986532 223355778999999999999999999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++ ++.++|+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 99999999999999999865 3456899999999999999999999998 99999999999998 67999999999
Q ss_pred cccCCCCC---CcceeeeeccCccccCcccccc---------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHH
Q 036144 205 AKLGPTGG---KDHVSTRVMGTYGYCAPEYAMT---------GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV 272 (336)
Q Consensus 205 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~ 272 (336)
+....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-- 253 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW-- 253 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH--
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 86542211 1122334568999999999864 357899999999999999999999997654322111
Q ss_pred HHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 273 TWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
... .. ..+.. .....+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 254 ----~~~-~~------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 254 ----QMG-TG------MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp ----HHH-TT------CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred ----Hhc-cC------CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 110 00 00000 01123346889999999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=329.37 Aligned_cols=257 Identities=25% Similarity=0.319 Sum_probs=182.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHH-HHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVL-MLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+..|+. +++.++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 4789999999999999999999999999999999875432 22334555655 777889999999999999999999999
Q ss_pred EcCCCCChhhhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 131 EFMSNGSLENHFLDLP-PDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||++ ++|.+++.... .....+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9996 58877765311 1246789999999999999999999998 8 999999999999999999999999999764
Q ss_pred CCCCCcceeeeeccCccccCcccc----ccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYA----MTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
... .......||+.|+|||++ .+..++.++|||||||++|+|++|..||........ . . ..
T Consensus 177 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~----~---~~ 241 (327)
T 3aln_A 177 VDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q----L---TQ 241 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------CC
T ss_pred ccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H----H---HH
Confidence 332 123334799999999998 456789999999999999999999999976432110 0 0 00
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......+.+........+..+.+|+.+||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00001111111122334568999999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=356.44 Aligned_cols=258 Identities=22% Similarity=0.321 Sum_probs=206.5
Q ss_pred HhcCCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+...... ..+.+.+|+.+++.++||||+++++++. .+..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 346788899999999999999998643 567999998654332 3367889999999999999999999985 45689
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 467 lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 99999999999999975 2456899999999999999999999998 99999999999999999999999999986
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (336)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+. ...
T Consensus 541 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~-------~~~--- 609 (656)
T 2j0j_A 541 MEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGE--- 609 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------HTC---
T ss_pred cCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-------cCC---
Confidence 53322 122334557889999999999999999999999999999997 999998754332111110 100
Q ss_pred cccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 610 -------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 610 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01123345568999999999999999999999999998763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=335.38 Aligned_cols=269 Identities=22% Similarity=0.264 Sum_probs=184.0
Q ss_pred cCCCC-cccccccCceEEEEEEEc--ccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeEEE
Q 036144 54 ENFNP-DCLVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQRIL 128 (336)
Q Consensus 54 ~~y~~-~~~ig~G~~g~v~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 128 (336)
+.|.+ .++||+|+||.||+|.++ .++..||+|++.... ....+.+|+.+++.++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44666 457999999999999976 568899999986543 23568899999999999999999999954 678999
Q ss_pred EEEcCCCCChhhhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE----CCCCceEE
Q 036144 129 VYEFMSNGSLENHFLDLP-----PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL----DAEFNPKL 199 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~----~~~~~~kl 199 (336)
||||+. ++|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999995 68877765311 12335899999999999999999999999 9999999999999 67789999
Q ss_pred ccccccccCCCCCC-cceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCccc------ccH
Q 036144 200 SDFGLAKLGPTGGK-DHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE------QNL 271 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~------~~~ 271 (336)
+|||++........ .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||........ ...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999986543211 1223456899999999998874 589999999999999999999999976543210 001
Q ss_pred HHHHHHHhhcc--cccccc-------------cCCccCC--------CCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 272 VTWAKPLLRDK--KKFTMM-------------ADPLLEG--------QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 272 ~~~~~~~~~~~--~~~~~~-------------~~~~~~~--------~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......+... .....+ ....... ......+..+.+||.+||+.||.+|||++|+|+
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11000000000 000000 0000000 000011457889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=327.84 Aligned_cols=260 Identities=23% Similarity=0.331 Sum_probs=199.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--cHHHHHHHHHHHhhccCCCccceEEEEEeCCe-----
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ----- 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 125 (336)
..+|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46799999999999999999999999999999998654322 23568899999999999999999999987654
Q ss_pred -EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 126 -RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 126 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
.++||||+. ++|.+++. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999995 68877763 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH-----HH
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK-----PL 278 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~ 278 (336)
+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.... ..
T Consensus 173 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 975422 2344678999999999887 678999999999999999999999998765332211111000 00
Q ss_pred hhc--c-------cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRD--K-------KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~--~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... . ..........+ .......+..+.+|+.+||+.||++|||++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0 00000000001 1122345678999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=321.17 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=195.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe----------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD---------- 122 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------- 122 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46799999999999999999999999999999998543 2334678899999999999999999998865
Q ss_pred ---CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEE
Q 036144 123 ---GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKL 199 (336)
Q Consensus 123 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl 199 (336)
....++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 3567899999999999999975 2356788899999999999999999998 999999999999999999999
Q ss_pred ccccccccCCCCCC------------cceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 036144 200 SDFGLAKLGPTGGK------------DHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPS 266 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 266 (336)
+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 99999976432110 1123446799999999998764 78999999999999999998 443211
Q ss_pred ccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 267 EEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........... ........++...+..+.+++.+||+.||.+|||+.++++
T Consensus 233 ---~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ---ERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---HHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111111110 0111222344455667899999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=326.08 Aligned_cols=265 Identities=18% Similarity=0.228 Sum_probs=204.3
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccC-eEEEEEeecCCCCccHHHHHHHHHHHhhccCCC------ccceEEEEEeCC
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVD-QVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN------LVNLIGYCADGD 124 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~~~ 124 (336)
..++|++.+.||+|+||.||+|.+..++ ..||+|++... ....+.+.+|+.+++.++|++ ++.+++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3578999999999999999999998776 79999998643 233466888999999998765 899999999999
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE-------------
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL------------- 191 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~------------- 191 (336)
..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 999999999 77777777652 2356899999999999999999999998 9999999999999
Q ss_pred ------CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 036144 192 ------DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRP 265 (336)
Q Consensus 192 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 265 (336)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56788999999999764322 3345799999999999999999999999999999999999999987554
Q ss_pred cccccHHHHHH-----HHhhccccccccc--------------------CC-ccCCCCcHHHHHHHHHHHHhhcCCCCCC
Q 036144 266 SEEQNLVTWAK-----PLLRDKKKFTMMA--------------------DP-LLEGQYPRKGLYQALAVAGMCLQEDADS 319 (336)
Q Consensus 266 ~~~~~~~~~~~-----~~~~~~~~~~~~~--------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~ 319 (336)
.+......... ............. .+ ..........+..+.+|+.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 32211111100 0000000000000 00 0000112344668999999999999999
Q ss_pred CCCHHHHHH
Q 036144 320 RPFMVDVVT 328 (336)
Q Consensus 320 Rpt~~evl~ 328 (336)
|||+.++++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=328.88 Aligned_cols=244 Identities=22% Similarity=0.355 Sum_probs=202.6
Q ss_pred HHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc------cHHHHHHHHHHHhhcc--CCCccceEEEEE
Q 036144 50 ADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ------GSREFFAEVLMLSLVQ--HQNLVNLIGYCA 121 (336)
Q Consensus 50 ~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~ 121 (336)
....++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999999999999999998654221 1234668999999996 599999999999
Q ss_pred eCCeEEEEEEcCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC-CCCceEE
Q 036144 122 DGDQRILVYEFMSN-GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD-AEFNPKL 199 (336)
Q Consensus 122 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~-~~~~~kl 199 (336)
..+..++|||++.+ ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 899999875 456899999999999999999999999 99999999999998 7789999
Q ss_pred ccccccccCCCCCCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH
Q 036144 200 SDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL 278 (336)
Q Consensus 200 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 278 (336)
+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .
T Consensus 192 ~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~ 255 (320)
T 3a99_A 192 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------I 255 (320)
T ss_dssp CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H
T ss_pred eeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------h
Confidence 999999865432 2334579999999999887766 6889999999999999999999964210 0
Q ss_pred hhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 LRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... . .++...+..+.+|+.+||+.||.+|||++++++
T Consensus 256 ~~~~--------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 IRGQ--------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHCC--------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccc--------c----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1000 0 112234457999999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=325.77 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=195.2
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc------cHHHHHHHHHHHhhc----cCCCccceE
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ------GSREFFAEVLMLSLV----QHQNLVNLI 117 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~iv~~~ 117 (336)
+.....++|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3345568899999999999999999999999999999998654321 123356799999988 899999999
Q ss_pred EEEEeCCeEEEEEEc-CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC-CCC
Q 036144 118 GYCADGDQRILVYEF-MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD-AEF 195 (336)
Q Consensus 118 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~-~~~ 195 (336)
+++...+..++|||+ +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999875 356899999999999999999999998 99999999999998 888
Q ss_pred ceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH
Q 036144 196 NPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT-KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW 274 (336)
Q Consensus 196 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 274 (336)
.++|+|||++...... ......||+.|+|||++.+..+. .++|||||||++|+|++|..||.....
T Consensus 178 ~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------- 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------- 244 (312)
T ss_dssp EEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred eEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------
Confidence 9999999999865432 23445799999999998877664 589999999999999999999964210
Q ss_pred HHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... ...++...+..+.+++.+||+.||++|||++++++
T Consensus 245 ---~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ---ILEA------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ---HHHT------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---Hhhh------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01123344568999999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=319.58 Aligned_cols=253 Identities=27% Similarity=0.336 Sum_probs=183.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc-H-HHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG-S-REFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
..++|++.+.||+|+||.||+|.+..+|+.||+|++....... . +.+.++..+++.++||||+++++++......++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3467999999999999999999999999999999987653321 2 2344555677888999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
|||+ ++.+..+... ....+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++...
T Consensus 103 ~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp ECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred Eecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999 5566555543 245789999999999999999999985 8 999999999999999999999999999754
Q ss_pred CCCCCcceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
... .......||+.|+|||++. +..++.++|||||||++|+|++|..||....... ..........
T Consensus 176 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~- 246 (318)
T 2dyl_A 176 VDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEE- 246 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSC-
T ss_pred cCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccC-
Confidence 332 1233457999999999984 4578899999999999999999999998643221 1111111110
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+.+. .....+..+.+++.+||+.||.+|||+.++++
T Consensus 247 ------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 ------PPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------CCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00010 01123457999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=331.70 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=187.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEEc
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+....++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 445667889999999998754 456899999998643 245678999999876 899999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCC---CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-------------Cc
Q 036144 133 MSNGSLENHFLDLPPDQEPL---DWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-------------FN 196 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l---~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-------------~~ 196 (336)
+. |+|.+++.......... ++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence 95 69999997643222211 23345789999999999999998 9999999999999654 47
Q ss_pred eEEccccccccCCCCCCcc--eeeeeccCccccCcccccc-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCc
Q 036144 197 PKLSDFGLAKLGPTGGKDH--VSTRVMGTYGYCAPEYAMT-------GQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPS 266 (336)
Q Consensus 197 ~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~ 266 (336)
+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998764432211 1234679999999999875 578999999999999999999 99999764332
Q ss_pred ccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 267 EEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. .. ........ +......+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 247 ~----~~----i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 E----SN----IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H----HH----HHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----HH----HhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 01 11111111 11111224567789999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.50 Aligned_cols=267 Identities=21% Similarity=0.222 Sum_probs=202.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEe------CCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD------GDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 125 (336)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 478999999999999999999999999999999987542 2334668899999999999999999998765 667
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCc---eEEccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFN---PKLSDF 202 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~---~kl~Df 202 (336)
.++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. ++|+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999987643 2346888899999999999999999998 999999999999987765 999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccc-cHH-HHHHH-Hh
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ-NLV-TWAKP-LL 279 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~-~~~~~-~~ 279 (336)
|++....... ......||+.|+|||.+.+..++.++|||||||++|+|++|..||......... ... ..... ..
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~ 245 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence 9998654332 234567999999999999999999999999999999999999999764321100 000 00000 00
Q ss_pred hc---ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 036144 280 RD---KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDV 326 (336)
Q Consensus 280 ~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~ev 326 (336)
.. ...............+....+..+.+++.+||..||++|||+.++
T Consensus 246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00 000000001111234556678899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=328.89 Aligned_cols=250 Identities=22% Similarity=0.261 Sum_probs=186.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..+|.+.+.||+|+||+|+. ....+|+.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 35688999999999999764 3344589999999865432 2356899999998 79999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-----CCceEEccccccc
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-----EFNPKLSDFGLAK 206 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-----~~~~kl~Dfg~~~ 206 (336)
|+. |+|.+++... ........++.++.|++.||.|||+.+ |+||||||+|||++. ...+||+|||++.
T Consensus 99 ~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 995 6999998763 233444456789999999999999999 999999999999953 2357899999998
Q ss_pred cCCCCCCc-ceeeeeccCccccCccccc---cCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 207 LGPTGGKD-HVSTRVMGTYGYCAPEYAM---TGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
........ ......+||+.|+|||++. ...++.++|||||||++|+|++ |..||........ . ... .
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~---~~~-~ 243 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----N---ILL-G 243 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----H---HHT-T
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----H---HHh-c
Confidence 65432211 2234567999999999987 4567889999999999999999 8999865432111 0 000 0
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..... . .......+..+.+|+.+||+.||.+|||+.++++
T Consensus 244 ~~~~~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSLD-----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCCT-----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCcc-----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00000 0 0112345667899999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.68 Aligned_cols=232 Identities=15% Similarity=0.128 Sum_probs=186.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc---HHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG---SREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999999999999999997654322 36788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||++|++|.+++.. . .....+..++.|++.||.|||+.+ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999853 2 345578889999999999999999 9999999999999999999998543
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
|++ .++.++|||||||++|+|++|..||............. .......
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~~ 222 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---------RDTAGQP 222 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------BCTTSCB
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------HHhccCC
Confidence 223 36889999999999999999999998765432110000 0000000
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
. .........+..+.+|+.+||+.||.+| |+.++++.|+.+.
T Consensus 223 ~--~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 223 I--EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp C--CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred C--ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0 0001112345579999999999999999 9999999998764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=340.48 Aligned_cols=239 Identities=23% Similarity=0.291 Sum_probs=193.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcc-cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCe-----
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA-VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ----- 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----- 125 (336)
.++|++.+.||+|+||.||+|.+.. +|+.||||++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999976 689999999865432 334567899999999999999999999987665
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999876532 6899999999999999999999999 9999999999999875 8999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||........
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------- 284 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------- 284 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------
T ss_pred hhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-----------------
Confidence 865332 345799999999988765 48999999999999999999988764211100
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHHhc
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-MVDVVTALEY 332 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-~~evl~~L~~ 332 (336)
.........+..+.+||.+||+.||.+||+ ++++...|..
T Consensus 285 -------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 -------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000111223457899999999999999995 5556665554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=305.31 Aligned_cols=228 Identities=19% Similarity=0.277 Sum_probs=182.3
Q ss_pred hcCCCCc-ccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHH-hhccCCCccceEEEEEe----CCeE
Q 036144 53 TENFNPD-CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLML-SLVQHQNLVNLIGYCAD----GDQR 126 (336)
Q Consensus 53 ~~~y~~~-~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~----~~~~ 126 (336)
.++|.+. +.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4667777 789999999999999999999999999853 24577888888 56689999999999987 6778
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC---CCceEEcccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA---EFNPKLSDFG 203 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~---~~~~kl~Dfg 203 (336)
++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999863 3357999999999999999999999999 999999999999988 7889999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
++.... +..++.++|||||||++|+|++|..||.......... .
T Consensus 166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------------~ 209 (299)
T 3m2w_A 166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------G 209 (299)
T ss_dssp TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------------C
T ss_pred cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------------H
Confidence 986421 2457889999999999999999999997644321100 0
Q ss_pred ccccccCCccCCCCc----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLEGQYP----RKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......... ..++ ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 210 ~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000 0111 234668999999999999999999999987
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=324.61 Aligned_cols=242 Identities=14% Similarity=0.148 Sum_probs=184.0
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC---ccHHHHHHHHHHHhhccC-CCcc---------c------
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN---QGSREFFAEVLMLSLVQH-QNLV---------N------ 115 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~iv---------~------ 115 (336)
+|...+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.+.| +|.. .
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 47778899999999999999999999999999874332 235678999999999987 2211 1
Q ss_pred ------eEEEEEe-----CCeEEEEEEcCCCCChhhhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 036144 116 ------LIGYCAD-----GDQRILVYEFMSNGSLENHFLDL---PPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIY 181 (336)
Q Consensus 116 ------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H 181 (336)
+..++.. ....+++|+++ +++|.+++... ......+++..++.++.|++.||.|||+.+ |+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 1111111 22457788876 78999888521 123456788899999999999999999999 999
Q ss_pred CCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCcccc----------ccCCCCCccchhhHHHHHH
Q 036144 182 RDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA----------MTGQLTKKSDVYSFGVVLL 251 (336)
Q Consensus 182 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwslG~il~ 251 (336)
|||||+|||++.++.+||+|||++..... .....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999999999999999875322 2445678 999999998 5556889999999999999
Q ss_pred HHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 252 ELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 252 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+|++|+.||.......... .+.... ...+..+.+|+.+||+.||++|||+.++++
T Consensus 309 elltg~~Pf~~~~~~~~~~----------------~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSE----------------WIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSG----------------GGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhhHH----------------HHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999997654322111 111100 122357999999999999999999887764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=310.99 Aligned_cols=242 Identities=16% Similarity=0.133 Sum_probs=185.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--------CccHHHHHHHHHHHhhcc---------CCCccc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--------NQGSREFFAEVLMLSLVQ---------HQNLVN 115 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~iv~ 115 (336)
.++|++.+.||+|+||.||+|.+ +|+.||||++.... ....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 57999999997543 223367889999999886 777777
Q ss_pred eEEEEE------------------------------eCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHH
Q 036144 116 LIGYCA------------------------------DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165 (336)
Q Consensus 116 ~~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~ 165 (336)
+.+++. .....++||||+++|++.+.+.. ..+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 777643 26789999999999987776633 5689999999999999
Q ss_pred HHHHHHH-hCCCCCeeeCCCCCCCeEECCCC--------------------ceEEccccccccCCCCCCcceeeeeccCc
Q 036144 166 KGLEYLH-DVADPPVIYRDFKASNILLDAEF--------------------NPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224 (336)
Q Consensus 166 ~~l~~lh-~~~~~~i~H~dikp~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 224 (336)
.||.||| +.+ |+||||||+|||++.++ .+||+|||++..... ...+||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 899 99999999999999887 899999999986432 2347999
Q ss_pred cccCccccccCCCCCccchhhHHHH-HHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHH
Q 036144 225 GYCAPEYAMTGQLTKKSDVYSFGVV-LLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLY 303 (336)
Q Consensus 225 ~y~aPE~~~~~~~~~~~DvwslG~i-l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (336)
.|+|||++.+.. +.++||||+|++ .+++++|..||.... ........+... .. .............+.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~-~~----~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQ-MT----FKTKCNTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHT-CC----CSSCCCSHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhh-hc----cCcccchhhhhhcCH
Confidence 999999998766 899999998777 777888998884310 000000111100 00 011111123446788
Q ss_pred HHHHHHHhhcCCCCCCCCCHHHHH
Q 036144 304 QALAVAGMCLQEDADSRPFMVDVV 327 (336)
Q Consensus 304 ~l~~li~~cl~~dp~~Rpt~~evl 327 (336)
.+.+||.+||+.| |++|++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 9999999999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=281.80 Aligned_cols=185 Identities=17% Similarity=0.098 Sum_probs=132.5
Q ss_pred ccccCceEEEEEEEcccCeEEEEEeecCCCC----------ccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEEE
Q 036144 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN----------QGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 62 ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.+.|++|.+..+....+|+.+|+|++..... ...+++.+|+++|+++ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5667777777777777899999999965421 1234688999999999 6999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||++|++|.+++.. ..+++.. +|+.||+.||+|+|++| ||||||||+|||++.+|.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999976 3556654 58899999999999999 99999999999999999999999999986543
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSA 259 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p 259 (336)
.. ....+.+||+.|+|||++.+ .+..++|+||+|+++++|.++..+
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 22 23455789999999998875 467789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=246.60 Aligned_cols=185 Identities=19% Similarity=0.228 Sum_probs=144.1
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--------cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--------GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
...+.||+|+||.||+|... +..+++|........ ..+.+.+|+.+++.++||||+++..++......++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 45668999999999999544 678899986442211 12347899999999999999966666667777899
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999864 4589999999999999999 999999999999998 9999999999876
Q ss_pred CCCCCcc-----eeeeeccCccccCcccccc--CCCCCccchhhHHHHHHHHHhCCCCC
Q 036144 209 PTGGKDH-----VSTRVMGTYGYCAPEYAMT--GQLTKKSDVYSFGVVLLELITGRSAI 260 (336)
Q Consensus 209 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~ 260 (336)
....... .....+||+.|+|||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 4321111 1245789999999999987 67888999999999988888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-27 Score=204.92 Aligned_cols=148 Identities=15% Similarity=0.037 Sum_probs=117.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc------------------cHHHHHHHHHHHhhccCCCc
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ------------------GSREFFAEVLMLSLVQHQNL 113 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~~i 113 (336)
....|.+.+.||+|+||.||+|.+ .+|+.||+|++...... ....+.+|+.+++.++|
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--- 163 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--- 163 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---
T ss_pred CCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---
Confidence 344566779999999999999999 77999999998643211 23458899999999984
Q ss_pred cceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC
Q 036144 114 VNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA 193 (336)
Q Consensus 114 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~ 193 (336)
+++.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++
T Consensus 164 ~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS- 227 (282)
T ss_dssp SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence 555555443 45699999999999988 421 123579999999999999999 99999999999999
Q ss_pred CCceEEccccccccCCCCCCcceeeeeccCccccCcccccc
Q 036144 194 EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234 (336)
Q Consensus 194 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (336)
++.+||+|||++.. +..+.|||.+..
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999999863 445788997753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.3e-23 Score=176.04 Aligned_cols=138 Identities=15% Similarity=0.072 Sum_probs=107.1
Q ss_pred CCCCcccccccCceEEEEEEEcccCeE--EEEEeecCCCCcc------------------------HHHHHHHHHHHhhc
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQV--VAVKQLDRSGNQG------------------------SREFFAEVLMLSLV 108 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~--vavK~~~~~~~~~------------------------~~~~~~e~~~l~~l 108 (336)
-|.+.+.||+|+||.||+|.+..+|+. ||||+++...... ...+.+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367888999999999999999777888 9999875432110 12578899999999
Q ss_pred cCCCc--cceEEEEEeCCeEEEEEEcCCC-C----ChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCee
Q 036144 109 QHQNL--VNLIGYCADGDQRILVYEFMSN-G----SLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH-DVADPPVI 180 (336)
Q Consensus 109 ~h~~i--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh-~~~~~~i~ 180 (336)
.|+++ +.++++ ...++||||+.+ | +|.++... .++.....++.|++.||.||| +.+ |+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---iv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence 88754 444443 246899999942 3 66665432 123356789999999999999 888 99
Q ss_pred eCCCCCCCeEECCCCceEEccccccccC
Q 036144 181 YRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 181 H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||||+|||++. .++|+|||++...
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999988 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5e-20 Score=163.40 Aligned_cols=137 Identities=12% Similarity=0.088 Sum_probs=100.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc--------------cHHH--------HHHHHHHHhhccCC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ--------------GSRE--------FFAEVLMLSLVQHQ 111 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~e~~~l~~l~h~ 111 (336)
.-|.+.+.||.|++|.||+|.+. +|+.||||+++..... .... ..+|...|..+.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34999999999999999999986 4899999987532100 0011 23567777777554
Q ss_pred Ccc--ceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCe
Q 036144 112 NLV--NLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNI 189 (336)
Q Consensus 112 ~iv--~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Ni 189 (336)
++. ..+++ . ..++||||++|++|..+... + ....++.|++.+|.+||+.| ||||||||.||
T Consensus 174 gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~--------~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NI 236 (397)
T 4gyi_A 174 GFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV--------P--DPASLYADLIALILRLAKHG---LIHGDFNEFNI 236 (397)
T ss_dssp TCSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC--------S--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred CCCCCeeeec--c--CceEEEEecCCccHhhhccc--------H--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 432 23322 2 23799999999888665321 1 23567899999999999998 99999999999
Q ss_pred EECCCC----------ceEEccccccccC
Q 036144 190 LLDAEF----------NPKLSDFGLAKLG 208 (336)
Q Consensus 190 l~~~~~----------~~kl~Dfg~~~~~ 208 (336)
|++.++ .+.|+||+-+...
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred EEeCCCCcccccccccceEEEEeCCcccC
Confidence 998776 3899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=2.5e-14 Score=122.02 Aligned_cols=145 Identities=14% Similarity=0.076 Sum_probs=113.2
Q ss_pred HHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEE
Q 036144 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 51 ~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv 129 (336)
.....|.+...++.|+.+.||++... +..+++|............+.+|+.+++.+. +..+.++++++......++|
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34467888888999999999999754 6789999986432122345889999999885 67788999999998999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA---------------------------------- 175 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~---------------------------------- 175 (336)
|||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 89 MSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999876321 1123467888999999999821
Q ss_pred ----------------------CCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 176 ----------------------DPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 176 ----------------------~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
...++|+|++|.||+++.+..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1348999999999999875556799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.40 E-value=9.5e-13 Score=111.85 Aligned_cols=138 Identities=15% Similarity=0.062 Sum_probs=100.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCC--ccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN--LVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~ 130 (336)
...|.+..+.+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +.+++++.......++||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 34455544445666799999965 34678999987543 2345778999999886544 566888888878889999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA----------------------------------- 175 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~----------------------------------- 175 (336)
||++|.+|. ... .+ ...++.+++.+|..||+..
T Consensus 95 e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 95 GEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp ECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999998884 211 11 2356777888888888753
Q ss_pred --------------------CCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 176 --------------------DPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 176 --------------------~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
...++|+|++|.||+++.++.+.|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999876556799999975
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.1e-11 Score=110.43 Aligned_cols=142 Identities=14% Similarity=0.191 Sum_probs=106.2
Q ss_pred CcccccccCceEEEEEEEcccCeEEEEEeec--CCC-CccHHHHHHHHHHHhhcc--CCCccceEEEEEeC---CeEEEE
Q 036144 58 PDCLVGEGGYGRVYKGYIEAVDQVVAVKQLD--RSG-NQGSREFFAEVLMLSLVQ--HQNLVNLIGYCADG---DQRILV 129 (336)
Q Consensus 58 ~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv 129 (336)
..+.|+.|.++.||++... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. ...++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3557899999999998875 4678899875 322 122346788999999987 45688899888766 347999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA---------------------------------- 175 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~---------------------------------- 175 (336)
|||++|.++.+.. -..++......++.+++.+|..||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999988775421 234677788889999999999999831
Q ss_pred ---------------------CCCeeeCCCCCCCeEECCCCc--eEEcccccccc
Q 036144 176 ---------------------DPPVIYRDFKASNILLDAEFN--PKLSDFGLAKL 207 (336)
Q Consensus 176 ---------------------~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~ 207 (336)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999987753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.1e-11 Score=106.09 Aligned_cols=183 Identities=20% Similarity=0.226 Sum_probs=119.7
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCC--ccceEEEEEeCC---eEEEEEEc
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQN--LVNLIGYCADGD---QRILVYEF 132 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~lv~e~ 132 (336)
.+.++.|....||++. ..+++|+.... .....+.+|+.+++.+. +.. +.+++....... ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3458999999999863 35889985432 33467889999998884 332 445555443333 34789999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA------------------------------------- 175 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~------------------------------------- 175 (336)
++|.+|.+... ..++..+...++.+++..+..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988865332 23566777788888888888888621
Q ss_pred ------------------CCCeeeCCCCCCCeEECC--CCceEEccccccccCCCCCCcceeeeeccCccc---cCcccc
Q 036144 176 ------------------DPPVIYRDFKASNILLDA--EFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGY---CAPEYA 232 (336)
Q Consensus 176 ------------------~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~ 232 (336)
...++|+|++|.||+++. ...+.|+||+.+...... .+ ......+ ..|+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~D-----l~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-ND-----FISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HH-----HHTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HH-----HHHHHhhccccCHHHH
Confidence 134899999999999987 455789999998653221 00 0000011 122211
Q ss_pred cc-----CC---------CCCccchhhHHHHHHHHHhCCCCC
Q 036144 233 MT-----GQ---------LTKKSDVYSFGVVLLELITGRSAI 260 (336)
Q Consensus 233 ~~-----~~---------~~~~~DvwslG~il~~l~~g~~p~ 260 (336)
.. +. .....+.|++|.++|.+.+|..+|
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 10 00 012258899999999999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=3.6e-08 Score=83.94 Aligned_cols=135 Identities=17% Similarity=0.159 Sum_probs=99.4
Q ss_pred ccccCce-EEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEEcCCCCChh
Q 036144 62 VGEGGYG-RVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYEFMSNGSLE 139 (336)
Q Consensus 62 ig~G~~g-~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 139 (336)
+..|..+ .||+......+..+++|.... .....+.+|...|+.+. +-.+.+++.++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4455554 689988776677899998643 23456788999998885 445778899999999999999999998887
Q ss_pred hhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 036144 140 NHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA-------------------------------------------- 175 (336)
Q Consensus 140 ~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~-------------------------------------------- 175 (336)
+..... ......+..+++..|..||...
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654321 1123456667777777777531
Q ss_pred -----------CCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 176 -----------DPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 176 -----------~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
...++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999998776677999998863
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=5.2e-08 Score=84.61 Aligned_cols=136 Identities=18% Similarity=0.147 Sum_probs=95.3
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC---CccceEEEEE-eCCeEEEEEEcCC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ---NLVNLIGYCA-DGDQRILVYEFMS 134 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~ 134 (336)
.+.++.|....||++ |..+++|+.. .......+..|+.+|+.+.+. .+.+.+.+.. .....++||++++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 345888998999988 4568888743 222346788999999999752 3566777664 4456789999999
Q ss_pred CCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 036144 135 NGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA--------------------------------------- 175 (336)
Q Consensus 135 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~--------------------------------------- 175 (336)
|.++.+... ..++......++.+++..|..||+..
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988876321 12344455556666666666666532
Q ss_pred ------------------CCCeeeCCCCCCCeEECC---CCce-EEcccccccc
Q 036144 176 ------------------DPPVIYRDFKASNILLDA---EFNP-KLSDFGLAKL 207 (336)
Q Consensus 176 ------------------~~~i~H~dikp~Nil~~~---~~~~-kl~Dfg~~~~ 207 (336)
...++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999987 4554 8999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=1.6e-07 Score=83.30 Aligned_cols=81 Identities=7% Similarity=0.009 Sum_probs=56.3
Q ss_pred ccc-cccCceEEEEEEEc--c----cCeEEEEEeecCCC---CccHHHHHHHHHHHhhcc-C--CCccceEEEEEeC---
Q 036144 60 CLV-GEGGYGRVYKGYIE--A----VDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQ-H--QNLVNLIGYCADG--- 123 (336)
Q Consensus 60 ~~i-g~G~~g~v~~~~~~--~----~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~--- 123 (336)
+.| +.|....+|++... . ++..+++|...... ......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88999999988754 0 15678899764322 111245778999998885 3 3577888877655
Q ss_pred CeEEEEEEcCCCCChhh
Q 036144 124 DQRILVYEFMSNGSLEN 140 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~ 140 (336)
...++|||+++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=4.2e-07 Score=81.89 Aligned_cols=76 Identities=17% Similarity=0.109 Sum_probs=50.0
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCC-------ccHHHHHHHHHHHhhccC--CC-ccceEEEEEeCCeEEE
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-------QGSREFFAEVLMLSLVQH--QN-LVNLIGYCADGDQRIL 128 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~l 128 (336)
.+.||.|..+.||++....++..+++|....... .....+..|.++++.+.. +. +.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4469999999999997765578899998653211 123456789999888742 33 4455543 3455689
Q ss_pred EEEcCCCC
Q 036144 129 VYEFMSNG 136 (336)
Q Consensus 129 v~e~~~~g 136 (336)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.39 E-value=5.5e-06 Score=72.72 Aligned_cols=141 Identities=15% Similarity=0.269 Sum_probs=79.2
Q ss_pred cccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC--CCccceEE------EEEeCCeEEEEEEc
Q 036144 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH--QNLVNLIG------YCADGDQRILVYEF 132 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~------~~~~~~~~~lv~e~ 132 (336)
.|+.|..+.||++... +..+++|+.... ...+..|+.+++.|.. -.+.+++. +.......+++|+|
T Consensus 39 ~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4666778899998765 345899988642 2344556666665531 12333332 12346678899999
Q ss_pred CCCCChhh--------------hhc----cCC-CCC-----CCCCHHH-------------------------------H
Q 036144 133 MSNGSLEN--------------HFL----DLP-PDQ-----EPLDWFT-------------------------------R 157 (336)
Q Consensus 133 ~~~g~L~~--------------~l~----~~~-~~~-----~~l~~~~-------------------------------~ 157 (336)
++|.++.. .+. ... ... ..-.+.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99865420 011 110 000 0011111 0
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 158 MKIAGGAAKGLEYLHD----------VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 158 ~~i~~~l~~~l~~lh~----------~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
..+...+..++.+|+. .....++|+|++|.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223345666653 0134599999999999998888899999998853
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.30 E-value=6.7e-06 Score=71.25 Aligned_cols=75 Identities=23% Similarity=0.154 Sum_probs=60.0
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc---CCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ---HQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
.+.|+.|....+|++... +..+++|+.... ....+..|...|+.|. ...+++++.+.......++|||+++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346899999999998763 667889986532 3566889999998884 35688899988888889999999998
Q ss_pred CCh
Q 036144 136 GSL 138 (336)
Q Consensus 136 g~L 138 (336)
.++
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.14 E-value=1.9e-05 Score=71.55 Aligned_cols=76 Identities=16% Similarity=0.187 Sum_probs=45.2
Q ss_pred CCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcceeeeecc--CccccCccccccCC---CCCccchhhHHHHHH
Q 036144 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMG--TYGYCAPEYAMTGQ---LTKKSDVYSFGVVLL 251 (336)
Q Consensus 177 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DvwslG~il~ 251 (336)
..++|+|++|.||+++.++ +.++||+.+......- + .....+ ...|++|+...... -....++.++...+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-D--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-H--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-H--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 4499999999999998776 9999999987532110 0 000011 13456665443111 112344557777777
Q ss_pred HHHhC
Q 036144 252 ELITG 256 (336)
Q Consensus 252 ~l~~g 256 (336)
+.+++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=5e-05 Score=67.54 Aligned_cols=143 Identities=16% Similarity=0.180 Sum_probs=83.2
Q ss_pred ccccccCceEEEEEEEcc-------cCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEEE
Q 036144 60 CLVGEGGYGRVYKGYIEA-------VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e 131 (336)
+.|..|-...+|++.... .+..+++|+.... ........+|..+++.|. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 457778888899988742 3468999986332 233456678999998885 3334566666543 28999
Q ss_pred cCCCCChhhh-----------------hccCC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 036144 132 FMSNGSLENH-----------------FLDLP-PDQEPLD--WFTRMKIAGGAAK-------------------GLEY-- 170 (336)
Q Consensus 132 ~~~~g~L~~~-----------------l~~~~-~~~~~l~--~~~~~~i~~~l~~-------------------~l~~-- 170 (336)
|++|.+|... +.... ....... +.++..+..++.. .+..
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 11110 1111122 3344445443321 1222
Q ss_pred --HHhC-CCCCeeeCCCCCCCeEECCC----CceEEcccccccc
Q 036144 171 --LHDV-ADPPVIYRDFKASNILLDAE----FNPKLSDFGLAKL 207 (336)
Q Consensus 171 --lh~~-~~~~i~H~dikp~Nil~~~~----~~~kl~Dfg~~~~ 207 (336)
|... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2221 13459999999999999876 6899999998863
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.90 E-value=4.9e-05 Score=65.08 Aligned_cols=79 Identities=18% Similarity=0.184 Sum_probs=56.6
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC---CCccceEEEEEeCCeEEEEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH---QNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~lv~e 131 (336)
+..-.+.+|.|..+.||++.... |+.|++|+...........+..|+..|+.|.. -.+.+++++. ..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 34445678999999999998754 78999998755444444567889999998852 2355666542 2478999
Q ss_pred cCCCCCh
Q 036144 132 FMSNGSL 138 (336)
Q Consensus 132 ~~~~g~L 138 (336)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.90 E-value=5.8e-05 Score=65.05 Aligned_cols=71 Identities=7% Similarity=0.083 Sum_probs=45.4
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCc-cceEEEEEeCCeEEEEEEcC-CCC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL-VNLIGYCADGDQRILVYEFM-SNG 136 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~-~~g 136 (336)
.+.|+.|....+|++ ..+++|+....... ......|+.+++.+...++ .+++.+ +....++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 667999999999998 34789987543221 1223568888887753333 455543 344457899999 665
Q ss_pred Ch
Q 036144 137 SL 138 (336)
Q Consensus 137 ~L 138 (336)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 55
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.89 E-value=6.1e-05 Score=60.65 Aligned_cols=101 Identities=14% Similarity=0.037 Sum_probs=65.7
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
-||.+.|.. ...++++.++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|+|.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 378888876 46899999999999999998877622111 12333457899999999988764 1110
Q ss_pred eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCC
Q 036144 216 VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR 257 (336)
Q Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 257 (336)
.....+.|||... ...+.+.=|||||+++|.-+--.
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 1233466888653 34467788999999999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.85 E-value=5.7e-05 Score=68.55 Aligned_cols=74 Identities=14% Similarity=0.195 Sum_probs=50.2
Q ss_pred cccccccCceEEEEEEEcc-------cCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCc-cceEEEEEeCCeEEEEE
Q 036144 59 DCLVGEGGYGRVYKGYIEA-------VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL-VNLIGYCADGDQRILVY 130 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~ 130 (336)
.+.|+.|....+|++.... .+..+++|+.... .....+..|..+++.|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3467888889999998753 2568899987432 112456689999988864333 566665532 3899
Q ss_pred EcCCCCCh
Q 036144 131 EFMSNGSL 138 (336)
Q Consensus 131 e~~~~g~L 138 (336)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.0002 Score=65.37 Aligned_cols=75 Identities=11% Similarity=0.032 Sum_probs=48.8
Q ss_pred cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCc-cceEEEEEeCCeEEEEEEcCCCCC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL-VNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
.+.|+.|....+|++.....+..+++|+........ -....|..+++.|...++ .++++.+. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 346788888999999876545788999875432211 112578889988875444 56776663 2 25999998755
Q ss_pred h
Q 036144 138 L 138 (336)
Q Consensus 138 L 138 (336)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00035 Score=60.62 Aligned_cols=156 Identities=12% Similarity=0.087 Sum_probs=83.5
Q ss_pred HHHHHHhcCCCC-----cccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCC--ccceEE-
Q 036144 47 QELADATENFNP-----DCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN--LVNLIG- 118 (336)
Q Consensus 47 ~~~~~~~~~y~~-----~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~- 118 (336)
..+......|.+ .+.|+.|....+|++.... ..+++|+..... ....+..|+.+++.+...+ +.+++.
T Consensus 10 ~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~--g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~ 85 (322)
T 2ppq_A 10 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR 85 (322)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred HHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC--ccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence 344444445554 2346778888999987653 368899876521 2235667888877764222 233332
Q ss_pred -----EEEeCCeEEEEEEcCCCCChhh------------------hhccCCCCC-CCCC---HHHHHH------------
Q 036144 119 -----YCADGDQRILVYEFMSNGSLEN------------------HFLDLPPDQ-EPLD---WFTRMK------------ 159 (336)
Q Consensus 119 -----~~~~~~~~~lv~e~~~~g~L~~------------------~l~~~~~~~-~~l~---~~~~~~------------ 159 (336)
+.......+++|++++|.++.. ......... .... +.....
T Consensus 86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~ 165 (322)
T 2ppq_A 86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG 165 (322)
T ss_dssp TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence 1123456789999998865421 111111100 0011 111000
Q ss_pred HHHHHHHHHHHHHhC----CCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 160 IAGGAAKGLEYLHDV----ADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 160 i~~~l~~~l~~lh~~----~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
+...+...+..++.. ...+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133445555432 13459999999999999877556899999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00051 Score=59.95 Aligned_cols=141 Identities=14% Similarity=0.046 Sum_probs=71.2
Q ss_pred cccccCceE-EEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC--CCccceEEEEEeCCeEEEEEEcCCCCC
Q 036144 61 LVGEGGYGR-VYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH--QNLVNLIGYCADGDQRILVYEFMSNGS 137 (336)
Q Consensus 61 ~ig~G~~g~-v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~ 137 (336)
.|+.|+... +|+.... ++..+++|....... ..+..|+.+++.+.. -.+.+++.+... ..+++||++.+.+
T Consensus 25 ~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp C--------CCEEEECT-TCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred ECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 465565444 6666542 255677776543221 234567777777642 235566765322 2378999997766
Q ss_pred hhhhhccC---------------------CCC-CCCCCHHHHH-------HH-------------HHHHHHHHHHHH---
Q 036144 138 LENHFLDL---------------------PPD-QEPLDWFTRM-------KI-------------AGGAAKGLEYLH--- 172 (336)
Q Consensus 138 L~~~l~~~---------------------~~~-~~~l~~~~~~-------~i-------------~~~l~~~l~~lh--- 172 (336)
+.+++... ... ...++..... .+ ...+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65433211 000 0112211100 00 001111222221
Q ss_pred hCCCCCeeeCCCCCCCeEECCC----CceEEcccccccc
Q 036144 173 DVADPPVIYRDFKASNILLDAE----FNPKLSDFGLAKL 207 (336)
Q Consensus 173 ~~~~~~i~H~dikp~Nil~~~~----~~~kl~Dfg~~~~ 207 (336)
......++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123459999999999999874 6789999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00027 Score=62.68 Aligned_cols=74 Identities=8% Similarity=0.038 Sum_probs=44.9
Q ss_pred ccccccCceEEEEEEEccc--------CeEEEEEeecCCCCccHHHHHHHHHHHhhccCCC-ccceEEEEEeCCeEEEEE
Q 036144 60 CLVGEGGYGRVYKGYIEAV--------DQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN-LVNLIGYCADGDQRILVY 130 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 130 (336)
..|+.|....+|++..... +..+++|+..... ........|..+++.+...+ +.++++.. . .++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 3577888889999987541 2678899865432 11112467888888875333 44666544 2 36899
Q ss_pred EcCCCCCh
Q 036144 131 EFMSNGSL 138 (336)
Q Consensus 131 e~~~~g~L 138 (336)
+|++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.0006 Score=59.26 Aligned_cols=142 Identities=13% Similarity=0.052 Sum_probs=79.5
Q ss_pred cccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC--CccceEEE-----EEeCCeEEEEEEcC
Q 036144 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ--NLVNLIGY-----CADGDQRILVYEFM 133 (336)
Q Consensus 61 ~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~-----~~~~~~~~lv~e~~ 133 (336)
.++ |....||++... .|+.+++|...... .....+..|..+++.+... .+++++.. .......+++|+++
T Consensus 33 ~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 777889987654 35678999986332 2345677788888877522 23444432 22345668899999
Q ss_pred CCCChhh------------------hhccCCC-CCCCCCHHHH----------------------HHHHHHHHHHHHHHH
Q 036144 134 SNGSLEN------------------HFLDLPP-DQEPLDWFTR----------------------MKIAGGAAKGLEYLH 172 (336)
Q Consensus 134 ~~g~L~~------------------~l~~~~~-~~~~l~~~~~----------------------~~i~~~l~~~l~~lh 172 (336)
+|.++.. ....... ....++.... ...+..++..+..+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754321 0001100 0111221110 111122222222221
Q ss_pred h-CCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 173 D-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 173 ~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
. .....++|+|++|.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1234489999999999998 4 899999988754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00062 Score=59.67 Aligned_cols=31 Identities=23% Similarity=0.221 Sum_probs=27.5
Q ss_pred CCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 177 ~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
..++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.014 Score=52.46 Aligned_cols=75 Identities=11% Similarity=0.012 Sum_probs=48.7
Q ss_pred cccccccCceEEEEEEEccc-------CeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeEEEEE
Q 036144 59 DCLVGEGGYGRVYKGYIEAV-------DQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.+.+..|-...+|++..... +..+++++..... ...-...+|..+++.+. +.-..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 34577788889999887521 4678999864432 22223457888888885 333455665332 36899
Q ss_pred EcCCCCCh
Q 036144 131 EFMSNGSL 138 (336)
Q Consensus 131 e~~~~g~L 138 (336)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.54 E-value=0.069 Score=47.68 Aligned_cols=29 Identities=28% Similarity=0.337 Sum_probs=24.9
Q ss_pred eeeCCCCCCCeEE------CCCCceEEcccccccc
Q 036144 179 VIYRDFKASNILL------DAEFNPKLSDFGLAKL 207 (336)
Q Consensus 179 i~H~dikp~Nil~------~~~~~~kl~Dfg~~~~ 207 (336)
++|+|+.+.||++ +.+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4556799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.79 E-value=0.32 Score=38.96 Aligned_cols=117 Identities=7% Similarity=0.043 Sum_probs=78.0
Q ss_pred cCCCccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 036144 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASN 188 (336)
Q Consensus 109 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~N 188 (336)
.||+.+.. .+-.+.+...+.++.-+ +...+-. -...+....++++.+|+....++++ -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 47888876 56666666555555432 2222211 1347778899999999887755543 5788899999
Q ss_pred eEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 036144 189 ILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDN 262 (336)
Q Consensus 189 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 262 (336)
++++.++.+++.=.|+-..+ +|. .++...=+-.+=|++..+++++..|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999877765332 221 112222334678889999999888753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.51 E-value=0.54 Score=37.80 Aligned_cols=115 Identities=11% Similarity=0.081 Sum_probs=76.4
Q ss_pred cCCCccceEEEEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeCCCCCC
Q 036144 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE-YLHDVADPPVIYRDFKAS 187 (336)
Q Consensus 109 ~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~-~lh~~~~~~i~H~dikp~ 187 (336)
.||++ -..+-.+++.+.+.++.-+++.=...+ ..++...+++++.+|+.... ++++ -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 444556677777767654333223333 33677888999998887665 4433 688899999
Q ss_pred CeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCC
Q 036144 188 NILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAID 261 (336)
Q Consensus 188 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 261 (336)
||+++.++.+++.-.|+-..+ +|.. .+...=+-++=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL-------------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB-------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC-------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999887765432 2221 1111123367888888998887775
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.92 E-value=0.054 Score=49.39 Aligned_cols=63 Identities=10% Similarity=0.028 Sum_probs=18.9
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEE------EeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAV------KQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD 122 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 122 (336)
.+.+.|| ||.||+|.......+||+ |...... ......+.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 4455676 999999999765567888 6654322 2223457788889999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 336 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-71 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (563), Expect = 2e-71
Identities = 75/279 (26%), Positives = 123/279 (44%), Gaps = 27/279 (9%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIG 118
+G G +G VYKG VAVK L+ + Q + F EV +L +H N++ +G
Sbjct: 15 RIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
Y Q +V ++ SL +H L + + + IA A+G++YLH
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHH---LHIIETKFEMIKLIDIARQTAQGMDYLHA---KS 124
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT---G 235
+I+RD K++NI L + K+ DFGLA + H ++ G+ + APE
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 236 QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295
+ +SDVY+FG+VL EL+TG+ N ++ + L D K
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK---- 240
Query: 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
+ CL++ D RP ++ ++E L+
Sbjct: 241 --------AMKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (516), Expect = 5e-64
Identities = 68/306 (22%), Positives = 126/306 (41%), Gaps = 38/306 (12%)
Query: 44 FKYQELADATENFNPDC---------LVGEGGYGRVYKGYIEAVDQ---VVAVKQLDRSG 91
F +++ +A F + ++G G +G V G+++ + VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 92 N-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQE 150
+ R+F +E ++ H N+++L G +++ EFM NGSL++ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 151 PLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210
+ + G A G++YL D ++RD A NIL+++ K+SDFGL++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 211 GGKDHVSTRV---MGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267
D T + APE + T SDV+S+G+V+ E+++ RP
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG-----ERPYW 235
Query: 268 EQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327
+ + +D + P + C Q+D + RP +V
Sbjct: 236 DMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 328 TALEYL 333
L+ +
Sbjct: 285 NTLDKM 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 2e-63
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 11/221 (4%)
Query: 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQH 110
++F +G G G V+K + V+A K + R E+ +L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
+V G + + E M GSL+ + + K++ KGL Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
L + +++RD K SNIL+++ KL DFG++ D ++ +GT Y +PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPE 173
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNL 271
+ +SD++S G+ L+E+ GR I E + +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-62
Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 27/279 (9%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
++ +G G +G V G VA+K + + EF E ++ + H+ L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKL 61
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
V L G C ++ E+M+NG L N+ L + +++ + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNY---LREMRHRFQTQQLLEMCKDVCEAMEYLE- 117
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
++RD A N L++ + K+SDFGL++ + S + PE M
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLM 174
Query: 234 TGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292
+ + KSD+++FGV++ E+ + G+ + SE + L R
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------------ 222
Query: 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
P + + C E AD RP +++ +
Sbjct: 223 -----PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-62
Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 28/284 (9%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
E +G G +G V+ GY VAVK L + + F AE ++ +QHQ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRL 70
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
V L + ++ E+M NGSL + P L + +A A+G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
I+RD +A+NIL+ + K++DFGLA+L + + APE
Sbjct: 128 ---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 234 TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ-NLVTWAKPLLRDKKKFTMMADPL 292
G T KSDV+SFG++L E++T + E + ++R
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------------ 231
Query: 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE-YLSS 335
P + + +C +E + RP + + LE + ++
Sbjct: 232 -----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 1e-61
Identities = 62/294 (21%), Positives = 114/294 (38%), Gaps = 29/294 (9%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCA 121
+G+G +G V++G + VAVK + S AE+ +++H+N++ I
Sbjct: 11 IGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 122 DGD----QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH----- 172
+ Q LV ++ +GSL ++ ++ + +K+A A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK--DHVSTRVMGTYGYCAPE 230
P + +RD K+ NIL+ ++D GLA + D +GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 231 YAMT------GQLTKKSDVYSFGVVLLELITGRS----AIDNSRPSEEQNLVTWAKPLLR 280
+ K++D+Y+ G+V E+ S D P + + +R
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 281 DKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
+ + + L + C + +R + + L LS
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-61
Identities = 63/281 (22%), Positives = 110/281 (39%), Gaps = 25/281 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
+G G +G V+ GY VA+K + +F E ++ + H L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKL 62
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
V L G C + LV+EFM +G L ++ + T + + +G+ YL
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE- 118
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
+ VI+RD A N L+ K+SDFG+ + + ST + +PE
Sbjct: 119 --EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 234 TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293
+ + KSDV+SFGV++ E+ + +R + E ++ D + P L
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL 226
Query: 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
+ C +E + RP ++ L ++
Sbjct: 227 AST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-61
Identities = 76/283 (26%), Positives = 125/283 (44%), Gaps = 29/283 (10%)
Query: 61 LVGEGGYGRVYKGYI---EAVDQVVAVKQLDRSGNQGS-REFFAEVLMLSLVQHQNLVNL 116
++G G +G VY G + + AVK L+R + G +F E +++ H N+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 117 IGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
+G C + +V +M +G L N + + AKG+++L
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLAS-- 148
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD--HVSTRVMGTYGYCAPEYAM 233
++RD A N +LD +F K++DFGLA+ D H T + A E
Sbjct: 149 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 234 TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293
T + T KSDV+SFGV+L EL+T + P + N LL+ + LL
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGR--------RLL 254
Query: 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+ +Y LY+ V C A+ RP ++V+ + + S
Sbjct: 255 QPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 8e-61
Identities = 65/315 (20%), Positives = 112/315 (35%), Gaps = 45/315 (14%)
Query: 45 KYQELADATENFNPDCLVGEGGYGRVYKGYIEAVD-----QVVAVKQLDRSGNQGSR-EF 98
K L N +GEG +GRV++ + +VAVK L + + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 99 FAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENH----------------- 141
E +++ + N+V L+G CA G L++E+M+ G L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 142 ---FLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK 198
P PL ++ IA A G+ YL + ++RD N L+ K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 199 LSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRS 258
++DFGL++ + + PE + T +SDV+++GVVL E+ +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 259 AIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDAD 318
EE +L P + + +C +
Sbjct: 241 QPYYGMAHEEVIYYVRDGNIL----------------ACPENCPLELYNLMRLCWSKLPA 284
Query: 319 SRPFMVDVVTALEYL 333
RP + L+ +
Sbjct: 285 DRPSFCSIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-60
Identities = 61/280 (21%), Positives = 110/280 (39%), Gaps = 25/280 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQ 111
E++ +G G YGR K ++ +++ K+LD + + +EV +L ++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 112 NLVNLIGYCADGDQRIL--VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
N+V D L V E+ G L + +++ LD +++ L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 170 YLHDVAD--PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
H +D V++RD K +N+ LD + N KL DFGLA++ + +GT Y
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287
+PE +KSD++S G +L EL E + K
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---------- 231
Query: 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327
+ +Y + + L RP + +++
Sbjct: 232 ---RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-60
Identities = 73/292 (25%), Positives = 110/292 (37%), Gaps = 39/292 (13%)
Query: 61 LVGEGGYGRVYKGYIEAVD-----QVVAVKQLDRSGNQGSRE-FFAEVLMLS-LVQHQNL 113
+G G +G+V + + VAVK L S + RE +E+ +LS L H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENH--------------FLDLPPDQEPLDWFTRMK 159
VNL+G C G +++ E+ G L N + D+ LD +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 160 IAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTR 219
+ AKG+ +L I+RD A NILL K+ DFGLA+ V
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 220 VMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLL 279
+ APE T +SDV+S+G+ L EL + S+ P + +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---------- 256
Query: 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
F M P + + C D RP +V +E
Sbjct: 257 -----FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-60
Identities = 71/304 (23%), Positives = 117/304 (38%), Gaps = 44/304 (14%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ-----VVAVKQLDRSGNQGSRE-FFAEV-LMLS 106
EN ++G G +G+V + + VAVK L + RE +E+ +M
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 107 LVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENH-------------------FLDLPP 147
L H+N+VNL+G C L++E+ G L N+ L+
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 148 DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207
D L + + A AKG+E+L ++RD A N+L+ K+ DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSE 267
+ V + APE G T KSDV+S+G++L E+ + P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG-----VNPYP 268
Query: 268 EQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327
+ L+++ K P + + C D+ RP ++
Sbjct: 269 GIPVDANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 328 TALE 331
+ L
Sbjct: 319 SFLG 322
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (487), Expect = 8e-60
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 23/293 (7%)
Query: 41 PNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFA 100
P+ Y + + +G G YG VY+G + VAVK L + EF
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLK 62
Query: 101 EVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI 160
E ++ ++H NLV L+G C ++ EFM+ G+L ++ + + + + +
Sbjct: 63 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYM 120
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRV 220
A + +EYL I+RD A N L+ K++DFGL++L G
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGA 176
Query: 221 MGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLR 280
+ APE + + KSDV++FGV+L E+ T +
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------I 220
Query: 281 DKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
D + + + + P + + C Q + RP ++ A E +
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-59
Identities = 66/292 (22%), Positives = 120/292 (41%), Gaps = 33/292 (11%)
Query: 53 TENFNPDC-----LVGEGGYGRVYKGYI----EAVDQVVAVKQLDRSGNQGSR-EFFAEV 102
T +P C ++G G +G VYKG + + VA+K L + R +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 103 LMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG 162
++ H N++ L G + +++ E+M NG+L+ + + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLR 117
Query: 163 GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKD-HVSTRVM 221
G A G++YL + ++RD A NIL+++ K+SDFGL+++ + + ++
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281
+ APE + T SDV+SFG+V+ E++T + E
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------- 221
Query: 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
+ P + C Q++ RP D+V+ L+ L
Sbjct: 222 ---VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-59
Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 31/283 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
+ +G+G +G V G VAVK + + F AE +++ ++H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 114 VNLIGYCADGDQRI-LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
V L+G + + +V E+M+ GSL ++ + L +K + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
++RD A N+L+ + K+SDFGL K + + APE
Sbjct: 121 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEAL 172
Query: 233 MTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292
+ + KSDV+SFG++L E+ + P L + + K
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFG-----RVPYPRIPLKDVVPRVEKGYKM-------- 219
Query: 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335
P V C DA RP + + LE++ +
Sbjct: 220 ---DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 1e-58
Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 26/276 (9%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQN 112
E+++ +GEG YG V ++ VAVK +D E E+ + ++ H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
+V G+ +G+ + L E+ S G L + + + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 173 DVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
+ +RD K N+LLD N K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 233 MTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ-NLVTWAKPLLRDKKKFTMMAD 290
+ + DV+S G+VL ++ G D S ++ + K L KK
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 237
Query: 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDV 326
LL L E+ +R + D+
Sbjct: 238 ALLHK----------------ILVENPSARITIPDI 257
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-58
Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 36/292 (12%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH 110
+ + + +G+G +G+VYK + + A K +D + ++ E+ +L+ H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
N+V L+ + ++ EF + G+++ L+L + PL + L Y
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNY 125
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
LH D +I+RD KA NIL + + KL+DFG++ +GT + APE
Sbjct: 126 LH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPE 180
Query: 231 YAMTGQL-----TKKSDVYSFGVVLLELITGRSAIDNSRPSEE-QNLVTWAKPLLRDKKK 284
M K+DV+S G+ L+E+ P + P L +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 240
Query: 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
++ L+ CL+++ D+R T + L P
Sbjct: 241 WSSNFKDFLKK----------------CLEKNVDARW------TTSQLLQHP 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 5e-58
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 30/291 (10%)
Query: 47 QELADATENFNP-DCLVGEGGYGRVYKGYIEAVD--QVVAVKQLDRSGNQGSRE-FFAEV 102
++L +N D +G G +G V +G VA+K L + + E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 103 LMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAG 162
++ + + +V LIG C + +LV E G L + +E + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 163 GAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGKDHVSTRVM 221
+ G++YL + ++RD A N+LL K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLR 280
+ APE + + +SDV+S+GV + E ++ G+ + E + K +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-- 231
Query: 281 DKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
+ P + + A+ C + RP + V +
Sbjct: 232 ---------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-57
Identities = 63/296 (21%), Positives = 114/296 (38%), Gaps = 38/296 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEA--VDQVVAVKQLDRSGN-QGSREFFAEV-LMLSLVQ 109
+ ++GEG +G+V K I+ + A+K++ + R+F E+ ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENH------------FLDLPPDQEPLDWFTR 157
H N++NL+G C L E+ +G+L + F L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
+ A A+G++YL I+RD A NIL+ + K++DFGL++ K
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 218 TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277
T + A E T SDV+S+GV+L E+++ P +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCAELYEK 238
Query: 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
L + + + P + + C +E RP ++ +L +
Sbjct: 239 LPQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-57
Identities = 60/277 (21%), Positives = 108/277 (38%), Gaps = 32/277 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---REFFAEVLMLSLVQH 110
E+F +G+G +G VY + ++A+K L ++ + + + EV + S ++H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
N++ L GY D + L+ E+ G++ D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSY 121
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
H VI+RD K N+LL + K++DFG + P T + GT Y PE
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 174
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290
+K D++S GV+ E + G+ + + E ++ +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------- 221
Query: 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327
+P A + L+ + RP + +V+
Sbjct: 222 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-57
Identities = 66/275 (24%), Positives = 112/275 (40%), Gaps = 31/275 (11%)
Query: 63 GEGGYGRVYKGYIEA--VDQVVAVKQLDRSGNQGS--REFFAEVLMLSLVQHQNLVNLIG 118
G G +G V KGY + V + VAVK L N + E AE ++ + + +V +IG
Sbjct: 16 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 75
Query: 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPP 178
C + + +LV E G L + + +++ + G++YL +
Sbjct: 76 IC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEE---SN 127
Query: 179 VIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL 237
++RD A N+LL + K+SDFGL+K L T + APE +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 238 TKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQ 296
+ KSDV+SFGV++ E + G+ + SE ++ + +
Sbjct: 188 SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----------------G 230
Query: 297 YPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
P + + +C D ++RP V L
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 1e-56
Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 35/293 (11%)
Query: 41 PNVFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---RE 97
P+V + D + F+ +G G +G VY +VVA+K++ SG Q + ++
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 98 FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTR 157
EV L ++H N + G LV E+ + + + ++PL
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEI 117
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
+ GA +GL YLH +I+RD KA NILL KL DFG A + +
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168
Query: 218 TRVMGTYGYCAPEYAMT---GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW 274
+GT + APE + GQ K DV+S G+ +EL + + N +
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 275 AKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327
+ ++ ++ CLQ+ RP ++
Sbjct: 229 NESPALQSGHWSEYFRNFVDS----------------CLQKIPQDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-56
Identities = 68/287 (23%), Positives = 118/287 (41%), Gaps = 33/287 (11%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH 110
D + + +G+G G VY A Q VA++Q++ E+L++ ++
Sbjct: 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
N+VN + GD+ +V E+++ GSL + + +D + + LE+
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEF 131
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
LH VI+RD K+ NILL + + KL+DFG + + ++GT + APE
Sbjct: 132 LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPE 186
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE-QNLVTWAKPLLRDKKKFTMMA 289
K D++S G++ +E+I G N P + T P L++ +K + +
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
L CL D + R +A E L
Sbjct: 247 RDFLNR----------------CLDMDVEKRG------SAKELLQHQ 271
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-56
Identities = 60/273 (21%), Positives = 110/273 (40%), Gaps = 32/273 (11%)
Query: 62 VGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGY 119
+G G + VYKG VA +L + F E ML +QH N+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 120 CADGDQR----ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
+ +LV E M++G+L+ + + + KGL++LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 176 DPPVIYRDFKASNILLDAE-FNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT 234
PP+I+RD K NI + + K+ D GLA L + + V+GT + APE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-YE 186
Query: 235 GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLE 294
+ + DVY+FG+ +LE+ T + + + + + +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSGVKP 231
Query: 295 GQYPRKGLYQALAVAGMCLQEDADSRPFMVDVV 327
+ + + + + C++++ D R + D++
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-56
Identities = 67/284 (23%), Positives = 113/284 (39%), Gaps = 26/284 (9%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
E+ + +G+G +G V+ G VA+K L F E ++ ++H+ L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKL 74
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
V L + +V E+MS GSL + + L + +A A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 174 VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAM 233
++RD +A+NIL+ K++DFGLA+L + + APE A+
Sbjct: 132 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 234 TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293
G+ T KSDV+SFG++L EL T + E +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQVERGY 231
Query: 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE-YLSSP 336
P + + C +++ + RP + LE Y +S
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-56
Identities = 69/286 (24%), Positives = 124/286 (43%), Gaps = 30/286 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYI----EAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV 108
F ++G G +G VYKG E V VA+K+L + + + ++E E +++ V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 109 QHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168
+ ++ L+G C + L+ + M G L ++ + ++ + + AKG+
Sbjct: 69 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGM 124
Query: 169 EYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCA 228
YL D +++RD A N+L+ + K++DFGLAKL K++ + + A
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 229 PEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287
E + T +SDV+S+GV + EL+T G D SE +++ + L
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--------- 232
Query: 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
P + C DADSRP +++ +
Sbjct: 233 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 4e-54
Identities = 68/285 (23%), Positives = 104/285 (36%), Gaps = 29/285 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVD---QVVAVKQLDR---SGNQGSREFFAEVLMLSL 107
++ +G+G +G V +G +A VAVK L S + +F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 108 VQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
+ H+NL+ L G ++ V E GSL + Q T + A A+G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHV-STRVMGTYGY 226
+ YL I+RD A N+LL K+ DFGL + P +V + +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 227 CAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFT 286
CAPE T + SD + FGV L E+ T P N + ++ ++
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYG-----QEPWIGLNGSQILHKIDKEGERL- 234
Query: 287 MMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
P V C + RP V + L
Sbjct: 235 ---------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-53
Identities = 66/295 (22%), Positives = 124/295 (42%), Gaps = 31/295 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAV-----DQVVAVKQLDRSGNQGSR-EFFAEVLMLSL 107
E +G+G +G VY+G + V + VA+K ++ + + R EF E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 108 VQHQNLVNLIGYCADGDQRILVYEFMSNGSLENH------FLDLPPDQEPLDWFTRMKIA 161
++V L+G + G +++ E M+ G L+++ + P P +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 162 GGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVM 221
G A G+ YL+ ++RD A N ++ +F K+ DFG+ + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 222 GTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281
+ +PE G T SDV+SFGVVL E+ T +E+
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------ 244
Query: 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+M LL+ P + MC Q + RP ++++++++ P
Sbjct: 245 --LRFVMEGGLLD--KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 4e-53
Identities = 66/300 (22%), Positives = 112/300 (37%), Gaps = 38/300 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVD-----QVVAVKQLDRSGNQGS-REFFAEV-LMLS 106
+ +G G +G+V + +D + VAVK L R +E+ +++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 107 LVQHQNLVNLIGYCA-DGDQRILVYEFMSNGSLENH------------FLDLPPDQEPLD 153
+ H N+VNL+G C G +++ EF G+L + ++ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 154 WFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213
+ + AKG+E+L I+RD A NILL + K+ DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT 273
+ APE T +SDV+SFGV+L E+ + + P +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDE 244
Query: 274 WAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
L++ + + P + C + RP ++V L L
Sbjct: 245 EFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-52
Identities = 58/278 (20%), Positives = 106/278 (38%), Gaps = 30/278 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQ---VVAVKQLDRSGNQGSRE-FFAEVLMLSLVQHQNLVNL 116
+GEG +G V++G + + VA+K + RE F E L + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 117 IGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVAD 176
IG + + ++ E + G L + + LD + + A + L YL
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 177 PPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQ 236
++RD A N+L+ + KL DFGL++ + +++ + APE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRR 185
Query: 237 LTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEG 295
T SDV+ FGV + E++ G + ++ + + L
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL----------------- 228
Query: 296 QYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
P ++ C D RP ++ L +
Sbjct: 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 3e-52
Identities = 59/286 (20%), Positives = 100/286 (34%), Gaps = 28/286 (9%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQH 110
E+F ++GEG + V A + A+K L++ E ++S + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
V L D ++ + NG L L D LEY
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
LH +I+RD K NILL+ + + +++DFG AK+ K + +GT Y +PE
Sbjct: 124 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290
K SD+++ G ++ +L+ G + +
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY------------- 227
Query: 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+P K +A + L DA R ++ + P
Sbjct: 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-50
Identities = 68/304 (22%), Positives = 117/304 (38%), Gaps = 42/304 (13%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ-------VVAVKQLDRSGNQGS-REFFAEV-LM 104
+ +GEG +G+V +D+ VAVK L + + +E+ +M
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 105 LSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENH------------FLDLPPDQEPL 152
+ +H+N++NL+G C ++ E+ S G+L + + +E L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 153 DWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212
+ A A+G+EYL I+RD A N+L+ + K++DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEE-QNL 271
+T + APE T +SDV+SFGV+L E+ T + P EE L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 272 VTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
+ + P + + C RP +V L+
Sbjct: 250 LKEGHRM-----------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 332 YLSS 335
+ +
Sbjct: 293 RIVA 296
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (411), Expect = 8e-48
Identities = 61/285 (21%), Positives = 105/285 (36%), Gaps = 31/285 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL 113
++++ +G G +G V++ A A K + E+ +S+++H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 114 VNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD 173
VNL D ++ +++YEFMS G L + + + ++ KGL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEK---VADEHNKMSEDEAVEYMRQVCKGLCHMH- 141
Query: 174 VADPPVIYRDFKASNILLDAEFNP--KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
+ ++ D K NI+ + + KL DFGL V GT + APE
Sbjct: 142 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEV 196
Query: 232 AMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291
A + +D++S GV+ L++G S E LR+ K D
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----------TLRNVKSCDWNMDD 246
Query: 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
L D ++R T + L P
Sbjct: 247 SAFSGISE----DGKDFIRKLLLADPNTRM------TIHQALEHP 281
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (407), Expect = 3e-47
Identities = 55/278 (19%), Positives = 106/278 (38%), Gaps = 31/278 (11%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
+G G +G V++ +A +V K ++ E+ +++ + H L+NL
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
D + +L+ EF+S G L + + + + A +GL+++H + ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 181 YRDFKASNILLDAEFNP--KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
+ D K NI+ + + K+ DFGLA D + T + APE +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 239 KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYP 298
+D+++ GV+ L++G S E L++ K+ D
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------TLQNVKRCDWEFDEDAFSSVS 256
Query: 299 RKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+A LQ++ R T + L P
Sbjct: 257 P----EAKDFIKNLLQKEPRKRL------TVHDALEHP 284
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (407), Expect = 3e-47
Identities = 71/276 (25%), Positives = 110/276 (39%), Gaps = 35/276 (12%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQ- 109
+F+ ++G GG+G VY ++ A+K LD+ QG E +MLSLV
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 110 --HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKG 167
+V + D+ + + M+ G L H E F +I G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI----ILG 119
Query: 168 LEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
LE++H + V+YRD K +NILLD + ++SD GLA +GT+GY
Sbjct: 120 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYM 172
Query: 228 APEYAMTGQ-LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAKPLLRDKKKF 285
APE G +D +S G +L +L+ G S + ++ + + F
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
+ LLEG LQ D + R
Sbjct: 233 SPELRSLLEG----------------LLQRDVNRRL 252
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (403), Expect = 4e-47
Identities = 57/292 (19%), Positives = 112/292 (38%), Gaps = 28/292 (9%)
Query: 46 YQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLM 104
+++ D + ++ ++G G + V + ++VA+K + + +G E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 105 LSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGA 164
L ++H N+V L G L+ + +S G L + ++ + ++
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQV 116
Query: 165 AKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTY 224
++YLHD+ + LD + +SDFGL+K+ V + GT
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTP 173
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284
GY APE +K D +S GV+ L+ G P ++N + +L+ + +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYE 227
Query: 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
F D A +++D + R T + L P
Sbjct: 228 F----DSPYWDDISD----SAKDFIRHLMEKDPEKRF------TCEQALQHP 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (389), Expect = 2e-45
Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 29/277 (10%)
Query: 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---REFFAEVLMLSLVQ 109
++ + ++G GG V+ + + VAVK L + F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 110 HQNLVNLIGYCAD----GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
H +V + G +V E++ +L D+ + P+ +++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR----DIVHTEGPMTPKRAIEVIADAC 121
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGKDHVSTRVMGTY 224
+ L + H +I+RD K +NI++ A K+ DFG+A+ + +G + V+GT
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 225 GYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284
Y +PE A + +SDVYS G VL E++TG P P+ +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238
Query: 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
+ AD AV L ++ ++R
Sbjct: 239 EGLSAD--------------LDAVVLKALAKNPENRY 261
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-45
Identities = 46/280 (16%), Positives = 107/280 (38%), Gaps = 36/280 (12%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
+G G +G V++ + + K + G E+ +L++ +H+N+++L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 121 ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVI 180
++ ++++EF+S + + L+ + + L++LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFER---INTSAFELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 181 YRDFKASNILLDAEFNP--KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLT 238
+ D + NI+ + K+ +FG A+ G + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 239 KKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK--KKFTMMADPLLEGQ 296
+D++S G ++ L++G + + + A+ ++ K+ ++ A ++
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR- 240
Query: 297 YPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
L ++ SR TA E L P
Sbjct: 241 ---------------LLVKERKSRM------TASEALQHP 259
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-45
Identities = 64/272 (23%), Positives = 106/272 (38%), Gaps = 31/272 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLV-Q 109
E+F ++G+G +G+V+ + +Q A+K L + + E +LSL +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
H L ++ + V E+++ G L H D A GL+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQ 117
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
+LH ++YRD K NILLD + + K++DFG+ K G GT Y AP
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAP 172
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289
E + + D +SFGV+L E++ G+S E + + P
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------------ 220
Query: 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
YPR +A + + + R
Sbjct: 221 ------FYPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-44
Identities = 63/302 (20%), Positives = 109/302 (36%), Gaps = 26/302 (8%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-FFAEVLMLSLVQ 109
D + +GEG YG V Y VA+K++ +Q + E+ +L +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 110 HQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLE 169
H+N++ + + ++ + L Q L +GL+
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLK 123
Query: 170 YLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK-LGPTGGKDHVSTRVMGTYGYCA 228
Y+H V++RD K SN+LL+ + K+ DFGLA+ P T + T Y A
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 229 PEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--KPLLRDKKKF 285
PE + + TK D++S G +L E+++ R ++ N + P D
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 286 TMMADPLLEGQYPRKGLY-----------QALAVAGMCLQEDADSRPFMVDVVTALEYLS 334
+ P K +AL + L + R + L+
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI------EVEQALA 294
Query: 335 SP 336
P
Sbjct: 295 HP 296
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (386), Expect = 1e-44
Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 15/232 (6%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQH 110
++F +G G +GRV+ + A+K L + + E LMLS+V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
++ + G D Q ++ +++ L + A LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
LH +IYRD K NILLD + K++DFG AK P V+ + GT Y APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282
T K D +SFG+++ E++ G + +S + + A+
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 223
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 151 bits (383), Expect = 2e-44
Identities = 62/299 (20%), Positives = 102/299 (34%), Gaps = 46/299 (15%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS---------REFFAEV-L 103
EN+ P ++G G V + + + AVK +D +G EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 104 MLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGG 163
+ + H N++ L LV++ M G L ++ ++ L KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRA 118
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
+ + LH +++RD K NILLD + N KL+DFG + G V GT
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGT 172
Query: 224 YGYCAPEYAMTGQL------TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP 277
Y APE K+ D++S GV++ L+ G + + ++
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232
Query: 278 LLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+ + L R TA E L+ P
Sbjct: 233 QFGSPEWDDYSDT--------------VKDLVSRFLVVQPQKRY------TAEEALAHP 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 63/292 (21%), Positives = 114/292 (39%), Gaps = 31/292 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE-----FFAEVLMLSLVQHQNLVN 115
+GEG + VYK + +Q+VA+K++ +++ E+ +L + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 116 LIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
L+ LV++FM + + + + L +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH--- 117
Query: 176 DPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG 235
+++RD K +N+LLD KL+DFGLAK G + T + T Y APE
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 236 QL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV--TWAKPLLRDKKKFTMMADPL 292
++ D+++ G +L EL+ + ++ + T P + D +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 293 LEGQYPRKGLY--------QALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+P L+ L + + +R TA + L
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI------TATQALKMK 281
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-43
Identities = 66/304 (21%), Positives = 110/304 (36%), Gaps = 43/304 (14%)
Query: 43 VFKYQELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSR------ 96
VF+ + + D ++ +G G + V K ++ A K + + + SR
Sbjct: 2 VFRQENVDD---YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 97 EFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFT 156
+ EV +L +QH N++ L + IL+ E ++ G L + ++E L
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEE 114
Query: 157 RMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP----KLSDFGLAKLGPTGG 212
+ G+ YLH + + D K NI+L P K+ DFGLA G
Sbjct: 115 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV 272
+ + GT + APE L ++D++S GV+ L++G S E V
Sbjct: 172 E---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228
Query: 273 TWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEY 332
+ D +Y A L +D R T +
Sbjct: 229 SAVNYEFED--------------EYFSNTSALAKDFIRRLLVKDPKKRM------TIQDS 268
Query: 333 LSSP 336
L P
Sbjct: 269 LQHP 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-42
Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 26/296 (8%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQL--DRSGNQGSREFFAEVLMLSLVQHQ 111
ENF +GEG YG VYK + +VVA+K++ D E+ +L + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL 171
N+V L+ ++ LV+EF+ + + +GL +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
H V++RD K N+L++ E KL+DFGLA+ + + + V+ +
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEIL 174
Query: 232 AMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291
+ D++S G + E++T R+ ++ + + + + P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 292 LLEGQYPRKGLY-----------QALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+ +P+ ++ L D + R +A L+ P
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI------SAKAALAHP 284
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-42
Identities = 60/303 (19%), Positives = 111/303 (36%), Gaps = 31/303 (10%)
Query: 52 ATENFNPDCLVGEGGYGRVYKGY-IEAVDQVVAVKQLDRSGNQGS--REFFAEVL---ML 105
A + + +GEG YG+V+K ++ + VA+K++ + EV L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 106 SLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDL--PPDQEPLDWFTRMKIAGG 163
+H N+V L C + ++ + + T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 164 AAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGT 223
+GL++LH V++RD K NIL+ + KL+DFGLA++ T V+ T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVT 178
Query: 224 YGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV----------T 273
Y APE + D++S G + E+ + S ++ +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 274 WAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333
W + + ++ F + +E ++ + CL + R +A L
Sbjct: 239 WPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRI------SAYSAL 291
Query: 334 SSP 336
S P
Sbjct: 292 SHP 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 4e-41
Identities = 52/280 (18%), Positives = 93/280 (33%), Gaps = 28/280 (10%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
+G G +G +Y G A + VA+K + E + ++Q + I +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 121 -ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
A+GD ++V E + + T + +A +EY+H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 180 IYRDFKASNIL---LDAEFNPKLSDFGLAKLGPTGG-----KDHVSTRVMGTYGYCAPEY 231
I+RD K N L + DFGLAK + + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 232 AMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291
+ + +++ D+ S G VL+ G + + ++ R +K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------ERISEKKMSTPIE 238
Query: 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331
+L YP + C D +P +
Sbjct: 239 VLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 9e-41
Identities = 57/300 (19%), Positives = 108/300 (36%), Gaps = 34/300 (11%)
Query: 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLV 114
++ ++G G +G VY+ + ++VA+K++ Q R E+ ++ + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 115 NLIGYCADGDQR------ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGL 168
L + ++ LV +++ ++ L + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA-RHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 169 EYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
Y+H + +RD K N+LLD + KL DFG AK G + + + Y
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRA 190
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA------KPLLRD 281
T DV+S G VL EL+ G+ ++ + + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 282 KKKFTMMADPLLEGQYPRKGLY-----QALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+T P ++ K +A+A+ L+ +R T LE +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL------TPLEACAHS 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-40
Identities = 59/276 (21%), Positives = 102/276 (36%), Gaps = 44/276 (15%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSRE------FFAEVLMLSLVQ--HQN 112
L+G GG+G VY G + + VA+K +++ E EV++L V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 113 LVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLH 172
++ L+ + D +L+ E F+ ++ L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCH 127
Query: 173 DVADPPVIYRDFKASNILLDAE-FNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
+ V++RD K NIL+D KL DFG L KD V T GT Y PE+
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEW 180
Query: 232 AMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290
+ + + V+S G++L +++ G P E + + R + +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDI------PFEHDEEIIRGQVFFRQ--RVSSECQ 232
Query: 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDV 326
L+ CL RP ++
Sbjct: 233 HLIRW----------------CLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-39
Identities = 52/284 (18%), Positives = 101/284 (35%), Gaps = 37/284 (13%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV-LMLSLVQHQNLVNLIGY 119
++G G G+V + + + + A+K L + EV L Q ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 120 C----ADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA 175
A ++V E + G L + D + +I + ++YLH +
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 176 DPPVIYRDFKASNILLDAEFNP---KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYA 232
+ +RD K N+L ++ KL+DFG AK + T Y APE
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVL 185
Query: 233 MTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292
+ K D++S GV++ L+ G P + + + + +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+ + + L+ + R T E+++ P
Sbjct: 240 EWSEVSE----EVKMLIRNLLKTEPTQRM------TITEFMNHP 273
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (348), Expect = 3e-39
Identities = 44/272 (16%), Positives = 92/272 (33%), Gaps = 30/272 (11%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH-QNLVNLIGY 119
+GEG +G +++G +Q VA+K R + + E L+ + N+ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 120 CADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPV 179
+G +LV + + + L T A ++ +H+ +
Sbjct: 70 GQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSL 122
Query: 180 IYRDFKASNILLDAEFNP-----KLSDFGLAKL-----GPTGGKDHVSTRVMGTYGYCAP 229
+YRD K N L+ + + DFG+ K + GT Y +
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 230 EYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289
+ + +++ D+ + G V + + G + + + R +K
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------ERIGEKKQSTP 236
Query: 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRP 321
L +P + Y+ + D+ P
Sbjct: 237 LRELCAGFP-EEFYKYMH---YARNLAFDATP 264
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 137 bits (345), Expect = 6e-39
Identities = 53/296 (17%), Positives = 108/296 (36%), Gaps = 28/296 (9%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQL--DRSGNQGSREFFAEVLMLSLVQHQ 111
E ++ +GEG YG VYK + A+K++ ++ E+ +L ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL 171
N+V L + +LV+E + + L + L+ T G+ Y
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKK----LLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
HD V++RD K N+L++ E K++DFGLA+ + + ++ +
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVL 172
Query: 232 AMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291
+ + + D++S G + E++ G +++ + K + P
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 292 LLEGQYPRKGLY-----------QALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+ + + + L+ D + R TA + L
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI------TAKQALEHA 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 9e-39
Identities = 64/286 (22%), Positives = 106/286 (37%), Gaps = 31/286 (10%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQH 110
+F+ L+G+G +G+V +A + A+K L + E +L +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 111 QNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
L L D+ V E+ + G L H FT + A+ +
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFYGAEIVSA 117
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE 230
L + V+YRD K N++LD + + K++DFGL K G + G GT Y APE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPE 175
Query: 231 YAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290
+ D + GVV+ E++ GR N L+ +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI------------- 222
Query: 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
++PR +A ++ L++D R A E +
Sbjct: 223 -----RFPRTLSPEAKSLLAGLLKKDPKQRLGG-GPSDAKEVMEHR 262
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 8e-38
Identities = 60/313 (19%), Positives = 116/313 (37%), Gaps = 40/313 (12%)
Query: 51 DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--REFFAEVLMLSLV 108
D + +G+G +G V+K Q VA+K++ + E+ +L L+
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 109 QHQNLVNLIGYCADGDQRI--------LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKI 160
+H+N+VNLI C LV++F + L FT +I
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEI 119
Query: 161 AGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS--T 218
L L+ + +++RD KA+N+L+ + KL+DFGLA+ + T
Sbjct: 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 219 RVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK- 276
+ T Y PE + + D++ G ++ E+ T + + + L++
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 239
Query: 277 -------PLLRDKKKFTMMADPLLEGQYPRKGLY------QALAVAGMCLQEDADSRPFM 323
P + + + + + + + + L AL + L D R
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI-- 297
Query: 324 VDVVTALEYLSSP 336
+ + L+
Sbjct: 298 ----DSDDALNHD 306
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-37
Identities = 57/297 (19%), Positives = 102/297 (34%), Gaps = 28/297 (9%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQ 111
+ + +GEG YG V+K ++VA+K++ + E+ +L ++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 112 NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYL 171
N+V L + LV+EF + LD KGL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD----SCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 172 HDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEY 231
H V++RD K N+L++ KL++FGLA+ + + S V+ +
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVL 173
Query: 232 AMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ------------NLVTWAKPLL 279
+ D++S G + EL + ++Q + L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
D K + M K + L+ + R +A E L P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI------SAEEALQHP 284
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-36
Identities = 67/312 (21%), Positives = 118/312 (37%), Gaps = 32/312 (10%)
Query: 44 FKYQELADAT----ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSRE 97
F QE+ + VG G YG V VA+K+L R ++
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 98 FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTR 157
+ E+ +L ++H+N++ L+ + +F L E L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
+ KGL Y+H +I+RD K N+ ++ + K+ DFGLA+ ++
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ----ADSEMT 176
Query: 218 TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV----- 272
V+ + + T+ D++S G ++ E+ITG++ S ++ +
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 273 ----TWAKPLLRDKKKFTMMADPLLEGQYPRKGLY----QALAVAGMCLQEDADSRPFMV 324
+ + L D+ K M P LE + L A+ + L DA+ R
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV--- 293
Query: 325 DVVTALEYLSSP 336
TA E L+ P
Sbjct: 294 ---TAGEALAHP 302
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 2e-35
Identities = 60/265 (22%), Positives = 101/265 (38%), Gaps = 20/265 (7%)
Query: 16 KDKRRSSKQRRIAAEIRKFGKAKKTPNVFKYQELADATENFNPDCLVGEGGYGRVYKGYI 75
K + S + +A F K +TP+ Q + F+ +G G +GRV
Sbjct: 8 KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQ-----LDQFDRIKTLGTGSFGRVMLVKH 62
Query: 76 EAVDQVVAVKQLDRSGNQGSRE---FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132
+ A+K LD+ ++ E +L V LV L D +V E+
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD 192
++ G + +H A EYLH + +IYRD K N+L+D
Sbjct: 123 VAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLID 175
Query: 193 AEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLE 252
+ +++DFG AK + + GT APE ++ K D ++ GV++ E
Sbjct: 176 QQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230
Query: 253 LITGRSAIDNSRPSEEQNLVTWAKP 277
+ G +P + + K
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKV 255
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (311), Expect = 1e-33
Identities = 44/221 (19%), Positives = 92/221 (41%), Gaps = 21/221 (9%)
Query: 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEV-LMLSLVQHQN 112
+++ +G G Y V++ ++ V VK L ++ E+ ++ +L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPN 91
Query: 113 LVNLIGYCADGDQR--ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEY 170
++ L D R LV+E ++N + + + L + K L+Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDY 144
Query: 171 LHDVADPPVIYRDFKASNILLDAEFNP-KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAP 229
H + +++RD K N+++D E +L D+GLA+ G + + + + P
Sbjct: 145 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGP 198
Query: 230 EYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ 269
E + Q+ D++S G +L +I + + + +Q
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 6e-31
Identities = 66/293 (22%), Positives = 110/293 (37%), Gaps = 33/293 (11%)
Query: 54 ENFNPDCLVGEGGYGRVYKGY---IEAVDQVVAVKQLDRSG----NQGSREFFAEVLMLS 106
ENF ++G G YG+V+ ++ A+K L ++ + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 107 LVQHQ-NLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAA 165
++ LV L + L+ ++++ G L H E +I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV---- 139
Query: 166 KGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYG 225
LE+LH +IYRD K NILLD+ + L+DFGL+K + + GT
Sbjct: 140 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 226 YCAPEYAMTGQ--LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283
Y AP+ G K D +S GV++ EL+TG S E+ + ++ +L+ +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD--GEKNSQAEISRRILKSEP 253
Query: 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336
+ A + L +D R A E
Sbjct: 254 PYPQEMSA------------LAKDLIQRLLMKDPKKRLGCGP-RDADEIKEHL 293
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 7e-31
Identities = 65/312 (20%), Positives = 116/312 (37%), Gaps = 32/312 (10%)
Query: 44 FKYQELA----DATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGS--RE 97
F QEL + E + VG G YG V + VAVK+L R +
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 98 FFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTR 157
+ E+ +L ++H+N++ L+ + L L+ + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 158 MKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDHVS 217
+ +GL+Y+H +I+RD K SN+ ++ + K+ DFGLA+ D ++
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMT 176
Query: 218 TRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV----- 272
V + + D++S G ++ EL+TGR+ + ++ L+
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 273 TWAKPLLRDKKKFTMMADPLLEGQYPRKGLY--------QALAVAGMCLQEDADSRPFMV 324
T LL+ + Q P+ A+ + L D+D R
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI--- 293
Query: 325 DVVTALEYLSSP 336
TA + L+
Sbjct: 294 ---TAAQALAHA 302
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-29
Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 27/275 (9%)
Query: 42 NVFKYQELADAT----ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGS 95
N F E+ D+T + + +G G G V Y +D+ VA+K+L R +
Sbjct: 1 NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60
Query: 96 REFFAEVLMLSLVQHQNLVNLIGYCA------DGDQRILVYEFMSNGSLENHFLDLPPDQ 149
+ + E++++ V H+N+++L+ + LV E M + Q
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------Q 113
Query: 150 EPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209
LD + G+++LH +I+RD K SNI++ ++ K+ DFGLA+
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--- 167
Query: 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ 269
T G + T + T Y APE + + D++S G ++ E++ + ++
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
Query: 270 NLVTWAK--PLLRDKKKFTMMADPLLEGQYPRKGL 302
N V P KK +E + GL
Sbjct: 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 8e-27
Identities = 39/210 (18%), Positives = 75/210 (35%), Gaps = 16/210 (7%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYC 120
+G G + V+ + VA+K + + E+ +L V +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 121 ADGDQRIL-VYEFMSNGSLENHFLDLPPDQEPLDWFTRMK-----------IAGGAAKGL 168
A+ ++L + + + + L + + I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 169 EYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYC 227
+Y+H +I+ D K N+L++ L +A LG D T + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 228 APEYAMTGQLTKKSDVYSFGVVLLELITGR 257
+PE + +D++S ++ ELITG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.6 bits (172), Expect = 4e-15
Identities = 22/160 (13%), Positives = 45/160 (28%), Gaps = 30/160 (18%)
Query: 61 LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG----------NQGSREFFAEVLMLSLVQH 110
L+GEG V+ Y E VK + G F + + +
Sbjct: 7 LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 111 QNLVNLIGYCA----DGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAK 166
+ L L G + ++ E + L ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVR-----------VENPDEVLDMILE 114
Query: 167 GLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206
+ + +++ D N+L+ E + DF +
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 336 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.98 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.36 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.53 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.51 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.18 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-61 Score=413.50 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=210.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 3679999999999999999999999999999999865432 234568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|......
T Consensus 84 y~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999864 467999999999999999999999999 999999999999999999999999999876544
Q ss_pred CCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
......+..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||............. ...
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-----~~~--------- 222 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEK--------- 222 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-----HTT---------
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcC---------
Confidence 43444566789999999999988876 578999999999999999999997654322111110 000
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..........+..+.+|+.+||+.||++|||++|+++
T Consensus 223 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 -KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001112344568899999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-60 Score=413.11 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=214.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|++.+.||+|+||+||+|.++.+|+.||||++........+.+.+|+.+++.++||||+++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999999999999999997665556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
+||+|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998764 46999999999999999999999999 9999999999999999999999999998754322
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+....+ .... ..
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~~~~---------~~ 234 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNG---------TP 234 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHC---------SC
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH------HhCC---------CC
Confidence 2345568999999999999999999999999999999999999999765432211111 1110 01
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
....+...+..+.+||.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11234456678999999999999999999999985
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-61 Score=409.14 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=211.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||.||+|.++.+++.||+|++.+. .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999998643 2233567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999875 456999999999999999999999999 99999999999999999999999999976533
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+ ...
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~--------- 219 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------SRV--------- 219 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTT---------
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH------HcC---------
Confidence 2 234568999999999999999999999999999999999999999765432221111 111
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...++...+..+.+|+.+||+.||++|||++|+++
T Consensus 220 ---~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 ---EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 01233445668999999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-61 Score=417.74 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=209.4
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||+||+|.++.+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999998643 2234567899999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||++||+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|.....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999998865 467999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
..........+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+... .+....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i~~~~-------- 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------KIIKLE-------- 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHTTC--------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH------HHHcCC--------
Confidence 444444556789999999999999999999999999999999999999998654322111 111110
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA 329 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~ 329 (336)
..++...+..+.+||.+||+.||++|||++|++..
T Consensus 227 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 12333456689999999999999999999987544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-60 Score=410.27 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=212.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
+.|++.+.||+|+||.||+|.++.+|..||+|++........+.+.+|+++|+.++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56899999999999999999999999999999998766666678999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++..... .
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 99999998765 2457999999999999999999999999 99999999999999999999999999975322 1
Q ss_pred cceeeeeccCccccCccccc-----cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccc
Q 036144 214 DHVSTRVMGTYGYCAPEYAM-----TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMM 288 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (336)
.......+||+.|+|||++. +..|+.++|||||||++|+|++|..||...+..+....+. ...
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~------~~~------ 231 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA------KSE------ 231 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH------HSC------
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH------cCC------
Confidence 12234568999999999984 4568999999999999999999999998765433221111 110
Q ss_pred cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 289 ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 289 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
......+...+..+.+|+.+||+.||++|||++|+++
T Consensus 232 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 ---PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111223456678999999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-61 Score=411.31 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=200.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEe--CCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCAD--GDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 129 (336)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ....|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 679999999999999999999999999999999876542 234568899999999999999999999864 4568999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA--DPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
|||+++|+|.+++.........+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||++..
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998754444678999999999999999999999864 23499999999999999999999999999987
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+ ... ..
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i------~~~--~~-- 231 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI------REG--KF-- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHT--CC--
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH------HcC--CC--
Confidence 5432 22344578999999999999999999999999999999999999999865432211111 110 00
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...+...+..+.+|+.+||+.||++|||++|+++
T Consensus 232 -------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1223345668999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-60 Score=409.72 Aligned_cols=260 Identities=25% Similarity=0.379 Sum_probs=217.2
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|++.+.||+|+||.||+|.++.+|+.||||+++... ...+.+.+|+.+|+.++|||||++++++.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 4567899999999999999999999999999999987554 346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred cccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 99999999998752 3567899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
.........||+.|+|||++.+..|+.++|||||||++|||++|..||........ ... .+..+
T Consensus 169 -~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~----~i~~~--------- 232 (287)
T d1opja_ 169 -TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKD--------- 232 (287)
T ss_dssp -SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHHTT---------
T ss_pred -CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHH----HHhcC---------
Confidence 22333445689999999999999999999999999999999997766544322111 111 11111
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+|+.+||+.||++|||++++++.|+.+.
T Consensus 233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112234455668999999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-59 Score=402.71 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=205.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
.++|.+.+.||+|+||.||+|+++. .||||+++... ....+.+.+|+.+++.++|||||++++++.+ ...++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 4679999999999999999998753 59999986542 3345678999999999999999999998754 5689999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999875 3456999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcceeeeeccCccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMT---GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
...........||+.|+|||++.+ ..|+.++|||||||++|||+||..||............ ...+.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------~~~~~---- 226 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------VGRGY---- 226 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HHHTS----
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH------HhcCC----
Confidence 444444566789999999999864 35899999999999999999999999875543221111 11110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..+.+ ...+...+..+.+|+.+||+.||++|||++++++.|+.|.
T Consensus 227 -~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 227 -LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp -CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 01100 1123345568999999999999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-60 Score=414.95 Aligned_cols=265 Identities=20% Similarity=0.252 Sum_probs=208.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||+||+|.+..+|+.||+|+++... ......+.+|+.+|+.++|||||++++++.+....++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 478999999999999999999999999999999987543 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
|++||+|.+++.. ...+++..++.++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|.....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999875 3569999999999999999999997 47 99999999999999999999999999985422
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHH-HHHHHH-----------
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLV-TWAKPL----------- 278 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~----------- 278 (336)
....+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+........ ......
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2234578999999999999999999999999999999999999999875533211000 000000
Q ss_pred ----hh------ccc----ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 ----LR------DKK----KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 ----~~------~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ... ..................+..+.+|+.+||+.||++|||++|+|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 000 000000000000111224568999999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-59 Score=405.78 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=196.8
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..+.|++.+.||+|+||+||+|.++.+|+.||||++..... .....+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34679999999999999999999999999999999875432 22355779999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC---CCCceEEcccccccc
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD---AEFNPKLSDFGLAKL 207 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~ 207 (336)
||++||+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+||++. .++.+||+|||++..
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999965 467999999999999999999999999 99999999999994 578899999999986
Q ss_pred CCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.... ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......+.... +...
T Consensus 160 ~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~~~------ 224 (307)
T d1a06a_ 160 EDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ------ILKA------ 224 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHTT------
T ss_pred ccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH------Hhcc------
Confidence 5332 224457899999999999999999999999999999999999999986543221111 1111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
............+..+.+|+.+||+.||++|||++|+++
T Consensus 225 --~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 225 --EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011112223345668999999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7e-59 Score=411.40 Aligned_cols=253 Identities=22% Similarity=0.269 Sum_probs=214.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999999999999999999776555567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC--CCceEEccccccccCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA--EFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~--~~~~kl~Dfg~~~~~~~ 210 (336)
++||+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999864 3457999999999999999999999999 999999999999954 57899999999987543
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .......||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....+ .....
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~------- 242 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDW------- 242 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCC-------
T ss_pred c---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC-------
Confidence 2 2345678999999999999999999999999999999999999999865432221111 11110
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
..........+..+.+||.+||+.||++|||++|+++
T Consensus 243 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 243 -NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp -CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111122345668999999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.9e-58 Score=408.96 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=214.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.++.+|+.||||++..........+.+|+.+|+.++||||+++++++.+.+..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46799999999999999999999999999999999766555556788999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC--CCCceEEccccccccCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD--AEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~--~~~~~kl~Dfg~~~~~~~ 210 (336)
++||+|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++.....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 999999887754 3457999999999999999999999999 99999999999997 578999999999987644
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
. .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....+....+ ... +
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~--------~ 244 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRC--------D 244 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHC--------C
T ss_pred C---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhC--------C
Confidence 3 2355678999999999999999999999999999999999999999875533221111 111 1
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
...........+..+.+||.+||+.||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112223345668999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-59 Score=403.15 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=201.2
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe---EEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ---VVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.+|++.++||+|+||+||+|.++.+++ .||||.+..... ...+.+.+|+.+|+.++|||||++++++.+....++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467888899999999999999976654 689998865433 3346789999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998875 3457999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCcce---eeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 210 TGGKDHV---STRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 210 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
....... .....||+.|+|||.+.++.|+.++|||||||++|||+| |..||......+....+ ..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i-------~~~--- 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-------EQD--- 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTT---
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC---
Confidence 3322211 223468999999999999999999999999999999998 89999876543221111 111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.|
T Consensus 250 -------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 250 -------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122344566899999999999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-59 Score=397.33 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=202.1
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|++.+.||+|+||.||+|.++. ++.||||++.... ...+++.+|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 468889999999999999999874 6789999997543 34578999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 99999999875 3467899999999999999999999999 9999999999999999999999999998654322
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITG-RSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
........||+.|+|||++.+..|+.++|||||||++|||+|+ .+||......+. ..... .+
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~---~~~i~----~~---------- 218 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDIS----TG---------- 218 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH---HHHHH----HT----------
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH---HHHHH----hc----------
Confidence 2223346799999999999999999999999999999999995 555554332221 11111 11
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....+...+..+.+|+.+||+.||++|||++++++.|+.|.
T Consensus 219 ~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 219 FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 011123344568999999999999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-58 Score=394.61 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=200.1
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe----CCeEEEEE
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD----GDQRILVY 130 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 130 (336)
++.+.||+|+||+||+|.+..++..||+|++.... ....+.+.+|+++|+.++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999999999999999986542 2334568899999999999999999999865 34678999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEEC-CCCceEEccccccccCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLD-AEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~ 209 (336)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||++....
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999865 457899999999999999999999864 4599999999999996 57899999999998643
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
. ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||........ ....+. .+
T Consensus 167 ~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~~~~i~-~~------- 228 (270)
T d1t4ha_ 167 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVT-SG------- 228 (270)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHT-TT-------
T ss_pred C----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----HHHHHH-cC-------
Confidence 2 22446789999999998865 699999999999999999999999976443221 111111 10
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.....++...+..+.+|+.+||+.||++|||++|+++
T Consensus 229 --~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 --VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0011122334557899999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-58 Score=404.98 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=211.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccC-----eEEEEEeecCCC-CccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVD-----QVVAVKQLDRSG-NQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (336)
.++|++.+.||+|+||+||+|++..++ ..||+|.+.... ......+.+|+.+++.+ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 367899999999999999999987654 369999986542 33446788999999988 89999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 036144 126 RILVYEFMSNGSLENHFLDLPP-------------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKA 186 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp 186 (336)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999976321 1245899999999999999999999998 99999999
Q ss_pred CCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 036144 187 SNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRP 265 (336)
Q Consensus 187 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~ 265 (336)
+|||++.++.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||++|||++ |..||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986554444444556778999999999999999999999999999999997 8999987554
Q ss_pred cccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHh
Q 036144 266 SEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALE 331 (336)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~ 331 (336)
.... . .....+ .....+...+..+.+|+.+||+.||++|||++||++.|.
T Consensus 273 ~~~~--~----~~~~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANF--Y----KLIQNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHH--H----HHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH--H----HHHhcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3221 1 111111 111234455678999999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-58 Score=400.21 Aligned_cols=246 Identities=27% Similarity=0.367 Sum_probs=205.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
..|+..+.||+|+||.||+|.+..+|+.||||++...... ..+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3589999999999999999999999999999998765432 2356889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+.+|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999776654 467999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCcceeeeeccCccccCcccccc---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMT---GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
....+||+.|+|||++.+ +.|+.++|||||||++|+|++|..||......+... ......
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i~~~~----- 230 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNE----- 230 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSC-----
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhCC-----
Confidence 334679999999999864 468999999999999999999999998654322111 111110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.+. ..+...+..+.+|+.+||+.||.+|||++|+++
T Consensus 231 --~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 --SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 000 112234568999999999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-58 Score=403.05 Aligned_cols=249 Identities=26% Similarity=0.342 Sum_probs=212.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
.++|++.+.||+|+||.||+|+++.+|+.||||++++. .......+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999999999999999998653 233456788999999999999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999875 467899999999999999999999999 9999999999999999999999999998653
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+.... ....
T Consensus 157 ~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------i~~~-------- 220 (337)
T d1o6la_ 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ILME-------- 220 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHC--------
T ss_pred cC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHH------HhcC--------
Confidence 32 2234567899999999999999999999999999999999999999987654322111 1111
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
...++...+..+.+||.+||+.||.+||+ ++|+++
T Consensus 221 ----~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 ----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 01234455678999999999999999995 888876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=386.18 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=214.8
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcC
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFM 133 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 133 (336)
++|++.+.||+|+||+||+|+++ ++..||||+++.... ..+++.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57999999999999999999986 578999999976543 4578999999999999999999999999999999999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++|+|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~- 154 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 154 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC-
Confidence 99999998765 3567889999999999999999999998 9999999999999999999999999997654332
Q ss_pred cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 214 DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 214 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+....+. .+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-------~~---------- 217 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QG---------- 217 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TT----------
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-------hC----------
Confidence 223344679999999999999999999999999999999998 899998765433221111 11
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+|+.+||+.||++|||++++++.|..|
T Consensus 218 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 01122334456899999999999999999999999999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-58 Score=398.07 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=210.6
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC------CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG------NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|++.+.||+|+||+||+|.++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 467999999999999999999999999999999986432 12346789999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC----ceEEccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF----NPKLSDF 202 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~----~~kl~Df 202 (336)
++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 999999999999999875 457999999999999999999999999 99999999999998776 4999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK 282 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (336)
|++.....+. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+ ....
T Consensus 162 G~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------SAVN 232 (293)
T ss_dssp TTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HTTC
T ss_pred hhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH------HhcC
Confidence 9998754332 244567999999999999999999999999999999999999999865432221111 1110
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ......+...+..+.+||.+||+.||++|||++|+++
T Consensus 233 ~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 Y--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011112234568999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-58 Score=394.39 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=209.2
Q ss_pred cCCCCccc-ccccCceEEEEEEEcc--cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCL-VGEGGYGRVYKGYIEA--VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~-ig~G~~g~v~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
++|.+.+. ||+|+||.||+|.++. ++..||||+++.... ...+.+.+|+.+|+.++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 9999999999998754 455899999976533 334678999999999999999999999865 458999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. .+..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999998754 3567999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCc-ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 210 TGGKD-HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
..... .......||+.|+|||++.++.++.++|||||||++|||+| |..||......+....+ ..+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i-------~~~~---- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGK---- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-------HTTC----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC----
Confidence 43222 22334568999999999999999999999999999999998 89999876543322111 1111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 230 ------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1123445566899999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-58 Score=392.01 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=207.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.++. +..||||++.... ...+.+.+|+.+++.++|||||++++++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 4678899999999999999999874 7889999997543 345789999999999999999999998754 567899999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999998754 22346899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCC-CCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSA-IDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
........||+.|+|||++.++.++.++|||||||++|||+||..| |......+. ... +..+
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~---~~~----i~~~--------- 226 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQN----LERG--------- 226 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHH----HHTT---------
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHhc---------
Confidence 2233446789999999999999999999999999999999996555 443332111 111 1111
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+|+.+||+.||++|||+++|++.|+.+
T Consensus 227 -~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11122334556899999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-57 Score=396.66 Aligned_cols=245 Identities=27% Similarity=0.371 Sum_probs=209.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++.+.||+|+||+||+|+++.+|+.||||++.+. .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999999999999999998643 2234567889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||++||+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999998875 566888899999999999999999998 99999999999999999999999999987533
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+.... +....
T Consensus 157 -----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~~-------- 217 (316)
T d1fota_ 157 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK------ILNAE-------- 217 (316)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHCC--------
T ss_pred -----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH------HHcCC--------
Confidence 23457899999999999999999999999999999999999999987543322111 11110
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+++.+||+.||.+|+ |++++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 122334556899999999999999996 8999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-57 Score=387.73 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=201.7
Q ss_pred ccccccCceEEEEEEEc--ccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEcCCC
Q 036144 60 CLVGEGGYGRVYKGYIE--AVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEFMSN 135 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 135 (336)
+.||+|+||.||+|.++ .+++.||||+++... ....+.+.+|+.+|+.++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999864 456789999986543 2234678999999999999999999999865 457899999999
Q ss_pred CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCCcc
Q 036144 136 GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGKDH 215 (336)
Q Consensus 136 g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 215 (336)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999875 466999999999999999999999998 9999999999999999999999999998754433222
Q ss_pred -eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccCCcc
Q 036144 216 -VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPLL 293 (336)
Q Consensus 216 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (336)
......||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+ ..+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i-------~~~~---------- 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGE---------- 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTC----------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH-------HcCC----------
Confidence 2334679999999999999999999999999999999998 89999875533221111 1111
Q ss_pred CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 294 EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 294 ~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1123344566899999999999999999999999988753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-57 Score=389.19 Aligned_cols=258 Identities=24% Similarity=0.400 Sum_probs=202.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccC----eEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVD----QVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
..|+..++||+|+||.||+|.++.++ ..||||++...... ....+.+|+.+++.++|||||++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 45788899999999999999987654 47999998754332 33568899999999999999999999999999999
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+.++++.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999988765 3467999999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCC-cceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGK-DHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
..... ........||+.|+|||++.++.++.++|||||||++|||++|..|+....... ..... +..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~~----i~~------ 228 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKA----IND------ 228 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHH----HHT------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHHH----Hhc------
Confidence 43222 122334568999999999999999999999999999999999765554332211 11111 111
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
......+...+..+.+|+.+||+.||++|||+.+|++.|+.|
T Consensus 229 ----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 229 ----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp ----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ----cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 111223344566899999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.7e-57 Score=388.92 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=207.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc---cHHHHHHHHHHHhhccCCCccceEEEEEeCC----e
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ---GSREFFAEVLMLSLVQHQNLVNLIGYCADGD----Q 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~ 125 (336)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 47799999999999999999999999999999999765332 2346889999999999999999999987654 4
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.|+||||++|++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999998865 457999999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCC-CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccc
Q 036144 206 KLGPTGG-KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKK 284 (336)
Q Consensus 206 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (336)
....... ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...+..+.. .........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCCC
Confidence 7543322 222345578999999999999999999999999999999999999999865432211 111111111
Q ss_pred cccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHHhcccC
Q 036144 285 FTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-FMVDVVTALEYLSS 335 (336)
Q Consensus 285 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-t~~evl~~L~~i~~ 335 (336)
.........+..+.++|.+||+.||.+|| |++++++.|..+.+
T Consensus 233 --------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 233 --------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp --------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred --------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 11112233456899999999999999999 89999999987753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-56 Score=397.21 Aligned_cols=245 Identities=24% Similarity=0.291 Sum_probs=209.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCC---CCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS---GNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 130 (336)
++|++++.||+|+||.||+|.++.+|+.||||++.+. .....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6899999999999999999999999999999998642 2233467889999999999999999999999999999999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPT 210 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 210 (336)
||+.+|+|..++.. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.++.+||+|||++.....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999865 457999999999999999999999999 99999999999999999999999999987532
Q ss_pred CCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 211 GGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
......||+.|+|||++.+..|+.++|||||||++|+|++|..||...+....... +....
T Consensus 194 -----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~~-------- 254 (350)
T d1rdqe_ 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK------IVSGK-------- 254 (350)
T ss_dssp -----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCC--------
T ss_pred -----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH------HhcCC--------
Confidence 23456899999999999999999999999999999999999999986543221111 11110
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
..++...+..+.+||.+||+.||.+|+ |++++++
T Consensus 255 ----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112334556899999999999999994 8999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=392.52 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=206.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe----EEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ----VVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.+|++.++||+|+||+||+|.+..+|+ .||+|.+.... ....+.+.+|+.+++.++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999987776 58888886533 34457799999999999999999999999865 4678
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
+|+++.+|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876 4567999999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
.............||+.|+|||++.++.|+.++|||||||++|||+| |.+||......+....+. .+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~~---- 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---- 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HTC----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC----
Confidence 55444444455679999999999999999999999999999999998 789988765433222221 110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
....+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 231 ------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1122344566899999999999999999999999998765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=392.53 Aligned_cols=253 Identities=16% Similarity=0.237 Sum_probs=210.9
Q ss_pred HhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
..++|.+.+.||+|+||+||+|.++.+|+.||+|+++... .....+.+|+.+|+.++||||+++++++.+.+..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999999999999999997653 334568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC--CceEEccccccccCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE--FNPKLSDFGLAKLGP 209 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~--~~~kl~Dfg~~~~~~ 209 (336)
|++||+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ ..+||+|||++....
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999865 3357999999999999999999999999 9999999999999754 479999999998653
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. .......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...+..+.... +......+
T Consensus 156 ~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~------i~~~~~~~---- 222 (321)
T d1tkia_ 156 PG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIEN------IMNAEYTF---- 222 (321)
T ss_dssp TT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHTCCCC----
T ss_pred cC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCCCCC----
Confidence 32 234557899999999999999999999999999999999999999987553322111 11111000
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........+..+.+||.+||+.||++|||+.|+++
T Consensus 223 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 ----DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111134567899999999999999999999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.7e-56 Score=381.25 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=210.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCcc---------HHHHHHHHHHHhhcc-CCCccceEEEEEe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQG---------SREFFAEVLMLSLVQ-HQNLVNLIGYCAD 122 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 122 (336)
.++|++.+.||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999987643211 235789999999997 9999999999999
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
++..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999975 457999999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCcccccc------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHH
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMT------GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 276 (336)
|++....... .....+||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.......+
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i---- 227 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---- 227 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH----
Confidence 9998764432 2455689999999998853 35788999999999999999999999876532221111
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... ...........+..+.+|+.+||+.||++|||++|+++
T Consensus 228 --~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 --MSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp --HHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --HhCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111 01112223456678999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-56 Score=389.44 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=214.8
Q ss_pred HhcCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCe
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 125 (336)
..++|++.+.||+|+||.||+|++++ +++.||||++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 45789999999999999999999863 5688999998765433 24568999999999999999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 036144 126 RILVYEFMSNGSLENHFLDLP--------------------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFK 185 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dik 185 (336)
.+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence 999999999999999986421 12345889999999999999999999999 9999999
Q ss_pred CCCeEECCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCC
Q 036144 186 ASNILLDAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR-SAIDNSR 264 (336)
Q Consensus 186 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~-~p~~~~~ 264 (336)
|+|||++.++.+||+|||++............+...||+.|+|||.+.+..|+.++|||||||++|||++|. +||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998654444444455678999999999999999999999999999999999986 6777654
Q ss_pred CcccccHHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 265 PSEEQNLVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
..+....+ ..+. ....+...+.++.+|+.+||+.||++|||+.+|++.|+.|.
T Consensus 248 ~~e~~~~v-------~~~~----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVIYYV-------RDGN----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHH-------HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHH-------HcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 43322111 1110 01223345568999999999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=392.92 Aligned_cols=248 Identities=27% Similarity=0.416 Sum_probs=207.9
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHHHHHHHh-hccCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFAEVLMLS-LVQHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 129 (336)
++|++.+.||+|+||+||+|.++.+|+.||||++++.. ....+.+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999996431 233456667777665 68999999999999999999999
Q ss_pred EEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCC
Q 036144 130 YEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGP 209 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 209 (336)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999875 456899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccccccc
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMA 289 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (336)
.. ....+..+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+....+. ..
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~~-------- 218 (320)
T d1xjda_ 155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------MD-------- 218 (320)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC--------
T ss_pred cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH------cC--------
Confidence 32 233455689999999999999999999999999999999999999998755432211111 11
Q ss_pred CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHH
Q 036144 290 DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMV-DVVT 328 (336)
Q Consensus 290 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~-evl~ 328 (336)
.+ .++...+..+.+||.+||+.||.+|||+. ++++
T Consensus 219 ~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 22334566899999999999999999995 6653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.4e-56 Score=394.24 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=204.3
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC---CccHHHHHH---HHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG---NQGSREFFA---EVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.. ......+.+ ++.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999999999999999986421 111223333 46677778899999999999999999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
|+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|.
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999875 466889999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 207 LGPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||......+...... ...
T Consensus 156 ~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~------ 222 (364)
T d1omwa3 156 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTL------ 222 (364)
T ss_dssp ECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---HSS------
T ss_pred ecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcc------
Confidence 65432 2345679999999999875 578999999999999999999999998755433221111 100
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHH
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPF-----MVDVVT 328 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt-----~~evl~ 328 (336)
.....++...+..+.+||.+||+.||++||| ++|+++
T Consensus 223 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 ------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0011223345668999999999999999999 688875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=383.60 Aligned_cols=257 Identities=22% Similarity=0.325 Sum_probs=202.0
Q ss_pred hcCCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCCCc-cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSGNQ-GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRIL 128 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 128 (336)
.++|++.+.||+|+||.||+|.+..+ +..||||.++..... ..+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 36799999999999999999998654 457999998654433 2456899999999999999999999985 467899
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccC
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLG 208 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 208 (336)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998765 3567899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccccc
Q 036144 209 PTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTM 287 (336)
Q Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (336)
... .........||+.|+|||++.+..|+.++|||||||++|||++ |.+||......+....+. .+.
T Consensus 159 ~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-------~~~---- 226 (273)
T d1mp8a_ 159 EDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGE---- 226 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC----
T ss_pred cCC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCC----
Confidence 432 2223445678999999999999999999999999999999998 899998766543221111 110
Q ss_pred ccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 288 MADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 288 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
....+...+..+.+|+.+||+.||++|||+.||++.|+.|.
T Consensus 227 ------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11234455678999999999999999999999999998763
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=388.48 Aligned_cols=253 Identities=19% Similarity=0.238 Sum_probs=202.8
Q ss_pred hcCCCCcc-cccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhh-ccCCCccceEEEEEe----CCeE
Q 036144 53 TENFNPDC-LVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSL-VQHQNLVNLIGYCAD----GDQR 126 (336)
Q Consensus 53 ~~~y~~~~-~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~----~~~~ 126 (336)
.++|.+.+ .||+|+||.||+|.+..+++.||||+++. ...+.+|+.++.+ ++||||++++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46798875 69999999999999999999999999853 3467789998755 589999999999875 4568
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC---CCceEEcccc
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA---EFNPKLSDFG 203 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~---~~~~kl~Dfg 203 (336)
|+|||||+||+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccc
Confidence 9999999999999999762 2357999999999999999999999999 999999999999975 4569999999
Q ss_pred ccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 204 LAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||............. ..
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~------~~-- 228 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK------TR-- 228 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------C--
T ss_pred eeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH------HH--
Confidence 998654432 2445689999999999999999999999999999999999999997654332211110 00
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
................+..+.+||.+||+.||++|||+.|+++
T Consensus 229 --i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 229 --IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000001111122345678999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=383.73 Aligned_cols=275 Identities=21% Similarity=0.280 Sum_probs=209.0
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 689999999999999999999999999999999965432 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+.+ ++.+++.. .....+++..++.++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 44444433 24567999999999999999999999999 999999999999999999999999999765332
Q ss_pred CCcceeeeeccCccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH--------hhcc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL--------LRDK 282 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 282 (336)
........||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+..+....+...... ....
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 22334467999999999887765 578999999999999999999999865433221111100000 0000
Q ss_pred cccccccCCccCCCC---cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--HhcccCC
Q 036144 283 KKFTMMADPLLEGQY---PRKGLYQALAVAGMCLQEDADSRPFMVDVVTA--LEYLSSP 336 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~--L~~i~~~ 336 (336)
..............+ ....+..+.+|+.+||+.||++|||++|+++. ++.+..|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 000000000000000 11335688999999999999999999999984 7766655
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-56 Score=381.48 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=202.9
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.++|++.+.||+|+||.||+|.++.+ ..||||++.... ...+.+.+|+.+++.++|||||++++++.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 46899999999999999999999875 579999996543 445789999999999999999999999854 567899999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+++|+|..++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~- 166 (285)
T d1fmka3 93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN- 166 (285)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC-
Confidence 9999999888652 2356999999999999999999999998 999999999999999999999999999765332
Q ss_pred CcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCCc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADPL 292 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (336)
.........||+.|+|||++..+.++.++|||||||++|||++|..|+....... ...... ..+
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~i----~~~---------- 230 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQV----ERG---------- 230 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHH----HTT----------
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHH----Hhc----------
Confidence 2223445679999999999999999999999999999999999765554432211 111111 110
Q ss_pred cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 293 LEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 293 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 11123345566899999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=383.41 Aligned_cols=262 Identities=27% Similarity=0.389 Sum_probs=211.4
Q ss_pred hcCCCCcccccccCceEEEEEEEcccC-------eEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVD-------QVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADG 123 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 123 (336)
.++|.+.+.||+|+||.||+|++..++ ..||||++..... .....+.+|+..+..+ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 468999999999999999999986554 4799999976543 2346788899988888 799999999999999
Q ss_pred CeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
...++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999976421 2356899999999999999999999999 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQN 270 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~ 270 (336)
+.++.+||+|||++................||+.|+|||.+.++.|+.++|||||||++|||++ |.+||......+...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999987655444444556789999999999999999999999999999999998 788887655332111
Q ss_pred HHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+..+. ....+...+..+.+|+.+||+.||++|||+.||++.|+.|.
T Consensus 249 -------~i~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 249 -------LLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -------HHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHcCC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111111 11223345568999999999999999999999999998863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-56 Score=377.47 Aligned_cols=251 Identities=26% Similarity=0.372 Sum_probs=201.7
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEe-CCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCAD-GDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 131 (336)
.++|++.+.||+|+||.||+|.++ |..||||+++.. ...+.+.+|+.++++++||||+++++++.+ .+..++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 357888999999999999999986 678999999654 345679999999999999999999999855 456899999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
|+++|+|.+++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-
Confidence 99999999998652 2345899999999999999999999998 99999999999999999999999999975432
Q ss_pred CCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhcccccccccC
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMAD 290 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (336)
......+|..|+|||++.++.++.++|||||||++|||+| |.+||......+. .... ..
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i----~~--------- 215 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRV----EK--------- 215 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHH----TT---------
T ss_pred ----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----Hc---------
Confidence 2334568999999999999999999999999999999998 6888876544332 2111 11
Q ss_pred CccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 291 PLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 291 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.....++...+..+.+|+.+||+.||.+|||+.++++.|+.|+
T Consensus 216 -~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 216 -GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1112334455668999999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=384.85 Aligned_cols=263 Identities=25% Similarity=0.333 Sum_probs=201.5
Q ss_pred HhcCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhc-cCCCccceEEEEEeC-
Q 036144 52 ATENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLV-QHQNLVNLIGYCADG- 123 (336)
Q Consensus 52 ~~~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~- 123 (336)
..++|++.+.||+|+||.||+|.+.. +++.||||++..... ...+.+.+|..++.++ +|+||+.+++++...
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 34789999999999999999999754 457899999875433 2345677888888776 589999999988664
Q ss_pred CeEEEEEEcCCCCChhhhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 124 DQRILVYEFMSNGSLENHFLDLPP------------DQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 124 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
...++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+++ |+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 468999999999999999865321 2345899999999999999999999999 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCccccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR-SAIDNSRPSEEQN 270 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~-~p~~~~~~~~~~~ 270 (336)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. +||......+.
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-- 245 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 245 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 999999999999998655444333445578999999999999999999999999999999999874 67765543221
Q ss_pred HHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
... .+..+. ....+...+..+.+|+.+||+.||++|||++|+++.|+.|
T Consensus 246 ~~~----~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 FCR----RLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp HHH----HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----HHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 111111 1122334456899999999999999999999999999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=380.14 Aligned_cols=262 Identities=21% Similarity=0.191 Sum_probs=199.1
Q ss_pred CcccccccCceEEEEEEEcccCeEEEEEeecCCCCc-----cHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEEc
Q 036144 58 PDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ-----GSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYEF 132 (336)
Q Consensus 58 ~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 132 (336)
.+++||+|+||+||+|.++.+|+.||||+++..... ..+.+.+|+.+++.++|||||++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 356899999999999999999999999998654321 124688999999999999999999999999999999999
Q ss_pred CCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCC
Q 036144 133 MSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGG 212 (336)
Q Consensus 133 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 212 (336)
+.++++..+.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 98887766553 3567888899999999999999999999 9999999999999999999999999997654322
Q ss_pred CcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----Hhhcccccc
Q 036144 213 KDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-----LLRDKKKFT 286 (336)
Q Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 286 (336)
......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||......+....+..... .+.......
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 22345689999999999875 4689999999999999999999999987554332211111000 000000000
Q ss_pred cccCCccCCCC-----cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 287 MMADPLLEGQY-----PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 287 ~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........... ....+..+.+|+.+||+.||++|||++|+|+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000000000 1134568999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=376.10 Aligned_cols=257 Identities=26% Similarity=0.333 Sum_probs=200.0
Q ss_pred cCCCCcccccccCceEEEEEEEccc---CeEEEEEeecCCC---CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAV---DQVVAVKQLDRSG---NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 127 (336)
++|++.+.||+|+||.||+|.+... ...||||++.... ....+.+.+|+.+++.++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5699999999999999999987532 3479999986542 2334678999999999999999999999976 4678
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||||+++|++.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999988765 3456999999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCCcc-eeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcccccHHHHHHHHhhccccc
Q 036144 208 GPTGGKDH-VSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQNLVTWAKPLLRDKKKF 285 (336)
Q Consensus 208 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
........ ......|+..|+|||++.+..++.++|||||||++|||+| |..||...+..+.. ..+...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~------~~i~~~~--- 231 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEG--- 231 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTSC---
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH------HHHHhCC---
Confidence 64443322 2334568889999999999999999999999999999998 89999865433221 1111111
Q ss_pred ccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 286 TMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 232 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 -------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122334456899999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-55 Score=380.40 Aligned_cols=258 Identities=24% Similarity=0.357 Sum_probs=208.3
Q ss_pred cCCCCcccccccCceEEEEEEEcccCe--EEEEEeecCC-CCccHHHHHHHHHHHhhc-cCCCccceEEEEEeCCeEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQ--VVAVKQLDRS-GNQGSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 129 (336)
++|++.++||+|+||.||+|.++.+|. .||||.+... .....+.+.+|+.+|+.+ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 679999999999999999999988876 4778887543 333456789999999998 799999999999999999999
Q ss_pred EEcCCCCChhhhhccC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCce
Q 036144 130 YEFMSNGSLENHFLDL------------PPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNP 197 (336)
Q Consensus 130 ~e~~~~g~L~~~l~~~------------~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~ 197 (336)
|||+++|+|.+++... ......+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998753 123567999999999999999999999998 9999999999999999999
Q ss_pred EEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCcccccHHHHHH
Q 036144 198 KLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR-SAIDNSRPSEEQNLVTWAK 276 (336)
Q Consensus 198 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~ 276 (336)
||+|||++...... .......||..|+|||.+.++.|+.++|||||||++|||++|. +||...+..+. ..
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~~--- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE--- 237 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HH---
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---HH---
Confidence 99999999754322 1223456899999999999999999999999999999999976 56765443221 11
Q ss_pred HHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 277 PLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
.+ ..+ .....+...+..+.+||.+||+.||++|||+++|++.|+.|.
T Consensus 238 ~i-~~~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 238 KL-PQG----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HG-GGT----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH-Hhc----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 111 111233445678999999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=379.56 Aligned_cols=262 Identities=26% Similarity=0.374 Sum_probs=214.4
Q ss_pred hcCCCCcccccccCceEEEEEEEc-----ccCeEEEEEeecCCCCc-cHHHHHHHHHHHhhc-cCCCccceEEEEEeCCe
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIE-----AVDQVVAVKQLDRSGNQ-GSREFFAEVLMLSLV-QHQNLVNLIGYCADGDQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 125 (336)
.++|++.+.||+|+||.||+|++. .++..||||+++..... ....+.+|+.+++.+ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 468899999999999999999863 46789999999765432 345688999999999 69999999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEE
Q 036144 126 RILVYEFMSNGSLENHFLDLP--------------PDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILL 191 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~--------------~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~ 191 (336)
.++||||+++|+|.+++.... .....+++..+..++.||+.||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999987532 12346899999999999999999999999 9999999999999
Q ss_pred CCCCceEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCccccc
Q 036144 192 DAEFNPKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELIT-GRSAIDNSRPSEEQN 270 (336)
Q Consensus 192 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~-g~~p~~~~~~~~~~~ 270 (336)
+.++.++|+|||++...............+||+.|+|||.+.++.++.++|||||||++|||+| |.+||......+...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987665544455566789999999999999999999999999999999999 555565544322111
Q ss_pred HHHHHHHHhhcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 271 LVTWAKPLLRDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
. .+..+ .....+...+..+.+||.+||+.||++|||+++|++.|+.+
T Consensus 259 --~----~i~~~----------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 --K----MIKEG----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp --H----HHHHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --H----HHhcC----------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1 11111 11122334556899999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=376.66 Aligned_cols=241 Identities=22% Similarity=0.359 Sum_probs=200.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc------cHHHHHHHHHHHhhcc--CCCccceEEEEEeCC
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ------GSREFFAEVLMLSLVQ--HQNLVNLIGYCADGD 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 124 (336)
.++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46799999999999999999999999999999998653211 1233668999999987 899999999999999
Q ss_pred eEEEEEEcCCC-CChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCC-CceEEccc
Q 036144 125 QRILVYEFMSN-GSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAE-FNPKLSDF 202 (336)
Q Consensus 125 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~-~~~kl~Df 202 (336)
..++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 99999999976 577777754 467999999999999999999999999 9999999999999854 78999999
Q ss_pred cccccCCCCCCcceeeeeccCccccCccccccCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 203 GLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQL-TKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 203 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
|++...... ..+...||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ....
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------------i~~~ 219 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRG 219 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHC
T ss_pred ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------------Hhhc
Confidence 999864332 2445789999999999987765 5779999999999999999999975210 1111
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
. ..++...+..+.+||.+||+.||++|||++|+++
T Consensus 220 ~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0 0122334568999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=376.91 Aligned_cols=264 Identities=23% Similarity=0.407 Sum_probs=215.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcc-----cCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEA-----VDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQR 126 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 126 (336)
.++|.+.+.||+|+||.||+|.++. ++..||||+++.... .....+.+|+.++++++||||+++++++......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4788999999999999999999863 357899999975433 2234588999999999999999999999999999
Q ss_pred EEEEEcCCCCChhhhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEc
Q 036144 127 ILVYEFMSNGSLENHFLDL------PPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLS 200 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~------~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~ 200 (336)
++||||+++|+|.+++... ......+++..+..++.|++.||.|||+++ |+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999987531 122345788999999999999999999998 9999999999999999999999
Q ss_pred cccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCcccccHHHHHHHHh
Q 036144 201 DFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGR-SAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 201 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
|||++................||+.|+|||.+.+..++.++|||||||++|||++|. +||...+..+....+ .
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i------~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------M 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH------H
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH------H
Confidence 999998654433333344557899999999999999999999999999999999985 777655433221111 1
Q ss_pred hcccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccCC
Q 036144 280 RDKKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSSP 336 (336)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~~ 336 (336)
.+. ....+...+..+.+|+.+||+.||++|||+++|++.|+....|
T Consensus 250 -~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 250 -EGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp -TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred -hCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 111 0112334456899999999999999999999999999987665
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=371.80 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=203.0
Q ss_pred cccccccCceEEEEEEEcccC---eEEEEEeecCCC-CccHHHHHHHHHHHhhccCCCccceEEEEEe-CCeEEEEEEcC
Q 036144 59 DCLVGEGGYGRVYKGYIEAVD---QVVAVKQLDRSG-NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD-GDQRILVYEFM 133 (336)
Q Consensus 59 ~~~ig~G~~g~v~~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 133 (336)
.++||+|+||+||+|.+..++ ..||||.++... ......+.+|+.+|++++||||+++++++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 467999999999999986543 469999997543 3344679999999999999999999999875 45889999999
Q ss_pred CCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCCCC
Q 036144 134 SNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTGGK 213 (336)
Q Consensus 134 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 213 (336)
++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999998875 4556788889999999999999999998 99999999999999999999999999986543322
Q ss_pred c--ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcccccccccCC
Q 036144 214 D--HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKKKFTMMADP 291 (336)
Q Consensus 214 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (336)
. .......||+.|+|||.+.+..++.++||||||+++|||++|..||....... +.... +. .+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~---i~-~g~-------- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY---LL-QGR-------- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HH-TTC--------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH---HH-cCC--------
Confidence 1 12334578999999999999999999999999999999999888776533211 11111 11 111
Q ss_pred ccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcccC
Q 036144 292 LLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLSS 335 (336)
Q Consensus 292 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~~ 335 (336)
....+...+..+.+|+.+||+.||++|||+.||++.|+.|.+
T Consensus 252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011223345689999999999999999999999999998753
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-54 Score=373.63 Aligned_cols=267 Identities=21% Similarity=0.252 Sum_probs=202.4
Q ss_pred hcCCCCcccccccCceEEEEEEEccc-CeEEEEEeecCCC--CccHHHHHHHHHHHhhc---cCCCccceEEEEEe----
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAV-DQVVAVKQLDRSG--NQGSREFFAEVLMLSLV---QHQNLVNLIGYCAD---- 122 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~---- 122 (336)
.++|++.+.||+|+||+||+|.+..+ ++.||||++.... ......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999999655 6789999986432 22233566788877766 79999999999853
Q ss_pred -CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcc
Q 036144 123 -GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSD 201 (336)
Q Consensus 123 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~D 201 (336)
....+++|||+.++++...... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3467899999988776544433 4567899999999999999999999999 99999999999999999999999
Q ss_pred ccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHH---
Q 036144 202 FGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPL--- 278 (336)
Q Consensus 202 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 278 (336)
||++..... ........||+.|+|||++.+..|+.++||||+||++|||++|.+||...+..+....+......
T Consensus 160 fg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 999875422 23345678999999999999999999999999999999999999999876543322221111000
Q ss_pred --hhccccc-ccc---cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 279 --LRDKKKF-TMM---ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 279 --~~~~~~~-~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
+...... ... ........+....+..+.+|+.+||+.||++|||++|+|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000 000 0000011223345668999999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-53 Score=367.99 Aligned_cols=265 Identities=21% Similarity=0.270 Sum_probs=202.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|++.+.||+|+||+||+|.++ +|+.||||++..... .....+.+|+.+|+.++||||+++++++.+.+..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 68999999999999999999996 689999999965432 234678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
++.++.+..+.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+......
T Consensus 81 ~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 997766665553 3577999999999999999999999998 999999999999999999999999999865332
Q ss_pred CCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----Hhhccccc
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-----LLRDKKKF 285 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 285 (336)
. .......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+..+....+..... .+......
T Consensus 154 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 2 223445799999999998764 579999999999999999999999987654332211111000 00000000
Q ss_pred ccc------cCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 286 TMM------ADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 286 ~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
... ..+.....+....+..+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000011222344668999999999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=369.29 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=199.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHH--HHHHHHhhccCCCccceEEEEEeCC----eEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFF--AEVLMLSLVQHQNLVNLIGYCADGD----QRI 127 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~h~~iv~~~~~~~~~~----~~~ 127 (336)
++|.+.+.||+|+||.||+|++. |+.||||++.... ...+. .|+..+..++||||+++++++.+.+ ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 56788889999999999999874 7899999986432 23333 4555566789999999999997654 578
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDV-----ADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~-----~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +.++|+||||||+||||+.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 99999999999999975 4689999999999999999999974 1234999999999999999999999999
Q ss_pred cccccCCCCCCc--ceeeeeccCccccCccccccCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCcccc-----
Q 036144 203 GLAKLGPTGGKD--HVSTRVMGTYGYCAPEYAMTGQ------LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQ----- 269 (336)
Q Consensus 203 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~----- 269 (336)
|++......... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||.........
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 999865433222 1234578999999999987643 577899999999999999999887543322110
Q ss_pred ---cHHHHHHHHhhcccccccccCCccCCCC-cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhccc
Q 036144 270 ---NLVTWAKPLLRDKKKFTMMADPLLEGQY-PRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYLS 334 (336)
Q Consensus 270 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i~ 334 (336)
............ ....+.+.... +......+.+|+.+||+.||++|||+.||++.|+.|.
T Consensus 233 ~~~~~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CSSCCHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 011111111111 11111111111 2345567999999999999999999999999998874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=372.59 Aligned_cols=269 Identities=20% Similarity=0.259 Sum_probs=201.7
Q ss_pred CCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCccceEEEEEeC------CeEEE
Q 036144 55 NFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNLVNLIGYCADG------DQRIL 128 (336)
Q Consensus 55 ~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~l 128 (336)
+|...++||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 68889999999999999999999999999999965432 234799999999999999999998542 35789
Q ss_pred EEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEcccccccc
Q 036144 129 VYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKL 207 (336)
Q Consensus 129 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~ 207 (336)
||||++++.+ ..+.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVY-RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHH-HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccH-HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 9999976543 333322234567999999999999999999999998 99999999999999775 899999999986
Q ss_pred CCCCCCcceeeeeccCccccCcccccc-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH--------HHH
Q 036144 208 GPTGGKDHVSTRVMGTYGYCAPEYAMT-GQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA--------KPL 278 (336)
Q Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~ 278 (336)
..... .....+||+.|+|||.+.+ ..|+.++||||+||++|||++|..||......+....+... ...
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 54332 2345689999999998875 47899999999999999999999999876543322111100 000
Q ss_pred hhcc---cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhccc
Q 036144 279 LRDK---KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT--ALEYLS 334 (336)
Q Consensus 279 ~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~--~L~~i~ 334 (336)
.... ..........+........+..+.+|+.+||+.||++|||+.|+|+ .++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000 0001111111111222345668999999999999999999999996 344443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-52 Score=363.25 Aligned_cols=268 Identities=21% Similarity=0.248 Sum_probs=200.0
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEe--------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCAD-------- 122 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-------- 122 (336)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999999999999999986442 2334678899999999999999999998855
Q ss_pred CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccc
Q 036144 123 GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDF 202 (336)
Q Consensus 123 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Df 202 (336)
....++||||+.++.+..... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 346789999997776654432 3567899999999999999999999999 999999999999999999999999
Q ss_pred cccccCCCCCCc--ceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHh
Q 036144 203 GLAKLGPTGGKD--HVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLL 279 (336)
Q Consensus 203 g~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 279 (336)
|++......... ......+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||...........+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999765432211 223346799999999998765 68999999999999999999999998655433222221111000
Q ss_pred hccccccccc--------CCccCCCC-c------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 RDKKKFTMMA--------DPLLEGQY-P------RKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ~~~~~~~~~~--------~~~~~~~~-~------~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.. ....... ........ . ...+..+.+|+.+||+.||++|||++|+++
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CT-TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Ch-hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 0000000 00000000 0 112446789999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=368.15 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=201.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeCC------
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD------ 124 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------ 124 (336)
.++|++.+.||+|+||+||+|.++.+|+.||||+++.... ...+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4789999999999999999999999999999999975432 23456889999999999999999999997654
Q ss_pred eEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccc
Q 036144 125 QRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGL 204 (336)
Q Consensus 125 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 204 (336)
..++||||+ +.+|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 569999999 7778777653 56999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----H
Q 036144 205 AKLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-----L 278 (336)
Q Consensus 205 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~ 278 (336)
+..... ..+...||+.|+|||++.+. .++.++||||+||++|+|++|.+||...+............. .
T Consensus 168 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 986532 23456799999999998764 578999999999999999999999987653332111111000 0
Q ss_pred hhc---------ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH--Hhcc
Q 036144 279 LRD---------KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTA--LEYL 333 (336)
Q Consensus 279 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~--L~~i 333 (336)
... ...........+ .......+..+.+||.+||+.||.+|||+.|+|+. ++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000 000000000000 11122345678999999999999999999999973 5444
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=356.33 Aligned_cols=272 Identities=20% Similarity=0.233 Sum_probs=213.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCC--CccHHHHHHHHHHHhhccCCCccceEEEEEeCCeEEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSG--NQGSREFFAEVLMLSLVQHQNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 131 (336)
++|++++.||+|+||+||+|++..+|+.||||+++... ......+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999999999999999986543 2335678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEccccccccCCCC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKLGPTG 211 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 211 (336)
++.+++|..++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999888877754 567899999999999999999999999 999999999999999999999999999875433
Q ss_pred CCcceeeeeccCccccCccccccCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc--------
Q 036144 212 GKDHVSTRVMGTYGYCAPEYAMTGQ-LTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK-------- 282 (336)
Q Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 282 (336)
. .......+++.|+|||.+.+.. ++.++||||+||++|+|++|..||......... ...........
T Consensus 155 ~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTG
T ss_pred C--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhh
Confidence 2 2233456889999999887664 689999999999999999999997654432211 11111100000
Q ss_pred ------cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH--HHhcccCC
Q 036144 283 ------KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT--ALEYLSSP 336 (336)
Q Consensus 283 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~--~L~~i~~~ 336 (336)
...................+..+.+|+.+||+.||++|||++|+|+ .++.+.+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~ 292 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence 0000000001111223345668999999999999999999999997 56666665
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-51 Score=358.02 Aligned_cols=261 Identities=19% Similarity=0.239 Sum_probs=203.1
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCC-ccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN-LVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 131 (336)
+++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+..|+++++.++|+| |+.+.+++.+....++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4679999999999999999999999999999998865432 245788999999998766 5555666788889999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC---CCceEEccccccccC
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA---EFNPKLSDFGLAKLG 208 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~---~~~~kl~Dfg~~~~~ 208 (336)
|+ +++|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..++|+|||++...
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 6677776654 3467999999999999999999999999 999999999999854 456999999999875
Q ss_pred CCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHH-HHHhhcc
Q 036144 209 PTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWA-KPLLRDK 282 (336)
Q Consensus 209 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 282 (336)
...... .......||+.|+|||++.+..++.++|||||||++|||++|..||............... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~- 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-
Confidence 433221 2234568999999999999999999999999999999999999999876654433222211 111100
Q ss_pred cccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 283 KKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
... . .....+..+.+++..||+.||++||+++++.+.|+.+
T Consensus 236 -~~~-----~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 236 -PIE-----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -CHH-----H----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -Chh-----H----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000 0 1112345789999999999999999999998888754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.1e-51 Score=359.69 Aligned_cols=259 Identities=19% Similarity=0.284 Sum_probs=202.5
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeC--CeEEEEE
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADG--DQRILVY 130 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~ 130 (336)
++|++.+.||+|+||+||+|++..+|+.||||+++.. ..+.+.+|+.+|+.++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6799999999999999999999999999999998653 3567889999999996 99999999999744 5689999
Q ss_pred EcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCC-ceEEccccccccCC
Q 036144 131 EFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEF-NPKLSDFGLAKLGP 209 (336)
Q Consensus 131 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 209 (336)
||+.+++|..+. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||++....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987653 35899999999999999999999999 99999999999998655 59999999998654
Q ss_pred CCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccH-HH-HH-HH----Hh--
Q 036144 210 TGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNL-VT-WA-KP----LL-- 279 (336)
Q Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~-~~-~~-~~----~~-- 279 (336)
... .....+||+.|+|||.+.+. .++.++||||+||++|+|++|..||........... +. .. .+ ..
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 332 24556799999999998765 579999999999999999999999987654322110 00 00 00 00
Q ss_pred ---hccccccccc--------CCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 ---RDKKKFTMMA--------DPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ---~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.......... ............+..+.+||.+||+.||++|||++|+|+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 001111222345668999999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=368.63 Aligned_cols=268 Identities=20% Similarity=0.273 Sum_probs=199.5
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC-ccHHHHHHHHHHHhhccCCCccceEEEEEeCC----eEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN-QGSREFFAEVLMLSLVQHQNLVNLIGYCADGD----QRI 127 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~ 127 (336)
+++|++.+.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4679999999999999999999999999999999975432 23457889999999999999999999987543 224
Q ss_pred EEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 128 LVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 128 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
++++++.+|+|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 44455669999999865 36999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCc-ceeeeeccCccccCccccc-cCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhcc---
Q 036144 208 GPTGGKD-HVSTRVMGTYGYCAPEYAM-TGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDK--- 282 (336)
Q Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 282 (336)
....... ......+||+.|+|||++. +..++.++||||+||++|+|++|..||......+...............
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 5332221 1234567999999999985 4567899999999999999999999998765432221111100000000
Q ss_pred -------cccccccCCccCCC---CcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 283 -------KKFTMMADPLLEGQ---YPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 283 -------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.............. .....+..+.+|+.+||+.||.+|||++|+|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000000 01123457899999999999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-51 Score=355.28 Aligned_cols=262 Identities=16% Similarity=0.193 Sum_probs=210.2
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC-CCccceEEEEEeCCeEEEEEE
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH-QNLVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 131 (336)
.++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4689999999999999999999999999999998855432 3457789999999875 899999999999999999999
Q ss_pred cCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECC-----CCceEEccccccc
Q 036144 132 FMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDA-----EFNPKLSDFGLAK 206 (336)
Q Consensus 132 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~-----~~~~kl~Dfg~~~ 206 (336)
|+ +++|.+++.. ....++...+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 8899998875 3457899999999999999999999999 999999999999964 5679999999998
Q ss_pred cCCCCCCc-----ceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhc
Q 036144 207 LGPTGGKD-----HVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRD 281 (336)
Q Consensus 207 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 281 (336)
........ ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 75432211 2234568999999999999999999999999999999999999999876554332222211111000
Q ss_pred ccccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHHhcc
Q 036144 282 KKKFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVTALEYL 333 (336)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~~L~~i 333 (336)
..... + ....+..+.+++..|+..+|++||+++.+.+.|+.+
T Consensus 235 -~~~~~-----l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 235 -TPLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp -SCHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred -CChHH-----h----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00111 1 112345789999999999999999999988877654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=362.86 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=207.4
Q ss_pred cCCCCcccccccCceEEEEEEE---cccCeEEEEEeecCCC----CccHHHHHHHHHHHhhccC-CCccceEEEEEeCCe
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYI---EAVDQVVAVKQLDRSG----NQGSREFFAEVLMLSLVQH-QNLVNLIGYCADGDQ 125 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 125 (336)
++|++.+.||+|+||+||+|.+ +.+|+.||||++.+.. ....+.+.+|+.+++.++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999987 4578999999986532 2234567899999999987 899999999999999
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.+++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999875 456788999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHHHhhccc
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTG--QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKPLLRDKK 283 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (336)
...... .........|++.|+|||.+.+. .++.++|||||||++|+|++|..||......+....+..... ..
T Consensus 177 ~~~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~--~~-- 251 (322)
T d1vzoa_ 177 KEFVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL--KS-- 251 (322)
T ss_dssp EECCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH--HC--
T ss_pred hhhccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc--cC--
Confidence 765332 22234456799999999998765 468899999999999999999999987665443332221111 00
Q ss_pred ccccccCCccCCCCcHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHH
Q 036144 284 KFTMMADPLLEGQYPRKGLYQALAVAGMCLQEDADSRP-----FMVDVVT 328 (336)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp-----t~~evl~ 328 (336)
...++...+..+.+++.+||+.||.+|| |++|+++
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0123445667899999999999999999 4788876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-51 Score=361.50 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=193.7
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEe------CCe
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCAD------GDQ 125 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~ 125 (336)
++|++.++||+|+||+||+|.++.+|+.||||++..... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 679999999999999999999999999999999975432 233568899999999999999999999963 368
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.|+||||+.++.+. .+. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.++++|||++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 89999999665544 432 35889999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHH-----------
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTW----------- 274 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 274 (336)
..... ....+..+||+.|+|||++.+..+++++||||+||++|+|++|++||...+.......+..
T Consensus 167 ~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 75433 2234556799999999999999999999999999999999999999986543222111100
Q ss_pred -----HHHHhhccccc-----cccc-CCcc--CCCCcHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 275 -----AKPLLRDKKKF-----TMMA-DPLL--EGQYPRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 275 -----~~~~~~~~~~~-----~~~~-~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
........... .... +... ........+..+.+|+.+||+.||++|||++|+|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000 0000 0000 11123346778999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=355.05 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=198.8
Q ss_pred hcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCC--ccHHHHHHHHHHHhhccCCCccceEEEEEeC-----Ce
Q 036144 53 TENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGN--QGSREFFAEVLMLSLVQHQNLVNLIGYCADG-----DQ 125 (336)
Q Consensus 53 ~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 125 (336)
.++|++.+.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4689999999999999999999999999999999976533 2335688999999999999999999998643 23
Q ss_pred EEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceEEcccccc
Q 036144 126 RILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPKLSDFGLA 205 (336)
Q Consensus 126 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 205 (336)
.+++|+++.+|+|.+++.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4566777789999998853 46999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeeeccCccccCccccccC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHHHHHH-----Hh
Q 036144 206 KLGPTGGKDHVSTRVMGTYGYCAPEYAMTG-QLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVTWAKP-----LL 279 (336)
Q Consensus 206 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~ 279 (336)
.... .......||+.|+|||.+.+. .++.++|||||||++|+|++|.+||...+.......+..... ..
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 7532 224456799999999987765 468999999999999999999999987654332222211100 00
Q ss_pred hccc-----ccccccCCccCCCC---cHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 036144 280 RDKK-----KFTMMADPLLEGQY---PRKGLYQALAVAGMCLQEDADSRPFMVDVVT 328 (336)
Q Consensus 280 ~~~~-----~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~Rpt~~evl~ 328 (336)
.... .............+ ....+..+.+||.+||+.||++|||++|+|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0000 00000000000000 1124567899999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-44 Score=322.36 Aligned_cols=265 Identities=18% Similarity=0.183 Sum_probs=193.6
Q ss_pred cCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-----------CCCccceEEEEEe
Q 036144 54 ENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-----------HQNLVNLIGYCAD 122 (336)
Q Consensus 54 ~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~~~~ 122 (336)
.+|++.++||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999999999999999997542 23456788999888875 5789999988754
Q ss_pred --CCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCeEECCCCc---
Q 036144 123 --GDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHD-VADPPVIYRDFKASNILLDAEFN--- 196 (336)
Q Consensus 123 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~-~~~~~i~H~dikp~Nil~~~~~~--- 196 (336)
....+++|+++..+......... .....+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 45667777776554433322221 245678899999999999999999997 77 999999999999976654
Q ss_pred ---eEEccccccccCCCCCCcceeeeeccCccccCccccccCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcccccHHH
Q 036144 197 ---PKLSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPEYAMTGQLTKKSDVYSFGVVLLELITGRSAIDNSRPSEEQNLVT 273 (336)
Q Consensus 197 ---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~ 273 (336)
++++|||.+..... .....+||+.|+|||++.+..|+.++||||+||++++|++|+.||.............
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999975432 2345679999999999999999999999999999999999999997654322111111
Q ss_pred ----HHHH-------Hhhccc----------ccccccCCc---------cCCCCcHHHHHHHHHHHHhhcCCCCCCCCCH
Q 036144 274 ----WAKP-------LLRDKK----------KFTMMADPL---------LEGQYPRKGLYQALAVAGMCLQEDADSRPFM 323 (336)
Q Consensus 274 ----~~~~-------~~~~~~----------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rpt~ 323 (336)
.... ...... ....+.... ....+....+..+.+|+.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 0000 000000 000000000 0123456678899999999999999999999
Q ss_pred HHHHH
Q 036144 324 VDVVT 328 (336)
Q Consensus 324 ~evl~ 328 (336)
+|+|+
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=3.7e-27 Score=190.16 Aligned_cols=164 Identities=15% Similarity=0.089 Sum_probs=119.0
Q ss_pred CCcccccccCceEEEEEEEcccCeEEEEEeecCCCCc------------------cHHHHHHHHHHHhhccCCCccceEE
Q 036144 57 NPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQ------------------GSREFFAEVLMLSLVQHQNLVNLIG 118 (336)
Q Consensus 57 ~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~~iv~~~~ 118 (336)
.+.+.||+|+||.||+|.+. +|+.||||+++..... .......|...+..+.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45678999999999999986 5899999987532110 0122456888999999999999886
Q ss_pred EEEeCCeEEEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCeEECCCCceE
Q 036144 119 YCADGDQRILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVADPPVIYRDFKASNILLDAEFNPK 198 (336)
Q Consensus 119 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~~~~i~H~dikp~Nil~~~~~~~k 198 (336)
+.. .+++|||+++..+.++ +......++.|++.++.|||+.+ |+||||||+|||++.+ .++
T Consensus 82 ~~~----~~lvme~~~~~~~~~l-----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WEG----NAVLMELIDAKELYRV-----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EET----TEEEEECCCCEEGGGC-----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred ecC----CEEEEEeeccccccch-----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 532 3799999987665432 22345678999999999999999 9999999999999865 599
Q ss_pred EccccccccCCCCCCcceeeeeccCccccCcc-----ccccCCCCCccchhhHHHHH
Q 036144 199 LSDFGLAKLGPTGGKDHVSTRVMGTYGYCAPE-----YAMTGQLTKKSDVYSFGVVL 250 (336)
Q Consensus 199 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwslG~il 250 (336)
|+|||.|.....+... .|.... .+..+.|+.++|+||+.--+
T Consensus 143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999999764332211 111110 01246788999999986544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.98 E-value=2e-09 Score=89.31 Aligned_cols=149 Identities=15% Similarity=0.091 Sum_probs=104.4
Q ss_pred HHHHHhcCCCCcccccccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhcc-CCCccceEEEEEeCCeE
Q 036144 48 ELADATENFNPDCLVGEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQ-HQNLVNLIGYCADGDQR 126 (336)
Q Consensus 48 ~~~~~~~~y~~~~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 126 (336)
++....+.|+..+..+.++.+.||++... +..+++|............+.+|...+..+. +-.+.+++.+...++..
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~--~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC--CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 44555677777766666666789987643 5677889876554444455778888888775 44467888888888999
Q ss_pred EEEEEcCCCCChhhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 036144 127 ILVYEFMSNGSLENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA------------------------------- 175 (336)
Q Consensus 127 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~------------------------------- 175 (336)
++||++++|.++.+..... . ....++.++++.+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 9999999998886554220 1 12334555666666666521
Q ss_pred -------------------------CCCeeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 176 -------------------------DPPVIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 176 -------------------------~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
...++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999998766567999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.37 E-value=2.4e-06 Score=69.75 Aligned_cols=129 Identities=17% Similarity=0.109 Sum_probs=86.6
Q ss_pred ccccC-ceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccC--CCccceEEEEEeCCeEEEEEEcCCCCCh
Q 036144 62 VGEGG-YGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQH--QNLVNLIGYCADGDQRILVYEFMSNGSL 138 (336)
Q Consensus 62 ig~G~-~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~g~L 138 (336)
+..|. .+.||++.... +..+++|...... ...+..|...++.+.. -.+.+++.+..++...++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTT-SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCC-CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44454 36789887654 6678899765432 2346778888887753 3467788888888889999999988776
Q ss_pred hhhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 036144 139 ENHFLDLPPDQEPLDWFTRMKIAGGAAKGLEYLHDVA------------------------------------------- 175 (336)
Q Consensus 139 ~~~l~~~~~~~~~l~~~~~~~i~~~l~~~l~~lh~~~------------------------------------------- 175 (336)
.+.. ... ...+.++...|.-||+..
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 4321 111 112334444455555311
Q ss_pred ------------CCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 176 ------------DPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 176 ------------~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
...++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999877667799999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.36 E-value=1.1e-06 Score=76.66 Aligned_cols=77 Identities=18% Similarity=0.119 Sum_probs=49.9
Q ss_pred ccccccCceEEEEEEEcccCeEEEEEeecCC-------CCccHHHHHHHHHHHhhcc-C--CCccceEEEEEeCCeEEEE
Q 036144 60 CLVGEGGYGRVYKGYIEAVDQVVAVKQLDRS-------GNQGSREFFAEVLMLSLVQ-H--QNLVNLIGYCADGDQRILV 129 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~lv 129 (336)
+.||.|....||++....+++.+++|.-.+. ......+...|++.|+.+. + ..+++++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 3589999999999998877888999975431 1122345667888887764 2 345556544 45556899
Q ss_pred EEcCCCCCh
Q 036144 130 YEFMSNGSL 138 (336)
Q Consensus 130 ~e~~~~g~L 138 (336)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.53 E-value=0.00024 Score=61.56 Aligned_cols=73 Identities=12% Similarity=0.168 Sum_probs=50.6
Q ss_pred ccccccCceEEEEEEEcc-------cCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCC-ccceEEEEEeCCeEEEEEE
Q 036144 60 CLVGEGGYGRVYKGYIEA-------VDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQN-LVNLIGYCADGDQRILVYE 131 (336)
Q Consensus 60 ~~ig~G~~g~v~~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 131 (336)
+.|+.|-.-.+|++.... .+..|.+++... . .......+|..+++.+.-.+ ..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 468888889999998743 245688887653 2 23345678999999886334 4567776643 58999
Q ss_pred cCCCCCh
Q 036144 132 FMSNGSL 138 (336)
Q Consensus 132 ~~~~g~L 138 (336)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.51 E-value=0.00034 Score=58.82 Aligned_cols=136 Identities=13% Similarity=0.065 Sum_probs=76.9
Q ss_pred eEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCCCc--cceE-----EEEEeCCeEEEEEEcCCCCChhh
Q 036144 68 GRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQNL--VNLI-----GYCADGDQRILVYEFMSNGSLEN 140 (336)
Q Consensus 68 g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~lv~e~~~~g~L~~ 140 (336)
-.||++.... |..|++|+.+.. .....++..|...+..|....+ +..+ ..+......+.++++++|..+..
T Consensus 36 N~vy~v~~~d-g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDED-RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCTT-CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcCC-CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 4799988754 788999997654 3345678889988888752221 1111 12345667788999997643311
Q ss_pred ------------------hhccCC-CCCCCCCHH----------------------HHHHHHHHHHHHHHHHH-hCCCCC
Q 036144 141 ------------------HFLDLP-PDQEPLDWF----------------------TRMKIAGGAAKGLEYLH-DVADPP 178 (336)
Q Consensus 141 ------------------~l~~~~-~~~~~l~~~----------------------~~~~i~~~l~~~l~~lh-~~~~~~ 178 (336)
...... ..+..++.. .....+.++...+...- +....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 011110 111111111 11122233333332221 112345
Q ss_pred eeeCCCCCCCeEECCCCceEEcccccccc
Q 036144 179 VIYRDFKASNILLDAEFNPKLSDFGLAKL 207 (336)
Q Consensus 179 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 207 (336)
+||+|+.|.|||++++ ..++||+-|..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.18 E-value=0.001 Score=55.47 Aligned_cols=158 Identities=11% Similarity=0.004 Sum_probs=81.5
Q ss_pred cHHHHHHHhcCCCCcccc-----cccCceEEEEEEEcccCeEEEEEeecCCCCccHHHHHHHHHHHhhccCC-----Ccc
Q 036144 45 KYQELADATENFNPDCLV-----GEGGYGRVYKGYIEAVDQVVAVKQLDRSGNQGSREFFAEVLMLSLVQHQ-----NLV 114 (336)
Q Consensus 45 ~~~~~~~~~~~y~~~~~i-----g~G~~g~v~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~-----~iv 114 (336)
+.+++.....+|.+.+.. ..|---+.|++.... ..+++|++.... ....+..|+.++..|... ..+
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~--g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC--CcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 445667777778775543 456567789987764 358999985432 234556677777776422 222
Q ss_pred ceE---EEEEeCCeEEEEEEcCCCCChhhh--------------h----ccCC-CCCCCCCHH-----------------
Q 036144 115 NLI---GYCADGDQRILVYEFMSNGSLENH--------------F----LDLP-PDQEPLDWF----------------- 155 (336)
Q Consensus 115 ~~~---~~~~~~~~~~lv~e~~~~g~L~~~--------------l----~~~~-~~~~~l~~~----------------- 155 (336)
... .+.........++.++.+...... + .... .........
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 112234456667777765433110 0 0000 000000000
Q ss_pred -HHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCeEECCCCceEEccccccc
Q 036144 156 -TRMKIAGGAAKGLEYLHDV-ADPPVIYRDFKASNILLDAEFNPKLSDFGLAK 206 (336)
Q Consensus 156 -~~~~i~~~l~~~l~~lh~~-~~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 206 (336)
.....+..+...+...+.. -..++||+|+.++||+++.+...-+.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111122222222222221 13459999999999999988767899999986
|